cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
HNSC	cis	1	rs1000113	chr5:150240076	LOC134466	chr5:150310000-150326146:-	0.43	5.75	1.54E-8	Crohn's disease	
HNSC	cis	1	rs10002332	chr4:129875301	C4orf33	chr4:130014829-130033842:+	0.42	8.15	3.11E-15	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs10003641	chr4:71340427	AMTN	chr4:71384298-71398459:+	0.25	4.26	2.43E-5	Alcoholism (heaviness of drinking)	
HNSC	cis	1	rs10008757	chr4:76903036	NAAA	chr4:76831809-76862166:-	-0.5	-11.65	7.4E-28	Longevity	
HNSC	cis	1	rs10009541	chr4:17682218	FAM184B	chr4:17633711-17783135:-	0.18	4.48	9.15E-6	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10009541	chr4:17682218	LAP3	chr4:17578927-17609590:+	0.16	4.16	3.81E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10011835	chr4:71340722	AMTN	chr4:71384298-71398459:+	0.25	4.26	2.43E-5	Alcoholism (heaviness of drinking)	
HNSC	cis	1	rs10011865	chr4:17645710	FAM184B	chr4:17633711-17783135:-	-0.16	-3.95	8.87E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10012335	chr4:17628630	FAM184B	chr4:17633711-17783135:-	-0.15	-3.7	0.000243	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1001373	chr1:171684506	VAMP4	chr1:171669298-171711214:-	0.26	4.51	8.05E-6	Hippocampal atrophy	
HNSC	cis	1	rs10018478	chr4:108891986	HADH	chr4:108910940-108956330:+	0.26	3.96	8.55E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs10023155	chr4:108890626	HADH	chr4:108910940-108956330:+	0.29	4.08	5.22E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs10023335	chr4:77358987	STBD1	chr4:77172853-77232282:+	-0.25	-5.23	2.56E-7	Creatinine levels	
HNSC	cis	1	rs10027755	chr4:17615954	FAM184B	chr4:17633711-17783135:-	-0.16	-3.96	8.53E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10028351	chr4:71295971	AMTN	chr4:71384298-71398459:+	0.21	3.74	0.000204	Alcoholism (heaviness of drinking)	
HNSC	cis	1	rs10030019	chr4:106998448	TBCK	chr4:106967233-107237861:-	0.27	5.26	2.1E-7	Airflow obstruction	
HNSC	cis	1	rs10032326	chr4:17630717	FAM184B	chr4:17633711-17783135:-	-0.17	-4.04	6.13E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10032326	chr4:17630717	LAP3	chr4:17578927-17609590:+	-0.15	-3.85	0.000134	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10035646	chr5:115534974	COMMD10	chr5:115420727-115628978:+	0.37	4.44	1.1E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs10036292	chr5:115595871	COMMD10	chr5:115420727-115628978:+	0.32	3.75	0.000197	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs1003719	chr21:38491095	PIGP	chr21:38437664-38445458:-	-0.42	-8.82	2.01E-17	Eye color traits	
HNSC	cis	1	rs10037872	chr5:82439920	XRCC4	chr5:82373317-82649577:+	-0.2	-4.02	6.74E-5	Hypertension	
HNSC	cis	1	rs10041402	chr5:90738948	LOC100129716	chr5:90676164-90716531:+	0.3	4.35	1.64E-5	Smoking behavior	
HNSC	cis	1	rs10042278	chr5:115532928	COMMD10	chr5:115420727-115628978:+	0.37	4.44	1.1E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs10042854	chr5:82439695	XRCC4	chr5:82373317-82649577:+	0.24	4.83	1.82E-6	Hypertension	
HNSC	cis	1	rs10043018	chr5:82434317	XRCC4	chr5:82373317-82649577:+	-0.2	-3.89	0.000114	Hypertension	
HNSC	cis	1	rs10043228	chr5:115597048	COMMD10	chr5:115420727-115628978:+	0.32	3.75	0.000197	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.82	13.96	1.48E-37	Type 2 diabetes	
HNSC	cis	1	rs10051804	chr5:150226424	LOC134466	chr5:150310000-150326146:-	0.36	4.94	1.09E-6	Crohn's disease	
HNSC	cis	1	rs10051924	chr5:150226639	LOC134466	chr5:150310000-150326146:-	0.36	4.94	1.09E-6	Crohn's disease	
HNSC	cis	1	rs1005224	chr14:76173860	TTLL5	chr14:76127621-76421421:+	0.22	4.76	2.6E-6	Large artery stroke	
HNSC	cis	1	rs10052993	chr5:131969279	SLC22A4	chr5:131630145-131679897:+	0.2	3.78	0.000173	Asthma (childhood onset)	
HNSC	cis	1	rs10053750	chr5:150270051	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs10055844	chr5:82437095	XRCC4	chr5:82373317-82649577:+	-0.2	-3.91	0.000105	Hypertension	
HNSC	cis	1	rs10055948	chr5:82439256	XRCC4	chr5:82373317-82649577:+	-0.2	-3.9	0.000109	Hypertension	
HNSC	cis	1	rs10058025	chr5:90689052	LOC100129716	chr5:90676164-90716531:+	0.28	3.91	0.000104	Smoking behavior	
HNSC	cis	1	rs10058821	chr5:150226385	LOC134466	chr5:150310000-150326146:-	0.36	4.94	1.09E-6	Crohn's disease	
HNSC	cis	1	rs10058943	chr5:150226586	LOC134466	chr5:150310000-150326146:-	0.36	4.94	1.09E-6	Crohn's disease	
HNSC	cis	1	rs10059163	chr5:90742444	LOC100129716	chr5:90676164-90716531:+	0.3	4.37	1.52E-5	Smoking behavior	
HNSC	cis	1	rs10061521	chr5:82429755	XRCC4	chr5:82373317-82649577:+	-0.2	-3.88	0.000118	Hypertension	
HNSC	cis	1	rs10062350	chr5:115453497	COMMD10	chr5:115420727-115628978:+	0.36	3.98	7.98E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs10065172	chr5:150227998	LOC134466	chr5:150310000-150326146:-	0.37	5.14	3.9E-7	Crohn's disease	
HNSC	cis	1	rs10066259	chr5:115451892	COMMD10	chr5:115420727-115628978:+	0.36	4.43	1.16E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs1006722	chr4:17618713	FAM184B	chr4:17633711-17783135:-	0.15	3.71	0.000234	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10067439	chr5:82432093	XRCC4	chr5:82373317-82649577:+	-0.2	-3.88	0.000119	Hypertension	
HNSC	cis	1	rs10069402	chr5:82429595	XRCC4	chr5:82373317-82649577:+	-0.2	-3.91	0.000107	Hypertension	
HNSC	cis	1	rs10073364	chr5:115592582	COMMD10	chr5:115420727-115628978:+	0.32	3.75	0.000197	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs10073935	chr5:90742188	LOC100129716	chr5:90676164-90716531:+	0.3	4.37	1.52E-5	Smoking behavior	
HNSC	cis	1	rs10076000	chr5:82457448	XRCC4	chr5:82373317-82649577:+	-0.2	-3.94	9.29E-5	Hypertension	
HNSC	cis	1	rs10076271	chr5:82429694	XRCC4	chr5:82373317-82649577:+	-0.2	-3.88	0.000118	Hypertension	
HNSC	cis	1	rs10076274	chr5:82429727	XRCC4	chr5:82373317-82649577:+	-0.2	-3.88	0.000118	Hypertension	
HNSC	cis	1	rs10076701	chr5:131596419	SLC22A5	chr5:131705401-131731302:+	-0.29	-5.65	2.71E-8	Blood metabolite levels	
HNSC	cis	1	rs10077862	chr5:82437141	XRCC4	chr5:82373317-82649577:+	-0.2	-3.91	0.000105	Hypertension	
HNSC	cis	1	rs10078	chr5:438102	C5orf55	chr5:441645-443258:-	0.31	5.27	2.06E-7	Fat distribution (HIV)	
HNSC	cis	1	rs10079394	chr5:115600919	COMMD10	chr5:115420727-115628978:+	0.32	3.75	0.000198	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs10080429	chr6:109738106	AKD1	chr6:109814059-110012415:-	-0.21	-4.29	2.11E-5	Height	
HNSC	cis	1	rs10080429	chr6:109738106	SMPD2	chr6:109761931-109765121:+	0.28	5.85	8.92E-9	Height	
HNSC	cis	1	rs1008374	chr4:17683219	FAM184B	chr4:17633711-17783135:-	-0.16	-3.78	0.000173	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10084773	chr4:108922798	HADH	chr4:108910940-108956330:+	-0.28	-4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs10086541	chr8:96033950	C8orf38	chr8:95908040-96088396:+	-0.27	-4.34	1.74E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs10088439	chr8:8576699	FLJ10661	chr8:8086092-8102386:+	0.25	4.19	3.24E-5	Obesity-related traits	
HNSC	cis	1	rs1009051	chr3:49521549	AMT	chr3:49454212-49460012:-	0.17	3.83	0.000145	Menarche (age at onset)	
HNSC	cis	1	rs10092003	chr8:96036422	C8orf38	chr8:95908040-96088396:+	-0.32	-4.86	1.58E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs10093594	chr8:96033236	C8orf38	chr8:95908040-96088396:+	0.27	4.11	4.65E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs10095733	chr8:8574646	FLJ10661	chr8:8086092-8102386:+	0.24	4.13	4.21E-5	Obesity-related traits	
HNSC	cis	1	rs10096455	chr8:96041250	C8orf38	chr8:95908040-96088396:+	-0.33	-5.14	3.95E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs10097930	chr8:96025735	C8orf38	chr8:95908040-96088396:+	-0.28	-4.47	9.53E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs10098197	chr8:96042890	C8orf38	chr8:95908040-96088396:+	-0.34	-5.18	3.27E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs10098234	chr8:8576692	FLJ10661	chr8:8086092-8102386:+	0.26	4.4	1.31E-5	Obesity-related traits	
HNSC	cis	1	rs10098453	chr8:96029756	C8orf38	chr8:95908040-96088396:+	0.3	4.53	7.42E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs1009977	chr14:55603002	KIAA0831	chr14:55833110-55878576:-	-0.22	-4.05	5.86E-5	Protein biomarker	
HNSC	cis	1	rs10100089	chr8:96025093	C8orf38	chr8:95908040-96088396:+	-0.29	-4.49	8.96E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs10100842	chr8:96025903	C8orf38	chr8:95908040-96088396:+	-0.28	-4.36	1.56E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs1010117	chr20:23608421	CST1	chr20:23728191-23731574:-	0.33	5.17	3.43E-7	Chronic kidney disease	
HNSC	cis	1	rs1010117	chr20:23608421	CST4	chr20:23666277-23669662:-	0.26	4.26	2.43E-5	Chronic kidney disease	
HNSC	cis	1	rs10103769	chr8:8573036	FLJ10661	chr8:8086092-8102386:+	0.27	4.48	9.21E-6	Obesity-related traits	
HNSC	cis	1	rs10103841	chr8:96025904	C8orf38	chr8:95908040-96088396:+	-0.28	-4.36	1.56E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs1010447	chr1:11269796	DFFA	chr1:10520605-10532613:-	0.2	3.84	0.000137	Body mass index	
HNSC	cis	1	rs1010447	chr1:11269796	PEX14	chr1:10535003-10690813:+	0.17	4.01	6.97E-5	Body mass index	
HNSC	cis	1	rs10106491	chr8:96038959	C8orf38	chr8:95908040-96088396:+	-0.34	-5.19	3.07E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs10109812	chr8:41524899	ZMAT4	chr8:40388116-40755343:-	-0.19	-3.81	0.000157	Type 2 diabetes	
HNSC	cis	1	rs10110591	chr8:8576608	FLJ10661	chr8:8086092-8102386:+	-0.23	-4	7.16E-5	Obesity-related traits	
HNSC	cis	1	rs10110635	chr8:96025069	C8orf38	chr8:95908040-96088396:+	-0.29	-4.46	1.0E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs10111300	chr8:96025631	C8orf38	chr8:95908040-96088396:+	-0.28	-4.36	1.56E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs10112230	chr8:96038072	C8orf38	chr8:95908040-96088396:+	-0.34	-5.19	3.07E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs10113545	chr8:96029707	C8orf38	chr8:95908040-96088396:+	-0.29	-4.4	1.33E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs10119076	chr9:21665604	CDKN2BAS	chr9:21994790-22121091:+	-0.22	-3.73	0.000218	Gut microbiome composition (winter)	
HNSC	cis	1	rs10119803	chr9:21666066	CDKN2BAS	chr9:21994790-22121091:+	-0.26	-4.63	4.63E-6	Gut microbiome composition (winter)	
HNSC	cis	1	rs1012376	chr14:65294790	CHURC1	chr14:65381140-65411309:+	0.38	4.13	4.27E-5	Daytime sleep phenotypes	
HNSC	cis	1	rs10136440	chr14:104397367	TDRD9	chr14:104394817-104519002:+	-0.35	-5.71	1.97E-8	Bipolar disorder	
HNSC	cis	1	rs10136948	chr14:75511075	MLH3	chr14:75480467-75518235:-	0.32	6.61	1.02E-10	Height	
HNSC	cis	1	rs10138183	chr14:75615227	MLH3	chr14:75480467-75518235:-	0.3	6.26	8.4E-10	Height	
HNSC	cis	1	rs10138763	chr14:88457402	GPR65	chr14:88471496-88478414:+	0.13	3.97	8.28E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs10140433	chr14:74659989	LIN52	chr14:74551656-74667117:+	-0.3	-8.1	4.21E-15	Common traits (Other)	
HNSC	cis	1	rs10140851	chr14:75512612	MLH3	chr14:75480467-75518235:-	0.31	6.55	1.46E-10	Height	
HNSC	cis	1	rs10142626	chr14:75555636	MLH3	chr14:75480467-75518235:-	0.29	5.89	7.04E-9	Height	
HNSC	cis	1	rs10142865	chr14:75555624	MLH3	chr14:75480467-75518235:-	0.29	5.89	7.04E-9	Height	
HNSC	cis	1	rs10143132	chr14:75525850	MLH3	chr14:75480467-75518235:-	0.31	6.43	2.98E-10	Height	
HNSC	cis	1	rs10144220	chr14:74647904	LIN52	chr14:74551656-74667117:+	-0.3	-8.39	5.17E-16	Common traits (Other)	
HNSC	cis	1	rs10146482	chr14:75574087	MLH3	chr14:75480467-75518235:-	0.3	6.26	8.58E-10	Height	
HNSC	cis	1	rs10149435	chr14:55627489	KIAA0831	chr14:55833110-55878576:-	-0.24	-4.33	1.85E-5	Protein biomarker	
HNSC	cis	1	rs10149651	chr14:104394440	TDRD9	chr14:104394817-104519002:+	-0.32	-5.32	1.58E-7	Bipolar disorder	
HNSC	cis	1	rs10149880	chr14:75633008	MLH3	chr14:75480467-75518235:-	-0.29	-6.02	3.37E-9	Height	
HNSC	cis	1	rs10150201	chr14:74649157	LIN52	chr14:74551656-74667117:+	-0.3	-8.34	7.35E-16	Common traits (Other)	
HNSC	cis	1	rs10155014	chr3:49432321	AMT	chr3:49454212-49460012:-	0.17	3.95	9.13E-5	Menarche (age at onset)	
HNSC	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.7	-18.51	1.74E-58	Homocysteine levels	
HNSC	cis	1	rs10157597	chr1:45990278	MMACHC	chr1:45965856-45976737:+	-0.21	-4.18	3.43E-5	Homocysteine levels	
HNSC	cis	1	rs10164319	chr19:18569833	SSBP4	chr19:18530221-18545371:+	-0.19	-4.4	1.33E-5	Breast cancer	
HNSC	cis	1	rs10164323	chr19:18569492	SSBP4	chr19:18530221-18545371:+	-0.21	-4.87	1.51E-6	Breast cancer	
HNSC	cis	1	rs10165561	chr2:234172915	ATG16L1	chr2:234160217-234204319:+	0.28	4.94	1.08E-6	Crohn's disease	
HNSC	cis	1	rs10169714	chr2:73808773	ALMS1P	chr2:73872046-73912692:+	0.25	4.16	3.68E-5	Metabolite levels	
HNSC	cis	1	rs10175180	chr2:73673123	ALMS1P	chr2:73872046-73912692:+	0.26	4.41	1.26E-5	Metabolite levels	
HNSC	cis	1	rs10178409	chr2:73855507	ALMS1P	chr2:73872046-73912692:+	0.23	3.8	0.000161	Urinary metabolites	
HNSC	cis	1	rs10178982	chr2:202227640	CASP8	chr2:202098166-202152434:+	0.19	3.98	8.03E-5	Basal cell carcinoma	
HNSC	cis	1	rs10178982	chr2:202227640	PPIL3	chr2:201735680-201753999:-	-0.19	-4.04	6.28E-5	Basal cell carcinoma	
HNSC	cis	1	rs10179134	chr2:73637519	ALMS1P	chr2:73872046-73912692:+	0.24	4.05	6.03E-5	Metabolite levels	
HNSC	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.6	13.59	6.01E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs10184268	chr2:73627044	ALMS1P	chr2:73872046-73912692:+	0.25	4.27	2.35E-5	Metabolite levels	
HNSC	cis	1	rs10186501	chr2:73697844	ALMS1P	chr2:73872046-73912692:+	0.26	4.46	1.03E-5	Metabolite levels	
HNSC	cis	1	rs10187192	chr2:73713500	ALMS1P	chr2:73872046-73912692:+	0.24	3.87	0.000123	Metabolite levels	
HNSC	cis	1	rs10187416	chr2:73713741	ALMS1P	chr2:73872046-73912692:+	0.26	4.29	2.13E-5	Metabolite levels	
HNSC	cis	1	rs10187501	chr2:165532454	SLC38A11	chr2:165754812-165812035:-	0.22	4.24	2.65E-5	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
HNSC	cis	1	rs1018836	chr8:91570362	LRRC69	chr8:92114847-92231464:+	-0.22	-4.11	4.55E-5	Ejection fraction in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10189574	chr2:73698518	ALMS1P	chr2:73872046-73912692:+	0.26	4.34	1.77E-5	Metabolite levels	
HNSC	cis	1	rs10189996	chr2:240908800	NDUFA10	chr2:240900158-240964798:-	0.21	3.79	0.000166	Odorant perception (isobutyraldehyde)	
HNSC	cis	1	rs10190219	chr2:73658331	ALMS1P	chr2:73872046-73912692:+	0.25	4.17	3.66E-5	Metabolite levels	
HNSC	cis	1	rs10193373	chr2:281886	SH3YL1	chr2:218138-264810:-	-0.66	-12.79	1.55E-32	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs10193610	chr2:240940618	NDUFA10	chr2:240900158-240964798:-	0.2	3.71	0.000229	Odorant perception (isobutyraldehyde)	
HNSC	cis	1	rs10193972	chr2:73717656	ALMS1P	chr2:73872046-73912692:+	0.27	4.54	7.23E-6	Metabolite levels	
HNSC	cis	1	rs10205487	chr2:70151471	GMCL1	chr2:70056818-70106727:+	-0.12	-3.84	0.000141	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs10206231	chr2:202229225	CASP8	chr2:202098166-202152434:+	0.19	3.97	8.19E-5	Basal cell carcinoma	
HNSC	cis	1	rs10206231	chr2:202229225	PPIL3	chr2:201735680-201753999:-	-0.18	-3.72	0.000219	Basal cell carcinoma	
HNSC	cis	1	rs10207220	chr2:73785046	ALMS1P	chr2:73872046-73912692:+	0.25	4.15	3.84E-5	Metabolite levels	
HNSC	cis	1	rs10209928	chr2:108863898	SULT1C2	chr2:108905095-108926370:+	0.29	4.8	2.13E-6	Blood pressure	
HNSC	cis	1	rs10214634	chr6:26564582	BTN2A3	chr6:26422317-26431927:+	0.16	3.74	0.00021	Educational attainment	
HNSC	cis	1	rs10214634	chr6:26564582	BTN3A2	chr6:26365398-26378546:+	0.18	4.19	3.28E-5	Educational attainment	
HNSC	cis	1	rs10215948	chr7:65747786	NCRNA00174	chr7:65841032-65865395:-	0.73	15.43	4.24E-44	Aortic root size	
HNSC	cis	1	rs10215948	chr7:65747786	TYW1	chr7:66461817-66704496:+	-0.2	-3.73	0.00021	Aortic root size	
HNSC	cis	1	rs10216533	chr8:143763690	LOC100133669	chr8:144063448-144099807:-	0.2	4	7.42E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs10216533	chr8:143763690	LY6K	chr8:143781529-143785582:+	0.33	7.36	7.99E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs10216533	chr8:143763690	PSCA	chr8:143761875-143764142:+	0.42	10.25	1.83E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs10218795	chr1:145416056	NOTCH2NL	chr1:145209111-145295525:+	0.75	8.23	1.68E-15	Coronary heart disease	
HNSC	cis	1	rs10220572	chr14:88464887	GPR65	chr14:88471496-88478414:+	0.12	3.72	0.00022	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs10228845	chr7:21583617	DNAH11	chr7:21582833-21941455:+	-0.51	-11.49	3.04E-27	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
HNSC	cis	1	rs10229224	chr7:21583921	DNAH11	chr7:21582833-21941455:+	-0.52	-11.55	1.71E-27	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
HNSC	cis	1	rs10234018	chr7:66146284	NCRNA00174	chr7:65841032-65865395:-	0.56	10.89	6.5E-25	Aortic root size	
HNSC	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.57	8.63	8.26E-17	Paget's disease	
HNSC	cis	1	rs10238520	chr7:3341615	C7orf27	chr7:2577511-2595146:-	0.17	3.9	0.000108	Motion sickness	
HNSC	cis	1	rs10242018	chr7:110929652	IMMP2L	chr7:110303110-111202538:-	0.22	3.94	9.28E-5	Schizophrenia	
HNSC	cis	1	rs10244498	chr7:66116056	NCRNA00174	chr7:65841032-65865395:-	-0.7	-13.92	2.2E-37	Aortic root size	
HNSC	cis	1	rs10244498	chr7:66116056	STAG3L4	chr7:66767616-66786512:+	-0.22	-3.95	9.12E-5	Aortic root size	
HNSC	cis	1	rs10247526	chr7:65780696	NCRNA00174	chr7:65841032-65865395:-	0.46	4.97	9.34E-7	Diabetic kidney disease	
HNSC	cis	1	rs10247526	chr7:65780696	STAG3L4	chr7:66767616-66786512:+	0.4	4.47	9.81E-6	Diabetic kidney disease	
HNSC	cis	1	rs10251155	chr7:97618536	MGC72080	chr7:97503667-97601638:-	0.49	5.36	1.28E-7	Sudden cardiac arrest	
HNSC	cis	1	rs10252765	chr7:66228732	NCRNA00174	chr7:65841032-65865395:-	-0.54	-10.5	2.12E-23	Aortic root size	
HNSC	cis	1	rs10256972	chr7:1039003	ZFAND2A	chr7:1192544-1199855:-	0.35	7.25	1.66E-12	Longevity;Endometriosis	
HNSC	cis	1	rs10257427	chr7:65743208	NCRNA00174	chr7:65841032-65865395:-	0.74	15.49	2.13E-44	Aortic root size	
HNSC	cis	1	rs10274773	chr7:66133578	NCRNA00174	chr7:65841032-65865395:-	0.55	10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs1027730	chr8:94085539	C8orf83	chr8:93895865-94029901:-	-0.35	-3.99	7.6E-5	Attention deficit hyperactivity disorder	
HNSC	cis	1	rs1028449	chr14:35512995	PPP2R3C	chr14:35554679-35591679:-	0.42	6.92	1.38E-11	Atopic dermatitis	
HNSC	cis	1	rs1029406	chr11:2309580	C11orf21	chr11:2317507-2323143:-	-0.3	-6.18	1.33E-9	Obesity-related traits	
HNSC	cis	1	rs1029407	chr11:2309582	C11orf21	chr11:2317507-2323143:-	-0.3	-6.18	1.33E-9	Obesity-related traits	
HNSC	cis	1	rs1029408	chr11:2309855	C11orf21	chr11:2317507-2323143:-	-0.31	-6.17	1.44E-9	Obesity-related traits	
HNSC	cis	1	rs1030831	chr4:130025037	C4orf33	chr4:130014829-130033842:+	-0.47	-9.66	2.45E-20	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1031902	chr5:82448127	XRCC4	chr5:82373317-82649577:+	-0.21	-4.04	6.08E-5	Hypertension	
HNSC	cis	1	rs1034219	chr1:93022678	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs1035142	chr2:202153078	ALS2CR12	chr2:202153148-202222101:-	-0.23	-4.01	7.02E-5	Melanoma;Esophageal squamous cell carcinoma	
HNSC	cis	1	rs1035476	chr5:90745976	LOC100129716	chr5:90676164-90716531:+	0.29	4.04	6.19E-5	Smoking behavior	
HNSC	cis	1	rs1035477	chr5:90743325	LOC100129716	chr5:90676164-90716531:+	0.31	4.47	9.68E-6	Smoking behavior	
HNSC	cis	1	rs1037036	chr17:18764077	ALKBH5	chr17:18086867-18113265:+	0.22	3.88	0.000119	Educational attainment (years of education)	
HNSC	cis	1	rs1037147	chr4:130025873	C4orf33	chr4:130014829-130033842:+	-0.48	-9.69	1.96E-20	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1039664	chr7:65449716	CRCP	chr7:65579805-65619551:+	-0.33	-3.83	0.000143	Diabetic kidney disease	
HNSC	cis	1	rs1039664	chr7:65449716	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.7	3.42E-6	Diabetic kidney disease	
HNSC	cis	1	rs1040316	chr10:89757173	PAPSS2	chr10:89419476-89507460:+	-0.2	-3.86	0.00013	Type 2 diabetes	
HNSC	cis	1	rs1040317	chr10:89762464	PAPSS2	chr10:89419476-89507460:+	-0.2	-3.87	0.000124	Type 2 diabetes	
HNSC	cis	1	rs10403249	chr19:18604942	SSBP4	chr19:18530221-18545371:+	-0.21	-4.88	1.41E-6	Breast cancer	
HNSC	cis	1	rs10403540	chr19:39204846	LGALS7B	chr19:39279850-39282393:+	0.29	6.51	1.82E-10	Heart rate	
HNSC	cis	1	rs10405457	chr19:44296582	ZNF155	chr19:44488355-44502477:+	-0.23	-4.56	6.41E-6	Breast cancer	
HNSC	cis	1	rs10405636	chr19:18538742	SSBP4	chr19:18530221-18545371:+	-0.21	-4.85	1.64E-6	Breast cancer	
HNSC	cis	1	rs10406778	chr19:39170473	LGALS7B	chr19:39279850-39282393:+	0.26	5.78	1.36E-8	Heart rate	
HNSC	cis	1	rs1040726	chr20:3264267	ITPA	chr20:3190056-3204504:+	-0.18	-3.76	0.000193	IFN-related cytopenia	
HNSC	cis	1	rs10409483	chr19:18590223	SSBP4	chr19:18530221-18545371:+	-0.21	-4.81	2.05E-6	Breast cancer	
HNSC	cis	1	rs10409505	chr19:18590251	SSBP4	chr19:18530221-18545371:+	-0.21	-4.81	2.05E-6	Breast cancer	
HNSC	cis	1	rs10411009	chr19:18606266	SSBP4	chr19:18530221-18545371:+	-0.21	-4.85	1.68E-6	Breast cancer	
HNSC	cis	1	rs10413237	chr19:18548249	SSBP4	chr19:18530221-18545371:+	-0.21	-4.78	2.29E-6	Breast cancer	
HNSC	cis	1	rs10416218	chr19:33599127	GPATCH1	chr19:33571786-33621318:+	0.2	3.81	0.000159	Bone properties (heel)	
HNSC	cis	1	rs10416600	chr19:18386063	KIAA1683	chr19:18367906-18385319:-	-0.25	-6.31	6.28E-10	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs1041748	chr22:24700854	POM121L9P	chr22:24647589-24661490:+	-0.33	-6.96	1.07E-11	Gut microbiome composition (summer)	
HNSC	cis	1	rs10418728	chr19:39247302	LGALS7B	chr19:39279850-39282393:+	0.3	6.54	1.53E-10	Heart rate	
HNSC	cis	1	rs10421560	chr19:39186613	LGALS7B	chr19:39279850-39282393:+	0.28	6.16	1.52E-9	Heart rate	
HNSC	cis	1	rs10421887	chr19:44294849	ZNF155	chr19:44488355-44502477:+	0.22	4.47	9.57E-6	Breast cancer	
HNSC	cis	1	rs10423531	chr19:33600140	GPATCH1	chr19:33571786-33621318:+	0.2	3.81	0.000159	Bone properties (heel)	
HNSC	cis	1	rs10425982	chr19:18586519	SSBP4	chr19:18530221-18545371:+	-0.21	-4.88	1.43E-6	Breast cancer	
HNSC	cis	1	rs10426297	chr19:37798373	ZNF793	chr19:37997841-38034237:+	0.27	4.39	1.38E-5	Coronary artery calcification	
HNSC	cis	1	rs10427083	chr19:18550276	SSBP4	chr19:18530221-18545371:+	-0.21	-4.85	1.67E-6	Breast cancer	
HNSC	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.53	10.63	6.59E-24	Multiple sclerosis	
HNSC	cis	1	rs10431505	chr12:58178589	OS9	chr12:58087886-58115338:+	-0.19	-3.68	0.000264	Multiple sclerosis	
HNSC	cis	1	rs10431505	chr12:58178589	TSFM	chr12:58176536-58191367:+	-0.34	-7.51	2.83E-13	Multiple sclerosis	
HNSC	cis	1	rs1043515	chr17:36922196	PSMB3	chr17:36909002-36920477:+	0.12	3.78	0.000178	Height	
HNSC	cis	1	rs1043674	chr14:75549370	MLH3	chr14:75480467-75518235:-	0.29	5.93	5.74E-9	Height	
HNSC	cis	1	rs10440301	chr4:17663199	FAM184B	chr4:17633711-17783135:-	-0.18	-4.16	3.76E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10442	chr19:18545341	SSBP4	chr19:18530221-18545371:+	-0.21	-4.85	1.67E-6	Breast cancer	
HNSC	cis	1	rs10443172	chr1:85485768	MCOLN2	chr1:85391267-85462796:-	0.22	4.29	2.14E-5	Serum sulfate level	
HNSC	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.72	-18.64	4.35E-59	Homocysteine levels	
HNSC	cis	1	rs1044717	chr1:45976587	MMACHC	chr1:45965856-45976737:+	-0.19	-3.74	0.000208	Homocysteine levels	
HNSC	cis	1	rs10454142	chr2:48646399	KLRAQ1	chr2:48667908-48742524:+	0.43	7.41	5.47E-13	Sex hormone-binding globulin levels	
HNSC	cis	1	rs10454142	chr2:48646399	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.19	-3.76	0.000189	Sex hormone-binding globulin levels	
HNSC	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.61	-13.39	4.21E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs1045531	chr8:143763547	LOC100133669	chr8:144063448-144099807:-	0.2	3.98	8.05E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs1045531	chr8:143763547	LY6K	chr8:143781529-143785582:+	0.33	7.33	9.32E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs1045531	chr8:143763547	PSCA	chr8:143761875-143764142:+	0.42	10.29	1.26E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.65	-13.73	1.5E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.63	-13.4	3.77E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.61	-13.39	4.21E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs1045547	chr8:143763757	LOC100133669	chr8:144063448-144099807:-	0.2	3.98	8.05E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs1045547	chr8:143763757	LY6K	chr8:143781529-143785582:+	0.33	7.33	9.32E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs1045547	chr8:143763757	PSCA	chr8:143761875-143764142:+	0.42	10.29	1.26E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs1045574	chr8:143763958	LOC100133669	chr8:144063448-144099807:-	0.2	3.94	9.45E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs1045574	chr8:143763958	LY6K	chr8:143781529-143785582:+	0.31	6.94	1.24E-11	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs1045574	chr8:143763958	PSCA	chr8:143761875-143764142:+	0.42	10.18	3.15E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs1045605	chr8:143764101	LOC100133669	chr8:144063448-144099807:-	0.2	3.98	8.05E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs1045605	chr8:143764101	LY6K	chr8:143781529-143785582:+	0.33	7.33	9.32E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs1045605	chr8:143764101	PSCA	chr8:143761875-143764142:+	0.42	10.29	1.26E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs10456622	chr6:49396453	CENPQ	chr6:49431096-49460820:+	-0.36	-8.44	3.54E-16	Folate pathway vitamin levels	
HNSC	cis	1	rs10456622	chr6:49396453	MUT	chr6:49398994-49431031:-	0.44	9.38	2.34E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.8	14.1	3.48E-38	Type 2 diabetes	
HNSC	cis	1	rs10463307	chr5:150254620	LOC134466	chr5:150310000-150326146:-	0.4	5.32	1.54E-7	Crohn's disease	
HNSC	cis	1	rs10463316	chr5:150746034	SLC36A1	chr5:150816553-150871939:+	0.22	4.34	1.71E-5	Metabolite levels (Pyroglutamine)	
HNSC	cis	1	rs10465756	chr1:93029698	EVI5	chr1:92974255-93257961:-	-0.24	-4.4	1.3E-5	Cholesterol, total	
HNSC	cis	1	rs1046875	chr17:80685426	FN3KRP	chr17:80674582-80685889:+	0.31	5.51	5.86E-8	Glycated hemoglobin levels	
HNSC	cis	1	rs1046896	chr17:80685533	FN3KRP	chr17:80674582-80685889:+	0.32	5.65	2.78E-8	Glycated hemoglobin levels	
HNSC	cis	1	rs1046917	chr17:80685655	FN3KRP	chr17:80674582-80685889:+	0.31	5.5	6.14E-8	Glycated hemoglobin levels	
HNSC	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.27	-6.81	2.86E-11	Longevity	
HNSC	cis	1	rs1047206	chr11:64089216	C11orf20	chr11:64067863-64072238:+	-0.26	-3.71	0.000231	Mean platelet volume	
HNSC	cis	1	rs10474093	chr5:82437431	XRCC4	chr5:82373317-82649577:+	-0.19	-3.82	0.000148	Hypertension	
HNSC	cis	1	rs10474094	chr5:82450497	XRCC4	chr5:82373317-82649577:+	-0.2	-3.84	0.000141	Hypertension	
HNSC	cis	1	rs1047418	chr14:75605792	MLH3	chr14:75480467-75518235:-	0.31	6.44	2.91E-10	Height	
HNSC	cis	1	rs10474353	chr5:90732285	LOC100129716	chr5:90676164-90716531:+	0.3	4.41	1.25E-5	Smoking behavior	
HNSC	cis	1	rs1047556	chr14:55600282	KIAA0831	chr14:55833110-55878576:-	-0.23	-4.25	2.56E-5	Protein biomarker	
HNSC	cis	1	rs10478278	chr5:115452758	COMMD10	chr5:115420727-115628978:+	0.34	4	7.17E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs10478288	chr5:115505621	COMMD10	chr5:115420727-115628978:+	0.32	3.69	0.000245	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs10484286	chr6:118956447	C6orf204	chr6:118786239-119031238:-	-0.24	-4.1	4.8E-5	Renal cell carcinoma	
HNSC	cis	1	rs10484442	chr6:26555879	BTN2A3	chr6:26422317-26431927:+	0.17	3.82	0.000153	Educational attainment	
HNSC	cis	1	rs10484442	chr6:26555879	BTN3A2	chr6:26365398-26378546:+	0.18	4.26	2.48E-5	Educational attainment	
HNSC	cis	1	rs10488943	chr4:108951874	HADH	chr4:108910940-108956330:+	-0.26	-3.71	0.000231	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs10489249	chr1:171714521	VAMP4	chr1:171669298-171711214:-	0.27	4.54	7.21E-6	Hippocampal atrophy	
HNSC	cis	1	rs10489251	chr1:171717534	VAMP4	chr1:171669298-171711214:-	0.26	4.43	1.18E-5	Hippocampal atrophy	
HNSC	cis	1	rs10494874	chr1:205754688	PM20D1	chr1:205797154-205819245:-	-0.24	-4.46	1.0E-5	Prostate-specific antigen levels	
HNSC	cis	1	rs10496174	chr2:70153436	GMCL1	chr2:70056818-70106727:+	0.11	3.66	0.000279	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs10496191	chr2:73673798	ALMS1P	chr2:73872046-73912692:+	0.26	4.41	1.26E-5	Metabolite levels	
HNSC	cis	1	rs10496193	chr2:73773503	ALMS1P	chr2:73872046-73912692:+	0.26	4.37	1.51E-5	Metabolite levels	
HNSC	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.64	13.59	6.21E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs10500303	chr19:50512033	SIGLEC16	chr19:50472912-50479075:+	0.55	6.34	5.07E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
HNSC	cis	1	rs10509744	chr10:102271579	SEC31B	chr10:102246403-102289636:-	-0.19	-6.13	1.78E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10510026	chr10:118862420	KIAA1598	chr10:118644308-118886097:-	0.33	4.63	4.65E-6	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
HNSC	cis	1	rs10510761	chr3:52965255	TMEM110	chr3:52867139-52931547:-	-0.46	-5.72	1.81E-8	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs10519203	chr15:78814046	CHRNA5	chr15:78857906-78886458:+	0.25	5.28	1.91E-7	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs1051931	chr6:46672943	TDRD6	chr6:46655866-46670149:+	0.2	3.75	0.000199	Lipoprotein-associated phospholipase A2 activity and mass	
HNSC	cis	1	rs1052501	chr3:41925398	ULK4	chr3:41288091-42003660:-	-0.78	-13.58	6.83E-36	Diastolic blood pressure	
HNSC	cis	1	rs1052676	chr1:171673054	VAMP4	chr1:171669298-171711214:-	0.26	4.39	1.4E-5	Hippocampal atrophy	
HNSC	cis	1	rs1054399	chr10:102312565	SEC31B	chr10:102246403-102289636:-	-0.18	-5.46	7.66E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs1056667	chr6:26510564	BTN3A2	chr6:26365398-26378546:+	0.19	4.41	1.25E-5	Educational attainment	
HNSC	cis	1	rs1057027	chr1:159002377	AIM2	chr1:159032275-159046647:-	0.2	4.06	5.75E-5	Obesity-related traits	
HNSC	cis	1	rs1057028	chr1:159002389	AIM2	chr1:159032275-159046647:-	-0.2	-4.15	3.85E-5	Obesity-related traits	
HNSC	cis	1	rs1057208	chr20:44563007	CD40	chr20:44746906-44758384:+	0.23	3.88	0.000119	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
HNSC	cis	1	rs1060452	chr3:100040337	TBC1D23	chr3:99979686-100044078:+	0.23	4.35	1.68E-5	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs1064039	chr20:23618427	CST1	chr20:23728191-23731574:-	0.34	5.34	1.45E-7	Chronic kidney disease	
HNSC	cis	1	rs1064039	chr20:23618427	CST4	chr20:23666277-23669662:-	0.27	4.33	1.8E-5	Chronic kidney disease	
HNSC	cis	1	rs1065201	chr22:39069510	LOC646851	chr22:38974125-39052634:-	0.15	3.91	0.000104	Resting heart rate	
HNSC	cis	1	rs10732856	chr11:116907113	PCSK7	chr11:117075789-117102811:-	-0.26	-3.7	0.00024	Protein quantitative trait loci	
HNSC	cis	1	rs10734259	chr11:18314865	GTF2H1	chr11:18343816-18388590:+	0.31	5.3	1.79E-7	Pancreatic cancer	
HNSC	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.63	16.58	2.13E-49	Homocysteine levels	
HNSC	cis	1	rs10741741	chr11:18342081	GTF2H1	chr11:18343816-18388590:+	-0.27	-4.97	9.41E-7	Pancreatic cancer	
HNSC	cis	1	rs10741742	chr11:18342160	GTF2H1	chr11:18343816-18388590:+	0.3	5.16	3.56E-7	Pancreatic cancer	
HNSC	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.54	10.64	5.92E-24	Multiple sclerosis	
HNSC	cis	1	rs10747783	chr12:58176614	TSFM	chr12:58176536-58191367:+	-0.35	-7.62	1.32E-13	Multiple sclerosis	
HNSC	cis	1	rs10749609	chr10:82249752	C10orf58	chr10:82168242-82196869:+	-0.25	-3.87	0.000126	Post bronchodilator FEV1	
HNSC	cis	1	rs10749674	chr1:150077069	HORMAD1	chr1:150670542-150693352:-	0.25	3.78	0.000178	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
HNSC	cis	1	rs10749860	chr1:46328210	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.44	4.66E-13	Body mass index	
HNSC	cis	1	rs10750100	chr11:116917244	PCSK7	chr11:117075789-117102811:-	-0.28	-4.16	3.75E-5	Protein quantitative trait loci	
HNSC	cis	1	rs10750101	chr11:116979689	PCSK7	chr11:117075789-117102811:-	-0.33	-4.67	3.86E-6	Protein quantitative trait loci	
HNSC	cis	1	rs10759636	chr9:116018777	CDC26	chr9:116029290-116037869:-	-0.44	-8.87	1.31E-17	Hematology traits	
HNSC	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.22	-4.66	4.13E-6	Rheumatoid arthritis	
HNSC	cis	1	rs10760121	chr9:123647915	TRAF1	chr9:123664672-123691479:-	0.13	3.69	0.000254	Rheumatoid arthritis	
HNSC	cis	1	rs10777709	chr12:95975986	TMCC3	chr12:94960900-95044324:-	0.18	3.68	0.000258	Post bronchodilator FEV1 in COPD	
HNSC	cis	1	rs10782239	chr6:130713724	EPB41L2	chr6:131160488-131384462:-	-0.23	-3.91	0.000106	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);Exploratory eye movement dysfunction in schizophrenia (cognitive search score);Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
HNSC	cis	1	rs10782922	chr1:92974595	EVI5	chr1:92974255-93257961:-	-0.23	-4.3	2.02E-5	Cholesterol, total	
HNSC	cis	1	rs10783594	chr12:54067135	ATP5G2	chr12:54058945-54070512:-	0.23	5.91	6.3E-9	Height	
HNSC	cis	1	rs10783832	chr12:57961494	TSFM	chr12:58176536-58191367:+	-0.19	-4.32	1.88E-5	Rheumatoid arthritis	
HNSC	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.53	10.63	6.59E-24	Multiple sclerosis	
HNSC	cis	1	rs10783847	chr12:58196447	OS9	chr12:58087886-58115338:+	-0.19	-3.68	0.000264	Multiple sclerosis	
HNSC	cis	1	rs10783847	chr12:58196447	TSFM	chr12:58176536-58191367:+	-0.34	-7.51	2.83E-13	Multiple sclerosis	
HNSC	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.53	10.63	6.59E-24	Multiple sclerosis	
HNSC	cis	1	rs10783848	chr12:58196528	OS9	chr12:58087886-58115338:+	-0.19	-3.68	0.000264	Multiple sclerosis	
HNSC	cis	1	rs10783848	chr12:58196528	TSFM	chr12:58176536-58191367:+	-0.34	-7.51	2.83E-13	Multiple sclerosis	
HNSC	cis	1	rs10786569	chr10:101513585	ABCC2	chr10:101542463-101611662:+	0.22	4.01	6.92E-5	Obesity-related traits	
HNSC	cis	1	rs10786596	chr10:102282126	SEC31B	chr10:102246403-102289636:-	-0.19	-6.07	2.54E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10786597	chr10:102291287	SEC31B	chr10:102246403-102289636:-	-0.19	-5.82	1.04E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10786598	chr10:102291579	SEC31B	chr10:102246403-102289636:-	-0.19	-5.82	1.04E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs1078679	chr6:26568741	BTN2A3	chr6:26422317-26431927:+	0.16	3.67	0.000273	Educational attainment	
HNSC	cis	1	rs1078679	chr6:26568741	BTN3A2	chr6:26365398-26378546:+	0.17	4.08	5.24E-5	Educational attainment	
HNSC	cis	1	rs10787751	chr10:118826441	KIAA1598	chr10:118644308-118886097:-	-0.32	-4.55	6.81E-6	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
HNSC	cis	1	rs10788574	chr10:89768488	PAPSS2	chr10:89419476-89507460:+	-0.2	-3.96	8.72E-5	Type 2 diabetes	
HNSC	cis	1	rs10788795	chr1:150758047	GOLPH3L	chr1:150618701-150669672:-	-0.33	-4.46	9.99E-6	Congenital left-sided heart lesions	
HNSC	cis	1	rs10788795	chr1:150758047	HORMAD1	chr1:150670542-150693352:-	0.37	4.59	5.58E-6	Congenital left-sided heart lesions	
HNSC	cis	1	rs10789475	chr1:46304177	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.61	1.37E-13	Body mass index	
HNSC	cis	1	rs10789481	chr1:46383583	CCDC163P	chr1:45960581-45965646:-	-0.36	-7.86	2.5E-14	Body mass index	
HNSC	cis	1	rs10789487	chr1:46420221	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.6	1.48E-13	Body mass index	
HNSC	cis	1	rs1078968	chr3:53123486	RFT1	chr3:53122503-53164470:-	-0.27	-5.41	9.81E-8	Height	
HNSC	cis	1	rs10790172	chr11:116927740	PCSK7	chr11:117075789-117102811:-	-0.3	-4.3	2.1E-5	Protein quantitative trait loci	
HNSC	cis	1	rs10793273	chr11:77742595	ALG8	chr11:77811988-77850699:-	-0.22	-4.11	4.6E-5	Pelvic organ prolapse	
HNSC	cis	1	rs10794302	chr11:234102	PSMD13	chr11:236808-252984:+	-0.19	-3.76	0.000189	Menarche (age at onset)	
HNSC	cis	1	rs10794639	chr16:377367	DECR2	chr16:451858-462486:+	0.18	3.75	0.000197	Bone mineral density (spine);Bone mineral density	
HNSC	cis	1	rs10804111	chr2:202145612	ALS2CR12	chr2:202153148-202222101:-	-0.23	-4	7.21E-5	Melanoma;Esophageal squamous cell carcinoma	
HNSC	cis	1	rs10804632	chr3:134294501	ANAPC13	chr3:134196547-134204865:-	0.48	10.23	2.12E-22	Height	
HNSC	cis	1	rs10804632	chr3:134294501	CEP63	chr3:134204575-134293852:+	0.26	5.6	3.5E-8	Height	
HNSC	cis	1	rs10805357	chr4:17652352	FAM184B	chr4:17633711-17783135:-	-0.17	-3.97	8.36E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10805358	chr4:17652450	FAM184B	chr4:17633711-17783135:-	-0.16	-3.83	0.000144	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10805359	chr4:17684886	FAM184B	chr4:17633711-17783135:-	-0.16	-3.94	9.28E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10805359	chr4:17684886	LAP3	chr4:17578927-17609590:+	-0.15	-3.94	9.3E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1080698	chr10:102295114	SEC31B	chr10:102246403-102289636:-	-0.18	-5.47	7.07E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10807701	chr7:65724686	NCRNA00174	chr7:65841032-65865395:-	0.46	4.97	9.34E-7	Diabetic kidney disease	
HNSC	cis	1	rs10807702	chr7:65767843	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.67	3.81E-6	Diabetic kidney disease	
HNSC	cis	1	rs10807702	chr7:65767843	STAG3L4	chr7:66767616-66786512:+	-0.38	-4.15	3.98E-5	Diabetic kidney disease	
HNSC	cis	1	rs10811580	chr9:21664307	CDKN2BAS	chr9:21994790-22121091:+	-0.22	-3.71	0.000229	Gut microbiome composition (winter)	
HNSC	cis	1	rs10824026	chr10:75421208	NUDT13	chr10:74870210-74891580:+	-0.27	-4.42	1.24E-5	Atrial fibrillation	
HNSC	cis	1	rs10827823	chr10:38039381	LOC399744	chr10:38717074-38741080:+	0.29	3.86	0.000127	Obesity (extreme)	
HNSC	cis	1	rs10827824	chr10:38047039	LOC399744	chr10:38717074-38741080:+	0.29	3.92	0.000103	Obesity (extreme)	
HNSC	cis	1	rs10827829	chr10:38104282	LOC399744	chr10:38717074-38741080:+	0.28	3.83	0.000144	Obesity (extreme)	
HNSC	cis	1	rs10827831	chr10:38110813	LOC399744	chr10:38717074-38741080:+	0.26	3.66	0.000277	Obesity (extreme)	
HNSC	cis	1	rs10827832	chr10:38119941	LOC399744	chr10:38717074-38741080:+	0.26	3.66	0.000277	Obesity (extreme)	
HNSC	cis	1	rs10829407	chr10:130249824	NPS	chr10:129347613-129350935:+	0.18	4.17	3.53E-5	Cognitive performance	
HNSC	cis	1	rs10832921	chr11:18380835	GTF2H1	chr11:18343816-18388590:+	0.3	5.16	3.58E-7	Pancreatic cancer	
HNSC	cis	1	rs10832956	chr11:18645668	SPTY2D1	chr11:18627949-18656020:-	-0.18	-3.81	0.000156	Cholesterol, total	
HNSC	cis	1	rs10837697	chr11:5281018	HBG1	chr11:5269502-5271087:-	0.23	4.1	4.75E-5	Hemoglobin levels	
HNSC	cis	1	rs10838738	chr11:47663049	C1QTNF4	chr11:47611216-47615961:-	-0.29	-6.1	2.18E-9	Subjective well-being	
HNSC	cis	1	rs10838747	chr11:47716324	C1QTNF4	chr11:47611216-47615961:-	-0.28	-5.65	2.67E-8	Subjective well-being	
HNSC	cis	1	rs10838747	chr11:47716324	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.03	6.5E-5	Subjective well-being	
HNSC	cis	1	rs10838748	chr11:47716381	C1QTNF4	chr11:47611216-47615961:-	-0.29	-5.87	7.98E-9	Subjective well-being	
HNSC	cis	1	rs10838748	chr11:47716381	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.99	7.64E-5	Subjective well-being	
HNSC	cis	1	rs10838757	chr11:47763016	C1QTNF4	chr11:47611216-47615961:-	-0.28	-5.7	2.03E-8	Subjective well-being	
HNSC	cis	1	rs10838757	chr11:47763016	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.86	0.000126	Subjective well-being	
HNSC	cis	1	rs10840085	chr11:8613949	TRIM66	chr11:8633586-8693413:-	0.16	3.7	0.000236	Body mass index	
HNSC	cis	1	rs10846579	chr12:124407403	DNAH10	chr12:124247042-124420265:+	0.3	5.54	4.97E-8	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs10846580	chr12:124415453	DNAH10	chr12:124247042-124420265:+	0.29	5.25	2.22E-7	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs10849605	chr12:1064438	RAD52	chr12:1021255-1099219:-	-0.27	-5.83	1.03E-8	Lung cancer	
HNSC	cis	1	rs10851599	chr15:56154064	NEDD4	chr15:56119131-56285835:-	0.22	5.33	1.53E-7	Keloid	
HNSC	cis	1	rs1085243	chr1:46544768	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.47	3.75E-13	Body mass index	
HNSC	cis	1	rs1085244	chr1:46563680	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.24	1.71E-12	Body mass index	
HNSC	cis	1	rs10853057	chr17:62998023	AMZ2P1	chr17:62962668-62971703:-	0.49	8.12	3.68E-15	White matter microstructure (global fractional anisotropy)	
HNSC	cis	1	rs10857712	chr10:135225666	MTG1	chr10:135207621-135234173:+	0.26	5.26	2.17E-7	Systemic lupus erythematosus	
HNSC	cis	1	rs10857811	chr1:110617688	ALX3	chr1:110602998-110613322:-	0.2	3.87	0.000123	Blood metabolite levels	
HNSC	cis	1	rs10865914	chr3:41919499	ULK4	chr3:41288091-42003660:-	-0.78	-13.64	3.77E-36	Diastolic blood pressure	
HNSC	cis	1	rs10865956	chr3:49581559	AMT	chr3:49454212-49460012:-	0.18	3.88	0.000118	Menarche (age at onset)	
HNSC	cis	1	rs10872032	chr6:109676776	AKD1	chr6:109814059-110012415:-	-0.22	-4.49	8.87E-6	Height	
HNSC	cis	1	rs10872032	chr6:109676776	SMPD2	chr6:109761931-109765121:+	0.27	5.64	2.93E-8	Height	
HNSC	cis	1	rs10872623	chr6:101165047	ASCC3	chr6:100956609-101329224:-	-0.2	-5.26	2.18E-7	Menarche (age at onset)	
HNSC	cis	1	rs10873275	chr14:75531460	MLH3	chr14:75480467-75518235:-	0.32	6.66	7.19E-11	Height	
HNSC	cis	1	rs10874122	chr1:75235866	CRYZ	chr1:75171175-75199092:-	-0.64	-12.44	4.34E-31	Resistin levels	
HNSC	cis	1	rs10874656	chr1:92947024	EVI5	chr1:92974255-93257961:-	-0.22	-3.95	8.96E-5	Cholesterol, total	
HNSC	cis	1	rs10876480	chr12:54066271	ATP5G2	chr12:54058945-54070512:-	0.23	5.99	4.17E-9	Height	
HNSC	cis	1	rs10876481	chr12:54066743	ATP5G2	chr12:54058945-54070512:-	0.23	5.99	4.06E-9	Height	
HNSC	cis	1	rs10877012	chr12:58162085	FAM119B	chr12:58166383-58176323:+	0.53	10.32	1.01E-22	Multiple sclerosis	
HNSC	cis	1	rs10877012	chr12:58162085	TSFM	chr12:58176536-58191367:+	-0.37	-8.09	4.71E-15	Multiple sclerosis	
HNSC	cis	1	rs10877013	chr12:58165085	FAM119B	chr12:58166383-58176323:+	0.52	10.49	2.19E-23	Multiple sclerosis	
HNSC	cis	1	rs10877013	chr12:58165085	TSFM	chr12:58176536-58191367:+	-0.35	-7.77	4.71E-14	Multiple sclerosis	
HNSC	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.52	10.43	3.67E-23	Multiple sclerosis	
HNSC	cis	1	rs10877014	chr12:58167661	TSFM	chr12:58176536-58191367:+	-0.35	-7.7	7.42E-14	Multiple sclerosis	
HNSC	cis	1	rs10877015	chr12:58167788	FAM119B	chr12:58166383-58176323:+	0.52	10.21	2.42E-22	Multiple sclerosis	
HNSC	cis	1	rs10877015	chr12:58167788	TSFM	chr12:58176536-58191367:+	-0.38	-8.19	2.28E-15	Multiple sclerosis	
HNSC	cis	1	rs10877019	chr12:58172929	FAM119B	chr12:58166383-58176323:+	-0.53	-10.34	8.08E-23	Multiple sclerosis	
HNSC	cis	1	rs10877019	chr12:58172929	TSFM	chr12:58176536-58191367:+	0.37	8.03	7.44E-15	Multiple sclerosis	
HNSC	cis	1	rs10882644	chr10:97388579	ENTPD1	chr10:97471536-97637022:+	0.24	7.3	1.2E-12	Blood metabolite levels	
HNSC	cis	1	rs10883492	chr10:102206089	SEC31B	chr10:102246403-102289636:-	-0.18	-5.77	1.42E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883493	chr10:102208188	SEC31B	chr10:102246403-102289636:-	-0.18	-5.77	1.42E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883496	chr10:102221931	SEC31B	chr10:102246403-102289636:-	-0.18	-5.66	2.58E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883497	chr10:102228519	SEC31B	chr10:102246403-102289636:-	-0.18	-5.65	2.69E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883499	chr10:102232188	SEC31B	chr10:102246403-102289636:-	-0.18	-5.82	1.09E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883500	chr10:102238324	SEC31B	chr10:102246403-102289636:-	-0.19	-5.83	1.01E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883501	chr10:102238326	SEC31B	chr10:102246403-102289636:-	-0.19	-5.83	1.01E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883502	chr10:102238343	SEC31B	chr10:102246403-102289636:-	-0.19	-5.83	1.01E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883503	chr10:102275504	SEC31B	chr10:102246403-102289636:-	-0.18	-5.6	3.54E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883504	chr10:102280687	SEC31B	chr10:102246403-102289636:-	-0.18	-5.55	4.71E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883505	chr10:102280772	SEC31B	chr10:102246403-102289636:-	-0.19	-5.82	1.04E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883506	chr10:102289743	SEC31B	chr10:102246403-102289636:-	-0.19	-5.82	1.04E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883507	chr10:102291275	SEC31B	chr10:102246403-102289636:-	-0.19	-5.82	1.04E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883508	chr10:102294413	SEC31B	chr10:102246403-102289636:-	-0.19	-5.84	9.26E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883509	chr10:102296461	SEC31B	chr10:102246403-102289636:-	-0.18	-5.67	2.46E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883510	chr10:102297018	SEC31B	chr10:102246403-102289636:-	-0.17	-5.25	2.24E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883511	chr10:102299407	SEC31B	chr10:102246403-102289636:-	-0.18	-5.63	3.05E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883512	chr10:102308516	SEC31B	chr10:102246403-102289636:-	-0.17	-5.44	8.38E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10883513	chr10:102316964	SEC31B	chr10:102246403-102289636:-	-0.16	-4.72	3.03E-6	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs10887759	chr10:89603424	PAPSS2	chr10:89419476-89507460:+	0.2	4.13	4.34E-5	Type 2 diabetes	
HNSC	cis	1	rs10887765	chr10:89754941	PAPSS2	chr10:89419476-89507460:+	-0.19	-3.72	0.000225	Type 2 diabetes	
HNSC	cis	1	rs10887766	chr10:89755075	PAPSS2	chr10:89419476-89507460:+	0.19	3.8	0.000163	Type 2 diabetes	
HNSC	cis	1	rs10887770	chr10:89760474	PAPSS2	chr10:89419476-89507460:+	-0.2	-3.99	7.73E-5	Type 2 diabetes	
HNSC	cis	1	rs10887771	chr10:89760477	PAPSS2	chr10:89419476-89507460:+	-0.2	-3.9	0.000111	Type 2 diabetes	
HNSC	cis	1	rs10887772	chr10:89761243	PAPSS2	chr10:89419476-89507460:+	-0.2	-3.9	0.000111	Type 2 diabetes	
HNSC	cis	1	rs10887773	chr10:89765945	PAPSS2	chr10:89419476-89507460:+	-0.2	-3.92	0.000102	Type 2 diabetes	
HNSC	cis	1	rs10887775	chr10:89766368	PAPSS2	chr10:89419476-89507460:+	-0.2	-3.92	0.000102	Type 2 diabetes	
HNSC	cis	1	rs10888396	chr1:150777514	GOLPH3L	chr1:150618701-150669672:-	-0.32	-4.36	1.61E-5	Congenital left-sided heart lesions	
HNSC	cis	1	rs10888396	chr1:150777514	HORMAD1	chr1:150670542-150693352:-	0.37	4.54	7.08E-6	Congenital left-sided heart lesions	
HNSC	cis	1	rs10888501	chr1:152537954	LCE3C	chr1:152573138-152573562:+	-0.32	-7.74	5.76E-14	Response to antipsychotic treatment	
HNSC	cis	1	rs10888527	chr1:153001363	LCE3C	chr1:152573138-152573562:+	0.23	5.29	1.83E-7	Inflammatory skin disease	
HNSC	cis	1	rs1088984	chr11:2377581	C11orf21	chr11:2317507-2323143:-	-0.23	-5.52	5.55E-8	Bacteremia	
HNSC	cis	1	rs1088984	chr11:2377581	MOB2	chr11:1490693-1507976:-	0.19	3.9	0.000111	Bacteremia	
HNSC	cis	1	rs1088985	chr11:2377852	C11orf21	chr11:2317507-2323143:-	-0.24	-5.57	4.21E-8	Bacteremia	
HNSC	cis	1	rs1088985	chr11:2377852	MOB2	chr11:1490693-1507976:-	0.2	4	7.46E-5	Bacteremia	
HNSC	cis	1	rs1088986	chr11:2377862	C11orf21	chr11:2317507-2323143:-	-0.24	-5.82	1.09E-8	Bacteremia	
HNSC	cis	1	rs1088986	chr11:2377862	TSPAN32	chr11:2323243-2339430:+	-0.17	-3.7	0.000241	Bacteremia	
HNSC	cis	1	rs1088987	chr11:2379196	C11orf21	chr11:2317507-2323143:-	-0.24	-5.8	1.21E-8	Bacteremia	
HNSC	cis	1	rs1088987	chr11:2379196	TSPAN32	chr11:2323243-2339430:+	-0.17	-3.67	0.00027	Bacteremia	
HNSC	cis	1	rs1088988	chr11:2380470	C11orf21	chr11:2317507-2323143:-	-0.23	-5.56	4.38E-8	Bacteremia	
HNSC	cis	1	rs1088988	chr11:2380470	MOB2	chr11:1490693-1507976:-	0.2	4	7.18E-5	Bacteremia	
HNSC	cis	1	rs1088990	chr11:2381771	C11orf21	chr11:2317507-2323143:-	-0.23	-5.57	4.21E-8	Bacteremia	
HNSC	cis	1	rs1088993	chr11:2382631	C11orf21	chr11:2317507-2323143:-	-0.24	-5.78	1.34E-8	Bacteremia	
HNSC	cis	1	rs1088993	chr11:2382631	MOB2	chr11:1490693-1507976:-	0.19	3.71	0.000231	Bacteremia	
HNSC	cis	1	rs10890352	chr1:46283628	CCDC163P	chr1:45960581-45965646:-	-0.36	-7.75	5.25E-14	Body mass index	
HNSC	cis	1	rs10890354	chr1:46305347	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.63	1.18E-13	Body mass index	
HNSC	cis	1	rs10890361	chr1:46346234	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.07	5.18E-12	Body mass index	
HNSC	cis	1	rs10890363	chr1:46356148	CCDC163P	chr1:45960581-45965646:-	0.34	7.54	2.24E-13	Body mass index	
HNSC	cis	1	rs10890383	chr1:46588503	CCDC163P	chr1:45960581-45965646:-	-0.34	-6.97	1.01E-11	Body mass index	
HNSC	cis	1	rs10893380	chr11:125311674	CHEK1	chr11:125495036-125546148:+	0.24	4.34	1.73E-5	Schizophrenia	
HNSC	cis	1	rs10893380	chr11:125311674	STT3A	chr11:125462739-125491280:+	0.24	4.12	4.51E-5	Schizophrenia	
HNSC	cis	1	rs10893380	chr11:125311674	TIRAP	chr11:126152982-126164828:+	0.22	3.77	0.000185	Schizophrenia	
HNSC	cis	1	rs10896043	chr11:65543827	SNX32	chr11:65601410-65621170:+	-0.25	-3.81	0.000158	Systemic lupus erythematosus	
HNSC	cis	1	rs10896598	chr11:57052007	PRG2	chr11:57151267-57191532:-	-0.35	-3.66	0.000283	Low high density lipoprotein cholesterol levels	
HNSC	cis	1	rs10896608	chr11:57108911	PRG2	chr11:57151267-57191532:-	-0.34	-4.06	5.68E-5	Low high density lipoprotein cholesterol levels	
HNSC	cis	1	rs10900685	chr5:112707306	YTHDC2	chr5:112849410-112930979:+	0.19	3.66	0.00028	Cerebral amyloid angiopathy	
HNSC	cis	1	rs10901513	chr10:127699936	UROS	chr10:127477148-127511837:-	-0.19	-4.2	3.16E-5	Visceral fat	
HNSC	cis	1	rs10901514	chr10:127700066	UROS	chr10:127477148-127511837:-	-0.19	-4.2	3.16E-5	Visceral fat	
HNSC	cis	1	rs10901520	chr10:127718837	UROS	chr10:127477148-127511837:-	-0.21	-4.63	4.72E-6	Visceral fat	
HNSC	cis	1	rs10902853	chr10:124740621	C10orf88	chr10:124690419-124713919:-	-0.2	-3.68	0.000259	Migraine without aura	
HNSC	cis	1	rs10903	chr1:171673236	VAMP4	chr1:171669298-171711214:-	0.26	4.39	1.42E-5	Hippocampal atrophy	
HNSC	cis	1	rs10908494	chr1:156263097	BGLAP	chr1:156182784-156213112:+	0.19	3.67	0.000268	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs10908495	chr1:156263940	BGLAP	chr1:156182784-156213112:+	0.19	3.67	0.000265	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs10908496	chr1:156264000	BGLAP	chr1:156182784-156213112:+	0.19	3.7	0.000238	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs10908498	chr1:156278175	BGLAP	chr1:156182784-156213112:+	0.19	3.84	0.000138	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs10908499	chr1:156279176	BGLAP	chr1:156182784-156213112:+	0.19	3.84	0.000138	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs10908500	chr1:156280671	BGLAP	chr1:156182784-156213112:+	0.19	3.76	0.000187	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs10908502	chr1:156300082	BGLAP	chr1:156182784-156213112:+	0.2	3.89	0.000115	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs10913475	chr1:171650139	VAMP4	chr1:171669298-171711214:-	0.26	4.61	5.15E-6	Hippocampal atrophy	
HNSC	cis	1	rs10913489	chr1:171653384	VAMP4	chr1:171669298-171711214:-	0.28	4.75	2.68E-6	Hippocampal atrophy	
HNSC	cis	1	rs10913490	chr1:171653401	VAMP4	chr1:171669298-171711214:-	0.28	4.75	2.68E-6	Hippocampal atrophy	
HNSC	cis	1	rs10913511	chr1:171668951	VAMP4	chr1:171669298-171711214:-	0.27	4.61	5.19E-6	Hippocampal atrophy	
HNSC	cis	1	rs10913514	chr1:171670823	VAMP4	chr1:171669298-171711214:-	0.26	4.43	1.14E-5	Hippocampal atrophy	
HNSC	cis	1	rs10913529	chr1:171679465	VAMP4	chr1:171669298-171711214:-	0.26	4.58	5.86E-6	Hippocampal atrophy	
HNSC	cis	1	rs10913565	chr1:171706706	VAMP4	chr1:171669298-171711214:-	0.26	4.51	8.27E-6	Hippocampal atrophy	
HNSC	cis	1	rs10913582	chr1:171715585	VAMP4	chr1:171669298-171711214:-	0.27	4.7	3.39E-6	Hippocampal atrophy	
HNSC	cis	1	rs10918605	chr1:166955638	FMO9P	chr1:166573153-166594471:+	0.23	4.41	1.26E-5	Refractive astigmatism	
HNSC	cis	1	rs10918606	chr1:166957249	FMO9P	chr1:166573153-166594471:+	0.23	4.41	1.26E-5	Refractive astigmatism	
HNSC	cis	1	rs10935120	chr3:134233092	ANAPC13	chr3:134196547-134204865:-	-0.51	-11	2.61E-25	Height	
HNSC	cis	1	rs10935120	chr3:134233092	CEP63	chr3:134204575-134293852:+	-0.29	-6.35	4.89E-10	Height	
HNSC	cis	1	rs10935186	chr3:136346206	PCCB	chr3:135969167-136056737:+	0.21	4.77	2.4E-6	Schizophrenia	
HNSC	cis	1	rs10938353	chr4:44582487	GUF1	chr4:44680433-44702696:+	-0.28	-3.75	0.000196	Body mass index	
HNSC	cis	1	rs10939740	chr4:17617490	FAM184B	chr4:17633711-17783135:-	-0.16	-3.8	0.000162	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10939742	chr4:17659936	FAM184B	chr4:17633711-17783135:-	-0.17	-4.11	4.59E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10939744	chr4:17664473	FAM184B	chr4:17633711-17783135:-	-0.16	-3.73	0.000212	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10939746	chr4:17684951	FAM184B	chr4:17633711-17783135:-	0.16	3.96	8.48E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10939746	chr4:17684951	LAP3	chr4:17578927-17609590:+	0.15	4.07	5.41E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10939747	chr4:17691166	LAP3	chr4:17578927-17609590:+	-0.15	-3.83	0.000142	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10939748	chr4:17691230	LAP3	chr4:17578927-17609590:+	-0.15	-3.83	0.000142	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10939749	chr4:17692319	LAP3	chr4:17578927-17609590:+	-0.14	-3.8	0.000161	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10939756	chr4:17693867	LAP3	chr4:17578927-17609590:+	-0.15	-3.91	0.000103	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.62	-13.61	4.71E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.64	-13.5	1.5E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.61	-13.38	4.9E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.61	-13.4	4.04E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs10946198	chr6:167404432	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs10946199	chr6:167404492	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.61E-8	Crohn's disease	
HNSC	cis	1	rs1094677	chr3:195129744	C3orf21	chr3:194789015-194991895:-	-0.16	-3.68	0.000264	Body mass index	
HNSC	cis	1	rs10946834	chr6:26533664	BTN2A3	chr6:26422317-26431927:+	0.16	3.66	0.000275	Educational attainment	
HNSC	cis	1	rs10946834	chr6:26533664	BTN3A2	chr6:26365398-26378546:+	0.18	4.36	1.57E-5	Educational attainment	
HNSC	cis	1	rs10946835	chr6:26533757	BTN2A3	chr6:26422317-26431927:+	0.16	3.66	0.000275	Educational attainment	
HNSC	cis	1	rs10946835	chr6:26533757	BTN3A2	chr6:26365398-26378546:+	0.18	4.36	1.57E-5	Educational attainment	
HNSC	cis	1	rs10950032	chr7:65738591	NCRNA00174	chr7:65841032-65865395:-	0.46	4.97	9.34E-7	Diabetic kidney disease	
HNSC	cis	1	rs10953454	chr7:104503813	RINT1	chr7:105172532-105208124:+	0.43	3.72	0.000221	Obesity	
HNSC	cis	1	rs10953455	chr7:104503978	RINT1	chr7:105172532-105208124:+	0.43	3.72	0.000221	Obesity	
HNSC	cis	1	rs10954872	chr8:29978612	MBOAT4	chr8:29989188-30002200:-	-0.36	-4.65	4.34E-6	Migraine	
HNSC	cis	1	rs10957125	chr8:61194170	CA8	chr8:61101423-61193954:-	0.21	4.48	9.48E-6	Response to amphetamines	
HNSC	cis	1	rs10986432	chr9:127570640	LOC100129034	chr9:127115752-127121461:+	0.22	3.91	0.000106	Venous thromboembolism (SNP x SNP interaction)	
HNSC	cis	1	rs10999518	chr10:72519326	C10orf27	chr10:72530995-72545157:-	0.33	3.99	7.7E-5	Prion diseases	
HNSC	cis	1	rs10999524	chr10:72525761	C10orf27	chr10:72530995-72545157:-	0.31	3.73	0.000213	Prion diseases	
HNSC	cis	1	rs10999525	chr10:72525764	C10orf27	chr10:72530995-72545157:-	0.32	3.85	0.000134	Prion diseases	
HNSC	cis	1	rs10999526	chr10:72525813	C10orf27	chr10:72530995-72545157:-	0.31	3.73	0.000213	Prion diseases	
HNSC	cis	1	rs10999527	chr10:72525859	C10orf27	chr10:72530995-72545157:-	0.31	3.73	0.000213	Prion diseases	
HNSC	cis	1	rs1100046	chr7:102549295	FAM185A	chr7:102389399-102467706:+	-0.22	-3.86	0.000126	Morning vs. evening chronotype	
HNSC	cis	1	rs11011339	chr10:37996346	LOC399744	chr10:38717074-38741080:+	0.28	4.01	7.05E-5	Obesity (extreme)	
HNSC	cis	1	rs11011344	chr10:38004846	LOC399744	chr10:38717074-38741080:+	0.31	4.48	9.21E-6	Obesity (extreme)	
HNSC	cis	1	rs11011366	chr10:38074158	LOC399744	chr10:38717074-38741080:+	0.28	3.77	0.00018	Obesity (extreme)	
HNSC	cis	1	rs11011370	chr10:38083018	LOC399744	chr10:38717074-38741080:+	0.28	3.81	0.000157	Obesity (extreme)	
HNSC	cis	1	rs11011372	chr10:38087283	LOC399744	chr10:38717074-38741080:+	0.28	3.77	0.00018	Obesity (extreme)	
HNSC	cis	1	rs11026416	chr11:22125058	ANO5	chr11:22214722-22304913:+	0.17	3.74	0.000205	Parkinson's disease	
HNSC	cis	1	rs11036474	chr11:5275178	HBG1	chr11:5269502-5271087:-	0.2	3.7	0.000236	Hemoglobin levels	
HNSC	cis	1	rs11039255	chr11:47495746	C1QTNF4	chr11:47611216-47615961:-	-0.29	-6.11	2.05E-9	Subjective well-being	
HNSC	cis	1	rs11039255	chr11:47495746	MYBPC3	chr11:47352958-47374253:-	-0.21	-4.13	4.2E-5	Subjective well-being	
HNSC	cis	1	rs11039390	chr11:47796295	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.55	4.76E-8	Subjective well-being	
HNSC	cis	1	rs11039390	chr11:47796295	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.95	8.85E-5	Subjective well-being	
HNSC	cis	1	rs11039412	chr11:47841581	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.44	8.4E-8	Subjective well-being	
HNSC	cis	1	rs11039412	chr11:47841581	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.94	9.15E-5	Subjective well-being	
HNSC	cis	1	rs11039426	chr11:47863119	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.43	9.04E-8	Subjective well-being	
HNSC	cis	1	rs11039426	chr11:47863119	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.92	0.000103	Subjective well-being	
HNSC	cis	1	rs11045982	chr12:8665760	CLEC4D	chr12:8666136-8674958:+	0.22	3.74	0.000205	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
HNSC	cis	1	rs11045983	chr12:8666118	CLEC4D	chr12:8666136-8674958:+	0.22	3.71	0.000227	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
HNSC	cis	1	rs11049516	chr12:28452582	CCDC91	chr12:28332210-28703098:+	0.27	4.45	1.07E-5	Height	
HNSC	cis	1	rs11049532	chr12:28476912	CCDC91	chr12:28332210-28703098:+	0.25	4.12	4.36E-5	Height	
HNSC	cis	1	rs11051970	chr12:32537488	FGD4	chr12:32638906-32798982:+	-0.37	-7.12	3.93E-12	Response to tocilizumab in rheumatoid arthritis	
HNSC	cis	1	rs11057394	chr12:124407676	DNAH10	chr12:124247042-124420265:+	0.3	5.54	4.97E-8	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs11059384	chr12:123170301	GPR109B	chr12:123199304-123201439:-	0.34	5.45	7.81E-8	Adiponectin levels	
HNSC	cis	1	rs1106287	chr1:113242122	ST7L	chr1:113066142-113162405:-	0.39	5.92	6.15E-9	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs11064881	chr12:120146925	PRKAB1	chr12:120105757-120119428:+	-0.75	-8.03	7.02E-15	Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs1106565	chr10:102211613	SEC31B	chr10:102246403-102289636:-	-0.19	-5.83	1.01E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11067231	chr12:109993603	MMAB	chr12:109991523-110011358:-	-0.18	-4.46	1.04E-5	HDL cholesterol	
HNSC	cis	1	rs11079034	chr17:40288890	DHX58	chr17:40253422-40264751:-	-0.34	-7.05	5.91E-12	Fibrinogen levels	
HNSC	cis	1	rs11079508	chr17:61750066	FTSJ3	chr17:61896795-61905031:-	0.2	3.72	0.000223	Body mass index	
HNSC	cis	1	rs11080114	chr17:28407287	EFCAB5	chr17:28256874-28435469:+	-0.21	-3.83	0.000144	Coffee consumption (cups per day)	
HNSC	cis	1	rs11083475	chr19:39188112	LGALS7B	chr19:39279850-39282393:+	0.28	6.29	6.95E-10	Heart rate	
HNSC	cis	1	rs1108431	chr16:31054607	MYST1	chr16:31128985-31142713:+	0.23	5.38	1.16E-7	Response to metformin (IC50)	
HNSC	cis	1	rs11084785	chr19:35282054	ZNF181	chr19:35225151-35233774:+	-0.19	-4.82	1.95E-6	Urate levels (BMI interaction)	
HNSC	cis	1	rs11084786	chr19:35282181	ZNF181	chr19:35225151-35233774:+	-0.19	-4.84	1.75E-6	Urate levels (BMI interaction)	
HNSC	cis	1	rs11086102	chr19:18398628	KIAA1683	chr19:18367906-18385319:-	-0.25	-6.43	3.01E-10	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs1109114	chr5:148615946	AFAP1L1	chr5:148651401-148721365:+	0.21	4.1	4.88E-5	Body mass index	
HNSC	cis	1	rs1109227	chr3:48479207	TREX1	chr3:48501186-48509043:+	-0.3	-7.45	4.28E-13	Longevity	
HNSC	cis	1	rs1109501	chr4:71329490	AMTN	chr4:71384298-71398459:+	0.24	4.13	4.25E-5	Alcoholism (heaviness of drinking)	
HNSC	cis	1	rs1109619	chr8:8571616	FLJ10661	chr8:8086092-8102386:+	0.27	4.48	9.29E-6	Obesity-related traits	
HNSC	cis	1	rs11097912	chr4:107000462	TBCK	chr4:106967233-107237861:-	0.27	5.32	1.58E-7	Airflow obstruction	
HNSC	cis	1	rs1110042	chr1:113236534	ST7L	chr1:113066142-113162405:-	0.39	5.81	1.11E-8	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs11100712	chr4:142160229	ZNF330	chr4:142142049-142155848:+	-0.28	-4.55	6.78E-6	Conduct disorder	
HNSC	cis	1	rs11100713	chr4:142163347	ZNF330	chr4:142142049-142155848:+	-0.26	-3.93	9.82E-5	Conduct disorder	
HNSC	cis	1	rs1110183	chr9:38456365	EXOSC3	chr9:37779949-37785067:-	0.2	3.94	9.36E-5	Hypertension	
HNSC	cis	1	rs11105306	chr12:89897388	POC1B	chr12:89813501-89919777:-	-0.2	-3.8	0.000163	NT-proBNP levels in acute coronary syndrome	
HNSC	cis	1	rs11119429	chr1:210345078	SYT14	chr1:210111538-210337631:+	-0.2	-3.71	0.000233	Manic episodes in bipolar disorder	
HNSC	cis	1	rs1112137	chr1:247215375	ZNF670	chr1:247200087-247242069:-	-0.3	-6.57	1.28E-10	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.6	-11.09	1.16E-25	Renal function-related traits (BUN)	
HNSC	cis	1	rs11123170	chr2:113978940	PAX8	chr2:113973575-114036498:-	-0.62	-11.27	2.26E-26	Renal function-related traits (BUN)	
HNSC	cis	1	rs111252524	chr2:203199188	NOP58	chr2:203130515-203168382:+	0.24	3.79	0.00017	Urate levels	
HNSC	cis	1	rs11126251	chr2:70163434	GMCL1	chr2:70056818-70106727:+	0.13	4.02	6.67E-5	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs11127188	chr2:28972852	TRMT61B	chr2:29072690-29093175:-	-0.36	-7.81	3.49E-14	Body mass index	
HNSC	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.3	-7.38	6.56E-13	Longevity	
HNSC	cis	1	rs11130171	chr3:48462461	TREX1	chr3:48501186-48509043:+	-0.26	-6.41	3.37E-10	Longevity	
HNSC	cis	1	rs11130189	chr3:49347357	AMT	chr3:49454212-49460012:-	0.19	4.28	2.29E-5	Menarche (age at onset)	
HNSC	cis	1	rs11130190	chr3:49402137	AMT	chr3:49454212-49460012:-	0.19	4.14	4.03E-5	Menarche (age at onset)	
HNSC	cis	1	rs11130338	chr3:53120924	RFT1	chr3:53122503-53164470:-	-0.26	-5.28	1.91E-7	Height	
HNSC	cis	1	rs11130537	chr3:56685904	CCDC66	chr3:56591184-56655846:+	0.18	4.94	1.09E-6	Height	
HNSC	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-0.65	-10.57	1.14E-23	Triptolide cytotoxicity	
HNSC	cis	1	rs11132254	chr4:185611592	MLF1IP	chr4:185615220-185655286:-	-0.45	-10.84	1.03E-24	Kawasaki disease	
HNSC	cis	1	rs1114380	chr2:73804708	ALMS1P	chr2:73872046-73912692:+	0.25	4.09	5.06E-5	Metabolite levels	
HNSC	cis	1	rs11156875	chr14:35619816	PPP2R3C	chr14:35554679-35591679:-	0.42	7.02	7.52E-12	Atopic dermatitis	
HNSC	cis	1	rs11158559	chr14:65240949	CHURC1	chr14:65381140-65411309:+	0.26	4	7.4E-5	Obesity-related traits	
HNSC	cis	1	rs11159067	chr14:74637444	LIN52	chr14:74551656-74667117:+	0.23	6.61	9.92E-11	Common traits (Other)	
HNSC	cis	1	rs11159117	chr14:75584867	MLH3	chr14:75480467-75518235:-	0.29	6.01	3.57E-9	Height	
HNSC	cis	1	rs111596617	chr6:26191678	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.57E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs11159833	chr14:88476004	GPR65	chr14:88471496-88478414:+	0.12	3.73	0.000211	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs111641740	chr20:33707177	PROCR	chr20:33758727-33765164:+	-0.3	-4.07	5.38E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs11164654	chr1:92968312	EVI5	chr1:92974255-93257961:-	-0.22	-3.92	0.000101	Cholesterol, total;LDL cholesterol	
HNSC	cis	1	rs11167515	chr5:150239471	LOC134466	chr5:150310000-150326146:-	0.46	5.67	2.41E-8	Crohn's disease	
HNSC	cis	1	rs11167518	chr5:150258920	LOC134466	chr5:150310000-150326146:-	0.38	5.33	1.52E-7	Crohn's disease	
HNSC	cis	1	rs11167519	chr5:150265407	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs11167520	chr5:150265639	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs11167526	chr5:150332481	LOC134466	chr5:150310000-150326146:-	0.5	5.71	2.0E-8	Crohn's disease	
HNSC	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.52	10.19	2.97E-22	Multiple sclerosis	
HNSC	cis	1	rs11172333	chr12:58170335	TSFM	chr12:58176536-58191367:+	-0.38	-8.33	8.08E-16	Multiple sclerosis	
HNSC	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.53	10.34	8.4E-23	Multiple sclerosis	
HNSC	cis	1	rs11172335	chr12:58175201	TSFM	chr12:58176536-58191367:+	-0.37	-7.87	2.21E-14	Multiple sclerosis	
HNSC	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.53	10.23	2.11E-22	Multiple sclerosis	
HNSC	cis	1	rs11172342	chr12:58187758	TSFM	chr12:58176536-58191367:+	-0.38	-8.18	2.5E-15	Multiple sclerosis	
HNSC	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.53	10.23	2.11E-22	Multiple sclerosis	
HNSC	cis	1	rs11172343	chr12:58188157	TSFM	chr12:58176536-58191367:+	-0.38	-8.18	2.5E-15	Multiple sclerosis	
HNSC	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.53	10.63	6.59E-24	Multiple sclerosis	
HNSC	cis	1	rs11172344	chr12:58193448	OS9	chr12:58087886-58115338:+	-0.19	-3.68	0.000264	Multiple sclerosis	
HNSC	cis	1	rs11172344	chr12:58193448	TSFM	chr12:58176536-58191367:+	-0.34	-7.51	2.83E-13	Multiple sclerosis	
HNSC	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.54	10.11	6.03E-22	Multiple sclerosis	
HNSC	cis	1	rs11172349	chr12:58212528	TSFM	chr12:58176536-58191367:+	-0.36	-7.51	2.84E-13	Multiple sclerosis	
HNSC	cis	1	rs11172351	chr12:58213485	FAM119B	chr12:58166383-58176323:+	0.54	9.99	1.56E-21	Multiple sclerosis	
HNSC	cis	1	rs11172351	chr12:58213485	TSFM	chr12:58176536-58191367:+	-0.37	-7.74	5.83E-14	Multiple sclerosis	
HNSC	cis	1	rs11180559	chr12:75920285	GLIPR1L2	chr12:75784889-75825591:+	0.36	4.7	3.41E-6	Daytime sleep phenotypes	
HNSC	cis	1	rs11185790	chr10:91372533	FLJ37201	chr10:91451057-91457685:-	0.27	3.66	0.00028	Metabolic traits	
HNSC	cis	1	rs11188394	chr10:97365458	ENTPD1	chr10:97471536-97637022:+	0.25	7.6	1.49E-13	Blood metabolite levels	
HNSC	cis	1	rs11188396	chr10:97367510	ENTPD1	chr10:97471536-97637022:+	0.25	7.5	3.1E-13	Blood metabolite levels	
HNSC	cis	1	rs11188398	chr10:97369093	ENTPD1	chr10:97471536-97637022:+	0.24	7.32	9.99E-13	Blood metabolite levels	
HNSC	cis	1	rs11188400	chr10:97371327	ENTPD1	chr10:97471536-97637022:+	0.24	7.32	9.99E-13	Blood metabolite levels	
HNSC	cis	1	rs11188406	chr10:97390195	ENTPD1	chr10:97471536-97637022:+	0.24	7.3	1.2E-12	Blood metabolite levels	
HNSC	cis	1	rs11188407	chr10:97390533	ENTPD1	chr10:97471536-97637022:+	0.24	7.3	1.2E-12	Blood metabolite levels	
HNSC	cis	1	rs11188411	chr10:97397344	ENTPD1	chr10:97471536-97637022:+	0.24	7.4	6.0E-13	Blood metabolite levels	
HNSC	cis	1	rs11188417	chr10:97411680	ENTPD1	chr10:97471536-97637022:+	-0.24	-7.38	6.59E-13	Blood metabolite levels	
HNSC	cis	1	rs111899361	chr7:1112348	ZFAND2A	chr7:1192544-1199855:-	-0.28	-3.78	0.000176	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs111901203	chr11:58297542	ZFP91-CNTF	chr11:58346587-58393203:+	0.3	4.32	1.92E-5	Lymphoma	
HNSC	cis	1	rs11190263	chr10:101506383	ABCC2	chr10:101542463-101611662:+	0.22	3.87	0.000121	Obesity-related traits	
HNSC	cis	1	rs111902838	chr19:50496614	SIGLEC16	chr19:50472912-50479075:+	0.51	5.86	8.52E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
HNSC	cis	1	rs11190540	chr10:102202629	SEC31B	chr10:102246403-102289636:-	-0.19	-5.85	8.92E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190541	chr10:102203071	SEC31B	chr10:102246403-102289636:-	-0.18	-5.73	1.74E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190551	chr10:102204734	SEC31B	chr10:102246403-102289636:-	-0.18	-5.77	1.42E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190552	chr10:102206607	SEC31B	chr10:102246403-102289636:-	-0.18	-5.72	1.86E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190555	chr10:102209160	SEC31B	chr10:102246403-102289636:-	-0.18	-5.79	1.24E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190556	chr10:102209223	SEC31B	chr10:102246403-102289636:-	-0.18	-5.79	1.24E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190557	chr10:102209369	SEC31B	chr10:102246403-102289636:-	-0.18	-5.79	1.24E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190558	chr10:102209397	SEC31B	chr10:102246403-102289636:-	-0.18	-5.79	1.24E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190569	chr10:102227409	SEC31B	chr10:102246403-102289636:-	-0.18	-5.74	1.62E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190570	chr10:102227702	SEC31B	chr10:102246403-102289636:-	-0.18	-5.63	3.06E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190572	chr10:102232879	SEC31B	chr10:102246403-102289636:-	-0.18	-5.85	9.09E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190578	chr10:102238953	SEC31B	chr10:102246403-102289636:-	-0.18	-5.81	1.12E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190587	chr10:102266638	SEC31B	chr10:102246403-102289636:-	-0.19	-5.77	1.39E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190589	chr10:102275471	SEC31B	chr10:102246403-102289636:-	-0.19	-5.94	5.4E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190592	chr10:102291059	SEC31B	chr10:102246403-102289636:-	-0.18	-5.81	1.11E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190595	chr10:102291761	SEC31B	chr10:102246403-102289636:-	-0.19	-5.82	1.04E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190597	chr10:102293676	SEC31B	chr10:102246403-102289636:-	-0.18	-5.8	1.19E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190599	chr10:102295420	SEC31B	chr10:102246403-102289636:-	-0.19	-5.79	1.23E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190601	chr10:102296730	SEC31B	chr10:102246403-102289636:-	-0.18	-5.52	5.44E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190602	chr10:102297256	SEC31B	chr10:102246403-102289636:-	-0.18	-5.64	2.88E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190604	chr10:102302457	SEC31B	chr10:102246403-102289636:-	-0.16	-4.97	9.18E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190607	chr10:102303614	SEC31B	chr10:102246403-102289636:-	-0.18	-5.45	8.13E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11190613	chr10:102313997	SEC31B	chr10:102246403-102289636:-	0.19	5.86	8.67E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs11191416	chr10:104604916	SFXN2	chr10:104474298-104498946:+	0.35	4.54	7.07E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
HNSC	cis	1	rs11191419	chr10:104612335	AS3MT	chr10:104613967-104661653:+	-0.22	-4.91	1.27E-6	Schizophrenia	
HNSC	cis	1	rs11191419	chr10:104612335	C10orf32	chr10:104613967-104624718:+	-0.3	-5.74	1.66E-8	Schizophrenia	
HNSC	cis	1	rs11191425	chr10:104625970	SFXN2	chr10:104474298-104498946:+	-0.35	-4.25	2.61E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
HNSC	cis	1	rs11197887	chr10:118836682	KIAA1598	chr10:118644308-118886097:-	0.27	3.76	0.00019	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
HNSC	cis	1	rs11197899	chr10:118861724	KIAA1598	chr10:118644308-118886097:-	0.32	4.6	5.42E-6	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
HNSC	cis	1	rs11200964	chr10:81731442	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs11200965	chr10:81731452	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs11200967	chr10:81731562	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs11200971	chr10:81731950	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs11200982	chr10:81732349	LOC650623	chr10:81442731-81448648:+	0.36	4.03	6.45E-5	Rheumatoid arthritis	
HNSC	cis	1	rs11200984	chr10:81732366	LOC650623	chr10:81442731-81448648:+	0.36	4.03	6.45E-5	Rheumatoid arthritis	
HNSC	cis	1	rs11200985	chr10:81732653	LOC650623	chr10:81442731-81448648:+	0.36	4.01	7.12E-5	Rheumatoid arthritis	
HNSC	cis	1	rs11201312	chr10:81795778	LOC219347	chr10:81805991-81838949:-	0.6	6.63	9.01E-11	Chronic obstructive pulmonary disease-related biomarkers	
HNSC	cis	1	rs11201660	chr10:81854531	LOC219347	chr10:81805991-81838949:-	-0.56	-6.79	3.15E-11	Chronic obstructive pulmonary disease-related biomarkers	
HNSC	cis	1	rs11201799	chr10:81881954	LOC219347	chr10:81805991-81838949:-	-0.5	-5.98	4.39E-9	Chronic obstructive pulmonary disease-related biomarkers	
HNSC	cis	1	rs11203031	chr10:90964395	IFIT5	chr10:91174325-91180758:+	-0.24	-3.86	0.00013	Heart failure	
HNSC	cis	1	rs11203032	chr10:90964614	IFIT5	chr10:91174325-91180758:+	-0.24	-3.85	0.000133	Heart failure	
HNSC	cis	1	rs11203033	chr10:90964731	IFIT5	chr10:91174325-91180758:+	0.25	4.18	3.43E-5	Heart failure	
HNSC	cis	1	rs11204700	chr1:150660702	GOLPH3L	chr1:150618701-150669672:-	-0.3	-4.1	4.82E-5	Congenital left-sided heart lesions	
HNSC	cis	1	rs11204700	chr1:150660702	HORMAD1	chr1:150670542-150693352:-	0.35	4.4	1.32E-5	Congenital left-sided heart lesions	
HNSC	cis	1	rs11205316	chr1:150007105	HORMAD1	chr1:150670542-150693352:-	0.25	3.66	0.000281	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
HNSC	cis	1	rs11210359	chr1:74339167	LRRIQ3	chr1:74491704-74663871:-	0.22	3.98	7.96E-5	Bipolar disorder and schizophrenia	
HNSC	cis	1	rs1121089	chr4:17676476	FAM184B	chr4:17633711-17783135:-	-0.17	-4.12	4.38E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1121089	chr4:17676476	LAP3	chr4:17578927-17609590:+	-0.17	-4.34	1.71E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1121090	chr4:17676437	FAM184B	chr4:17633711-17783135:-	-0.17	-4.14	4.03E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1121090	chr4:17676437	LAP3	chr4:17578927-17609590:+	-0.16	-4.07	5.4E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1121091	chr4:17676386	FAM184B	chr4:17633711-17783135:-	-0.17	-4.14	4.03E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1121091	chr4:17676386	LAP3	chr4:17578927-17609590:+	-0.16	-4.07	5.4E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.7	-18.51	1.74E-58	Homocysteine levels	
HNSC	cis	1	rs11211132	chr1:45990516	MMACHC	chr1:45965856-45976737:+	-0.21	-4.18	3.43E-5	Homocysteine levels	
HNSC	cis	1	rs11211199	chr1:46287869	CCDC163P	chr1:45960581-45965646:-	-0.36	-7.79	3.96E-14	Body mass index	
HNSC	cis	1	rs11211208	chr1:46334256	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.44	4.55E-13	Body mass index	
HNSC	cis	1	rs11211230	chr1:46406767	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.69	8.25E-14	Body mass index	
HNSC	cis	1	rs11211234	chr1:46438787	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.68	8.38E-14	Body mass index	
HNSC	cis	1	rs11211241	chr1:46452683	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.68	8.38E-14	Body mass index	
HNSC	cis	1	rs11216316	chr11:117081500	PCSK7	chr11:117075789-117102811:-	0.33	4.54	7.19E-6	Protein quantitative trait loci	
HNSC	cis	1	rs112181719	chr10:81728929	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs112201728	chr6:160551486	LOC729603	chr6:160514114-160517244:+	0.41	3.91	0.000105	Cholesterol, total	
HNSC	cis	1	rs11227284	chr11:65503224	SNX32	chr11:65601410-65621170:+	0.28	4.12	4.37E-5	Systemic lupus erythematosus	
HNSC	cis	1	rs11227288	chr11:65516588	SNX32	chr11:65601410-65621170:+	0.25	3.81	0.000158	Systemic lupus erythematosus	
HNSC	cis	1	rs112293138	chr1:171714002	VAMP4	chr1:171669298-171711214:-	0.27	4.51	8.15E-6	Hippocampal atrophy	
HNSC	cis	1	rs11229535	chr11:58348386	ZFP91-CNTF	chr11:58346587-58393203:+	0.29	4.17	3.59E-5	Lymphoma	
HNSC	cis	1	rs112306637	chr2:203198918	NOP58	chr2:203130515-203168382:+	0.24	3.81	0.000156	Urate levels	
HNSC	cis	1	rs11241206	chr5:112736692	YTHDC2	chr5:112849410-112930979:+	0.22	3.87	0.000122	Cerebral amyloid angiopathy	
HNSC	cis	1	rs11241209	chr5:112768936	YTHDC2	chr5:112849410-112930979:+	0.2	3.67	0.000266	Cerebral amyloid angiopathy	
HNSC	cis	1	rs112428033	chr5:115618260	COMMD10	chr5:115420727-115628978:+	0.37	3.89	0.000114	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs11242	chr3:53125922	RFT1	chr3:53122503-53164470:-	0.24	5.11	4.72E-7	Height	
HNSC	cis	1	rs11248348	chr10:124730840	C10orf88	chr10:124690419-124713919:-	-0.21	-3.81	0.000158	Migraine without aura	
HNSC	cis	1	rs11249502	chr4:71341161	AMTN	chr4:71384298-71398459:+	0.25	4.38	1.43E-5	Alcoholism (heaviness of drinking)	
HNSC	cis	1	rs112526325	chr16:67761917	GFOD2	chr16:67708437-67753273:-	-0.26	-3.85	0.000136	Crohn's disease	
HNSC	cis	1	rs112529587	chr8:96060035	C8orf38	chr8:95908040-96088396:+	-0.35	-5.21	2.73E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs11264464	chr1:156250887	BGLAP	chr1:156182784-156213112:+	0.19	3.68	0.000262	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs11264468	chr1:156274585	BGLAP	chr1:156182784-156213112:+	0.19	3.67	0.000265	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs1127030	chr3:128338953	RAB43	chr3:128806418-128880029:-	-0.2	-3.93	9.88E-5	Monocyte count	
HNSC	cis	1	rs1127489	chr6:170107702	C6orf70	chr6:170151721-170181617:+	0.22	3.79	0.000171	Thiazide-induced adverse metabolic effects in hypertensive patients	
HNSC	cis	1	rs112751982	chr6:26191958	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.57E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs112753638	chr2:203199219	NOP58	chr2:203130515-203168382:+	0.24	3.79	0.00017	Urate levels	
HNSC	cis	1	rs112777695	chr20:33693177	PROCR	chr20:33758727-33765164:+	-0.3	-3.94	9.29E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs1128322	chr11:244197	PSMD13	chr11:236808-252984:+	0.18	3.71	0.000235	Menarche (age at onset)	
HNSC	cis	1	rs11292	chr10:102313607	SEC31B	chr10:102246403-102289636:-	-0.17	-5.23	2.49E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs1129448	chr22:38170026	LGALS2	chr22:37966254-37976024:-	-0.13	-3.75	0.0002	Optic cup area;Vertical cup-disc ratio	
HNSC	cis	1	rs113075795	chr14:65968955	LOC645431	chr14:65877313-65879335:-	-0.3	-4.02	6.65E-5	Ischemic stroke	
HNSC	cis	1	rs113143821	chr5:127893353	FBN2	chr5:127593602-127873916:-	0.34	4.21	3.08E-5	Multiple system atrophy	
HNSC	cis	1	rs113146460	chr7:1105164	ZFAND2A	chr7:1192544-1199855:-	-0.28	-3.72	0.000222	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs11344	chr16:29910518	LOC440356	chr16:29875004-29879374:+	-0.19	-4.08	5.27E-5	Response to taxane treatment (placlitaxel)	
HNSC	cis	1	rs113491584	chr2:203196447	NOP58	chr2:203130515-203168382:+	0.24	3.81	0.000156	Urate levels	
HNSC	cis	1	rs113575110	chr7:1084394	ZFAND2A	chr7:1192544-1199855:-	-0.27	-3.67	0.000273	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs113638727	chr15:40706101	C15orf23	chr15:40674922-40686488:+	0.47	7.07	5.35E-12	Heschl's gyrus morphology	
HNSC	cis	1	rs1138273	chr3:134261437	ANAPC13	chr3:134196547-134204865:-	0.49	10.62	7.09E-24	Height	
HNSC	cis	1	rs1138273	chr3:134261437	CEP63	chr3:134204575-134293852:+	0.28	6.01	3.57E-9	Height	
HNSC	cis	1	rs113835537	chr11:66339639	ACTN3	chr11:66313866-66330797:+	0.29	3.92	0.000103	Airway imaging phenotypes	
HNSC	cis	1	rs113855569	chr10:81728958	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs113877751	chr2:203194721	NOP58	chr2:203130515-203168382:+	0.24	3.81	0.000156	Urate levels	
HNSC	cis	1	rs1140047	chr11:18327684	GTF2H1	chr11:18343816-18388590:+	0.32	5.52	5.37E-8	Pancreatic cancer	
HNSC	cis	1	rs114007205	chr20:33647503	PROCR	chr20:33758727-33765164:+	-0.29	-3.69	0.000254	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs1141321	chr6:49412433	CENPQ	chr6:49431096-49460820:+	-0.41	-9.61	3.74E-20	Folate pathway vitamin levels	
HNSC	cis	1	rs1141321	chr6:49412433	MUT	chr6:49398994-49431031:-	0.41	8.55	1.58E-16	Folate pathway vitamin levels	
HNSC	cis	1	rs114200987	chr14:35586916	PPP2R3C	chr14:35554679-35591679:-	0.44	7.24	1.71E-12	Atopic dermatitis	
HNSC	cis	1	rs114244137	chr5:150264753	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs1144894	chr7:65542894	NCRNA00174	chr7:65841032-65865395:-	0.73	14.59	2.54E-40	Aortic root size	
HNSC	cis	1	rs1144895	chr7:65541307	NCRNA00174	chr7:65841032-65865395:-	0.73	14.6	2.14E-40	Aortic root size	
HNSC	cis	1	rs114490726	chr4:17680898	FAM184B	chr4:17633711-17783135:-	-0.16	-3.91	0.000106	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs114490726	chr4:17680898	LAP3	chr4:17578927-17609590:+	-0.16	-4.33	1.8E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs114562844	chr3:52991584	RFT1	chr3:53122503-53164470:-	0.32	3.66	0.000279	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs114562844	chr3:52991584	TMEM110	chr3:52867139-52931547:-	0.52	5.99	4.07E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs1148000	chr12:75936301	GLIPR1L2	chr12:75784889-75825591:+	-0.27	-4.53	7.36E-6	Polycystic ovary syndrome	
HNSC	cis	1	rs1148003	chr12:75978996	GLIPR1L2	chr12:75784889-75825591:+	-0.25	-4.32	1.88E-5	Polycystic ovary syndrome	
HNSC	cis	1	rs1148004	chr12:75978677	GLIPR1L2	chr12:75784889-75825591:+	-0.26	-4.27	2.3E-5	Polycystic ovary syndrome	
HNSC	cis	1	rs1148005	chr12:75978513	GLIPR1L2	chr12:75784889-75825591:+	-0.26	-4.39	1.39E-5	Polycystic ovary syndrome	
HNSC	cis	1	rs1148006	chr12:75978358	GLIPR1L2	chr12:75784889-75825591:+	-0.26	-4.4	1.31E-5	Polycystic ovary syndrome	
HNSC	cis	1	rs114822886	chr2:71070074	VAX2	chr2:71127720-71160573:+	-0.27	-3.85	0.000133	IgG glycosylation	
HNSC	cis	1	rs114914341	chr16:4617621	NMRAL1	chr16:4511696-4526307:-	-0.54	-5.51	5.91E-8	Obesity-related traits	
HNSC	cis	1	rs11492508	chr10:38098136	LOC399744	chr10:38717074-38741080:+	0.26	3.65	0.000287	Obesity (extreme)	
HNSC	cis	1	rs114948279	chr20:33733641	PROCR	chr20:33758727-33765164:+	-0.28	-3.68	0.000257	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs11514917	chr7:102609221	FAM185A	chr7:102389399-102467706:+	-0.24	-4.25	2.57E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs11532322	chr12:123731423	CDK2AP1	chr12:123745542-123756687:-	0.42	7.74	5.6E-14	Schizophrenia	
HNSC	cis	1	rs11538349	chr7:65421871	CRCP	chr7:65579805-65619551:+	-0.33	-3.92	0.000101	Diabetic kidney disease	
HNSC	cis	1	rs11538349	chr7:65421871	NCRNA00174	chr7:65841032-65865395:-	-0.45	-4.96	9.67E-7	Diabetic kidney disease	
HNSC	cis	1	rs115515961	chr18:51836253	POLI	chr18:51795849-51824602:+	0.22	3.88	0.000121	Psoriasis	
HNSC	cis	1	rs11553746	chr2:272203	SH3YL1	chr2:218138-264810:-	-0.66	-12.59	1.07E-31	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs11557072	chr15:40713374	C15orf23	chr15:40674922-40686488:+	0.47	7.11	4.16E-12	Heschl's gyrus morphology	
HNSC	cis	1	rs11576221	chr1:171653696	VAMP4	chr1:171669298-171711214:-	0.28	4.75	2.68E-6	Hippocampal atrophy	
HNSC	cis	1	rs11577073	chr1:171716724	VAMP4	chr1:171669298-171711214:-	-0.23	-3.89	0.000114	Hippocampal atrophy	
HNSC	cis	1	rs11577745	chr1:171720909	VAMP4	chr1:171669298-171711214:-	0.26	4.32	1.85E-5	Hippocampal atrophy	
HNSC	cis	1	rs115779493	chr13:96300448	DZIP1	chr13:96229329-96296957:-	0.27	3.84	0.000137	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
HNSC	cis	1	rs115779493	chr13:96300448	UGGT2	chr13:96453838-96705736:-	-0.24	-3.9	0.000108	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
HNSC	cis	1	rs11578336	chr1:166958710	FMO9P	chr1:166573153-166594471:+	0.24	4.54	7.0E-6	Refractive astigmatism	
HNSC	cis	1	rs11578699	chr1:171719769	VAMP4	chr1:171669298-171711214:-	0.26	4.43	1.18E-5	Hippocampal atrophy	
HNSC	cis	1	rs11579634	chr1:46466391	CCDC163P	chr1:45960581-45965646:-	0.32	6.89	1.67E-11	Body mass index	
HNSC	cis	1	rs11579698	chr1:171666922	VAMP4	chr1:171669298-171711214:-	0.26	4.64	4.56E-6	Hippocampal atrophy	
HNSC	cis	1	rs11580415	chr1:171666832	VAMP4	chr1:171669298-171711214:-	0.27	4.78	2.37E-6	Hippocampal atrophy	
HNSC	cis	1	rs11580522	chr1:171720978	VAMP4	chr1:171669298-171711214:-	-0.25	-4.3	2.1E-5	Hippocampal atrophy	
HNSC	cis	1	rs11583920	chr1:171683611	VAMP4	chr1:171669298-171711214:-	0.26	4.39	1.41E-5	Hippocampal atrophy	
HNSC	cis	1	rs11589562	chr1:46466721	CCDC163P	chr1:45960581-45965646:-	0.34	6.7	5.82E-11	Body mass index	
HNSC	cis	1	rs11590680	chr1:171716574	VAMP4	chr1:171669298-171711214:-	0.26	4.41	1.26E-5	Hippocampal atrophy	
HNSC	cis	1	rs11592213	chr10:97396103	ENTPD1	chr10:97471536-97637022:+	0.24	7.37	7.3E-13	Blood metabolite levels	
HNSC	cis	1	rs11595684	chr10:38083804	LOC399744	chr10:38717074-38741080:+	0.28	3.77	0.00018	Obesity (extreme)	
HNSC	cis	1	rs115965884	chr22:24594662	SUSD2	chr22:24577444-24585074:+	0.99	10.86	8.63E-25	Amyotrophic lateral sclerosis	
HNSC	cis	1	rs11596783	chr10:37962891	LOC399744	chr10:38717074-38741080:+	0.26	3.71	0.00023	Obesity (extreme)	
HNSC	cis	1	rs11597286	chr10:38106455	LOC399744	chr10:38717074-38741080:+	0.26	3.66	0.000277	Obesity (extreme)	
HNSC	cis	1	rs11600990	chr11:64082807	C11orf20	chr11:64067863-64072238:+	-0.26	-3.69	0.000247	Mean platelet volume	
HNSC	cis	1	rs11602266	chr11:57094509	PRG2	chr11:57151267-57191532:-	-0.36	-3.95	8.86E-5	Low high density lipoprotein cholesterol levels	
HNSC	cis	1	rs11603691	chr11:57107617	PRG2	chr11:57151267-57191532:-	-0.36	-3.86	0.000127	Low high density lipoprotein cholesterol levels	
HNSC	cis	1	rs11605774	chr11:47832793	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.54	5.02E-8	Subjective well-being	
HNSC	cis	1	rs11605774	chr11:47832793	MYBPC3	chr11:47352958-47374253:-	-0.21	-4	7.31E-5	Subjective well-being	
HNSC	cis	1	rs116101630	chr11:506826	PHRF1	chr11:576483-612220:+	-0.25	-3.71	0.000227	Body mass index	
HNSC	cis	1	rs11611670	chr12:9385535	LOC642846	chr12:9436253-9466684:+	0.12	3.81	0.000156	Breast size	
HNSC	cis	1	rs1161171	chr3:8442494	RAD18	chr3:8921561-9005146:-	0.17	4.08	5.18E-5	Low high density lipoprotein cholesterol levels	
HNSC	cis	1	rs116134049	chr5:115529655	COMMD10	chr5:115420727-115628978:+	0.38	3.96	8.73E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs116139393	chr7:6771660	PMS2CL	chr7:6749757-6793492:+	-0.31	-4.92	1.18E-6	Alzheimer's disease (APOE e4 interaction)	
HNSC	cis	1	rs11621351	chr14:55616740	KIAA0831	chr14:55833110-55878576:-	-0.21	-3.68	0.000256	Protein biomarker	
HNSC	cis	1	rs11622475	chr14:104509076	TDRD9	chr14:104394817-104519002:+	0.36	5.88	7.71E-9	Bipolar disorder	
HNSC	cis	1	rs11622962	chr14:65299145	CHURC1	chr14:65381140-65411309:+	0.4	4.16	3.82E-5	Daytime sleep phenotypes	
HNSC	cis	1	rs11623413	chr14:75588824	MLH3	chr14:75480467-75518235:-	-0.27	-5.58	4.02E-8	Height	
HNSC	cis	1	rs11624293	chr14:88488821	GPR65	chr14:88471496-88478414:+	0.14	4	7.33E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs11625697	chr14:104464800	TDRD9	chr14:104394817-104519002:+	0.34	5.49	6.4E-8	Bipolar disorder	
HNSC	cis	1	rs11628710	chr14:74649280	LIN52	chr14:74551656-74667117:+	0.3	8.36	6.69E-16	Common traits (Other)	
HNSC	cis	1	rs11631963	chr15:83318202	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.16	4.12	4.35E-5	Schizophrenia	
HNSC	cis	1	rs11632096	chr15:56210499	NEDD4	chr15:56119131-56285835:-	0.23	5.54	4.89E-8	Keloid	
HNSC	cis	1	rs11633263	chr15:56135559	NEDD4	chr15:56119131-56285835:-	0.2	4.91	1.24E-6	Keloid	
HNSC	cis	1	rs11633313	chr15:56135709	NEDD4	chr15:56119131-56285835:-	0.21	5.04	6.56E-7	Keloid	
HNSC	cis	1	rs11633958	chr15:78862064	CHRNA5	chr15:78857906-78886458:+	-0.28	-5.65	2.65E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs11637433	chr15:83321336	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.16	4.16	3.71E-5	Schizophrenia	
HNSC	cis	1	rs11638297	chr15:84782417	LOC388152	chr15:84867600-84898920:-	-0.26	-4.62	4.97E-6	Schizophrenia	
HNSC	cis	1	rs11638394	chr15:84778928	LOC388152	chr15:84867600-84898920:-	-0.28	-4.95	1.03E-6	Schizophrenia	
HNSC	cis	1	rs11638815	chr15:83352282	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.22	4.99	8.5E-7	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	
HNSC	cis	1	rs11640439	chr16:57303194	HERPUD1	chr16:56965748-56977793:+	0.28	3.65	0.000288	Sleep duration	
HNSC	cis	1	rs11641566	chr16:58835180	GOT2	chr16:58741035-58768246:-	-0.26	-5.37	1.21E-7	Blood metabolite ratios	
HNSC	cis	1	rs11641836	chr16:58832047	GOT2	chr16:58741035-58768246:-	-0.27	-5.64	2.83E-8	Blood metabolite ratios	
HNSC	cis	1	rs116434420	chr5:115582971	COMMD10	chr5:115420727-115628978:+	0.38	3.91	0.000104	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs11644891	chr16:58833825	GOT2	chr16:58741035-58768246:-	-0.26	-5.47	7.22E-8	Blood metabolite ratios	
HNSC	cis	1	rs11645002	chr16:20617841	ACSM1	chr16:20634559-20709066:-	0.37	4.76	2.49E-6	Urinary metabolites	
HNSC	cis	1	rs11648514	chr16:58832080	GOT2	chr16:58741035-58768246:-	-0.26	-5.48	6.94E-8	Blood metabolite ratios	
HNSC	cis	1	rs11650372	chr17:45721795	C17orf57	chr17:45401142-45518675:+	0.2	4.81	2.05E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs11650372	chr17:45721795	TBKBP1	chr17:45772630-45789427:+	-0.23	-4.56	6.36E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs11651264	chr17:79576394	RAC3	chr17:79989532-79992079:+	-0.17	-4.14	4.05E-5	Eye color traits	
HNSC	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.22	-5.66	2.52E-8	Eye color traits	
HNSC	cis	1	rs11652797	chr17:79574124	RAC3	chr17:79989532-79992079:+	0.17	4.02	6.77E-5	Eye color traits	
HNSC	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.22	5.67	2.46E-8	Eye color traits	
HNSC	cis	1	rs11658329	chr17:61763031	FTSJ3	chr17:61896795-61905031:-	-0.21	-3.94	9.41E-5	Body mass index	
HNSC	cis	1	rs11658740	chr17:61751069	FTSJ3	chr17:61896795-61905031:-	0.2	3.68	0.000258	Body mass index	
HNSC	cis	1	rs11665924	chr19:44286982	ZNF155	chr19:44488355-44502477:+	-0.2	-4.04	6.26E-5	Breast cancer	
HNSC	cis	1	rs11669175	chr19:44289824	ZNF155	chr19:44488355-44502477:+	-0.21	-4.2	3.18E-5	Breast cancer	
HNSC	cis	1	rs11673344	chr19:37684966	ZNF781	chr19:38158650-38183216:-	-0.24	-5.23	2.45E-7	Obesity-related traits	
HNSC	cis	1	rs1167411	chr7:65539264	NCRNA00174	chr7:65841032-65865395:-	0.72	14.55	3.53E-40	Aortic root size	
HNSC	cis	1	rs11674602	chr2:73723185	ALMS1P	chr2:73872046-73912692:+	0.27	4.55	6.72E-6	Metabolite levels	
HNSC	cis	1	rs1167612	chr7:65567976	NCRNA00174	chr7:65841032-65865395:-	0.73	14.59	2.56E-40	Aortic root size	
HNSC	cis	1	rs1167613	chr7:65487439	CRCP	chr7:65579805-65619551:+	-0.33	-3.86	0.00013	Diabetic kidney disease	
HNSC	cis	1	rs1167613	chr7:65487439	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.6	5.37E-6	Diabetic kidney disease	
HNSC	cis	1	rs1167725	chr12:120968559	GATC	chr12:120884284-120897761:+	-0.28	-4.16	3.7E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1167725	chr12:120968559	POP5	chr12:121016849-121019201:-	-0.23	-4.11	4.56E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1167725	chr12:120968559	SFRS9	chr12:120899472-120907558:-	-0.25	-3.9	0.000108	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1167725	chr12:120968559	TRIAP1	chr12:120881765-120884215:-	-0.24	-4.16	3.77E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1167726	chr12:120967364	GATC	chr12:120884284-120897761:+	0.24	3.67	0.000269	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1167726	chr12:120967364	SFRS9	chr12:120899472-120907558:-	0.23	3.7	0.000244	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1167726	chr12:120967364	TRIAP1	chr12:120881765-120884215:-	0.21	3.75	0.000197	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1167727	chr12:120965508	GATC	chr12:120884284-120897761:+	-0.28	-4.2	3.22E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1167727	chr12:120965508	POP5	chr12:121016849-121019201:-	-0.23	-4.16	3.73E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1167727	chr12:120965508	SFRS9	chr12:120899472-120907558:-	-0.25	-3.98	8.09E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1167727	chr12:120965508	TRIAP1	chr12:120881765-120884215:-	-0.24	-4.16	3.76E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1167827	chr7:75163169	PMS2L3	chr7:75137070-75157418:-	-0.46	-12.23	3.18E-30	Body mass index	
HNSC	cis	1	rs1167827	chr7:75163169	SPDYE5	chr7:75124299-75133627:+	0.17	3.77	0.000186	Body mass index	
HNSC	cis	1	rs11685222	chr2:120748571	TMEM177	chr2:120436743-120481191:+	-0.29	-4.26	2.4E-5	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	
HNSC	cis	1	rs116876680	chr11:517473	PHRF1	chr11:576483-612220:+	-0.28	-4.09	4.96E-5	Body mass index	
HNSC	cis	1	rs11688129	chr2:28952581	TRMT61B	chr2:29072690-29093175:-	0.37	7.87	2.23E-14	Body mass index	
HNSC	cis	1	rs11689392	chr2:73622026	ALMS1P	chr2:73872046-73912692:+	0.25	4.26	2.46E-5	Metabolite levels	
HNSC	cis	1	rs11689435	chr2:218314253	DIRC3	chr2:218148748-218621316:-	0.31	4.05	5.98E-5	Metabolite levels (MHPG)	
HNSC	cis	1	rs11690423	chr2:28951537	TRMT61B	chr2:29072690-29093175:-	0.37	7.85	2.63E-14	Body mass index	
HNSC	cis	1	rs11696501	chr20:44124523	WFDC3	chr20:44402847-44420547:-	0.25	4.21	3.05E-5	Brain structure	
HNSC	cis	1	rs116988415	chr14:65292145	CHURC1	chr14:65381140-65411309:+	0.35	3.76	0.000191	Daytime sleep phenotypes	
HNSC	cis	1	rs11699551	chr20:55087964	C20orf43	chr20:55043647-55093942:+	0.21	4.27	2.31E-5	Refractive astigmatism	
HNSC	cis	1	rs11699883	chr20:55087041	C20orf43	chr20:55043647-55093942:+	0.22	4.34	1.77E-5	Refractive astigmatism	
HNSC	cis	1	rs11703914	chr22:24767602	POM121L9P	chr22:24647589-24661490:+	-0.32	-6.89	1.74E-11	Gut microbiome composition (summer)	
HNSC	cis	1	rs11704021	chr22:39074716	LOC646851	chr22:38974125-39052634:-	0.15	3.95	8.96E-5	Resting heart rate	
HNSC	cis	1	rs1170543	chr1:34744384	ZSCAN20	chr1:33938232-33961993:+	0.21	3.85	0.000132	Epilepsy (generalized)	
HNSC	cis	1	rs11705483	chr22:46630544	PKDREJ	chr22:46651561-46659219:-	-0.43	-4.93	1.1E-6	Cholesterol, total;LDL cholesterol	
HNSC	cis	1	rs11705483	chr22:46630544	TTC38	chr22:46663861-46689903:+	-0.37	-3.92	0.000103	Cholesterol, total;LDL cholesterol	
HNSC	cis	1	rs11706035	chr3:53011868	TMEM110	chr3:52867139-52931547:-	0.45	5.01	7.71E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11706117	chr3:134212526	ANAPC13	chr3:134196547-134204865:-	0.49	10.4	4.95E-23	Height	
HNSC	cis	1	rs11706117	chr3:134212526	CEP63	chr3:134204575-134293852:+	0.27	5.74	1.62E-8	Height	
HNSC	cis	1	rs11707575	chr3:53113762	TMEM110	chr3:52867139-52931547:-	0.29	4.08	5.3E-5	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11707780	chr3:53084326	TMEM110	chr3:52867139-52931547:-	-0.28	-3.99	7.56E-5	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.48	10.31	1.02E-22	Height	
HNSC	cis	1	rs11708531	chr3:134224902	CEP63	chr3:134204575-134293852:+	0.28	6.03	3.27E-9	Height	
HNSC	cis	1	rs11710292	chr3:53117798	TMEM110	chr3:52867139-52931547:-	0.45	5.46	7.36E-8	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11710434	chr3:49346130	AMT	chr3:49454212-49460012:-	0.19	4.32	1.9E-5	Menarche (age at onset)	
HNSC	cis	1	rs11710707	chr3:52975916	TMEM110	chr3:52867139-52931547:-	0.53	5.97	4.51E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs1171112	chr6:84226568	PRSS35	chr6:84222274-84235419:+	0.18	3.79	0.000169	Bipolar disorder with mood-incongruent psychosis	
HNSC	cis	1	rs1171113	chr6:84226595	PRSS35	chr6:84222274-84235419:+	0.18	3.79	0.000169	Bipolar disorder with mood-incongruent psychosis	
HNSC	cis	1	rs1171115	chr6:84229623	PRSS35	chr6:84222274-84235419:+	0.18	3.81	0.000158	Bipolar disorder with mood-incongruent psychosis	
HNSC	cis	1	rs11712111	chr3:156608940	LEKR1	chr3:156544076-156763918:+	0.22	4.67	3.93E-6	Multiple sclerosis (severity)	
HNSC	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.3	-7.47	3.65E-13	Longevity	
HNSC	cis	1	rs11712653	chr3:53070875	TMEM110	chr3:52867139-52931547:-	-0.42	-5.41	9.77E-8	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11713206	chr3:52999243	TMEM110	chr3:52867139-52931547:-	0.54	6.06	2.67E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11713290	chr3:52971579	TMEM110	chr3:52867139-52931547:-	0.53	6.12	1.86E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11713859	chr3:53042080	TMEM110	chr3:52867139-52931547:-	0.49	5.56	4.54E-8	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11714406	chr3:121372513	IQCB1	chr3:121488610-121553926:-	0.25	6.18	1.36E-9	Cognitive performance	
HNSC	cis	1	rs11714876	chr3:53101640	TMEM110	chr3:52867139-52931547:-	-0.42	-5.04	6.64E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11717619	chr3:53003179	TMEM110	chr3:52867139-52931547:-	0.31	3.89	0.000116	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11718538	chr3:52975987	TMEM110	chr3:52867139-52931547:-	0.53	6.12	1.86E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11718752	chr3:53130745	RFT1	chr3:53122503-53164470:-	0.32	4.23	2.73E-5	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11718834	chr3:52963668	TMEM110	chr3:52867139-52931547:-	0.54	6.2	1.21E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11719458	chr3:121382005	IQCB1	chr3:121488610-121553926:-	0.26	6.61	9.84E-11	Cognitive performance	
HNSC	cis	1	rs11719762	chr3:49409002	AMT	chr3:49454212-49460012:-	0.18	4.13	4.22E-5	Menarche (age at onset)	
HNSC	cis	1	rs11720191	chr3:53013839	TMEM110	chr3:52867139-52931547:-	0.46	5.09	5.01E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs11720542	chr3:49357427	AMT	chr3:49454212-49460012:-	0.2	4.42	1.24E-5	Menarche (age at onset)	
HNSC	cis	1	rs11721318	chr3:121429485	IQCB1	chr3:121488610-121553926:-	0.24	6.07	2.53E-9	Cognitive performance	
HNSC	cis	1	rs11722037	chr4:17683811	FAM184B	chr4:17633711-17783135:-	-0.16	-3.92	0.000101	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs11722037	chr4:17683811	LAP3	chr4:17578927-17609590:+	-0.15	-3.91	0.000106	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs117236853	chr20:33667783	PROCR	chr20:33758727-33765164:+	-0.3	-3.72	0.000218	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs11724495	chr4:17621310	FAM184B	chr4:17633711-17783135:-	-0.16	-3.82	0.000151	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs11727312	chr4:17669185	FAM184B	chr4:17633711-17783135:-	-0.16	-3.81	0.000157	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs11727312	chr4:17669185	LAP3	chr4:17578927-17609590:+	-0.16	-4.11	4.65E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs11729657	chr4:1737585	FAM53A	chr4:1641609-1685854:-	-0.34	-5.89	7.21E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs117316403	chr20:33693175	PROCR	chr20:33758727-33765164:+	-0.29	-3.82	0.00015	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs11732156	chr4:4952811	OTOP1	chr4:4190530-4228621:-	0.44	3.97	8.17E-5	Coronary heart disease	
HNSC	cis	1	rs11732213	chr4:1704244	FAM53A	chr4:1641609-1685854:-	0.37	6.3	6.5E-10	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs11737138	chr4:17657986	FAM184B	chr4:17633711-17783135:-	-0.17	-4.05	5.93E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.82	14.14	2.31E-38	Type 2 diabetes	
HNSC	cis	1	rs11739619	chr5:150264662	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs11739677	chr5:150294883	LOC134466	chr5:150310000-150326146:-	0.53	6.76	3.84E-11	Crohn's disease	
HNSC	cis	1	rs11740172	chr5:150300278	LOC134466	chr5:150310000-150326146:-	0.52	6.9	1.64E-11	Crohn's disease	
HNSC	cis	1	rs11740478	chr5:82446386	XRCC4	chr5:82373317-82649577:+	-0.2	-3.95	9.09E-5	Hypertension	
HNSC	cis	1	rs11741861	chr5:150277909	LOC134466	chr5:150310000-150326146:-	-0.51	-6.62	9.47E-11	Crohn's disease	
HNSC	cis	1	rs11741897	chr5:82453065	XRCC4	chr5:82373317-82649577:+	-0.2	-3.94	9.29E-5	Hypertension	
HNSC	cis	1	rs11741963	chr5:112702773	YTHDC2	chr5:112849410-112930979:+	0.19	3.7	0.000241	Cerebral amyloid angiopathy	
HNSC	cis	1	rs11746108	chr5:150264622	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs11746128	chr5:156421250	TIMD4	chr5:156346293-156390266:-	-0.18	-4.24	2.7E-5	Hypertriglyceridemia	
HNSC	cis	1	rs11746807	chr5:150300419	LOC134466	chr5:150310000-150326146:-	0.51	6.9	1.56E-11	Crohn's disease	
HNSC	cis	1	rs11746907	chr5:598224	SLC9A3	chr5:473334-524549:-	-0.22	-4.08	5.16E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs11747065	chr5:150295486	LOC134466	chr5:150310000-150326146:-	0.52	6.8	3.05E-11	Crohn's disease	
HNSC	cis	1	rs11747270	chr5:150258867	LOC134466	chr5:150310000-150326146:-	-0.36	-5.07	5.67E-7	Crohn's disease	
HNSC	cis	1	rs11748151	chr5:150226292	LOC134466	chr5:150310000-150326146:-	0.36	4.94	1.09E-6	Crohn's disease	
HNSC	cis	1	rs11748158	chr5:150226345	LOC134466	chr5:150310000-150326146:-	0.36	4.94	1.09E-6	Crohn's disease	
HNSC	cis	1	rs11749391	chr5:150229066	LOC134466	chr5:150310000-150326146:-	0.36	5.04	6.7E-7	Crohn's disease	
HNSC	cis	1	rs11750945	chr5:112710755	YTHDC2	chr5:112849410-112930979:+	0.19	3.66	0.00028	Cerebral amyloid angiopathy	
HNSC	cis	1	rs11754744	chr6:26202605	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.47	9.62E-6	Renal underexcretion gout;Gout	
HNSC	cis	1	rs11755210	chr6:26202768	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.47	9.62E-6	Renal underexcretion gout;Gout	
HNSC	cis	1	rs11756120	chr6:26529808	BTN2A3	chr6:26422317-26431927:+	0.16	3.66	0.000275	Educational attainment	
HNSC	cis	1	rs11756120	chr6:26529808	BTN3A2	chr6:26365398-26378546:+	0.18	4.36	1.57E-5	Educational attainment	
HNSC	cis	1	rs11756783	chr6:101118109	ASCC3	chr6:100956609-101329224:-	0.22	5.78	1.34E-8	Menarche (age at onset)	
HNSC	cis	1	rs117573845	chr20:33651621	PROCR	chr20:33758727-33765164:+	-0.3	-3.77	0.000184	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs11758351	chr6:26203910	HIST1H2AE	chr6:26217148-26217711:+	-0.3	-4.51	8.22E-6	Renal underexcretion gout;Gout	
HNSC	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.63	-13.28	1.25E-34	Response to antipsychotic treatment	
HNSC	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.63	-13.76	1.14E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs117620519	chr16:68194889	C16orf86	chr16:67700717-67702659:+	-0.36	-4.05	6.06E-5	Crohn's disease	
HNSC	cis	1	rs117620519	chr16:68194889	GFOD2	chr16:67708437-67753273:-	-0.28	-3.77	0.000181	Crohn's disease	
HNSC	cis	1	rs11763020	chr7:1060288	ZFAND2A	chr7:1192544-1199855:-	-0.28	-3.88	0.000116	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs11763147	chr7:65326821	NCRNA00174	chr7:65841032-65865395:-	0.51	9.82	6.77E-21	Corneal structure	
HNSC	cis	1	rs11765693	chr7:75985373	UPK3B	chr7:76139745-76157197:+	-0.23	-4.58	5.91E-6	Multiple sclerosis	
HNSC	cis	1	rs11765693	chr7:75985373	ZP3	chr7:76026841-76071387:+	-0.2	-3.93	9.65E-5	Multiple sclerosis	
HNSC	cis	1	rs11766526	chr7:1101433	ZFAND2A	chr7:1192544-1199855:-	-0.28	-3.72	0.000222	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs11770686	chr7:75348306	HIP1	chr7:75163409-75368279:-	0.13	3.92	0.000103	Essential tremor	
HNSC	cis	1	rs11770909	chr7:1086716	ZFAND2A	chr7:1192544-1199855:-	-0.27	-3.67	0.000273	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs11773829	chr7:66141074	NCRNA00174	chr7:65841032-65865395:-	0.55	10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs11774085	chr8:96020877	C8orf38	chr8:95908040-96088396:+	-0.31	-4.63	4.74E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs11776189	chr8:96036741	C8orf38	chr8:95908040-96088396:+	-0.32	-4.86	1.58E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs11780931	chr8:96043829	C8orf38	chr8:95908040-96088396:+	-0.32	-4.97	9.15E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs11781040	chr8:96041746	C8orf38	chr8:95908040-96088396:+	-0.33	-5.14	3.95E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs11781619	chr8:96017323	C8orf38	chr8:95908040-96088396:+	-0.36	-5.27	2.0E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs11782107	chr8:11115503	AMAC1L2	chr8:11188495-11189695:+	0.3	3.74	0.000206	Response to antipsychotic therapy (extrapyramidal side effects)	
HNSC	cis	1	rs11782652	chr8:82653644	CHMP4C	chr8:82644688-82671746:+	-0.83	-9.18	1.17E-18	Epithelial ovarian cancer;Ovarian cancer	
HNSC	cis	1	rs11786380	chr8:96028136	C8orf38	chr8:95908040-96088396:+	-0.29	-4.46	1.01E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs11786878	chr8:96033292	C8orf38	chr8:95908040-96088396:+	-0.31	-4.67	3.95E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs11789795	chr9:21663844	CDKN2BAS	chr9:21994790-22121091:+	-0.22	-3.71	0.000229	Gut microbiome composition (winter)	
HNSC	cis	1	rs11790232	chr9:21664040	CDKN2BAS	chr9:21994790-22121091:+	-0.22	-3.71	0.000229	Gut microbiome composition (winter)	
HNSC	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.59	-13.34	7.0E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs11792861	chr9:111809295	C9orf5	chr9:111777416-111882225:-	0.2	3.97	8.11E-5	Menarche (age at onset)	
HNSC	cis	1	rs11799420	chr1:171652978	VAMP4	chr1:171669298-171711214:-	-0.28	-4.84	1.78E-6	Hippocampal atrophy	
HNSC	cis	1	rs11801695	chr1:205916175	PM20D1	chr1:205797154-205819245:-	-0.2	-3.81	0.000154	Cystic fibrosis-related diabetes	
HNSC	cis	1	rs11801846	chr1:171674241	VAMP4	chr1:171669298-171711214:-	0.26	4.39	1.4E-5	Hippocampal atrophy	
HNSC	cis	1	rs11802265	chr1:171649936	VAMP4	chr1:171669298-171711214:-	0.26	4.54	7.02E-6	Hippocampal atrophy	
HNSC	cis	1	rs11803174	chr1:171674338	VAMP4	chr1:171669298-171711214:-	0.26	4.39	1.4E-5	Hippocampal atrophy	
HNSC	cis	1	rs11810993	chr1:46478793	CCDC163P	chr1:45960581-45965646:-	-0.33	-7.16	2.93E-12	Body mass index	
HNSC	cis	1	rs118110670	chr10:81792242	LOC219347	chr10:81805991-81838949:-	0.59	6.34	5.05E-10	Chronic obstructive pulmonary disease-related biomarkers	
HNSC	cis	1	rs11811780	chr1:171652759	VAMP4	chr1:171669298-171711214:-	0.28	4.79	2.19E-6	Hippocampal atrophy	
HNSC	cis	1	rs11816840	chr10:102309220	SEC31B	chr10:102246403-102289636:-	-0.18	-5.47	7.31E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs1182882	chr7:65562063	NCRNA00174	chr7:65841032-65865395:-	0.72	14.49	7.09E-40	Aortic root size	
HNSC	cis	1	rs1183245	chr7:65541185	NCRNA00174	chr7:65841032-65865395:-	0.73	14.59	2.54E-40	Aortic root size	
HNSC	cis	1	rs11833002	chr12:124446616	DNAH10	chr12:124247042-124420265:+	0.29	5.36	1.31E-7	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs11835839	chr12:124431049	DNAH10	chr12:124247042-124420265:+	0.31	5.65	2.76E-8	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs11838472	chr13:73741149	PIBF1	chr13:73356230-73590589:+	-0.37	-3.74	0.000202	Myopia (pathological)	
HNSC	cis	1	rs11845639	chr14:75570293	MLH3	chr14:75480467-75518235:-	0.29	6.04	3.0E-9	Height	
HNSC	cis	1	rs11850847	chr14:65933798	LOC645431	chr14:65877313-65879335:-	-0.29	-3.77	0.000181	Ischemic stroke	
HNSC	cis	1	rs11851013	chr14:66016212	LOC645431	chr14:65877313-65879335:-	-0.3	-4.06	5.74E-5	Ischemic stroke	
HNSC	cis	1	rs11851772	chr14:66022047	LOC645431	chr14:65877313-65879335:-	-0.3	-3.98	7.93E-5	Ischemic stroke	
HNSC	cis	1	rs11852984	chr15:35105657	C15orf24	chr15:34376226-34394053:-	0.23	3.97	8.23E-5	Suicide behavior	
HNSC	cis	1	rs11852984	chr15:35105657	NOP10	chr15:34633917-34635362:-	0.19	3.98	8.02E-5	Suicide behavior	
HNSC	cis	1	rs11852984	chr15:35105657	TMEM85	chr15:34517245-34522350:+	0.25	4.16	3.73E-5	Suicide behavior	
HNSC	cis	1	rs11856184	chr15:43919162	ADAL	chr15:43622872-43646094:+	-0.41	-5.71	1.97E-8	Tumor biomarkers	
HNSC	cis	1	rs11856184	chr15:43919162	CATSPER2	chr15:43922774-43959900:-	-0.45	-7.3	1.18E-12	Tumor biomarkers	
HNSC	cis	1	rs11856184	chr15:43919162	CKMT1A	chr15:43985084-43991419:+	-0.48	-6.66	7.2E-11	Tumor biomarkers	
HNSC	cis	1	rs11856184	chr15:43919162	CKMT1B	chr15:43885252-43891603:+	-0.34	-4.73	2.97E-6	Tumor biomarkers	
HNSC	cis	1	rs11862083	chr16:4649720	NMRAL1	chr16:4511696-4526307:-	-0.59	-6.61	9.8E-11	Obesity-related traits	
HNSC	cis	1	rs11862744	chr16:31057800	HSD3B7	chr16:30996519-31000473:+	0.23	4.18	3.39E-5	Response to metformin (IC50)	
HNSC	cis	1	rs11862744	chr16:31057800	MYST1	chr16:31128985-31142713:+	0.24	5.83	1.02E-8	Response to metformin (IC50)	
HNSC	cis	1	rs11865098	chr16:67857436	GFOD2	chr16:67708437-67753273:-	-0.26	-3.86	0.000128	Crohn's disease	
HNSC	cis	1	rs11867405	chr17:40570741	NAGLU	chr17:40687951-40696464:+	-0.2	-4.02	6.64E-5	Crohn's disease	
HNSC	cis	1	rs11869069	chr17:40287101	DHX58	chr17:40253422-40264751:-	-0.35	-7.2	2.31E-12	Fibrinogen levels	
HNSC	cis	1	rs11870935	chr17:45732605	C17orf57	chr17:45401142-45518675:+	-0.2	-4.78	2.27E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs11870935	chr17:45732605	TBKBP1	chr17:45772630-45789427:+	0.2	3.97	8.33E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs11871801	chr17:40570772	NAGLU	chr17:40687951-40696464:+	-0.2	-4.1	4.87E-5	Crohn's disease	
HNSC	cis	1	rs1187446	chr14:104409896	TDRD9	chr14:104394817-104519002:+	0.34	5.51	5.87E-8	Bipolar disorder	
HNSC	cis	1	rs1187448	chr14:104406627	TDRD9	chr14:104394817-104519002:+	0.32	5.32	1.58E-7	Bipolar disorder	
HNSC	cis	1	rs11879853	chr19:23029434	ZNF492	chr19:22817126-22850472:+	0.33	5.28	1.9E-7	Bronchopulmonary dysplasia	
HNSC	cis	1	rs11880710	chr19:12156895	C19orf43	chr19:12841455-12845529:-	0.22	3.78	0.000174	Multiple sclerosis	
HNSC	cis	1	rs11880710	chr19:12156895	C19orf56	chr19:12778881-12780465:-	0.22	3.92	0.000101	Multiple sclerosis	
HNSC	cis	1	rs11880710	chr19:12156895	RAD23A	chr19:13056654-13064455:+	0.26	3.77	0.000181	Multiple sclerosis	
HNSC	cis	1	rs11880710	chr19:12156895	ZNF490	chr19:12686920-12721623:-	0.28	3.91	0.000107	Multiple sclerosis	
HNSC	cis	1	rs11880710	chr19:12156895	ZNF763	chr19:12035900-12091196:+	0.26	3.87	0.000122	Multiple sclerosis	
HNSC	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.61	13.46	2.07E-35	Schizophrenia	
HNSC	cis	1	rs11882498	chr19:23060012	ZNF492	chr19:22817126-22850472:+	-0.31	-4.87	1.48E-6	Bronchopulmonary dysplasia	
HNSC	cis	1	rs11887056	chr2:99243861	UNC50	chr2:99225042-99234975:+	-0.23	-3.93	9.89E-5	Bipolar disorder	
HNSC	cis	1	rs11893832	chr2:88507537	THNSL2	chr2:88469835-88486145:+	-0.48	-5.15	3.71E-7	Plasma clusterin levels	
HNSC	cis	1	rs11893881	chr2:73824373	ALMS1P	chr2:73872046-73912692:+	0.26	4.45	1.08E-5	Metabolite levels	
HNSC	cis	1	rs11899740	chr2:73631212	ALMS1P	chr2:73872046-73912692:+	0.23	3.83	0.000144	Metabolite levels	
HNSC	cis	1	rs11899902	chr2:73631564	ALMS1P	chr2:73872046-73912692:+	0.25	4.24	2.68E-5	Metabolite levels	
HNSC	cis	1	rs11901272	chr2:73720444	ALMS1P	chr2:73872046-73912692:+	0.26	4.43	1.16E-5	Metabolite levels	
HNSC	cis	1	rs11902198	chr2:70144596	GMCL1	chr2:70056818-70106727:+	0.12	3.73	0.000213	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs11903916	chr2:73815328	ALMS1P	chr2:73872046-73912692:+	0.27	4.54	7.02E-6	Metabolite levels	
HNSC	cis	1	rs11905354	chr20:33677164	PROCR	chr20:33758727-33765164:+	-0.27	-3.79	0.000171	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs11908683	chr20:33720920	PROCR	chr20:33758727-33765164:+	-0.3	-3.89	0.000115	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs11918291	chr3:99927994	TBC1D23	chr3:99979686-100044078:+	0.25	4.92	1.18E-6	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs11919350	chr3:134235970	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.36	7.2E-23	Height	
HNSC	cis	1	rs11919350	chr3:134235970	CEP63	chr3:134204575-134293852:+	-0.26	-5.58	3.9E-8	Height	
HNSC	cis	1	rs11920015	chr3:99962381	TBC1D23	chr3:99979686-100044078:+	0.23	4.56	6.57E-6	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs11927068	chr3:134266321	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.52	1.7E-23	Height	
HNSC	cis	1	rs11927068	chr3:134266321	CEP63	chr3:134204575-134293852:+	-0.26	-5.68	2.27E-8	Height	
HNSC	cis	1	rs11928090	chr3:49604904	AMT	chr3:49454212-49460012:-	0.17	3.84	0.000141	Menarche (age at onset)	
HNSC	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.37	6.27E-23	Height	
HNSC	cis	1	rs11928499	chr3:134232350	CEP63	chr3:134204575-134293852:+	-0.27	-5.7	2.06E-8	Height	
HNSC	cis	1	rs11932207	chr4:71330534	AMTN	chr4:71384298-71398459:+	0.25	4.18	3.47E-5	Alcoholism (heaviness of drinking)	
HNSC	cis	1	rs11942153	chr4:106960172	TBCK	chr4:106967233-107237861:-	0.24	4.73	2.94E-6	Airflow obstruction	
HNSC	cis	1	rs11947857	chr4:17691047	LAP3	chr4:17578927-17609590:+	0.19	4.85	1.63E-6	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs11948075	chr5:90680579	LOC100129716	chr5:90676164-90716531:+	0.29	4.04	6.3E-5	Smoking behavior	
HNSC	cis	1	rs11950530	chr5:90688740	LOC100129716	chr5:90676164-90716531:+	0.28	3.91	0.000104	Smoking behavior	
HNSC	cis	1	rs11951515	chr5:43382858	C5orf34	chr5:43486810-43515187:-	-0.2	-4.94	1.08E-6	Metabolite levels  (X-11787)	
HNSC	cis	1	rs11957134	chr5:150230950	LOC134466	chr5:150310000-150326146:-	-0.48	-5.98	4.4E-9	Crohn's disease	
HNSC	cis	1	rs11958314	chr5:82428748	XRCC4	chr5:82373317-82649577:+	-0.2	-3.91	0.000106	Hypertension	
HNSC	cis	1	rs11965538	chr6:28239915	ZNF389	chr6:28129551-28137375:+	-0.27	-4.19	3.34E-5	Depression	
HNSC	cis	1	rs11965538	chr6:28239915	ZSCAN23	chr6:28393287-28411279:-	0.24	3.72	0.000224	Depression	
HNSC	cis	1	rs11971949	chr7:65626014	NCRNA00174	chr7:65841032-65865395:-	0.74	14.96	5.63E-42	Aortic root size	
HNSC	cis	1	rs11974219	chr7:65647410	NCRNA00174	chr7:65841032-65865395:-	0.75	15.79	9.17E-46	Aortic root size	
HNSC	cis	1	rs11974264	chr7:65647582	NCRNA00174	chr7:65841032-65865395:-	0.73	14.89	1.11E-41	Aortic root size	
HNSC	cis	1	rs11975942	chr7:143740580	ARHGEF35	chr7:143883677-143892736:-	-0.35	-7.39	6.13E-13	Obesity-related traits	
HNSC	cis	1	rs11975942	chr7:143740580	OR2A7	chr7:143955790-143974852:-	0.2	3.86	0.000129	Obesity-related traits	
HNSC	cis	1	rs11976020	chr7:72247800	SBDSP1	chr7:72299952-72307976:+	-0.32	-5.33	1.49E-7	Educational attainment (years of education)	
HNSC	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	0.89	17.19	3.27E-52	Educational attainment (years of education)	
HNSC	cis	1	rs11976037	chr7:143741024	ARHGEF35	chr7:143883677-143892736:-	-0.36	-7.59	1.58E-13	Obesity-related traits	
HNSC	cis	1	rs11976037	chr7:143741024	OR2A7	chr7:143955790-143974852:-	0.2	3.82	0.000149	Obesity-related traits	
HNSC	cis	1	rs11976180	chr7:143741580	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.08	5.06E-12	Obesity-related traits	
HNSC	cis	1	rs11976180	chr7:143741580	OR2A7	chr7:143955790-143974852:-	0.22	4.05	5.92E-5	Obesity-related traits	
HNSC	cis	1	rs11986414	chr8:1746950	CLN8	chr8:1711870-1734735:+	0.29	4.48	9.45E-6	Gaucher disease severity	
HNSC	cis	1	rs1199095	chr10:59950760	CISD1	chr10:60028895-60049018:+	0.25	4.5	8.38E-6	Inflammatory bowel disease	
HNSC	cis	1	rs1199095	chr10:59950760	IPMK	chr10:59955618-60027694:-	0.28	6.87	1.89E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1199096	chr10:59950234	CISD1	chr10:60028895-60049018:+	0.26	4.58	5.97E-6	Inflammatory bowel disease	
HNSC	cis	1	rs1199096	chr10:59950234	IPMK	chr10:59955618-60027694:-	0.29	6.94	1.2E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1199099	chr10:59948335	CISD1	chr10:60028895-60049018:+	0.27	4.72	3.14E-6	Inflammatory bowel disease	
HNSC	cis	1	rs1199099	chr10:59948335	IPMK	chr10:59955618-60027694:-	0.28	6.89	1.66E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1199100	chr10:59948044	CISD1	chr10:60028895-60049018:+	0.27	4.72	3.14E-6	Inflammatory bowel disease	
HNSC	cis	1	rs1199100	chr10:59948044	IPMK	chr10:59955618-60027694:-	0.28	6.89	1.66E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1199101	chr10:59947901	CISD1	chr10:60028895-60049018:+	0.26	4.54	7.23E-6	Inflammatory bowel disease	
HNSC	cis	1	rs1199101	chr10:59947901	IPMK	chr10:59955618-60027694:-	0.27	6.52	1.76E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1199103	chr10:59947231	CISD1	chr10:60028895-60049018:+	-0.26	-4.54	7.18E-6	Inflammatory bowel disease	
HNSC	cis	1	rs1199103	chr10:59947231	IPMK	chr10:59955618-60027694:-	-0.28	-6.79	3.33E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1199104	chr10:59946781	CISD1	chr10:60028895-60049018:+	0.26	4.61	5.16E-6	Inflammatory bowel disease	
HNSC	cis	1	rs1199104	chr10:59946781	IPMK	chr10:59955618-60027694:-	0.29	6.91	1.51E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1199107	chr10:59943709	CISD1	chr10:60028895-60049018:+	0.26	4.51	8.19E-6	Inflammatory bowel disease	
HNSC	cis	1	rs1199107	chr10:59943709	IPMK	chr10:59955618-60027694:-	0.28	6.8	2.95E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1199108	chr10:59942324	CISD1	chr10:60028895-60049018:+	0.26	4.51	8.19E-6	Inflammatory bowel disease	
HNSC	cis	1	rs1199108	chr10:59942324	IPMK	chr10:59955618-60027694:-	0.28	6.8	2.95E-11	Inflammatory bowel disease	
HNSC	cis	1	rs12021587	chr1:46472759	CCDC163P	chr1:45960581-45965646:-	-0.33	-7.1	4.4E-12	Body mass index	
HNSC	cis	1	rs12022194	chr1:156312331	BGLAP	chr1:156182784-156213112:+	0.19	3.7	0.000238	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12023438	chr1:156254358	BGLAP	chr1:156182784-156213112:+	0.19	3.68	0.000262	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12030612	chr1:113215637	ST7L	chr1:113066142-113162405:-	0.39	5.75	1.53E-8	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs12030641	chr1:113215717	ST7L	chr1:113066142-113162405:-	0.39	5.75	1.53E-8	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs1203156	chr6:88079694	C6orf162	chr6:88032306-88052043:+	-0.18	-3.71	0.000229	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs1203156	chr6:88079694	C6orf164	chr6:88032306-88109459:+	-0.23	-4.28	2.29E-5	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs12033668	chr1:210341410	SYT14	chr1:210111538-210337631:+	-0.2	-3.73	0.000213	Manic episodes in bipolar disorder	
HNSC	cis	1	rs12037222	chr1:40064961	BMP8A	chr1:39957318-39995537:+	0.21	4.34	1.75E-5	C-reactive protein levels or triglyceride levels (pleiotropy)	
HNSC	cis	1	rs12037222	chr1:40064961	PABPC4	chr1:40026485-40042521:-	-0.35	-5.82	1.03E-8	C-reactive protein levels or triglyceride levels (pleiotropy)	
HNSC	cis	1	rs12037569	chr1:109923677	AMIGO1	chr1:110049447-110052336:-	0.24	3.74	0.000208	Major depressive disorder	
HNSC	cis	1	rs12038481	chr1:156284815	BGLAP	chr1:156182784-156213112:+	0.2	3.87	0.000122	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12039431	chr1:38082122	GNL2	chr1:38032414-38061586:-	-0.24	-4.04	6.14E-5	Epithelial ovarian cancer	
HNSC	cis	1	rs12040988	chr1:113173804	ST7L	chr1:113066142-113162405:-	0.4	5.96	4.72E-9	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs12041164	chr1:156279811	BGLAP	chr1:156182784-156213112:+	0.19	3.84	0.000138	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12045339	chr1:156294211	BGLAP	chr1:156182784-156213112:+	0.19	3.84	0.000138	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12045807	chr1:150584834	GOLPH3L	chr1:150618701-150669672:-	-0.26	-3.67	0.000269	Congenital left-sided heart lesions	
HNSC	cis	1	rs12045807	chr1:150584834	HORMAD1	chr1:150670542-150693352:-	0.39	5.07	5.61E-7	Congenital left-sided heart lesions	
HNSC	cis	1	rs12046650	chr1:38082123	GNL2	chr1:38032414-38061586:-	-0.24	-4.04	6.14E-5	Epithelial ovarian cancer	
HNSC	cis	1	rs12049330	chr1:110031188	AMIGO1	chr1:110049447-110052336:-	0.26	4.15	3.96E-5	Major depressive disorder	
HNSC	cis	1	rs12049588	chr1:46472422	CCDC163P	chr1:45960581-45965646:-	-0.33	-7.12	3.76E-12	Body mass index	
HNSC	cis	1	rs12051443	chr16:71691329	DHODH	chr16:72042643-72058954:+	-0.21	-4.54	7.06E-6	Prostate cancer	
HNSC	cis	1	rs12052257	chr2:202241594	CASP8	chr2:202098166-202152434:+	-0.21	-4.5	8.66E-6	Basal cell carcinoma	
HNSC	cis	1	rs12054923	chr5:150249059	LOC134466	chr5:150310000-150326146:-	0.37	5.15	3.78E-7	Crohn's disease	
HNSC	cis	1	rs12055786	chr6:153431125	RGS17	chr6:153332041-153452389:-	-0.21	-3.91	0.000106	Prostate cancer	
HNSC	cis	1	rs12091564	chr1:145395604	NOTCH2NL	chr1:145209111-145295525:+	-0.69	-8.04	6.52E-15	Coronary heart disease	
HNSC	cis	1	rs12105996	chr20:33731010	PROCR	chr20:33758727-33765164:+	-0.27	-3.85	0.000132	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs12117903	chr1:156311165	BGLAP	chr1:156182784-156213112:+	0.19	3.78	0.000174	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12117947	chr1:156244058	BGLAP	chr1:156182784-156213112:+	0.19	3.68	0.000262	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12117951	chr1:156305286	BGLAP	chr1:156182784-156213112:+	0.2	3.81	0.000159	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12120956	chr1:113202571	ST7L	chr1:113066142-113162405:-	0.39	5.76	1.44E-8	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs12121805	chr1:156257876	BGLAP	chr1:156182784-156213112:+	0.19	3.68	0.000262	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12122290	chr1:247215810	ZNF670	chr1:247200087-247242069:-	-0.3	-6.57	1.31E-10	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs12125429	chr1:171651153	VAMP4	chr1:171669298-171711214:-	0.28	4.79	2.19E-6	Hippocampal atrophy	
HNSC	cis	1	rs12126971	chr1:113231286	ST7L	chr1:113066142-113162405:-	0.39	5.74	1.65E-8	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs12128536	chr1:171674607	VAMP4	chr1:171669298-171711214:-	0.26	4.39	1.4E-5	Hippocampal atrophy	
HNSC	cis	1	rs12130075	chr1:247218491	ZNF670	chr1:247200087-247242069:-	-0.3	-6.58	1.23E-10	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs12130243	chr1:113169667	ST7L	chr1:113066142-113162405:-	0.4	5.96	4.72E-9	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs12130629	chr1:166953284	FMO9P	chr1:166573153-166594471:+	0.22	4.37	1.54E-5	Refractive astigmatism	
HNSC	cis	1	rs12132221	chr1:171685694	VAMP4	chr1:171669298-171711214:-	0.26	4.5	8.5E-6	Hippocampal atrophy	
HNSC	cis	1	rs12132794	chr1:156281020	BGLAP	chr1:156182784-156213112:+	-0.19	-3.66	0.000281	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12132919	chr1:156318141	BGLAP	chr1:156182784-156213112:+	0.2	3.7	0.000243	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12133583	chr1:113240790	ST7L	chr1:113066142-113162405:-	0.39	5.88	7.54E-9	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs12134983	chr1:156290409	BGLAP	chr1:156182784-156213112:+	0.2	3.87	0.000122	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12138117	chr1:16305279	C1orf64	chr1:16330731-16333180:+	-0.19	-3.71	0.000228	Dilated cardiomyopathy	
HNSC	cis	1	rs12139630	chr1:46350935	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.51	2.85E-13	Body mass index	
HNSC	cis	1	rs12139860	chr1:120262848	ZNF697	chr1:120162000-120190390:-	-0.37	-5.68	2.28E-8	Height	
HNSC	cis	1	rs12141236	chr1:156302575	BGLAP	chr1:156182784-156213112:+	0.2	3.89	0.000115	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12144094	chr1:120264823	ZNF697	chr1:120162000-120190390:-	-0.37	-5.42	9.23E-8	Height	
HNSC	cis	1	rs12144263	chr1:46352446	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.51	2.85E-13	Body mass index	
HNSC	cis	1	rs12147450	chr14:20957433	PNP	chr14:20937542-20945246:+	-0.32	-6.42	3.15E-10	Response to antipsychotic therapy (extrapyramidal side effects)	
HNSC	cis	1	rs12147450	chr14:20957433	RNASE10	chr14:20973696-20979314:+	-0.48	-7.56	1.96E-13	Response to antipsychotic therapy (extrapyramidal side effects)	
HNSC	cis	1	rs12152964	chr5:115609965	COMMD10	chr5:115420727-115628978:+	0.4	4.24	2.64E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs12153717	chr5:115571914	COMMD10	chr5:115420727-115628978:+	0.37	3.72	0.000218	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.62	-13.61	4.71E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12171333	chr4:129879711	C4orf33	chr4:130014829-130033842:+	0.42	7.95	1.24E-14	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs12185102	chr15:75352201	SCAMP5	chr15:75287901-75313836:+	0.43	8.72	4.22E-17	Blood trace element (Zn levels)	
HNSC	cis	1	rs12185764	chr20:44550020	CD40	chr20:44746906-44758384:+	0.23	3.78	0.000174	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
HNSC	cis	1	rs12188164	chr5:428236	EXOC3	chr5:443334-467407:+	-0.24	-4.22	2.91E-5	Cystic fibrosis severity	
HNSC	cis	1	rs12188678	chr5:428231	EXOC3	chr5:443334-467407:+	-0.24	-4.22	2.91E-5	Cystic fibrosis severity	
HNSC	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.61	-12.78	1.74E-32	Response to antipsychotic treatment	
HNSC	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.63	-13.58	6.32E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12192208	chr6:124693764	NKAIN2	chr6:124125069-125146784:+	0.38	7.37	7.47E-13	Neuroticism	
HNSC	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.63	-13.88	3.33E-37	Response to antipsychotic treatment	
HNSC	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.64	-13.59	5.75E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.65	-13.56	8.27E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12196937	chr6:49382808	CENPQ	chr6:49431096-49460820:+	-0.4	-9.43	1.6E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs12196937	chr6:49382808	MUT	chr6:49398994-49431031:-	0.42	9.12	1.98E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs12197114	chr6:109735498	AKD1	chr6:109814059-110012415:-	-0.25	-4.81	2.01E-6	Height	
HNSC	cis	1	rs12197114	chr6:109735498	SMPD2	chr6:109761931-109765121:+	0.3	5.88	7.42E-9	Height	
HNSC	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.63	-14.04	6.85E-38	Response to antipsychotic treatment	
HNSC	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.64	-14.37	2.33E-39	Response to antipsychotic treatment	
HNSC	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.63	-13.73	1.51E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.63	-13.76	1.14E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.61	-13.35	6.23E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.61	-13.59	5.96E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.62	-13.61	4.71E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12202075	chr6:49427655	CENPQ	chr6:49431096-49460820:+	-0.4	-9.64	2.94E-20	Folate pathway vitamin levels	
HNSC	cis	1	rs12202075	chr6:49427655	MUT	chr6:49398994-49431031:-	0.41	8.85	1.56E-17	Folate pathway vitamin levels	
HNSC	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.64	-13.91	2.39E-37	Response to antipsychotic treatment	
HNSC	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.64	-13.87	3.56E-37	Response to antipsychotic treatment	
HNSC	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.59	-13.48	1.71E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.61	-13.62	4.27E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12204812	chr6:124681503	NKAIN2	chr6:124125069-125146784:+	0.42	8.32	8.76E-16	Neuroticism	
HNSC	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.63	-13.78	9.33E-37	Response to antipsychotic treatment	
HNSC	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.64	-13.57	7.56E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.64	-14.37	2.33E-39	Response to antipsychotic treatment	
HNSC	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.61	-13.47	2.0E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs12208357	chr6:160543148	LOC729603	chr6:160514114-160517244:+	0.4	3.78	0.000174	Cholesterol, total	
HNSC	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.63	-13.73	1.46E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.63	-13.78	9.33E-37	Response to antipsychotic treatment	
HNSC	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.63	-13.65	3.17E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.63	-13.73	1.46E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.61	-13.63	3.8E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.63	-13.45	2.31E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.6	-13.08	8.81E-34	Response to antipsychotic treatment	
HNSC	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.62	-13.61	4.92E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.62	-13.6	5.55E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12217477	chr10:81731756	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs12218176	chr10:81731372	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs12218952	chr10:81731392	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs12219080	chr10:81709279	LOC650623	chr10:81442731-81448648:+	-0.38	-4.22	2.94E-5	Rheumatoid arthritis	
HNSC	cis	1	rs12219158	chr10:102302923	SEC31B	chr10:102246403-102289636:-	-0.17	-5.42	9.53E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs12219789	chr10:102213778	SEC31B	chr10:102246403-102289636:-	-0.18	-5.74	1.62E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs12220777	chr10:81788104	LOC219347	chr10:81805991-81838949:-	-0.58	-7.04	6.61E-12	Chronic obstructive pulmonary disease-related biomarkers	
HNSC	cis	1	rs12232351	chr15:56140995	NEDD4	chr15:56119131-56285835:-	0.22	5.32	1.61E-7	Keloid	
HNSC	cis	1	rs12232914	chr2:70117176	GMCL1	chr2:70056818-70106727:+	0.12	3.74	0.000208	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs12237653	chr9:2551654	FLJ35024	chr9:2422702-2622373:-	0.41	6.03	3.21E-9	Gambling	
HNSC	cis	1	rs12241958	chr10:81731274	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs12242005	chr10:81731290	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs12243433	chr10:81732777	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs12245535	chr10:81733004	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs12247653	chr10:81731061	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs12247705	chr10:81731118	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs12264259	chr10:81732788	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs12286683	chr11:18348662	GTF2H1	chr11:18343816-18388590:+	0.33	5.64	2.93E-8	Pancreatic cancer	
HNSC	cis	1	rs12287832	chr11:65553492	SNX32	chr11:65601410-65621170:+	0.33	4.72	3.04E-6	Systemic lupus erythematosus	
HNSC	cis	1	rs12288023	chr11:67421341	SAPS3	chr11:68228186-68382799:+	-0.39	-3.99	7.46E-5	Serum metabolite levels	
HNSC	cis	1	rs12299125	chr12:123862447	CDK2AP1	chr12:123745542-123756687:-	-0.55	-9.52	7.44E-20	Educational attainment;Height;Head circumference (infant)	
HNSC	cis	1	rs12301299	chr12:991710	RAD52	chr12:1021255-1099219:-	-0.33	-5.31	1.64E-7	Colorectal cancer	
HNSC	cis	1	rs12309274	chr12:975948	RAD52	chr12:1021255-1099219:-	-0.33	-5.31	1.69E-7	Colorectal cancer	
HNSC	cis	1	rs12310837	chr12:120880572	SFRS9	chr12:120899472-120907558:-	-0.22	-3.68	0.000263	Type 1 diabetes nephropathy	
HNSC	cis	1	rs12310837	chr12:120880572	TRIAP1	chr12:120881765-120884215:-	-0.22	-4	7.37E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs12312603	chr12:988269	RAD52	chr12:1021255-1099219:-	-0.32	-5.3	1.76E-7	Colorectal cancer	
HNSC	cis	1	rs12317176	chr12:124404718	DNAH10	chr12:124247042-124420265:+	0.3	5.57	4.22E-8	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs12324912	chr15:75361006	SCAMP5	chr15:75287901-75313836:+	0.42	8.31	9.1E-16	Blood trace element (Zn levels)	
HNSC	cis	1	rs12325866	chr17:61755974	FTSJ3	chr17:61896795-61905031:-	0.21	3.82	0.000153	Body mass index	
HNSC	cis	1	rs12326600	chr18:44596497	HDHD2	chr18:44633782-44676871:-	0.39	4.33	1.82E-5	Sitting height ratio	
HNSC	cis	1	rs12332658	chr5:115545606	COMMD10	chr5:115420727-115628978:+	0.37	4.24	2.62E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs12333080	chr6:118845410	C6orf204	chr6:118786239-119031238:-	-0.25	-4.34	1.76E-5	Renal cell carcinoma	
HNSC	cis	1	rs12340629	chr9:21663529	CDKN2BAS	chr9:21994790-22121091:+	-0.22	-3.71	0.000229	Gut microbiome composition (winter)	
HNSC	cis	1	rs12350534	chr9:89558064	C9orf170	chr9:89763559-89774641:+	-0.3	-3.7	0.000237	White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	
HNSC	cis	1	rs12354411	chr10:102294537	SEC31B	chr10:102246403-102289636:-	-0.19	-5.79	1.23E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs12355721	chr10:102244911	SEC31B	chr10:102246403-102289636:-	-0.19	-5.82	1.05E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs12357418	chr10:37993860	LOC399744	chr10:38717074-38741080:+	0.27	3.66	0.000279	Obesity (extreme)	
HNSC	cis	1	rs12358094	chr10:38015506	LOC399744	chr10:38717074-38741080:+	0.28	3.72	0.000219	Obesity (extreme)	
HNSC	cis	1	rs12358108	chr10:38015607	LOC399744	chr10:38717074-38741080:+	0.28	3.72	0.000219	Obesity (extreme)	
HNSC	cis	1	rs12358187	chr10:102284449	SEC31B	chr10:102246403-102289636:-	-0.19	-5.82	1.04E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs12358475	chr10:11848792	ECHDC3	chr10:11784356-11806064:+	-0.29	-3.76	0.000193	Breast cancer (survival)	
HNSC	cis	1	rs12359272	chr10:97365163	ENTPD1	chr10:97471536-97637022:+	0.25	7.6	1.51E-13	Blood metabolite levels	
HNSC	cis	1	rs12360411	chr10:38046634	LOC399744	chr10:38717074-38741080:+	0.29	3.92	0.000103	Obesity (extreme)	
HNSC	cis	1	rs12361031	chr11:47783076	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.55	4.76E-8	Subjective well-being	
HNSC	cis	1	rs12361031	chr11:47783076	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.95	8.85E-5	Subjective well-being	
HNSC	cis	1	rs12363232	chr11:47623890	C1QTNF4	chr11:47611216-47615961:-	-0.3	-6.26	8.37E-10	Subjective well-being	
HNSC	cis	1	rs12363232	chr11:47623890	MYBPC3	chr11:47352958-47374253:-	-0.19	-3.74	0.000206	Subjective well-being	
HNSC	cis	1	rs12365551	chr11:58358368	ZFP91-CNTF	chr11:58346587-58393203:+	0.29	4.2	3.14E-5	Lymphoma	
HNSC	cis	1	rs12405451	chr1:46384326	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.71	6.99E-14	Body mass index	
HNSC	cis	1	rs12409773	chr1:46358831	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.43	4.76E-13	Body mass index	
HNSC	cis	1	rs12410060	chr1:75245848	CRYZ	chr1:75171175-75199092:-	-0.64	-12.43	4.95E-31	Resistin levels	
HNSC	cis	1	rs12410071	chr1:46358886	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.43	4.76E-13	Body mass index	
HNSC	cis	1	rs12411269	chr1:46271052	CCDC163P	chr1:45960581-45965646:-	-0.36	-7.75	5.25E-14	Body mass index	
HNSC	cis	1	rs12416687	chr10:104629011	AS3MT	chr10:104613967-104661653:+	-0.23	-4.45	1.05E-5	Arsenic metabolism	
HNSC	cis	1	rs12416687	chr10:104629011	C10orf32	chr10:104613967-104624718:+	-0.37	-6.42	3.26E-10	Arsenic metabolism	
HNSC	cis	1	rs12418852	chr11:47868853	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.43	9.04E-8	Subjective well-being	
HNSC	cis	1	rs12418852	chr11:47868853	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.92	0.000103	Subjective well-being	
HNSC	cis	1	rs12419692	chr11:47624714	C1QTNF4	chr11:47611216-47615961:-	0.28	5.87	8.1E-9	Subjective well-being	
HNSC	cis	1	rs12419692	chr11:47624714	MYBPC3	chr11:47352958-47374253:-	0.19	3.75	0.0002	Subjective well-being	
HNSC	cis	1	rs12421210	chr11:47779586	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.55	4.76E-8	Subjective well-being	
HNSC	cis	1	rs12421210	chr11:47779586	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.95	8.85E-5	Subjective well-being	
HNSC	cis	1	rs1242229	chr11:117062370	PCSK7	chr11:117075789-117102811:-	-0.35	-4.91	1.25E-6	Protein quantitative trait loci	
HNSC	cis	1	rs12428035	chr13:96300872	DZIP1	chr13:96229329-96296957:-	-0.28	-4.06	5.63E-5	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
HNSC	cis	1	rs12428035	chr13:96300872	UGGT2	chr13:96453838-96705736:-	0.24	3.94	9.21E-5	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
HNSC	cis	1	rs12429254	chr13:96299663	DZIP1	chr13:96229329-96296957:-	0.29	4.05	6.01E-5	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
HNSC	cis	1	rs12429254	chr13:96299663	UGGT2	chr13:96453838-96705736:-	-0.26	-4.14	4.11E-5	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
HNSC	cis	1	rs12431420	chr14:66001076	LOC645431	chr14:65877313-65879335:-	-0.28	-3.9	0.000111	Ischemic stroke	
HNSC	cis	1	rs12433827	chr14:66055610	LOC645431	chr14:65877313-65879335:-	-0.28	-3.77	0.000184	Ischemic stroke	
HNSC	cis	1	rs12434101	chr14:88478827	GPR65	chr14:88471496-88478414:+	0.14	4.01	6.99E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs12434585	chr14:65938368	LOC645431	chr14:65877313-65879335:-	-0.3	-3.97	8.12E-5	Ischemic stroke	
HNSC	cis	1	rs12435391	chr14:75601737	MLH3	chr14:75480467-75518235:-	0.31	6.42	3.19E-10	Height	
HNSC	cis	1	rs12435835	chr14:65499909	CHURC1	chr14:65381140-65411309:+	0.41	7.31	1.09E-12	Red blood cell traits	
HNSC	cis	1	rs12435908	chr14:66121468	LOC645431	chr14:65877313-65879335:-	0.26	3.75	0.000196	Ischemic stroke	
HNSC	cis	1	rs12443102	chr15:43932103	ADAL	chr15:43622872-43646094:+	-0.39	-5.33	1.5E-7	Tumor biomarkers	
HNSC	cis	1	rs12443102	chr15:43932103	CATSPER2	chr15:43922774-43959900:-	-0.32	-5.07	5.69E-7	Tumor biomarkers	
HNSC	cis	1	rs12443102	chr15:43932103	CKMT1A	chr15:43985084-43991419:+	-0.41	-5.43	9.01E-8	Tumor biomarkers	
HNSC	cis	1	rs12445650	chr16:31044897	HSD3B7	chr16:30996519-31000473:+	0.23	4.18	3.38E-5	Response to metformin (IC50)	
HNSC	cis	1	rs12445650	chr16:31044897	MYST1	chr16:31128985-31142713:+	0.24	5.83	9.79E-9	Response to metformin (IC50)	
HNSC	cis	1	rs12449000	chr16:89872970	FANCA	chr16:89803959-89883065:-	-0.22	-5.33	1.48E-7	Schizophrenia	
HNSC	cis	1	rs12460161	chr19:44293986	ZNF155	chr19:44488355-44502477:+	-0.21	-4.21	2.98E-5	Breast cancer	
HNSC	cis	1	rs12462270	chr19:39201488	LGALS7B	chr19:39279850-39282393:+	0.29	6.46	2.47E-10	Heart rate	
HNSC	cis	1	rs12464624	chr2:71734898	DYSF	chr2:71680753-71913892:+	-0.14	-4.05	6.0E-5	Urate levels in overweight individuals	
HNSC	cis	1	rs12468750	chr2:71734954	DYSF	chr2:71680753-71913892:+	-0.13	-3.83	0.000143	Urate levels in overweight individuals	
HNSC	cis	1	rs12470837	chr2:132582511	C2orf27A	chr2:132480064-132524977:+	0.38	6.24	9.53E-10	Cerebrospinal fluid clusterin levels in APOEe4+ carriers;Cerebrospinal fluid clusterin levels	
HNSC	cis	1	rs12472278	chr2:108873433	SULT1C2	chr2:108905095-108926370:+	-0.29	-4.81	1.97E-6	Blood pressure	
HNSC	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.49	-5.5	5.99E-8	Plasma clusterin levels	
HNSC	cis	1	rs12474969	chr2:9697067	ITGB1BP1	chr2:9545823-9563643:-	-0.18	-3.75	0.000199	Alcohol dependence (age at onset)	
HNSC	cis	1	rs12475412	chr2:70167197	GMCL1	chr2:70056818-70106727:+	0.13	3.98	7.96E-5	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs12477202	chr2:108867112	SULT1C2	chr2:108905095-108926370:+	0.31	5	8.07E-7	Blood pressure	
HNSC	cis	1	rs12486660	chr3:100024553	TBC1D23	chr3:99979686-100044078:+	0.22	4.2	3.15E-5	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs12486865	chr3:99956556	TBC1D23	chr3:99979686-100044078:+	0.23	4.56	6.57E-6	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs12487542	chr3:48426076	ATRIP	chr3:48488141-48507708:+	0.16	3.71	0.000232	Longevity	
HNSC	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.28	-6.9	1.6E-11	Longevity	
HNSC	cis	1	rs12490043	chr3:99947260	TBC1D23	chr3:99979686-100044078:+	0.23	4.43	1.17E-5	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs12490140	chr3:99962992	TBC1D23	chr3:99979686-100044078:+	0.26	5.07	5.52E-7	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs12490835	chr3:134223730	ANAPC13	chr3:134196547-134204865:-	0.5	10.54	1.47E-23	Height	
HNSC	cis	1	rs12490835	chr3:134223730	CEP63	chr3:134204575-134293852:+	0.28	6.11	1.99E-9	Height	
HNSC	cis	1	rs12492610	chr3:99946822	TBC1D23	chr3:99979686-100044078:+	0.23	4.5	8.3E-6	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs12500426	chr4:95514609	PDLIM5	chr4:95373038-95589376:+	-0.15	-3.77	0.000181	Prostate cancer	
HNSC	cis	1	rs12507142	chr4:17656103	FAM184B	chr4:17633711-17783135:-	-0.16	-3.96	8.68E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs12507142	chr4:17656103	LAP3	chr4:17578927-17609590:+	-0.14	-3.74	0.000206	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs12509366	chr4:107003343	TBCK	chr4:106967233-107237861:-	0.26	5.08	5.4E-7	Airflow obstruction	
HNSC	cis	1	rs12509640	chr4:106996677	TBCK	chr4:106967233-107237861:-	-0.27	-5.34	1.41E-7	Airflow obstruction	
HNSC	cis	1	rs12510966	chr4:106983604	TBCK	chr4:106967233-107237861:-	0.26	5.14	4.01E-7	Airflow obstruction	
HNSC	cis	1	rs12512683	chr4:106999471	TBCK	chr4:106967233-107237861:-	0.26	5.2	2.89E-7	Airflow obstruction	
HNSC	cis	1	rs12515251	chr5:115626966	COMMD10	chr5:115420727-115628978:+	0.36	3.9	0.000111	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs12515308	chr5:115450441	COMMD10	chr5:115420727-115628978:+	0.34	3.95	8.96E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs12515466	chr5:115591877	COMMD10	chr5:115420727-115628978:+	0.32	3.75	0.000197	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs12516418	chr5:112707789	YTHDC2	chr5:112849410-112930979:+	0.19	3.66	0.00028	Cerebral amyloid angiopathy	
HNSC	cis	1	rs12517431	chr5:156392248	TIMD4	chr5:156346293-156390266:-	-0.17	-4.27	2.36E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
HNSC	cis	1	rs12517508	chr5:115423574	COMMD10	chr5:115420727-115628978:+	0.35	4	7.4E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs12518722	chr5:151231460	G3BP1	chr5:151151476-151184913:+	-0.2	-3.65	0.000287	Preschool internalizing problems	
HNSC	cis	1	rs12520632	chr5:115591766	COMMD10	chr5:115420727-115628978:+	0.4	4.03	6.56E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs12521612	chr5:115582605	COMMD10	chr5:115420727-115628978:+	0.38	3.91	0.000104	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs12522027	chr5:115616531	COMMD10	chr5:115420727-115628978:+	0.36	3.9	0.00011	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs12522441	chr5:115523805	COMMD10	chr5:115420727-115628978:+	0.36	4.33	1.82E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs12523022	chr5:598643	SLC9A3	chr5:473334-524549:-	-0.22	-4.08	5.31E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs12523255	chr5:112722085	YTHDC2	chr5:112849410-112930979:+	0.19	3.71	0.00023	Cerebral amyloid angiopathy	
HNSC	cis	1	rs12525128	chr6:101174245	ASCC3	chr6:100956609-101329224:-	0.23	6	3.92E-9	Menarche (age at onset)	
HNSC	cis	1	rs12526217	chr6:130757720	EPB41L2	chr6:131160488-131384462:-	0.22	3.67	0.000266	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);Exploratory eye movement dysfunction in schizophrenia (cognitive search score);Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
HNSC	cis	1	rs12526680	chr6:26550954	BTN2A3	chr6:26422317-26431927:+	0.18	4.09	5.12E-5	Educational attainment	
HNSC	cis	1	rs12526680	chr6:26550954	BTN3A2	chr6:26365398-26378546:+	0.18	4.3	2.1E-5	Educational attainment	
HNSC	cis	1	rs12532998	chr7:65967459	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.94	2.04E-46	Aortic root size	
HNSC	cis	1	rs12533997	chr7:65965377	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.86	4.73E-46	Aortic root size	
HNSC	cis	1	rs12537549	chr7:3361023	C7orf27	chr7:2577511-2595146:-	-0.17	-4.01	7.14E-5	Motion sickness	
HNSC	cis	1	rs12537549	chr7:3361023	GNA12	chr7:2767743-2883959:-	-0.14	-3.71	0.000228	Motion sickness	
HNSC	cis	1	rs12543128	chr8:144595042	GSDMD	chr8:144635557-144645229:+	0.15	3.77	0.000181	Venous thromboembolism (SNP x SNP interaction)	
HNSC	cis	1	rs12545109	chr8:57313906	PENK	chr8:57353513-57359282:-	-0.34	-6.13	1.76E-9	Obesity-related traits	
HNSC	cis	1	rs12545771	chr8:8567977	FLJ10661	chr8:8086092-8102386:+	0.29	4.71	3.24E-6	Obesity-related traits	
HNSC	cis	1	rs12547721	chr8:8570671	FLJ10661	chr8:8086092-8102386:+	0.26	4.28	2.23E-5	Obesity-related traits	
HNSC	cis	1	rs12547941	chr8:29980332	MBOAT4	chr8:29989188-30002200:-	0.33	4.5	8.67E-6	Migraine	
HNSC	cis	1	rs12550458	chr8:8567832	FLJ10661	chr8:8086092-8102386:+	0.29	4.71	3.24E-6	Obesity-related traits	
HNSC	cis	1	rs12550762	chr8:8576535	FLJ10661	chr8:8086092-8102386:+	0.25	4.3	2.07E-5	Obesity-related traits	
HNSC	cis	1	rs12561806	chr1:46396776	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.74	5.76E-14	Body mass index	
HNSC	cis	1	rs12563631	chr1:156258953	BGLAP	chr1:156182784-156213112:+	0.19	3.67	0.000274	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs12564541	chr1:46380237	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.71	6.99E-14	Body mass index	
HNSC	cis	1	rs12567136	chr1:11883731	CLCN6	chr1:11866207-11907674:+	-0.22	-3.69	0.000252	QRS complex (12-leadsum)	
HNSC	cis	1	rs12569084	chr1:166943352	FMO9P	chr1:166573153-166594471:+	0.2	3.88	0.000116	Refractive astigmatism	
HNSC	cis	1	rs12571820	chr10:38009354	LOC399744	chr10:38717074-38741080:+	0.29	3.87	0.000121	Obesity (extreme)	
HNSC	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.39	-6.83	2.46E-11	Forced vital capacity	
HNSC	cis	1	rs12583	chr3:49571462	AMT	chr3:49454212-49460012:-	-0.18	-3.9	0.000112	Menarche (age at onset)	
HNSC	cis	1	rs12588240	chr14:75612083	MLH3	chr14:75480467-75518235:-	0.3	6.24	9.24E-10	Height	
HNSC	cis	1	rs12589376	chr14:75561152	MLH3	chr14:75480467-75518235:-	0.31	6.38	4.05E-10	Height	
HNSC	cis	1	rs12589815	chr14:75544101	MLH3	chr14:75480467-75518235:-	0.3	6.16	1.5E-9	Height	
HNSC	cis	1	rs12589876	chr14:75544189	MLH3	chr14:75480467-75518235:-	0.3	6.08	2.48E-9	Height	
HNSC	cis	1	rs12590452	chr14:75548756	MLH3	chr14:75480467-75518235:-	0.29	5.93	5.74E-9	Height	
HNSC	cis	1	rs1259180	chr15:83244680	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.16	-4.01	7.13E-5	Schizophrenia	
HNSC	cis	1	rs12597458	chr16:72030970	DHODH	chr16:72042643-72058954:+	-0.24	-5.21	2.73E-7	Prostate cancer	
HNSC	cis	1	rs12598978	chr16:30482540	LOC595101	chr16:30278914-30346695:-	0.21	3.75	0.0002	Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs12599931	chr16:58826531	GOT2	chr16:58741035-58768246:-	-0.26	-5.56	4.51E-8	Blood metabolite ratios	
HNSC	cis	1	rs12600855	chr17:28279591	EFCAB5	chr17:28256874-28435469:+	0.25	4.45	1.04E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs12600993	chr17:28291222	EFCAB5	chr17:28256874-28435469:+	0.22	4.05	5.97E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs12602901	chr17:4824625	GP1BA	chr17:4835592-4838324:+	-0.2	-3.77	0.000181	Blood metabolite levels	
HNSC	cis	1	rs12603327	chr17:40290552	DHX58	chr17:40253422-40264751:-	-0.34	-7.07	5.36E-12	Fibrinogen levels	
HNSC	cis	1	rs12603330	chr17:40290589	DHX58	chr17:40253422-40264751:-	-0.34	-7.07	5.37E-12	Fibrinogen levels	
HNSC	cis	1	rs12608504	chr19:18389135	KIAA1683	chr19:18367906-18385319:-	-0.25	-6.36	4.7E-10	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs12610373	chr19:18398284	KIAA1683	chr19:18367906-18385319:-	-0.25	-6.39	3.83E-10	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs12611088	chr19:44072802	PHLDB3	chr19:43979256-44008985:-	-0.15	-3.67	0.000265	Plasma amyloid beta peptide concentrations (ABx-42)	
HNSC	cis	1	rs12613947	chr2:70161342	GMCL1	chr2:70056818-70106727:+	0.12	3.75	0.000201	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs12616140	chr2:108867728	SULT1C2	chr2:108905095-108926370:+	0.29	4.75	2.66E-6	Blood pressure	
HNSC	cis	1	rs12618769	chr2:99239931	UNC50	chr2:99225042-99234975:+	0.25	4.24	2.67E-5	Bipolar disorder	
HNSC	cis	1	rs12620050	chr2:108919798	SULT1C2	chr2:108905095-108926370:+	0.46	7.53	2.45E-13	Lobe size	
HNSC	cis	1	rs12623494	chr2:99245917	UNC50	chr2:99225042-99234975:+	-0.26	-4.5	8.62E-6	Bipolar disorder	
HNSC	cis	1	rs12637751	chr3:134266124	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.52	1.7E-23	Height	
HNSC	cis	1	rs12637751	chr3:134266124	CEP63	chr3:134204575-134293852:+	-0.26	-5.68	2.27E-8	Height	
HNSC	cis	1	rs12638253	chr3:156626091	LEKR1	chr3:156544076-156763918:+	-0.21	-4.67	3.87E-6	Multiple sclerosis (severity)	
HNSC	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	0.74	12.64	6.26E-32	Diastolic blood pressure	
HNSC	cis	1	rs12642900	chr4:107010329	TBCK	chr4:106967233-107237861:-	0.26	5.2	2.99E-7	Airflow obstruction	
HNSC	cis	1	rs12651840	chr5:90729592	LOC100129716	chr5:90676164-90716531:+	0.3	4.21	3.04E-5	Smoking behavior	
HNSC	cis	1	rs12652003	chr5:150231945	LOC134466	chr5:150310000-150326146:-	0.47	5.68	2.31E-8	Crohn's disease	
HNSC	cis	1	rs12653750	chr5:131971902	SLC22A5	chr5:131705401-131731302:+	0.23	3.71	0.00023	Asthma (childhood onset)	
HNSC	cis	1	rs12654787	chr5:90713259	LOC100129716	chr5:90676164-90716531:+	0.29	4.04	6.23E-5	Smoking behavior	
HNSC	cis	1	rs12655973	chr5:90736537	LOC100129716	chr5:90676164-90716531:+	0.29	4.3	2.1E-5	Smoking behavior	
HNSC	cis	1	rs12656350	chr5:90751343	LOC100129716	chr5:90676164-90716531:+	0.3	4.26	2.41E-5	Smoking behavior	
HNSC	cis	1	rs12656538	chr5:150251380	LOC134466	chr5:150310000-150326146:-	0.5	6.3	6.55E-10	Crohn's disease	
HNSC	cis	1	rs12656600	chr5:150311872	LOC134466	chr5:150310000-150326146:-	0.54	7.19	2.49E-12	Crohn's disease	
HNSC	cis	1	rs12657266	chr5:156396003	TIMD4	chr5:156346293-156390266:-	-0.18	-4.43	1.18E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
HNSC	cis	1	rs12658240	chr5:81173265	ATG10	chr5:81267844-81551211:+	-0.24	-4.3	2.03E-5	Cognitive function	
HNSC	cis	1	rs12658259	chr5:81173250	ATG10	chr5:81267844-81551211:+	-0.27	-4.67	3.9E-6	Cognitive function	
HNSC	cis	1	rs12659118	chr5:150324622	LOC134466	chr5:150310000-150326146:-	0.57	7.02	7.6E-12	Crohn's disease	
HNSC	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.64	-13.5	1.5E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.61	-13.62	4.27E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.62	13.76	1.07E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12664322	chr6:87803671	C6orf164	chr6:88032306-88109459:+	0.23	4.48	9.41E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
HNSC	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.62	13.68	2.43E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.64	-13.57	7.56E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs1267657	chr15:83215251	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.18	-4.69	3.5E-6	Schizophrenia	
HNSC	cis	1	rs1267817	chr7:66110040	NCRNA00174	chr7:65841032-65865395:-	-0.47	-4.99	8.53E-7	Gout	
HNSC	cis	1	rs1267817	chr7:66110040	STAG3L4	chr7:66767616-66786512:+	-0.37	-4.06	5.65E-5	Gout	
HNSC	cis	1	rs1267818	chr7:66107024	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.91	1.21E-6	Gout	
HNSC	cis	1	rs1267818	chr7:66107024	STAG3L4	chr7:66767616-66786512:+	-0.37	-4.04	6.29E-5	Gout	
HNSC	cis	1	rs1267820	chr7:66050295	NCRNA00174	chr7:65841032-65865395:-	-0.48	-5.12	4.39E-7	Diabetic kidney disease	
HNSC	cis	1	rs1267820	chr7:66050295	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.21	3.04E-5	Diabetic kidney disease	
HNSC	cis	1	rs12680842	chr8:95582606	KIAA1429	chr8:95500600-95565688:-	-0.17	-3.69	0.000249	Body mass index	
HNSC	cis	1	rs12681963	chr8:29982518	MBOAT4	chr8:29989188-30002200:-	-0.33	-4.12	4.51E-5	Migraine	
HNSC	cis	1	rs12685591	chr9:21669886	CDKN2BAS	chr9:21994790-22121091:+	-0.26	-4.43	1.15E-5	Gut microbiome composition (winter)	
HNSC	cis	1	rs12691307	chr16:29939877	LOC595101	chr16:30278914-30346695:-	-0.21	-3.68	0.000255	Schizophrenia	
HNSC	cis	1	rs12692737	chr2:165554309	SLC38A11	chr2:165754812-165812035:-	0.23	4.5	8.64E-6	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
HNSC	cis	1	rs12698509	chr7:65418876	CRCP	chr7:65579805-65619551:+	-0.34	-4	7.25E-5	Diabetic kidney disease	
HNSC	cis	1	rs12698509	chr7:65418876	NCRNA00174	chr7:65841032-65865395:-	-0.47	-5.16	3.64E-7	Diabetic kidney disease	
HNSC	cis	1	rs12698523	chr7:65968113	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.84	5.47E-46	Aortic root size	
HNSC	cis	1	rs12698523	chr7:65968113	TYW1	chr7:66461817-66704496:+	0.2	3.69	0.000248	Aortic root size	
HNSC	cis	1	rs12700789	chr7:3358276	C7orf27	chr7:2577511-2595146:-	-0.17	-3.83	0.000143	Motion sickness	
HNSC	cis	1	rs12701220	chr7:1022728	ZFAND2A	chr7:1192544-1199855:-	-0.32	-4.78	2.3E-6	Bronchopulmonary dysplasia	
HNSC	cis	1	rs12709013	chr16:58829790	GOT2	chr16:58741035-58768246:-	0.26	5.58	3.89E-8	Blood metabolite ratios	
HNSC	cis	1	rs12709812	chr19:37794850	ZNF793	chr19:37997841-38034237:+	-0.27	-4.46	1.02E-5	Coronary artery calcification	
HNSC	cis	1	rs12710454	chr21:40656919	HMGN1	chr21:40714247-40721270:-	-0.18	-3.87	0.000123	Cognitive function	
HNSC	cis	1	rs12712612	chr2:38907605	GALM	chr2:38893052-38961908:+	0.33	5.02	7.24E-7	5-HTT brain serotonin transporter levels	
HNSC	cis	1	rs12713801	chr2:74202385	SLC4A5	chr2:74438733-74590554:-	0.27	3.77	0.000183	Systemic lupus erythematosus	
HNSC	cis	1	rs12741825	chr1:159670145	KCNJ9	chr1:160051360-160059212:+	0.21	3.82	0.000152	C-reactive protein levels or triglyceride levels (pleiotropy)	
HNSC	cis	1	rs12742376	chr1:27285195	PDIK1L	chr1:26437656-26452024:+	-0.28	-3.65	0.000285	HDL cholesterol;Triglycerides;LDL cholesterol	
HNSC	cis	1	rs12744221	chr1:145645606	NUDT17	chr1:145586494-145590461:-	0.26	5.22	2.64E-7	Epilepsy (remission after treatment)	
HNSC	cis	1	rs1275468	chr12:75935157	GLIPR1L2	chr12:75784889-75825591:+	-0.28	-4.72	3.04E-6	Polycystic ovary syndrome	
HNSC	cis	1	rs1275469	chr12:75935230	GLIPR1L2	chr12:75784889-75825591:+	-0.27	-4.6	5.48E-6	Polycystic ovary syndrome	
HNSC	cis	1	rs1275537	chr2:27441302	C2orf28	chr2:27434899-27440044:+	0.16	3.72	0.000219	Blood metabolite levels	
HNSC	cis	1	rs1275538	chr2:27441397	C2orf28	chr2:27434899-27440044:+	0.17	3.82	0.00015	Blood metabolite levels	
HNSC	cis	1	rs12755606	chr1:159670336	KCNJ9	chr1:160051360-160059212:+	0.21	3.82	0.000152	C-reactive protein levels or triglyceride levels (pleiotropy)	
HNSC	cis	1	rs12760175	chr1:46447840	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.3	1.18E-12	Body mass index	
HNSC	cis	1	rs12761224	chr10:72527517	C10orf27	chr10:72530995-72545157:-	0.31	3.79	0.00017	Prion diseases	
HNSC	cis	1	rs12763390	chr10:38084432	LOC399744	chr10:38717074-38741080:+	0.28	3.77	0.00018	Obesity (extreme)	
HNSC	cis	1	rs12763409	chr10:38092690	LOC399744	chr10:38717074-38741080:+	0.28	3.82	0.000149	Obesity (extreme)	
HNSC	cis	1	rs12766567	chr10:38035222	LOC399744	chr10:38717074-38741080:+	0.29	3.86	0.00013	Obesity (extreme)	
HNSC	cis	1	rs12769346	chr10:89764490	PAPSS2	chr10:89419476-89507460:+	-0.2	-3.92	0.000102	Type 2 diabetes	
HNSC	cis	1	rs12772239	chr10:37988944	LOC399744	chr10:38717074-38741080:+	0.27	3.66	0.000278	Obesity (extreme)	
HNSC	cis	1	rs12777243	chr10:91336117	FLJ37201	chr10:91451057-91457685:-	-0.28	-3.66	0.000279	Metabolic traits	
HNSC	cis	1	rs12781703	chr10:38044627	LOC399744	chr10:38717074-38741080:+	0.29	3.92	0.000103	Obesity (extreme)	
HNSC	cis	1	rs12782327	chr10:38092443	LOC399744	chr10:38717074-38741080:+	0.28	3.82	0.000149	Obesity (extreme)	
HNSC	cis	1	rs1278493	chr3:135814009	PCCB	chr3:135969167-136056737:+	-0.2	-4.49	8.71E-6	Gestational age at birth (child effect)	
HNSC	cis	1	rs12787330	chr11:47812311	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.55	4.67E-8	Subjective well-being	
HNSC	cis	1	rs12787330	chr11:47812311	MYBPC3	chr11:47352958-47374253:-	-0.21	-3.97	8.19E-5	Subjective well-being	
HNSC	cis	1	rs1278769	chr13:113536627	MCF2L	chr13:113622757-113752863:+	0.15	4.29	2.17E-5	Interstitial lung disease	
HNSC	cis	1	rs1279831	chr3:135933264	PCCB	chr3:135969167-136056737:+	0.21	4.8	2.12E-6	Gestational age at birth (child effect)	
HNSC	cis	1	rs12809125	chr12:124407991	DNAH10	chr12:124247042-124420265:+	0.3	5.54	4.97E-8	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs1281121	chr4:8202211	SH3TC1	chr4:8201060-8242828:+	-0.23	-3.81	0.000154	Response to metformin (IC50)	
HNSC	cis	1	rs1281124	chr4:8203416	SH3TC1	chr4:8201060-8242828:+	0.23	3.83	0.000147	Response to metformin (IC50)	
HNSC	cis	1	rs1281125	chr4:8203537	SH3TC1	chr4:8201060-8242828:+	0.24	3.97	8.23E-5	Response to metformin (IC50)	
HNSC	cis	1	rs12828040	chr12:7326541	PEX5	chr12:7341759-7371167:+	0.23	4.63	4.73E-6	IgG glycosylation	
HNSC	cis	1	rs12828421	chr12:7335217	PEX5	chr12:7341759-7371167:+	-0.24	-4.65	4.3E-6	IgG glycosylation	
HNSC	cis	1	rs1284464	chr12:57964617	TSFM	chr12:58176536-58191367:+	-0.2	-4.4	1.35E-5	Rheumatoid arthritis	
HNSC	cis	1	rs12879542	chr14:75507525	MLH3	chr14:75480467-75518235:-	0.33	6.86	2.09E-11	Height	
HNSC	cis	1	rs12879736	chr14:24674793	TSSK4	chr14:24674903-24677452:+	0.27	3.76	0.000187	Systolic blood pressure (cigarette smoking interaction)	
HNSC	cis	1	rs12886745	chr14:104523839	TDRD9	chr14:104394817-104519002:+	0.38	6.05	2.81E-9	Bipolar disorder	
HNSC	cis	1	rs12889168	chr14:104481957	TDRD9	chr14:104394817-104519002:+	0.35	5.65	2.72E-8	Bipolar disorder	
HNSC	cis	1	rs12889309	chr14:75593902	MLH3	chr14:75480467-75518235:-	0.31	6.36	4.53E-10	Height	
HNSC	cis	1	rs12889472	chr14:75543979	MLH3	chr14:75480467-75518235:-	0.3	6.18	1.38E-9	Height	
HNSC	cis	1	rs12897094	chr14:75579416	MLH3	chr14:75480467-75518235:-	0.3	6.19	1.25E-9	Height	
HNSC	cis	1	rs12898259	chr15:75369780	SCAMP5	chr15:75287901-75313836:+	0.37	7.53	2.39E-13	Blood trace element (Zn levels)	
HNSC	cis	1	rs12899592	chr15:89233041	ACAN	chr15:89346674-89418585:+	0.18	3.69	0.000252	Obesity-related traits	
HNSC	cis	1	rs12901243	chr15:75374233	SCAMP5	chr15:75287901-75313836:+	0.37	7.53	2.39E-13	Blood trace element (Zn levels)	
HNSC	cis	1	rs12902672	chr15:84716986	LOC388152	chr15:84867600-84898920:-	-0.28	-4.93	1.12E-6	Schizophrenia	
HNSC	cis	1	rs12903201	chr15:75370776	SCAMP5	chr15:75287901-75313836:+	0.37	7.53	2.39E-13	Blood trace element (Zn levels)	
HNSC	cis	1	rs12903820	chr15:84723820	LOC388152	chr15:84867600-84898920:-	-0.28	-4.97	9.13E-7	Schizophrenia	
HNSC	cis	1	rs12910644	chr15:75358388	SCAMP5	chr15:75287901-75313836:+	0.43	8.69	5.3E-17	Blood trace element (Zn levels)	
HNSC	cis	1	rs12915074	chr15:89238934	ACAN	chr15:89346674-89418585:+	0.19	3.77	0.000186	Obesity-related traits	
HNSC	cis	1	rs12915234	chr15:84758301	LOC388152	chr15:84867600-84898920:-	-0.28	-4.85	1.64E-6	Schizophrenia	
HNSC	cis	1	rs12916348	chr15:84765527	LOC388152	chr15:84867600-84898920:-	-0.28	-4.86	1.6E-6	Schizophrenia	
HNSC	cis	1	rs12926993	chr16:58823122	GOT2	chr16:58741035-58768246:-	-0.26	-5.39	1.08E-7	Blood metabolite ratios	
HNSC	cis	1	rs12930239	chr16:29908777	LOC440356	chr16:29875004-29879374:+	-0.19	-3.94	9.22E-5	Response to taxane treatment (placlitaxel)	
HNSC	cis	1	rs12936076	chr17:78601195	NPTX1	chr17:78440633-78450404:-	-0.2	-3.83	0.000145	Obesity	
HNSC	cis	1	rs12937756	chr17:40576813	NAGLU	chr17:40687951-40696464:+	-0.2	-4.05	6.05E-5	Crohn's disease	
HNSC	cis	1	rs12938856	chr17:40570649	NAGLU	chr17:40687951-40696464:+	-0.2	-3.99	7.7E-5	Crohn's disease	
HNSC	cis	1	rs12943498	chr17:40593901	NAGLU	chr17:40687951-40696464:+	-0.19	-3.68	0.000259	Crohn's disease	
HNSC	cis	1	rs12946636	chr17:46472432	HOXB2	chr17:46620021-46622393:-	-0.22	-3.71	0.000228	Epithelial ovarian cancer;Ovarian cancer	
HNSC	cis	1	rs12948099	chr17:79600799	RAC3	chr17:79989532-79992079:+	0.18	4.12	4.42E-5	Eye color traits	
HNSC	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.23	5.74	1.7E-8	Eye color traits	
HNSC	cis	1	rs12948909	chr17:40570602	NAGLU	chr17:40687951-40696464:+	-0.19	-3.74	0.000205	Crohn's disease	
HNSC	cis	1	rs12951549	chr17:40593502	NAGLU	chr17:40687951-40696464:+	-0.19	-3.68	0.000259	Crohn's disease	
HNSC	cis	1	rs12951640	chr17:40594298	NAGLU	chr17:40687951-40696464:+	-0.19	-3.68	0.000259	Crohn's disease	
HNSC	cis	1	rs12969657	chr18:67536496	CD226	chr18:67530195-67624232:-	0.11	4.32	1.89E-5	Type 1 diabetes;Type 1 diabetes autoantibodies	
HNSC	cis	1	rs12980225	chr19:23026745	ZNF492	chr19:22817126-22850472:+	-0.34	-5.51	5.8E-8	Bronchopulmonary dysplasia	
HNSC	cis	1	rs12980403	chr19:18398139	KIAA1683	chr19:18367906-18385319:-	-0.25	-6.38	4.15E-10	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs12983770	chr19:23023614	ZNF492	chr19:22817126-22850472:+	-0.34	-5.51	5.8E-8	Bronchopulmonary dysplasia	
HNSC	cis	1	rs1298472	chr4:8202841	SH3TC1	chr4:8201060-8242828:+	-0.26	-4.34	1.75E-5	Response to metformin (IC50)	
HNSC	cis	1	rs12992201	chr2:218312036	DIRC3	chr2:218148748-218621316:-	-0.35	-4.91	1.26E-6	Metabolite levels (MHPG)	
HNSC	cis	1	rs12994971	chr2:234178453	ATG16L1	chr2:234160217-234204319:+	0.27	4.66	4.13E-6	Crohn's disease	
HNSC	cis	1	rs12994997	chr2:234173503	ATG16L1	chr2:234160217-234204319:+	0.28	4.94	1.06E-6	Crohn's disease	
HNSC	cis	1	rs12995491	chr2:88527414	THNSL2	chr2:88469835-88486145:+	-0.24	-4.05	5.86E-5	Response to metformin (IC50)	
HNSC	cis	1	rs13003464	chr2:61186829	C2orf74	chr2:61372243-61391964:+	0.38	6.96	1.11E-11	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs13004237	chr2:172833139	DYNC1I2	chr2:172543982-172604919:+	-0.18	-4.15	3.87E-5	Schizophrenia	
HNSC	cis	1	rs13006376	chr2:38914251	GALM	chr2:38893052-38961908:+	0.33	5.02	7.12E-7	5-HTT brain serotonin transporter levels	
HNSC	cis	1	rs13009506	chr2:234175706	ATG16L1	chr2:234160217-234204319:+	-0.24	-4.26	2.42E-5	Crohn's disease	
HNSC	cis	1	rs13010022	chr2:38909706	GALM	chr2:38893052-38961908:+	0.32	4.59	5.64E-6	5-HTT brain serotonin transporter levels	
HNSC	cis	1	rs13012704	chr2:38918793	GALM	chr2:38893052-38961908:+	0.26	4.13	4.27E-5	5-HTT brain serotonin transporter levels	
HNSC	cis	1	rs13014235	chr2:202215492	PPIL3	chr2:201735680-201753999:-	-0.21	-4.33	1.85E-5	Basal cell carcinoma	
HNSC	cis	1	rs13015457	chr2:70125763	GMCL1	chr2:70056818-70106727:+	0.11	3.69	0.000248	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs13016963	chr2:202162811	CASP8	chr2:202098166-202152434:+	0.2	3.88	0.00012	Melanoma;Esophageal squamous cell carcinoma	
HNSC	cis	1	rs13032333	chr2:9620701	ITGB1BP1	chr2:9545823-9563643:-	-0.19	-3.81	0.000156	Alcohol dependence (age at onset)	
HNSC	cis	1	rs13038305	chr20:23610262	CST1	chr20:23728191-23731574:-	0.33	5.13	4.24E-7	Chronic kidney disease	
HNSC	cis	1	rs13038305	chr20:23610262	CST4	chr20:23666277-23669662:-	0.26	4.23	2.77E-5	Chronic kidney disease	
HNSC	cis	1	rs13039536	chr20:23612305	CST1	chr20:23728191-23731574:-	0.33	5.17	3.44E-7	Chronic kidney disease	
HNSC	cis	1	rs13039536	chr20:23612305	CST4	chr20:23666277-23669662:-	0.26	4.24	2.67E-5	Chronic kidney disease	
HNSC	cis	1	rs13040018	chr20:31720864	PLUNC	chr20:31823802-31831114:+	0.22	3.78	0.000177	Ulcerative colitis	
HNSC	cis	1	rs13041070	chr20:23614261	CST1	chr20:23728191-23731574:-	0.34	5.23	2.57E-7	Chronic kidney disease	
HNSC	cis	1	rs13041070	chr20:23614261	CST4	chr20:23666277-23669662:-	0.27	4.36	1.58E-5	Chronic kidney disease	
HNSC	cis	1	rs13041953	chr20:55081353	C20orf43	chr20:55043647-55093942:+	0.23	4.68	3.75E-6	Refractive astigmatism	
HNSC	cis	1	rs13043526	chr20:55088798	C20orf43	chr20:55043647-55093942:+	0.2	4.02	6.8E-5	Refractive astigmatism	
HNSC	cis	1	rs13056719	chr22:24724099	POM121L9P	chr22:24647589-24661490:+	-0.31	-6.63	8.72E-11	Gut microbiome composition (summer)	
HNSC	cis	1	rs13058817	chr3:53024139	TMEM110	chr3:52867139-52931547:-	0.45	5.16	3.53E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs13059720	chr3:134242021	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.52	1.69E-23	Height	
HNSC	cis	1	rs13059720	chr3:134242021	CEP63	chr3:134204575-134293852:+	-0.26	-5.68	2.3E-8	Height	
HNSC	cis	1	rs13069006	chr3:52973305	TMEM110	chr3:52867139-52931547:-	0.53	5.97	4.51E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs13069724	chr3:48478039	TREX1	chr3:48501186-48509043:+	-0.29	-7.33	9.27E-13	Longevity	
HNSC	cis	1	rs13071337	chr3:48438189	ATRIP	chr3:48488141-48507708:+	0.16	3.68	0.000263	Longevity	
HNSC	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.28	-6.93	1.32E-11	Longevity	
HNSC	cis	1	rs13071551	chr3:134310867	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.65	5.7E-24	Height	
HNSC	cis	1	rs13071551	chr3:134310867	CEP63	chr3:134204575-134293852:+	-0.27	-5.86	8.58E-9	Height	
HNSC	cis	1	rs13072395	chr3:52980573	TMEM110	chr3:52867139-52931547:-	0.54	6.04	3.09E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs13072457	chr3:53102389	TMEM110	chr3:52867139-52931547:-	0.5	5.88	7.69E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs13072818	chr3:53074263	PHF7	chr3:52444527-52457656:+	0.39	3.9	0.000108	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs13072818	chr3:53074263	TMEM110	chr3:52867139-52931547:-	0.46	5.18	3.23E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs13074524	chr3:52974184	TMEM110	chr3:52867139-52931547:-	0.52	6.04	3.02E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs13076076	chr3:48479039	TREX1	chr3:48501186-48509043:+	-0.26	-6.41	3.32E-10	Longevity	
HNSC	cis	1	rs13078971	chr3:53103645	TMEM110	chr3:52867139-52931547:-	0.5	5.87	8.07E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs13081177	chr3:134289860	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.55	1.37E-23	Height	
HNSC	cis	1	rs13081177	chr3:134289860	CEP63	chr3:134204575-134293852:+	-0.27	-5.71	1.98E-8	Height	
HNSC	cis	1	rs13081688	chr3:134259954	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.52	1.69E-23	Height	
HNSC	cis	1	rs13081688	chr3:134259954	CEP63	chr3:134204575-134293852:+	-0.26	-5.68	2.3E-8	Height	
HNSC	cis	1	rs13083794	chr3:121464928	IQCB1	chr3:121488610-121553926:-	0.24	6.07	2.53E-9	Cognitive performance	
HNSC	cis	1	rs13087578	chr3:121369207	IQCB1	chr3:121488610-121553926:-	0.24	5.99	4.13E-9	Cognitive performance	
HNSC	cis	1	rs13087719	chr3:41951576	ULK4	chr3:41288091-42003660:-	-0.78	-13.73	1.41E-36	Diastolic blood pressure	
HNSC	cis	1	rs13087875	chr3:134261123	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.52	1.7E-23	Height	
HNSC	cis	1	rs13087875	chr3:134261123	CEP63	chr3:134204575-134293852:+	-0.26	-5.68	2.27E-8	Height	
HNSC	cis	1	rs13088281	chr3:53147576	TMEM110	chr3:52867139-52931547:-	-0.44	-5.11	4.58E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs13088309	chr3:49368317	AMT	chr3:49454212-49460012:-	0.19	4.3	2.03E-5	Menarche (age at onset)	
HNSC	cis	1	rs13089966	chr3:134279197	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.5	2.08E-23	Height	
HNSC	cis	1	rs13089966	chr3:134279197	CEP63	chr3:134204575-134293852:+	-0.26	-5.64	2.83E-8	Height	
HNSC	cis	1	rs13090969	chr3:134307257	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.63	6.45E-24	Height	
HNSC	cis	1	rs13090969	chr3:134307257	CEP63	chr3:134204575-134293852:+	-0.27	-5.81	1.14E-8	Height	
HNSC	cis	1	rs13091785	chr3:48494098	ATRIP	chr3:48488141-48507708:+	0.17	3.88	0.000119	Longevity	
HNSC	cis	1	rs13091785	chr3:48494098	TREX1	chr3:48501186-48509043:+	-0.31	-7.64	1.1E-13	Longevity	
HNSC	cis	1	rs13091844	chr3:53010271	TMEM110	chr3:52867139-52931547:-	0.45	5.01	7.71E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs13092352	chr3:52969697	TMEM110	chr3:52867139-52931547:-	0.53	6.12	1.86E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs13096474	chr3:49443081	AMT	chr3:49454212-49460012:-	-0.2	-4.69	3.46E-6	Menarche (age at onset)	
HNSC	cis	1	rs13096604	chr3:134250099	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.52	1.69E-23	Height	
HNSC	cis	1	rs13096604	chr3:134250099	CEP63	chr3:134204575-134293852:+	-0.26	-5.68	2.3E-8	Height	
HNSC	cis	1	rs13099	chr14:75599155	MLH3	chr14:75480467-75518235:-	-0.33	-6.68	6.36E-11	Height	
HNSC	cis	1	rs13106338	chr4:17676871	FAM184B	chr4:17633711-17783135:-	0.2	4.83	1.81E-6	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs13106338	chr4:17676871	LAP3	chr4:17578927-17609590:+	0.16	4.24	2.63E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs13107797	chr4:108928069	HADH	chr4:108910940-108956330:+	-0.28	-4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs13109003	chr4:129975969	C4orf33	chr4:130014829-130033842:+	-0.46	-8.85	1.55E-17	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs13118159	chr4:1365127	CRIPAK	chr4:1385340-1389782:+	0.19	3.82	0.000148	Longevity	
HNSC	cis	1	rs13119927	chr4:17691640	LAP3	chr4:17578927-17609590:+	0.16	4.13	4.19E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs13130762	chr4:130022875	C4orf33	chr4:130014829-130033842:+	-0.48	-9.73	1.39E-20	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs13136331	chr4:88707081	IBSP	chr4:88720702-88733599:+	0.2	3.82	0.000148	Sitting height ratio	
HNSC	cis	1	rs13148900	chr4:71361114	AMTN	chr4:71384298-71398459:+	-0.22	-3.83	0.000144	Alcoholism (heaviness of drinking)	
HNSC	cis	1	rs13161048	chr5:148615269	AFAP1L1	chr5:148651401-148721365:+	-0.21	-4.19	3.33E-5	Body mass index	
HNSC	cis	1	rs13169155	chr5:156426663	TIMD4	chr5:156346293-156390266:-	-0.16	-3.67	0.00027	Hypertriglyceridemia	
HNSC	cis	1	rs13169465	chr5:156426916	TIMD4	chr5:156346293-156390266:-	-0.16	-3.73	0.000212	Hypertriglyceridemia	
HNSC	cis	1	rs1317149	chr11:47486885	C1QTNF4	chr11:47611216-47615961:-	-0.29	-5.99	3.99E-9	Subjective well-being	
HNSC	cis	1	rs1317149	chr11:47486885	MYBPC3	chr11:47352958-47374253:-	-0.19	-3.78	0.000174	Subjective well-being	
HNSC	cis	1	rs13171669	chr5:148601243	AFAP1L1	chr5:148651401-148721365:+	0.21	4.18	3.47E-5	Body mass index	
HNSC	cis	1	rs131801	chr22:50966634	TYMP	chr22:50964184-50968514:-	0.17	5.01	7.61E-7	Mean corpuscular hemoglobin	
HNSC	cis	1	rs13187289	chr5:133849177	CDKN2AIPNL	chr5:133737835-133747589:-	0.26	4.38	1.47E-5	Menarche (age at onset)	
HNSC	cis	1	rs13187289	chr5:133849177	UBE2B	chr5:133706870-133727798:+	0.25	4.3	2.05E-5	Menarche (age at onset)	
HNSC	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.62	-13.67	2.74E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs13195401	chr6:26463574	BTN3A2	chr6:26365398-26378546:+	-0.86	-11.66	6.67E-28	Schizophrenia	
HNSC	cis	1	rs13195402	chr6:26463575	BTN3A2	chr6:26365398-26378546:+	-0.86	-11.66	6.67E-28	Schizophrenia	
HNSC	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.63	-13.49	1.61E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.59	-13.56	7.97E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs1319987	chr6:118782236	C6orf204	chr6:118786239-119031238:-	-0.25	-4.41	1.3E-5	Renal cell carcinoma	
HNSC	cis	1	rs1319988	chr6:118782379	C6orf204	chr6:118786239-119031238:-	-0.25	-4.41	1.3E-5	Renal cell carcinoma	
HNSC	cis	1	rs13200462	chr6:28218199	ZNF389	chr6:28129551-28137375:+	-0.28	-4.29	2.11E-5	Depression	
HNSC	cis	1	rs13200462	chr6:28218199	ZSCAN23	chr6:28393287-28411279:-	0.25	3.88	0.000117	Depression	
HNSC	cis	1	rs13201083	chr6:89918597	GABRR1	chr6:89887223-89927496:-	0.34	4.84	1.75E-6	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs1320893	chr7:143752112	ARHGEF35	chr7:143883677-143892736:-	-0.33	-7.03	6.81E-12	Obesity-related traits	
HNSC	cis	1	rs1320893	chr7:143752112	OR2A7	chr7:143955790-143974852:-	0.21	3.98	8.01E-5	Obesity-related traits	
HNSC	cis	1	rs1320894	chr7:143751802	ARHGEF35	chr7:143883677-143892736:-	-0.35	-7.62	1.28E-13	Obesity-related traits	
HNSC	cis	1	rs1321479	chr6:26501897	BTN3A2	chr6:26365398-26378546:+	-0.17	-4.09	5.06E-5	Educational attainment	
HNSC	cis	1	rs1321480	chr6:26532742	BTN3A2	chr6:26365398-26378546:+	0.19	4.47	9.93E-6	Educational attainment	
HNSC	cis	1	rs1321481	chr6:26538210	BTN2A3	chr6:26422317-26431927:+	0.16	3.69	0.00025	Educational attainment	
HNSC	cis	1	rs1321481	chr6:26538210	BTN3A2	chr6:26365398-26378546:+	0.18	4.26	2.49E-5	Educational attainment	
HNSC	cis	1	rs13215017	chr6:89918264	GABRR1	chr6:89887223-89927496:-	0.34	4.87	1.54E-6	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs13215566	chr6:89918638	GABRR1	chr6:89887223-89927496:-	0.29	4.37	1.49E-5	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.62	-14.09	3.89E-38	Response to antipsychotic treatment	
HNSC	cis	1	rs1321798	chr6:117731192	ROS1	chr6:117609530-117747018:-	-0.18	-3.94	9.17E-5	Lung cancer	
HNSC	cis	1	rs1321799	chr6:117731177	ROS1	chr6:117609530-117747018:-	0.18	4.04	6.16E-5	Lung cancer	
HNSC	cis	1	rs1321816	chr6:117734533	ROS1	chr6:117609530-117747018:-	-0.18	-4.02	6.63E-5	Lung cancer	
HNSC	cis	1	rs13220495	chr6:26441640	BTN3A2	chr6:26365398-26378546:+	-0.89	-11.88	8.47E-29	Schizophrenia	
HNSC	cis	1	rs13220510	chr6:56779141	BEND6	chr6:56819773-56892138:+	-0.4	-6.97	1.04E-11	Menarche (age at onset)	
HNSC	cis	1	rs13220510	chr6:56779141	RAB23	chr6:57053591-57087101:-	0.22	3.94	9.4E-5	Menarche (age at onset)	
HNSC	cis	1	rs13220979	chr7:65363204	CRCP	chr7:65579805-65619551:+	-0.34	-4.07	5.5E-5	Diabetic kidney disease	
HNSC	cis	1	rs13220979	chr7:65363204	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.76	2.59E-6	Diabetic kidney disease	
HNSC	cis	1	rs1322319	chr10:38145509	LOC399744	chr10:38717074-38741080:+	0.28	3.76	0.000188	Obesity (extreme)	
HNSC	cis	1	rs13226728	chr7:143746578	ARHGEF35	chr7:143883677-143892736:-	-0.35	-7.38	6.7E-13	Obesity-related traits	
HNSC	cis	1	rs13230698	chr7:3361125	C7orf27	chr7:2577511-2595146:-	-0.17	-4.01	7.14E-5	Motion sickness	
HNSC	cis	1	rs13230698	chr7:3361125	GNA12	chr7:2767743-2883959:-	-0.14	-3.71	0.000228	Motion sickness	
HNSC	cis	1	rs13233521	chr7:102593794	FAM185A	chr7:102389399-102467706:+	0.22	3.81	0.000157	Morning vs. evening chronotype	
HNSC	cis	1	rs13235972	chr7:65883605	NCRNA00174	chr7:65841032-65865395:-	-0.47	-5.09	4.98E-7	Diabetic kidney disease	
HNSC	cis	1	rs13235972	chr7:65883605	STAG3L4	chr7:66767616-66786512:+	-0.38	-4.21	2.99E-5	Diabetic kidney disease	
HNSC	cis	1	rs13237037	chr7:65997882	NCRNA00174	chr7:65841032-65865395:-	-0.49	-5.17	3.49E-7	Diabetic kidney disease	
HNSC	cis	1	rs13237037	chr7:65997882	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.21	3.09E-5	Diabetic kidney disease	
HNSC	cis	1	rs13239254	chr7:110917686	IMMP2L	chr7:110303110-111202538:-	0.21	3.75	0.000198	Schizophrenia	
HNSC	cis	1	rs13239306	chr7:66136017	NCRNA00174	chr7:65841032-65865395:-	0.53	9.9	3.44E-21	Aortic root size	
HNSC	cis	1	rs13240464	chr7:110898915	IMMP2L	chr7:110303110-111202538:-	0.21	3.67	0.000273	Schizophrenia	
HNSC	cis	1	rs13243677	chr7:143746572	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.31	1.06E-12	Obesity-related traits	
HNSC	cis	1	rs13243677	chr7:143746572	OR2A7	chr7:143955790-143974852:-	0.2	3.75	0.000194	Obesity-related traits	
HNSC	cis	1	rs13247184	chr7:65358928	CRCP	chr7:65579805-65619551:+	-0.33	-3.84	0.000141	Diabetic kidney disease	
HNSC	cis	1	rs13247184	chr7:65358928	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.38	1.43E-5	Diabetic kidney disease	
HNSC	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	0.83	18.7	2.32E-59	Bone mineral density	
HNSC	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	0.82	18.59	7.95E-59	Bone mineral density	
HNSC	cis	1	rs13255935	chr8:95965685	TP53INP1	chr8:95938201-95961615:-	-0.18	-4.45	1.06E-5	Type 2 diabetes	
HNSC	cis	1	rs13256369	chr8:8577379	FLJ10661	chr8:8086092-8102386:+	0.23	3.97	8.41E-5	Obesity-related traits	
HNSC	cis	1	rs13266699	chr8:8570313	FLJ10661	chr8:8086092-8102386:+	-0.26	-4.28	2.22E-5	Obesity-related traits	
HNSC	cis	1	rs13267501	chr8:8574058	FLJ10661	chr8:8086092-8102386:+	0.26	4.4	1.31E-5	Obesity-related traits	
HNSC	cis	1	rs13268130	chr8:11116321	AMAC1L2	chr8:11188495-11189695:+	0.31	3.88	0.000117	Response to antipsychotic therapy (extrapyramidal side effects)	
HNSC	cis	1	rs13271966	chr8:8575472	FLJ10661	chr8:8086092-8102386:+	0.26	4.38	1.43E-5	Obesity-related traits	
HNSC	cis	1	rs1327866	chr1:166952910	FMO9P	chr1:166573153-166594471:+	-0.23	-4.37	1.5E-5	Refractive astigmatism	
HNSC	cis	1	rs13282915	chr8:8570891	FLJ10661	chr8:8086092-8102386:+	0.27	4.47	9.53E-6	Obesity-related traits	
HNSC	cis	1	rs13308002	chr7:97620247	ACN9	chr7:96745905-96811073:+	0.32	3.77	0.000185	Sudden cardiac arrest	
HNSC	cis	1	rs13308002	chr7:97620247	MGC72080	chr7:97503667-97601638:-	0.49	5.71	1.93E-8	Sudden cardiac arrest	
HNSC	cis	1	rs13310597	chr7:65598540	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs1331215	chr20:3376565	ITPA	chr20:3190056-3204504:+	-0.2	-4.09	5.0E-5	IFN-related cytopenia	
HNSC	cis	1	rs13314659	chr3:48449149	ATRIP	chr3:48488141-48507708:+	-0.16	-3.73	0.000215	Longevity	
HNSC	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.27	6.96	1.09E-11	Longevity	
HNSC	cis	1	rs13322305	chr3:134310791	ANAPC13	chr3:134196547-134204865:-	0.49	10.57	1.09E-23	Height	
HNSC	cis	1	rs13322305	chr3:134310791	CEP63	chr3:134204575-134293852:+	0.27	5.8	1.16E-8	Height	
HNSC	cis	1	rs13322887	chr3:49555583	AMT	chr3:49454212-49460012:-	-0.18	-3.85	0.000135	Menarche (age at onset)	
HNSC	cis	1	rs13324903	chr3:195086647	C3orf21	chr3:194789015-194991895:-	-0.16	-3.66	0.00028	Body mass index	
HNSC	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.64	9.65	2.6E-20	Diastolic blood pressure	
HNSC	cis	1	rs13331733	chr16:29848417	LOC440356	chr16:29875004-29879374:+	-0.23	-3.77	0.000186	Multiple sclerosis	
HNSC	cis	1	rs13332078	chr16:29850705	LOC440356	chr16:29875004-29879374:+	-0.23	-3.68	0.000263	Multiple sclerosis	
HNSC	cis	1	rs13333317	chr16:67872251	GFOD2	chr16:67708437-67753273:-	-0.25	-3.68	0.000264	Crohn's disease	
HNSC	cis	1	rs13335998	chr16:4651921	NMRAL1	chr16:4511696-4526307:-	-0.57	-5.59	3.76E-8	Obesity-related traits	
HNSC	cis	1	rs13339239	chr16:67809401	GFOD2	chr16:67708437-67753273:-	-0.26	-3.86	0.000127	Crohn's disease	
HNSC	cis	1	rs13357258	chr5:115444166	COMMD10	chr5:115420727-115628978:+	0.34	3.95	8.96E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs13358361	chr5:82456056	XRCC4	chr5:82373317-82649577:+	-0.2	-3.84	0.000139	Hypertension	
HNSC	cis	1	rs13361189	chr5:150223387	LOC134466	chr5:150310000-150326146:-	0.38	5.13	4.17E-7	Crohn's disease	
HNSC	cis	1	rs13362043	chr5:115596262	COMMD10	chr5:115420727-115628978:+	0.32	3.75	0.000197	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.61	-13.6	5.15E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.63	-13.77	1.01E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs13383762	chr2:38907001	GALM	chr2:38893052-38961908:+	0.32	4.94	1.05E-6	5-HTT brain serotonin transporter levels	
HNSC	cis	1	rs13383871	chr2:73631779	ALMS1P	chr2:73872046-73912692:+	0.25	4.09	4.99E-5	Metabolite levels	
HNSC	cis	1	rs13385191	chr2:20888265	C2orf43	chr2:20883803-21022827:-	-0.37	-5.86	8.62E-9	Prostate cancer	
HNSC	cis	1	rs13387221	chr2:44135314	LRPPRC	chr2:44113363-44223144:-	-0.24	-4.99	8.57E-7	Intelligence (childhood)	
HNSC	cis	1	rs13391356	chr2:234170369	ATG16L1	chr2:234160217-234204319:+	0.27	4.79	2.18E-6	Crohn's disease	
HNSC	cis	1	rs1339494	chr1:150001470	HORMAD1	chr1:150670542-150693352:-	0.25	3.66	0.000283	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
HNSC	cis	1	rs1339580	chr10:60027122	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1339580	chr10:60027122	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1339582	chr10:59937183	CISD1	chr10:60028895-60049018:+	0.25	4.38	1.45E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1339582	chr10:59937183	IPMK	chr10:59955618-60027694:-	0.26	6.31	6.04E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1339583	chr10:59937003	CISD1	chr10:60028895-60049018:+	0.24	4.31	1.94E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1339583	chr10:59937003	IPMK	chr10:59955618-60027694:-	0.26	6.32	5.86E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1339584	chr10:59936857	CISD1	chr10:60028895-60049018:+	0.25	4.38	1.45E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1339584	chr10:59936857	IPMK	chr10:59955618-60027694:-	0.26	6.31	6.04E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1339585	chr10:59936841	CISD1	chr10:60028895-60049018:+	0.25	4.42	1.2E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1339585	chr10:59936841	IPMK	chr10:59955618-60027694:-	0.27	6.55	1.45E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1339586	chr10:60017646	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1339586	chr10:60017646	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1339588	chr10:59998210	CISD1	chr10:60028895-60049018:+	0.24	4.22	2.86E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1339588	chr10:59998210	IPMK	chr10:59955618-60027694:-	0.28	6.74	4.34E-11	Inflammatory bowel disease	
HNSC	cis	1	rs13398075	chr2:202376269	PPIL3	chr2:201735680-201753999:-	0.36	4.39	1.39E-5	Rheumatoid arthritis	
HNSC	cis	1	rs13398956	chr2:73720258	ALMS1P	chr2:73872046-73912692:+	0.26	4.32	1.87E-5	Metabolite levels	
HNSC	cis	1	rs13408294	chr2:202171573	PPIL3	chr2:201735680-201753999:-	-0.53	-7.65	1.06E-13	Rheumatoid arthritis	
HNSC	cis	1	rs1341759	chr6:26195502	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.57E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs13421462	chr2:73719875	ALMS1P	chr2:73872046-73912692:+	0.26	4.36	1.57E-5	Metabolite levels	
HNSC	cis	1	rs13424612	chr2:240900121	NDUFA10	chr2:240900158-240964798:-	0.22	4.12	4.36E-5	Odorant perception (isobutyraldehyde)	
HNSC	cis	1	rs13426118	chr2:203255485	NOP58	chr2:203130515-203168382:+	0.22	3.89	0.000115	Urate levels	
HNSC	cis	1	rs13428235	chr2:73633430	ALMS1P	chr2:73872046-73912692:+	0.25	4.24	2.68E-5	Metabolite levels	
HNSC	cis	1	rs13431267	chr2:73782200	ALMS1P	chr2:73872046-73912692:+	0.25	4.14	4.13E-5	Metabolite levels	
HNSC	cis	1	rs13432605	chr2:73810981	ALMS1P	chr2:73872046-73912692:+	0.25	4.21	2.99E-5	Metabolite levels	
HNSC	cis	1	rs13436667	chr5:82464767	XRCC4	chr5:82373317-82649577:+	-0.2	-3.87	0.000125	Hypertension	
HNSC	cis	1	rs13437605	chr6:118899014	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.54E-5	Renal cell carcinoma	
HNSC	cis	1	rs13438327	chr7:97620691	MGC72080	chr7:97503667-97601638:-	0.41	4.92	1.17E-6	Sudden cardiac arrest	
HNSC	cis	1	rs134869	chr22:42652074	CYP2D6	chr22:42522502-42526883:-	-0.42	-11.44	4.66E-27	Cognitive function	
HNSC	cis	1	rs134873	chr22:42657566	CYP2D6	chr22:42522502-42526883:-	-0.41	-11.18	5.0E-26	Cognitive function	
HNSC	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.39	-10.61	8.23E-24	Cognitive function	
HNSC	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.39	-10.57	1.08E-23	Cognitive function	
HNSC	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.4	-10.83	1.15E-24	Cognitive function	
HNSC	cis	1	rs1351452	chr11:116943354	PCSK7	chr11:117075789-117102811:-	0.29	4.11	4.61E-5	Protein quantitative trait loci	
HNSC	cis	1	rs1355412	chr8:29985683	MBOAT4	chr8:29989188-30002200:-	0.3	4.11	4.72E-5	Migraine	
HNSC	cis	1	rs1357762	chr3:134264859	ANAPC13	chr3:134196547-134204865:-	0.48	10.3	1.12E-22	Height	
HNSC	cis	1	rs1357762	chr3:134264859	CEP63	chr3:134204575-134293852:+	0.27	5.85	8.75E-9	Height	
HNSC	cis	1	rs1358023	chr3:133484393	TF	chr3:133419211-133497635:+	-0.3	-5.54	4.9E-8	Iron status biomarkers	
HNSC	cis	1	rs1359239	chr6:80956146	BCKDHB	chr6:80816344-81055987:+	0.16	3.77	0.00018	Sitting height ratio	
HNSC	cis	1	rs1361353	chr10:59938091	CISD1	chr10:60028895-60049018:+	0.25	4.38	1.45E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1361353	chr10:59938091	IPMK	chr10:59955618-60027694:-	0.26	6.31	6.04E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1363055	chr7:65943275	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.88	3.77E-46	Aortic root size	
HNSC	cis	1	rs1363055	chr7:65943275	TYW1	chr7:66461817-66704496:+	0.2	3.66	0.000278	Aortic root size	
HNSC	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.65	-11.62	9.44E-28	Type 2 diabetes	
HNSC	cis	1	rs1374469	chr4:1724799	FAM53A	chr4:1641609-1685854:-	-0.35	-6	3.74E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs1382363	chr5:82452572	XRCC4	chr5:82373317-82649577:+	-0.2	-3.94	9.29E-5	Hypertension	
HNSC	cis	1	rs1382364	chr5:82452496	XRCC4	chr5:82373317-82649577:+	-0.2	-3.94	9.29E-5	Hypertension	
HNSC	cis	1	rs1382366	chr5:82452171	XRCC4	chr5:82373317-82649577:+	-0.2	-3.84	0.000139	Hypertension	
HNSC	cis	1	rs1382368	chr5:82451075	XRCC4	chr5:82373317-82649577:+	-0.2	-3.84	0.000139	Hypertension	
HNSC	cis	1	rs1382369	chr5:82441429	XRCC4	chr5:82373317-82649577:+	-0.21	-4.02	6.69E-5	Hypertension	
HNSC	cis	1	rs1382371	chr5:82441119	XRCC4	chr5:82373317-82649577:+	-0.21	-4.06	5.74E-5	Hypertension	
HNSC	cis	1	rs1382372	chr5:82441056	XRCC4	chr5:82373317-82649577:+	-0.21	-4.06	5.74E-5	Hypertension	
HNSC	cis	1	rs138544659	chr15:78900701	CHRNA5	chr15:78857906-78886458:+	-0.26	-5.14	3.9E-7	Post bronchodilator FEV1;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs1388527	chr11:6948441	ZNF215	chr11:6947654-7005861:+	-0.37	-5.83	9.82E-9	Response to cytadine analogues (cytosine arabinoside)	
HNSC	cis	1	rs1390006	chr17:56890663	RAD51C	chr17:56769963-56811690:+	-0.33	-8.66	6.84E-17	Cognitive test performance	
HNSC	cis	1	rs1392104	chr7:65759107	NCRNA00174	chr7:65841032-65865395:-	0.46	4.97	9.34E-7	Diabetic kidney disease	
HNSC	cis	1	rs1399715	chr3:108858490	GUCA1C	chr3:108626642-108672677:-	-0.27	-4.42	1.2E-5	Homeostasis model assessment of beta-cell function (interaction)	
HNSC	cis	1	rs140330585	chr15:78866445	CHRNA5	chr15:78857906-78886458:+	-0.27	-5.46	7.57E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs1404147	chr7:65264524	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.84	1.72E-6	Diabetic kidney disease	
HNSC	cis	1	rs1406947	chr20:33969530	CPNE1	chr20:34213968-34262539:-	0.23	4.16	3.82E-5	Height	
HNSC	cis	1	rs1406947	chr20:33969530	UQCC	chr20:33890383-33999833:-	0.33	6.11	2.05E-9	Height	
HNSC	cis	1	rs1407185	chr6:117733650	ROS1	chr6:117609530-117747018:-	-0.18	-3.97	8.15E-5	Lung cancer	
HNSC	cis	1	rs1408916	chr1:92992627	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs1413695	chr1:210326476	SYT14	chr1:210111538-210337631:+	-0.2	-3.76	0.000194	Manic episodes in bipolar disorder	
HNSC	cis	1	rs141518190	chr15:78900647	CHRNA5	chr15:78857906-78886458:+	-0.26	-5.14	3.9E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.64	-13.89	2.91E-37	Response to antipsychotic treatment	
HNSC	cis	1	rs1416763	chr10:60029163	CISD1	chr10:60028895-60049018:+	0.23	4.08	5.2E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1416763	chr10:60029163	IPMK	chr10:59955618-60027694:-	0.27	6.46	2.45E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1416764	chr10:60040351	CISD1	chr10:60028895-60049018:+	0.24	4.21	3.05E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1416764	chr10:60040351	IPMK	chr10:59955618-60027694:-	0.28	6.91	1.5E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1416766	chr10:59978237	CISD1	chr10:60028895-60049018:+	0.23	4.01	7.11E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1416766	chr10:59978237	IPMK	chr10:59955618-60027694:-	0.27	6.49	2.08E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1417804	chr1:159003983	AIM2	chr1:159032275-159046647:-	0.19	3.78	0.000177	Obesity-related traits	
HNSC	cis	1	rs1417823	chr10:102227886	SEC31B	chr10:102246403-102289636:-	0.19	5.87	7.95E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs1419183	chr6:28242794	ZNF389	chr6:28129551-28137375:+	-0.27	-4.22	2.92E-5	Depression	
HNSC	cis	1	rs1419183	chr6:28242794	ZSCAN23	chr6:28393287-28411279:-	0.24	3.77	0.000181	Depression	
HNSC	cis	1	rs1422500	chr5:115569312	COMMD10	chr5:115420727-115628978:+	0.36	3.69	0.000248	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.74	13.22	2.21E-34	Type 2 diabetes	
HNSC	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.73	13.15	4.41E-34	Type 2 diabetes	
HNSC	cis	1	rs1428551	chr5:150259832	LOC134466	chr5:150310000-150326146:-	0.39	5.44	8.36E-8	Crohn's disease	
HNSC	cis	1	rs1428554	chr5:150257616	LOC134466	chr5:150310000-150326146:-	0.38	5.27	2.01E-7	Crohn's disease	
HNSC	cis	1	rs1428555	chr5:150257391	LOC134466	chr5:150310000-150326146:-	-0.32	-4.34	1.74E-5	Crohn's disease	
HNSC	cis	1	rs1435127	chr4:142159511	ZNF330	chr4:142142049-142155848:+	-0.3	-4.86	1.59E-6	Conduct disorder	
HNSC	cis	1	rs1435134	chr4:142153343	ZNF330	chr4:142142049-142155848:+	-0.29	-4.56	6.55E-6	Conduct disorder	
HNSC	cis	1	rs1439620	chr15:93429646	CHD2	chr15:93429433-93571236:+	-0.17	-3.78	0.000175	Body mass index	
HNSC	cis	1	rs1439621	chr15:93441907	CHD2	chr15:93429433-93571236:+	-0.17	-3.71	0.000228	Body mass index	
HNSC	cis	1	rs144098432	chr18:51816394	POLI	chr18:51795849-51824602:+	0.24	4.6	5.48E-6	Inflammatory skin disease	
HNSC	cis	1	rs1442744	chr6:153441733	RGS17	chr6:153332041-153452389:-	-0.22	-4.01	6.91E-5	Prostate cancer	
HNSC	cis	1	rs1451707	chr6:56801877	BEND6	chr6:56819773-56892138:+	-0.42	-7.01	8.06E-12	Menarche (age at onset)	
HNSC	cis	1	rs1451707	chr6:56801877	RAB23	chr6:57053591-57087101:-	0.22	3.86	0.000131	Menarche (age at onset)	
HNSC	cis	1	rs1451708	chr6:56802201	BEND6	chr6:56819773-56892138:+	-0.42	-7.04	6.31E-12	Menarche (age at onset)	
HNSC	cis	1	rs1451708	chr6:56802201	RAB23	chr6:57053591-57087101:-	0.22	3.86	0.000127	Menarche (age at onset)	
HNSC	cis	1	rs1459242	chr3:48413537	ATRIP	chr3:48488141-48507708:+	-0.18	-4.12	4.4E-5	Longevity	
HNSC	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.27	6.64	8.22E-11	Longevity	
HNSC	cis	1	rs146009840	chr15:78906177	CHRNA5	chr15:78857906-78886458:+	-0.27	-5.36	1.29E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs1460561	chr6:56797574	BEND6	chr6:56819773-56892138:+	-0.42	-7.08	5.06E-12	Menarche (age at onset)	
HNSC	cis	1	rs1464569	chr3:49460350	AMT	chr3:49454212-49460012:-	0.17	3.72	0.000219	Menarche (age at onset)	
HNSC	cis	1	rs1465880	chr2:240932326	NDUFA10	chr2:240900158-240964798:-	0.2	3.67	0.000268	Odorant perception (isobutyraldehyde)	
HNSC	cis	1	rs1466211	chr2:108856412	SULT1C2	chr2:108905095-108926370:+	0.32	5.24	2.39E-7	Blood pressure	
HNSC	cis	1	rs1466212	chr2:108856532	SULT1C2	chr2:108905095-108926370:+	0.33	5.26	2.17E-7	Blood pressure	
HNSC	cis	1	rs1466213	chr2:108856607	SULT1C2	chr2:108905095-108926370:+	0.32	5.15	3.75E-7	Blood pressure	
HNSC	cis	1	rs1466788	chr1:110618730	ALX3	chr1:110602998-110613322:-	-0.19	-3.84	0.000141	Blood metabolite levels	
HNSC	cis	1	rs1469712	chr19:19528821	HAPLN4	chr19:19366453-19384074:-	0.21	4.5	8.39E-6	Schizophrenia	
HNSC	cis	1	rs147144681	chr15:78900908	CHRNA5	chr15:78857906-78886458:+	-0.25	-4.88	1.43E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs147499554	chr15:78900650	CHRNA5	chr15:78857906-78886458:+	-0.26	-5.14	3.94E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.48	10.27	1.45E-22	Height	
HNSC	cis	1	rs1498718	chr3:134205920	CEP63	chr3:134204575-134293852:+	0.28	5.96	4.94E-9	Height	
HNSC	cis	1	rs1499613	chr7:65730860	NCRNA00174	chr7:65841032-65865395:-	0.46	4.97	9.34E-7	Diabetic kidney disease	
HNSC	cis	1	rs1499614	chr7:65730798	NCRNA00174	chr7:65841032-65865395:-	-0.48	-5.18	3.25E-7	Diabetic kidney disease	
HNSC	cis	1	rs1501908	chr5:156398169	TIMD4	chr5:156346293-156390266:-	0.16	4.03	6.37E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
HNSC	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.35	-9.16	1.43E-18	Ankylosing spondylitis	
HNSC	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.39	7.34	8.62E-13	Ankylosing spondylitis	
HNSC	cis	1	rs1520884	chr11:18309700	GTF2H1	chr11:18343816-18388590:+	-0.32	-5.61	3.39E-8	Pancreatic cancer	
HNSC	cis	1	rs1525892	chr3:133484712	TF	chr3:133419211-133497635:+	-0.29	-5.45	7.94E-8	Iron status biomarkers	
HNSC	cis	1	rs1529957	chr19:37739801	ZNF793	chr19:37997841-38034237:+	0.25	4.14	4.08E-5	Coronary artery calcification	
HNSC	cis	1	rs1533266	chr7:143766714	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.35	8.51E-13	Obesity-related traits	
HNSC	cis	1	rs1533266	chr7:143766714	OR2A7	chr7:143955790-143974852:-	0.19	3.77	0.000182	Obesity-related traits	
HNSC	cis	1	rs1533267	chr7:143766440	ARHGEF35	chr7:143883677-143892736:-	-0.33	-7.29	1.24E-12	Obesity-related traits	
HNSC	cis	1	rs1533267	chr7:143766440	OR2A7	chr7:143955790-143974852:-	0.19	3.73	0.00021	Obesity-related traits	
HNSC	cis	1	rs1533268	chr7:143766358	ARHGEF35	chr7:143883677-143892736:-	-0.33	-7.29	1.24E-12	Obesity-related traits	
HNSC	cis	1	rs1533268	chr7:143766358	OR2A7	chr7:143955790-143974852:-	0.19	3.73	0.00021	Obesity-related traits	
HNSC	cis	1	rs1533825	chr11:214163	PSMD13	chr11:236808-252984:+	0.2	4.06	5.81E-5	Menarche (age at onset)	
HNSC	cis	1	rs1534025	chr3:134313304	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.49	2.25E-23	Height	
HNSC	cis	1	rs1534025	chr3:134313304	CEP63	chr3:134204575-134293852:+	-0.27	-5.83	9.84E-9	Height	
HNSC	cis	1	rs1534026	chr3:134284767	ANAPC13	chr3:134196547-134204865:-	0.48	10.41	4.32E-23	Height	
HNSC	cis	1	rs1534026	chr3:134284767	CEP63	chr3:134204575-134293852:+	0.27	5.95	5.0E-9	Height	
HNSC	cis	1	rs1534471	chr2:73647508	ALMS1P	chr2:73872046-73912692:+	0.26	4.39	1.36E-5	Metabolite levels	
HNSC	cis	1	rs1535277	chr6:26567802	BTN2A3	chr6:26422317-26431927:+	0.16	3.67	0.000273	Educational attainment	
HNSC	cis	1	rs1535277	chr6:26567802	BTN3A2	chr6:26365398-26378546:+	0.17	4.08	5.24E-5	Educational attainment	
HNSC	cis	1	rs1540651	chr7:65650121	NCRNA00174	chr7:65841032-65865395:-	0.73	14.89	1.11E-41	Aortic root size	
HNSC	cis	1	rs1540894	chr7:143767676	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.31	1.05E-12	Obesity-related traits	
HNSC	cis	1	rs1540894	chr7:143767676	OR2A7	chr7:143955790-143974852:-	0.21	4.02	6.73E-5	Obesity-related traits	
HNSC	cis	1	rs1540927	chr20:33931344	CPNE1	chr20:34213968-34262539:-	0.24	4.37	1.55E-5	Height	
HNSC	cis	1	rs1540927	chr20:33931344	UQCC	chr20:33890383-33999833:-	0.32	6.14	1.65E-9	Height	
HNSC	cis	1	rs1544549	chr7:66090663	NCRNA00174	chr7:65841032-65865395:-	0.69	13.52	1.14E-35	Aortic root size	
HNSC	cis	1	rs1546059	chr7:65654709	NCRNA00174	chr7:65841032-65865395:-	0.44	4.76	2.57E-6	Diabetic kidney disease	
HNSC	cis	1	rs1548226	chr20:43983777	SYS1-DBNDD2	chr20:43991701-44039245:+	0.35	5.35	1.33E-7	Psoriasis	
HNSC	cis	1	rs1550773	chr10:60044441	CISD1	chr10:60028895-60049018:+	0.26	4.58	5.88E-6	Inflammatory bowel disease	
HNSC	cis	1	rs1550773	chr10:60044441	IPMK	chr10:59955618-60027694:-	0.28	6.82	2.71E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1553174	chr7:65731194	NCRNA00174	chr7:65841032-65865395:-	0.46	4.97	9.34E-7	Diabetic kidney disease	
HNSC	cis	1	rs1553609	chr7:66197139	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.91	5.73E-25	Aortic root size	
HNSC	cis	1	rs1553610	chr7:66197233	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs1555337	chr20:61863641	BIRC7	chr20:61867276-61871853:+	-0.38	-4.26	2.46E-5	Response to cytadine analogues (cytosine arabinoside)	
HNSC	cis	1	rs1555569	chr17:2149425	SRR	chr17:2207248-2228553:+	-0.42	-8.14	3.16E-15	Esophageal cancer (squamous cell)	
HNSC	cis	1	rs1556562	chr1:93034023	EVI5	chr1:92974255-93257961:-	0.25	4.68	3.67E-6	Cholesterol, total	
HNSC	cis	1	rs1558377	chr4:17650758	FAM184B	chr4:17633711-17783135:-	-0.17	-4.07	5.55E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1558377	chr4:17650758	LAP3	chr4:17578927-17609590:+	-0.14	-3.79	0.000166	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1558378	chr4:17650351	FAM184B	chr4:17633711-17783135:-	-0.17	-4.07	5.55E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1558378	chr4:17650351	LAP3	chr4:17578927-17609590:+	-0.14	-3.79	0.000166	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.74	13.09	8.33E-34	Type 2 diabetes	
HNSC	cis	1	rs1563736	chr3:48436794	ATRIP	chr3:48488141-48507708:+	0.16	3.68	0.000263	Longevity	
HNSC	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.28	-6.89	1.71E-11	Longevity	
HNSC	cis	1	rs156421	chr7:23312487	GPNMB	chr7:23286316-23314728:+	-0.18	-3.66	0.000275	Parkinson's disease	
HNSC	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	0.74	12.64	6.26E-32	Diastolic blood pressure	
HNSC	cis	1	rs1565531	chr7:65663113	NCRNA00174	chr7:65841032-65865395:-	0.74	15.59	7.8E-45	Aortic root size	
HNSC	cis	1	rs15655	chr1:171673272	VAMP4	chr1:171669298-171711214:-	0.26	4.39	1.4E-5	Hippocampal atrophy	
HNSC	cis	1	rs1570004	chr20:33958253	CPNE1	chr20:34213968-34262539:-	0.24	4.31	1.98E-5	Height	
HNSC	cis	1	rs1570004	chr20:33958253	UQCC	chr20:33890383-33999833:-	0.33	6.26	8.31E-10	Height	
HNSC	cis	1	rs1570836	chr1:92972457	EVI5	chr1:92974255-93257961:-	-0.23	-4.3	2.02E-5	Cholesterol, total	
HNSC	cis	1	rs1570837	chr1:93006816	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs1571388	chr14:61402545	PPM1A	chr14:60712470-60765803:+	-0.43	-3.91	0.000104	Immune reponse to smallpox (secreted IFN-alpha)	
HNSC	cis	1	rs1573897	chr1:247215054	ZNF670	chr1:247200087-247242069:-	-0.29	-6.36	4.68E-10	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.65	-13.73	1.43E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.64	-13.87	3.59E-37	Response to antipsychotic treatment	
HNSC	cis	1	rs15870	chr14:55619311	KIAA0831	chr14:55833110-55878576:-	-0.23	-4.17	3.62E-5	Protein biomarker	
HNSC	cis	1	rs1592917	chr5:115569414	COMMD10	chr5:115420727-115628978:+	0.36	3.69	0.000248	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs1599280	chr6:56792576	BEND6	chr6:56819773-56892138:+	-0.42	-7.39	6.47E-13	Menarche (age at onset)	
HNSC	cis	1	rs1599280	chr6:56792576	RAB23	chr6:57053591-57087101:-	0.22	4.02	6.75E-5	Menarche (age at onset)	
HNSC	cis	1	rs1599281	chr6:56789311	BEND6	chr6:56819773-56892138:+	0.34	6.04	2.98E-9	Menarche (age at onset)	
HNSC	cis	1	rs1599281	chr6:56789311	RAB23	chr6:57053591-57087101:-	-0.2	-3.67	0.000269	Menarche (age at onset)	
HNSC	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.53	10.23	2.11E-22	Multiple sclerosis	
HNSC	cis	1	rs1599932	chr12:58177943	TSFM	chr12:58176536-58191367:+	-0.38	-8.18	2.5E-15	Multiple sclerosis	
HNSC	cis	1	rs160633	chr7:65528228	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.65	4.22E-6	Diabetic kidney disease	
HNSC	cis	1	rs160634	chr7:65528664	NCRNA00174	chr7:65841032-65865395:-	0.39	4.21	3.08E-5	Diabetic kidney disease	
HNSC	cis	1	rs160637	chr7:65584318	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.73	2.99E-6	Diabetic kidney disease	
HNSC	cis	1	rs160639	chr7:65579987	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.81	2.0E-6	Diabetic kidney disease	
HNSC	cis	1	rs160642	chr7:65558373	NCRNA00174	chr7:65841032-65865395:-	-0.41	-4.51	8.26E-6	Diabetic kidney disease	
HNSC	cis	1	rs160643	chr7:65558222	NCRNA00174	chr7:65841032-65865395:-	-0.34	-4.06	5.66E-5	Diabetic kidney disease	
HNSC	cis	1	rs160644	chr7:65558186	NCRNA00174	chr7:65841032-65865395:-	-0.41	-4.51	8.26E-6	Diabetic kidney disease	
HNSC	cis	1	rs160646	chr7:65556280	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.79	2.26E-6	Diabetic kidney disease	
HNSC	cis	1	rs160648	chr7:65543384	NCRNA00174	chr7:65841032-65865395:-	-0.48	-5.26	2.14E-7	Diabetic kidney disease	
HNSC	cis	1	rs160652	chr7:65538431	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.52	7.81E-6	Diabetic kidney disease	
HNSC	cis	1	rs160655	chr7:65533214	NCRNA00174	chr7:65841032-65865395:-	-0.49	-5.38	1.16E-7	Diabetic kidney disease	
HNSC	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-0.8	-14.13	2.62E-38	Diastolic blood pressure	
HNSC	cis	1	rs1614182	chr1:159004526	AIM2	chr1:159032275-159046647:-	0.19	3.91	0.000103	Obesity-related traits	
HNSC	cis	1	rs1614223	chr12:120964043	GATC	chr12:120884284-120897761:+	-0.28	-4.2	3.22E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1614223	chr12:120964043	POP5	chr12:121016849-121019201:-	-0.23	-4.16	3.73E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1614223	chr12:120964043	SFRS9	chr12:120899472-120907558:-	-0.25	-3.98	8.09E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1614223	chr12:120964043	TRIAP1	chr12:120881765-120884215:-	-0.24	-4.16	3.76E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs1615243	chr3:41965234	ULK4	chr3:41288091-42003660:-	-0.79	-14.56	3.36E-40	Diastolic blood pressure	
HNSC	cis	1	rs1618814	chr10:59963477	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1618814	chr10:59963477	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1618893	chr7:66096119	CRCP	chr7:65579805-65619551:+	-0.31	-3.98	8.07E-5	Diabetic kidney disease	
HNSC	cis	1	rs1618893	chr7:66096119	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.04	6.4E-7	Diabetic kidney disease	
HNSC	cis	1	rs1618893	chr7:66096119	STAG3L4	chr7:66767616-66786512:+	-0.37	-4.42	1.23E-5	Diabetic kidney disease	
HNSC	cis	1	rs1623294	chr10:59939025	CISD1	chr10:60028895-60049018:+	0.24	4.26	2.49E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1623294	chr10:59939025	IPMK	chr10:59955618-60027694:-	0.26	6.12	1.95E-9	Inflammatory bowel disease	
HNSC	cis	1	rs1629460	chr3:41927449	ULK4	chr3:41288091-42003660:-	-0.77	-13.71	1.82E-36	Diastolic blood pressure	
HNSC	cis	1	rs1630731	chr10:59959530	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1630731	chr10:59959530	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1633256	chr1:159002557	AIM2	chr1:159032275-159046647:-	0.2	4.09	5.1E-5	Obesity-related traits	
HNSC	cis	1	rs1633262	chr1:159004888	AIM2	chr1:159032275-159046647:-	0.19	3.91	0.000103	Obesity-related traits	
HNSC	cis	1	rs1633265	chr1:159005727	AIM2	chr1:159032275-159046647:-	0.19	3.84	0.000142	Obesity-related traits	
HNSC	cis	1	rs1633360	chr12:58108052	FAM119B	chr12:58166383-58176323:+	-0.3	-6.17	1.41E-9	Rheumatoid arthritis	
HNSC	cis	1	rs1633360	chr12:58108052	TSFM	chr12:58176536-58191367:+	0.21	4.85	1.69E-6	Rheumatoid arthritis	
HNSC	cis	1	rs1638731	chr7:66144679	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.98	8.74E-7	Gout	
HNSC	cis	1	rs1638731	chr7:66144679	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.34	1.74E-5	Gout	
HNSC	cis	1	rs1638734	chr7:66097539	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.91	1.21E-6	Diabetic kidney disease	
HNSC	cis	1	rs1638734	chr7:66097539	STAG3L4	chr7:66767616-66786512:+	-0.37	-4.04	6.29E-5	Diabetic kidney disease	
HNSC	cis	1	rs1665362	chr4:1726367	FAM53A	chr4:1641609-1685854:-	-0.34	-5.96	4.92E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs1665364	chr4:1727206	FAM53A	chr4:1641609-1685854:-	0.33	5.88	7.57E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs1665366	chr4:1728381	FAM53A	chr4:1641609-1685854:-	0.34	5.97	4.64E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs1678542	chr12:57968715	TSFM	chr12:58176536-58191367:+	0.19	4.25	2.55E-5	Rheumatoid arthritis	
HNSC	cis	1	rs1679381	chr12:75946124	GLIPR1L2	chr12:75784889-75825591:+	-0.26	-4.51	8.03E-6	Polycystic ovary syndrome	
HNSC	cis	1	rs1679709	chr6:28228342	ZNF389	chr6:28129551-28137375:+	0.27	4.17	3.56E-5	Depression	
HNSC	cis	1	rs1679709	chr6:28228342	ZSCAN23	chr6:28393287-28411279:-	-0.25	-3.85	0.000132	Depression	
HNSC	cis	1	rs1679732	chr6:28221264	ZNF389	chr6:28129551-28137375:+	0.27	4.25	2.5E-5	Depression	
HNSC	cis	1	rs1679732	chr6:28221264	ZSCAN23	chr6:28393287-28411279:-	-0.24	-3.78	0.000178	Depression	
HNSC	cis	1	rs16826864	chr3:156580033	LEKR1	chr3:156544076-156763918:+	-0.45	-7.11	4.16E-12	Bone mineral density	
HNSC	cis	1	rs16830920	chr2:135465466	TMEM163	chr2:135213331-135525334:-	-0.27	-4.86	1.59E-6	Gut microbiome composition (winter)	
HNSC	cis	1	rs16830945	chr2:135471748	TMEM163	chr2:135213331-135525334:-	0.3	5.03	6.8E-7	Gut microbiome composition (winter)	
HNSC	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.5	6.84	2.33E-11	Rheumatoid arthritis	
HNSC	cis	1	rs16839077	chr2:203208693	NOP58	chr2:203130515-203168382:+	0.25	3.95	8.97E-5	Urate levels	
HNSC	cis	1	rs16840074	chr1:150683156	GOLPH3L	chr1:150618701-150669672:-	0.32	3.93	9.65E-5	Congenital left-sided heart lesions	
HNSC	cis	1	rs16840074	chr1:150683156	HORMAD1	chr1:150670542-150693352:-	-0.34	-3.77	0.000185	Congenital left-sided heart lesions	
HNSC	cis	1	rs16850866	chr4:75161652	PARM1	chr4:75858298-75975323:+	-0.34	-3.75	0.000195	Immune reponse to smallpox (secreted IL-1beta)	
HNSC	cis	1	rs16863064	chr3:187887577	FLJ42393	chr3:187896331-187898596:+	0.25	3.76	0.000192	Schizophrenia	
HNSC	cis	1	rs16863064	chr3:187887577	LPP	chr3:187871719-188597441:+	-0.18	-3.76	0.000188	Schizophrenia	
HNSC	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.6	-13.81	6.5E-37	Response to antipsychotic treatment	
HNSC	cis	1	rs16891378	chr6:26188864	HIST1H2AE	chr6:26217148-26217711:+	-0.27	-3.72	0.000219	Renal underexcretion gout;Gout	
HNSC	cis	1	rs16891397	chr6:26200256	HIST1H2AE	chr6:26217148-26217711:+	-0.3	-4.35	1.69E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs16891401	chr6:26202337	HIST1H2AE	chr6:26217148-26217711:+	-0.31	-4.43	1.14E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs16891405	chr6:26204506	HIST1H2AE	chr6:26217148-26217711:+	-0.31	-4.61	5.2E-6	Renal underexcretion gout;Gout	
HNSC	cis	1	rs16899276	chr5:81165704	ATG10	chr5:81267844-81551211:+	0.29	5.31	1.62E-7	Cognitive function	
HNSC	cis	1	rs16909919	chr9:98265780	FBP1	chr9:97365423-97402531:-	-0.17	-3.73	0.000211	Height	
HNSC	cis	1	rs16917224	chr8:96030110	C8orf38	chr8:95908040-96088396:+	-0.28	-4.31	2.0E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs16917233	chr8:96044967	C8orf38	chr8:95908040-96088396:+	0.33	4.94	1.09E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs16932756	chr9:35921694	LOC158376	chr9:35909480-35911617:+	-0.3	-3.71	0.00023	Urate levels (BMI interaction)	
HNSC	cis	1	rs16947014	chr17:61719032	FTSJ3	chr17:61896795-61905031:-	0.21	3.8	0.000162	Body mass index	
HNSC	cis	1	rs16947042	chr17:61766457	FTSJ3	chr17:61896795-61905031:-	0.2	3.66	0.000275	Body mass index	
HNSC	cis	1	rs16952611	chr18:48382668	MRO	chr18:48321491-48351754:-	-0.23	-3.97	8.23E-5	Entorhinal cortical thickness	
HNSC	cis	1	rs16952848	chr18:44597829	HDHD2	chr18:44633782-44676871:-	0.39	4.33	1.84E-5	Sitting height ratio	
HNSC	cis	1	rs16957524	chr16:67798005	GFOD2	chr16:67708437-67753273:-	-0.23	-3.96	8.69E-5	Crohn's disease	
HNSC	cis	1	rs16958432	chr18:44631773	HDHD2	chr18:44633782-44676871:-	0.43	4.82	1.93E-6	Sitting height ratio	
HNSC	cis	1	rs16958440	chr18:44632884	HDHD2	chr18:44633782-44676871:-	0.43	4.82	1.93E-6	Sitting height ratio	
HNSC	cis	1	rs16958701	chr18:44655241	HDHD2	chr18:44633782-44676871:-	0.44	5.02	7.41E-7	Sitting height ratio	
HNSC	cis	1	rs16972767	chr19:39153044	LGALS7B	chr19:39279850-39282393:+	0.27	5.95	5.16E-9	Heart rate	
HNSC	cis	1	rs1697978	chr5:642829	SLC9A3	chr5:473334-524549:-	0.22	4.27	2.38E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs16979973	chr20:55056589	C20orf43	chr20:55043647-55093942:+	0.2	4.07	5.39E-5	Refractive astigmatism	
HNSC	cis	1	rs1697	chr3:128356852	RAB43	chr3:128806418-128880029:-	-0.2	-4	7.31E-5	Monocyte count	
HNSC	cis	1	rs1697	chr3:128356852	RPN1	chr3:128338813-128399918:-	-0.19	-3.84	0.000138	Monocyte count	
HNSC	cis	1	rs1698392	chr10:59967089	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1698392	chr10:59967089	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1698395	chr10:59938724	CISD1	chr10:60028895-60049018:+	0.25	4.31	1.95E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1698395	chr10:59938724	IPMK	chr10:59955618-60027694:-	0.25	6.08	2.37E-9	Inflammatory bowel disease	
HNSC	cis	1	rs1698396	chr10:59937308	CISD1	chr10:60028895-60049018:+	0.25	4.38	1.45E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1698396	chr10:59937308	IPMK	chr10:59955618-60027694:-	0.26	6.31	6.04E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1698402	chr10:59936444	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.35E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1698402	chr10:59936444	IPMK	chr10:59955618-60027694:-	0.25	6	3.87E-9	Inflammatory bowel disease	
HNSC	cis	1	rs1698468	chr10:59961590	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1698468	chr10:59961590	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1699379	chr4:129992337	C4orf33	chr4:130014829-130033842:+	-0.46	-9.02	4.32E-18	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1699389	chr4:130004079	C4orf33	chr4:130014829-130033842:+	-0.46	-9.03	4.0E-18	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1699391	chr4:130005096	C4orf33	chr4:130014829-130033842:+	-0.46	-9.03	4.0E-18	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1699392	chr4:130022347	C4orf33	chr4:130014829-130033842:+	-0.48	-9.73	1.39E-20	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1699393	chr4:130019352	C4orf33	chr4:130014829-130033842:+	-0.48	-9.52	7.97E-20	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1699394	chr4:130019312	C4orf33	chr4:130014829-130033842:+	-0.47	-9.56	5.72E-20	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1700490	chr5:176402401	CDHR2	chr5:175976365-176022769:+	0.21	3.71	0.000232	Menopause (age at onset);Menarche and menopause (age at onset)	
HNSC	cis	1	rs17007017	chr4:142142729	ZNF330	chr4:142142049-142155848:+	-0.28	-4.49	8.74E-6	Conduct disorder	
HNSC	cis	1	rs17007038	chr4:142161731	ZNF330	chr4:142142049-142155848:+	-0.25	-3.92	0.000101	Conduct disorder	
HNSC	cis	1	rs1701750	chr7:65467145	CRCP	chr7:65579805-65619551:+	-0.33	-3.84	0.000137	Diabetic kidney disease	
HNSC	cis	1	rs1701750	chr7:65467145	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.69	3.62E-6	Diabetic kidney disease	
HNSC	cis	1	rs1701758	chr7:65470201	CRCP	chr7:65579805-65619551:+	-0.33	-3.84	0.000137	Diabetic kidney disease	
HNSC	cis	1	rs1701758	chr7:65470201	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.69	3.62E-6	Diabetic kidney disease	
HNSC	cis	1	rs17030613	chr1:113190807	ST7L	chr1:113066142-113162405:-	0.4	5.93	5.62E-9	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs17030651	chr1:113239382	ST7L	chr1:113066142-113162405:-	0.39	5.75	1.59E-8	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs17036023	chr1:117129711	IGSF3	chr1:117117031-117210314:-	0.32	3.72	0.000224	Asthma (childhood onset)	
HNSC	cis	1	rs17036023	chr1:117129711	TTF2	chr1:117602949-117645489:+	0.28	3.71	0.00023	Asthma (childhood onset)	
HNSC	cis	1	rs17036023	chr1:117129711	VANGL1	chr1:116184574-116240845:+	0.31	3.78	0.000174	Asthma (childhood onset)	
HNSC	cis	1	rs17037427	chr1:11873416	CLCN6	chr1:11866207-11907674:+	0.22	3.78	0.000174	QRS complex (12-leadsum)	
HNSC	cis	1	rs17038243	chr4:108893397	HADH	chr4:108910940-108956330:+	0.28	4.07	5.46E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs17038246	chr4:108899748	HADH	chr4:108910940-108956330:+	0.28	4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs17038253	chr4:108902766	HADH	chr4:108910940-108956330:+	-0.28	-4.11	4.56E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs17038261	chr4:108906344	HADH	chr4:108910940-108956330:+	0.28	4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs17038296	chr4:108913941	HADH	chr4:108910940-108956330:+	0.28	4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs17038304	chr4:108915125	HADH	chr4:108910940-108956330:+	-0.3	-4.08	5.18E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs17038307	chr4:108916256	HADH	chr4:108910940-108956330:+	0.28	4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs17052727	chr3:53070914	TMEM110	chr3:52867139-52931547:-	0.38	4.62	4.98E-6	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs17058997	chr6:130755711	EPB41L2	chr6:131160488-131384462:-	0.22	3.67	0.000266	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);Exploratory eye movement dysfunction in schizophrenia (cognitive search score);Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
HNSC	cis	1	rs17061431	chr3:41792655	ULK4	chr3:41288091-42003660:-	0.71	12.26	2.46E-30	Diastolic blood pressure	
HNSC	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	0.75	12.51	2.33E-31	Diastolic blood pressure	
HNSC	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	0.74	12.64	6.26E-32	Diastolic blood pressure	
HNSC	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	0.74	12.64	6.26E-32	Diastolic blood pressure	
HNSC	cis	1	rs17070580	chr6:109738714	AKD1	chr6:109814059-110012415:-	0.23	4.69	3.55E-6	Height	
HNSC	cis	1	rs17070580	chr6:109738714	SMPD2	chr6:109761931-109765121:+	-0.27	-5.49	6.35E-8	Height	
HNSC	cis	1	rs1707304	chr1:46598269	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.48	3.54E-13	Body mass index	
HNSC	cis	1	rs1707321	chr1:46505309	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.74	5.82E-14	Body mass index	
HNSC	cis	1	rs1707335	chr1:46571921	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.24	1.71E-12	Body mass index	
HNSC	cis	1	rs1707336	chr1:46493460	CCDC163P	chr1:45960581-45965646:-	-0.33	-7.14	3.3E-12	Body mass index	
HNSC	cis	1	rs1707340	chr1:46514942	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.49	3.21E-13	Body mass index	
HNSC	cis	1	rs17080292	chr6:118850266	C6orf204	chr6:118786239-119031238:-	-0.25	-4.34	1.76E-5	Renal cell carcinoma	
HNSC	cis	1	rs17080302	chr6:118854037	C6orf204	chr6:118786239-119031238:-	-0.25	-4.34	1.76E-5	Renal cell carcinoma	
HNSC	cis	1	rs17083581	chr6:153429447	RGS17	chr6:153332041-153452389:-	-0.21	-3.91	0.000106	Prostate cancer	
HNSC	cis	1	rs17093141	chr14:74326903	LIN52	chr14:74551656-74667117:+	0.25	4.54	7.15E-6	Morning vs. evening chronotype	
HNSC	cis	1	rs17093474	chr14:74342413	LIN52	chr14:74551656-74667117:+	0.24	4.36	1.59E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs17094021	chr14:74394295	LIN52	chr14:74551656-74667117:+	0.23	3.96	8.46E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs17096228	chr14:74558669	LIN52	chr14:74551656-74667117:+	0.29	8.1	4.5E-15	Common traits (Other)	
HNSC	cis	1	rs17109512	chr10:100127551	PYROXD2	chr10:100143323-100174978:-	0.56	4.58	5.93E-6	Aspartate aminotransferase	
HNSC	cis	1	rs17111376	chr5:150226899	LOC134466	chr5:150310000-150326146:-	0.37	5.14	3.9E-7	Crohn's disease	
HNSC	cis	1	rs17112431	chr14:20957490	PNP	chr14:20937542-20945246:+	0.28	5.96	4.71E-9	Response to antipsychotic therapy (extrapyramidal side effects)	
HNSC	cis	1	rs17112431	chr14:20957490	RNASE10	chr14:20973696-20979314:+	0.44	7.23	1.84E-12	Response to antipsychotic therapy (extrapyramidal side effects)	
HNSC	cis	1	rs17113137	chr10:102241998	SEC31B	chr10:102246403-102289636:-	-0.19	-5.84	9.38E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs17115100	chr10:104591393	SFXN2	chr10:104474298-104498946:+	-0.34	-4.22	2.88E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
HNSC	cis	1	rs17115231	chr12:75933675	GLIPR1L2	chr12:75784889-75825591:+	-0.28	-4.76	2.6E-6	Polycystic ovary syndrome	
HNSC	cis	1	rs17117088	chr10:90961799	IFIT5	chr10:91174325-91180758:+	-0.25	-4.02	6.83E-5	Heart failure	
HNSC	cis	1	rs17117124	chr10:90963997	IFIT5	chr10:91174325-91180758:+	-0.25	-3.94	9.47E-5	Heart failure	
HNSC	cis	1	rs17117126	chr10:90964026	IFIT5	chr10:91174325-91180758:+	-0.25	-3.94	9.47E-5	Heart failure	
HNSC	cis	1	rs17120139	chr11:116774201	PCSK7	chr11:117075789-117102811:-	0.3	4.09	5.11E-5	Protein quantitative trait loci	
HNSC	cis	1	rs17123957	chr14:88449322	GPR65	chr14:88471496-88478414:+	0.15	3.84	0.000141	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs17135597	chr5:112719722	YTHDC2	chr5:112849410-112930979:+	0.19	3.73	0.00021	Cerebral amyloid angiopathy	
HNSC	cis	1	rs17135616	chr5:112761680	YTHDC2	chr5:112849410-112930979:+	0.21	3.9	0.000108	Cerebral amyloid angiopathy	
HNSC	cis	1	rs17138884	chr5:115425628	COMMD10	chr5:115420727-115628978:+	0.36	4.41	1.25E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs17138917	chr5:115469316	COMMD10	chr5:115420727-115628978:+	0.31	3.66	0.000281	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs17139224	chr5:115568193	COMMD10	chr5:115420727-115628978:+	0.37	3.71	0.000227	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs17139265	chr5:115578810	COMMD10	chr5:115420727-115628978:+	0.37	3.89	0.000112	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs17139314	chr5:115607127	COMMD10	chr5:115420727-115628978:+	0.4	4.05	6.07E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs17139457	chr5:115640603	COMMD10	chr5:115420727-115628978:+	-0.37	-4.36	1.59E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs171408	chr3:8608920	LOH3CR2A	chr3:8613468-8615580:+	0.31	4.9	1.29E-6	Mitral valve prolapse	
HNSC	cis	1	rs17149161	chr7:75978229	UPK3B	chr7:76139745-76157197:+	-0.23	-4.47	9.68E-6	Multiple sclerosis	
HNSC	cis	1	rs17149161	chr7:75978229	ZP3	chr7:76026841-76071387:+	-0.2	-3.75	0.000196	Multiple sclerosis	
HNSC	cis	1	rs1715235	chr7:65488394	CRCP	chr7:65579805-65619551:+	-0.33	-3.81	0.000155	Diabetic kidney disease	
HNSC	cis	1	rs1715235	chr7:65488394	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.57	6.25E-6	Diabetic kidney disease	
HNSC	cis	1	rs17161692	chr7:98953863	CYP3A5	chr7:99245818-99332821:-	-0.55	-6.94	1.23E-11	Blood metabolite levels	
HNSC	cis	1	rs17164851	chr7:130003487	CPA5	chr7:129984630-130008571:+	0.57	8	8.89E-15	Age-related hearing impairment (interaction)	
HNSC	cis	1	rs1716642	chr3:41965865	ULK4	chr3:41288091-42003660:-	-0.79	-14.56	3.36E-40	Diastolic blood pressure	
HNSC	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-0.8	-14.13	2.62E-38	Diastolic blood pressure	
HNSC	cis	1	rs1716651	chr3:41975099	ULK4	chr3:41288091-42003660:-	-0.8	-14.72	6.7E-41	Diastolic blood pressure	
HNSC	cis	1	rs1716657	chr3:41918456	ULK4	chr3:41288091-42003660:-	-0.78	-13.64	3.77E-36	Diastolic blood pressure	
HNSC	cis	1	rs1716661	chr3:41962818	ULK4	chr3:41288091-42003660:-	-0.78	-14.1	3.64E-38	Diastolic blood pressure	
HNSC	cis	1	rs1716664	chr3:41948378	ULK4	chr3:41288091-42003660:-	-0.77	-13.77	9.63E-37	Diastolic blood pressure	
HNSC	cis	1	rs1716685	chr3:41925301	ULK4	chr3:41288091-42003660:-	0.79	13.94	1.85E-37	Diastolic blood pressure	
HNSC	cis	1	rs1716688	chr3:41926546	ULK4	chr3:41288091-42003660:-	-0.77	-13.72	1.66E-36	Diastolic blood pressure	
HNSC	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-0.77	-13.55	8.66E-36	Diastolic blood pressure	
HNSC	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-0.8	-14.21	1.14E-38	Diastolic blood pressure	
HNSC	cis	1	rs1717001	chr3:41934949	ULK4	chr3:41288091-42003660:-	-0.78	-13.79	7.83E-37	Diastolic blood pressure	
HNSC	cis	1	rs1717006	chr3:41940448	ULK4	chr3:41288091-42003660:-	0.75	13.48	1.79E-35	Diastolic blood pressure	
HNSC	cis	1	rs1717009	chr3:41946308	ULK4	chr3:41288091-42003660:-	-0.78	-13.92	2.12E-37	Diastolic blood pressure	
HNSC	cis	1	rs1717011	chr3:41980199	ULK4	chr3:41288091-42003660:-	-0.79	-14.56	3.36E-40	Diastolic blood pressure	
HNSC	cis	1	rs1717020	chr3:41981490	ULK4	chr3:41288091-42003660:-	0.76	13.34	7.03E-35	Diastolic blood pressure	
HNSC	cis	1	rs17190683	chr6:101158143	ASCC3	chr6:100956609-101329224:-	0.23	6.08	2.4E-9	Menarche (age at onset)	
HNSC	cis	1	rs17194199	chr2:218312376	DIRC3	chr2:218148748-218621316:-	0.32	4.28	2.22E-5	Metabolite levels (MHPG)	
HNSC	cis	1	rs17207042	chr18:67537351	CD226	chr18:67530195-67624232:-	0.09	3.81	0.00016	Type 1 diabetes;Type 1 diabetes autoantibodies	
HNSC	cis	1	rs17223420	chr12:983720	RAD52	chr12:1021255-1099219:-	-0.34	-5.62	3.12E-8	Colorectal cancer	
HNSC	cis	1	rs1723267	chr7:65473314	CRCP	chr7:65579805-65619551:+	-0.34	-3.93	9.88E-5	Diabetic kidney disease	
HNSC	cis	1	rs1723267	chr7:65473314	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.71	3.26E-6	Diabetic kidney disease	
HNSC	cis	1	rs1723269	chr7:65472786	CRCP	chr7:65579805-65619551:+	-0.32	-3.73	0.000217	Diabetic kidney disease	
HNSC	cis	1	rs1723269	chr7:65472786	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.48	9.21E-6	Diabetic kidney disease	
HNSC	cis	1	rs1723270	chr7:65469830	CRCP	chr7:65579805-65619551:+	-0.32	-3.71	0.000231	Diabetic kidney disease	
HNSC	cis	1	rs1723270	chr7:65469830	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.57	6.28E-6	Diabetic kidney disease	
HNSC	cis	1	rs17246007	chr14:65865671	LOC645431	chr14:65877313-65879335:-	0.27	3.71	0.000227	Ischemic stroke	
HNSC	cis	1	rs17279521	chr3:99938137	TBC1D23	chr3:99979686-100044078:+	-0.25	-5.06	6.05E-7	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs17284288	chr5:82444816	XRCC4	chr5:82373317-82649577:+	-0.2	-3.97	8.23E-5	Hypertension	
HNSC	cis	1	rs17293608	chr10:1056252	IDI2	chr10:1064847-1071799:-	-0.29	-4.4	1.3E-5	Response to angiotensin II receptor blocker therapy	
HNSC	cis	1	rs17311679	chr19:50521331	SIGLEC16	chr19:50472912-50479075:+	-0.46	-5.62	3.26E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
HNSC	cis	1	rs17319967	chr20:33693650	PROCR	chr20:33758727-33765164:+	-0.3	-4	7.27E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs173334	chr6:88080223	C6orf162	chr6:88032306-88052043:+	-0.18	-3.7	0.000239	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs173334	chr6:88080223	C6orf164	chr6:88032306-88109459:+	-0.23	-4.32	1.9E-5	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs17335566	chr3:99974472	TBC1D23	chr3:99979686-100044078:+	-0.21	-3.93	9.53E-5	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs17335614	chr3:99978562	TBC1D23	chr3:99979686-100044078:+	0.22	4.22	2.92E-5	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs17340509	chr1:27274700	PDIK1L	chr1:26437656-26452024:+	-0.28	-3.65	0.000285	HDL cholesterol;Triglycerides;LDL cholesterol	
HNSC	cis	1	rs17350440	chr4:142161479	ZNF330	chr4:142142049-142155848:+	-0.27	-4.32	1.89E-5	Conduct disorder	
HNSC	cis	1	rs17356923	chr1:27282676	PDIK1L	chr1:26437656-26452024:+	-0.28	-3.65	0.000285	HDL cholesterol;Triglycerides;LDL cholesterol	
HNSC	cis	1	rs17360994	chr1:27278573	PDIK1L	chr1:26437656-26452024:+	-0.28	-3.66	0.000276	HDL cholesterol;Triglycerides;LDL cholesterol	
HNSC	cis	1	rs17374749	chr3:136768010	PCCB	chr3:135969167-136056737:+	-0.21	-4.33	1.78E-5	Anxiety in major depressive disorder	
HNSC	cis	1	rs17424234	chr6:118808521	C6orf204	chr6:118786239-119031238:-	-0.25	-4.16	3.71E-5	Renal cell carcinoma	
HNSC	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.89	27.16	5.67E-100	Carotid intima media thickness	
HNSC	cis	1	rs17433780	chr1:89474818	RBMXL1	chr1:89445140-89458643:-	0.16	4.33	1.83E-5	Carotid intima media thickness	
HNSC	cis	1	rs17450853	chr6:56788004	BEND6	chr6:56819773-56892138:+	-0.35	-6.33	5.58E-10	Menarche (age at onset)	
HNSC	cis	1	rs17450853	chr6:56788004	RAB23	chr6:57053591-57087101:-	0.21	4.07	5.48E-5	Menarche (age at onset)	
HNSC	cis	1	rs17496332	chr1:107546375	PRMT6	chr1:107599267-107601907:+	0.45	9.07	2.93E-18	Sex hormone-binding globulin levels	
HNSC	cis	1	rs17507481	chr4:17620066	FAM184B	chr4:17633711-17783135:-	-0.15	-3.71	0.000234	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs17513621	chr2:99246559	UNC50	chr2:99225042-99234975:+	-0.24	-4.14	4.13E-5	Bipolar disorder	
HNSC	cis	1	rs17538840	chr2:61077817	C2orf74	chr2:61372243-61391964:+	-0.26	-3.81	0.000159	Inflammatory skin disease	
HNSC	cis	1	rs17540509	chr12:56943840	RBMS2	chr12:56915609-56989980:+	0.22	4.05	5.93E-5	Adiponectin levels	
HNSC	cis	1	rs175425	chr14:75626131	MLH3	chr14:75480467-75518235:-	-0.32	-6.57	1.27E-10	Height	
HNSC	cis	1	rs175426	chr14:75624134	MLH3	chr14:75480467-75518235:-	-0.31	-6.5	2.02E-10	Height	
HNSC	cis	1	rs175436	chr14:75608683	MLH3	chr14:75480467-75518235:-	-0.33	-6.86	2.12E-11	Height	
HNSC	cis	1	rs175442	chr14:75603564	MLH3	chr14:75480467-75518235:-	-0.32	-6.67	6.93E-11	Height	
HNSC	cis	1	rs175443	chr14:75601963	MLH3	chr14:75480467-75518235:-	-0.33	-6.79	3.28E-11	Height	
HNSC	cis	1	rs175449	chr14:75590846	MLH3	chr14:75480467-75518235:-	-0.33	-6.86	2.03E-11	Height	
HNSC	cis	1	rs175492	chr14:75545220	MLH3	chr14:75480467-75518235:-	0.32	6.82	2.63E-11	Height	
HNSC	cis	1	rs17550794	chr4:108911051	HADH	chr4:108910940-108956330:+	0.28	4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs175512	chr14:75523382	MLH3	chr14:75480467-75518235:-	-0.33	-6.73	4.87E-11	Height	
HNSC	cis	1	rs17551703	chr1:166957879	FMO9P	chr1:166573153-166594471:+	0.23	4.41	1.26E-5	Refractive astigmatism	
HNSC	cis	1	rs17554465	chr10:11849626	ECHDC3	chr10:11784356-11806064:+	0.3	3.89	0.000114	Breast cancer (survival)	
HNSC	cis	1	rs17566701	chr7:66193183	NCRNA00174	chr7:65841032-65865395:-	-0.52	-10.03	1.13E-21	Aortic root size	
HNSC	cis	1	rs17570978	chr11:116457391	PCSK7	chr11:117075789-117102811:-	-0.36	-4.28	2.25E-5	Clozapine-induced cytotoxicity	
HNSC	cis	1	rs17570978	chr11:116457391	ZNF259	chr11:116649277-116658739:-	-0.32	-3.93	9.86E-5	Clozapine-induced cytotoxicity	
HNSC	cis	1	rs17576507	chr2:38910131	GALM	chr2:38893052-38961908:+	0.33	5	7.93E-7	5-HTT brain serotonin transporter levels	
HNSC	cis	1	rs1757924	chr4:130019599	C4orf33	chr4:130014829-130033842:+	-0.46	-9.05	3.2E-18	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1757925	chr4:130020791	C4orf33	chr4:130014829-130033842:+	0.47	9.46	1.27E-19	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1757927	chr4:130022069	C4orf33	chr4:130014829-130033842:+	-0.48	-9.73	1.39E-20	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1757928	chr4:130022161	C4orf33	chr4:130014829-130033842:+	-0.48	-9.73	1.39E-20	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1757930	chr4:130022356	C4orf33	chr4:130014829-130033842:+	-0.48	-9.67	2.26E-20	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1757935	chr4:130023759	C4orf33	chr4:130014829-130033842:+	-0.48	-9.73	1.39E-20	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.42	-7.84	2.85E-14	Forced vital capacity	
HNSC	cis	1	rs17598927	chr6:26184640	HIST1H2AE	chr6:26217148-26217711:+	0.32	4.2	3.2E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs17600642	chr10:72462994	ADAMTS14	chr10:72432559-72522193:+	0.19	4.27	2.38E-5	Bipolar disorder	
HNSC	cis	1	rs17605685	chr19:50486741	SIGLEC16	chr19:50472912-50479075:+	0.56	6.35	4.82E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
HNSC	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.43	-9.51	8.33E-20	Temperament	
HNSC	cis	1	rs17608677	chr2:219936871	DNAJB2	chr2:220144040-220151622:+	0.21	4.29	2.16E-5	Height	
HNSC	cis	1	rs17608677	chr2:219936871	FAM134A	chr2:220042939-220050190:+	0.33	4.98	8.91E-7	Height	
HNSC	cis	1	rs17649068	chr1:171713893	VAMP4	chr1:171669298-171711214:-	0.26	4.58	5.97E-6	Hippocampal atrophy	
HNSC	cis	1	rs17649250	chr1:171720586	VAMP4	chr1:171669298-171711214:-	0.27	4.57	6.13E-6	Hippocampal atrophy	
HNSC	cis	1	rs17653722	chr12:52587518	LOC283404	chr12:52604714-52617595:+	0.25	3.95	8.88E-5	Telomere length	
HNSC	cis	1	rs17661933	chr19:50534520	SIGLEC16	chr19:50472912-50479075:+	-0.39	-4.8	2.13E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
HNSC	cis	1	rs17671250	chr15:40673124	C15orf23	chr15:40674922-40686488:+	-0.38	-6.15	1.6E-9	Heschl's gyrus morphology	
HNSC	cis	1	rs17685143	chr6:56774788	BEND6	chr6:56819773-56892138:+	-0.4	-7.04	6.57E-12	Menarche (age at onset)	
HNSC	cis	1	rs17685143	chr6:56774788	RAB23	chr6:57053591-57087101:-	0.22	3.92	0.000101	Menarche (age at onset)	
HNSC	cis	1	rs1768803	chr1:46546208	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.47	3.75E-13	Body mass index	
HNSC	cis	1	rs1768816	chr1:46528599	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.45	4.23E-13	Body mass index	
HNSC	cis	1	rs1769003	chr10:59937590	CISD1	chr10:60028895-60049018:+	0.25	4.38	1.45E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1769003	chr10:59937590	IPMK	chr10:59955618-60027694:-	0.26	6.31	6.04E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1769005	chr10:59935940	CISD1	chr10:60028895-60049018:+	0.25	4.42	1.22E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1769005	chr10:59935940	IPMK	chr10:59955618-60027694:-	0.26	6.36	4.65E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1769006	chr10:59935547	CISD1	chr10:60028895-60049018:+	0.25	4.42	1.22E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1769006	chr10:59935547	IPMK	chr10:59955618-60027694:-	0.26	6.36	4.65E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1769040	chr10:59954081	CISD1	chr10:60028895-60049018:+	0.25	4.44	1.09E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1769040	chr10:59954081	IPMK	chr10:59955618-60027694:-	0.28	6.85	2.24E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1769042	chr10:59956734	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1769042	chr10:59956734	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1769044	chr10:59958956	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1769044	chr10:59958956	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1769045	chr10:59960522	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1769045	chr10:59960522	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1769046	chr10:59960630	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1769046	chr10:59960630	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs1769047	chr10:59963046	CISD1	chr10:60028895-60049018:+	0.24	4.13	4.24E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1769047	chr10:59963046	IPMK	chr10:59955618-60027694:-	0.27	6.53	1.66E-10	Inflammatory bowel disease	
HNSC	cis	1	rs17691170	chr3:121357626	IQCB1	chr3:121488610-121553926:-	0.25	6.22	1.08E-9	Cognitive performance	
HNSC	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.48	10.3	1.14E-22	Height	
HNSC	cis	1	rs17694011	chr3:134213981	CEP63	chr3:134204575-134293852:+	0.27	5.9	6.93E-9	Height	
HNSC	cis	1	rs17694493	chr9:22041998	CDKN2BAS	chr9:21994790-22121091:+	0.26	3.73	0.000211	Prostate cancer	
HNSC	cis	1	rs17694493	chr9:22041998	CDKN2B	chr9:22002906-22009312:-	0.3	4.09	5.04E-5	Prostate cancer	
HNSC	cis	1	rs17713396	chr2:227201	SH3YL1	chr2:218138-264810:-	-0.64	-12.47	3.29E-31	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs17713729	chr2:249092	SH3YL1	chr2:218138-264810:-	-0.66	-13.06	1.13E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs17714252	chr2:285471	SH3YL1	chr2:218138-264810:-	-0.68	-13.41	3.61E-35	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs17723330	chr7:43286893	POLM	chr7:44111849-44122129:-	-0.41	-3.95	8.97E-5	Esophageal adenocarcinoma	
HNSC	cis	1	rs1772408	chr1:159005649	AIM2	chr1:159032275-159046647:-	0.19	3.79	0.000167	Obesity-related traits	
HNSC	cis	1	rs1772415	chr1:159002778	AIM2	chr1:159032275-159046647:-	0.2	4.15	3.85E-5	Obesity-related traits	
HNSC	cis	1	rs17727568	chr5:150244688	LOC134466	chr5:150310000-150326146:-	0.56	6.89	1.66E-11	Crohn's disease	
HNSC	cis	1	rs177377	chr14:73753519	ACOT1	chr14:74003928-74042357:+	-0.21	-4.63	4.75E-6	Bipolar disorder with mood-incongruent psychosis	
HNSC	cis	1	rs177377	chr14:73753519	HEATR4	chr14:73945193-74025651:-	-0.35	-6.92	1.44E-11	Bipolar disorder with mood-incongruent psychosis	
HNSC	cis	1	rs17746014	chr10:102315354	SEC31B	chr10:102246403-102289636:-	-0.17	-5.31	1.64E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs1775148	chr1:205757824	PM20D1	chr1:205797154-205819245:-	-0.36	-7.27	1.4E-12	Prostate cancer	
HNSC	cis	1	rs1775148	chr1:205757824	RAB7L1	chr1:205737115-205744610:-	0.35	6.57	1.3E-10	Prostate cancer	
HNSC	cis	1	rs1775151	chr1:205745684	PM20D1	chr1:205797154-205819245:-	-0.29	-5.6	3.49E-8	Parkinson's disease	
HNSC	cis	1	rs1775151	chr1:205745684	RAB7L1	chr1:205737115-205744610:-	0.3	5.29	1.84E-7	Parkinson's disease	
HNSC	cis	1	rs17752459	chr6:56798755	BEND6	chr6:56819773-56892138:+	-0.42	-7.18	2.5E-12	Menarche (age at onset)	
HNSC	cis	1	rs17752459	chr6:56798755	RAB23	chr6:57053591-57087101:-	0.22	3.88	0.000118	Menarche (age at onset)	
HNSC	cis	1	rs17770334	chr18:61202255	PHLPP1	chr18:60382734-60647665:+	-0.3	-3.65	0.000288	Pyoderma gangrenosum in inflammatory bowel disease	
HNSC	cis	1	rs1778508	chr6:28229881	ZNF187	chr6:28234788-28245978:+	0.2	3.68	0.000257	Depression	
HNSC	cis	1	rs1778508	chr6:28229881	ZNF389	chr6:28129551-28137375:+	0.29	4.66	4.16E-6	Depression	
HNSC	cis	1	rs1778508	chr6:28229881	ZSCAN23	chr6:28393287-28411279:-	-0.25	-4.01	6.94E-5	Depression	
HNSC	cis	1	rs1778511	chr6:28229411	ZNF389	chr6:28129551-28137375:+	0.27	4.22	2.95E-5	Depression	
HNSC	cis	1	rs1778511	chr6:28229411	ZSCAN23	chr6:28393287-28411279:-	-0.25	-3.88	0.000118	Depression	
HNSC	cis	1	rs17796315	chr8:11124758	AMAC1L2	chr8:11188495-11189695:+	0.31	3.8	0.000162	Response to antipsychotic therapy (extrapyramidal side effects)	
HNSC	cis	1	rs17800886	chr5:150309539	LOC134466	chr5:150310000-150326146:-	0.49	6.57	1.28E-10	Crohn's disease	
HNSC	cis	1	rs17800987	chr5:150323428	LOC134466	chr5:150310000-150326146:-	0.52	6.75	4.23E-11	Crohn's disease	
HNSC	cis	1	rs17806990	chr2:218312398	DIRC3	chr2:218148748-218621316:-	0.32	4.36	1.59E-5	Metabolite levels (MHPG)	
HNSC	cis	1	rs17818399	chr2:46826026	ATP6V1E2	chr2:46738988-46769696:-	-0.24	-4.28	2.28E-5	Height	
HNSC	cis	1	rs17818399	chr2:46826026	PIGF	chr2:46808414-46844251:-	0.24	4.93	1.14E-6	Height	
HNSC	cis	1	rs17826448	chr14:65852017	LOC645431	chr14:65877313-65879335:-	0.31	4.39	1.36E-5	Ischemic stroke	
HNSC	cis	1	rs17826580	chr14:65915262	LOC645431	chr14:65877313-65879335:-	-0.29	-3.92	9.95E-5	Ischemic stroke	
HNSC	cis	1	rs17826790	chr14:66103427	LOC645431	chr14:65877313-65879335:-	-0.27	-3.74	0.000204	Ischemic stroke	
HNSC	cis	1	rs17826820	chr14:66113837	LOC645431	chr14:65877313-65879335:-	-0.28	-3.74	0.000209	Ischemic stroke	
HNSC	cis	1	rs17839567	chr16:31057945	HSD3B7	chr16:30996519-31000473:+	0.23	4.27	2.35E-5	Response to metformin (IC50)	
HNSC	cis	1	rs17839567	chr16:31057945	MYST1	chr16:31128985-31142713:+	0.24	5.79	1.29E-8	Response to metformin (IC50)	
HNSC	cis	1	rs17878846	chr10:104630412	SFXN2	chr10:104474298-104498946:+	-0.35	-4.25	2.52E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
HNSC	cis	1	rs1788103	chr18:67538824	CD226	chr18:67530195-67624232:-	-0.1	-3.95	9.05E-5	Type 1 diabetes;Type 1 diabetes autoantibodies	
HNSC	cis	1	rs1794693	chr6:167405670	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs1795379	chr12:75941042	GLIPR1L2	chr12:75784889-75825591:+	-0.3	-4.96	9.64E-7	Polycystic ovary syndrome	
HNSC	cis	1	rs1796220	chr7:66062100	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.98	8.74E-7	Diabetic kidney disease	
HNSC	cis	1	rs1796220	chr7:66062100	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.34	1.74E-5	Diabetic kidney disease	
HNSC	cis	1	rs1796228	chr7:66033084	NCRNA00174	chr7:65841032-65865395:-	-0.49	-5.17	3.49E-7	Diabetic kidney disease	
HNSC	cis	1	rs1796228	chr7:66033084	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.21	3.09E-5	Diabetic kidney disease	
HNSC	cis	1	rs1798219	chr12:123180061	GPR109B	chr12:123199304-123201439:-	0.35	5.64	2.94E-8	Adiponectin levels	
HNSC	cis	1	rs1800615	chr1:15832281	CASP9	chr1:15817324-15851384:-	0.18	4.13	4.22E-5	Glomerular filtration rate (creatinine)	
HNSC	cis	1	rs1800662	chr10:102289078	SEC31B	chr10:102246403-102289636:-	-0.19	-5.82	1.04E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs1800789	chr4:155482743	RNF175	chr4:154631313-154681387:-	-0.22	-3.66	0.000277	Fibrinogen levels	
HNSC	cis	1	rs1807019	chr18:48378106	MRO	chr18:48321491-48351754:-	-0.21	-3.81	0.000158	Entorhinal cortical thickness	
HNSC	cis	1	rs1808382	chr19:39151034	LGALS7B	chr19:39279850-39282393:+	0.28	6.25	8.73E-10	Heart rate	
HNSC	cis	1	rs1810563	chr1:12054030	MFN2	chr1:12040238-12073571:+	0.21	4.61	5.04E-6	Platelet count	
HNSC	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.51	10.85	9.29E-25	Height	
HNSC	cis	1	rs1814336	chr3:134200823	CEP63	chr3:134204575-134293852:+	0.28	6.05	2.86E-9	Height	
HNSC	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.49	10.44	3.57E-23	Height	
HNSC	cis	1	rs1814337	chr3:134200682	CEP63	chr3:134204575-134293852:+	0.28	5.96	4.77E-9	Height	
HNSC	cis	1	rs1815787	chr11:116921397	PCSK7	chr11:117075789-117102811:-	-0.28	-4.18	3.49E-5	Subjective well-being	
HNSC	cis	1	rs1816752	chr13:24980949	PARP4	chr13:24995075-25086948:-	0.2	4.55	6.77E-6	Obesity-related traits	
HNSC	cis	1	rs1818950	chr15:84722521	LOC388152	chr15:84867600-84898920:-	-0.28	-4.97	9.13E-7	Schizophrenia	
HNSC	cis	1	rs1819333	chr6:167373547	RNASET2	chr6:167343008-167412795:-	-0.2	-4.99	8.41E-7	Crohn's disease	
HNSC	cis	1	rs1823061	chr19:37800626	ZNF793	chr19:37997841-38034237:+	0.27	4.39	1.38E-5	Coronary artery calcification	
HNSC	cis	1	rs1823874	chr15:100357435	C15orf51	chr15:100330361-100347132:-	-0.24	-5.58	4.01E-8	IgG glycosylation	
HNSC	cis	1	rs1830074	chr7:6718674	PMS2CL	chr7:6749757-6793492:+	-0.23	-4.5	8.48E-6	Body mass index	
HNSC	cis	1	rs1832556	chr10:60028248	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.84E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1832556	chr10:60028248	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.14E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.74	13.1	7.21E-34	Type 2 diabetes	
HNSC	cis	1	rs183618	chr17:53235974	COX11	chr17:53029259-53046064:-	0.3	6.21	1.16E-9	Menarche (age at onset)	
HNSC	cis	1	rs1839622	chr12:7334534	PEX5	chr12:7341759-7371167:+	0.26	5.09	5.0E-7	IgG glycosylation	
HNSC	cis	1	rs1848093	chr15:84755527	LOC388152	chr15:84867600-84898920:-	-0.28	-4.85	1.64E-6	Schizophrenia	
HNSC	cis	1	rs1854774	chr4:129988405	C4orf33	chr4:130014829-130033842:+	-0.47	-9.18	1.23E-18	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs1856564	chr10:60017452	CISD1	chr10:60028895-60049018:+	0.23	4.11	4.71E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1856564	chr10:60017452	IPMK	chr10:59955618-60027694:-	0.28	6.84	2.33E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.63	-13.76	1.14E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.62	-13.61	4.71E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs185968827	chr6:56708510	BEND6	chr6:56819773-56892138:+	-0.27	-4.26	2.44E-5	Alzheimer disease and age of onset	
HNSC	cis	1	rs1860596	chr4:17660082	FAM184B	chr4:17633711-17783135:-	-0.16	-3.84	0.000139	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1860597	chr4:17657650	FAM184B	chr4:17633711-17783135:-	-0.17	-4.05	5.93E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.74	13.16	3.95E-34	Type 2 diabetes	
HNSC	cis	1	rs186378	chr7:65582058	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.73	2.99E-6	Diabetic kidney disease	
HNSC	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.49	10.43	3.91E-23	Height	
HNSC	cis	1	rs1863913	chr3:134200205	CEP63	chr3:134204575-134293852:+	0.28	6.12	1.87E-9	Height	
HNSC	cis	1	rs1864367	chr3:53111704	RFT1	chr3:53122503-53164470:-	-0.23	-4.59	5.5E-6	Height	
HNSC	cis	1	rs1865517	chr8:11111957	AMAC1L2	chr8:11188495-11189695:+	0.3	3.67	0.000271	Response to antipsychotic therapy (extrapyramidal side effects)	
HNSC	cis	1	rs1865761	chr18:67539392	CD226	chr18:67530195-67624232:-	0.1	3.88	0.000116	Type 1 diabetes;Type 1 diabetes autoantibodies	
HNSC	cis	1	rs1867146	chr15:75354971	SCAMP5	chr15:75287901-75313836:+	0.43	8.69	5.3E-17	Blood trace element (Zn levels)	
HNSC	cis	1	rs1867571	chr10:60038850	CISD1	chr10:60028895-60049018:+	0.24	4.29	2.15E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1867571	chr10:60038850	IPMK	chr10:59955618-60027694:-	0.28	6.83	2.52E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1867572	chr10:60038940	CISD1	chr10:60028895-60049018:+	0.24	4.29	2.15E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1867572	chr10:60038940	IPMK	chr10:59955618-60027694:-	0.28	6.83	2.52E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1867573	chr10:60042972	CISD1	chr10:60028895-60049018:+	-0.26	-4.48	9.19E-6	Inflammatory bowel disease	
HNSC	cis	1	rs1867573	chr10:60042972	IPMK	chr10:59955618-60027694:-	-0.28	-6.79	3.32E-11	Inflammatory bowel disease	
HNSC	cis	1	rs1869365	chr17:40293865	DHX58	chr17:40253422-40264751:-	-0.34	-6.93	1.29E-11	Fibrinogen levels	
HNSC	cis	1	rs1872829	chr12:32535100	FGD4	chr12:32638906-32798982:+	-0.36	-7.03	6.84E-12	Response to tocilizumab in rheumatoid arthritis	
HNSC	cis	1	rs1873494	chr7:65649899	NCRNA00174	chr7:65841032-65865395:-	0.44	4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs1874883	chr3:134205071	ANAPC13	chr3:134196547-134204865:-	0.5	10.59	9.57E-24	Height	
HNSC	cis	1	rs1874883	chr3:134205071	CEP63	chr3:134204575-134293852:+	0.28	6.04	3.07E-9	Height	
HNSC	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.53	10.16	3.75E-22	Multiple sclerosis	
HNSC	cis	1	rs1875124	chr12:58196802	TSFM	chr12:58176536-58191367:+	-0.38	-8.02	7.85E-15	Multiple sclerosis	
HNSC	cis	1	rs1876673	chr5:115450773	COMMD10	chr5:115420727-115628978:+	0.37	3.8	0.000163	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs1876674	chr5:115450969	COMMD10	chr5:115420727-115628978:+	0.34	4	7.17E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs1877316	chr17:61766880	FTSJ3	chr17:61896795-61905031:-	0.21	3.79	0.000167	Body mass index	
HNSC	cis	1	rs1880376	chr3:134270347	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.52	1.7E-23	Height	
HNSC	cis	1	rs1880376	chr3:134270347	CEP63	chr3:134204575-134293852:+	-0.26	-5.68	2.27E-8	Height	
HNSC	cis	1	rs1880377	chr3:134270468	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.47	2.57E-23	Height	
HNSC	cis	1	rs1880377	chr3:134270468	CEP63	chr3:134204575-134293852:+	-0.26	-5.65	2.65E-8	Height	
HNSC	cis	1	rs1881123	chr7:1084706	ZFAND2A	chr7:1192544-1199855:-	-0.27	-3.67	0.000273	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs1881245	chr2:73649928	ALMS1P	chr2:73872046-73912692:+	0.25	4.31	2.01E-5	Metabolite levels	
HNSC	cis	1	rs1882099	chr4:1352685	CRIPAK	chr4:1385340-1389782:+	0.36	6.2	1.19E-9	Systolic blood pressure	
HNSC	cis	1	rs1882655	chr7:66147057	NCRNA00174	chr7:65841032-65865395:-	0.46	4.98	8.74E-7	Gout	
HNSC	cis	1	rs1882655	chr7:66147057	STAG3L4	chr7:66767616-66786512:+	0.39	4.34	1.74E-5	Gout	
HNSC	cis	1	rs1884418	chr20:55070076	C20orf43	chr20:55043647-55093942:+	0.21	4.27	2.33E-5	Refractive astigmatism	
HNSC	cis	1	rs1884946	chr6:26545308	BTN3A2	chr6:26365398-26378546:+	0.18	4.17	3.65E-5	Educational attainment	
HNSC	cis	1	rs1884948	chr6:26567988	BTN2A3	chr6:26422317-26431927:+	0.16	3.67	0.000273	Educational attainment	
HNSC	cis	1	rs1884948	chr6:26567988	BTN3A2	chr6:26365398-26378546:+	0.17	4.08	5.24E-5	Educational attainment	
HNSC	cis	1	rs1884949	chr6:26568067	BTN2A3	chr6:26422317-26431927:+	0.16	3.67	0.000273	Educational attainment	
HNSC	cis	1	rs1884949	chr6:26568067	BTN3A2	chr6:26365398-26378546:+	0.17	4.08	5.24E-5	Educational attainment	
HNSC	cis	1	rs1886682	chr1:92977275	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs1886683	chr1:92976023	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs188759	chr4:25234122	PI4K2B	chr4:25162285-25280831:+	-0.27	-3.69	0.000248	Cannabis dependence	
HNSC	cis	1	rs1895448	chr5:90743854	LOC100129716	chr5:90676164-90716531:+	0.33	4.71	3.17E-6	Smoking behavior	
HNSC	cis	1	rs1896708	chr5:150245076	LOC134466	chr5:150310000-150326146:-	0.37	5.15	3.78E-7	Crohn's disease	
HNSC	cis	1	rs1898355	chr10:118828369	KIAA1598	chr10:118644308-118886097:-	-0.27	-4.06	5.66E-5	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
HNSC	cis	1	rs1899669	chr18:48371698	MRO	chr18:48321491-48351754:-	-0.23	-4.08	5.24E-5	Entorhinal cortical thickness	
HNSC	cis	1	rs1903330	chr6:56776985	BEND6	chr6:56819773-56892138:+	0.39	6.97	1.01E-11	Menarche (age at onset)	
HNSC	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.8	13.99	1.1E-37	Type 2 diabetes	
HNSC	cis	1	rs1904302	chr10:118868941	KIAA1598	chr10:118644308-118886097:-	0.33	4.66	4.05E-6	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
HNSC	cis	1	rs1911155	chr15:84787635	LOC388152	chr15:84867600-84898920:-	-0.28	-4.82	1.93E-6	Schizophrenia	
HNSC	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.59	-13.56	7.97E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.62	-13.68	2.31E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs1917130	chr3:134313773	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.53	1.66E-23	Height	
HNSC	cis	1	rs1917130	chr3:134313773	CEP63	chr3:134204575-134293852:+	-0.28	-5.94	5.35E-9	Height	
HNSC	cis	1	rs1919948	chr7:143762843	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.5	2.9E-13	Obesity-related traits	
HNSC	cis	1	rs1919949	chr7:143767723	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.43	4.87E-13	Obesity-related traits	
HNSC	cis	1	rs1919949	chr7:143767723	OR2A7	chr7:143955790-143974852:-	0.19	3.73	0.000213	Obesity-related traits	
HNSC	cis	1	rs1919950	chr7:143767898	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.39	6.22E-13	Obesity-related traits	
HNSC	cis	1	rs1919950	chr7:143767898	OR2A7	chr7:143955790-143974852:-	0.2	3.81	0.000154	Obesity-related traits	
HNSC	cis	1	rs1919951	chr7:143768891	ARHGEF35	chr7:143883677-143892736:-	-0.37	-7.95	1.3E-14	Obesity-related traits	
HNSC	cis	1	rs1919951	chr7:143768891	OR2A7	chr7:143955790-143974852:-	0.21	4.09	5.04E-5	Obesity-related traits	
HNSC	cis	1	rs1933182	chr1:109999838	AMIGO1	chr1:110049447-110052336:-	-0.18	-4.11	4.55E-5	Chronic kidney disease	
HNSC	cis	1	rs1933488	chr6:153441079	RGS17	chr6:153332041-153452389:-	-0.21	-3.94	9.47E-5	Prostate cancer	
HNSC	cis	1	rs1934258	chr10:130251107	NPS	chr10:129347613-129350935:+	0.17	4.04	6.23E-5	Cognitive performance	
HNSC	cis	1	rs1936365	chr6:28268452	ZNF389	chr6:28129551-28137375:+	0.24	3.78	0.000177	Depression	
HNSC	cis	1	rs1936365	chr6:28268452	ZSCAN23	chr6:28393287-28411279:-	-0.24	-3.93	9.78E-5	Depression	
HNSC	cis	1	rs1941746	chr11:65502413	RBM14	chr11:66384053-66397390:+	0.24	3.99	7.61E-5	Atopic dermatitis	
HNSC	cis	1	rs1947861	chr6:49482687	CENPQ	chr6:49431096-49460820:+	-0.24	-5.39	1.12E-7	Brain structure	
HNSC	cis	1	rs1950500	chr14:24830850	DHRS1	chr14:24759806-24769039:-	0.16	3.83	0.000146	Height	
HNSC	cis	1	rs1952467	chr10:135353499	CYP2E1	chr10:135340867-135374724:+	0.26	4.46	1.03E-5	Obesity-related traits	
HNSC	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.61	-13.35	6.32E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs1964292	chr5:90743608	LOC100129716	chr5:90676164-90716531:+	0.31	4.44	1.09E-5	Smoking behavior	
HNSC	cis	1	rs1964692	chr7:65454183	CRCP	chr7:65579805-65619551:+	-0.33	-3.8	0.000164	Diabetic kidney disease	
HNSC	cis	1	rs1964692	chr7:65454183	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.65	4.22E-6	Diabetic kidney disease	
HNSC	cis	1	rs1965221	chr12:95975038	TMCC3	chr12:94960900-95044324:-	-0.19	-3.82	0.000152	Post bronchodilator FEV1 in COPD	
HNSC	cis	1	rs1968225	chr7:65874773	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.62	5.64E-45	Aortic root size	
HNSC	cis	1	rs1968225	chr7:65874773	TYW1	chr7:66461817-66704496:+	0.2	3.7	0.000237	Aortic root size	
HNSC	cis	1	rs1971762	chr12:54058238	ATP5G2	chr12:54058945-54070512:-	0.23	6.01	3.71E-9	Height	
HNSC	cis	1	rs1974624	chr4:17650281	FAM184B	chr4:17633711-17783135:-	-0.16	-3.94	9.35E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1974624	chr4:17650281	LAP3	chr4:17578927-17609590:+	-0.14	-3.71	0.000227	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs1974653	chr22:20134350	ZDHHC8	chr22:20119365-20135529:+	0.21	3.83	0.000147	Schizophrenia	
HNSC	cis	1	rs1975284	chr8:57314663	PENK	chr8:57353513-57359282:-	-0.31	-5.46	7.67E-8	Obesity-related traits	
HNSC	cis	1	rs1975957	chr1:150104269	HORMAD1	chr1:150670542-150693352:-	0.25	3.76	0.000192	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
HNSC	cis	1	rs1979823	chr7:65704613	NCRNA00174	chr7:65841032-65865395:-	0.46	4.97	9.34E-7	Diabetic kidney disease	
HNSC	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.92	-15.12	1.08E-42	Schizophrenia	
HNSC	cis	1	rs1981798	chr7:65954903	NCRNA00174	chr7:65841032-65865395:-	-0.73	-15.11	1.18E-42	Aortic root size	
HNSC	cis	1	rs1981798	chr7:65954903	TYW1	chr7:66461817-66704496:+	0.21	3.79	0.00017	Aortic root size	
HNSC	cis	1	rs1982861	chr3:49577665	AMT	chr3:49454212-49460012:-	0.18	3.87	0.000123	Menarche (age at onset)	
HNSC	cis	1	rs198806	chr6:26133616	BTN3A2	chr6:26365398-26378546:+	0.18	4.18	3.51E-5	Schizophrenia	
HNSC	cis	1	rs199348	chr7:23293098	GPNMB	chr7:23286316-23314728:+	-0.18	-3.76	0.000188	Parkinson's disease	
HNSC	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.68	10.03	1.15E-21	Diastolic blood pressure	
HNSC	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.62	-13.68	2.31E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs1997243	chr7:1083777	ZFAND2A	chr7:1192544-1199855:-	-0.27	-3.69	0.000248	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs1998035	chr14:66126230	LOC645431	chr14:65877313-65879335:-	-0.27	-3.65	0.000289	Ischemic stroke	
HNSC	cis	1	rs1998207	chr14:94957714	SERPINA9	chr14:94929060-94942670:-	-0.24	-4.2	3.14E-5	Obesity-related traits	
HNSC	cis	1	rs1998615	chr6:87808289	C6orf164	chr6:88032306-88109459:+	0.23	4.41	1.27E-5	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
HNSC	cis	1	rs1998616	chr6:87808430	C6orf164	chr6:88032306-88109459:+	0.23	4.41	1.27E-5	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
HNSC	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.63	-14.17	1.7E-38	Response to antipsychotic treatment	
HNSC	cis	1	rs1999997	chr10:59996969	CISD1	chr10:60028895-60049018:+	0.24	4.22	2.86E-5	Inflammatory bowel disease	
HNSC	cis	1	rs1999997	chr10:59996969	IPMK	chr10:59955618-60027694:-	0.28	6.74	4.34E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2000614	chr11:116915742	PCSK7	chr11:117075789-117102811:-	-0.28	-4.16	3.75E-5	Protein quantitative trait loci	
HNSC	cis	1	rs2000615	chr11:116915819	PCSK7	chr11:117075789-117102811:-	-0.3	-4.25	2.54E-5	Protein quantitative trait loci	
HNSC	cis	1	rs2000616	chr11:116916529	PCSK7	chr11:117075789-117102811:-	-0.28	-4.16	3.75E-5	Protein quantitative trait loci	
HNSC	cis	1	rs2001703	chr3:128383097	RAB43	chr3:128806418-128880029:-	-0.2	-4.02	6.75E-5	Monocyte count	
HNSC	cis	1	rs2003284	chr10:102202338	SEC31B	chr10:102246403-102289636:-	-0.18	-5.73	1.74E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2003301	chr7:66147656	NCRNA00174	chr7:65841032-65865395:-	0.55	10.91	5.73E-25	Aortic root size	
HNSC	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.4	-7.07	5.17E-12	Forced vital capacity	
HNSC	cis	1	rs2007981	chr19:18567555	SSBP4	chr19:18530221-18545371:+	-0.19	-4.35	1.62E-5	Breast cancer	
HNSC	cis	1	rs2008905	chr11:17184623	DKFZp686O24166	chr11:17373317-17398869:+	0.19	4.55	6.83E-6	Schizophrenia	
HNSC	cis	1	rs2008905	chr11:17184623	KCNJ11	chr11:17406798-17410878:-	0.17	4.46	1.03E-5	Schizophrenia	
HNSC	cis	1	rs2010648	chr14:35604892	PPP2R3C	chr14:35554679-35591679:-	0.44	7.27	1.45E-12	Atopic dermatitis	
HNSC	cis	1	rs2013815	chr6:167373812	RNASET2	chr6:167343008-167412795:-	0.21	5.14	4.06E-7	Crohn's disease	
HNSC	cis	1	rs2014521	chr17:40283413	DHX58	chr17:40253422-40264751:-	-0.35	-7.21	2.12E-12	Fibrinogen levels	
HNSC	cis	1	rs2015336	chr17:18073610	LOC220594	chr17:18414577-18445234:-	-0.32	-5.1	4.84E-7	Obesity-related traits	
HNSC	cis	1	rs2016161	chr20:23621174	CST1	chr20:23728191-23731574:-	-0.35	-5.62	3.22E-8	Chronic kidney disease	
HNSC	cis	1	rs2016161	chr20:23621174	CST4	chr20:23666277-23669662:-	-0.28	-4.56	6.51E-6	Chronic kidney disease	
HNSC	cis	1	rs2017962	chr19:22208751	ZNF257	chr19:22235266-22273901:+	0.26	4.83	1.82E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2019022	chr10:60024052	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2019022	chr10:60024052	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2019097	chr2:202193463	PPIL3	chr2:201735680-201753999:-	-0.52	-7.19	2.46E-12	Rheumatoid arthritis	
HNSC	cis	1	rs2019814	chr11:93168885	C11orf75	chr11:93211641-93276546:-	-0.3	-5.53	5.32E-8	Pulmonary function decline	
HNSC	cis	1	rs2019814	chr11:93168885	CCDC67	chr11:93063156-93171634:+	-0.25	-4.23	2.82E-5	Pulmonary function decline	
HNSC	cis	1	rs2021786	chr20:17421978	RRBP1	chr20:17594323-17662928:-	-0.19	-3.76	0.000188	Preschool internalizing problems	
HNSC	cis	1	rs2027763	chr11:73035799	MRPL48	chr11:73498917-73575655:+	0.25	3.67	0.000265	Pulmonary function (interaction)	
HNSC	cis	1	rs2027763	chr11:73035799	RAB6A	chr11:73386690-73472201:-	0.26	3.72	0.000221	Pulmonary function (interaction)	
HNSC	cis	1	rs2028299	chr15:90374257	AP3S2	chr15:90373832-90456222:-	-0.66	-11.45	4.31E-27	Type 2 diabetes	
HNSC	cis	1	rs2031365	chr6:87805592	C6orf164	chr6:88032306-88109459:+	0.23	4.59	5.53E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
HNSC	cis	1	rs2031366	chr6:87805890	C6orf164	chr6:88032306-88109459:+	0.23	4.59	5.53E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
HNSC	cis	1	rs2031367	chr6:87807180	C6orf164	chr6:88032306-88109459:+	0.23	4.52	7.64E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
HNSC	cis	1	rs2031494	chr1:92965969	EVI5	chr1:92974255-93257961:-	-0.22	-3.92	0.0001	Cholesterol, total	
HNSC	cis	1	rs2036264	chr7:65799904	NCRNA00174	chr7:65841032-65865395:-	0.72	14.74	5.25E-41	Aortic root size	
HNSC	cis	1	rs2036264	chr7:65799904	TYW1	chr7:66461817-66704496:+	-0.2	-3.69	0.000253	Aortic root size	
HNSC	cis	1	rs2036402	chr5:156464242	TIMD4	chr5:156346293-156390266:-	-0.17	-3.84	0.000137	Hypertriglyceridemia	
HNSC	cis	1	rs2039415	chr1:160854445	ITLN1	chr1:160846332-160854960:-	0.19	3.9	0.000109	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs2039800	chr1:150095754	HORMAD1	chr1:150670542-150693352:-	0.25	3.66	0.000278	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
HNSC	cis	1	rs2042133	chr7:65931922	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.89	3.28E-46	Aortic root size	
HNSC	cis	1	rs2045554	chr3:48494542	ATRIP	chr3:48488141-48507708:+	-0.17	-4.01	7.06E-5	Longevity	
HNSC	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.27	6.56	1.33E-10	Longevity	
HNSC	cis	1	rs2050265	chr1:11879699	CLCN6	chr1:11866207-11907674:+	0.22	3.7	0.000237	QRS complex (12-leadsum)	
HNSC	cis	1	rs2052553	chr5:90729906	LOC100129716	chr5:90676164-90716531:+	0.31	4.5	8.58E-6	Smoking behavior	
HNSC	cis	1	rs2055127	chr1:235598973	B3GALNT2	chr1:235610533-235667781:-	-0.21	-4.34	1.72E-5	Adiposity	
HNSC	cis	1	rs2055127	chr1:235598973	RBM34	chr1:235294499-235324772:-	-0.15	-3.86	0.000127	Adiposity	
HNSC	cis	1	rs2055127	chr1:235598973	TBCE	chr1:235530728-235612280:+	-0.24	-5.06	5.88E-7	Adiposity	
HNSC	cis	1	rs2055619	chr5:176415964	CDHR2	chr5:175976365-176022769:+	0.22	3.97	8.23E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
HNSC	cis	1	rs2055682	chr7:66260289	NCRNA00174	chr7:65841032-65865395:-	-0.52	-9.92	2.89E-21	Aortic root size	
HNSC	cis	1	rs2056486	chr2:73717567	ALMS1P	chr2:73872046-73912692:+	0.27	4.54	7.23E-6	Metabolite levels	
HNSC	cis	1	rs2056603	chr3:134312749	ANAPC13	chr3:134196547-134204865:-	0.49	10.65	5.42E-24	Height	
HNSC	cis	1	rs2056603	chr3:134312749	CEP63	chr3:134204575-134293852:+	0.28	6.1	2.17E-9	Height	
HNSC	cis	1	rs2056604	chr3:134312648	ANAPC13	chr3:134196547-134204865:-	0.49	10.57	1.09E-23	Height	
HNSC	cis	1	rs2056604	chr3:134312648	CEP63	chr3:134204575-134293852:+	0.27	5.8	1.16E-8	Height	
HNSC	cis	1	rs2056938	chr20:44022672	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	5.37	1.24E-7	Psoriasis	
HNSC	cis	1	rs2058059	chr7:72311817	NSUN5	chr7:72717227-72722823:-	0.17	3.68	0.000254	Subcutaneous adipose tissue	
HNSC	cis	1	rs2058059	chr7:72311817	TYW1B	chr7:72023729-72298813:-	-0.34	-5.14	4.04E-7	Subcutaneous adipose tissue	
HNSC	cis	1	rs2058337	chr4:17678649	FAM184B	chr4:17633711-17783135:-	-0.17	-4.11	4.67E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2058337	chr4:17678649	LAP3	chr4:17578927-17609590:+	-0.15	-4.08	5.27E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2058338	chr4:17678600	FAM184B	chr4:17633711-17783135:-	0.15	3.68	0.000263	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2058338	chr4:17678600	LAP3	chr4:17578927-17609590:+	0.16	4.21	3.04E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2058339	chr4:17678456	FAM184B	chr4:17633711-17783135:-	-0.16	-3.89	0.000114	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2058339	chr4:17678456	LAP3	chr4:17578927-17609590:+	-0.16	-4.09	5.0E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2058805	chr12:109998591	KCTD10	chr12:109886460-109915155:-	-0.16	-3.71	0.000235	HDL cholesterol	
HNSC	cis	1	rs2058805	chr12:109998591	MMAB	chr12:109991523-110011358:-	-0.19	-4.6	5.46E-6	HDL cholesterol	
HNSC	cis	1	rs2059207	chr5:90731931	LOC100129716	chr5:90676164-90716531:+	0.28	4.08	5.31E-5	Smoking behavior	
HNSC	cis	1	rs2059208	chr5:90732065	LOC100129716	chr5:90676164-90716531:+	0.31	4.65	4.19E-6	Smoking behavior	
HNSC	cis	1	rs2061164	chr11:18329006	GTF2H1	chr11:18343816-18388590:+	0.33	5.79	1.28E-8	Pancreatic cancer	
HNSC	cis	1	rs2061973	chr6:49487125	CENPQ	chr6:49431096-49460820:+	0.24	5.41	9.76E-8	Brain structure	
HNSC	cis	1	rs2061973	chr6:49487125	MUT	chr6:49398994-49431031:-	-0.19	-3.85	0.000132	Brain structure	
HNSC	cis	1	rs2064088	chr22:39053382	LOC646851	chr22:38974125-39052634:-	0.14	3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs2068737	chr10:59999575	CISD1	chr10:60028895-60049018:+	0.24	4.22	2.86E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2068737	chr10:59999575	IPMK	chr10:59955618-60027694:-	0.28	6.74	4.34E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2069502	chr12:58144665	FAM119B	chr12:58166383-58176323:+	-0.49	-9.36	2.75E-19	Multiple sclerosis	
HNSC	cis	1	rs2069502	chr12:58144665	TSFM	chr12:58176536-58191367:+	0.38	8.27	1.26E-15	Multiple sclerosis	
HNSC	cis	1	rs2070180	chr3:121351338	IQCB1	chr3:121488610-121553926:-	-0.24	-5.85	9.16E-9	Cognitive performance	
HNSC	cis	1	rs2072052	chr12:58146719	FAM119B	chr12:58166383-58176323:+	0.5	9.61	3.83E-20	Multiple sclerosis	
HNSC	cis	1	rs2072052	chr12:58146719	TSFM	chr12:58176536-58191367:+	-0.39	-8.48	2.64E-16	Multiple sclerosis	
HNSC	cis	1	rs2072293	chr14:74537885	LIN52	chr14:74551656-74667117:+	0.29	8.1	4.5E-15	Common traits (Other)	
HNSC	cis	1	rs2072435	chr7:75959188	UPK3B	chr7:76139745-76157197:+	-0.23	-4.56	6.37E-6	Multiple sclerosis	
HNSC	cis	1	rs2072435	chr7:75959188	ZP3	chr7:76026841-76071387:+	-0.2	-3.88	0.00012	Multiple sclerosis	
HNSC	cis	1	rs2072795	chr22:39064209	LOC646851	chr22:38974125-39052634:-	-0.14	-3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs2072796	chr22:39064230	LOC646851	chr22:38974125-39052634:-	0.15	3.87	0.000123	Resting heart rate	
HNSC	cis	1	rs2074018	chr11:2309634	C11orf21	chr11:2317507-2323143:-	0.29	6.03	3.18E-9	Obesity-related traits	
HNSC	cis	1	rs2075603	chr14:55609955	KIAA0831	chr14:55833110-55878576:-	-0.21	-3.68	0.00026	Protein biomarker	
HNSC	cis	1	rs2077593	chr7:65892530	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.71	2.13E-45	Aortic root size	
HNSC	cis	1	rs2077593	chr7:65892530	TYW1	chr7:66461817-66704496:+	0.2	3.67	0.000267	Aortic root size	
HNSC	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.7	-18.51	1.74E-58	Homocysteine levels	
HNSC	cis	1	rs2077808	chr1:45988115	MMACHC	chr1:45965856-45976737:+	-0.21	-4.18	3.43E-5	Homocysteine levels	
HNSC	cis	1	rs2078089	chr19:22209753	ZNF257	chr19:22235266-22273901:+	0.26	4.83	1.82E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2080303	chr2:202165206	ALS2CR12	chr2:202153148-202222101:-	-0.22	-3.68	0.000255	Basal cell carcinoma	
HNSC	cis	1	rs2080303	chr2:202165206	CASP8	chr2:202098166-202152434:+	0.23	4.44	1.1E-5	Basal cell carcinoma	
HNSC	cis	1	rs2080303	chr2:202165206	PPIL3	chr2:201735680-201753999:-	-0.34	-6.63	9.11E-11	Basal cell carcinoma	
HNSC	cis	1	rs2083634	chr4:129976478	C4orf33	chr4:130014829-130033842:+	-0.46	-8.85	1.55E-17	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs2083731	chr15:75368538	SCAMP5	chr15:75287901-75313836:+	0.37	7.53	2.39E-13	Blood trace element (Zn levels)	
HNSC	cis	1	rs2087647	chr7:65593188	NCRNA00174	chr7:65841032-65865395:-	0.74	15.54	1.27E-44	Aortic root size	
HNSC	cis	1	rs2089162	chr15:78739763	CHRNA5	chr15:78857906-78886458:+	-0.2	-3.93	9.76E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs2092990	chr20:3346338	ITPA	chr20:3190056-3204504:+	-0.2	-4.13	4.29E-5	IFN-related cytopenia	
HNSC	cis	1	rs2095892	chr10:60023719	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2095892	chr10:60023719	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2095893	chr10:59969551	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2095893	chr10:59969551	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2095894	chr10:59968671	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2095894	chr10:59968671	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2098297	chr14:75619118	MLH3	chr14:75480467-75518235:-	-0.28	-5.73	1.72E-8	Height	
HNSC	cis	1	rs2105220	chr10:59969064	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2105220	chr10:59969064	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2109522	chr4:17658645	FAM184B	chr4:17633711-17783135:-	-0.17	-4.05	5.93E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.81	14	9.52E-38	Type 2 diabetes	
HNSC	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	0.81	14.1	3.67E-38	Type 2 diabetes	
HNSC	cis	1	rs2115069	chr5:150252365	LOC134466	chr5:150310000-150326146:-	0.41	5.38	1.16E-7	Crohn's disease	
HNSC	cis	1	rs2119992	chr6:153449670	RGS17	chr6:153332041-153452389:-	-0.21	-3.95	9.12E-5	Prostate cancer	
HNSC	cis	1	rs2120019	chr15:75334184	SCAMP5	chr15:75287901-75313836:+	0.44	8.79	2.53E-17	Blood trace element (Zn levels)	
HNSC	cis	1	rs2123694	chr2:108857505	SULT1C2	chr2:108905095-108926370:+	0.32	5.24	2.39E-7	Blood pressure	
HNSC	cis	1	rs2125211	chr4:103559876	CENPE	chr4:104026963-104119566:-	0.17	4.08	5.15E-5	Primary biliary cirrhosis	
HNSC	cis	1	rs2126129	chr2:212548	SH3YL1	chr2:218138-264810:-	-0.67	-13.11	6.42E-34	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs2126988	chr5:82442315	XRCC4	chr5:82373317-82649577:+	-0.2	-3.96	8.54E-5	Hypertension	
HNSC	cis	1	rs2126990	chr5:82457170	XRCC4	chr5:82373317-82649577:+	-0.21	-4.01	6.89E-5	Hypertension	
HNSC	cis	1	rs2127905	chr11:117026374	PCSK7	chr11:117075789-117102811:-	-0.3	-4.43	1.14E-5	Protein quantitative trait loci	
HNSC	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	0.7	11.9	6.86E-29	Diastolic blood pressure	
HNSC	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	0.74	12.64	6.26E-32	Diastolic blood pressure	
HNSC	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.5	-12.67	4.88E-32	Kawasaki disease	
HNSC	cis	1	rs2134044	chr6:101075354	ASCC3	chr6:100956609-101329224:-	0.22	5.71	1.96E-8	Menarche (age at onset)	
HNSC	cis	1	rs2134688	chr1:150816886	GOLPH3L	chr1:150618701-150669672:-	-0.32	-4.26	2.4E-5	Congenital left-sided heart lesions	
HNSC	cis	1	rs2134688	chr1:150816886	HORMAD1	chr1:150670542-150693352:-	0.37	4.56	6.45E-6	Congenital left-sided heart lesions	
HNSC	cis	1	rs2140195	chr2:73702344	ALMS1P	chr2:73872046-73912692:+	0.26	4.39	1.4E-5	Metabolite levels	
HNSC	cis	1	rs2140270	chr3:49439440	AMT	chr3:49454212-49460012:-	-0.19	-4.21	3.09E-5	Menarche (age at onset)	
HNSC	cis	1	rs2141924	chr7:66186246	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.91	1.23E-6	Gout	
HNSC	cis	1	rs2141924	chr7:66186246	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.28	2.21E-5	Gout	
HNSC	cis	1	rs2142136	chr10:89763070	PAPSS2	chr10:89419476-89507460:+	-0.2	-3.92	9.99E-5	Type 2 diabetes	
HNSC	cis	1	rs2143062	chr6:27353852	ZNF391	chr6:27356524-27369227:+	0.29	5.26	2.18E-7	Glomerular filtration rate (creatinine)	
HNSC	cis	1	rs2143290	chr1:169088679	SCYL3	chr1:169821804-169863076:-	0.23	3.68	0.000256	QT interval	
HNSC	cis	1	rs2143346	chr6:26198449	HIST1H2AE	chr6:26217148-26217711:+	0.34	4.81	2.04E-6	Renal underexcretion gout;Gout	
HNSC	cis	1	rs2143347	chr6:26198494	HIST1H2AE	chr6:26217148-26217711:+	-0.3	-4.14	4.05E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs2143950	chr14:35572357	PPP2R3C	chr14:35554679-35591679:-	0.43	7.12	3.84E-12	Atopic dermatitis	
HNSC	cis	1	rs2149085	chr6:167371110	RNASET2	chr6:167343008-167412795:-	0.2	5.01	7.63E-7	Crohn's disease	
HNSC	cis	1	rs2149090	chr6:167372764	RNASET2	chr6:167343008-167412795:-	0.21	5.18	3.18E-7	Crohn's disease	
HNSC	cis	1	rs2149091	chr6:167372786	RNASET2	chr6:167343008-167412795:-	0.21	5.18	3.18E-7	Crohn's disease	
HNSC	cis	1	rs2152375	chr14:65915778	LOC645431	chr14:65877313-65879335:-	-0.3	-3.91	0.000104	Ischemic stroke	
HNSC	cis	1	rs2152916	chr10:97392265	ENTPD1	chr10:97471536-97637022:+	0.24	7.34	8.68E-13	Blood metabolite levels	
HNSC	cis	1	rs2153281	chr10:59972453	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2153281	chr10:59972453	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2153282	chr10:59972416	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2153282	chr10:59972416	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2153283	chr10:59972299	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2153283	chr10:59972299	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2154536	chr21:38492147	PIGP	chr21:38437664-38445458:-	-0.41	-8.7	5.01E-17	Eye color traits	
HNSC	cis	1	rs2155583	chr11:116915217	PCSK7	chr11:117075789-117102811:-	-0.28	-4.02	6.71E-5	Protein quantitative trait loci	
HNSC	cis	1	rs2159583	chr4:17658838	FAM184B	chr4:17633711-17783135:-	-0.17	-4.1	4.88E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2163167	chr3:53131772	RFT1	chr3:53122503-53164470:-	-0.27	-5.34	1.39E-7	Height	
HNSC	cis	1	rs2166580	chr4:1743169	FAM53A	chr4:1641609-1685854:-	-0.36	-6.23	9.96E-10	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.59	-13.48	1.73E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs2169748	chr2:28957753	TRMT61B	chr2:29072690-29093175:-	0.35	7.15	3.08E-12	Body mass index	
HNSC	cis	1	rs2169751	chr2:28966758	TRMT61B	chr2:29072690-29093175:-	-0.37	-7.84	2.74E-14	Body mass index	
HNSC	cis	1	rs2171205	chr3:99992812	TBC1D23	chr3:99979686-100044078:+	0.21	4.03	6.38E-5	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs2175366	chr19:22128279	ZNF257	chr19:22235266-22273901:+	0.26	4.71	3.15E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2177268	chr3:49439725	AMT	chr3:49454212-49460012:-	-0.19	-4.21	3.09E-5	Menarche (age at onset)	
HNSC	cis	1	rs2177601	chr3:134245434	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.52	1.7E-23	Height	
HNSC	cis	1	rs2177601	chr3:134245434	CEP63	chr3:134204575-134293852:+	-0.26	-5.68	2.27E-8	Height	
HNSC	cis	1	rs2177703	chr7:65391717	CRCP	chr7:65579805-65619551:+	-0.33	-3.97	8.29E-5	Diabetic kidney disease	
HNSC	cis	1	rs2177703	chr7:65391717	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.97	9.18E-7	Diabetic kidney disease	
HNSC	cis	1	rs2179142	chr22:39037954	LOC646851	chr22:38974125-39052634:-	0.14	3.75	0.000196	Resting heart rate	
HNSC	cis	1	rs2184602	chr14:65915672	LOC645431	chr14:65877313-65879335:-	-0.29	-3.92	9.95E-5	Ischemic stroke	
HNSC	cis	1	rs2185769	chr9:115462594	ZFP37	chr9:115804174-115818996:-	-0.29	-3.75	0.0002	Age-related hearing impairment (interaction)	
HNSC	cis	1	rs2187143	chr18:48371565	MRO	chr18:48321491-48351754:-	0.25	4.33	1.81E-5	Entorhinal cortical thickness	
HNSC	cis	1	rs2198463	chr2:108875093	SULT1C2	chr2:108905095-108926370:+	0.3	4.9	1.33E-6	Blood pressure	
HNSC	cis	1	rs2203433	chr14:62645070	KCNH5	chr14:63173947-63568584:-	-0.23	-3.68	0.000257	Iron status biomarkers	
HNSC	cis	1	rs2205802	chr22:39046327	LOC646851	chr22:38974125-39052634:-	0.14	3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs2208331	chr6:26507319	BTN3A2	chr6:26365398-26378546:+	0.19	4.41	1.25E-5	Educational attainment	
HNSC	cis	1	rs2210913	chr1:157668993	FCRL3	chr1:157646278-157670775:-	0.35	11.31	1.54E-26	Type 1 diabetes autoantibodies	
HNSC	cis	1	rs2215450	chr4:17675394	LAP3	chr4:17578927-17609590:+	-0.16	-4.3	2.07E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2217957	chr8:57313360	PENK	chr8:57353513-57359282:-	-0.35	-6.25	9.07E-10	Obesity-related traits	
HNSC	cis	1	rs2219078	chr2:108875198	SULT1C2	chr2:108905095-108926370:+	0.29	4.71	3.24E-6	Blood pressure	
HNSC	cis	1	rs2220626	chr7:65546062	NCRNA00174	chr7:65841032-65865395:-	0.73	14.71	7.23E-41	Aortic root size	
HNSC	cis	1	rs2224380	chr6:26553943	BTN2A3	chr6:26422317-26431927:+	0.16	3.74	0.000208	Educational attainment	
HNSC	cis	1	rs2224380	chr6:26553943	BTN3A2	chr6:26365398-26378546:+	0.18	4.32	1.85E-5	Educational attainment	
HNSC	cis	1	rs2227401	chr4:155486381	RNF175	chr4:154631313-154681387:-	-0.23	-3.79	0.000169	Fibrinogen levels	
HNSC	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.57	14.99	4.02E-42	Homocysteine levels	
HNSC	cis	1	rs2229384	chr6:49425521	MUT	chr6:49398994-49431031:-	-0.21	-4.23	2.83E-5	Homocysteine levels	
HNSC	cis	1	rs2231626	chr20:44002665	SYS1-DBNDD2	chr20:43991701-44039245:+	0.34	5.15	3.85E-7	Psoriasis	
HNSC	cis	1	rs2236089	chr20:3257194	ITPA	chr20:3190056-3204504:+	-0.19	-3.84	0.000138	IFN-related cytopenia	
HNSC	cis	1	rs2236092	chr20:3258188	ITPA	chr20:3190056-3204504:+	-0.19	-3.88	0.00012	IFN-related cytopenia	
HNSC	cis	1	rs2236098	chr20:3267133	ITPA	chr20:3190056-3204504:+	-0.19	-3.87	0.000124	IFN-related cytopenia	
HNSC	cis	1	rs2236104	chr20:3277602	ITPA	chr20:3190056-3204504:+	-0.18	-3.67	0.00027	IFN-related cytopenia	
HNSC	cis	1	rs2236106	chr20:3278410	ITPA	chr20:3190056-3204504:+	-0.19	-3.87	0.000124	IFN-related cytopenia	
HNSC	cis	1	rs2236108	chr20:3286331	ITPA	chr20:3190056-3204504:+	-0.19	-3.87	0.000124	IFN-related cytopenia	
HNSC	cis	1	rs2236117	chr20:3302021	ITPA	chr20:3190056-3204504:+	-0.2	-4.04	6.16E-5	IFN-related cytopenia	
HNSC	cis	1	rs2236122	chr20:3305240	ITPA	chr20:3190056-3204504:+	-0.2	-4.08	5.3E-5	IFN-related cytopenia	
HNSC	cis	1	rs2236123	chr20:3305305	ITPA	chr20:3190056-3204504:+	0.2	4.11	4.61E-5	IFN-related cytopenia	
HNSC	cis	1	rs2236246	chr14:104379206	TDRD9	chr14:104394817-104519002:+	-0.32	-5.28	1.96E-7	Bipolar disorder	
HNSC	cis	1	rs2236247	chr14:104378087	TDRD9	chr14:104394817-104519002:+	0.3	5.07	5.58E-7	Bipolar disorder	
HNSC	cis	1	rs2236786	chr4:1719294	FAM53A	chr4:1641609-1685854:-	0.38	6.18	1.35E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs2239557	chr14:74551970	LIN52	chr14:74551656-74667117:+	0.29	7.94	1.34E-14	Common traits (Other)	
HNSC	cis	1	rs2240009	chr17:40283142	DHX58	chr17:40253422-40264751:-	-0.35	-7.23	1.89E-12	Fibrinogen levels	
HNSC	cis	1	rs2240010	chr17:40278081	DHX58	chr17:40253422-40264751:-	-0.35	-7.21	2.15E-12	Fibrinogen levels	
HNSC	cis	1	rs2240032	chr5:131977127	SLC22A4	chr5:131630145-131679897:+	0.21	3.87	0.000121	Asthma (childhood onset)	
HNSC	cis	1	rs2240032	chr5:131977127	SLC22A5	chr5:131705401-131731302:+	0.25	3.92	0.0001	Asthma (childhood onset)	
HNSC	cis	1	rs2241878	chr2:234183718	ATG16L1	chr2:234160217-234204319:+	0.27	4.76	2.5E-6	Crohn's disease	
HNSC	cis	1	rs2241879	chr2:234183468	ATG16L1	chr2:234160217-234204319:+	0.28	4.9	1.32E-6	Crohn's disease	
HNSC	cis	1	rs2241880	chr2:234183368	ATG16L1	chr2:234160217-234204319:+	0.28	4.92	1.18E-6	Crohn's disease	
HNSC	cis	1	rs2242150	chr3:48505964	ATRIP	chr3:48488141-48507708:+	-0.17	-4	7.3E-5	Longevity	
HNSC	cis	1	rs2242150	chr3:48505964	TREX1	chr3:48501186-48509043:+	0.26	6.59	1.13E-10	Longevity	
HNSC	cis	1	rs2242471	chr4:76878716	NAAA	chr4:76831809-76862166:-	0.49	11.44	4.79E-27	Longevity	
HNSC	cis	1	rs2242473	chr4:76878956	NAAA	chr4:76831809-76862166:-	0.5	11.79	1.97E-28	Longevity	
HNSC	cis	1	rs2242474	chr4:76878982	NAAA	chr4:76831809-76862166:-	0.5	11.79	1.97E-28	Longevity	
HNSC	cis	1	rs224329	chr20:34019579	CPNE1	chr20:34213968-34262539:-	-0.24	-4.43	1.16E-5	Height	
HNSC	cis	1	rs224329	chr20:34019579	UQCC	chr20:33890383-33999833:-	-0.33	-6.14	1.75E-9	Height	
HNSC	cis	1	rs2243480	chr7:65599196	NCRNA00174	chr7:65841032-65865395:-	-0.41	-4.47	9.76E-6	Diabetic kidney disease	
HNSC	cis	1	rs2245715	chr15:43818052	ADAL	chr15:43622872-43646094:+	-0.4	-5.71	1.92E-8	Tumor biomarkers	
HNSC	cis	1	rs2245715	chr15:43818052	CATSPER2	chr15:43922774-43959900:-	-0.36	-6.03	3.27E-9	Tumor biomarkers	
HNSC	cis	1	rs2245715	chr15:43818052	CKMT1A	chr15:43985084-43991419:+	-0.37	-5.19	3.03E-7	Tumor biomarkers	
HNSC	cis	1	rs2245715	chr15:43818052	CKMT1B	chr15:43885252-43891603:+	-0.3	-4.34	1.73E-5	Tumor biomarkers	
HNSC	cis	1	rs2245717	chr20:43995880	SYS1-DBNDD2	chr20:43991701-44039245:+	0.35	5.28	1.95E-7	Psoriasis	
HNSC	cis	1	rs2247037	chr20:44031295	SYS1-DBNDD2	chr20:43991701-44039245:+	0.35	5.18	3.24E-7	Psoriasis	
HNSC	cis	1	rs2248393	chr20:33926103	CPNE1	chr20:34213968-34262539:-	-0.27	-5.01	7.75E-7	Height	
HNSC	cis	1	rs2248393	chr20:33926103	UQCC	chr20:33890383-33999833:-	-0.33	-6.17	1.39E-9	Height	
HNSC	cis	1	rs2248637	chr20:43997240	SYS1-DBNDD2	chr20:43991701-44039245:+	-0.34	-5.14	4.02E-7	Psoriasis	
HNSC	cis	1	rs2249694	chr10:135352153	CYP2E1	chr10:135340867-135374724:+	0.27	4.59	5.65E-6	Obesity-related traits	
HNSC	cis	1	rs2249695	chr10:135352168	CYP2E1	chr10:135340867-135374724:+	0.26	4.44	1.11E-5	Obesity-related traits	
HNSC	cis	1	rs2251039	chr10:60028894	CISD1	chr10:60028895-60049018:+	0.24	4.19	3.36E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2251039	chr10:60028894	IPMK	chr10:59955618-60027694:-	0.27	6.62	9.6E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2251115	chr6:49446509	CENPQ	chr6:49431096-49460820:+	-0.56	-14.28	5.65E-39	Homocysteine levels	
HNSC	cis	1	rs2251115	chr6:49446509	MUT	chr6:49398994-49431031:-	0.25	4.91	1.27E-6	Homocysteine levels	
HNSC	cis	1	rs2251301	chr8:11119037	AMAC1L2	chr8:11188495-11189695:+	-0.34	-4.21	3.08E-5	Response to antipsychotic therapy (extrapyramidal side effects)	
HNSC	cis	1	rs2251844	chr15:43836478	ADAL	chr15:43622872-43646094:+	-0.36	-5.24	2.44E-7	Tumor biomarkers	
HNSC	cis	1	rs2251844	chr15:43836478	CATSPER2	chr15:43922774-43959900:-	-0.36	-6.07	2.58E-9	Tumor biomarkers	
HNSC	cis	1	rs2251844	chr15:43836478	CKMT1A	chr15:43985084-43991419:+	-0.36	-5.15	3.73E-7	Tumor biomarkers	
HNSC	cis	1	rs2251844	chr15:43836478	CKMT1B	chr15:43885252-43891603:+	-0.3	-4.39	1.37E-5	Tumor biomarkers	
HNSC	cis	1	rs2252502	chr7:158738634	ESYT2	chr7:158523689-158622319:-	-0.18	-3.66	0.000284	Height	
HNSC	cis	1	rs2253105	chr20:44011301	SYS1-DBNDD2	chr20:43991701-44039245:+	0.35	5.25	2.27E-7	Psoriasis	
HNSC	cis	1	rs2253192	chr10:59999323	CISD1	chr10:60028895-60049018:+	-0.24	-4.22	2.85E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2253192	chr10:59999323	IPMK	chr10:59955618-60027694:-	-0.27	-6.6	1.06E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2253209	chr3:53115160	RFT1	chr3:53122503-53164470:-	-0.25	-4.98	8.92E-7	Height	
HNSC	cis	1	rs2253656	chr3:53119099	RFT1	chr3:53122503-53164470:-	-0.26	-5.27	2.06E-7	Height	
HNSC	cis	1	rs2253685	chr3:53119703	RFT1	chr3:53122503-53164470:-	-0.26	-5.36	1.26E-7	Height	
HNSC	cis	1	rs2253796	chr3:53120098	RFT1	chr3:53122503-53164470:-	-0.26	-5.36	1.26E-7	Height	
HNSC	cis	1	rs2254545	chr10:60034981	CISD1	chr10:60028895-60049018:+	0.23	4.1	4.74E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2254545	chr10:60034981	IPMK	chr10:59955618-60027694:-	0.27	6.67	6.83E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2254775	chr10:60036815	CISD1	chr10:60028895-60049018:+	0.24	4.29	2.15E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2254775	chr10:60036815	IPMK	chr10:59955618-60027694:-	0.28	6.83	2.52E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2255042	chr15:43834318	ADAL	chr15:43622872-43646094:+	0.36	5.33	1.51E-7	Tumor biomarkers	
HNSC	cis	1	rs2255042	chr15:43834318	CATSPER2	chr15:43922774-43959900:-	0.37	6.44	2.89E-10	Tumor biomarkers	
HNSC	cis	1	rs2255042	chr15:43834318	CKMT1A	chr15:43985084-43991419:+	0.35	5.06	5.93E-7	Tumor biomarkers	
HNSC	cis	1	rs2255042	chr15:43834318	CKMT1B	chr15:43885252-43891603:+	0.31	4.58	5.91E-6	Tumor biomarkers	
HNSC	cis	1	rs2255042	chr15:43834318	TUBGCP4	chr15:43663313-43698238:+	-0.2	-3.79	0.000172	Tumor biomarkers	
HNSC	cis	1	rs2255051	chr15:43846161	ADAL	chr15:43622872-43646094:+	-0.37	-5.22	2.61E-7	Tumor biomarkers	
HNSC	cis	1	rs2255051	chr15:43846161	CATSPER2	chr15:43922774-43959900:-	-0.39	-6.56	1.4E-10	Tumor biomarkers	
HNSC	cis	1	rs2255051	chr15:43846161	CKMT1A	chr15:43985084-43991419:+	-0.38	-5.38	1.12E-7	Tumor biomarkers	
HNSC	cis	1	rs2255051	chr15:43846161	CKMT1B	chr15:43885252-43891603:+	-0.32	-4.54	7.07E-6	Tumor biomarkers	
HNSC	cis	1	rs2255070	chr6:26501777	BTN3A2	chr6:26365398-26378546:+	0.19	4.37	1.54E-5	Educational attainment	
HNSC	cis	1	rs2255440	chr15:43830467	ADAL	chr15:43622872-43646094:+	-0.38	-5.44	8.39E-8	Tumor biomarkers	
HNSC	cis	1	rs2255440	chr15:43830467	CATSPER2	chr15:43922774-43959900:-	-0.36	-5.99	3.95E-9	Tumor biomarkers	
HNSC	cis	1	rs2255440	chr15:43830467	CKMT1A	chr15:43985084-43991419:+	-0.35	-4.95	1.03E-6	Tumor biomarkers	
HNSC	cis	1	rs2255440	chr15:43830467	CKMT1B	chr15:43885252-43891603:+	-0.3	-4.28	2.24E-5	Tumor biomarkers	
HNSC	cis	1	rs2256686	chr20:44017331	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	5.43	8.64E-8	Psoriasis	
HNSC	cis	1	rs2257790	chr7:65600450	CRCP	chr7:65579805-65619551:+	-0.32	-3.73	0.000215	Diabetic kidney disease	
HNSC	cis	1	rs2257790	chr7:65600450	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.79	2.26E-6	Diabetic kidney disease	
HNSC	cis	1	rs2262909	chr19:22135270	ZNF257	chr19:22235266-22273901:+	0.28	5.15	3.71E-7	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2263759	chr20:44011502	SYS1-DBNDD2	chr20:43991701-44039245:+	0.35	5.3	1.79E-7	Psoriasis	
HNSC	cis	1	rs2263764	chr20:44025815	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	5.42	9.59E-8	Psoriasis	
HNSC	cis	1	rs2263768	chr20:44031241	SYS1-DBNDD2	chr20:43991701-44039245:+	0.35	5.18	3.24E-7	Psoriasis	
HNSC	cis	1	rs2267138	chr22:29793641	RFPL1	chr22:29834572-29838443:+	0.3	4.08	5.2E-5	Myopia (pathological)	
HNSC	cis	1	rs2268617	chr14:75608728	MLH3	chr14:75480467-75518235:-	0.3	6.11	1.97E-9	Height	
HNSC	cis	1	rs2268960	chr14:66145500	LOC645431	chr14:65877313-65879335:-	-0.27	-3.66	0.000275	Ischemic stroke	
HNSC	cis	1	rs2269186	chr14:104379912	TDRD9	chr14:104394817-104519002:+	0.34	5.65	2.77E-8	Bipolar disorder	
HNSC	cis	1	rs2269558	chr16:682250	C16orf13	chr16:684429-686347:-	0.15	4.22	2.89E-5	Height	
HNSC	cis	1	rs2269558	chr16:682250	PIGQ	chr16:617032-634108:+	-0.22	-5.08	5.27E-7	Height	
HNSC	cis	1	rs2269558	chr16:682250	WFIKKN1	chr16:679239-684116:+	0.28	5.77	1.42E-8	Height	
HNSC	cis	1	rs2269685	chr12:51417671	SLC11A2	chr12:51373319-51422058:-	-0.21	-3.67	0.00027	Type 2 diabetes	
HNSC	cis	1	rs2270291	chr1:156244992	BGLAP	chr1:156182784-156213112:+	0.19	3.68	0.000262	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs2270968	chr3:182755209	MCCC1	chr3:182733008-182833860:-	0.17	3.97	8.33E-5	Blood metabolite levels;Parkinson's disease	
HNSC	cis	1	rs2272390	chr2:202195311	PPIL3	chr2:201735680-201753999:-	-0.44	-5.04	6.47E-7	Rheumatoid arthritis	
HNSC	cis	1	rs2272563	chr11:236871	PSMD13	chr11:236808-252984:+	-0.18	-3.66	0.000276	Menarche (age at onset)	
HNSC	cis	1	rs2273602	chr6:117730592	ROS1	chr6:117609530-117747018:-	-0.18	-3.97	8.21E-5	Lung cancer	
HNSC	cis	1	rs2273610	chr14:104387642	TDRD9	chr14:104394817-104519002:+	0.35	5.74	1.65E-8	Bipolar disorder	
HNSC	cis	1	rs2273694	chr10:102256496	SEC31B	chr10:102246403-102289636:-	-0.2	-6.41	3.32E-10	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2273695	chr10:102259568	SEC31B	chr10:102246403-102289636:-	-0.15	-4.92	1.2E-6	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2273	chr4:76889388	NAAA	chr4:76831809-76862166:-	0.49	11.59	1.24E-27	Longevity	
HNSC	cis	1	rs2274273	chr14:55614636	KIAA0831	chr14:55833110-55878576:-	0.22	3.99	7.71E-5	Protein biomarker	
HNSC	cis	1	rs2274292	chr13:96295321	DZIP1	chr13:96229329-96296957:-	0.29	4.05	6.01E-5	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
HNSC	cis	1	rs2274292	chr13:96295321	UGGT2	chr13:96453838-96705736:-	-0.26	-4.14	4.11E-5	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
HNSC	cis	1	rs2275426	chr1:46487552	CCDC163P	chr1:45960581-45965646:-	-0.33	-7.17	2.77E-12	Body mass index	
HNSC	cis	1	rs2276014	chr11:64081445	C11orf20	chr11:64067863-64072238:+	-0.26	-3.73	0.000215	Mean platelet volume	
HNSC	cis	1	rs2276161	chr2:135470735	TMEM163	chr2:135213331-135525334:-	-0.3	-5.29	1.84E-7	Gut microbiome composition (winter)	
HNSC	cis	1	rs2276547	chr2:28975107	TRMT61B	chr2:29072690-29093175:-	-0.36	-7.62	1.3E-13	Body mass index	
HNSC	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.7	-10.1	6.25E-22	Cholesterol, total	
HNSC	cis	1	rs2277869	chr12:1016910	RAD52	chr12:1021255-1099219:-	-0.34	-5.29	1.81E-7	Colorectal cancer	
HNSC	cis	1	rs2277870	chr1:156246792	BGLAP	chr1:156182784-156213112:+	0.19	3.68	0.000262	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs2277871	chr1:156246742	BGLAP	chr1:156182784-156213112:+	0.19	3.68	0.000262	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs2278238	chr19:18576484	SSBP4	chr19:18530221-18545371:+	-0.21	-4.8	2.15E-6	Breast cancer	
HNSC	cis	1	rs2279077	chr3:48474249	TREX1	chr3:48501186-48509043:+	-0.3	-7.45	4.26E-13	Longevity	
HNSC	cis	1	rs2279144	chr19:39201781	LGALS7B	chr19:39279850-39282393:+	0.29	6.46	2.47E-10	Heart rate	
HNSC	cis	1	rs2280017	chr16:15151361	RRN3	chr16:15153881-15188158:-	0.29	6.26	8.62E-10	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid);Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
HNSC	cis	1	rs2280018	chr16:15150833	RRN3	chr16:15153881-15188158:-	-0.28	-5.92	6.02E-9	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid);Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
HNSC	cis	1	rs2281019	chr22:39064378	LOC646851	chr22:38974125-39052634:-	0.15	3.94	9.39E-5	Resting heart rate	
HNSC	cis	1	rs2281020	chr22:39064406	LOC646851	chr22:38974125-39052634:-	0.15	3.94	9.39E-5	Resting heart rate	
HNSC	cis	1	rs2281021	chr22:39064667	LOC646851	chr22:38974125-39052634:-	0.15	3.94	9.39E-5	Resting heart rate	
HNSC	cis	1	rs2281497	chr20:3258874	ITPA	chr20:3190056-3204504:+	-0.2	-4.09	5.07E-5	IFN-related cytopenia	
HNSC	cis	1	rs2281500	chr20:3262824	ITPA	chr20:3190056-3204504:+	-0.19	-3.94	9.15E-5	IFN-related cytopenia	
HNSC	cis	1	rs2281503	chr20:3263636	ITPA	chr20:3190056-3204504:+	-0.19	-3.96	8.67E-5	IFN-related cytopenia	
HNSC	cis	1	rs2285087	chr4:3088211	GRK4	chr4:2965343-3042474:+	-0.2	-3.75	0.000196	Parental longevity (mother's age at death)	
HNSC	cis	1	rs2285657	chr17:40272594	DHX58	chr17:40253422-40264751:-	-0.36	-7.25	1.66E-12	Fibrinogen levels	
HNSC	cis	1	rs2285946	chr7:21583329	DNAH11	chr7:21582833-21941455:+	-0.51	-11.43	5.24E-27	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
HNSC	cis	1	rs2285947	chr7:21584088	DNAH11	chr7:21582833-21941455:+	0.51	11.59	1.25E-27	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
HNSC	cis	1	rs2285949	chr7:21584243	DNAH11	chr7:21582833-21941455:+	-0.52	-11.52	2.37E-27	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
HNSC	cis	1	rs2285950	chr7:21584432	DNAH11	chr7:21582833-21941455:+	0.51	11.26	2.53E-26	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
HNSC	cis	1	rs2286614	chr11:64068310	C11orf20	chr11:64067863-64072238:+	-0.28	-4.09	5.05E-5	Mean platelet volume	
HNSC	cis	1	rs2286684	chr7:66129830	NCRNA00174	chr7:65841032-65865395:-	0.55	10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs2286771	chr4:17643848	FAM184B	chr4:17633711-17783135:-	-0.16	-3.95	8.87E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2287679	chr19:33600764	GPATCH1	chr19:33571786-33621318:+	0.2	3.81	0.000159	Bone properties (heel)	
HNSC	cis	1	rs2288073	chr2:24413298	C2orf84	chr2:24397531-24414566:+	-0.35	-6.46	2.53E-10	Venous thromboembolism (SNP x SNP interaction)	
HNSC	cis	1	rs2288344	chr15:56122347	NEDD4	chr15:56119131-56285835:-	0.2	5	7.96E-7	Keloid	
HNSC	cis	1	rs2289130	chr18:44626630	HDHD2	chr18:44633782-44676871:-	0.43	4.82	1.93E-6	Sitting height ratio	
HNSC	cis	1	rs2289131	chr18:44602864	HDHD2	chr18:44633782-44676871:-	0.42	4.78	2.37E-6	Sitting height ratio	
HNSC	cis	1	rs2289132	chr18:44602292	HDHD2	chr18:44633782-44676871:-	0.42	4.76	2.51E-6	Sitting height ratio	
HNSC	cis	1	rs2289472	chr2:234182240	ATG16L1	chr2:234160217-234204319:+	0.28	4.9	1.32E-6	Crohn's disease	
HNSC	cis	1	rs2289474	chr2:234181848	ATG16L1	chr2:234160217-234204319:+	0.28	4.9	1.32E-6	Crohn's disease	
HNSC	cis	1	rs2290822	chr3:48473204	TREX1	chr3:48501186-48509043:+	-0.26	-6.41	3.32E-10	Longevity	
HNSC	cis	1	rs2290850	chr11:47807774	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.5	6.05E-8	Subjective well-being	
HNSC	cis	1	rs2290850	chr11:47807774	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.95	9.11E-5	Subjective well-being	
HNSC	cis	1	rs2290911	chr2:224919	SH3YL1	chr2:218138-264810:-	-0.68	-13.3	1.07E-34	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs2291738	chr12:56815281	ATP5B	chr12:57031961-57039852:-	0.19	3.89	0.000115	Axial length	
HNSC	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.52	10.87	7.9E-25	Cognitive function	
HNSC	cis	1	rs2293167	chr11:211644	PSMD13	chr11:236808-252984:+	0.2	4.13	4.19E-5	Menarche (age at onset)	
HNSC	cis	1	rs2294008	chr8:143761931	LOC100133669	chr8:144063448-144099807:-	0.21	4.09	5.0E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2294008	chr8:143761931	LY6K	chr8:143781529-143785582:+	0.33	7.35	8.37E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2294008	chr8:143761931	PSCA	chr8:143761875-143764142:+	0.42	10.17	3.46E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2294010	chr8:143762430	LOC100133669	chr8:144063448-144099807:-	0.2	4.06	5.72E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2294010	chr8:143762430	LY6K	chr8:143781529-143785582:+	0.32	7.24	1.78E-12	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2294010	chr8:143762430	PSCA	chr8:143761875-143764142:+	0.42	10.18	3.12E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2294296	chr22:39053049	LOC646851	chr22:38974125-39052634:-	0.14	3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs2295770	chr10:102239829	SEC31B	chr10:102246403-102289636:-	-0.19	-5.79	1.27E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2295772	chr10:102265183	SEC31B	chr10:102246403-102289636:-	-0.19	-6.13	1.81E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2295773	chr10:102265815	SEC31B	chr10:102246403-102289636:-	-0.19	-6.13	1.81E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2295774	chr10:102265847	SEC31B	chr10:102246403-102289636:-	-0.19	-5.77	1.39E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2295776	chr10:102295629	SEC31B	chr10:102246403-102289636:-	-0.19	-5.79	1.23E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2295779	chr10:102296061	SEC31B	chr10:102246403-102289636:-	-0.17	-5.59	3.85E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2295780	chr10:102305965	SEC31B	chr10:102246403-102289636:-	-0.17	-5.1	4.81E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2295872	chr10:38146218	LOC399744	chr10:38717074-38741080:+	0.28	3.76	0.000188	Obesity (extreme)	
HNSC	cis	1	rs2295888	chr20:33722863	PROCR	chr20:33758727-33765164:+	-0.28	-4.03	6.54E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs2296691	chr10:97370989	ENTPD1	chr10:97471536-97637022:+	0.24	7.32	9.99E-13	Blood metabolite levels	
HNSC	cis	1	rs2296837	chr1:166958601	FMO9P	chr1:166573153-166594471:+	0.21	3.95	8.97E-5	Refractive astigmatism	
HNSC	cis	1	rs2298074	chr10:102247526	SEC31B	chr10:102246403-102289636:-	-0.17	-5.09	5.11E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2298075	chr10:102247408	SEC31B	chr10:102246403-102289636:-	-0.19	-5.84	9.39E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2298914	chr1:171710405	VAMP4	chr1:171669298-171711214:-	0.28	4.67	3.8E-6	Hippocampal atrophy	
HNSC	cis	1	rs2300601	chr14:75639571	MLH3	chr14:75480467-75518235:-	0.27	5.74	1.7E-8	Height	
HNSC	cis	1	rs2300872	chr14:66147761	LOC645431	chr14:65877313-65879335:-	-0.28	-3.67	0.000272	Ischemic stroke	
HNSC	cis	1	rs2301713	chr5:131951996	SLC22A4	chr5:131630145-131679897:+	-0.2	-3.79	0.000171	Asthma (childhood onset)	
HNSC	cis	1	rs2301713	chr5:131951996	SLC22A5	chr5:131705401-131731302:+	-0.22	-3.67	0.000273	Asthma (childhood onset)	
HNSC	cis	1	rs2302138	chr14:74363305	LIN52	chr14:74551656-74667117:+	0.22	4.09	4.94E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs2302139	chr14:74362935	LIN52	chr14:74551656-74667117:+	0.21	3.93	9.64E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs2303695	chr19:18562624	SSBP4	chr19:18530221-18545371:+	-0.19	-4.31	2.02E-5	Breast cancer	
HNSC	cis	1	rs2303697	chr19:18546678	SSBP4	chr19:18530221-18545371:+	-0.21	-4.84	1.76E-6	Breast cancer	
HNSC	cis	1	rs2303759	chr19:49869051	DKKL1	chr19:49867042-49878371:+	-0.35	-6.45	2.67E-10	Multiple sclerosis	
HNSC	cis	1	rs2304641	chr1:85513398	MCOLN2	chr1:85391267-85462796:-	-0.21	-3.73	0.000211	Serum sulfate level	
HNSC	cis	1	rs2305188	chr4:1739592	FAM53A	chr4:1641609-1685854:-	-0.34	-5.96	4.93E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs2305815	chr1:150956947	GOLPH3L	chr1:150618701-150669672:-	0.33	3.86	0.00013	Congenital left-sided heart lesions	
HNSC	cis	1	rs2305815	chr1:150956947	HORMAD1	chr1:150670542-150693352:-	-0.4	-4.17	3.66E-5	Congenital left-sided heart lesions	
HNSC	cis	1	rs2306937	chr1:113246506	ST7L	chr1:113066142-113162405:-	0.38	5.53	5.3E-8	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs2306940	chr1:113241052	ST7L	chr1:113066142-113162405:-	0.39	5.91	6.33E-9	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs2312462	chr3:49601255	AMT	chr3:49454212-49460012:-	0.2	4.66	4.0E-6	Menarche (age at onset)	
HNSC	cis	1	rs2312462	chr3:49601255	C3orf54	chr3:49840687-49842463:+	0.19	3.87	0.000122	Menarche (age at onset)	
HNSC	cis	1	rs2315281	chr19:19480099	HAPLN4	chr19:19366453-19384074:-	-0.21	-4.54	7.14E-6	Schizophrenia	
HNSC	cis	1	rs2315556	chr4:17670861	FAM184B	chr4:17633711-17783135:-	-0.17	-3.98	7.96E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2315556	chr4:17670861	LAP3	chr4:17578927-17609590:+	-0.15	-3.97	8.36E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2315560	chr4:17677305	FAM184B	chr4:17633711-17783135:-	-0.17	-4.14	4.03E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2315560	chr4:17677305	LAP3	chr4:17578927-17609590:+	-0.16	-4.07	5.4E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2315561	chr4:17679695	FAM184B	chr4:17633711-17783135:-	-0.16	-3.98	7.89E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2315561	chr4:17679695	LAP3	chr4:17578927-17609590:+	-0.16	-4.33	1.83E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2317134	chr3:56648363	CCDC66	chr3:56591184-56655846:+	0.16	4.54	7.14E-6	Height	
HNSC	cis	1	rs2317252	chr3:56687708	CCDC66	chr3:56591184-56655846:+	0.18	4.94	1.09E-6	Height	
HNSC	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.63	-13.7	2.01E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs2333194	chr14:73767214	ACOT1	chr14:74003928-74042357:+	-0.2	-4.48	9.17E-6	Bipolar disorder with mood-incongruent psychosis	
HNSC	cis	1	rs2333194	chr14:73767214	HEATR4	chr14:73945193-74025651:-	-0.34	-6.77	3.69E-11	Bipolar disorder with mood-incongruent psychosis	
HNSC	cis	1	rs2336540	chr3:52974589	TMEM110	chr3:52867139-52931547:-	0.53	6.12	1.86E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs2336541	chr3:52974630	TMEM110	chr3:52867139-52931547:-	0.53	6.12	1.86E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs2336723	chr3:53106047	RFT1	chr3:53122503-53164470:-	-0.23	-4.57	6.22E-6	Height	
HNSC	cis	1	rs2340536	chr8:96010435	C8orf38	chr8:95908040-96088396:+	-0.36	-5.27	2.0E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs2344180	chr5:150267357	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs2345001	chr5:150266518	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs2349075	chr2:202223566	CASP8	chr2:202098166-202152434:+	0.2	4.1	4.79E-5	Basal cell carcinoma	
HNSC	cis	1	rs2349075	chr2:202223566	PPIL3	chr2:201735680-201753999:-	-0.19	-3.98	8.07E-5	Basal cell carcinoma	
HNSC	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.66	-11.68	5.48E-28	Type 2 diabetes	
HNSC	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.66	-11.76	2.52E-28	Type 2 diabetes	
HNSC	cis	1	rs2356501	chr6:118942371	C6orf204	chr6:118786239-119031238:-	-0.24	-4.32	1.86E-5	Renal cell carcinoma	
HNSC	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.69	-18.2	5.44E-57	Homocysteine levels	
HNSC	cis	1	rs2356559	chr1:45981512	MMACHC	chr1:45965856-45976737:+	-0.2	-4.04	6.14E-5	Homocysteine levels	
HNSC	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.65	-16.97	3.3E-51	Homocysteine levels	
HNSC	cis	1	rs2358628	chr14:74631757	LIN52	chr14:74551656-74667117:+	-0.31	-8.47	2.77E-16	Common traits (Other)	
HNSC	cis	1	rs2358633	chr14:74647418	LIN52	chr14:74551656-74667117:+	-0.29	-8.14	3.25E-15	Common traits (Other)	
HNSC	cis	1	rs2359155	chr19:21671869	ZNF100	chr19:21906844-21950430:-	-0.22	-3.84	0.00014	Pain	
HNSC	cis	1	rs2359821	chr19:22208314	ZNF257	chr19:22235266-22273901:+	0.26	4.83	1.82E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.27	-6.77	3.63E-11	Longevity	
HNSC	cis	1	rs2362452	chr3:48418214	ATRIP	chr3:48488141-48507708:+	-0.17	-3.89	0.000115	Longevity	
HNSC	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.27	6.6	1.06E-10	Longevity	
HNSC	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.48	-5.43	8.71E-8	Plasma clusterin levels	
HNSC	cis	1	rs2367526	chr5:90740525	LOC100129716	chr5:90676164-90716531:+	0.31	4.47	9.62E-6	Smoking behavior	
HNSC	cis	1	rs2368984	chr14:104372055	TDRD9	chr14:104394817-104519002:+	0.29	4.82	1.92E-6	Bipolar disorder	
HNSC	cis	1	rs236918	chr11:117091609	PCSK7	chr11:117075789-117102811:-	0.32	4.36	1.61E-5	Protein quantitative trait loci	
HNSC	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.5	10.67	4.64E-24	Height	
HNSC	cis	1	rs2370578	chr3:134199612	CEP63	chr3:134204575-134293852:+	0.27	5.7	2.02E-8	Height	
HNSC	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.48	10.4	4.78E-23	Height	
HNSC	cis	1	rs2370641	chr3:134222161	CEP63	chr3:134204575-134293852:+	0.28	6.02	3.33E-9	Height	
HNSC	cis	1	rs2370642	chr3:134222136	ANAPC13	chr3:134196547-134204865:-	0.49	10.59	9.52E-24	Height	
HNSC	cis	1	rs2370642	chr3:134222136	CEP63	chr3:134204575-134293852:+	0.28	6.11	2.06E-9	Height	
HNSC	cis	1	rs2371244	chr7:143757611	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.52	2.55E-13	Obesity-related traits	
HNSC	cis	1	rs2371247	chr7:143764179	ARHGEF35	chr7:143883677-143892736:-	-0.35	-7.54	2.25E-13	Obesity-related traits	
HNSC	cis	1	rs2371248	chr7:143764189	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.5	2.9E-13	Obesity-related traits	
HNSC	cis	1	rs2373865	chr3:134291556	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.55	1.38E-23	Height	
HNSC	cis	1	rs2373865	chr3:134291556	CEP63	chr3:134204575-134293852:+	-0.27	-5.71	1.96E-8	Height	
HNSC	cis	1	rs2386238	chr5:82431085	XRCC4	chr5:82373317-82649577:+	-0.2	-3.88	0.000119	Hypertension	
HNSC	cis	1	rs2386239	chr5:82431158	XRCC4	chr5:82373317-82649577:+	-0.2	-3.88	0.000119	Hypertension	
HNSC	cis	1	rs2386240	chr5:82443011	XRCC4	chr5:82373317-82649577:+	-0.21	-4.06	5.74E-5	Hypertension	
HNSC	cis	1	rs2391159	chr1:92971951	EVI5	chr1:92974255-93257961:-	-0.23	-4.23	2.77E-5	Cholesterol, total	
HNSC	cis	1	rs2391160	chr1:92992797	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs239198	chr6:101134077	ASCC3	chr6:100956609-101329224:-	0.17	4.44	1.12E-5	Menarche (age at onset)	
HNSC	cis	1	rs2393670	chr6:26535541	BTN2A3	chr6:26422317-26431927:+	0.16	3.66	0.000275	Educational attainment	
HNSC	cis	1	rs2393670	chr6:26535541	BTN3A2	chr6:26365398-26378546:+	0.18	4.36	1.57E-5	Educational attainment	
HNSC	cis	1	rs239935	chr6:167411788	RNASET2	chr6:167343008-167412795:-	-0.21	-5.21	2.77E-7	Crohn's disease	
HNSC	cis	1	rs2403083	chr8:86108149	LRRCC1	chr8:86019377-86058312:+	0.19	3.84	0.000138	Plasma amyloid beta peptide concentrations (ABx-40)	
HNSC	cis	1	rs2413544	chr22:39059404	LOC646851	chr22:38974125-39052634:-	0.14	3.72	0.000224	Resting heart rate	
HNSC	cis	1	rs2413545	chr22:39092524	LOC646851	chr22:38974125-39052634:-	0.15	3.75	0.000196	Resting heart rate	
HNSC	cis	1	rs2413546	chr22:39107001	LOC646851	chr22:38974125-39052634:-	0.14	3.74	0.000203	Resting heart rate	
HNSC	cis	1	rs2413547	chr22:39107338	LOC646851	chr22:38974125-39052634:-	0.14	3.74	0.000203	Resting heart rate	
HNSC	cis	1	rs2415253	chr15:75375699	SCAMP5	chr15:75287901-75313836:+	0.37	7.37	7.22E-13	Blood trace element (Zn levels)	
HNSC	cis	1	rs2415255	chr15:75332412	SCAMP5	chr15:75287901-75313836:+	0.44	8.82	1.99E-17	Blood trace element (Zn levels)	
HNSC	cis	1	rs2420168	chr7:65630631	NCRNA00174	chr7:65841032-65865395:-	0.75	15.84	5.82E-46	Aortic root size	
HNSC	cis	1	rs2420170	chr7:65656053	NCRNA00174	chr7:65841032-65865395:-	0.44	4.76	2.57E-6	Diabetic kidney disease	
HNSC	cis	1	rs2420171	chr7:65637760	CRCP	chr7:65579805-65619551:+	0.32	3.68	0.000254	Diabetic kidney disease	
HNSC	cis	1	rs2420171	chr7:65637760	NCRNA00174	chr7:65841032-65865395:-	0.45	4.82	1.88E-6	Diabetic kidney disease	
HNSC	cis	1	rs2420591	chr7:65912381	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.88	3.77E-46	Aortic root size	
HNSC	cis	1	rs2420591	chr7:65912381	TYW1	chr7:66461817-66704496:+	0.2	3.66	0.000278	Aortic root size	
HNSC	cis	1	rs2420820	chr7:66091907	NCRNA00174	chr7:65841032-65865395:-	0.69	13.52	1.14E-35	Aortic root size	
HNSC	cis	1	rs2420824	chr7:66131116	NCRNA00174	chr7:65841032-65865395:-	0.54	10.56	1.23E-23	Aortic root size	
HNSC	cis	1	rs2421143	chr10:124737546	C10orf88	chr10:124690419-124713919:-	-0.21	-3.92	0.0001	Migraine without aura	
HNSC	cis	1	rs2421144	chr10:124733066	C10orf88	chr10:124690419-124713919:-	-0.2	-3.82	0.000149	Migraine without aura	
HNSC	cis	1	rs2421145	chr10:124730565	C10orf88	chr10:124690419-124713919:-	-0.2	-3.79	0.000168	Migraine without aura	
HNSC	cis	1	rs2421146	chr10:124730505	C10orf88	chr10:124690419-124713919:-	0.22	4.06	5.69E-5	Migraine without aura	
HNSC	cis	1	rs2421147	chr10:124730432	C10orf88	chr10:124690419-124713919:-	-0.21	-3.9	0.000109	Migraine without aura	
HNSC	cis	1	rs2421148	chr10:124728874	C10orf88	chr10:124690419-124713919:-	-0.21	-3.94	9.51E-5	Migraine without aura	
HNSC	cis	1	rs2421154	chr10:124747108	C10orf88	chr10:124690419-124713919:-	-0.2	-3.73	0.00021	Migraine without aura	
HNSC	cis	1	rs2421155	chr10:124725481	C10orf88	chr10:124690419-124713919:-	-0.21	-3.85	0.000134	Migraine without aura	
HNSC	cis	1	rs2421158	chr10:124721098	C10orf88	chr10:124690419-124713919:-	-0.2	-3.67	0.000266	Migraine without aura	
HNSC	cis	1	rs2421332	chr2:61876965	C2orf74	chr2:61372243-61391964:+	-0.26	-4.09	5.03E-5	Homeostasis model assessment of beta-cell function (interaction)	
HNSC	cis	1	rs2421555	chr2:73816955	ALMS1P	chr2:73872046-73912692:+	0.26	4.39	1.4E-5	Metabolite levels	
HNSC	cis	1	rs242271	chr6:88082029	C6orf164	chr6:88032306-88109459:+	-0.27	-4.91	1.22E-6	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs2425065	chr20:33926268	CPNE1	chr20:34213968-34262539:-	-0.24	-4.41	1.29E-5	Height	
HNSC	cis	1	rs2425065	chr20:33926268	UQCC	chr20:33890383-33999833:-	-0.33	-6.17	1.39E-9	Height	
HNSC	cis	1	rs2425066	chr20:33927006	CPNE1	chr20:34213968-34262539:-	-0.24	-4.36	1.56E-5	Height	
HNSC	cis	1	rs2425066	chr20:33927006	UQCC	chr20:33890383-33999833:-	-0.32	-6.1	2.09E-9	Height	
HNSC	cis	1	rs2425697	chr20:44025175	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	5.42	9.59E-8	Psoriasis	
HNSC	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.84	14.98	4.43E-42	Type 2 diabetes	
HNSC	cis	1	rs2440845	chr10:59971884	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2440845	chr10:59971884	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2440846	chr10:59974293	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2440846	chr10:59974293	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2440847	chr10:59996176	CISD1	chr10:60028895-60049018:+	0.23	4	7.28E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2440847	chr10:59996176	IPMK	chr10:59955618-60027694:-	0.27	6.51	1.82E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2440848	chr10:59996403	CISD1	chr10:60028895-60049018:+	0.23	4.01	7.11E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2440848	chr10:59996403	IPMK	chr10:59955618-60027694:-	0.27	6.49	2.08E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2440849	chr10:60002164	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2440849	chr10:60002164	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2440850	chr10:60011731	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2440850	chr10:60011731	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2440855	chr10:59964744	CISD1	chr10:60028895-60049018:+	0.24	4.14	4.02E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2440855	chr10:59964744	IPMK	chr10:59955618-60027694:-	0.27	6.54	1.55E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2440856	chr10:60030789	CISD1	chr10:60028895-60049018:+	0.24	4.24	2.61E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2440856	chr10:60030789	IPMK	chr10:59955618-60027694:-	0.28	6.8	3.0E-11	Inflammatory bowel disease	
HNSC	cis	1	rs244286	chr17:53232594	COX11	chr17:53029259-53046064:-	-0.3	-5.99	4.04E-9	Menarche (age at onset)	
HNSC	cis	1	rs244288	chr17:53231841	COX11	chr17:53029259-53046064:-	-0.3	-6.01	3.54E-9	Menarche (age at onset)	
HNSC	cis	1	rs244289	chr17:53231788	COX11	chr17:53029259-53046064:-	-0.29	-5.9	6.93E-9	Menarche (age at onset)	
HNSC	cis	1	rs244291	chr17:53231137	COX11	chr17:53029259-53046064:-	-0.25	-5.13	4.13E-7	Menarche (age at onset)	
HNSC	cis	1	rs244292	chr17:53230734	COX11	chr17:53029259-53046064:-	-0.29	-5.86	8.31E-9	Menarche (age at onset)	
HNSC	cis	1	rs244293	chr17:53230722	COX11	chr17:53029259-53046064:-	-0.25	-5.08	5.29E-7	Menarche (age at onset)	
HNSC	cis	1	rs244295	chr17:53242899	COX11	chr17:53029259-53046064:-	-0.3	-6.01	3.58E-9	Menarche (age at onset)	
HNSC	cis	1	rs244296	chr17:53242878	COX11	chr17:53029259-53046064:-	-0.3	-5.98	4.17E-9	Menarche (age at onset)	
HNSC	cis	1	rs244299	chr17:53240266	COX11	chr17:53029259-53046064:-	0.25	5.13	4.1E-7	Menarche (age at onset)	
HNSC	cis	1	rs244316	chr17:53215223	COX11	chr17:53029259-53046064:-	-0.26	-5.23	2.57E-7	Menarche (age at onset)	
HNSC	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.37	5.12	4.4E-7	Tumor biomarkers	
HNSC	cis	1	rs2447196	chr15:43893818	CATSPER2	chr15:43922774-43959900:-	0.41	6.85	2.26E-11	Tumor biomarkers	
HNSC	cis	1	rs2447196	chr15:43893818	CKMT1A	chr15:43985084-43991419:+	0.44	6.19	1.25E-9	Tumor biomarkers	
HNSC	cis	1	rs2447196	chr15:43893818	CKMT1B	chr15:43885252-43891603:+	0.31	4.32	1.92E-5	Tumor biomarkers	
HNSC	cis	1	rs2447208	chr15:43933895	ADAL	chr15:43622872-43646094:+	-0.41	-5.78	1.3E-8	Tumor biomarkers	
HNSC	cis	1	rs2447208	chr15:43933895	CATSPER2	chr15:43922774-43959900:-	-0.46	-7.71	7.08E-14	Tumor biomarkers	
HNSC	cis	1	rs2447208	chr15:43933895	CKMT1A	chr15:43985084-43991419:+	-0.5	-6.99	8.77E-12	Tumor biomarkers	
HNSC	cis	1	rs2447208	chr15:43933895	CKMT1B	chr15:43885252-43891603:+	-0.35	-4.95	1.03E-6	Tumor biomarkers	
HNSC	cis	1	rs2447211	chr15:43936351	ADAL	chr15:43622872-43646094:+	-0.41	-5.71	1.97E-8	Tumor biomarkers	
HNSC	cis	1	rs2447211	chr15:43936351	CATSPER2	chr15:43922774-43959900:-	-0.45	-7.3	1.18E-12	Tumor biomarkers	
HNSC	cis	1	rs2447211	chr15:43936351	CKMT1A	chr15:43985084-43991419:+	-0.48	-6.66	7.2E-11	Tumor biomarkers	
HNSC	cis	1	rs2447211	chr15:43936351	CKMT1B	chr15:43885252-43891603:+	-0.34	-4.73	2.97E-6	Tumor biomarkers	
HNSC	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.59	15.25	2.58E-43	Homocysteine levels	
HNSC	cis	1	rs2448704	chr6:49453672	MUT	chr6:49398994-49431031:-	-0.2	-3.95	8.9E-5	Homocysteine levels	
HNSC	cis	1	rs2448707	chr6:49446951	CENPQ	chr6:49431096-49460820:+	0.4	9.56	5.73E-20	Folate pathway vitamin levels	
HNSC	cis	1	rs2448707	chr6:49446951	MUT	chr6:49398994-49431031:-	-0.43	-9.27	5.98E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs2454722	chr12:123171218	GPR109B	chr12:123199304-123201439:-	0.33	5.39	1.07E-7	Adiponectin levels	
HNSC	cis	1	rs2455331	chr5:643593	SLC9A3	chr5:473334-524549:-	0.22	4.27	2.32E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs2456173	chr5:176514595	FGFR4	chr5:176513921-176525124:+	-0.33	-5.54	5.01E-8	Height	
HNSC	cis	1	rs2460422	chr7:65601505	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs2462569	chr7:65474846	NCRNA00174	chr7:65841032-65865395:-	0.42	4.72	3.05E-6	Diabetic kidney disease	
HNSC	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.35	-9.08	2.59E-18	Ankylosing spondylitis	
HNSC	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.39	7.46	4.05E-13	Ankylosing spondylitis	
HNSC	cis	1	rs2465120	chr7:65620974	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs2470134	chr15:43849886	ADAL	chr15:43622872-43646094:+	0.41	5.58	4.0E-8	Tumor biomarkers	
HNSC	cis	1	rs2470134	chr15:43849886	CATSPER2	chr15:43922774-43959900:-	0.32	4.96	9.54E-7	Tumor biomarkers	
HNSC	cis	1	rs2470134	chr15:43849886	CKMT1A	chr15:43985084-43991419:+	0.41	5.51	5.89E-8	Tumor biomarkers	
HNSC	cis	1	rs2471884	chr11:117010320	PCSK7	chr11:117075789-117102811:-	-0.37	-5.31	1.66E-7	Protein quantitative trait loci	
HNSC	cis	1	rs2480258	chr10:135352100	CYP2E1	chr10:135340867-135374724:+	0.26	4.46	1.03E-5	Obesity-related traits	
HNSC	cis	1	rs2480259	chr10:135352076	CYP2E1	chr10:135340867-135374724:+	0.25	4.44	1.13E-5	Obesity-related traits	
HNSC	cis	1	rs2485892	chr1:210347990	SYT14	chr1:210111538-210337631:+	0.2	3.66	0.000284	Manic episodes in bipolar disorder	
HNSC	cis	1	rs2486447	chr1:46545724	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.24	1.71E-12	Body mass index	
HNSC	cis	1	rs2486483	chr10:60003000	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2486483	chr10:60003000	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2486486	chr10:60046654	CISD1	chr10:60028895-60049018:+	0.26	4.54	7.14E-6	Inflammatory bowel disease	
HNSC	cis	1	rs2486486	chr10:60046654	IPMK	chr10:59955618-60027694:-	0.28	6.74	4.44E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2489034	chr10:102319192	SEC31B	chr10:102246403-102289636:-	-0.18	-5.35	1.32E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489035	chr10:102319395	SEC31B	chr10:102246403-102289636:-	-0.18	-5.39	1.09E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489036	chr10:102319581	SEC31B	chr10:102246403-102289636:-	-0.18	-5.35	1.32E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489037	chr10:102319918	SEC31B	chr10:102246403-102289636:-	0.17	4.93	1.13E-6	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489039	chr10:102328036	SEC31B	chr10:102246403-102289636:-	-0.17	-5.13	4.1E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489040	chr10:102331298	SEC31B	chr10:102246403-102289636:-	-0.17	-5.24	2.35E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489043	chr10:102334327	SEC31B	chr10:102246403-102289636:-	-0.19	-5.92	6.1E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489045	chr10:102344754	SEC31B	chr10:102246403-102289636:-	-0.18	-5.42	9.26E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489046	chr10:102346282	SEC31B	chr10:102246403-102289636:-	-0.2	-6.16	1.5E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489047	chr10:102347028	SEC31B	chr10:102246403-102289636:-	-0.19	-5.82	1.04E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489048	chr10:102348497	SEC31B	chr10:102246403-102289636:-	-0.19	-5.64	2.88E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489049	chr10:102350732	SEC31B	chr10:102246403-102289636:-	-0.2	-6.09	2.26E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489050	chr10:102350898	SEC31B	chr10:102246403-102289636:-	-0.18	-5.34	1.42E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489051	chr10:102351785	SEC31B	chr10:102246403-102289636:-	0.16	5.05	6.38E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2489053	chr10:102353341	SEC31B	chr10:102246403-102289636:-	-0.18	-5.49	6.58E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2494168	chr1:210347406	SYT14	chr1:210111538-210337631:+	-0.2	-3.66	0.000282	Manic episodes in bipolar disorder	
HNSC	cis	1	rs2494190	chr1:210345889	SYT14	chr1:210111538-210337631:+	-0.2	-3.66	0.000282	Manic episodes in bipolar disorder	
HNSC	cis	1	rs2495732	chr10:102357780	SEC31B	chr10:102246403-102289636:-	-0.18	-5.24	2.38E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495734	chr10:102338686	SEC31B	chr10:102246403-102289636:-	-0.17	-5.25	2.3E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495736	chr10:102338410	SEC31B	chr10:102246403-102289636:-	-0.18	-5.33	1.46E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495737	chr10:102338344	SEC31B	chr10:102246403-102289636:-	-0.18	-5.42	9.58E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495739	chr10:102335507	SEC31B	chr10:102246403-102289636:-	-0.18	-5.41	9.79E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495741	chr10:102331795	SEC31B	chr10:102246403-102289636:-	-0.19	-5.76	1.49E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495742	chr10:102331364	SEC31B	chr10:102246403-102289636:-	-0.18	-5.35	1.33E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495743	chr10:102329739	SEC31B	chr10:102246403-102289636:-	-0.16	-4.88	1.44E-6	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495745	chr10:102329075	SEC31B	chr10:102246403-102289636:-	-0.17	-5.44	8.22E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495747	chr10:102328247	SEC31B	chr10:102246403-102289636:-	-0.17	-5.28	1.91E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495750	chr10:102327708	SEC31B	chr10:102246403-102289636:-	-0.16	-4.73	2.96E-6	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495751	chr10:102327260	SEC31B	chr10:102246403-102289636:-	-0.17	-5.09	5.2E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495752	chr10:102326115	SEC31B	chr10:102246403-102289636:-	-0.17	-5.21	2.73E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495753	chr10:102325640	SEC31B	chr10:102246403-102289636:-	-0.16	-4.72	3.04E-6	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495754	chr10:102324812	SEC31B	chr10:102246403-102289636:-	-0.17	-5.3	1.73E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495755	chr10:102324649	SEC31B	chr10:102246403-102289636:-	-0.16	-4.75	2.67E-6	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495758	chr10:102321900	SEC31B	chr10:102246403-102289636:-	-0.16	-4.74	2.81E-6	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2495760	chr10:102318771	SEC31B	chr10:102246403-102289636:-	-0.15	-4.52	7.86E-6	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs2498471	chr6:49484433	CENPQ	chr6:49431096-49460820:+	0.25	5.57	4.16E-8	Brain structure	
HNSC	cis	1	rs2498471	chr6:49484433	MUT	chr6:49398994-49431031:-	-0.18	-3.71	0.000234	Brain structure	
HNSC	cis	1	rs2501962	chr6:49453636	CENPQ	chr6:49431096-49460820:+	0.4	9.59	4.25E-20	Folate pathway vitamin levels	
HNSC	cis	1	rs2501962	chr6:49453636	MUT	chr6:49398994-49431031:-	-0.42	-8.93	8.66E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs2501963	chr6:49454281	CENPQ	chr6:49431096-49460820:+	0.41	9.61	3.7E-20	Folate pathway vitamin levels	
HNSC	cis	1	rs2501963	chr6:49454281	MUT	chr6:49398994-49431031:-	-0.42	-9.05	3.42E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs2515644	chr10:135353079	CYP2E1	chr10:135340867-135374724:+	0.26	4.46	1.03E-5	Obesity-related traits	
HNSC	cis	1	rs2521263	chr11:2308762	C11orf21	chr11:2317507-2323143:-	-0.32	-6.59	1.12E-10	Obesity-related traits	
HNSC	cis	1	rs2524005	chr6:29899677	HCG4	chr6:29758809-29760850:-	-0.45	-7.64	1.15E-13	Bipolar disorder and schizophrenia	
HNSC	cis	1	rs2524005	chr6:29899677	HLA-L	chr6:30227339-30234728:+	-0.23	-3.72	0.00022	Bipolar disorder and schizophrenia	
HNSC	cis	1	rs2524005	chr6:29899677	VARS2	chr6:30881982-30894233:+	-0.27	-4.68	3.63E-6	Bipolar disorder and schizophrenia	
HNSC	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.5	8.24	1.57E-15	Bipolar disorder and schizophrenia	
HNSC	cis	1	rs2527199	chr7:158737113	ESYT2	chr7:158523689-158622319:-	-0.18	-3.75	0.0002	Height	
HNSC	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	0.82	14.16	2.03E-38	Type 2 diabetes	
HNSC	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	0.86	15.02	3.09E-42	Type 2 diabetes	
HNSC	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.8	13.91	2.46E-37	Type 2 diabetes	
HNSC	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.81	14.28	5.83E-39	Type 2 diabetes	
HNSC	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.81	14.17	1.72E-38	Type 2 diabetes	
HNSC	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	0.88	14.62	1.79E-40	Type 2 diabetes	
HNSC	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.83	-14.56	3.21E-40	Type 2 diabetes	
HNSC	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.84	14.98	4.43E-42	Type 2 diabetes	
HNSC	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.82	14.32	3.79E-39	Type 2 diabetes	
HNSC	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.85	15.11	1.12E-42	Type 2 diabetes	
HNSC	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.84	14.99	3.84E-42	Type 2 diabetes	
HNSC	cis	1	rs2533288	chr7:66056711	NCRNA00174	chr7:65841032-65865395:-	-0.48	-5.17	3.4E-7	Diabetic kidney disease	
HNSC	cis	1	rs2533288	chr7:66056711	STAG3L4	chr7:66767616-66786512:+	-0.38	-4.2	3.2E-5	Diabetic kidney disease	
HNSC	cis	1	rs2541164	chr9:131876908	PPP2R4	chr9:131873244-131911223:+	0.29	6.18	1.34E-9	Blood metabolite ratios	
HNSC	cis	1	rs25422	chr6:118807847	C6orf204	chr6:118786239-119031238:-	0.23	3.94	9.5E-5	Renal cell carcinoma	
HNSC	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.83	14.51	5.31E-40	Type 2 diabetes	
HNSC	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.83	14.51	5.31E-40	Type 2 diabetes	
HNSC	cis	1	rs2562456	chr19:21666210	ZNF100	chr19:21906844-21950430:-	0.24	4.26	2.48E-5	Pain	
HNSC	cis	1	rs2564921	chr3:53125585	RFT1	chr3:53122503-53164470:-	0.26	5.36	1.29E-7	Height	
HNSC	cis	1	rs2564926	chr3:53094730	TMEM110	chr3:52867139-52931547:-	-0.45	-5.88	7.71E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs2564940	chr3:53107569	RFT1	chr3:53122503-53164470:-	-0.23	-4.73	2.93E-6	Height	
HNSC	cis	1	rs2572910	chr8:143770135	LOC100133669	chr8:144063448-144099807:-	0.22	4.28	2.25E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2572910	chr8:143770135	LY6K	chr8:143781529-143785582:+	0.33	7.46	3.92E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2572910	chr8:143770135	PSCA	chr8:143761875-143764142:+	0.43	10.27	1.52E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2581782	chr3:53122257	RFT1	chr3:53122503-53164470:-	-0.26	-5.3	1.71E-7	Height	
HNSC	cis	1	rs2581783	chr3:53122258	RFT1	chr3:53122503-53164470:-	-0.26	-5.3	1.71E-7	Height	
HNSC	cis	1	rs2581786	chr3:53126143	RFT1	chr3:53122503-53164470:-	-0.26	-5.35	1.35E-7	Height	
HNSC	cis	1	rs2581787	chr3:53127677	RFT1	chr3:53122503-53164470:-	-0.27	-5.55	4.67E-8	Height	
HNSC	cis	1	rs2581800	chr3:53109352	RFT1	chr3:53122503-53164470:-	-0.21	-4.13	4.27E-5	Height	
HNSC	cis	1	rs2585179	chr8:143774193	LOC100133669	chr8:144063448-144099807:-	0.22	4.28	2.25E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2585179	chr8:143774193	LY6K	chr8:143781529-143785582:+	0.33	7.46	3.92E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2585179	chr8:143774193	PSCA	chr8:143761875-143764142:+	0.43	10.27	1.52E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2586759	chr18:48379064	MRO	chr18:48321491-48351754:-	-0.22	-3.9	0.000109	Entorhinal cortical thickness	
HNSC	cis	1	rs2586762	chr18:48367625	MRO	chr18:48321491-48351754:-	-0.21	-3.71	0.000234	Entorhinal cortical thickness	
HNSC	cis	1	rs2586765	chr18:48369584	MRO	chr18:48321491-48351754:-	-0.2	-3.67	0.00027	Entorhinal cortical thickness	
HNSC	cis	1	rs2590299	chr10:59969000	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590299	chr10:59969000	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2590305	chr10:59973844	CISD1	chr10:60028895-60049018:+	0.24	4.16	3.69E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590305	chr10:59973844	IPMK	chr10:59955618-60027694:-	0.28	6.68	6.57E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590306	chr10:59976966	CISD1	chr10:60028895-60049018:+	0.23	4.05	6.04E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590306	chr10:59976966	IPMK	chr10:59955618-60027694:-	0.27	6.56	1.33E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2590307	chr10:59977161	CISD1	chr10:60028895-60049018:+	0.23	4.1	4.79E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590307	chr10:59977161	IPMK	chr10:59955618-60027694:-	0.27	6.56	1.36E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2590308	chr10:59977569	CISD1	chr10:60028895-60049018:+	0.23	4.01	7.11E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590308	chr10:59977569	IPMK	chr10:59955618-60027694:-	0.27	6.49	2.08E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2590311	chr10:59983565	CISD1	chr10:60028895-60049018:+	0.22	3.88	0.000119	Inflammatory bowel disease	
HNSC	cis	1	rs2590311	chr10:59983565	IPMK	chr10:59955618-60027694:-	0.26	6.16	1.5E-9	Inflammatory bowel disease	
HNSC	cis	1	rs2590313	chr10:59986383	CISD1	chr10:60028895-60049018:+	0.23	4.01	7.11E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590313	chr10:59986383	IPMK	chr10:59955618-60027694:-	0.27	6.49	2.08E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2590315	chr10:59986492	CISD1	chr10:60028895-60049018:+	0.23	4.01	7.11E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590315	chr10:59986492	IPMK	chr10:59955618-60027694:-	0.27	6.49	2.08E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2590317	chr10:59987658	CISD1	chr10:60028895-60049018:+	0.23	4.01	7.11E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590317	chr10:59987658	IPMK	chr10:59955618-60027694:-	0.27	6.49	2.08E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2590321	chr10:59996693	CISD1	chr10:60028895-60049018:+	0.24	4.22	2.86E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590321	chr10:59996693	IPMK	chr10:59955618-60027694:-	0.28	6.74	4.34E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590323	chr10:60000781	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590323	chr10:60000781	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590330	chr10:60008219	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590330	chr10:60008219	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590335	chr10:60009389	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590335	chr10:60009389	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590336	chr10:60010497	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590336	chr10:60010497	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590339	chr10:60012231	CISD1	chr10:60028895-60049018:+	0.24	4.25	2.51E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590339	chr10:60012231	IPMK	chr10:59955618-60027694:-	0.28	6.87	1.96E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590340	chr10:60012271	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590340	chr10:60012271	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590344	chr10:60013067	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590344	chr10:60013067	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590348	chr10:60014595	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590348	chr10:60014595	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590349	chr10:60014646	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590349	chr10:60014646	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590356	chr10:60019047	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590356	chr10:60019047	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590357	chr10:60019964	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590357	chr10:60019964	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590358	chr10:60020982	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590358	chr10:60020982	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590359	chr10:60021247	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590359	chr10:60021247	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590364	chr10:60038406	CISD1	chr10:60028895-60049018:+	0.24	4.29	2.15E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590364	chr10:60038406	IPMK	chr10:59955618-60027694:-	0.28	6.83	2.52E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590367	chr10:60041574	CISD1	chr10:60028895-60049018:+	0.24	4.24	2.61E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590367	chr10:60041574	IPMK	chr10:59955618-60027694:-	0.28	6.8	3.0E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590368	chr10:60043482	CISD1	chr10:60028895-60049018:+	0.26	4.54	7.14E-6	Inflammatory bowel disease	
HNSC	cis	1	rs2590368	chr10:60043482	IPMK	chr10:59955618-60027694:-	0.28	6.74	4.44E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590370	chr10:60049020	CISD1	chr10:60028895-60049018:+	0.25	4.5	8.65E-6	Inflammatory bowel disease	
HNSC	cis	1	rs2590370	chr10:60049020	IPMK	chr10:59955618-60027694:-	0.28	6.78	3.55E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2590371	chr10:60054487	CISD1	chr10:60028895-60049018:+	0.24	4.21	3.0E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2590371	chr10:60054487	IPMK	chr10:59955618-60027694:-	0.26	6.29	7.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2595500	chr11:6963165	ZNF215	chr11:6947654-7005861:+	0.37	5.83	9.96E-9	Response to cytadine analogues (cytosine arabinoside)	
HNSC	cis	1	rs2595501	chr11:6955340	ZNF215	chr11:6947654-7005861:+	-0.36	-5.71	1.96E-8	Response to cytadine analogues (cytosine arabinoside)	
HNSC	cis	1	rs2605582	chr11:93163799	C11orf75	chr11:93211641-93276546:-	-0.28	-5.29	1.84E-7	Pulmonary function decline	
HNSC	cis	1	rs2605582	chr11:93163799	CCDC67	chr11:93063156-93171634:+	-0.23	-3.97	8.28E-5	Pulmonary function decline	
HNSC	cis	1	rs2605583	chr11:93164957	C11orf75	chr11:93211641-93276546:-	-0.29	-5.39	1.12E-7	Pulmonary function decline	
HNSC	cis	1	rs2605583	chr11:93164957	CCDC67	chr11:93063156-93171634:+	-0.23	-3.91	0.000107	Pulmonary function decline	
HNSC	cis	1	rs2605585	chr11:93171862	C11orf75	chr11:93211641-93276546:-	-0.27	-5.01	7.55E-7	Pulmonary function decline	
HNSC	cis	1	rs2608216	chr11:93149172	C11orf75	chr11:93211641-93276546:-	-0.28	-5.19	3.08E-7	Pulmonary function decline	
HNSC	cis	1	rs2608216	chr11:93149172	CCDC67	chr11:93063156-93171634:+	-0.24	-4.23	2.84E-5	Pulmonary function decline	
HNSC	cis	1	rs261360	chr20:5037774	C20orf30	chr20:5049130-5093733:-	-0.18	-3.67	0.000267	Hair morphology	
HNSC	cis	1	rs2614811	chr15:43913487	ADAL	chr15:43622872-43646094:+	-0.41	-5.55	4.79E-8	Tumor biomarkers	
HNSC	cis	1	rs2614811	chr15:43913487	CATSPER2	chr15:43922774-43959900:-	-0.45	-7.33	9.82E-13	Tumor biomarkers	
HNSC	cis	1	rs2614811	chr15:43913487	CKMT1A	chr15:43985084-43991419:+	-0.49	-6.63	8.92E-11	Tumor biomarkers	
HNSC	cis	1	rs2614811	chr15:43913487	CKMT1B	chr15:43885252-43891603:+	-0.37	-5.15	3.79E-7	Tumor biomarkers	
HNSC	cis	1	rs2617170	chr12:10560957	KLRC2	chr12:10579193-10588592:-	-0.25	-6.03	3.17E-9	Behcet's disease	
HNSC	cis	1	rs262147	chr7:158745142	WDR60	chr7:158649269-158738882:+	-0.28	-3.95	8.88E-5	Hippocampal volume	
HNSC	cis	1	rs2622605	chr4:89079386	ABCG2	chr4:89011417-89152474:-	0.24	4.29	2.2E-5	Gout	
HNSC	cis	1	rs2628313	chr17:53235352	COX11	chr17:53029259-53046064:-	-0.29	-5.78	1.29E-8	Menarche (age at onset)	
HNSC	cis	1	rs2628314	chr17:53235182	COX11	chr17:53029259-53046064:-	-0.24	-4.96	9.66E-7	Menarche (age at onset)	
HNSC	cis	1	rs2629540	chr10:126426148	METTL10	chr10:126447406-126480439:-	0.31	5.18	3.17E-7	Cocaine dependence	
HNSC	cis	1	rs2637678	chr6:116787378	FAM26F	chr6:116782556-116784933:+	0.2	5.58	3.98E-8	Ulcerative colitis	
HNSC	cis	1	rs2637681	chr6:116769845	FAM26F	chr6:116782556-116784933:+	0.2	5.64	2.92E-8	Ulcerative colitis	
HNSC	cis	1	rs2638090	chr11:6955142	ZNF215	chr11:6947654-7005861:+	-0.36	-5.68	2.33E-8	Response to cytadine analogues (cytosine arabinoside)	
HNSC	cis	1	rs2638092	chr11:6961746	ZNF215	chr11:6947654-7005861:+	-0.35	-5.58	3.96E-8	Response to cytadine analogues (cytosine arabinoside)	
HNSC	cis	1	rs2638953	chr12:28534415	CCDC91	chr12:28332210-28703098:+	-0.25	-4.66	4.01E-6	Height	
HNSC	cis	1	rs2643338	chr8:97247469	MTERFD1	chr8:97251645-97273796:-	0.25	5.69	2.19E-8	Lung function (FVC)	
HNSC	cis	1	rs2644128	chr1:201793440	SHISA4	chr1:201858032-201861426:+	0.14	3.76	0.00019	Body mass index	
HNSC	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.35	-9.02	4.3E-18	Ankylosing spondylitis	
HNSC	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.4	7.54	2.27E-13	Ankylosing spondylitis	
HNSC	cis	1	rs2651807	chr11:2378840	C11orf21	chr11:2317507-2323143:-	-0.24	-5.8	1.21E-8	Bacteremia	
HNSC	cis	1	rs2651807	chr11:2378840	TSPAN32	chr11:2323243-2339430:+	-0.17	-3.67	0.00027	Bacteremia	
HNSC	cis	1	rs2651829	chr11:2308304	C11orf21	chr11:2317507-2323143:-	0.28	5.88	7.52E-9	Obesity-related traits	
HNSC	cis	1	rs2653503	chr10:59964034	CISD1	chr10:60028895-60049018:+	0.24	4.17	3.64E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2653503	chr10:59964034	IPMK	chr10:59955618-60027694:-	0.27	6.56	1.4E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2653504	chr10:59964042	CISD1	chr10:60028895-60049018:+	0.24	4.17	3.64E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2653504	chr10:59964042	IPMK	chr10:59955618-60027694:-	0.27	6.56	1.4E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2653505	chr10:59964142	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2653505	chr10:59964142	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2655310	chr4:130017919	C4orf33	chr4:130014829-130033842:+	-0.47	-9.53	7.43E-20	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs2657365	chr7:158722753	ESYT2	chr7:158523689-158622319:-	-0.21	-4.3	2.07E-5	Height	
HNSC	cis	1	rs2657888	chr12:56938383	RBMS2	chr12:56915609-56989980:+	-0.19	-3.78	0.000179	Adiponectin levels	
HNSC	cis	1	rs2657890	chr12:56938577	RBMS2	chr12:56915609-56989980:+	-0.21	-3.95	8.99E-5	Adiponectin levels	
HNSC	cis	1	rs2657901	chr12:56933416	RBMS2	chr12:56915609-56989980:+	-0.24	-4.68	3.79E-6	Adiponectin levels	
HNSC	cis	1	rs2658778	chr11:93148948	C11orf75	chr11:93211641-93276546:-	-0.29	-5.31	1.65E-7	Pulmonary function decline	
HNSC	cis	1	rs2658778	chr11:93148948	CCDC67	chr11:93063156-93171634:+	-0.23	-4.07	5.51E-5	Pulmonary function decline	
HNSC	cis	1	rs2658779	chr11:93163137	C11orf75	chr11:93211641-93276546:-	0.27	5.18	3.3E-7	Pulmonary function decline	
HNSC	cis	1	rs2658779	chr11:93163137	CCDC67	chr11:93063156-93171634:+	0.22	3.97	8.14E-5	Pulmonary function decline	
HNSC	cis	1	rs2658781	chr11:93166368	C11orf75	chr11:93211641-93276546:-	0.29	5.43	8.9E-8	Pulmonary function decline	
HNSC	cis	1	rs2658781	chr11:93166368	CCDC67	chr11:93063156-93171634:+	0.25	4.4	1.31E-5	Pulmonary function decline	
HNSC	cis	1	rs2658782	chr11:93166731	C11orf75	chr11:93211641-93276546:-	-0.29	-5.35	1.37E-7	Pulmonary function decline	
HNSC	cis	1	rs2658782	chr11:93166731	CCDC67	chr11:93063156-93171634:+	-0.24	-4.17	3.53E-5	Pulmonary function decline	
HNSC	cis	1	rs2659889	chr7:66217112	NCRNA00174	chr7:65841032-65865395:-	-0.56	-11.01	2.33E-25	Aortic root size	
HNSC	cis	1	rs2659903	chr7:66180931	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.91	1.23E-6	Gout	
HNSC	cis	1	rs2659903	chr7:66180931	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.28	2.21E-5	Gout	
HNSC	cis	1	rs2659906	chr7:66165310	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.89	6.61E-25	Aortic root size	
HNSC	cis	1	rs2659909	chr7:66160279	NCRNA00174	chr7:65841032-65865395:-	-0.54	-10.56	1.23E-23	Aortic root size	
HNSC	cis	1	rs2659911	chr7:66158420	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.98	8.74E-7	Gout	
HNSC	cis	1	rs2659911	chr7:66158420	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.34	1.74E-5	Gout	
HNSC	cis	1	rs2659912	chr7:66157999	NCRNA00174	chr7:65841032-65865395:-	-0.56	-10.94	4.49E-25	Aortic root size	
HNSC	cis	1	rs2659913	chr7:66157336	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.98	8.74E-7	Gout	
HNSC	cis	1	rs2659913	chr7:66157336	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.34	1.74E-5	Gout	
HNSC	cis	1	rs2659915	chr7:66153101	NCRNA00174	chr7:65841032-65865395:-	-0.52	-10.16	3.95E-22	Aortic root size	
HNSC	cis	1	rs267736	chr1:150945607	GOLPH3L	chr1:150618701-150669672:-	0.31	3.8	0.000163	Congenital left-sided heart lesions	
HNSC	cis	1	rs267736	chr1:150945607	HORMAD1	chr1:150670542-150693352:-	-0.38	-4.25	2.55E-5	Congenital left-sided heart lesions	
HNSC	cis	1	rs2706345	chr5:131903928	SLC22A4	chr5:131630145-131679897:+	0.2	3.76	0.000188	Asthma (childhood onset)	
HNSC	cis	1	rs2706353	chr5:131913328	SLC22A4	chr5:131630145-131679897:+	0.2	3.9	0.00011	Asthma (childhood onset)	
HNSC	cis	1	rs2707828	chr7:66171377	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.98	8.74E-7	Gout	
HNSC	cis	1	rs2707828	chr7:66171377	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.34	1.74E-5	Gout	
HNSC	cis	1	rs2707830	chr7:66167645	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.98	8.74E-7	Gout	
HNSC	cis	1	rs2707830	chr7:66167645	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.34	1.74E-5	Gout	
HNSC	cis	1	rs2707831	chr7:66062511	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.98	8.74E-7	Diabetic kidney disease	
HNSC	cis	1	rs2707831	chr7:66062511	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.34	1.74E-5	Diabetic kidney disease	
HNSC	cis	1	rs2707832	chr7:66136549	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.87	1.52E-6	Gout	
HNSC	cis	1	rs2707832	chr7:66136549	STAG3L4	chr7:66767616-66786512:+	-0.38	-4.13	4.19E-5	Gout	
HNSC	cis	1	rs2707836	chr7:66160435	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs2707838	chr7:66159201	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.98	8.74E-7	Gout	
HNSC	cis	1	rs2707838	chr7:66159201	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.34	1.74E-5	Gout	
HNSC	cis	1	rs2707840	chr7:66158015	CRCP	chr7:65579805-65619551:+	-0.31	-3.66	0.000279	Gout	
HNSC	cis	1	rs2707840	chr7:66158015	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.9	1.32E-6	Gout	
HNSC	cis	1	rs2707840	chr7:66158015	STAG3L4	chr7:66767616-66786512:+	-0.41	-4.53	7.56E-6	Gout	
HNSC	cis	1	rs2707844	chr7:66059509	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.98	8.74E-7	Diabetic kidney disease	
HNSC	cis	1	rs2707844	chr7:66059509	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.34	1.74E-5	Diabetic kidney disease	
HNSC	cis	1	rs2707845	chr7:66198798	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs2707850	chr7:66203870	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs2707854	chr7:66212597	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs2707856	chr7:66211010	NCRNA00174	chr7:65841032-65865395:-	-0.56	-11.13	8.35E-26	Aortic root size	
HNSC	cis	1	rs2712381	chr3:128338600	RAB43	chr3:128806418-128880029:-	-0.2	-3.93	9.61E-5	Monocyte count	
HNSC	cis	1	rs2712417	chr3:128345179	RAB43	chr3:128806418-128880029:-	-0.2	-3.99	7.74E-5	Monocyte count	
HNSC	cis	1	rs2712417	chr3:128345179	RPN1	chr3:128338813-128399918:-	-0.18	-3.7	0.000244	Monocyte count	
HNSC	cis	1	rs2712419	chr3:128340896	RAB43	chr3:128806418-128880029:-	-0.2	-3.99	7.74E-5	Monocyte count	
HNSC	cis	1	rs2712419	chr3:128340896	RPN1	chr3:128338813-128399918:-	-0.18	-3.7	0.000244	Monocyte count	
HNSC	cis	1	rs271621	chr19:18631332	SSBP4	chr19:18530221-18545371:+	-0.21	-4.83	1.81E-6	Breast cancer	
HNSC	cis	1	rs271623	chr19:18628947	SSBP4	chr19:18530221-18545371:+	-0.2	-4.67	3.96E-6	Breast cancer	
HNSC	cis	1	rs271624	chr19:18627953	SSBP4	chr19:18530221-18545371:+	-0.2	-4.59	5.55E-6	Breast cancer	
HNSC	cis	1	rs2717562	chr8:143776668	LOC100133669	chr8:144063448-144099807:-	0.21	4.23	2.76E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2717562	chr8:143776668	LY6K	chr8:143781529-143785582:+	0.33	7.36	7.73E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2717562	chr8:143776668	PSCA	chr8:143761875-143764142:+	0.43	10.2	2.72E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2727405	chr11:13090942	TEAD1	chr11:12695969-12966298:+	0.15	3.76	0.000187	Obesity-related traits	
HNSC	cis	1	rs2730241	chr7:158723014	ESYT2	chr7:158523689-158622319:-	-0.2	-3.96	8.68E-5	Height	
HNSC	cis	1	rs2730245	chr7:158724789	ESYT2	chr7:158523689-158622319:-	-0.2	-4.04	6.24E-5	Height	
HNSC	cis	1	rs2734839	chr11:113286490	TTC12	chr11:113185251-113244016:+	-0.22	-3.68	0.000255	Information processing speed	
HNSC	cis	1	rs2736345	chr8:11352485	BLK	chr8:11351521-11422107:+	-0.21	-5.82	1.06E-8	Systemic lupus erythematosus	
HNSC	cis	1	rs2736371	chr8:11105529	AMAC1L2	chr8:11188495-11189695:+	0.21	3.95	8.81E-5	Retinal vascular caliber	
HNSC	cis	1	rs2736377	chr8:11118997	AMAC1L2	chr8:11188495-11189695:+	0.33	4.12	4.36E-5	Response to antipsychotic therapy (extrapyramidal side effects)	
HNSC	cis	1	rs2738219	chr10:38158260	LOC399744	chr10:38717074-38741080:+	-0.28	-3.74	0.000202	Obesity (extreme)	
HNSC	cis	1	rs2738223	chr10:38185898	LOC399744	chr10:38717074-38741080:+	-0.28	-3.82	0.000152	Obesity (extreme)	
HNSC	cis	1	rs2738225	chr10:38193129	LOC399744	chr10:38717074-38741080:+	-0.28	-3.69	0.000251	Obesity (extreme)	
HNSC	cis	1	rs2741432	chr20:43989514	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	5.44	8.25E-8	Psoriasis	
HNSC	cis	1	rs2741435	chr20:43988198	SYS1-DBNDD2	chr20:43991701-44039245:+	0.35	5.38	1.17E-7	Psoriasis	
HNSC	cis	1	rs2741611	chr20:44020809	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	5.37	1.23E-7	Psoriasis	
HNSC	cis	1	rs2741612	chr20:44019972	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	5.37	1.23E-7	Psoriasis	
HNSC	cis	1	rs2741639	chr20:44008432	SYS1-DBNDD2	chr20:43991701-44039245:+	0.34	5.2	2.98E-7	Psoriasis	
HNSC	cis	1	rs2741640	chr20:44008408	SYS1-DBNDD2	chr20:43991701-44039245:+	0.33	4.99	8.38E-7	Psoriasis	
HNSC	cis	1	rs2743237	chr20:44026618	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	5.53	5.09E-8	Psoriasis	
HNSC	cis	1	rs2743402	chr20:43985204	SYS1-DBNDD2	chr20:43991701-44039245:+	0.32	4.76	2.56E-6	Psoriasis	
HNSC	cis	1	rs2743414	chr20:43991566	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	5.37	1.22E-7	Psoriasis	
HNSC	cis	1	rs2743419	chr20:43992645	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	5.45	8.06E-8	Psoriasis	
HNSC	cis	1	rs2743423	chr20:43993539	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	5.45	8.06E-8	Psoriasis	
HNSC	cis	1	rs2743424	chr20:43993934	SYS1-DBNDD2	chr20:43991701-44039245:+	0.36	5.37	1.22E-7	Psoriasis	
HNSC	cis	1	rs2743439	chr20:43999636	SYS1-DBNDD2	chr20:43991701-44039245:+	0.34	5.1	4.93E-7	Psoriasis	
HNSC	cis	1	rs2749564	chr10:38178815	LOC399744	chr10:38717074-38741080:+	-0.27	-3.71	0.000231	Obesity (extreme)	
HNSC	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.36	-9.21	9.23E-19	Ankylosing spondylitis	
HNSC	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.38	7.18	2.67E-12	Ankylosing spondylitis	
HNSC	cis	1	rs2753878	chr10:38171504	LOC399744	chr10:38717074-38741080:+	-0.28	-3.82	0.000152	Obesity (extreme)	
HNSC	cis	1	rs2757042	chr6:167371234	RNASET2	chr6:167343008-167412795:-	0.2	4.85	1.65E-6	Crohn's disease	
HNSC	cis	1	rs2757047	chr6:167374489	RNASET2	chr6:167343008-167412795:-	0.21	5.14	4.06E-7	Crohn's disease	
HNSC	cis	1	rs2769347	chr6:167371737	RNASET2	chr6:167343008-167412795:-	0.21	5.12	4.29E-7	Crohn's disease	
HNSC	cis	1	rs2769352	chr6:167378619	RNASET2	chr6:167343008-167412795:-	0.22	5.5	6.22E-8	Crohn's disease	
HNSC	cis	1	rs2769354	chr6:167379771	RNASET2	chr6:167343008-167412795:-	0.22	5.55	4.71E-8	Crohn's disease	
HNSC	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.36	9.4	2.0E-19	Ankylosing spondylitis	
HNSC	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.38	-7.29	1.27E-12	Ankylosing spondylitis	
HNSC	cis	1	rs2790145	chr10:59976277	CISD1	chr10:60028895-60049018:+	0.23	4.01	7.11E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790145	chr10:59976277	IPMK	chr10:59955618-60027694:-	0.27	6.49	2.08E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2790146	chr10:59975743	CISD1	chr10:60028895-60049018:+	0.23	3.96	8.47E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790146	chr10:59975743	IPMK	chr10:59955618-60027694:-	0.27	6.53	1.67E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2790157	chr10:59973396	CISD1	chr10:60028895-60049018:+	0.24	4.16	3.73E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790157	chr10:59973396	IPMK	chr10:59955618-60027694:-	0.27	6.53	1.6E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2790159	chr10:60018794	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790159	chr10:60018794	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790161	chr10:59968090	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790161	chr10:59968090	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2790167	chr10:60024470	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790167	chr10:60024470	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790168	chr10:60025448	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790168	chr10:60025448	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790169	chr10:60025654	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790169	chr10:60025654	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790170	chr10:60028507	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790170	chr10:60028507	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790172	chr10:60008464	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790172	chr10:60008464	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790173	chr10:60031575	CISD1	chr10:60028895-60049018:+	0.24	4.29	2.13E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790173	chr10:60031575	IPMK	chr10:59955618-60027694:-	0.28	6.78	3.51E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790174	chr10:60031931	CISD1	chr10:60028895-60049018:+	0.24	4.24	2.61E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790174	chr10:60031931	IPMK	chr10:59955618-60027694:-	0.28	6.8	3.0E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790178	chr10:60034083	CISD1	chr10:60028895-60049018:+	0.24	4.22	2.92E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790178	chr10:60034083	IPMK	chr10:59955618-60027694:-	0.28	6.82	2.63E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790179	chr10:60035372	CISD1	chr10:60028895-60049018:+	-0.27	-4.74	2.83E-6	Inflammatory bowel disease	
HNSC	cis	1	rs2790179	chr10:60035372	IPMK	chr10:59955618-60027694:-	-0.27	-6.57	1.25E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2790185	chr10:60041840	CISD1	chr10:60028895-60049018:+	0.24	4.24	2.61E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790185	chr10:60041840	IPMK	chr10:59955618-60027694:-	0.28	6.8	3.0E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790188	chr10:60042186	CISD1	chr10:60028895-60049018:+	0.24	4.24	2.61E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790188	chr10:60042186	IPMK	chr10:59955618-60027694:-	0.28	6.8	3.0E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790189	chr10:60042576	CISD1	chr10:60028895-60049018:+	0.24	4.17	3.58E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790189	chr10:60042576	IPMK	chr10:59955618-60027694:-	0.27	6.64	8.37E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790191	chr10:60045091	CISD1	chr10:60028895-60049018:+	0.26	4.54	7.14E-6	Inflammatory bowel disease	
HNSC	cis	1	rs2790191	chr10:60045091	IPMK	chr10:59955618-60027694:-	0.28	6.74	4.44E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790193	chr10:60046226	CISD1	chr10:60028895-60049018:+	0.26	4.54	7.14E-6	Inflammatory bowel disease	
HNSC	cis	1	rs2790193	chr10:60046226	IPMK	chr10:59955618-60027694:-	0.28	6.74	4.44E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790212	chr10:60013138	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790212	chr10:60013138	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790214	chr10:60013404	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790214	chr10:60013404	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790216	chr10:59997926	CISD1	chr10:60028895-60049018:+	0.24	4.22	2.86E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790216	chr10:59997926	IPMK	chr10:59955618-60027694:-	0.28	6.74	4.34E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790217	chr10:59997644	CISD1	chr10:60028895-60049018:+	0.24	4.22	2.86E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790217	chr10:59997644	IPMK	chr10:59955618-60027694:-	0.28	6.74	4.34E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790218	chr10:59997301	CISD1	chr10:60028895-60049018:+	0.24	4.22	2.86E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790218	chr10:59997301	IPMK	chr10:59955618-60027694:-	0.28	6.74	4.34E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790219	chr10:60013849	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790219	chr10:60013849	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790222	chr10:59995438	CISD1	chr10:60028895-60049018:+	0.23	4.01	7.11E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790222	chr10:59995438	IPMK	chr10:59955618-60027694:-	0.27	6.49	2.08E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2790228	chr10:60014325	CISD1	chr10:60028895-60049018:+	0.24	4.27	2.39E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790228	chr10:60014325	IPMK	chr10:59955618-60027694:-	0.28	6.75	4.21E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790230	chr10:59989772	CISD1	chr10:60028895-60049018:+	0.23	4.01	7.11E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790230	chr10:59989772	IPMK	chr10:59955618-60027694:-	0.27	6.49	2.08E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2790231	chr10:59989010	CISD1	chr10:60028895-60049018:+	0.23	4.01	7.11E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790231	chr10:59989010	IPMK	chr10:59955618-60027694:-	0.27	6.49	2.08E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2790235	chr10:59985274	CISD1	chr10:60028895-60049018:+	0.23	4.01	7.11E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790235	chr10:59985274	IPMK	chr10:59955618-60027694:-	0.27	6.49	2.08E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2790238	chr10:59983573	CISD1	chr10:60028895-60049018:+	0.22	3.88	0.000119	Inflammatory bowel disease	
HNSC	cis	1	rs2790238	chr10:59983573	IPMK	chr10:59955618-60027694:-	0.26	6.16	1.5E-9	Inflammatory bowel disease	
HNSC	cis	1	rs2790240	chr10:59982139	CISD1	chr10:60028895-60049018:+	0.23	4.01	7.11E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790240	chr10:59982139	IPMK	chr10:59955618-60027694:-	0.27	6.49	2.08E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2790241	chr10:60015313	CISD1	chr10:60028895-60049018:+	0.24	4.29	2.15E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790241	chr10:60015313	IPMK	chr10:59955618-60027694:-	0.28	6.81	2.81E-11	Inflammatory bowel disease	
HNSC	cis	1	rs2790242	chr10:59980652	CISD1	chr10:60028895-60049018:+	-0.23	-4.07	5.55E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2790242	chr10:59980652	IPMK	chr10:59955618-60027694:-	-0.27	-6.52	1.78E-10	Inflammatory bowel disease	
HNSC	cis	1	rs2799077	chr6:28234597	ZNF389	chr6:28129551-28137375:+	-0.27	-4.23	2.73E-5	Depression	
HNSC	cis	1	rs2799077	chr6:28234597	ZSCAN23	chr6:28393287-28411279:-	0.25	3.86	0.000127	Depression	
HNSC	cis	1	rs2799079	chr6:28235176	TRIM27	chr6:28870780-28891768:-	-0.24	-4.15	3.87E-5	Depression	
HNSC	cis	1	rs2799079	chr6:28235176	ZNF187	chr6:28234788-28245978:+	-0.22	-4.28	2.25E-5	Depression	
HNSC	cis	1	rs2799079	chr6:28235176	ZNF389	chr6:28129551-28137375:+	-0.28	-4.57	6.14E-6	Depression	
HNSC	cis	1	rs2799079	chr6:28235176	ZSCAN23	chr6:28393287-28411279:-	0.24	3.9	0.000108	Depression	
HNSC	cis	1	rs280603	chr4:129915063	C4orf33	chr4:130014829-130033842:+	-0.42	-8.09	4.52E-15	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs280604	chr4:129921170	C4orf33	chr4:130014829-130033842:+	-0.43	-8.32	8.84E-16	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs2811488	chr3:128336517	RAB43	chr3:128806418-128880029:-	-0.19	-3.85	0.000133	Monocyte count	
HNSC	cis	1	rs2811489	chr3:128337371	RAB43	chr3:128806418-128880029:-	0.19	3.88	0.000121	Monocyte count	
HNSC	cis	1	rs2811490	chr3:128351755	RAB43	chr3:128806418-128880029:-	-0.2	-3.87	0.000122	Monocyte count	
HNSC	cis	1	rs2811490	chr3:128351755	RPN1	chr3:128338813-128399918:-	-0.19	-3.79	0.000168	Monocyte count	
HNSC	cis	1	rs2811497	chr3:128363332	RAB43	chr3:128806418-128880029:-	-0.2	-4	7.37E-5	Monocyte count	
HNSC	cis	1	rs2811497	chr3:128363332	RPN1	chr3:128338813-128399918:-	-0.19	-3.83	0.000146	Monocyte count	
HNSC	cis	1	rs2811500	chr3:128366256	RAB43	chr3:128806418-128880029:-	-0.2	-4	7.37E-5	Monocyte count	
HNSC	cis	1	rs2811500	chr3:128366256	RPN1	chr3:128338813-128399918:-	-0.19	-3.83	0.000146	Monocyte count	
HNSC	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.59	-13.37	5.29E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs2813803	chr6:83644743	PGM3	chr6:83878630-83903633:-	0.16	3.67	0.000273	Crohn's disease	
HNSC	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.59	-13.6	5.6E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.59	-13.43	2.91E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs2820292	chr1:201784287	SHISA4	chr1:201858032-201861426:+	-0.14	-3.66	0.000284	Body mass index	
HNSC	cis	1	rs282522	chr3:56629678	CCDC66	chr3:56591184-56655846:+	0.18	5.17	3.36E-7	Height	
HNSC	cis	1	rs282523	chr3:56630166	CCDC66	chr3:56591184-56655846:+	-0.18	-5.02	7.12E-7	Height	
HNSC	cis	1	rs2832191	chr21:30489300	N6AMT1	chr21:30244513-30257693:-	-0.2	-3.92	0.0001	Dental caries	
HNSC	cis	1	rs2835607	chr21:38491973	PIGP	chr21:38437664-38445458:-	-0.41	-8.7	4.85E-17	Eye color traits	
HNSC	cis	1	rs2835608	chr21:38493455	PIGP	chr21:38437664-38445458:-	-0.41	-8.7	5.01E-17	Eye color traits	
HNSC	cis	1	rs28363725	chr8:96027108	C8orf38	chr8:95908040-96088396:+	-0.29	-4.45	1.04E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs28365850	chr14:35591316	PPP2R3C	chr14:35554679-35591679:-	0.45	7.27	1.39E-12	Atopic dermatitis	
HNSC	cis	1	rs2836974	chr21:40663181	HMGN1	chr21:40714247-40721270:-	0.17	3.88	0.000118	Cognitive function	
HNSC	cis	1	rs28378156	chr8:96027127	C8orf38	chr8:95908040-96088396:+	-0.29	-4.45	1.04E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs28378477	chr16:20406481	GPRC5B	chr16:19870295-19896832:-	-0.2	-3.82	0.000149	Urinary uromodulin levels	
HNSC	cis	1	rs2838088	chr21:43092201	BACE2	chr21:42539728-42648523:+	-0.23	-3.66	0.000284	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	
HNSC	cis	1	rs28391259	chr4:107014012	TBCK	chr4:106967233-107237861:-	0.28	5.4	1.03E-7	Airflow obstruction	
HNSC	cis	1	rs2839181	chr21:47685939	C21orf57	chr21:47706267-47717664:+	-0.23	-4.74	2.75E-6	Testicular germ cell tumor	
HNSC	cis	1	rs2839186	chr21:47690068	C21orf57	chr21:47706267-47717664:+	-0.29	-5.93	5.62E-9	Testicular germ cell tumor	
HNSC	cis	1	rs2839627	chr21:44448718	WDR4	chr21:44263206-44299699:-	-0.27	-3.8	0.000161	Information processing speed	
HNSC	cis	1	rs28399702	chr14:35625217	PPP2R3C	chr14:35554679-35591679:-	0.41	6.98	9.83E-12	Atopic dermatitis	
HNSC	cis	1	rs28406132	chr8:96030377	C8orf38	chr8:95908040-96088396:+	-0.28	-4.29	2.19E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs28409322	chr3:134252385	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.52	1.7E-23	Height	
HNSC	cis	1	rs28409322	chr3:134252385	CEP63	chr3:134204575-134293852:+	-0.26	-5.68	2.27E-8	Height	
HNSC	cis	1	rs28427306	chr16:20406688	GPRC5B	chr16:19870295-19896832:-	-0.2	-3.82	0.000149	Urinary uromodulin levels	
HNSC	cis	1	rs28440026	chr8:96026744	C8orf38	chr8:95908040-96088396:+	-0.29	-4.45	1.04E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs28453840	chr2:136522941	ZRANB3	chr2:135957576-136288806:-	0.23	4.32	1.89E-5	Cholesterol, total	
HNSC	cis	1	rs28469723	chr20:33700717	PROCR	chr20:33758727-33765164:+	-0.32	-4.32	1.87E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs28477467	chr8:96032905	C8orf38	chr8:95908040-96088396:+	-0.29	-4.38	1.47E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs28480159	chr4:17685707	FAM184B	chr4:17633711-17783135:-	-0.17	-3.96	8.5E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs28480159	chr4:17685707	LAP3	chr4:17578927-17609590:+	-0.15	-3.98	8.01E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs28485881	chr17:80690014	FN3KRP	chr17:80674582-80685889:+	-0.32	-5.58	3.92E-8	Glycated hemoglobin levels	
HNSC	cis	1	rs2849246	chr18:48371896	MRO	chr18:48321491-48351754:-	-0.23	-4.14	4.02E-5	Entorhinal cortical thickness	
HNSC	cis	1	rs28496357	chr8:96030511	C8orf38	chr8:95908040-96088396:+	-0.3	-4.67	3.98E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs28497813	chr4:17685503	FAM184B	chr4:17633711-17783135:-	-0.17	-3.96	8.5E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs28497813	chr4:17685503	LAP3	chr4:17578927-17609590:+	-0.15	-3.98	8.01E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs28501187	chr4:17643620	FAM184B	chr4:17633711-17783135:-	-0.17	-4.08	5.34E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs28505517	chr16:4608099	NMRAL1	chr16:4511696-4526307:-	-0.55	-5.55	4.77E-8	Obesity-related traits	
HNSC	cis	1	rs28515202	chr4:108897819	HADH	chr4:108910940-108956330:+	0.28	4.07	5.46E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs28522614	chr10:102323141	SEC31B	chr10:102246403-102289636:-	-0.17	-5.25	2.25E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs28545485	chr4:17645376	FAM184B	chr4:17633711-17783135:-	-0.16	-3.95	8.87E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2855036	chr11:5272682	HBG1	chr11:5269502-5271087:-	0.25	4.44	1.13E-5	Hemoglobin levels	
HNSC	cis	1	rs2855039	chr11:5271671	HBG1	chr11:5269502-5271087:-	0.26	4.65	4.31E-6	Hemoglobin levels	
HNSC	cis	1	rs2855039	chr11:5271671	HBG2	chr11:5269502-5667011:-	0.22	4.01	7.1E-5	Hemoglobin levels	
HNSC	cis	1	rs2855121	chr11:5277291	HBG1	chr11:5269502-5271087:-	0.23	4.02	6.6E-5	Hemoglobin levels	
HNSC	cis	1	rs28552744	chr4:17620165	FAM184B	chr4:17633711-17783135:-	-0.17	-4.03	6.55E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs28558133	chr6:26531433	BTN2A3	chr6:26422317-26431927:+	0.16	3.66	0.000276	Educational attainment	
HNSC	cis	1	rs28558133	chr6:26531433	BTN3A2	chr6:26365398-26378546:+	0.18	4.36	1.59E-5	Educational attainment	
HNSC	cis	1	rs28558428	chr16:20406287	GPRC5B	chr16:19870295-19896832:-	-0.21	-3.9	0.000108	Urinary uromodulin levels	
HNSC	cis	1	rs28572537	chr19:18552208	SSBP4	chr19:18530221-18545371:+	-0.19	-4.29	2.19E-5	Breast cancer	
HNSC	cis	1	rs2857891	chr11:6962957	ZNF215	chr11:6947654-7005861:+	-0.37	-5.85	8.77E-9	Response to cytadine analogues (cytosine arabinoside)	
HNSC	cis	1	rs28591316	chr8:41524425	ZMAT4	chr8:40388116-40755343:-	-0.19	-3.81	0.000157	Type 2 diabetes	
HNSC	cis	1	rs28599680	chr16:29860685	LOC440356	chr16:29875004-29879374:+	-0.24	-3.76	0.000193	Multiple sclerosis	
HNSC	cis	1	rs2859998	chr8:59324162	UBXN2B	chr8:59323823-59364059:+	-0.28	-5.59	3.77E-8	Narcolepsy with cataplexy	
HNSC	cis	1	rs28602970	chr8:41524505	ZMAT4	chr8:40388116-40755343:-	-0.19	-3.81	0.000157	Type 2 diabetes	
HNSC	cis	1	rs28605789	chr6:118889952	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.54E-5	Renal cell carcinoma	
HNSC	cis	1	rs28616734	chr8:96021443	C8orf38	chr8:95908040-96088396:+	-0.28	-4.3	2.06E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs28622969	chr16:20406319	GPRC5B	chr16:19870295-19896832:-	-0.2	-3.71	0.000233	Urinary uromodulin levels	
HNSC	cis	1	rs28626045	chr14:75589195	MLH3	chr14:75480467-75518235:-	0.3	6.28	7.33E-10	Height	
HNSC	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.38	6.87	1.99E-11	Forced vital capacity	
HNSC	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.39	7.05	5.93E-12	Forced vital capacity	
HNSC	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.4	-7.25	1.6E-12	Forced vital capacity	
HNSC	cis	1	rs28649132	chr16:20406762	GPRC5B	chr16:19870295-19896832:-	-0.2	-3.82	0.000149	Urinary uromodulin levels	
HNSC	cis	1	rs28651964	chr8:96026781	C8orf38	chr8:95908040-96088396:+	-0.29	-4.36	1.59E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs28660477	chr15:56145267	NEDD4	chr15:56119131-56285835:-	0.22	5.3	1.74E-7	Keloid	
HNSC	cis	1	rs28661978	chr3:156579739	LEKR1	chr3:156544076-156763918:+	-0.45	-7.11	4.16E-12	Bone mineral density	
HNSC	cis	1	rs28664971	chr17:28437410	EFCAB5	chr17:28256874-28435469:+	0.22	4.14	4.02E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs28683528	chr12:123845351	CDK2AP1	chr12:123745542-123756687:-	-0.56	-9.97	1.96E-21	Educational attainment;Height;Head circumference (infant)	
HNSC	cis	1	rs28693609	chr4:17645233	FAM184B	chr4:17633711-17783135:-	-0.17	-4.07	5.55E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2869548	chr15:78922638	CHRNA5	chr15:78857906-78886458:+	-0.24	-4.9	1.3E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs28697089	chr12:56938703	RBMS2	chr12:56915609-56989980:+	0.21	4.05	6.06E-5	Adiponectin levels	
HNSC	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.68	10.03	1.15E-21	Diastolic blood pressure	
HNSC	cis	1	rs28712702	chr8:96026980	C8orf38	chr8:95908040-96088396:+	-0.29	-4.45	1.04E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs28716236	chr2:38899228	GALM	chr2:38893052-38961908:+	0.35	5.22	2.69E-7	5-HTT brain serotonin transporter levels	
HNSC	cis	1	rs2872958	chr4:17665032	FAM184B	chr4:17633711-17783135:-	-0.16	-3.72	0.000226	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2872959	chr4:17677163	FAM184B	chr4:17633711-17783135:-	0.2	4.78	2.36E-6	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs2872959	chr4:17677163	LAP3	chr4:17578927-17609590:+	0.16	4.24	2.67E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	0.74	12.64	6.26E-32	Diastolic blood pressure	
HNSC	cis	1	rs2874121	chr17:61731024	FTSJ3	chr17:61896795-61905031:-	0.2	3.76	0.000191	Body mass index	
HNSC	cis	1	rs2874490	chr3:156635513	LEKR1	chr3:156544076-156763918:+	-0.43	-7.19	2.48E-12	Bone mineral density	
HNSC	cis	1	rs2874491	chr3:156649111	LEKR1	chr3:156544076-156763918:+	-0.44	-7.24	1.76E-12	Bone mineral density	
HNSC	cis	1	rs28770330	chr15:56248743	NEDD4	chr15:56119131-56285835:-	0.25	5.86	8.7E-9	Keloid	
HNSC	cis	1	rs28773028	chr15:56262339	NEDD4	chr15:56119131-56285835:-	0.25	5.86	8.58E-9	Keloid	
HNSC	cis	1	rs2880791	chr5:150267376	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs28824259	chr3:48425675	ATRIP	chr3:48488141-48507708:+	0.16	3.71	0.000232	Longevity	
HNSC	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.28	-6.9	1.6E-11	Longevity	
HNSC	cis	1	rs2885510	chr3:48418226	ATRIP	chr3:48488141-48507708:+	-0.17	-3.93	9.53E-5	Longevity	
HNSC	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.27	6.66	7.11E-11	Longevity	
HNSC	cis	1	rs28856331	chr7:102543763	FAM185A	chr7:102389399-102467706:+	-0.21	-3.75	0.000195	Morning vs. evening chronotype	
HNSC	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.51	10.78	1.82E-24	Height	
HNSC	cis	1	rs2887797	chr3:134202506	CEP63	chr3:134204575-134293852:+	0.28	5.99	4.11E-9	Height	
HNSC	cis	1	rs28897193	chr4:107005529	TBCK	chr4:106967233-107237861:-	0.27	5.27	2.1E-7	Airflow obstruction	
HNSC	cis	1	rs2889873	chr20:33646841	PROCR	chr20:33758727-33765164:+	-0.29	-3.67	0.000266	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs2891586	chr10:38101643	LOC399744	chr10:38717074-38741080:+	0.26	3.65	0.000287	Obesity (extreme)	
HNSC	cis	1	rs2899832	chr14:35740941	PPP2R3C	chr14:35554679-35591679:-	0.24	3.81	0.000156	Response to zileuton treatment in asthma (FEV1 change interaction)	
HNSC	cis	1	rs2901354	chr10:124733038	C10orf88	chr10:124690419-124713919:-	-0.2	-3.74	0.000203	Migraine without aura	
HNSC	cis	1	rs2901355	chr10:124731766	C10orf88	chr10:124690419-124713919:-	-0.21	-3.81	0.000158	Migraine without aura	
HNSC	cis	1	rs2901438	chr2:73665656	ALMS1P	chr2:73872046-73912692:+	0.26	4.39	1.41E-5	Metabolite levels	
HNSC	cis	1	rs2905425	chr19:19475717	HAPLN4	chr19:19366453-19384074:-	-0.2	-4.4	1.35E-5	Schizophrenia	
HNSC	cis	1	rs2911131	chr5:96185949	ERAP1	chr5:96096515-96149837:-	0.17	4.04	6.28E-5	Urate levels (BMI interaction)	
HNSC	cis	1	rs2916068	chr19:19516433	HAPLN4	chr19:19366453-19384074:-	0.21	4.51	8.17E-6	Schizophrenia	
HNSC	cis	1	rs2920280	chr8:143761144	LOC100133669	chr8:144063448-144099807:-	0.2	3.98	7.91E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920280	chr8:143761144	LY6K	chr8:143781529-143785582:+	0.36	8.07	5.23E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920280	chr8:143761144	PSCA	chr8:143761875-143764142:+	0.44	10.49	2.26E-23	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920282	chr8:143757763	LOC100133669	chr8:144063448-144099807:-	0.21	4.13	4.24E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920282	chr8:143757763	LY6K	chr8:143781529-143785582:+	0.33	7.28	1.34E-12	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920282	chr8:143757763	PSCA	chr8:143761875-143764142:+	0.43	10.2	2.72E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920283	chr8:143757037	LOC100133669	chr8:144063448-144099807:-	0.21	4.06	5.72E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920283	chr8:143757037	LY6K	chr8:143781529-143785582:+	0.33	7.3	1.14E-12	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920283	chr8:143757037	PSCA	chr8:143761875-143764142:+	0.42	10.1	6.21E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920292	chr8:143765699	LOC100133669	chr8:144063448-144099807:-	0.2	3.97	8.2E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920292	chr8:143765699	LY6K	chr8:143781529-143785582:+	0.33	7.33	9.4E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920292	chr8:143765699	PSCA	chr8:143761875-143764142:+	0.42	10.29	1.22E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920293	chr8:143765414	LOC100133669	chr8:144063448-144099807:-	0.2	3.97	8.2E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920293	chr8:143765414	LY6K	chr8:143781529-143785582:+	0.33	7.33	9.4E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920293	chr8:143765414	PSCA	chr8:143761875-143764142:+	0.42	10.29	1.22E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920294	chr8:143765326	LOC100133669	chr8:144063448-144099807:-	0.2	3.97	8.2E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920294	chr8:143765326	LY6K	chr8:143781529-143785582:+	0.33	7.33	9.4E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920294	chr8:143765326	PSCA	chr8:143761875-143764142:+	0.42	10.29	1.22E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920295	chr8:143764937	LOC100133669	chr8:144063448-144099807:-	0.22	4.31	1.93E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920295	chr8:143764937	LY6K	chr8:143781529-143785582:+	0.32	7.15	3.18E-12	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920295	chr8:143764937	PSCA	chr8:143761875-143764142:+	0.42	10.01	1.36E-21	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920296	chr8:143763109	LOC100133669	chr8:144063448-144099807:-	0.2	3.98	8.05E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920296	chr8:143763109	LY6K	chr8:143781529-143785582:+	0.33	7.33	9.32E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920296	chr8:143763109	PSCA	chr8:143761875-143764142:+	0.42	10.29	1.26E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920297	chr8:143763083	LOC100133669	chr8:144063448-144099807:-	0.2	3.98	8.05E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920297	chr8:143763083	LY6K	chr8:143781529-143785582:+	0.33	7.33	9.32E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920297	chr8:143763083	PSCA	chr8:143761875-143764142:+	0.42	10.29	1.26E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920298	chr8:143763043	LOC100133669	chr8:144063448-144099807:-	0.2	3.98	8.05E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920298	chr8:143763043	LY6K	chr8:143781529-143785582:+	0.33	7.33	9.32E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920298	chr8:143763043	PSCA	chr8:143761875-143764142:+	0.42	10.29	1.26E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2920781	chr15:43924682	ADAL	chr15:43622872-43646094:+	-0.41	-5.71	1.97E-8	Tumor biomarkers	
HNSC	cis	1	rs2920781	chr15:43924682	CATSPER2	chr15:43922774-43959900:-	-0.45	-7.3	1.18E-12	Tumor biomarkers	
HNSC	cis	1	rs2920781	chr15:43924682	CKMT1A	chr15:43985084-43991419:+	-0.48	-6.66	7.2E-11	Tumor biomarkers	
HNSC	cis	1	rs2920781	chr15:43924682	CKMT1B	chr15:43885252-43891603:+	-0.34	-4.73	2.97E-6	Tumor biomarkers	
HNSC	cis	1	rs2927072	chr15:43922398	ADAL	chr15:43622872-43646094:+	-0.41	-5.71	1.97E-8	Tumor biomarkers	
HNSC	cis	1	rs2927072	chr15:43922398	CATSPER2	chr15:43922774-43959900:-	-0.45	-7.3	1.18E-12	Tumor biomarkers	
HNSC	cis	1	rs2927072	chr15:43922398	CKMT1A	chr15:43985084-43991419:+	-0.48	-6.66	7.2E-11	Tumor biomarkers	
HNSC	cis	1	rs2927072	chr15:43922398	CKMT1B	chr15:43885252-43891603:+	-0.34	-4.73	2.97E-6	Tumor biomarkers	
HNSC	cis	1	rs2932538	chr1:113216543	ST7L	chr1:113066142-113162405:-	-0.29	-5.22	2.62E-7	Systolic blood pressure;Hypertension;Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs2935183	chr17:45607572	C17orf57	chr17:45401142-45518675:+	-0.19	-4.55	6.83E-6	Multiple sclerosis or amyotrophic lateral sclerosis	
HNSC	cis	1	rs2935183	chr17:45607572	TBKBP1	chr17:45772630-45789427:+	0.21	4.25	2.59E-5	Multiple sclerosis or amyotrophic lateral sclerosis	
HNSC	cis	1	rs293526	chr6:83648056	PGM3	chr6:83878630-83903633:-	0.16	3.66	0.000277	Crohn's disease	
HNSC	cis	1	rs293566	chr20:31097877	MYLK2	chr20:30407178-30422500:+	-0.15	-3.82	0.000148	Age at first birth	
HNSC	cis	1	rs293567	chr20:31098565	MYLK2	chr20:30407178-30422500:+	0.16	4.18	3.44E-5	Age at first birth	
HNSC	cis	1	rs2938670	chr15:78740688	CHRNA5	chr15:78857906-78886458:+	-0.21	-4.39	1.36E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1 in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs2951308	chr7:143767149	ARHGEF35	chr7:143883677-143892736:-	0.33	7.11	4.14E-12	Obesity-related traits	
HNSC	cis	1	rs2951308	chr7:143767149	OR2A7	chr7:143955790-143974852:-	-0.2	-3.97	8.28E-5	Obesity-related traits	
HNSC	cis	1	rs2951353	chr7:143761116	ARHGEF35	chr7:143883677-143892736:-	-0.35	-7.53	2.39E-13	Obesity-related traits	
HNSC	cis	1	rs2951354	chr7:143761001	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.5	2.9E-13	Obesity-related traits	
HNSC	cis	1	rs2951360	chr7:143757349	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.43	4.88E-13	Obesity-related traits	
HNSC	cis	1	rs2951360	chr7:143757349	OR2A7	chr7:143955790-143974852:-	0.21	4	7.33E-5	Obesity-related traits	
HNSC	cis	1	rs2951363	chr7:143754724	ARHGEF35	chr7:143883677-143892736:-	-0.35	-7.66	9.94E-14	Obesity-related traits	
HNSC	cis	1	rs2951364	chr7:143754483	ARHGEF35	chr7:143883677-143892736:-	-0.35	-7.62	1.28E-13	Obesity-related traits	
HNSC	cis	1	rs2951368	chr7:143752821	ARHGEF35	chr7:143883677-143892736:-	-0.36	-7.71	7.05E-14	Obesity-related traits	
HNSC	cis	1	rs2951369	chr7:143752638	ARHGEF35	chr7:143883677-143892736:-	-0.35	-7.62	1.28E-13	Obesity-related traits	
HNSC	cis	1	rs2951372	chr7:143749503	ARHGEF35	chr7:143883677-143892736:-	-0.36	-7.77	4.74E-14	Obesity-related traits	
HNSC	cis	1	rs2952768	chr2:208494234	FZD5	chr2:208627312-208634143:-	0.2	3.77	0.000185	Opioid sensitivity	
HNSC	cis	1	rs2961102	chr7:65424658	CRCP	chr7:65579805-65619551:+	-0.32	-3.7	0.000242	Diabetic kidney disease	
HNSC	cis	1	rs2961102	chr7:65424658	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.58	5.96E-6	Diabetic kidney disease	
HNSC	cis	1	rs2961115	chr7:143753371	ARHGEF35	chr7:143883677-143892736:-	-0.36	-7.71	7.05E-14	Obesity-related traits	
HNSC	cis	1	rs2961117	chr7:143755253	ARHGEF35	chr7:143883677-143892736:-	-0.35	-7.65	1.07E-13	Obesity-related traits	
HNSC	cis	1	rs2961117	chr7:143755253	OR2A7	chr7:143955790-143974852:-	0.19	3.69	0.000248	Obesity-related traits	
HNSC	cis	1	rs2961118	chr7:143755443	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.52	2.55E-13	Obesity-related traits	
HNSC	cis	1	rs2961119	chr7:143755852	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.49	3.29E-13	Obesity-related traits	
HNSC	cis	1	rs2961120	chr7:143756585	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.43	4.88E-13	Obesity-related traits	
HNSC	cis	1	rs2961120	chr7:143756585	OR2A7	chr7:143955790-143974852:-	0.21	4	7.33E-5	Obesity-related traits	
HNSC	cis	1	rs2961125	chr7:143761770	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.5	2.9E-13	Obesity-related traits	
HNSC	cis	1	rs2961126	chr7:143762736	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.5	2.9E-13	Obesity-related traits	
HNSC	cis	1	rs2961128	chr7:143763483	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.5	2.9E-13	Obesity-related traits	
HNSC	cis	1	rs2961132	chr7:143768128	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.39	6.22E-13	Obesity-related traits	
HNSC	cis	1	rs2961132	chr7:143768128	OR2A7	chr7:143955790-143974852:-	0.2	3.81	0.000154	Obesity-related traits	
HNSC	cis	1	rs2961134	chr7:143771062	ARHGEF35	chr7:143883677-143892736:-	-0.36	-7.82	3.26E-14	Obesity-related traits	
HNSC	cis	1	rs2961134	chr7:143771062	OR2A7	chr7:143955790-143974852:-	0.21	3.99	7.62E-5	Obesity-related traits	
HNSC	cis	1	rs2961144	chr7:143747870	ARHGEF35	chr7:143883677-143892736:-	0.36	7.9	1.88E-14	Obesity-related traits	
HNSC	cis	1	rs2965188	chr19:19522557	HAPLN4	chr19:19366453-19384074:-	0.2	4.45	1.09E-5	Schizophrenia	
HNSC	cis	1	rs2965198	chr19:19473030	HAPLN4	chr19:19366453-19384074:-	-0.2	-4.28	2.24E-5	Schizophrenia	
HNSC	cis	1	rs2976388	chr8:143760256	LOC100133669	chr8:144063448-144099807:-	0.2	3.92	0.000103	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976388	chr8:143760256	LY6K	chr8:143781529-143785582:+	0.36	8.15	3.09E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976388	chr8:143760256	PSCA	chr8:143761875-143764142:+	0.44	10.42	4.24E-23	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976392	chr8:143762932	LOC100133669	chr8:144063448-144099807:-	0.2	4.06	5.72E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976392	chr8:143762932	LY6K	chr8:143781529-143785582:+	0.32	7.24	1.78E-12	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976392	chr8:143762932	PSCA	chr8:143761875-143764142:+	0.42	10.18	3.12E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976394	chr8:143763622	LOC100133669	chr8:144063448-144099807:-	0.2	3.98	8.05E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976394	chr8:143763622	LY6K	chr8:143781529-143785582:+	0.33	7.33	9.32E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976394	chr8:143763622	PSCA	chr8:143761875-143764142:+	0.42	10.29	1.26E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976396	chr8:143764001	LOC100133669	chr8:144063448-144099807:-	-0.21	-4.21	2.99E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976396	chr8:143764001	LY6K	chr8:143781529-143785582:+	-0.35	-8.06	5.68E-15	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976396	chr8:143764001	PSCA	chr8:143761875-143764142:+	-0.43	-10.65	5.75E-24	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976398	chr8:143764879	LOC100133669	chr8:144063448-144099807:-	0.2	3.97	8.2E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976398	chr8:143764879	LY6K	chr8:143781529-143785582:+	0.33	7.33	9.4E-13	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2976398	chr8:143764879	PSCA	chr8:143761875-143764142:+	0.42	10.29	1.22E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2978982	chr8:143763490	LOC100133669	chr8:144063448-144099807:-	0.2	4.06	5.72E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2978982	chr8:143763490	LY6K	chr8:143781529-143785582:+	0.32	7.24	1.78E-12	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2978982	chr8:143763490	PSCA	chr8:143761875-143764142:+	0.42	10.18	3.12E-22	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
HNSC	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.69	-17.97	6.84E-56	Homocysteine levels	
HNSC	cis	1	rs2993259	chr1:46001550	MMACHC	chr1:45965856-45976737:+	-0.21	-4.26	2.42E-5	Homocysteine levels	
HNSC	cis	1	rs2993834	chr10:59971616	CISD1	chr10:60028895-60049018:+	0.24	4.23	2.83E-5	Inflammatory bowel disease	
HNSC	cis	1	rs2993834	chr10:59971616	IPMK	chr10:59955618-60027694:-	0.27	6.59	1.11E-10	Inflammatory bowel disease	
HNSC	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.35	-9.08	2.59E-18	Ankylosing spondylitis	
HNSC	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.39	7.46	4.05E-13	Ankylosing spondylitis	
HNSC	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.37	-9.36	2.76E-19	Ankylosing spondylitis	
HNSC	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.4	7.52	2.61E-13	Ankylosing spondylitis	
HNSC	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.35	-9.1	2.27E-18	Ankylosing spondylitis	
HNSC	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.4	7.55	2.13E-13	Ankylosing spondylitis	
HNSC	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.35	-9.1	2.27E-18	Ankylosing spondylitis	
HNSC	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.4	7.55	2.13E-13	Ankylosing spondylitis	
HNSC	cis	1	rs3088162	chr20:23607752	CST1	chr20:23728191-23731574:-	0.32	5.02	7.13E-7	Chronic kidney disease	
HNSC	cis	1	rs3088162	chr20:23607752	CST4	chr20:23666277-23669662:-	0.24	3.95	9.03E-5	Chronic kidney disease	
HNSC	cis	1	rs3091242	chr1:25674785	RHCE	chr1:25688741-25756683:-	0.27	4.99	8.4E-7	Erythrocyte sedimentation rate	
HNSC	cis	1	rs3091242	chr1:25674785	RHD	chr1:25598981-25656935:+	-0.46	-9.14	1.58E-18	Erythrocyte sedimentation rate	
HNSC	cis	1	rs3092744	chr20:44025282	SYS1-DBNDD2	chr20:43991701-44039245:+	0.37	5.68	2.36E-8	Psoriasis	
HNSC	cis	1	rs3097417	chr3:53088601	TMEM110	chr3:52867139-52931547:-	-0.42	-5.38	1.17E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	0.83	14.32	4.05E-39	Type 2 diabetes	
HNSC	cis	1	rs3099555	chr4:1725651	FAM53A	chr4:1641609-1685854:-	-0.34	-5.84	9.63E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs3099899	chr4:129917368	C4orf33	chr4:130014829-130033842:+	-0.43	-8.41	4.47E-16	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs310124	chr1:153020275	LCE3C	chr1:152573138-152573562:+	-0.22	-5.24	2.34E-7	Inflammatory skin disease	
HNSC	cis	1	rs310124	chr1:153020275	SPRR1B	chr1:153003679-153005375:+	0.09	3.74	0.000207	Inflammatory skin disease	
HNSC	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.4	-5.5	6.03E-8	Tumor biomarkers	
HNSC	cis	1	rs3101443	chr15:43912372	CATSPER2	chr15:43922774-43959900:-	-0.45	-7.33	9.66E-13	Tumor biomarkers	
HNSC	cis	1	rs3101443	chr15:43912372	CKMT1A	chr15:43985084-43991419:+	-0.48	-6.61	1.03E-10	Tumor biomarkers	
HNSC	cis	1	rs3101443	chr15:43912372	CKMT1B	chr15:43885252-43891603:+	-0.36	-5.04	6.59E-7	Tumor biomarkers	
HNSC	cis	1	rs3105369	chr4:130022448	C4orf33	chr4:130014829-130033842:+	-0.48	-9.73	1.39E-20	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs3110496	chr17:27917771	EFCAB5	chr17:28256874-28435469:+	0.21	3.91	0.000103	Height	
HNSC	cis	1	rs3113489	chr4:129961179	C4orf33	chr4:130014829-130033842:+	-0.46	-8.89	1.18E-17	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs313553	chr4:25244743	PI4K2B	chr4:25162285-25280831:+	-0.26	-3.74	0.000204	Cannabis dependence	
HNSC	cis	1	rs313798	chr7:65493031	CRCP	chr7:65579805-65619551:+	-0.32	-3.73	0.000217	Diabetic kidney disease	
HNSC	cis	1	rs313798	chr7:65493031	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.48	9.21E-6	Diabetic kidney disease	
HNSC	cis	1	rs313799	chr7:65494330	CRCP	chr7:65579805-65619551:+	-0.33	-3.86	0.00013	Diabetic kidney disease	
HNSC	cis	1	rs313799	chr7:65494330	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.6	5.37E-6	Diabetic kidney disease	
HNSC	cis	1	rs313802	chr7:65516373	CRCP	chr7:65579805-65619551:+	-0.33	-3.72	0.000224	Diabetic kidney disease	
HNSC	cis	1	rs313802	chr7:65516373	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.43	1.17E-5	Diabetic kidney disease	
HNSC	cis	1	rs313803	chr7:65514731	CRCP	chr7:65579805-65619551:+	-0.33	-3.72	0.000224	Diabetic kidney disease	
HNSC	cis	1	rs313803	chr7:65514731	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.43	1.17E-5	Diabetic kidney disease	
HNSC	cis	1	rs313807	chr7:65499481	CRCP	chr7:65579805-65619551:+	-0.33	-3.86	0.00013	Diabetic kidney disease	
HNSC	cis	1	rs313807	chr7:65499481	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.6	5.37E-6	Diabetic kidney disease	
HNSC	cis	1	rs313809	chr7:65499983	CRCP	chr7:65579805-65619551:+	-0.32	-3.73	0.000217	Diabetic kidney disease	
HNSC	cis	1	rs313809	chr7:65499983	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.48	9.21E-6	Diabetic kidney disease	
HNSC	cis	1	rs3138137	chr12:56116981	RDH5	chr12:56114151-56118525:+	-0.22	-5.35	1.35E-7	Refractive error	
HNSC	cis	1	rs313813	chr7:65503500	CRCP	chr7:65579805-65619551:+	-0.33	-3.77	0.000185	Diabetic kidney disease	
HNSC	cis	1	rs313813	chr7:65503500	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.69	3.59E-6	Diabetic kidney disease	
HNSC	cis	1	rs3138144	chr12:56114769	RDH5	chr12:56114151-56118525:+	-0.21	-5.14	4.0E-7	Refractive error	
HNSC	cis	1	rs313814	chr7:65503293	CRCP	chr7:65579805-65619551:+	-0.32	-3.68	0.000258	Diabetic kidney disease	
HNSC	cis	1	rs313814	chr7:65503293	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.4	1.32E-5	Diabetic kidney disease	
HNSC	cis	1	rs313820	chr7:65574466	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.77	2.42E-6	Diabetic kidney disease	
HNSC	cis	1	rs313824	chr7:65581207	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.73	2.99E-6	Diabetic kidney disease	
HNSC	cis	1	rs313831	chr7:65551226	NCRNA00174	chr7:65841032-65865395:-	-0.4	-4.28	2.27E-5	Diabetic kidney disease	
HNSC	cis	1	rs313832	chr7:65550891	NCRNA00174	chr7:65841032-65865395:-	-0.4	-4.27	2.3E-5	Diabetic kidney disease	
HNSC	cis	1	rs316304	chr7:65616894	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs316307	chr7:65570171	CRCP	chr7:65579805-65619551:+	-0.32	-3.76	0.000193	Diabetic kidney disease	
HNSC	cis	1	rs316307	chr7:65570171	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.86	1.59E-6	Diabetic kidney disease	
HNSC	cis	1	rs316312	chr7:65596491	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs316313	chr7:65593548	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs316317	chr7:65613637	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs316318	chr7:65612904	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs316321	chr7:65611613	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs316322	chr7:65611233	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.58	5.81E-6	Diabetic kidney disease	
HNSC	cis	1	rs316325	chr7:65609518	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs316326	chr7:65609453	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs316327	chr7:65609201	CRCP	chr7:65579805-65619551:+	0.31	3.71	0.000232	Diabetic kidney disease	
HNSC	cis	1	rs316327	chr7:65609201	NCRNA00174	chr7:65841032-65865395:-	0.42	4.62	4.93E-6	Diabetic kidney disease	
HNSC	cis	1	rs316329	chr7:65608416	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs316330	chr7:65605372	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs316331	chr7:65604622	NCRNA00174	chr7:65841032-65865395:-	0.41	4.49	9.0E-6	Diabetic kidney disease	
HNSC	cis	1	rs316332	chr7:65604299	CRCP	chr7:65579805-65619551:+	-0.32	-3.73	0.000215	Diabetic kidney disease	
HNSC	cis	1	rs316332	chr7:65604299	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.79	2.26E-6	Diabetic kidney disease	
HNSC	cis	1	rs316334	chr7:65602126	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs31872	chr5:140372222	PCDHGA2	chr5:140718354-140892546:+	-0.17	-3.84	0.000142	Visceral adipose tissue adjusted for BMI	
HNSC	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.69	-12.42	5.09E-31	Dental caries	
HNSC	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.27	-6.79	3.28E-11	Longevity	
HNSC	cis	1	rs329119	chr5:133861716	CDKN2AIPNL	chr5:133737835-133747589:-	0.25	4.13	4.22E-5	Menarche (age at onset)	
HNSC	cis	1	rs329119	chr5:133861716	UBE2B	chr5:133706870-133727798:+	0.25	4.28	2.22E-5	Menarche (age at onset)	
HNSC	cis	1	rs3310	chr20:3237232	ITPA	chr20:3190056-3204504:+	-0.18	-3.73	0.000214	IFN-related cytopenia	
HNSC	cis	1	rs332529	chr5:90789470	LOC100129716	chr5:90676164-90716531:+	0.3	3.93	9.65E-5	Smoking behavior	
HNSC	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	0.81	13.9	2.57E-37	Type 2 diabetes	
HNSC	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.85	15.11	1.12E-42	Type 2 diabetes	
HNSC	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	0.82	14.28	5.52E-39	Type 2 diabetes	
HNSC	cis	1	rs33988592	chr3:121415610	IQCB1	chr3:121488610-121553926:-	0.24	6.07	2.53E-9	Cognitive performance	
HNSC	cis	1	rs33999310	chr3:52883332	TMEM110	chr3:52867139-52931547:-	0.56	5.97	4.56E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs34010330	chr19:18559657	SSBP4	chr19:18530221-18545371:+	-0.19	-4.27	2.33E-5	Breast cancer	
HNSC	cis	1	rs34086988	chr3:121352745	IQCB1	chr3:121488610-121553926:-	0.24	6.02	3.35E-9	Cognitive performance	
HNSC	cis	1	rs34102169	chr1:46424864	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.6	1.48E-13	Body mass index	
HNSC	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.61	-13.6	5.15E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs34121720	chr3:53072167	PHF7	chr3:52444527-52457656:+	0.39	3.9	0.000108	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs34121720	chr3:53072167	TMEM110	chr3:52867139-52931547:-	0.46	5.18	3.23E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs34123137	chr2:234167881	ATG16L1	chr2:234160217-234204319:+	0.25	4.43	1.17E-5	Crohn's disease	
HNSC	cis	1	rs34127220	chr16:29842891	LOC440356	chr16:29875004-29879374:+	-0.24	-3.87	0.000122	Multiple sclerosis	
HNSC	cis	1	rs34128973	chr11:47851376	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.43	9.04E-8	Subjective well-being	
HNSC	cis	1	rs34128973	chr11:47851376	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.92	0.000103	Subjective well-being	
HNSC	cis	1	rs34136756	chr7:65381256	CRCP	chr7:65579805-65619551:+	-0.33	-3.88	0.000121	Diabetic kidney disease	
HNSC	cis	1	rs34136756	chr7:65381256	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.89	1.39E-6	Diabetic kidney disease	
HNSC	cis	1	rs34171762	chr19:18559410	SSBP4	chr19:18530221-18545371:+	-0.21	-4.75	2.69E-6	Breast cancer	
HNSC	cis	1	rs34180939	chr5:148618964	AFAP1L1	chr5:148651401-148721365:+	0.18	3.84	0.000139	Body mass index	
HNSC	cis	1	rs34192067	chr7:65887657	NCRNA00174	chr7:65841032-65865395:-	-0.47	-5.09	4.98E-7	Diabetic kidney disease	
HNSC	cis	1	rs34192067	chr7:65887657	STAG3L4	chr7:66767616-66786512:+	-0.38	-4.21	2.99E-5	Diabetic kidney disease	
HNSC	cis	1	rs34193460	chr7:65393110	CRCP	chr7:65579805-65619551:+	-0.32	-3.73	0.000212	Diabetic kidney disease	
HNSC	cis	1	rs34193460	chr7:65393110	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.6	5.27E-6	Diabetic kidney disease	
HNSC	cis	1	rs342290	chr7:106367604	FLJ36031	chr7:106299150-106301591:-	-0.19	-3.93	9.6E-5	Mean platelet volume	
HNSC	cis	1	rs342292	chr7:106370644	FLJ36031	chr7:106299150-106301591:-	-0.2	-4.27	2.39E-5	Mean platelet volume	
HNSC	cis	1	rs342293	chr7:106372219	FLJ36031	chr7:106299150-106301591:-	0.2	4.39	1.37E-5	Mean platelet volume	
HNSC	cis	1	rs342294	chr7:106372622	FLJ36031	chr7:106299150-106301591:-	0.2	4.25	2.51E-5	Mean platelet volume	
HNSC	cis	1	rs342295	chr7:106372760	FLJ36031	chr7:106299150-106301591:-	-0.21	-4.31	1.99E-5	Mean platelet volume	
HNSC	cis	1	rs342296	chr7:106372903	FLJ36031	chr7:106299150-106301591:-	-0.21	-4.31	1.99E-5	Mean platelet volume	
HNSC	cis	1	rs34230359	chr5:156449561	TIMD4	chr5:156346293-156390266:-	-0.16	-3.68	0.000259	Hypertriglyceridemia	
HNSC	cis	1	rs34237279	chr15:75361121	SCAMP5	chr15:75287901-75313836:+	0.42	8.31	9.1E-16	Blood trace element (Zn levels)	
HNSC	cis	1	rs34244302	chr3:53102236	TMEM110	chr3:52867139-52931547:-	0.5	5.88	7.69E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs34252323	chr2:135486302	TMEM163	chr2:135213331-135525334:-	-0.3	-5.05	6.3E-7	Gut microbiome composition (winter)	
HNSC	cis	1	rs34256197	chr19:18606472	SSBP4	chr19:18530221-18545371:+	-0.2	-4.66	4.05E-6	Breast cancer	
HNSC	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.62	-13.65	3.18E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs34292685	chr11:64049021	C11orf20	chr11:64067863-64072238:+	-0.3	-4.38	1.47E-5	Mean platelet volume	
HNSC	cis	1	rs34313969	chr3:52995166	TMEM110	chr3:52867139-52931547:-	0.52	6.02	3.48E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs34319345	chr16:58820592	GOT2	chr16:58741035-58768246:-	-0.25	-5.22	2.6E-7	Blood metabolite ratios	
HNSC	cis	1	rs34333482	chr6:116855952	FAM26F	chr6:116782556-116784933:+	0.18	5.16	3.64E-7	Pelvic organ prolapse (moderate/severe)	
HNSC	cis	1	rs34344888	chr14:23387585	HAUS4	chr14:23415438-23426335:-	-0.22	-4.5	8.63E-6	Educational attainment (years of education)	
HNSC	cis	1	rs34374560	chr20:23609462	CST1	chr20:23728191-23731574:-	0.34	5.25	2.23E-7	Chronic kidney disease	
HNSC	cis	1	rs34374560	chr20:23609462	CST4	chr20:23666277-23669662:-	0.27	4.35	1.64E-5	Chronic kidney disease	
HNSC	cis	1	rs34405766	chr2:135486189	TMEM163	chr2:135213331-135525334:-	-0.3	-5.05	6.3E-7	Gut microbiome composition (winter)	
HNSC	cis	1	rs344081	chr3:156555984	LEKR1	chr3:156544076-156763918:+	-0.47	-7.89	2.02E-14	Bone mineral density	
HNSC	cis	1	rs344088	chr3:156561361	LEKR1	chr3:156544076-156763918:+	-0.49	-7.98	1.05E-14	Bone mineral density	
HNSC	cis	1	rs344090	chr3:156563140	LEKR1	chr3:156544076-156763918:+	-0.49	-7.98	1.05E-14	Bone mineral density	
HNSC	cis	1	rs34409160	chr2:28943865	TRMT61B	chr2:29072690-29093175:-	0.37	7.72	6.63E-14	Body mass index	
HNSC	cis	1	rs34409737	chr5:156457857	TIMD4	chr5:156346293-156390266:-	-0.17	-3.83	0.000146	Hypertriglyceridemia	
HNSC	cis	1	rs34453673	chr5:434722	EXOC3	chr5:443334-467407:+	-0.24	-4.26	2.45E-5	Cystic fibrosis severity	
HNSC	cis	1	rs3448	chr3:49396751	AMT	chr3:49454212-49460012:-	0.19	4.14	4.03E-5	Menarche (age at onset)	
HNSC	cis	1	rs34496143	chr10:37992658	LOC399744	chr10:38717074-38741080:+	0.27	3.66	0.000279	Obesity (extreme)	
HNSC	cis	1	rs34514856	chr1:27287560	PDIK1L	chr1:26437656-26452024:+	-0.28	-3.65	0.000285	HDL cholesterol;Triglycerides;LDL cholesterol	
HNSC	cis	1	rs34529418	chr7:65403209	CRCP	chr7:65579805-65619551:+	-0.33	-3.97	8.29E-5	Diabetic kidney disease	
HNSC	cis	1	rs34529418	chr7:65403209	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.97	9.18E-7	Diabetic kidney disease	
HNSC	cis	1	rs34530577	chr3:53103796	RFT1	chr3:53122503-53164470:-	-0.25	-4.99	8.42E-7	Height	
HNSC	cis	1	rs34544865	chr19:37801242	ZNF793	chr19:37997841-38034237:+	0.32	4.67	3.87E-6	Coronary artery calcification	
HNSC	cis	1	rs34560516	chr7:65404092	CRCP	chr7:65579805-65619551:+	-0.32	-3.7	0.000242	Diabetic kidney disease	
HNSC	cis	1	rs34560516	chr7:65404092	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.58	5.96E-6	Diabetic kidney disease	
HNSC	cis	1	rs34577383	chr7:65385726	CRCP	chr7:65579805-65619551:+	-0.33	-3.97	8.29E-5	Diabetic kidney disease	
HNSC	cis	1	rs34577383	chr7:65385726	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.97	9.18E-7	Diabetic kidney disease	
HNSC	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.62	-13.48	1.68E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs34610643	chr17:40574388	NAGLU	chr17:40687951-40696464:+	-0.2	-4.05	6.05E-5	Crohn's disease	
HNSC	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.62	-13.68	2.31E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs34629498	chr19:23060720	ZNF492	chr19:22817126-22850472:+	-0.31	-4.88	1.41E-6	Bronchopulmonary dysplasia	
HNSC	cis	1	rs34633905	chr4:89074771	ABCG2	chr4:89011417-89152474:-	0.24	4.28	2.22E-5	Gout	
HNSC	cis	1	rs34637256	chr7:65360131	CRCP	chr7:65579805-65619551:+	-0.35	-4.03	6.54E-5	Diabetic kidney disease	
HNSC	cis	1	rs34637256	chr7:65360131	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.72	3.02E-6	Diabetic kidney disease	
HNSC	cis	1	rs346785	chr17:74283769	FAM100B	chr17:74261286-74267379:+	0.17	3.93	9.77E-5	White matter hyperintensities in ischemic stroke	
HNSC	cis	1	rs34684276	chr15:78813155	CHRNA5	chr15:78857906-78886458:+	-0.25	-4.97	9.05E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio;Nicotine dependence	
HNSC	cis	1	rs34700722	chr8:96021876	C8orf38	chr8:95908040-96088396:+	-0.28	-4.42	1.19E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs34702770	chr7:65344823	CRCP	chr7:65579805-65619551:+	-0.37	-4.29	2.16E-5	Diabetic kidney disease	
HNSC	cis	1	rs34702770	chr7:65344823	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.86	1.57E-6	Diabetic kidney disease	
HNSC	cis	1	rs34703416	chr7:65300642	CRCP	chr7:65579805-65619551:+	-0.37	-4.26	2.42E-5	Diabetic kidney disease	
HNSC	cis	1	rs34703416	chr7:65300642	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.9	1.33E-6	Diabetic kidney disease	
HNSC	cis	1	rs34746918	chr19:18539744	SSBP4	chr19:18530221-18545371:+	-0.19	-4.39	1.37E-5	Breast cancer	
HNSC	cis	1	rs34751999	chr15:84758419	LOC388152	chr15:84867600-84898920:-	-0.28	-4.85	1.64E-6	Schizophrenia	
HNSC	cis	1	rs34812189	chr6:56806727	BEND6	chr6:56819773-56892138:+	-0.42	-7.06	5.55E-12	Menarche (age at onset)	
HNSC	cis	1	rs34812189	chr6:56806727	RAB23	chr6:57053591-57087101:-	0.22	3.76	0.000191	Menarche (age at onset)	
HNSC	cis	1	rs34815098	chr7:65292254	CRCP	chr7:65579805-65619551:+	-0.37	-4.31	1.99E-5	Diabetic kidney disease	
HNSC	cis	1	rs34815098	chr7:65292254	NCRNA00174	chr7:65841032-65865395:-	-0.45	-4.91	1.26E-6	Diabetic kidney disease	
HNSC	cis	1	rs34844680	chr15:89232751	ACAN	chr15:89346674-89418585:+	0.18	3.68	0.000264	Obesity-related traits	
HNSC	cis	1	rs34847072	chr5:437862	EXOC3	chr5:443334-467407:+	-0.24	-4.18	3.5E-5	Cystic fibrosis severity	
HNSC	cis	1	rs34848593	chr1:113240106	ST7L	chr1:113066142-113162405:-	0.39	5.82	1.03E-8	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs34849118	chr2:240919912	NDUFA10	chr2:240900158-240964798:-	0.21	3.8	0.000162	Odorant perception (isobutyraldehyde)	
HNSC	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.62	-13.87	3.79E-37	Response to antipsychotic treatment	
HNSC	cis	1	rs34865093	chr5:156424767	TIMD4	chr5:156346293-156390266:-	-0.17	-3.88	0.000118	Hypertriglyceridemia	
HNSC	cis	1	rs34878139	chr12:124446253	DNAH10	chr12:124247042-124420265:+	0.29	5.36	1.31E-7	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs34897231	chr20:23620268	CST1	chr20:23728191-23731574:-	0.34	5.27	2.06E-7	Chronic kidney disease	
HNSC	cis	1	rs34897231	chr20:23620268	CST4	chr20:23666277-23669662:-	0.26	4.26	2.48E-5	Chronic kidney disease	
HNSC	cis	1	rs34910028	chr11:47758449	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.49	6.58E-8	Subjective well-being	
HNSC	cis	1	rs34910028	chr11:47758449	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.9	0.000108	Subjective well-being	
HNSC	cis	1	rs34933390	chr3:53006265	TMEM110	chr3:52867139-52931547:-	0.46	5.35	1.35E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs34933526	chr7:65383199	CRCP	chr7:65579805-65619551:+	-0.34	-3.93	9.9E-5	Diabetic kidney disease	
HNSC	cis	1	rs34933526	chr7:65383199	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.94	1.06E-6	Diabetic kidney disease	
HNSC	cis	1	rs34943350	chr3:53012888	TMEM110	chr3:52867139-52931547:-	0.48	5.14	4.01E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs34943654	chr2:218313717	DIRC3	chr2:218148748-218621316:-	0.33	4.34	1.75E-5	Metabolite levels (MHPG)	
HNSC	cis	1	rs34947476	chr2:135486150	TMEM163	chr2:135213331-135525334:-	-0.3	-5.05	6.12E-7	Gut microbiome composition (winter)	
HNSC	cis	1	rs34949904	chr22:24695298	POM121L9P	chr22:24647589-24661490:+	-0.33	-7.1	4.32E-12	Gut microbiome composition (summer)	
HNSC	cis	1	rs34953792	chr20:55086281	C20orf43	chr20:55043647-55093942:+	0.21	4.16	3.78E-5	Refractive astigmatism	
HNSC	cis	1	rs34964872	chr14:104448435	TDRD9	chr14:104394817-104519002:+	0.34	5.57	4.21E-8	Bipolar disorder	
HNSC	cis	1	rs34970380	chr7:65431493	CRCP	chr7:65579805-65619551:+	-0.32	-3.7	0.000242	Diabetic kidney disease	
HNSC	cis	1	rs34970380	chr7:65431493	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.58	5.96E-6	Diabetic kidney disease	
HNSC	cis	1	rs34974928	chr7:65364006	CRCP	chr7:65579805-65619551:+	-0.34	-4.07	5.5E-5	Diabetic kidney disease	
HNSC	cis	1	rs34974928	chr7:65364006	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.76	2.59E-6	Diabetic kidney disease	
HNSC	cis	1	rs34979715	chr3:53048960	TMEM110	chr3:52867139-52931547:-	0.51	5.61	3.44E-8	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs34983295	chr20:55079380	C20orf43	chr20:55043647-55093942:+	0.22	4.43	1.17E-5	Refractive astigmatism	
HNSC	cis	1	rs35006492	chr4:129878342	C4orf33	chr4:130014829-130033842:+	0.42	8.25	1.41E-15	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs35046236	chr7:65408613	CRCP	chr7:65579805-65619551:+	-0.33	-3.89	0.000114	Diabetic kidney disease	
HNSC	cis	1	rs35046236	chr7:65408613	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.91	1.21E-6	Diabetic kidney disease	
HNSC	cis	1	rs35056702	chr6:109736326	AKD1	chr6:109814059-110012415:-	-0.21	-4.29	2.11E-5	Height	
HNSC	cis	1	rs35056702	chr6:109736326	SMPD2	chr6:109761931-109765121:+	0.28	5.85	8.92E-9	Height	
HNSC	cis	1	rs35058610	chr7:65390925	CRCP	chr7:65579805-65619551:+	-0.34	-3.93	9.9E-5	Diabetic kidney disease	
HNSC	cis	1	rs35058610	chr7:65390925	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.94	1.06E-6	Diabetic kidney disease	
HNSC	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.39	-7.03	6.8E-12	Forced vital capacity	
HNSC	cis	1	rs35106985	chr10:102307542	SEC31B	chr10:102246403-102289636:-	-0.19	-5.83	9.96E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs35124757	chr6:89918215	GABRR1	chr6:89887223-89927496:-	0.4	5.15	3.71E-7	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs35149210	chr7:65929925	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.88	3.77E-46	Aortic root size	
HNSC	cis	1	rs35149210	chr7:65929925	TYW1	chr7:66461817-66704496:+	0.2	3.66	0.000278	Aortic root size	
HNSC	cis	1	rs35163227	chr3:53127876	TMEM110	chr3:52867139-52931547:-	0.47	5.57	4.19E-8	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs35174175	chr3:53041509	TMEM110	chr3:52867139-52931547:-	0.49	5.56	4.54E-8	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs35184688	chr17:40272406	DHX58	chr17:40253422-40264751:-	-0.36	-7.25	1.66E-12	Fibrinogen levels	
HNSC	cis	1	rs35202312	chr6:56788937	BEND6	chr6:56819773-56892138:+	-0.39	-7.04	6.58E-12	Menarche (age at onset)	
HNSC	cis	1	rs35202312	chr6:56788937	RAB23	chr6:57053591-57087101:-	0.21	4.01	7.14E-5	Menarche (age at onset)	
HNSC	cis	1	rs35227660	chr20:43756697	SLPI	chr20:43880879-43883206:-	0.18	3.65	0.000288	Parental longevity (mother's age at death)	
HNSC	cis	1	rs35231079	chr11:515224	PHRF1	chr11:576483-612220:+	-0.26	-3.83	0.000143	Body mass index	
HNSC	cis	1	rs35258216	chr10:38018220	LOC399744	chr10:38717074-38741080:+	0.31	4.31	2.01E-5	Obesity (extreme)	
HNSC	cis	1	rs35272895	chr17:40580669	NAGLU	chr17:40687951-40696464:+	-0.19	-3.68	0.000263	Crohn's disease	
HNSC	cis	1	rs35273426	chr8:41524688	ZMAT4	chr8:40388116-40755343:-	-0.19	-3.75	0.000199	Type 2 diabetes	
HNSC	cis	1	rs35283677	chr7:65359233	CRCP	chr7:65579805-65619551:+	-0.33	-3.83	0.000145	Diabetic kidney disease	
HNSC	cis	1	rs35283677	chr7:65359233	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.37	1.49E-5	Diabetic kidney disease	
HNSC	cis	1	rs35297609	chr15:84772896	LOC388152	chr15:84867600-84898920:-	-0.28	-4.86	1.58E-6	Schizophrenia	
HNSC	cis	1	rs35300242	chr2:234168790	ATG16L1	chr2:234160217-234204319:+	0.25	4.43	1.16E-5	Crohn's disease	
HNSC	cis	1	rs35303215	chr22:24801535	POM121L9P	chr22:24647589-24661490:+	-0.31	-6.42	3.3E-10	Gut microbiome composition (summer)	
HNSC	cis	1	rs35309975	chr2:218314083	DIRC3	chr2:218148748-218621316:-	0.35	4.56	6.43E-6	Metabolite levels (MHPG)	
HNSC	cis	1	rs35332070	chr19:23034266	ZNF492	chr19:22817126-22850472:+	-0.33	-5.26	2.21E-7	Bronchopulmonary dysplasia	
HNSC	cis	1	rs353464	chr5:176403023	CDHR2	chr5:175976365-176022769:+	0.22	3.98	7.85E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
HNSC	cis	1	rs353467	chr5:176445698	CDHR2	chr5:175976365-176022769:+	0.22	4.05	5.94E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
HNSC	cis	1	rs353468	chr5:176445494	CDHR2	chr5:175976365-176022769:+	0.22	4.05	5.94E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
HNSC	cis	1	rs353478	chr5:176370988	CDHR2	chr5:175976365-176022769:+	0.2	3.68	0.000262	Menopause (age at onset);Menarche and menopause (age at onset)	
HNSC	cis	1	rs353490	chr5:176433063	CDHR2	chr5:175976365-176022769:+	0.22	3.91	0.000104	Menopause (age at onset);Menarche and menopause (age at onset)	
HNSC	cis	1	rs353493	chr5:176432585	CDHR2	chr5:175976365-176022769:+	0.22	3.97	8.25E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
HNSC	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.59	-13.43	2.92E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs35391607	chr7:65360829	CRCP	chr7:65579805-65619551:+	-0.34	-4.07	5.5E-5	Diabetic kidney disease	
HNSC	cis	1	rs35391607	chr7:65360829	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.76	2.59E-6	Diabetic kidney disease	
HNSC	cis	1	rs35396113	chr7:65495461	CRCP	chr7:65579805-65619551:+	-0.32	-3.73	0.000217	Diabetic kidney disease	
HNSC	cis	1	rs35396113	chr7:65495461	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.48	9.21E-6	Diabetic kidney disease	
HNSC	cis	1	rs35398388	chr19:37740358	ZNF793	chr19:37997841-38034237:+	0.28	4.54	6.99E-6	Coronary artery calcification	
HNSC	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.62	-13.65	3.18E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs35421653	chr7:65363429	CRCP	chr7:65579805-65619551:+	-0.33	-3.84	0.000141	Diabetic kidney disease	
HNSC	cis	1	rs35421653	chr7:65363429	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.38	1.43E-5	Diabetic kidney disease	
HNSC	cis	1	rs35432774	chr7:65393019	CRCP	chr7:65579805-65619551:+	-0.33	-3.97	8.29E-5	Diabetic kidney disease	
HNSC	cis	1	rs35432774	chr7:65393019	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.97	9.18E-7	Diabetic kidney disease	
HNSC	cis	1	rs35435780	chr17:79579602	RAC3	chr17:79989532-79992079:+	0.17	4.14	4.05E-5	Eye color traits	
HNSC	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.22	5.66	2.52E-8	Eye color traits	
HNSC	cis	1	rs35454259	chr6:27254475	BTN3A2	chr6:26365398-26378546:+	-0.33	-6.36	4.52E-10	Schizophrenia	
HNSC	cis	1	rs35454259	chr6:27254475	LOC100270746	chr6:26987146-26988085:-	0.22	3.98	7.91E-5	Schizophrenia	
HNSC	cis	1	rs35467789	chr2:218314047	DIRC3	chr2:218148748-218621316:-	0.35	4.56	6.43E-6	Metabolite levels (MHPG)	
HNSC	cis	1	rs35468353	chr16:31056433	HSD3B7	chr16:30996519-31000473:+	0.23	4.18	3.39E-5	Response to metformin (IC50)	
HNSC	cis	1	rs35468353	chr16:31056433	MYST1	chr16:31128985-31142713:+	0.24	5.83	1.02E-8	Response to metformin (IC50)	
HNSC	cis	1	rs35481514	chr7:97620097	MGC72080	chr7:97503667-97601638:-	0.48	5.4	1.03E-7	Sudden cardiac arrest	
HNSC	cis	1	rs35488434	chr20:23620401	CST1	chr20:23728191-23731574:-	0.34	5.27	2.06E-7	Chronic kidney disease	
HNSC	cis	1	rs35488434	chr20:23620401	CST4	chr20:23666277-23669662:-	0.26	4.26	2.48E-5	Chronic kidney disease	
HNSC	cis	1	rs35507120	chr3:53053924	TMEM110	chr3:52867139-52931547:-	0.52	5.72	1.87E-8	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs35522482	chr22:39063015	LOC646851	chr22:38974125-39052634:-	0.15	3.87	0.000123	Resting heart rate	
HNSC	cis	1	rs35527216	chr6:56791278	BEND6	chr6:56819773-56892138:+	-0.39	-6.86	2.04E-11	Menarche (age at onset)	
HNSC	cis	1	rs35527216	chr6:56791278	RAB23	chr6:57053591-57087101:-	0.21	3.94	9.3E-5	Menarche (age at onset)	
HNSC	cis	1	rs35542501	chr7:65431215	CRCP	chr7:65579805-65619551:+	-0.33	-3.92	0.000101	Diabetic kidney disease	
HNSC	cis	1	rs35542501	chr7:65431215	NCRNA00174	chr7:65841032-65865395:-	-0.45	-4.96	9.67E-7	Diabetic kidney disease	
HNSC	cis	1	rs35565791	chr22:39063011	LOC646851	chr22:38974125-39052634:-	0.15	3.87	0.000123	Resting heart rate	
HNSC	cis	1	rs35576914	chr3:53092270	TMEM110	chr3:52867139-52931547:-	0.5	5.76	1.49E-8	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs35577967	chr15:75354621	SCAMP5	chr15:75287901-75313836:+	0.43	8.69	5.3E-17	Blood trace element (Zn levels)	
HNSC	cis	1	rs35624992	chr11:47615798	C1QTNF4	chr11:47611216-47615961:-	-0.29	-6.1	2.09E-9	Subjective well-being	
HNSC	cis	1	rs35648189	chr15:84740748	LOC388152	chr15:84867600-84898920:-	-0.28	-4.86	1.55E-6	Schizophrenia	
HNSC	cis	1	rs35658069	chr15:84780146	LOC388152	chr15:84867600-84898920:-	-0.28	-4.95	1.03E-6	Schizophrenia	
HNSC	cis	1	rs35683065	chr12:123164062	GPR109B	chr12:123199304-123201439:-	0.33	5.38	1.13E-7	Adiponectin levels	
HNSC	cis	1	rs35696109	chr5:115527756	COMMD10	chr5:115420727-115628978:+	0.38	3.96	8.49E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs35703976	chr2:135486350	TMEM163	chr2:135213331-135525334:-	-0.3	-5.05	6.3E-7	Gut microbiome composition (winter)	
HNSC	cis	1	rs35712350	chr5:90679519	LOC100129716	chr5:90676164-90716531:+	0.3	4.27	2.38E-5	Smoking behavior	
HNSC	cis	1	rs35718987	chr3:134272783	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.47	2.57E-23	Height	
HNSC	cis	1	rs35718987	chr3:134272783	CEP63	chr3:134204575-134293852:+	-0.26	-5.65	2.65E-8	Height	
HNSC	cis	1	rs35720014	chr3:52982110	TMEM110	chr3:52867139-52931547:-	0.53	6.01	3.62E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs35735127	chr7:65300423	CRCP	chr7:65579805-65619551:+	-0.37	-4.31	1.99E-5	Diabetic kidney disease	
HNSC	cis	1	rs35735127	chr7:65300423	NCRNA00174	chr7:65841032-65865395:-	-0.45	-4.91	1.26E-6	Diabetic kidney disease	
HNSC	cis	1	rs35736167	chr15:75332002	SCAMP5	chr15:75287901-75313836:+	0.44	8.81	2.19E-17	Blood trace element (Zn levels)	
HNSC	cis	1	rs35737577	chr3:53002557	TMEM110	chr3:52867139-52931547:-	0.45	5.31	1.67E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.59	-13.27	1.45E-34	Response to antipsychotic treatment	
HNSC	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.65	-13.81	6.34E-37	Response to antipsychotic treatment	
HNSC	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.63	-13.97	1.37E-37	Response to antipsychotic treatment	
HNSC	cis	1	rs35820085	chr7:65442758	CRCP	chr7:65579805-65619551:+	-0.32	-3.72	0.000218	Diabetic kidney disease	
HNSC	cis	1	rs35820085	chr7:65442758	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.55	6.78E-6	Diabetic kidney disease	
HNSC	cis	1	rs35825738	chr7:65318027	CRCP	chr7:65579805-65619551:+	-0.37	-4.33	1.84E-5	Diabetic kidney disease	
HNSC	cis	1	rs35825738	chr7:65318027	NCRNA00174	chr7:65841032-65865395:-	-0.45	-4.89	1.36E-6	Diabetic kidney disease	
HNSC	cis	1	rs35835884	chr10:127708468	UROS	chr10:127477148-127511837:-	-0.2	-4.46	1.02E-5	Visceral fat	
HNSC	cis	1	rs35849389	chr3:53005235	TMEM110	chr3:52867139-52931547:-	0.45	5.32	1.61E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs35868174	chr5:156425303	TIMD4	chr5:156346293-156390266:-	-0.17	-3.92	9.92E-5	Hypertriglyceridemia	
HNSC	cis	1	rs35902101	chr11:47795169	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.55	4.76E-8	Subjective well-being	
HNSC	cis	1	rs35902101	chr11:47795169	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.95	8.85E-5	Subjective well-being	
HNSC	cis	1	rs359024	chr3:8446265	RAD18	chr3:8921561-9005146:-	-0.16	-3.76	0.000191	Low high density lipoprotein cholesterol levels	
HNSC	cis	1	rs359032	chr3:8457379	RAD18	chr3:8921561-9005146:-	0.17	4.32	1.9E-5	Low high density lipoprotein cholesterol levels	
HNSC	cis	1	rs359041	chr3:8438270	RAD18	chr3:8921561-9005146:-	-0.17	-3.92	0.000102	Low high density lipoprotein cholesterol levels	
HNSC	cis	1	rs359042	chr3:8438019	RAD18	chr3:8921561-9005146:-	-0.16	-3.65	0.000288	Low high density lipoprotein cholesterol levels	
HNSC	cis	1	rs35951606	chr10:38088347	LOC399744	chr10:38717074-38741080:+	0.28	3.77	0.00018	Obesity (extreme)	
HNSC	cis	1	rs35953049	chr6:89916692	GABRR1	chr6:89887223-89927496:-	0.36	5.2	2.99E-7	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs35969145	chr1:27259392	PDIK1L	chr1:26437656-26452024:+	-0.28	-3.65	0.000285	HDL cholesterol;Triglycerides;LDL cholesterol	
HNSC	cis	1	rs35977534	chr5:176335231	CDHR2	chr5:175976365-176022769:+	0.2	3.7	0.000239	Menopause (age at onset);Menarche and menopause (age at onset)	
HNSC	cis	1	rs35988617	chr3:121432902	IQCB1	chr3:121488610-121553926:-	0.24	6.07	2.53E-9	Cognitive performance	
HNSC	cis	1	rs36033484	chr7:65390558	CRCP	chr7:65579805-65619551:+	-0.32	-3.73	0.000212	Diabetic kidney disease	
HNSC	cis	1	rs36033484	chr7:65390558	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.6	5.27E-6	Diabetic kidney disease	
HNSC	cis	1	rs36035949	chr6:109736614	AKD1	chr6:109814059-110012415:-	-0.2	-4.14	4.17E-5	Height	
HNSC	cis	1	rs36035949	chr6:109736614	SMPD2	chr6:109761931-109765121:+	0.29	6.05	2.84E-9	Height	
HNSC	cis	1	rs36049182	chr15:89242735	ACAN	chr15:89346674-89418585:+	0.2	3.93	9.86E-5	Obesity-related traits	
HNSC	cis	1	rs36068983	chr7:65408991	CRCP	chr7:65579805-65619551:+	-0.33	-3.89	0.000114	Diabetic kidney disease	
HNSC	cis	1	rs36068983	chr7:65408991	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.91	1.21E-6	Diabetic kidney disease	
HNSC	cis	1	rs36090694	chr3:53010742	TMEM110	chr3:52867139-52931547:-	0.47	5.08	5.37E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.61	-13.62	4.53E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs36123022	chr3:12552980	TSEN2	chr3:12525931-12581122:+	0.31	4.05	6.07E-5	Prostate cancer (gene x gene interaction)	
HNSC	cis	1	rs36216559	chr2:262335	SH3YL1	chr2:218138-264810:-	-0.66	-12.91	4.66E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs364283	chr6:167383750	RNASET2	chr6:167343008-167412795:-	-0.22	-5.61	3.46E-8	Crohn's disease	
HNSC	cis	1	rs364451	chr6:167384756	RNASET2	chr6:167343008-167412795:-	-0.22	-5.53	5.32E-8	Crohn's disease	
HNSC	cis	1	rs365132	chr5:176378574	CDHR2	chr5:175976365-176022769:+	0.21	3.85	0.000134	Menopause (age at onset);Menarche and menopause (age at onset)	
HNSC	cis	1	rs365189	chr6:167384545	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.46E-8	Crohn's disease	
HNSC	cis	1	rs3730658	chr18:51794699	POLI	chr18:51795849-51824602:+	0.23	4.1	4.76E-5	Psoriasis	
HNSC	cis	1	rs3730682	chr18:51797332	POLI	chr18:51795849-51824602:+	0.22	4.08	5.31E-5	Psoriasis	
HNSC	cis	1	rs3730688	chr18:51797948	POLI	chr18:51795849-51824602:+	0.22	4.03	6.4E-5	Psoriasis	
HNSC	cis	1	rs3730721	chr18:51802928	POLI	chr18:51795849-51824602:+	0.21	3.84	0.000138	Psoriasis	
HNSC	cis	1	rs3730758	chr18:51812048	POLI	chr18:51795849-51824602:+	0.22	3.93	9.78E-5	Psoriasis	
HNSC	cis	1	rs3730764	chr18:51812814	POLI	chr18:51795849-51824602:+	0.21	3.9	0.000108	Psoriasis	
HNSC	cis	1	rs3730767	chr18:51813363	POLI	chr18:51795849-51824602:+	0.22	3.93	9.78E-5	Psoriasis	
HNSC	cis	1	rs3730787	chr18:51815443	POLI	chr18:51795849-51824602:+	0.21	3.9	0.000108	Psoriasis	
HNSC	cis	1	rs3730814	chr18:51818901	POLI	chr18:51795849-51824602:+	0.21	3.77	0.000185	Psoriasis	
HNSC	cis	1	rs3730818	chr18:51819101	POLI	chr18:51795849-51824602:+	0.22	3.93	9.78E-5	Psoriasis	
HNSC	cis	1	rs3731714	chr2:202060820	PPIL3	chr2:201735680-201753999:-	0.23	4.42	1.24E-5	Trans fatty acid levels	
HNSC	cis	1	rs3732408	chr3:121421179	IQCB1	chr3:121488610-121553926:-	0.24	6.07	2.53E-9	Cognitive performance	
HNSC	cis	1	rs3733484	chr4:142155518	ZNF330	chr4:142142049-142155848:+	-0.29	-4.54	7.07E-6	Conduct disorder	
HNSC	cis	1	rs3733579	chr4:17694943	LAP3	chr4:17578927-17609590:+	-0.14	-3.78	0.000177	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs3734530	chr6:26195408	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.57E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs3735148	chr7:65971009	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.84	5.47E-46	Aortic root size	
HNSC	cis	1	rs3735148	chr7:65971009	TYW1	chr7:66461817-66704496:+	0.2	3.69	0.000248	Aortic root size	
HNSC	cis	1	rs3736582	chr10:124742895	C10orf88	chr10:124690419-124713919:-	-0.22	-4.04	6.12E-5	Migraine without aura	
HNSC	cis	1	rs3736583	chr10:124742792	C10orf88	chr10:124690419-124713919:-	-0.22	-4.04	6.12E-5	Migraine without aura	
HNSC	cis	1	rs3736584	chr10:124742683	C10orf88	chr10:124690419-124713919:-	-0.22	-4.04	6.12E-5	Migraine without aura	
HNSC	cis	1	rs3736585	chr10:124742586	C10orf88	chr10:124690419-124713919:-	-0.22	-4.04	6.12E-5	Migraine without aura	
HNSC	cis	1	rs3736781	chr6:26505362	BTN3A2	chr6:26365398-26378546:+	0.19	4.41	1.27E-5	Educational attainment	
HNSC	cis	1	rs3736782	chr6:26505403	BTN3A2	chr6:26365398-26378546:+	0.19	4.41	1.27E-5	Educational attainment	
HNSC	cis	1	rs3738483	chr1:150801466	GOLPH3L	chr1:150618701-150669672:-	-0.34	-4.54	7.1E-6	Congenital left-sided heart lesions	
HNSC	cis	1	rs3738483	chr1:150801466	HORMAD1	chr1:150670542-150693352:-	0.4	4.88	1.41E-6	Congenital left-sided heart lesions	
HNSC	cis	1	rs3738848	chr2:73761881	ALMS1P	chr2:73872046-73912692:+	0.25	4.26	2.45E-5	Metabolite levels	
HNSC	cis	1	rs3739034	chr2:135483381	TMEM163	chr2:135213331-135525334:-	0.3	5.3	1.71E-7	Gut microbiome composition (winter)	
HNSC	cis	1	rs3739036	chr2:135483534	TMEM163	chr2:135213331-135525334:-	0.3	5.32	1.56E-7	Gut microbiome composition (winter)	
HNSC	cis	1	rs3740711	chr11:18379839	GTF2H1	chr11:18343816-18388590:+	0.3	5.16	3.58E-7	Pancreatic cancer	
HNSC	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.3	-6.51	1.84E-10	IgG glycosylation	
HNSC	cis	1	rs3742566	chr14:55595839	KIAA0831	chr14:55833110-55878576:-	-0.23	-4.24	2.62E-5	Protein biomarker	
HNSC	cis	1	rs3742704	chr14:88477882	GPR65	chr14:88471496-88478414:+	-0.13	-3.92	0.0001	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs3742773	chr14:75579643	MLH3	chr14:75480467-75518235:-	0.29	6	3.72E-9	Height	
HNSC	cis	1	rs3742778	chr14:75538217	MLH3	chr14:75480467-75518235:-	-0.3	-6.15	1.64E-9	Height	
HNSC	cis	1	rs3742780	chr14:75505008	MLH3	chr14:75480467-75518235:-	0.31	6.53	1.59E-10	Height	
HNSC	cis	1	rs3745859	chr19:39196745	LGALS7B	chr19:39279850-39282393:+	0.29	6.46	2.47E-10	Heart rate	
HNSC	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.6	12.74	2.34E-32	Schizophrenia	
HNSC	cis	1	rs3747113	chr22:24717518	POM121L9P	chr22:24647589-24661490:+	0.32	6.95	1.15E-11	Gut microbiome composition (summer)	
HNSC	cis	1	rs3747170	chr22:39067331	LOC646851	chr22:38974125-39052634:-	0.15	3.92	0.000101	Resting heart rate	
HNSC	cis	1	rs3747172	chr22:39067524	LOC646851	chr22:38974125-39052634:-	0.15	3.92	0.000101	Resting heart rate	
HNSC	cis	1	rs3747174	chr22:39069181	LOC646851	chr22:38974125-39052634:-	0.15	3.92	0.000101	Resting heart rate	
HNSC	cis	1	rs3748656	chr1:113236681	ST7L	chr1:113066142-113162405:-	0.39	5.81	1.11E-8	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs3750082	chr7:32919927	RP9	chr7:33134412-33149002:-	-0.18	-4.01	6.89E-5	Glomerular filtration rate (creatinine)	
HNSC	cis	1	rs3750626	chr10:102266316	SEC31B	chr10:102246403-102289636:-	-0.2	-6.14	1.67E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs3750627	chr10:102275642	SEC31B	chr10:102246403-102289636:-	-0.17	-5.23	2.55E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs3750629	chr10:102275727	SEC31B	chr10:102246403-102289636:-	-0.19	-5.9	6.9E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs3750630	chr10:102275780	SEC31B	chr10:102246403-102289636:-	-0.2	-6.34	5.27E-10	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs3750633	chr10:102308214	SEC31B	chr10:102246403-102289636:-	-0.17	-5.22	2.65E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs3750719	chr10:102248950	SEC31B	chr10:102246403-102289636:-	-0.17	-5.01	7.47E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs3750720	chr10:102248884	SEC31B	chr10:102246403-102289636:-	-0.16	-4.73	2.97E-6	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs3752749	chr4:1737262	FAM53A	chr4:1641609-1685854:-	-0.36	-6.22	1.04E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs3754210	chr1:150954261	HORMAD1	chr1:150670542-150693352:-	-0.42	-5.39	1.07E-7	Congenital left-sided heart lesions	
HNSC	cis	1	rs3754440	chr1:110613674	ALX3	chr1:110602998-110613322:-	-0.19	-3.69	0.000245	Blood metabolite levels	
HNSC	cis	1	rs3755346	chr2:71064695	VAX2	chr2:71127720-71160573:+	-0.27	-4.08	5.34E-5	IgG glycosylation	
HNSC	cis	1	rs3755348	chr2:71063725	VAX2	chr2:71127720-71160573:+	-0.27	-4	7.36E-5	IgG glycosylation	
HNSC	cis	1	rs3756106	chr4:142151262	ZNF330	chr4:142142049-142155848:+	-0.29	-4.52	7.64E-6	Conduct disorder	
HNSC	cis	1	rs3756416	chr5:43383502	C5orf34	chr5:43486810-43515187:-	-0.2	-5	7.95E-7	Metabolite levels  (X-11787)	
HNSC	cis	1	rs3757135	chr6:26200707	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.48	9.23E-6	Renal underexcretion gout;Gout	
HNSC	cis	1	rs3760891	chr19:33599708	GPATCH1	chr19:33571786-33621318:+	0.2	3.81	0.000159	Bone properties (heel)	
HNSC	cis	1	rs3760982	chr19:44286513	ZNF155	chr19:44488355-44502477:+	-0.2	-4.06	5.68E-5	Breast cancer	
HNSC	cis	1	rs3760983	chr19:44286660	ZNF155	chr19:44488355-44502477:+	0.2	4.07	5.55E-5	Breast cancer	
HNSC	cis	1	rs3761454	chr22:39066820	LOC646851	chr22:38974125-39052634:-	0.15	3.92	0.000101	Resting heart rate	
HNSC	cis	1	rs3761959	chr1:157669278	FCRL3	chr1:157646278-157670775:-	0.36	11.68	5.39E-28	Type 1 diabetes autoantibodies	
HNSC	cis	1	rs3763695	chr10:102269206	SEC31B	chr10:102246403-102289636:-	-0.19	-6.08	2.41E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs376551	chr6:167384923	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.46E-8	Crohn's disease	
HNSC	cis	1	rs376574	chr6:167389956	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.46E-8	Crohn's disease	
HNSC	cis	1	rs3769693	chr2:99259346	UNC50	chr2:99225042-99234975:+	-0.25	-4.42	1.19E-5	Bipolar disorder	
HNSC	cis	1	rs3769694	chr2:99259239	UNC50	chr2:99225042-99234975:+	-0.25	-4.34	1.71E-5	Bipolar disorder	
HNSC	cis	1	rs3769696	chr2:99258927	UNC50	chr2:99225042-99234975:+	-0.26	-4.6	5.48E-6	Bipolar disorder	
HNSC	cis	1	rs3769697	chr2:99242580	UNC50	chr2:99225042-99234975:+	-0.24	-4.06	5.68E-5	Bipolar disorder	
HNSC	cis	1	rs3769825	chr2:202111380	CASP10	chr2:202047621-202094110:+	-0.16	-3.8	0.000163	Chronic lymphocytic leukemia	
HNSC	cis	1	rs3770752	chr2:37576136	CEBPZ	chr2:37428778-37458740:-	0.21	4.33	1.82E-5	Schizophrenia	
HNSC	cis	1	rs3771531	chr2:70164034	GMCL1	chr2:70056818-70106727:+	0.13	4.03	6.58E-5	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs3772128	chr3:121345094	IQCB1	chr3:121488610-121553926:-	0.25	6.23	1.01E-9	Cognitive performance	
HNSC	cis	1	rs3772130	chr3:121344140	IQCB1	chr3:121488610-121553926:-	0.25	6.24	9.47E-10	Cognitive performance	
HNSC	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.71	10.84	1.05E-24	Diastolic blood pressure	
HNSC	cis	1	rs3774808	chr3:48481647	TREX1	chr3:48501186-48509043:+	-0.3	-7.45	4.26E-13	Longevity	
HNSC	cis	1	rs3775594	chr4:142143252	ZNF330	chr4:142142049-142155848:+	-0.29	-4.46	1.03E-5	Conduct disorder	
HNSC	cis	1	rs3778483	chr6:46627100	SLC25A27	chr6:46620679-46645925:+	-0.14	-3.89	0.000115	QRS complex (Sokolow-Lyon)	
HNSC	cis	1	rs3778909	chr7:66255646	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.81	1.32E-24	Aortic root size	
HNSC	cis	1	rs3781001	chr10:127706028	UROS	chr10:127477148-127511837:-	-0.2	-4.46	1.02E-5	Visceral fat	
HNSC	cis	1	rs3782130	chr12:58161898	FAM119B	chr12:58166383-58176323:+	0.53	10.39	5.29E-23	Multiple sclerosis	
HNSC	cis	1	rs3782130	chr12:58161898	TSFM	chr12:58176536-58191367:+	-0.38	-8.22	1.77E-15	Multiple sclerosis	
HNSC	cis	1	rs3782894	chr12:110026024	MMAB	chr12:109991523-110011358:-	-0.15	-3.78	0.000174	HDL cholesterol	
HNSC	cis	1	rs3786835	chr19:39155880	LGALS7B	chr19:39279850-39282393:+	0.27	6.07	2.51E-9	Heart rate	
HNSC	cis	1	rs3786837	chr19:39172042	LGALS7B	chr19:39279850-39282393:+	0.3	6.55	1.45E-10	Heart rate	
HNSC	cis	1	rs3786839	chr19:39182565	LGALS7B	chr19:39279850-39282393:+	0.29	6.29	7.13E-10	Heart rate	
HNSC	cis	1	rs3786845	chr19:39195083	LGALS7B	chr19:39279850-39282393:+	0.28	6.26	8.59E-10	Heart rate	
HNSC	cis	1	rs3786848	chr19:39207329	LGALS7B	chr19:39279850-39282393:+	0.29	6.49	2.08E-10	Heart rate	
HNSC	cis	1	rs3786851	chr19:39215333	LGALS7B	chr19:39279850-39282393:+	0.3	6.55	1.46E-10	Heart rate	
HNSC	cis	1	rs3786933	chr19:33602881	GPATCH1	chr19:33571786-33621318:+	0.2	3.81	0.000159	Bone properties (heel)	
HNSC	cis	1	rs3787395	chr20:55078573	C20orf43	chr20:55043647-55093942:+	-0.22	-4.53	7.31E-6	Refractive astigmatism	
HNSC	cis	1	rs3787498	chr20:23616781	CST1	chr20:23728191-23731574:-	0.34	5.23	2.57E-7	Chronic kidney disease	
HNSC	cis	1	rs3787498	chr20:23616781	CST4	chr20:23666277-23669662:-	0.27	4.36	1.58E-5	Chronic kidney disease	
HNSC	cis	1	rs3787499	chr20:23616807	CST1	chr20:23728191-23731574:-	0.33	5.1	4.88E-7	Chronic kidney disease	
HNSC	cis	1	rs3787499	chr20:23616807	CST4	chr20:23666277-23669662:-	0.27	4.24	2.68E-5	Chronic kidney disease	
HNSC	cis	1	rs3788545	chr22:39065172	LOC646851	chr22:38974125-39052634:-	0.15	3.87	0.000123	Resting heart rate	
HNSC	cis	1	rs3789967	chr12:124447339	DNAH10	chr12:124247042-124420265:+	0.3	5.45	7.82E-8	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs3791220	chr2:227066	SH3YL1	chr2:218138-264810:-	-0.67	-13.3	1.07E-34	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs3791221	chr2:226933	SH3YL1	chr2:218138-264810:-	-0.66	-13.25	1.63E-34	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs3791223	chr2:222336	SH3YL1	chr2:218138-264810:-	-0.66	-12.99	2.18E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs3791224	chr2:221981	SH3YL1	chr2:218138-264810:-	-0.65	-12.75	2.17E-32	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs3792112	chr2:234176609	ATG16L1	chr2:234160217-234204319:+	0.27	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs3792574	chr7:134254029	AKR1B15	chr7:134233849-134264300:+	0.23	4.97	9.28E-7	Longevity	
HNSC	cis	1	rs3793706	chr10:102269085	SEC31B	chr10:102246403-102289636:-	0.19	5.97	4.64E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs3793771	chr10:102222957	SEC31B	chr10:102246403-102289636:-	-0.18	-5.66	2.62E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs3793772	chr10:102222825	SEC31B	chr10:102246403-102289636:-	-0.17	-5.29	1.88E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs3795819	chr1:113234179	ST7L	chr1:113066142-113162405:-	-0.37	-5.63	3.05E-8	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs3796352	chr3:52913279	TMEM110	chr3:52867139-52931547:-	0.6	6.46	2.5E-10	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs3796689	chr4:185649866	MLF1IP	chr4:185615220-185655286:-	-0.47	-11.5	2.85E-27	Kawasaki disease	
HNSC	cis	1	rs3796991	chr4:108937461	HADH	chr4:108910940-108956330:+	-0.28	-4	7.44E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs3796992	chr4:108945631	HADH	chr4:108910940-108956330:+	-0.27	-3.76	0.000189	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs3798390	chr6:117726553	ROS1	chr6:117609530-117747018:-	-0.18	-4.04	6.24E-5	Lung cancer	
HNSC	cis	1	rs3798393	chr6:117731968	ROS1	chr6:117609530-117747018:-	-0.18	-4.01	7.05E-5	Lung cancer	
HNSC	cis	1	rs3798394	chr6:117732362	ROS1	chr6:117609530-117747018:-	-0.18	-4	7.28E-5	Lung cancer	
HNSC	cis	1	rs3800812	chr7:66223461	NCRNA00174	chr7:65841032-65865395:-	-0.56	-11.05	1.59E-25	Aortic root size	
HNSC	cis	1	rs3802315	chr8:41528178	ZMAT4	chr8:40388116-40755343:-	-0.19	-3.76	0.000193	Type 2 diabetes	
HNSC	cis	1	rs3802316	chr8:41528228	ZMAT4	chr8:40388116-40755343:-	-0.19	-3.67	0.000274	Type 2 diabetes	
HNSC	cis	1	rs3806407	chr1:156251742	BGLAP	chr1:156182784-156213112:+	0.19	3.68	0.000262	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs3806408	chr1:156252137	BGLAP	chr1:156182784-156213112:+	0.19	3.68	0.000262	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs3806409	chr1:156252291	BGLAP	chr1:156182784-156213112:+	0.19	3.68	0.000262	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs3806692	chr3:53080987	TMEM110	chr3:52867139-52931547:-	0.35	4.48	9.4E-6	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs3806988	chr6:49431569	CENPQ	chr6:49431096-49460820:+	-0.39	-9.28	5.33E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs3806988	chr6:49431569	MUT	chr6:49398994-49431031:-	0.44	9.57	4.98E-20	Folate pathway vitamin levels	
HNSC	cis	1	rs3809868	chr17:45750596	C17orf57	chr17:45401142-45518675:+	-0.2	-4.86	1.6E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs3809868	chr17:45750596	TBKBP1	chr17:45772630-45789427:+	0.2	3.98	8.04E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs3810429	chr19:18543270	SSBP4	chr19:18530221-18545371:+	-0.21	-4.84	1.7E-6	Breast cancer	
HNSC	cis	1	rs3811647	chr3:133484029	TF	chr3:133419211-133497635:+	-0.29	-5.36	1.25E-7	Iron status biomarkers	
HNSC	cis	1	rs3813227	chr2:73651967	ALMS1P	chr2:73872046-73912692:+	-0.25	-4.23	2.78E-5	Metabolite levels	
HNSC	cis	1	rs3813948	chr1:207269858	C4BPA	chr1:207277511-207318308:+	0.32	4.22	2.88E-5	C4b binding protein levels	
HNSC	cis	1	rs3815413	chr4:17654648	FAM184B	chr4:17633711-17783135:-	-0.17	-4.09	5.14E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs3815413	chr4:17654648	LAP3	chr4:17578927-17609590:+	-0.14	-3.82	0.000151	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs3816491	chr2:70048534	SNRNP27	chr2:70121090-70132348:+	-0.2	-3.66	0.00028	Colorectal or endometrial cancer	
HNSC	cis	1	rs3818233	chr6:101086372	ASCC3	chr6:100956609-101329224:-	-0.21	-5.6	3.57E-8	Menarche (age at onset)	
HNSC	cis	1	rs3823114	chr6:49431720	CENPQ	chr6:49431096-49460820:+	-0.4	-9.65	2.59E-20	Folate pathway vitamin levels	
HNSC	cis	1	rs3823114	chr6:49431720	MUT	chr6:49398994-49431031:-	0.42	9.03	3.77E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs3824584	chr10:38091309	LOC399744	chr10:38717074-38741080:+	0.28	3.82	0.000149	Obesity (extreme)	
HNSC	cis	1	rs3824754	chr10:104614350	SFXN2	chr10:104474298-104498946:+	-0.36	-4.42	1.24E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
HNSC	cis	1	rs3824755	chr10:104595849	SFXN2	chr10:104474298-104498946:+	-0.28	-3.74	0.000202	Hypertension;Systolic blood pressure;Diastolic blood pressure	
HNSC	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.54	10.17	3.61E-22	Multiple sclerosis	
HNSC	cis	1	rs3825079	chr12:58203354	TSFM	chr12:58176536-58191367:+	-0.37	-7.67	9.19E-14	Multiple sclerosis	
HNSC	cis	1	rs3825932	chr15:79235446	CTSH	chr15:79214092-79237420:-	0.26	5.84	9.65E-9	Type 1 diabetes	
HNSC	cis	1	rs3827066	chr20:44586023	WFDC3	chr20:44402847-44420547:-	-0.41	-5.96	4.87E-9	Abdominal aortic aneurysm	
HNSC	cis	1	rs3827107	chr20:55070539	C20orf43	chr20:55043647-55093942:+	0.21	4.27	2.33E-5	Refractive astigmatism	
HNSC	cis	1	rs3827142	chr20:23617007	CST1	chr20:23728191-23731574:-	0.33	5.1	4.88E-7	Chronic kidney disease	
HNSC	cis	1	rs3827142	chr20:23617007	CST4	chr20:23666277-23669662:-	0.27	4.24	2.68E-5	Chronic kidney disease	
HNSC	cis	1	rs3827143	chr20:23619617	CST1	chr20:23728191-23731574:-	0.34	5.36	1.28E-7	Chronic kidney disease	
HNSC	cis	1	rs3827143	chr20:23619617	CST4	chr20:23666277-23669662:-	0.27	4.33	1.78E-5	Chronic kidney disease	
HNSC	cis	1	rs3827357	chr22:39079413	LOC646851	chr22:38974125-39052634:-	0.15	3.89	0.000113	Resting heart rate	
HNSC	cis	1	rs3828165	chr2:220889	SH3YL1	chr2:218138-264810:-	-0.67	-12.87	6.72E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs3828309	chr2:234180410	ATG16L1	chr2:234160217-234204319:+	-0.28	-4.97	9.29E-7	Crohn's disease	
HNSC	cis	1	rs3829218	chr11:58331309	ZFP91-CNTF	chr11:58346587-58393203:+	0.3	4.25	2.59E-5	Lymphoma	
HNSC	cis	1	rs383402	chr7:65586653	CRCP	chr7:65579805-65619551:+	0.33	3.97	8.27E-5	Diabetic kidney disease	
HNSC	cis	1	rs383402	chr7:65586653	NCRNA00174	chr7:65841032-65865395:-	0.44	4.84	1.7E-6	Diabetic kidney disease	
HNSC	cis	1	rs3845800	chr2:203734365	ICA1L	chr2:203637873-203736371:-	-0.22	-3.83	0.000146	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
HNSC	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.5	10.69	3.98E-24	Height	
HNSC	cis	1	rs3846055	chr3:134203973	CEP63	chr3:134204575-134293852:+	0.28	5.95	5.0E-9	Height	
HNSC	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.49	10.42	4.27E-23	Height	
HNSC	cis	1	rs3846056	chr3:134227292	CEP63	chr3:134204575-134293852:+	0.28	6.1	2.1E-9	Height	
HNSC	cis	1	rs3846357	chr4:17635887	FAM184B	chr4:17633711-17783135:-	-0.16	-3.94	9.38E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs3846721	chr5:112754567	YTHDC2	chr5:112849410-112930979:+	-0.2	-3.85	0.000134	Cerebral amyloid angiopathy	
HNSC	cis	1	rs3847669	chr12:75949158	GLIPR1L2	chr12:75784889-75825591:+	-0.28	-4.67	3.81E-6	Polycystic ovary syndrome	
HNSC	cis	1	rs3850838	chr1:150065378	HORMAD1	chr1:150670542-150693352:-	0.25	3.74	0.000205	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
HNSC	cis	1	rs385113	chr6:167403971	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs3857422	chr5:150268609	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs3857688	chr7:66127806	NCRNA00174	chr7:65841032-65865395:-	0.55	10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs3858534	chr12:75947084	GLIPR1L2	chr12:75784889-75825591:+	-0.27	-4.63	4.79E-6	Polycystic ovary syndrome	
HNSC	cis	1	rs385863	chr6:167386615	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.46E-8	Crohn's disease	
HNSC	cis	1	rs386548	chr6:167385533	RNASET2	chr6:167343008-167412795:-	0.23	5.93	5.83E-9	Crohn's disease	
HNSC	cis	1	rs3870339	chr3:49536863	AMT	chr3:49454212-49460012:-	0.17	3.83	0.000145	Menarche (age at onset)	
HNSC	cis	1	rs3870366	chr6:153439767	RGS17	chr6:153332041-153452389:-	-0.21	-3.94	9.47E-5	Prostate cancer	
HNSC	cis	1	rs387676	chr7:65598220	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs3885839	chr7:65290403	CRCP	chr7:65579805-65619551:+	-0.36	-4.1	4.8E-5	Diabetic kidney disease	
HNSC	cis	1	rs3885839	chr7:65290403	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.52	7.72E-6	Diabetic kidney disease	
HNSC	cis	1	rs3890752	chr15:89240265	ACAN	chr15:89346674-89418585:+	0.2	4.11	4.72E-5	Obesity-related traits	
HNSC	cis	1	rs3892761	chr12:54070445	ATP5G2	chr12:54058945-54070512:-	0.22	5.95	5.1E-9	Height	
HNSC	cis	1	rs389946	chr6:167407268	RNASET2	chr6:167343008-167412795:-	-0.22	-5.36	1.28E-7	Crohn's disease	
HNSC	cis	1	rs389956	chr6:167407254	RNASET2	chr6:167343008-167412795:-	-0.22	-5.36	1.28E-7	Crohn's disease	
HNSC	cis	1	rs3900064	chr5:150264414	LOC134466	chr5:150310000-150326146:-	-0.39	-5.26	2.13E-7	Crohn's disease	
HNSC	cis	1	rs3906527	chr5:150266392	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs3906528	chr5:150266718	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs391396	chr4:130037653	C4orf33	chr4:130014829-130033842:+	-0.49	-9.96	2.09E-21	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs3931020	chr1:75235317	CRYZ	chr1:75171175-75199092:-	-0.63	-12.14	7.4E-30	Resistin levels	
HNSC	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.48	10.27	1.45E-22	Height	
HNSC	cis	1	rs3932818	chr3:134206069	CEP63	chr3:134204575-134293852:+	0.28	5.96	4.94E-9	Height	
HNSC	cis	1	rs3933453	chr4:17636319	FAM184B	chr4:17633711-17783135:-	-0.16	-3.92	0.0001	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs3933453	chr4:17636319	LAP3	chr4:17578927-17609590:+	-0.14	-3.69	0.000245	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-0.77	-13.55	8.66E-36	Diastolic blood pressure	
HNSC	cis	1	rs3935543	chr17:79579874	RAC3	chr17:79989532-79992079:+	0.17	4.14	4.05E-5	Eye color traits	
HNSC	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.22	5.66	2.52E-8	Eye color traits	
HNSC	cis	1	rs393558	chr6:167397750	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs393727	chr6:167398632	RNASET2	chr6:167343008-167412795:-	-0.22	-5.59	3.71E-8	Crohn's disease	
HNSC	cis	1	rs394522	chr6:167398071	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.67	-11.8	1.74E-28	Type 2 diabetes	
HNSC	cis	1	rs396007	chr5:176518426	FGFR4	chr5:176513921-176525124:+	-0.33	-5.53	5.25E-8	Height	
HNSC	cis	1	rs3963902	chr4:109431942	RPL34	chr4:109541722-109551637:+	0.15	3.74	0.000207	Height	
HNSC	cis	1	rs396508	chr16:20682354	ACSM1	chr16:20634559-20709066:-	-0.24	-4.35	1.64E-5	Schizophrenia	
HNSC	cis	1	rs3976455	chr16:29861447	LOC440356	chr16:29875004-29879374:+	-0.23	-3.74	0.000202	Multiple sclerosis	
HNSC	cis	1	rs397713	chr6:167386714	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.46E-8	Crohn's disease	
HNSC	cis	1	rs3981131	chr7:65951677	NCRNA00174	chr7:65841032-65865395:-	-0.72	-15.36	8.76E-44	Aortic root size	
HNSC	cis	1	rs3981131	chr7:65951677	TYW1	chr7:66461817-66704496:+	0.2	3.84	0.000138	Aortic root size	
HNSC	cis	1	rs3981351	chr10:115515120	CASP7	chr10:115438935-115490662:+	0.21	4.16	3.69E-5	Obesity-related traits	
HNSC	cis	1	rs398278	chr6:167388169	RNASET2	chr6:167343008-167412795:-	-0.22	-5.48	6.9E-8	Crohn's disease	
HNSC	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.3	-7.17	2.75E-12	Inflammatory skin disease	
HNSC	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.5	9.31	4.22E-19	Inflammatory skin disease	
HNSC	cis	1	rs400063	chr6:167386592	RNASET2	chr6:167343008-167412795:-	-0.23	-5.73	1.7E-8	Crohn's disease	
HNSC	cis	1	rs400176	chr6:167406238	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs4006360	chr17:39250639	KRT37	chr17:39576809-39580822:-	-0.16	-3.75	0.000199	Bipolar disorder and schizophrenia	
HNSC	cis	1	rs400837	chr6:167411008	RNASET2	chr6:167343008-167412795:-	-0.21	-5.15	3.84E-7	Crohn's disease	
HNSC	cis	1	rs402418	chr7:65509469	CRCP	chr7:65579805-65619551:+	-0.33	-3.72	0.000224	Diabetic kidney disease	
HNSC	cis	1	rs402418	chr7:65509469	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.43	1.17E-5	Diabetic kidney disease	
HNSC	cis	1	rs402511	chr5:176434440	CDHR2	chr5:175976365-176022769:+	0.22	3.97	8.25E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
HNSC	cis	1	rs402749	chr6:167386104	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.46E-8	Crohn's disease	
HNSC	cis	1	rs4037	chr10:97365820	ENTPD1	chr10:97471536-97637022:+	0.25	7.64	1.13E-13	Blood metabolite levels	
HNSC	cis	1	rs404222	chr6:167402150	RNASET2	chr6:167343008-167412795:-	-0.22	-5.54	4.81E-8	Crohn's disease	
HNSC	cis	1	rs4045344	chr5:595870	SLC9A3	chr5:473334-524549:-	-0.22	-4.18	3.44E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs405553	chr6:167395058	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.46E-8	Crohn's disease	
HNSC	cis	1	rs4058847	chr1:150058727	HORMAD1	chr1:150670542-150693352:-	0.25	3.73	0.000211	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
HNSC	cis	1	rs406095	chr6:167409087	RNASET2	chr6:167343008-167412795:-	-0.21	-5.15	3.84E-7	Crohn's disease	
HNSC	cis	1	rs406900	chr6:88085447	C6orf162	chr6:88032306-88052043:+	-0.18	-3.81	0.000155	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs406900	chr6:88085447	C6orf164	chr6:88032306-88109459:+	-0.24	-4.44	1.12E-5	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs4073846	chr1:46462881	CCDC163P	chr1:45960581-45965646:-	0.35	7.66	9.72E-14	Body mass index	
HNSC	cis	1	rs4074170	chr17:28381141	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.26	2.41E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs4074915	chr17:79579230	RAC3	chr17:79989532-79992079:+	-0.17	-4.12	4.48E-5	Eye color traits	
HNSC	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.22	-5.66	2.52E-8	Eye color traits	
HNSC	cis	1	rs4074916	chr17:79579248	RAC3	chr17:79989532-79992079:+	-0.17	-4.13	4.28E-5	Eye color traits	
HNSC	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.22	-5.64	2.95E-8	Eye color traits	
HNSC	cis	1	rs407515	chr6:167407544	RNASET2	chr6:167343008-167412795:-	-0.21	-5.15	3.84E-7	Crohn's disease	
HNSC	cis	1	rs4075623	chr17:28386526	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.26	2.41E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs4076006	chr1:46438076	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.68	8.43E-14	Body mass index	
HNSC	cis	1	rs4077341	chr8:22962348	C8orf58	chr8:22457122-22461660:+	0.21	4.06	5.81E-5	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
HNSC	cis	1	rs4077468	chr1:205914757	PM20D1	chr1:205797154-205819245:-	0.25	4.95	1.04E-6	Cystic fibrosis-related diabetes	
HNSC	cis	1	rs4077469	chr1:205914885	PM20D1	chr1:205797154-205819245:-	0.25	4.83	1.82E-6	Cystic fibrosis-related diabetes	
HNSC	cis	1	rs4078160	chr10:52565940	ASAH2B	chr10:52499696-52514567:+	-0.47	-7.49	3.26E-13	Urate levels in lean individuals	
HNSC	cis	1	rs408040	chr6:167398903	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs408080	chr6:167392522	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.51E-8	Crohn's disease	
HNSC	cis	1	rs408087	chr6:167398952	RNASET2	chr6:167343008-167412795:-	-0.23	-5.71	1.99E-8	Crohn's disease	
HNSC	cis	1	rs4083914	chr6:153427706	RGS17	chr6:153332041-153452389:-	0.21	3.86	0.000129	Prostate cancer	
HNSC	cis	1	rs408918	chr6:167399282	RNASET2	chr6:167343008-167412795:-	-0.23	-5.73	1.76E-8	Crohn's disease	
HNSC	cis	1	rs409356	chr6:167405226	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs410128	chr7:65603173	NCRNA00174	chr7:65841032-65865395:-	-0.41	-4.13	4.21E-5	Diabetic kidney disease	
HNSC	cis	1	rs41266807	chr6:26199822	HIST1H2AE	chr6:26217148-26217711:+	-0.3	-4.37	1.52E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs41266839	chr6:26409890	BTN3A2	chr6:26365398-26378546:+	-0.88	-11.73	3.36E-28	Schizophrenia	
HNSC	cis	1	rs41275472	chr1:11876300	CLCN6	chr1:11866207-11907674:+	0.22	3.69	0.000247	QRS complex (12-leadsum)	
HNSC	cis	1	rs41276626	chr1:120262112	ZNF697	chr1:120162000-120190390:-	-0.37	-5.66	2.57E-8	Height	
HNSC	cis	1	rs41277668	chr13:96295824	DZIP1	chr13:96229329-96296957:-	0.27	3.89	0.000113	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
HNSC	cis	1	rs41277668	chr13:96295824	UGGT2	chr13:96453838-96705736:-	-0.23	-3.77	0.000182	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
HNSC	cis	1	rs41294396	chr11:64078581	C11orf20	chr11:64067863-64072238:+	-0.26	-3.73	0.000215	Mean platelet volume	
HNSC	cis	1	rs4130590	chr9:130107964	RPL12	chr9:130209955-130213684:-	-0.15	-3.82	0.000148	Bipolar disorder	
HNSC	cis	1	rs4130590	chr9:130107964	SLC2A8	chr9:130159465-130170161:+	0.23	5.2	2.92E-7	Bipolar disorder	
HNSC	cis	1	rs4130590	chr9:130107964	ZNF79	chr9:130186653-130207650:+	0.24	5.03	7.03E-7	Bipolar disorder	
HNSC	cis	1	rs413232	chr6:167400972	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs4134386	chr1:46395089	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.74	5.76E-14	Body mass index	
HNSC	cis	1	rs414013	chr6:88085866	C6orf162	chr6:88032306-88052043:+	-0.19	-3.85	0.000132	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs414013	chr6:88085866	C6orf164	chr6:88032306-88109459:+	-0.24	-4.45	1.06E-5	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs4144081	chr2:70155482	GMCL1	chr2:70056818-70106727:+	0.12	3.71	0.000234	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs4144937	chr6:46628516	SLC25A27	chr6:46620679-46645925:+	-0.14	-3.88	0.000119	QRS complex (Sokolow-Lyon)	
HNSC	cis	1	rs4145008	chr7:65647511	NCRNA00174	chr7:65841032-65865395:-	0.44	4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs4149420	chr2:108913090	SULT1C2	chr2:108905095-108926370:+	0.48	7.81	3.4E-14	Lobe size	
HNSC	cis	1	rs4149423	chr2:108916044	SULT1C2	chr2:108905095-108926370:+	0.45	7.12	3.74E-12	Lobe size	
HNSC	cis	1	rs4149468	chr7:65825690	NCRNA00174	chr7:65841032-65865395:-	-0.49	-5.4	1.03E-7	Diabetic kidney disease	
HNSC	cis	1	rs4149468	chr7:65825690	STAG3L4	chr7:66767616-66786512:+	-0.35	-3.92	9.95E-5	Diabetic kidney disease	
HNSC	cis	1	rs4149547	chr2:240933308	NDUFA10	chr2:240900158-240964798:-	0.2	3.72	0.000223	Odorant perception (isobutyraldehyde)	
HNSC	cis	1	rs4149556	chr2:240915307	NDUFA10	chr2:240900158-240964798:-	0.21	3.88	0.000117	Odorant perception (isobutyraldehyde)	
HNSC	cis	1	rs4150550	chr11:18350898	GTF2H1	chr11:18343816-18388590:+	0.32	5.54	5.05E-8	Pancreatic cancer	
HNSC	cis	1	rs4150562	chr11:18354995	GTF2H1	chr11:18343816-18388590:+	0.3	5.16	3.61E-7	Pancreatic cancer	
HNSC	cis	1	rs4150564	chr11:18355308	GTF2H1	chr11:18343816-18388590:+	0.33	5.66	2.63E-8	Pancreatic cancer	
HNSC	cis	1	rs4150566	chr11:18355599	GTF2H1	chr11:18343816-18388590:+	0.33	5.72	1.88E-8	Pancreatic cancer	
HNSC	cis	1	rs4150575	chr11:18356466	GTF2H1	chr11:18343816-18388590:+	0.32	5.52	5.4E-8	Pancreatic cancer	
HNSC	cis	1	rs4150579	chr11:18357180	GTF2H1	chr11:18343816-18388590:+	-0.29	-5.01	7.78E-7	Pancreatic cancer	
HNSC	cis	1	rs4150610	chr11:18364140	GTF2H1	chr11:18343816-18388590:+	0.32	5.58	4.07E-8	Pancreatic cancer	
HNSC	cis	1	rs4150612	chr11:18364358	GTF2H1	chr11:18343816-18388590:+	0.32	5.59	3.83E-8	Pancreatic cancer	
HNSC	cis	1	rs4150615	chr11:18365028	GTF2H1	chr11:18343816-18388590:+	-0.31	-5.42	9.58E-8	Pancreatic cancer	
HNSC	cis	1	rs4150622	chr11:18365710	GTF2H1	chr11:18343816-18388590:+	0.34	5.89	7.16E-9	Pancreatic cancer	
HNSC	cis	1	rs4150641	chr11:18370739	GTF2H1	chr11:18343816-18388590:+	0.33	5.82	1.07E-8	Pancreatic cancer	
HNSC	cis	1	rs4150650	chr11:18374279	GTF2H1	chr11:18343816-18388590:+	0.3	5.31	1.64E-7	Pancreatic cancer	
HNSC	cis	1	rs4150651	chr11:18374425	GTF2H1	chr11:18343816-18388590:+	0.3	5.31	1.64E-7	Pancreatic cancer	
HNSC	cis	1	rs4150655	chr11:18375164	GTF2H1	chr11:18343816-18388590:+	-0.32	-5.62	3.24E-8	Pancreatic cancer	
HNSC	cis	1	rs4150661	chr11:18379629	GTF2H1	chr11:18343816-18388590:+	0.31	5.47	7.13E-8	Pancreatic cancer	
HNSC	cis	1	rs4150673	chr11:18383449	GTF2H1	chr11:18343816-18388590:+	0.28	4.87	1.51E-6	Pancreatic cancer	
HNSC	cis	1	rs415842	chr6:167406681	RNASET2	chr6:167343008-167412795:-	-0.22	-5.36	1.28E-7	Crohn's disease	
HNSC	cis	1	rs415890	chr6:167406633	RNASET2	chr6:167343008-167412795:-	0.21	5.3	1.71E-7	Crohn's disease	
HNSC	cis	1	rs416131	chr6:167406544	RNASET2	chr6:167343008-167412795:-	0.19	4.8	2.1E-6	Crohn's disease	
HNSC	cis	1	rs419603	chr7:65597341	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs420259	chr16:23634026	DCTN5	chr16:23652807-23681182:+	-0.29	-5.09	5.0E-7	Bipolar disorder	
HNSC	cis	1	rs421214	chr6:167396629	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.61E-8	Crohn's disease	
HNSC	cis	1	rs422094	chr6:167397033	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.61E-8	Crohn's disease	
HNSC	cis	1	rs422164	chr7:65586605	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs422421	chr5:176517326	FAM153A	chr5:177138237-177210399:-	-0.22	-3.69	0.000249	Height	
HNSC	cis	1	rs422421	chr5:176517326	FGFR4	chr5:176513921-176525124:+	-0.3	-4.78	2.34E-6	Height	
HNSC	cis	1	rs422562	chr6:167406318	RNASET2	chr6:167343008-167412795:-	-0.22	-5.37	1.22E-7	Crohn's disease	
HNSC	cis	1	rs422694	chr6:167406074	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs422780	chr6:167406209	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs4234393	chr3:56684520	CCDC66	chr3:56591184-56655846:+	0.18	4.94	1.09E-6	Height	
HNSC	cis	1	rs4235388	chr4:17682030	FAM184B	chr4:17633711-17783135:-	-0.16	-3.96	8.69E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs4235388	chr4:17682030	LAP3	chr4:17578927-17609590:+	-0.17	-4.47	9.53E-6	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.39	6.97	1.03E-11	Forced vital capacity	
HNSC	cis	1	rs4239227	chr17:28389103	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.26	2.41E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs4240522	chr10:135355557	CYP2E1	chr10:135340867-135374724:+	0.25	4.4	1.34E-5	Obesity-related traits	
HNSC	cis	1	rs4241407	chr3:49600319	AMT	chr3:49454212-49460012:-	0.17	3.77	0.000183	Menarche (age at onset)	
HNSC	cis	1	rs4242434	chr8:22501830	C8orf58	chr8:22457122-22461660:+	0.23	3.99	7.76E-5	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	
HNSC	cis	1	rs4244338	chr10:102272802	SEC31B	chr10:102246403-102289636:-	-0.19	-5.87	8.23E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs4245923	chr4:108939337	HADH	chr4:108910940-108956330:+	-0.28	-4	7.44E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs4245924	chr4:108946378	HADH	chr4:108910940-108956330:+	-0.27	-3.74	0.000202	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs4246215	chr11:61564299	FADS2	chr11:61583728-61634825:+	0.18	4.02	6.6E-5	Phospholipid levels (plasma);Platelet count;Red blood cell fatty acid levels;Trans fatty acid levels;Inflammatory bowel disease	
HNSC	cis	1	rs4253766	chr22:46623905	PKDREJ	chr22:46651561-46659219:-	-0.33	-4.01	6.99E-5	Cholesterol, total;LDL cholesterol	
HNSC	cis	1	rs4253772	chr22:46627603	PKDREJ	chr22:46651561-46659219:-	-0.41	-4.76	2.51E-6	Cholesterol, total;LDL cholesterol	
HNSC	cis	1	rs4253772	chr22:46627603	TTC38	chr22:46663861-46689903:+	-0.36	-3.8	0.00016	Cholesterol, total;LDL cholesterol	
HNSC	cis	1	rs4256922	chr10:52568616	ASAH2B	chr10:52499696-52514567:+	-0.47	-7.49	3.29E-13	Urate levels in lean individuals	
HNSC	cis	1	rs4263408	chr4:39785276	RPL9	chr4:39455747-39460568:-	-0.32	-6.19	1.23E-9	Plasma amyloid beta peptide concentrations (ABx-40)	
HNSC	cis	1	rs4267943	chr6:49439805	CENPQ	chr6:49431096-49460820:+	0.41	9.86	4.65E-21	Folate pathway vitamin levels	
HNSC	cis	1	rs4267943	chr6:49439805	MUT	chr6:49398994-49431031:-	-0.38	-8.13	3.59E-15	Folate pathway vitamin levels	
HNSC	cis	1	rs427044	chr7:65508545	CRCP	chr7:65579805-65619551:+	-0.33	-3.81	0.000159	Diabetic kidney disease	
HNSC	cis	1	rs427044	chr7:65508545	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.51	7.94E-6	Diabetic kidney disease	
HNSC	cis	1	rs4279493	chr7:66226620	NCRNA00174	chr7:65841032-65865395:-	-0.56	-11.05	1.59E-25	Aortic root size	
HNSC	cis	1	rs4280164	chr14:24771285	DHRS1	chr14:24759806-24769039:-	-0.23	-5.01	7.48E-7	Parent of origin effect on language impairment (paternal)	
HNSC	cis	1	rs4282209	chr4:76919536	NAAA	chr4:76831809-76862166:-	-0.49	-11.27	2.24E-26	Longevity	
HNSC	cis	1	rs428445	chr20:55036547	C20orf43	chr20:55043647-55093942:+	-0.18	-3.66	0.000276	Refractive astigmatism	
HNSC	cis	1	rs429083	chr6:167383972	RNASET2	chr6:167343008-167412795:-	-0.22	-5.61	3.46E-8	Crohn's disease	
HNSC	cis	1	rs4294134	chr7:135293128	PL-5283	chr7:135347221-135378160:+	0.44	6.61	1.02E-10	Paget's disease	
HNSC	cis	1	rs4298408	chr7:3358731	C7orf27	chr7:2577511-2595146:-	-0.17	-3.83	0.000145	Motion sickness	
HNSC	cis	1	rs430097	chr6:167405073	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs430293	chr6:167404958	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs430477	chr6:167389851	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.46E-8	Crohn's disease	
HNSC	cis	1	rs4309773	chr3:134277301	ANAPC13	chr3:134196547-134204865:-	0.48	10.35	7.37E-23	Height	
HNSC	cis	1	rs4309773	chr3:134277301	CEP63	chr3:134204575-134293852:+	0.27	5.9	6.77E-9	Height	
HNSC	cis	1	rs431076	chr7:65600320	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs431318	chr7:65511597	CRCP	chr7:65579805-65619551:+	-0.33	-3.72	0.000224	Diabetic kidney disease	
HNSC	cis	1	rs431318	chr7:65511597	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.43	1.17E-5	Diabetic kidney disease	
HNSC	cis	1	rs431328	chr19:22222236	ZNF257	chr19:22235266-22273901:+	0.27	5.2	2.91E-7	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	0.82	14.19	1.49E-38	Type 2 diabetes	
HNSC	cis	1	rs4322591	chr14:75600697	MLH3	chr14:75480467-75518235:-	0.31	6.36	4.58E-10	Height	
HNSC	cis	1	rs4323442	chr8:96022986	C8orf38	chr8:95908040-96088396:+	-0.28	-4.42	1.19E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.23	-4.75	2.73E-6	Rheumatoid arthritis	
HNSC	cis	1	rs4325265	chr10:81733655	LOC650623	chr10:81442731-81448648:+	-0.35	-3.68	0.000259	Rheumatoid arthritis	
HNSC	cis	1	rs4328498	chr17:28344276	EFCAB5	chr17:28256874-28435469:+	-0.26	-4.75	2.71E-6	Coffee consumption (cups per day)	
HNSC	cis	1	rs4334685	chr3:134304335	ANAPC13	chr3:134196547-134204865:-	0.49	10.56	1.22E-23	Height	
HNSC	cis	1	rs4334685	chr3:134304335	CEP63	chr3:134204575-134293852:+	0.27	5.76	1.51E-8	Height	
HNSC	cis	1	rs4335481	chr10:81733840	LOC650623	chr10:81442731-81448648:+	-0.35	-3.68	0.000259	Rheumatoid arthritis	
HNSC	cis	1	rs433598	chr16:20680206	ACSM1	chr16:20634559-20709066:-	0.26	4.74	2.81E-6	Schizophrenia	
HNSC	cis	1	rs434434	chr5:176516953	FGFR4	chr5:176513921-176525124:+	-0.32	-5.54	5.02E-8	Height	
HNSC	cis	1	rs4350617	chr17:28423088	EFCAB5	chr17:28256874-28435469:+	0.22	4.02	6.87E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs4353250	chr11:18323517	GTF2H1	chr11:18343816-18388590:+	0.32	5.4	1.01E-7	Pancreatic cancer	
HNSC	cis	1	rs436039	chr19:22214873	ZNF257	chr19:22235266-22273901:+	0.26	4.83	1.82E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs4363385	chr1:152989321	LCE3C	chr1:152573138-152573562:+	-0.21	-4.85	1.66E-6	Inflammatory skin disease	
HNSC	cis	1	rs4363513	chr10:135355534	CYP2E1	chr10:135340867-135374724:+	0.25	4.4	1.34E-5	Obesity-related traits	
HNSC	cis	1	rs436707	chr6:167388843	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.46E-8	Crohn's disease	
HNSC	cis	1	rs4367113	chr3:134287975	ANAPC13	chr3:134196547-134204865:-	0.48	10.48	2.4E-23	Height	
HNSC	cis	1	rs4367113	chr3:134287975	CEP63	chr3:134204575-134293852:+	0.27	5.97	4.41E-9	Height	
HNSC	cis	1	rs4368544	chr3:134300014	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.63	6.45E-24	Height	
HNSC	cis	1	rs4368544	chr3:134300014	CEP63	chr3:134204575-134293852:+	-0.27	-5.81	1.14E-8	Height	
HNSC	cis	1	rs4369337	chr10:81733742	LOC650623	chr10:81442731-81448648:+	-0.35	-3.68	0.000259	Rheumatoid arthritis	
HNSC	cis	1	rs4372836	chr2:28973883	TRMT61B	chr2:29072690-29093175:-	-0.37	-7.87	2.23E-14	Body mass index	
HNSC	cis	1	rs4373225	chr4:108890123	HADH	chr4:108910940-108956330:+	-0.28	-3.93	9.81E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs4375281	chr1:92987575	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs4375701	chr17:45712218	C17orf57	chr17:45401142-45518675:+	0.19	4.51	8.04E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs4375701	chr17:45712218	TBKBP1	chr17:45772630-45789427:+	-0.24	-4.84	1.76E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs4376778	chr1:46288846	CCDC163P	chr1:45960581-45965646:-	-0.36	-7.76	5.05E-14	Body mass index	
HNSC	cis	1	rs437889	chr7:65509234	CRCP	chr7:65579805-65619551:+	-0.33	-3.72	0.000224	Diabetic kidney disease	
HNSC	cis	1	rs437889	chr7:65509234	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.43	1.17E-5	Diabetic kidney disease	
HNSC	cis	1	rs4382199	chr5:90744228	LOC100129716	chr5:90676164-90716531:+	0.31	4.42	1.23E-5	Smoking behavior	
HNSC	cis	1	rs439237	chr6:167391392	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.46E-8	Crohn's disease	
HNSC	cis	1	rs439295	chr3:156572455	LEKR1	chr3:156544076-156763918:+	-0.48	-7.97	1.11E-14	Bone mineral density	
HNSC	cis	1	rs4394010	chr4:129894649	C4orf33	chr4:130014829-130033842:+	0.44	8.56	1.47E-16	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs439553	chr6:167391212	RNASET2	chr6:167343008-167412795:-	-0.23	-5.69	2.21E-8	Crohn's disease	
HNSC	cis	1	rs4407214	chr2:29118258	TRMT61B	chr2:29072690-29093175:-	0.26	5.08	5.49E-7	Breast cancer (estrogen-receptor negative);Breast cancer	
HNSC	cis	1	rs4409675	chr1:28262409	C1orf38	chr1:28199055-28213192:+	0.15	4.06	5.63E-5	Corneal astigmatism	
HNSC	cis	1	rs4409766	chr10:104616663	SFXN2	chr10:104474298-104498946:+	-0.3	-4.06	5.75E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
HNSC	cis	1	rs4417907	chr3:134291363	ANAPC13	chr3:134196547-134204865:-	0.49	10.65	5.68E-24	Height	
HNSC	cis	1	rs4417907	chr3:134291363	CEP63	chr3:134204575-134293852:+	0.28	6.04	3.02E-9	Height	
HNSC	cis	1	rs4421592	chr1:210338196	SYT14	chr1:210111538-210337631:+	-0.2	-3.76	0.000188	Manic episodes in bipolar disorder	
HNSC	cis	1	rs4423809	chr3:134300107	ANAPC13	chr3:134196547-134204865:-	-0.5	-10.71	3.34E-24	Height	
HNSC	cis	1	rs4423809	chr3:134300107	CEP63	chr3:134204575-134293852:+	-0.28	-5.95	5.13E-9	Height	
HNSC	cis	1	rs442856	chr5:176517292	FGFR4	chr5:176513921-176525124:+	-0.32	-5.41	9.65E-8	Height	
HNSC	cis	1	rs4441659	chr3:108851791	GUCA1C	chr3:108626642-108672677:-	0.23	3.85	0.000134	Homeostasis model assessment of beta-cell function (interaction)	
HNSC	cis	1	rs444988	chr6:167389674	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.51E-8	Crohn's disease	
HNSC	cis	1	rs4465649	chr17:28394747	EFCAB5	chr17:28256874-28435469:+	-0.25	-4.62	4.79E-6	Coffee consumption (cups per day)	
HNSC	cis	1	rs4465650	chr17:28396721	EFCAB5	chr17:28256874-28435469:+	0.22	4.05	6.06E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs4465830	chr20:44585420	CD40	chr20:44746906-44758384:+	0.24	3.91	0.000103	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
HNSC	cis	1	rs4466058	chr4:129923879	C4orf33	chr4:130014829-130033842:+	-0.44	-8.52	1.95E-16	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs4466773	chr10:81733564	LOC650623	chr10:81442731-81448648:+	-0.35	-3.68	0.000259	Rheumatoid arthritis	
HNSC	cis	1	rs4466774	chr10:81733786	LOC650623	chr10:81442731-81448648:+	-0.35	-3.68	0.000259	Rheumatoid arthritis	
HNSC	cis	1	rs4469291	chr6:49440614	CENPQ	chr6:49431096-49460820:+	-0.4	-9.56	5.8E-20	Folate pathway vitamin levels	
HNSC	cis	1	rs4469291	chr6:49440614	MUT	chr6:49398994-49431031:-	0.43	9.33	3.64E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs448060	chr6:167382622	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.46E-8	Crohn's disease	
HNSC	cis	1	rs4486677	chr12:8669116	CLEC4D	chr12:8666136-8674958:+	0.23	4.03	6.51E-5	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
HNSC	cis	1	rs4490383	chr3:48484683	ATRIP	chr3:48488141-48507708:+	0.16	3.67	0.000265	Longevity	
HNSC	cis	1	rs4490383	chr3:48484683	TREX1	chr3:48501186-48509043:+	-0.26	-6.54	1.57E-10	Longevity	
HNSC	cis	1	rs4490669	chr6:56789465	BEND6	chr6:56819773-56892138:+	-0.35	-6.32	5.8E-10	Menarche (age at onset)	
HNSC	cis	1	rs4490669	chr6:56789465	RAB23	chr6:57053591-57087101:-	0.21	4.11	4.66E-5	Menarche (age at onset)	
HNSC	cis	1	rs4497901	chr2:239969	SH3YL1	chr2:218138-264810:-	-0.65	-13.08	8.76E-34	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.5	10.67	4.64E-24	Height	
HNSC	cis	1	rs4498009	chr3:134198008	CEP63	chr3:134204575-134293852:+	0.27	5.7	2.02E-8	Height	
HNSC	cis	1	rs4511740	chr2:239865055	LOC643387	chr2:239140327-239142983:+	0.23	3.91	0.000106	Pulmonary function;Pulmonary function (interaction)	
HNSC	cis	1	rs4512473	chr9:21663040	CDKN2BAS	chr9:21994790-22121091:+	-0.26	-4.44	1.12E-5	Gut microbiome composition (winter)	
HNSC	cis	1	rs4512750	chr10:135358664	CYP2E1	chr10:135340867-135374724:+	0.25	4.46	1.01E-5	Obesity-related traits	
HNSC	cis	1	rs451396	chr7:65484074	CRCP	chr7:65579805-65619551:+	-0.33	-3.81	0.000155	Diabetic kidney disease	
HNSC	cis	1	rs451396	chr7:65484074	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.57	6.25E-6	Diabetic kidney disease	
HNSC	cis	1	rs4521419	chr4:108914578	HADH	chr4:108910940-108956330:+	0.27	3.94	9.19E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs4525561	chr18:51835955	POLI	chr18:51795849-51824602:+	0.21	3.87	0.000123	Psoriasis	
HNSC	cis	1	rs4531856	chr19:18388383	KIAA1683	chr19:18367906-18385319:-	-0.26	-6.42	3.23E-10	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs4533340	chr17:28277951	EFCAB5	chr17:28256874-28435469:+	0.23	4.04	6.32E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs4534636	chr12:8666801	CLEC4D	chr12:8666136-8674958:+	0.22	3.65	0.000286	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
HNSC	cis	1	rs4535272	chr3:134299916	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.65	5.65E-24	Height	
HNSC	cis	1	rs4535272	chr3:134299916	CEP63	chr3:134204575-134293852:+	-0.27	-5.77	1.37E-8	Height	
HNSC	cis	1	rs4545281	chr1:46360054	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.45	4.18E-13	Body mass index	
HNSC	cis	1	rs4548056	chr7:65298873	CRCP	chr7:65579805-65619551:+	-0.35	-4.1	4.78E-5	Diabetic kidney disease	
HNSC	cis	1	rs4548056	chr7:65298873	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.56	6.58E-6	Diabetic kidney disease	
HNSC	cis	1	rs4549034	chr2:28972579	TRMT61B	chr2:29072690-29093175:-	-0.37	-7.87	2.23E-14	Body mass index	
HNSC	cis	1	rs45559033	chr14:74341124	LIN52	chr14:74551656-74667117:+	0.24	4.24	2.65E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.44	8.83	1.85E-17	Hematology traits	
HNSC	cis	1	rs4572812	chr3:134291177	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.55	1.38E-23	Height	
HNSC	cis	1	rs4572812	chr3:134291177	CEP63	chr3:134204575-134293852:+	-0.27	-5.71	1.96E-8	Height	
HNSC	cis	1	rs4575590	chr17:28361969	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.26	2.41E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs4579248	chr5:150268151	LOC134466	chr5:150310000-150326146:-	0.53	6.7	5.8E-11	Crohn's disease	
HNSC	cis	1	rs4581755	chr17:28427898	EFCAB5	chr17:28256874-28435469:+	0.22	4.07	5.49E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs458291	chr7:65520479	CRCP	chr7:65579805-65619551:+	-0.33	-3.72	0.000224	Diabetic kidney disease	
HNSC	cis	1	rs458291	chr7:65520479	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.43	1.17E-5	Diabetic kidney disease	
HNSC	cis	1	rs4590162	chr5:82441440	XRCC4	chr5:82373317-82649577:+	-0.2	-4.03	6.45E-5	Hypertension	
HNSC	cis	1	rs4591730	chr5:82447802	XRCC4	chr5:82373317-82649577:+	-0.21	-4.04	6.08E-5	Hypertension	
HNSC	cis	1	rs4594164	chr14:35509571	PPP2R3C	chr14:35554679-35591679:-	0.42	6.84	2.34E-11	Atopic dermatitis	
HNSC	cis	1	rs4595905	chr19:18547305	SSBP4	chr19:18530221-18545371:+	-0.21	-4.85	1.67E-6	Breast cancer	
HNSC	cis	1	rs4604805	chr10:102261409	SEC31B	chr10:102246403-102289636:-	-0.19	-5.91	6.45E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs4604928	chr11:117044203	PCSK7	chr11:117075789-117102811:-	-0.32	-4.6	5.3E-6	Protein quantitative trait loci	
HNSC	cis	1	rs4605213	chr17:49244747	NME1-NME2	chr17:49230920-49249104:+	0.21	4.17	3.54E-5	Height	
HNSC	cis	1	rs4606360	chr1:173699007	SERPINC1	chr1:173872943-173886516:-	0.33	6.11	2.03E-9	Subjective well-being	
HNSC	cis	1	rs4609941	chr18:44645491	HDHD2	chr18:44633782-44676871:-	0.44	5.02	7.41E-7	Sitting height ratio	
HNSC	cis	1	rs4620204	chr7:102594217	FAM185A	chr7:102389399-102467706:+	0.22	3.94	9.43E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs462853	chr7:65558167	NCRNA00174	chr7:65841032-65865395:-	-0.41	-4.51	8.26E-6	Diabetic kidney disease	
HNSC	cis	1	rs4634330	chr5:82430782	XRCC4	chr5:82373317-82649577:+	-0.2	-3.88	0.000119	Hypertension	
HNSC	cis	1	rs4638651	chr18:51829870	POLI	chr18:51795849-51824602:+	0.21	3.87	0.000123	Psoriasis	
HNSC	cis	1	rs4640348	chr2:28965479	TRMT61B	chr2:29072690-29093175:-	-0.37	-7.83	2.97E-14	Body mass index	
HNSC	cis	1	rs4642241	chr4:17617111	FAM184B	chr4:17633711-17783135:-	-0.16	-3.75	0.000194	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.49	9.89	3.61E-21	Multiple sclerosis	
HNSC	cis	1	rs4646536	chr12:58157988	OS9	chr12:58087886-58115338:+	-0.2	-3.99	7.46E-5	Multiple sclerosis	
HNSC	cis	1	rs4646536	chr12:58157988	TSFM	chr12:58176536-58191367:+	-0.36	-7.99	9.9E-15	Multiple sclerosis	
HNSC	cis	1	rs464895	chr7:65527106	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.65	4.22E-6	Diabetic kidney disease	
HNSC	cis	1	rs465359	chr7:65558164	NCRNA00174	chr7:65841032-65865395:-	-0.41	-4.51	8.26E-6	Diabetic kidney disease	
HNSC	cis	1	rs4656958	chr1:160856964	ITLN1	chr1:160846332-160854960:-	0.2	4.12	4.44E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs4660303	chr1:40060473	BMP8A	chr1:39957318-39995537:+	0.21	4.42	1.21E-5	C-reactive protein levels or triglyceride levels (pleiotropy)	
HNSC	cis	1	rs4660303	chr1:40060473	PABPC4	chr1:40026485-40042521:-	-0.34	-5.72	1.81E-8	C-reactive protein levels or triglyceride levels (pleiotropy)	
HNSC	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.7	18.71	2.05E-59	Homocysteine levels	
HNSC	cis	1	rs4660306	chr1:45978675	MMACHC	chr1:45965856-45976737:+	0.2	4.08	5.27E-5	Homocysteine levels	
HNSC	cis	1	rs4660317	chr1:46326226	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.44	4.66E-13	Body mass index	
HNSC	cis	1	rs4660319	chr1:46341623	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.44	4.66E-13	Body mass index	
HNSC	cis	1	rs4660321	chr1:46366760	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.49	3.27E-13	Body mass index	
HNSC	cis	1	rs4660456	chr1:41239511	NFYC	chr1:41157242-41237273:+	-0.24	-3.87	0.000122	Platelet count	
HNSC	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.62	-16.11	3.22E-47	Homocysteine levels	
HNSC	cis	1	rs4660898	chr1:46402171	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.69	8.25E-14	Body mass index	
HNSC	cis	1	rs4660910	chr1:46548402	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.47	3.75E-13	Body mass index	
HNSC	cis	1	rs4666118	chr2:28951698	TRMT61B	chr2:29072690-29093175:-	-0.37	-8.07	5.45E-15	Body mass index	
HNSC	cis	1	rs4666119	chr2:28975690	TRMT61B	chr2:29072690-29093175:-	-0.35	-7.45	4.29E-13	Body mass index	
HNSC	cis	1	rs466983	chr7:65520496	CRCP	chr7:65579805-65619551:+	-0.35	-3.98	7.91E-5	Diabetic kidney disease	
HNSC	cis	1	rs466983	chr7:65520496	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.57	6.28E-6	Diabetic kidney disease	
HNSC	cis	1	rs4670885	chr2:38910402	GALM	chr2:38893052-38961908:+	0.34	5.13	4.16E-7	5-HTT brain serotonin transporter levels	
HNSC	cis	1	rs4677834	chr3:195093631	C3orf21	chr3:194789015-194991895:-	-0.16	-3.68	0.000263	Body mass index	
HNSC	cis	1	rs4681734	chr3:56715009	CCDC66	chr3:56591184-56655846:+	0.18	4.98	9.0E-7	Height	
HNSC	cis	1	rs4682000	chr3:56720591	CCDC66	chr3:56591184-56655846:+	0.18	5.06	5.97E-7	Height	
HNSC	cis	1	rs4684106	chr3:12550199	TSEN2	chr3:12525931-12581122:+	-0.29	-3.96	8.72E-5	Prostate cancer (gene x gene interaction)	
HNSC	cis	1	rs4687701	chr3:53121276	RFT1	chr3:53122503-53164470:-	0.27	5.64	2.83E-8	Height	
HNSC	cis	1	rs4690071	chr4:3086753	GRK4	chr4:2965343-3042474:+	-0.2	-3.82	0.000153	Parental longevity (mother's age at death)	
HNSC	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.37	-9.39	2.3E-19	Ankylosing spondylitis	
HNSC	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.4	7.53	2.42E-13	Ankylosing spondylitis	
HNSC	cis	1	rs4698198	chr4:17656536	FAM184B	chr4:17633711-17783135:-	-0.17	-3.99	7.73E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs4698199	chr4:17656738	FAM184B	chr4:17633711-17783135:-	-0.17	-3.99	7.73E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs4698200	chr4:17657051	FAM184B	chr4:17633711-17783135:-	-0.17	-4.09	5.11E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs4698432	chr4:15964763	FGFBP2	chr4:15961864-15964859:-	0.22	4.6	5.33E-6	QT interval	
HNSC	cis	1	rs4698433	chr4:15964863	FGFBP2	chr4:15961864-15964859:-	-0.2	-4.13	4.29E-5	QT interval	
HNSC	cis	1	rs4698634	chr4:17630192	FAM184B	chr4:17633711-17783135:-	0.17	4	7.31E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs4698635	chr4:17630242	FAM184B	chr4:17633711-17783135:-	-0.16	-3.91	0.000104	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs4698641	chr4:17642630	FAM184B	chr4:17633711-17783135:-	-0.16	-3.92	0.0001	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs4698641	chr4:17642630	LAP3	chr4:17578927-17609590:+	-0.14	-3.69	0.000245	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs4698648	chr4:17692715	LAP3	chr4:17578927-17609590:+	-0.14	-3.8	0.000161	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs4698649	chr4:17692782	LAP3	chr4:17578927-17609590:+	-0.14	-3.8	0.000161	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs4698651	chr4:17694223	LAP3	chr4:17578927-17609590:+	-0.14	-3.74	0.000203	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs470119	chr22:50966914	TYMP	chr22:50964184-50968514:-	-0.17	-4.96	9.96E-7	Mean corpuscular hemoglobin	
HNSC	cis	1	rs470360	chr11:65500530	RBM14	chr11:66384053-66397390:+	0.24	3.99	7.61E-5	Atopic dermatitis	
HNSC	cis	1	rs4704729	chr5:156424516	TIMD4	chr5:156346293-156390266:-	-0.17	-3.95	8.85E-5	Hypertriglyceridemia	
HNSC	cis	1	rs4704825	chr5:156382308	TIMD4	chr5:156346293-156390266:-	-0.16	-3.97	8.39E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
HNSC	cis	1	rs4705814	chr5:112696916	YTHDC2	chr5:112849410-112930979:+	0.2	3.84	0.00014	Cerebral amyloid angiopathy	
HNSC	cis	1	rs4705817	chr5:112724016	YTHDC2	chr5:112849410-112930979:+	0.2	3.82	0.000152	Cerebral amyloid angiopathy	
HNSC	cis	1	rs4705818	chr5:112754926	YTHDC2	chr5:112849410-112930979:+	0.2	3.82	0.000149	Cerebral amyloid angiopathy	
HNSC	cis	1	rs4705819	chr5:112754941	YTHDC2	chr5:112849410-112930979:+	0.2	3.82	0.000149	Cerebral amyloid angiopathy	
HNSC	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.59	-13.4	3.8E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.59	-13.56	7.97E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs4710147	chr6:167374239	RNASET2	chr6:167343008-167412795:-	0.21	5.14	4.06E-7	Crohn's disease	
HNSC	cis	1	rs4713006	chr6:26519872	BTN2A3	chr6:26422317-26431927:+	0.17	3.82	0.000148	Educational attainment	
HNSC	cis	1	rs4713006	chr6:26519872	BTN3A2	chr6:26365398-26378546:+	0.19	4.43	1.16E-5	Educational attainment	
HNSC	cis	1	rs4713008	chr6:26538268	BTN2A3	chr6:26422317-26431927:+	0.16	3.69	0.00025	Educational attainment	
HNSC	cis	1	rs4713008	chr6:26538268	BTN3A2	chr6:26365398-26378546:+	0.18	4.26	2.49E-5	Educational attainment	
HNSC	cis	1	rs4715129	chr6:49415043	CENPQ	chr6:49431096-49460820:+	-0.4	-9.46	1.29E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs4715129	chr6:49415043	MUT	chr6:49398994-49431031:-	0.43	9.24	7.38E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs4715130	chr6:49416825	CENPQ	chr6:49431096-49460820:+	-0.4	-9.4	2.05E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs4715130	chr6:49416825	MUT	chr6:49398994-49431031:-	0.41	8.66	6.55E-17	Folate pathway vitamin levels	
HNSC	cis	1	rs4715134	chr6:49488287	CENPQ	chr6:49431096-49460820:+	0.25	5.53	5.3E-8	Brain structure	
HNSC	cis	1	rs4715134	chr6:49488287	MUT	chr6:49398994-49431031:-	-0.2	-3.94	9.36E-5	Brain structure	
HNSC	cis	1	rs4717292	chr7:65895598	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.88	3.77E-46	Aortic root size	
HNSC	cis	1	rs4717292	chr7:65895598	TYW1	chr7:66461817-66704496:+	0.2	3.66	0.000278	Aortic root size	
HNSC	cis	1	rs4717300	chr7:65947380	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.88	3.77E-46	Aortic root size	
HNSC	cis	1	rs4717300	chr7:65947380	TYW1	chr7:66461817-66704496:+	0.2	3.66	0.000278	Aortic root size	
HNSC	cis	1	rs4717310	chr7:66161007	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.91	5.73E-25	Aortic root size	
HNSC	cis	1	rs4717319	chr7:66242593	NCRNA00174	chr7:65841032-65865395:-	-0.56	-10.93	4.7E-25	Aortic root size	
HNSC	cis	1	rs4718269	chr7:65200778	CRCP	chr7:65579805-65619551:+	0.36	4.18	3.38E-5	Diabetic kidney disease	
HNSC	cis	1	rs4718269	chr7:65200778	NCRNA00174	chr7:65841032-65865395:-	0.45	4.88	1.41E-6	Diabetic kidney disease	
HNSC	cis	1	rs4718270	chr7:65202407	CRCP	chr7:65579805-65619551:+	-0.32	-3.77	0.000182	Diabetic kidney disease	
HNSC	cis	1	rs4718270	chr7:65202407	NCRNA00174	chr7:65841032-65865395:-	-0.44	-4.75	2.68E-6	Diabetic kidney disease	
HNSC	cis	1	rs4718307	chr7:65610988	NCRNA00174	chr7:65841032-65865395:-	0.75	15.7	2.34E-45	Aortic root size	
HNSC	cis	1	rs4718309	chr7:65627764	NCRNA00174	chr7:65841032-65865395:-	0.44	4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs4718315	chr7:65648541	NCRNA00174	chr7:65841032-65865395:-	0.44	4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs4718316	chr7:65648731	NCRNA00174	chr7:65841032-65865395:-	0.44	4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs4718317	chr7:65648901	CRCP	chr7:65579805-65619551:+	0.32	3.83	0.000142	Diabetic kidney disease	
HNSC	cis	1	rs4718317	chr7:65648901	NCRNA00174	chr7:65841032-65865395:-	0.46	5.03	6.94E-7	Diabetic kidney disease	
HNSC	cis	1	rs4718333	chr7:65772758	NCRNA00174	chr7:65841032-65865395:-	0.46	4.97	9.34E-7	Diabetic kidney disease	
HNSC	cis	1	rs4718333	chr7:65772758	STAG3L4	chr7:66767616-66786512:+	0.4	4.47	9.81E-6	Diabetic kidney disease	
HNSC	cis	1	rs4718334	chr7:65789454	NCRNA00174	chr7:65841032-65865395:-	0.47	5.11	4.64E-7	Diabetic kidney disease	
HNSC	cis	1	rs4718334	chr7:65789454	STAG3L4	chr7:66767616-66786512:+	0.4	4.53	7.43E-6	Diabetic kidney disease	
HNSC	cis	1	rs4718343	chr7:65874288	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.62	5.64E-45	Aortic root size	
HNSC	cis	1	rs4718343	chr7:65874288	TYW1	chr7:66461817-66704496:+	0.2	3.7	0.000237	Aortic root size	
HNSC	cis	1	rs4718344	chr7:65874381	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.63	4.86E-45	Aortic root size	
HNSC	cis	1	rs4718357	chr7:65960878	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.84	5.47E-46	Aortic root size	
HNSC	cis	1	rs4718357	chr7:65960878	TYW1	chr7:66461817-66704496:+	0.2	3.69	0.000248	Aortic root size	
HNSC	cis	1	rs4726669	chr7:143758191	ARHGEF35	chr7:143883677-143892736:-	-0.34	-7.52	2.55E-13	Obesity-related traits	
HNSC	cis	1	rs4728142	chr7:128573967	IRF5	chr7:128577769-128590086:+	0.43	9.37	2.55E-19	Systemic lupus erythematosus;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs473073	chr10:131429646	MGMT	chr10:131265454-131565783:+	0.31	6.39	3.76E-10	Response to temozolomide	
HNSC	cis	1	rs4732038	chr7:134250322	AKR1B15	chr7:134233849-134264300:+	0.22	4.85	1.7E-6	Longevity	
HNSC	cis	1	rs473771	chr10:131408155	MGMT	chr10:131265454-131565783:+	0.29	5.87	7.8E-9	Response to temozolomide	
HNSC	cis	1	rs4749080	chr10:26162766	GPR158	chr10:25464290-25891155:+	-0.37	-3.85	0.000132	Obesity-related traits	
HNSC	cis	1	rs4749308	chr10:7888974	ATP5C1	chr10:7830093-7849755:+	0.29	3.75	0.0002	IgG glycosylation	
HNSC	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.31	-6.54	1.56E-10	Response to temozolomide	
HNSC	cis	1	rs4752028	chr10:118834991	KIAA1598	chr10:118644308-118886097:-	-0.29	-4.19	3.32E-5	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
HNSC	cis	1	rs4752797	chr11:47874364	C1QTNF4	chr11:47611216-47615961:-	-0.26	-5.32	1.57E-7	Subjective well-being	
HNSC	cis	1	rs4752797	chr11:47874364	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.91	0.000107	Subjective well-being	
HNSC	cis	1	rs4752856	chr11:47648042	C1QTNF4	chr11:47611216-47615961:-	-0.3	-6.17	1.44E-9	Subjective well-being	
HNSC	cis	1	rs4752857	chr11:47655752	C1QTNF4	chr11:47611216-47615961:-	-0.29	-6.02	3.47E-9	Subjective well-being	
HNSC	cis	1	rs4752857	chr11:47655752	MYBPC3	chr11:47352958-47374253:-	-0.19	-3.69	0.000245	Subjective well-being	
HNSC	cis	1	rs4752873	chr11:47857520	C1QTNF4	chr11:47611216-47615961:-	-0.26	-5.37	1.23E-7	Subjective well-being	
HNSC	cis	1	rs4752873	chr11:47857520	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.84	0.000137	Subjective well-being	
HNSC	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.38	-6.83	2.44E-11	Forced vital capacity	
HNSC	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.52	-10.94	4.22E-25	Cognitive function	
HNSC	cis	1	rs4759318	chr12:54420098	FLJ12825	chr12:54452038-54516018:+	0.22	4.06	5.77E-5	Bone mineral density	
HNSC	cis	1	rs4759361	chr12:123178280	GPR109B	chr12:123199304-123201439:-	0.34	5.44	8.45E-8	Adiponectin levels	
HNSC	cis	1	rs4763879	chr12:9910164	CLECL1	chr12:9868457-9885860:-	-0.23	-6.99	8.94E-12	Type 1 diabetes	
HNSC	cis	1	rs4764124	chr12:14966604	ERP27	chr12:15066977-15091463:-	-0.25	-4.53	7.32E-6	Pubertal anthropometrics	
HNSC	cis	1	rs4765305	chr12:124430612	DNAH10	chr12:124247042-124420265:+	0.3	5.63	3.05E-8	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs4769117	chr13:21054724	GJB2	chr13:20761606-20767114:-	-0.14	-4.16	3.79E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
HNSC	cis	1	rs4769117	chr13:21054724	SAP18	chr13:21714653-21723223:+	-0.22	-4.18	3.41E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
HNSC	cis	1	rs477692	chr10:131426022	MGMT	chr10:131265454-131565783:+	0.31	6.43	3.1E-10	Response to temozolomide	
HNSC	cis	1	rs4780401	chr16:11839326	TXNDC11	chr16:11772943-11836648:-	-0.21	-4.3	2.1E-5	Rheumatoid arthritis	
HNSC	cis	1	rs478597	chr12:117751425	NOS1	chr12:117650979-117799582:-	0.2	3.66	0.000284	Inattentive symptoms	
HNSC	cis	1	rs4787480	chr16:29857316	LOC440356	chr16:29875004-29879374:+	-0.23	-3.66	0.000282	Multiple sclerosis	
HNSC	cis	1	rs4788187	chr16:29845685	LOC440356	chr16:29875004-29879374:+	0.24	3.97	8.28E-5	Multiple sclerosis	
HNSC	cis	1	rs4788187	chr16:29845685	LOC595101	chr16:30278914-30346695:-	0.27	3.66	0.000285	Multiple sclerosis	
HNSC	cis	1	rs4788188	chr16:29860863	LOC440356	chr16:29875004-29879374:+	-0.22	-3.72	0.00022	Multiple sclerosis	
HNSC	cis	1	rs4788196	chr16:29967434	LOC595101	chr16:30278914-30346695:-	-0.24	-4.28	2.27E-5	Pubertal anthropometrics	
HNSC	cis	1	rs4789693	chr17:80421870	HEXDC	chr17:80376252-80400515:+	0.23	5.66	2.62E-8	Glucocorticoid-induced osteonecrosis	
HNSC	cis	1	rs4794016	chr17:45725931	C17orf57	chr17:45401142-45518675:+	-0.19	-4.69	3.48E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs4794016	chr17:45725931	TBKBP1	chr17:45772630-45789427:+	0.19	3.92	0.000101	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs4794048	chr17:45763073	C17orf57	chr17:45401142-45518675:+	0.21	5.08	5.31E-7	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs4794048	chr17:45763073	TBKBP1	chr17:45772630-45789427:+	-0.24	-4.82	1.95E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs4794202	chr17:45930539	SCRN2	chr17:45915049-45918699:-	-0.43	-6.64	8.13E-11	Alzheimer's disease (cognitive decline)	
HNSC	cis	1	rs479478	chr10:131428959	MGMT	chr10:131265454-131565783:+	0.31	6.46	2.48E-10	Response to temozolomide	
HNSC	cis	1	rs4795525	chr17:28388487	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.26	2.41E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs4802200	chr19:44289518	ZNF155	chr19:44488355-44502477:+	-0.21	-4.16	3.72E-5	Breast cancer	
HNSC	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.59	12.31	1.47E-30	Schizophrenia	
HNSC	cis	1	rs4803658	chr19:44290013	ZNF155	chr19:44488355-44502477:+	-0.21	-4.2	3.18E-5	Breast cancer	
HNSC	cis	1	rs480643	chr10:131400308	MGMT	chr10:131265454-131565783:+	0.3	6.09	2.23E-9	Response to temozolomide	
HNSC	cis	1	rs4808133	chr19:18608518	SSBP4	chr19:18530221-18545371:+	-0.21	-4.92	1.16E-6	Breast cancer	
HNSC	cis	1	rs4808134	chr19:18608579	SSBP4	chr19:18530221-18545371:+	-0.21	-4.92	1.16E-6	Breast cancer	
HNSC	cis	1	rs4808136	chr19:18618867	SSBP4	chr19:18530221-18545371:+	0.19	4.5	8.33E-6	Breast cancer	
HNSC	cis	1	rs4808200	chr19:19554803	HAPLN4	chr19:19366453-19384074:-	0.21	4.4	1.33E-5	Schizophrenia	
HNSC	cis	1	rs4808801	chr19:18571141	SSBP4	chr19:18530221-18545371:+	-0.18	-4.13	4.2E-5	Breast cancer	
HNSC	cis	1	rs4808804	chr19:18585325	SSBP4	chr19:18530221-18545371:+	-0.2	-4.58	5.95E-6	Breast cancer	
HNSC	cis	1	rs4811694	chr20:55029388	C20orf43	chr20:55043647-55093942:+	0.2	4.09	5.09E-5	Refractive astigmatism	
HNSC	cis	1	rs4812048	chr20:57587771	TH1L	chr20:57556311-57570186:+	-0.29	-4.08	5.32E-5	Mean platelet volume	
HNSC	cis	1	rs4817797	chr21:37801396	DYRK1A	chr21:38739859-38887678:+	-0.19	-4.17	3.61E-5	Pulmonary function	
HNSC	cis	1	rs4819388	chr21:45647421	ICOSLG	chr21:45646724-45660834:-	-0.28	-5.1	4.91E-7	Celiac disease	
HNSC	cis	1	rs4820294	chr22:38071043	LGALS2	chr22:37966254-37976024:-	0.13	3.75	0.000198	Fat distribution (HIV)	
HNSC	cis	1	rs4821808	chr22:39065739	LOC646851	chr22:38974125-39052634:-	0.15	3.9	0.000108	Resting heart rate	
HNSC	cis	1	rs4821809	chr22:39065743	LOC646851	chr22:38974125-39052634:-	0.15	3.9	0.000108	Resting heart rate	
HNSC	cis	1	rs4821811	chr22:39075145	LOC646851	chr22:38974125-39052634:-	0.15	3.93	9.68E-5	Resting heart rate	
HNSC	cis	1	rs4821812	chr22:39075235	LOC646851	chr22:38974125-39052634:-	0.15	3.89	0.000113	Resting heart rate	
HNSC	cis	1	rs4839103	chr1:110620701	ALX3	chr1:110602998-110613322:-	-0.2	-3.9	0.00011	Blood metabolite levels	
HNSC	cis	1	rs4840351	chr8:8573148	FLJ10661	chr8:8086092-8102386:+	0.25	4.25	2.54E-5	Obesity-related traits	
HNSC	cis	1	rs4840352	chr8:8573508	FLJ10661	chr8:8086092-8102386:+	0.26	4.33	1.77E-5	Obesity-related traits	
HNSC	cis	1	rs4841016	chr8:8572561	FLJ10661	chr8:8086092-8102386:+	0.27	4.47	9.56E-6	Obesity-related traits	
HNSC	cis	1	rs4841017	chr8:8577093	FLJ10661	chr8:8086092-8102386:+	0.24	4.2	3.23E-5	Obesity-related traits	
HNSC	cis	1	rs4845459	chr1:152603842	LCE3A	chr1:152595311-152595579:-	0.24	5.21	2.73E-7	Psoriasis	
HNSC	cis	1	rs4845459	chr1:152603842	LCE3C	chr1:152573138-152573562:+	-0.62	-15.56	1.07E-44	Psoriasis	
HNSC	cis	1	rs4847181	chr1:93028792	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs4852324	chr2:74202578	SLC4A5	chr2:74438733-74590554:-	0.27	3.82	0.000149	Systemic lupus erythematosus	
HNSC	cis	1	rs4852708	chr2:71063942	VAX2	chr2:71127720-71160573:+	-0.27	-4	7.36E-5	IgG glycosylation	
HNSC	cis	1	rs4852713	chr2:71076748	VAX2	chr2:71127720-71160573:+	-0.27	-3.95	8.8E-5	IgG glycosylation	
HNSC	cis	1	rs4854058	chr2:240923677	NDUFA10	chr2:240900158-240964798:-	0.21	3.8	0.000163	Odorant perception (isobutyraldehyde)	
HNSC	cis	1	rs4855579	chr3:108857881	GUCA1C	chr3:108626642-108672677:-	-0.27	-4.6	5.33E-6	Homeostasis model assessment of beta-cell function (interaction)	
HNSC	cis	1	rs4855581	chr3:108860645	GUCA1C	chr3:108626642-108672677:-	-0.31	-4.67	3.84E-6	Homeostasis model assessment of beta-cell function (interaction)	
HNSC	cis	1	rs4855696	chr3:108852822	GUCA1C	chr3:108626642-108672677:-	-0.27	-4.39	1.37E-5	Homeostasis model assessment of beta-cell function (interaction)	
HNSC	cis	1	rs485576	chr10:131425496	MGMT	chr10:131265454-131565783:+	0.31	6.43	3.1E-10	Response to temozolomide	
HNSC	cis	1	rs4858793	chr3:48415007	TREX1	chr3:48501186-48509043:+	0.26	6.33	5.45E-10	Longevity	
HNSC	cis	1	rs4858817	chr3:48416756	ATRIP	chr3:48488141-48507708:+	-0.17	-3.88	0.000116	Longevity	
HNSC	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.26	6.41	3.35E-10	Longevity	
HNSC	cis	1	rs4859413	chr4:76898250	NAAA	chr4:76831809-76862166:-	0.5	11.62	9.17E-28	Longevity	
HNSC	cis	1	rs4859581	chr4:76906974	NAAA	chr4:76831809-76862166:-	-0.5	-11.76	2.64E-28	Longevity	
HNSC	cis	1	rs4859582	chr4:76907213	NAAA	chr4:76831809-76862166:-	-0.5	-11.59	1.2E-27	Longevity	
HNSC	cis	1	rs4862406	chr4:185629339	MLF1IP	chr4:185615220-185655286:-	0.47	12.01	2.63E-29	Kawasaki disease	
HNSC	cis	1	rs486301	chr15:43836949	ADAL	chr15:43622872-43646094:+	-0.38	-5.46	7.68E-8	Tumor biomarkers	
HNSC	cis	1	rs486301	chr15:43836949	CATSPER2	chr15:43922774-43959900:-	-0.36	-5.95	5.0E-9	Tumor biomarkers	
HNSC	cis	1	rs486301	chr15:43836949	CKMT1A	chr15:43985084-43991419:+	-0.35	-4.87	1.48E-6	Tumor biomarkers	
HNSC	cis	1	rs486301	chr15:43836949	CKMT1B	chr15:43885252-43891603:+	-0.3	-4.3	2.09E-5	Tumor biomarkers	
HNSC	cis	1	rs4865463	chr4:1742400	FAM53A	chr4:1641609-1685854:-	-0.34	-5.89	7.21E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs4865467	chr4:1745500	FAM53A	chr4:1641609-1685854:-	0.34	5.87	7.84E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-0.97	-31.23	6.22E-119	Pediatric autoimmune diseases	
HNSC	cis	1	rs4871	chr6:26545632	BTN3A2	chr6:26365398-26378546:+	0.17	4.13	4.31E-5	Educational attainment	
HNSC	cis	1	rs4886238	chr13:61113739	TDRD3	chr13:60970591-61148012:+	0.24	4.24	2.63E-5	Menopause (age at onset)	
HNSC	cis	1	rs4887067	chr15:78886947	CHRNA5	chr15:78857906-78886458:+	-0.26	-5.3	1.76E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs4887783	chr16:74700743	RFWD3	chr16:74655298-74700779:-	-0.29	-7.32	1.01E-12	Testicular germ cell tumor	
HNSC	cis	1	rs4888262	chr16:74670458	RFWD3	chr16:74655298-74700779:-	-0.29	-7.36	7.76E-13	Testicular germ cell tumor	
HNSC	cis	1	rs4888264	chr16:74681632	RFWD3	chr16:74655298-74700779:-	-0.29	-7.45	4.18E-13	Testicular germ cell tumor	
HNSC	cis	1	rs4888265	chr16:74683737	RFWD3	chr16:74655298-74700779:-	-0.29	-7.47	3.65E-13	Testicular germ cell tumor	
HNSC	cis	1	rs4889609	chr16:31026427	HSD3B7	chr16:30996519-31000473:+	0.23	4.33	1.82E-5	Response to metformin (IC50)	
HNSC	cis	1	rs4889609	chr16:31026427	MYST1	chr16:31128985-31142713:+	0.24	5.94	5.41E-9	Response to metformin (IC50)	
HNSC	cis	1	rs4899148	chr14:65303778	CHURC1	chr14:65381140-65411309:+	0.44	4.46	1.0E-5	Daytime sleep phenotypes	
HNSC	cis	1	rs4899544	chr14:75546556	MLH3	chr14:75480467-75518235:-	0.3	6.12	1.93E-9	Height	
HNSC	cis	1	rs4899546	chr14:75594946	MLH3	chr14:75480467-75518235:-	0.3	6.26	8.33E-10	Height	
HNSC	cis	1	rs4903201	chr14:74659690	LIN52	chr14:74551656-74667117:+	-0.3	-8.1	4.21E-15	Common traits (Other)	
HNSC	cis	1	rs4903202	chr14:74660302	LIN52	chr14:74551656-74667117:+	-0.3	-8.1	4.21E-15	Common traits (Other)	
HNSC	cis	1	rs4903203	chr14:74660508	LIN52	chr14:74551656-74667117:+	-0.3	-8.1	4.21E-15	Common traits (Other)	
HNSC	cis	1	rs4903275	chr14:75512509	MLH3	chr14:75480467-75518235:-	0.33	6.86	2.09E-11	Height	
HNSC	cis	1	rs4903279	chr14:75546583	MLH3	chr14:75480467-75518235:-	0.3	6.12	1.93E-9	Height	
HNSC	cis	1	rs4903281	chr14:75554361	MLH3	chr14:75480467-75518235:-	0.29	6.05	2.92E-9	Height	
HNSC	cis	1	rs4903284	chr14:75592483	MLH3	chr14:75480467-75518235:-	0.32	6.54	1.51E-10	Height	
HNSC	cis	1	rs4903289	chr14:75623988	MLH3	chr14:75480467-75518235:-	-0.3	-6.32	6.03E-10	Height	
HNSC	cis	1	rs4911178	chr20:33952620	CPNE1	chr20:34213968-34262539:-	0.24	4.32	1.89E-5	Height	
HNSC	cis	1	rs4911178	chr20:33952620	UQCC	chr20:33890383-33999833:-	0.33	6.11	1.98E-9	Height	
HNSC	cis	1	rs4911180	chr20:33972948	CPNE1	chr20:34213968-34262539:-	0.26	4.66	4.09E-6	Height	
HNSC	cis	1	rs4911180	chr20:33972948	UQCC	chr20:33890383-33999833:-	0.33	6.13	1.83E-9	Height	
HNSC	cis	1	rs4911491	chr20:33947285	CPNE1	chr20:34213968-34262539:-	0.24	4.41	1.29E-5	Height	
HNSC	cis	1	rs4911491	chr20:33947285	UQCC	chr20:33890383-33999833:-	0.33	6.17	1.39E-9	Height	
HNSC	cis	1	rs4911492	chr20:33951799	CPNE1	chr20:34213968-34262539:-	0.24	4.33	1.77E-5	Height	
HNSC	cis	1	rs4911492	chr20:33951799	UQCC	chr20:33890383-33999833:-	0.33	6.14	1.7E-9	Height	
HNSC	cis	1	rs4911494	chr20:33971914	CPNE1	chr20:34213968-34262539:-	0.24	4.33	1.77E-5	Height	
HNSC	cis	1	rs4911494	chr20:33971914	UQCC	chr20:33890383-33999833:-	0.33	6.14	1.7E-9	Height	
HNSC	cis	1	rs4911496	chr20:33972053	CPNE1	chr20:34213968-34262539:-	-0.26	-4.62	4.9E-6	Height	
HNSC	cis	1	rs4911496	chr20:33972053	UQCC	chr20:33890383-33999833:-	-0.33	-5.97	4.56E-9	Height	
HNSC	cis	1	rs4917901	chr10:102201773	SEC31B	chr10:102246403-102289636:-	-0.18	-5.73	1.74E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs4919464	chr10:102221195	SEC31B	chr10:102246403-102289636:-	-0.18	-5.65	2.76E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs4919465	chr10:102221703	SEC31B	chr10:102246403-102289636:-	-0.18	-5.66	2.58E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs4919466	chr10:102241213	SEC31B	chr10:102246403-102289636:-	-0.18	-5.81	1.15E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs4919468	chr10:102288343	SEC31B	chr10:102246403-102289636:-	-0.19	-5.71	1.98E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs4919469	chr10:102298855	SEC31B	chr10:102246403-102289636:-	-0.18	-5.6	3.6E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs4919470	chr10:102298920	SEC31B	chr10:102246403-102289636:-	-0.17	-5.07	5.74E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs4919471	chr10:102299239	SEC31B	chr10:102246403-102289636:-	-0.18	-5.48	6.9E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs4919472	chr10:102315864	SEC31B	chr10:102246403-102289636:-	-0.17	-5.31	1.64E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs4919690	chr10:104616500	ACTR1A	chr10:104238987-104262512:-	-0.17	-3.83	0.000145	Arsenic metabolism	
HNSC	cis	1	rs4919690	chr10:104616500	AS3MT	chr10:104613967-104661653:+	0.22	4.3	2.04E-5	Arsenic metabolism	
HNSC	cis	1	rs4919690	chr10:104616500	C10orf32	chr10:104613967-104624718:+	0.37	6.45	2.65E-10	Arsenic metabolism	
HNSC	cis	1	rs4920092	chr21:43781114	C21orf128	chr21:43522244-43528644:-	0.24	4.15	3.93E-5	Pancreatic cancer	
HNSC	cis	1	rs4925166	chr17:18210810	LGALS9C	chr17:18380099-18398258:+	-0.18	-3.88	0.000118	Multiple sclerosis	
HNSC	cis	1	rs4925166	chr17:18210810	LOC220594	chr17:18414577-18445234:-	-0.25	-4.73	2.97E-6	Multiple sclerosis	
HNSC	cis	1	rs4925166	chr17:18210810	SHMT1	chr17:18231195-18266856:-	0.21	4.5	8.36E-6	Multiple sclerosis	
HNSC	cis	1	rs4925540	chr1:247214878	ZNF670	chr1:247200087-247242069:-	-0.31	-6.69	5.99E-11	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs4926407	chr1:150087824	HORMAD1	chr1:150670542-150693352:-	0.25	3.77	0.000181	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
HNSC	cis	1	rs4928116	chr3:99970895	TBC1D23	chr3:99979686-100044078:+	0.23	4.57	6.28E-6	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs4928117	chr3:99975485	TBC1D23	chr3:99979686-100044078:+	0.22	4.25	2.59E-5	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs4928161	chr3:99934895	TBC1D23	chr3:99979686-100044078:+	0.24	4.66	4.14E-6	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs4928170	chr3:100044455	TBC1D23	chr3:99979686-100044078:+	0.25	4.96	9.79E-7	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs4930726	chr12:124428331	DNAH10	chr12:124247042-124420265:+	0.3	5.62	3.27E-8	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.65	-11.53	2.13E-27	Type 2 diabetes	
HNSC	cis	1	rs494003	chr11:65542298	SNX32	chr11:65601410-65621170:+	0.25	3.74	0.000204	Systemic lupus erythematosus	
HNSC	cis	1	rs4945584	chr6:117750980	ROS1	chr6:117609530-117747018:-	-0.19	-4.13	4.2E-5	Lung cancer	
HNSC	cis	1	rs4951261	chr1:205717823	PM20D1	chr1:205797154-205819245:-	0.29	5.79	1.26E-8	Menarche (age at onset)	
HNSC	cis	1	rs4951261	chr1:205717823	RAB7L1	chr1:205737115-205744610:-	-0.32	-5.99	4.14E-9	Menarche (age at onset)	
HNSC	cis	1	rs4953925	chr2:135471290	TMEM163	chr2:135213331-135525334:-	-0.28	-5.03	6.87E-7	Gut microbiome composition (winter)	
HNSC	cis	1	rs4955485	chr3:134295843	ANAPC13	chr3:134196547-134204865:-	0.48	10.32	9.98E-23	Height	
HNSC	cis	1	rs4955485	chr3:134295843	CEP63	chr3:134204575-134293852:+	0.26	5.7	2.04E-8	Height	
HNSC	cis	1	rs4955555	chr3:134286427	ANAPC13	chr3:134196547-134204865:-	0.48	10.44	3.41E-23	Height	
HNSC	cis	1	rs4955555	chr3:134286427	CEP63	chr3:134204575-134293852:+	0.27	5.94	5.32E-9	Height	
HNSC	cis	1	rs4956032	chr4:108944579	HADH	chr4:108910940-108956330:+	-0.26	-3.91	0.000106	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs4956033	chr4:108944821	HADH	chr4:108910940-108956330:+	-0.27	-3.76	0.000189	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs4956145	chr4:108931039	HADH	chr4:108910940-108956330:+	-0.27	-3.92	0.0001	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs4956146	chr4:108934901	HADH	chr4:108910940-108956330:+	-0.28	-4	7.34E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs4956147	chr4:108935871	HADH	chr4:108910940-108956330:+	-0.28	-4	7.34E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs4958424	chr5:150225036	LOC134466	chr5:150310000-150326146:-	0.36	4.94	1.09E-6	Crohn's disease	
HNSC	cis	1	rs4958426	chr5:150278346	LOC134466	chr5:150310000-150326146:-	0.54	6.85	2.28E-11	Crohn's disease	
HNSC	cis	1	rs4958842	chr5:150224877	LOC134466	chr5:150310000-150326146:-	0.48	5.97	4.51E-9	Crohn's disease	
HNSC	cis	1	rs4958843	chr5:150224924	LOC134466	chr5:150310000-150326146:-	0.36	4.94	1.09E-6	Crohn's disease	
HNSC	cis	1	rs496584	chr15:43831923	ADAL	chr15:43622872-43646094:+	-0.34	-4.87	1.51E-6	Tumor biomarkers	
HNSC	cis	1	rs496584	chr15:43831923	CATSPER2	chr15:43922774-43959900:-	-0.31	-5.15	3.81E-7	Tumor biomarkers	
HNSC	cis	1	rs496584	chr15:43831923	CKMT1A	chr15:43985084-43991419:+	-0.34	-4.85	1.68E-6	Tumor biomarkers	
HNSC	cis	1	rs496584	chr15:43831923	CKMT1B	chr15:43885252-43891603:+	-0.26	-3.69	0.000248	Tumor biomarkers	
HNSC	cis	1	rs4968361	chr17:57502828	DHX40P1	chr17:58053385-58096336:-	0.33	4.56	6.42E-6	Schizophrenia	
HNSC	cis	1	rs4970696	chr1:92968853	EVI5	chr1:92974255-93257961:-	-0.23	-4.09	4.96E-5	Cholesterol, total	
HNSC	cis	1	rs4970698	chr1:92972933	EVI5	chr1:92974255-93257961:-	-0.24	-4.42	1.2E-5	Cholesterol, total	
HNSC	cis	1	rs4970705	chr1:92971828	EVI5	chr1:92974255-93257961:-	0.24	4.39	1.41E-5	Cholesterol, total	
HNSC	cis	1	rs4970708	chr1:92986514	EVI5	chr1:92974255-93257961:-	-0.24	-4.39	1.38E-5	Cholesterol, total	
HNSC	cis	1	rs4970709	chr1:92988592	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs4970710	chr1:92988717	EVI5	chr1:92974255-93257961:-	-0.23	-4.29	2.16E-5	Cholesterol, total	
HNSC	cis	1	rs4970712	chr1:92993547	EVI5	chr1:92974255-93257961:-	0.23	4.32	1.9E-5	Cholesterol, total	
HNSC	cis	1	rs4970948	chr1:151291243	HORMAD1	chr1:150670542-150693352:-	-0.3	-5.56	4.44E-8	Gut microbiota (functional units)	
HNSC	cis	1	rs4971316	chr1:247210903	ZNF670	chr1:247200087-247242069:-	-0.3	-6.49	2.07E-10	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs4971319	chr1:247211565	ZNF670	chr1:247200087-247242069:-	-0.3	-6.49	2.07E-10	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs4973991	chr3:41927273	ULK4	chr3:41288091-42003660:-	-0.77	-13.71	1.82E-36	Diastolic blood pressure	
HNSC	cis	1	rs4974483	chr3:134219001	ANAPC13	chr3:134196547-134204865:-	0.48	10.31	1.04E-22	Height	
HNSC	cis	1	rs4974483	chr3:134219001	CEP63	chr3:134204575-134293852:+	0.27	5.95	4.97E-9	Height	
HNSC	cis	1	rs4974484	chr3:134219019	ANAPC13	chr3:134196547-134204865:-	0.49	10.48	2.35E-23	Height	
HNSC	cis	1	rs4974484	chr3:134219019	CEP63	chr3:134204575-134293852:+	0.27	5.77	1.39E-8	Height	
HNSC	cis	1	rs4974493	chr3:134219993	ANAPC13	chr3:134196547-134204865:-	0.49	10.59	9.52E-24	Height	
HNSC	cis	1	rs4974493	chr3:134219993	CEP63	chr3:134204575-134293852:+	0.28	6.11	2.06E-9	Height	
HNSC	cis	1	rs4975193	chr4:129980630	C4orf33	chr4:130014829-130033842:+	-0.46	-9.02	4.14E-18	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs4975194	chr4:129982377	C4orf33	chr4:130014829-130033842:+	-0.46	-9.02	4.32E-18	Chronic obstructive pulmonary disease (moderate to severe)	
HNSC	cis	1	rs4980171	chr10:124743200	C10orf88	chr10:124690419-124713919:-	-0.22	-4.04	6.12E-5	Migraine without aura	
HNSC	cis	1	rs4980239	chr10:124741184	C10orf88	chr10:124690419-124713919:-	-0.22	-4.04	6.12E-5	Migraine without aura	
HNSC	cis	1	rs499818	chr6:13332467	TBC1D7	chr6:13266774-13328770:-	0.21	3.89	0.000116	Major CVD	
HNSC	cis	1	rs501220	chr6:25873025	BTN3A2	chr6:26365398-26378546:+	-0.41	-6.45	2.61E-10	Homocysteine levels	
HNSC	cis	1	rs5022636	chr1:151295061	HORMAD1	chr1:150670542-150693352:-	-0.32	-5.78	1.3E-8	Gut microbiota (functional units)	
HNSC	cis	1	rs5030707	chr20:23618656	CST1	chr20:23728191-23731574:-	0.34	5.36	1.28E-7	Chronic kidney disease	
HNSC	cis	1	rs5030707	chr20:23618656	CST4	chr20:23666277-23669662:-	0.27	4.33	1.78E-5	Chronic kidney disease	
HNSC	cis	1	rs503660	chr10:131418999	MGMT	chr10:131265454-131565783:+	0.3	6.23	1.03E-9	Response to temozolomide	
HNSC	cis	1	rs506274	chr10:131409392	MGMT	chr10:131265454-131565783:+	0.29	6.01	3.62E-9	Response to temozolomide	
HNSC	cis	1	rs507525	chr12:123181581	GPR109B	chr12:123199304-123201439:-	0.36	5.51	5.65E-8	Adiponectin levels	
HNSC	cis	1	rs508303	chr10:131424996	MGMT	chr10:131265454-131565783:+	-0.32	-6.47	2.34E-10	Response to temozolomide	
HNSC	cis	1	rs509548	chr12:123181855	GPR109B	chr12:123199304-123201439:-	0.34	5.51	5.73E-8	Adiponectin levels	
HNSC	cis	1	rs513736	chr10:131406489	MGMT	chr10:131265454-131565783:+	0.3	6.13	1.82E-9	Response to temozolomide	
HNSC	cis	1	rs516704	chr10:131419879	MGMT	chr10:131265454-131565783:+	0.29	6.05	2.79E-9	Response to temozolomide	
HNSC	cis	1	rs518272	chr11:57017557	PRG2	chr11:57151267-57191532:-	-0.35	-3.77	0.000182	Low high density lipoprotein cholesterol levels	
HNSC	cis	1	rs5219	chr11:17409572	DKFZp686O24166	chr11:17373317-17398869:+	0.22	4.86	1.62E-6	Type 2 diabetes	
HNSC	cis	1	rs522891	chr10:131430916	MGMT	chr10:131265454-131565783:+	-0.31	-6.39	3.76E-10	Response to temozolomide	
HNSC	cis	1	rs525215	chr12:123179771	GPR109B	chr12:123199304-123201439:-	0.35	5.64	2.94E-8	Adiponectin levels	
HNSC	cis	1	rs530466	chr10:131427717	MGMT	chr10:131265454-131565783:+	0.32	6.64	8.48E-11	Response to temozolomide	
HNSC	cis	1	rs531572	chr10:131427569	MGMT	chr10:131265454-131565783:+	-0.31	-6.47	2.43E-10	Response to temozolomide	
HNSC	cis	1	rs533928	chr1:150884271	HORMAD1	chr1:150670542-150693352:-	0.35	3.9	0.000107	Congenital left-sided heart lesions	
HNSC	cis	1	rs538969	chr10:131410608	MGMT	chr10:131265454-131565783:+	0.29	5.93	5.87E-9	Response to temozolomide	
HNSC	cis	1	rs541126	chr12:120972396	GATC	chr12:120884284-120897761:+	0.28	4.11	4.57E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs541126	chr12:120972396	POP5	chr12:121016849-121019201:-	0.24	4.24	2.65E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs541126	chr12:120972396	SFRS9	chr12:120899472-120907558:-	0.25	3.97	8.12E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs541126	chr12:120972396	TRIAP1	chr12:120881765-120884215:-	0.25	4.31	2.0E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs548390	chr10:131417427	MGMT	chr10:131265454-131565783:+	0.3	6.1	2.16E-9	Response to temozolomide	
HNSC	cis	1	rs553371	chr10:131413676	MGMT	chr10:131265454-131565783:+	0.3	6.11	2.02E-9	Response to temozolomide	
HNSC	cis	1	rs554792	chr10:131423181	MGMT	chr10:131265454-131565783:+	0.3	6.07	2.55E-9	Response to temozolomide	
HNSC	cis	1	rs555	chr4:17625658	FAM184B	chr4:17633711-17783135:-	-0.16	-3.88	0.000117	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs55661361	chr11:124613957	NRGN	chr11:124609829-124617102:+	0.22	4.24	2.67E-5	Schizophrenia	
HNSC	cis	1	rs55670848	chr1:171697497	VAMP4	chr1:171669298-171711214:-	0.26	4.52	7.79E-6	Hippocampal atrophy	
HNSC	cis	1	rs55697388	chr6:118891544	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.54E-5	Renal cell carcinoma	
HNSC	cis	1	rs55752096	chr18:48368918	MRO	chr18:48321491-48351754:-	0.23	3.97	8.28E-5	Entorhinal cortical thickness	
HNSC	cis	1	rs55753056	chr2:243929	SH3YL1	chr2:218138-264810:-	-0.65	-12.95	3.29E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs55786720	chr6:56783647	BEND6	chr6:56819773-56892138:+	-0.39	-6.91	1.46E-11	Menarche (age at onset)	
HNSC	cis	1	rs55786720	chr6:56783647	RAB23	chr6:57053591-57087101:-	0.22	4.03	6.55E-5	Menarche (age at onset)	
HNSC	cis	1	rs55791720	chr12:1066834	RAD52	chr12:1021255-1099219:-	0.25	5.08	5.33E-7	Lung cancer	
HNSC	cis	1	rs55795846	chr2:46178150	MCFD2	chr2:47129017-47168878:-	-0.23	-3.85	0.000134	QT interval	
HNSC	cis	1	rs55835850	chr2:28949296	TRMT61B	chr2:29072690-29093175:-	0.36	7.69	8.28E-14	Body mass index	
HNSC	cis	1	rs55842567	chr5:437586	EXOC3	chr5:443334-467407:+	-0.24	-4.18	3.5E-5	Cystic fibrosis severity	
HNSC	cis	1	rs55857306	chr1:11895795	CLCN6	chr1:11866207-11907674:+	0.26	4.12	4.46E-5	QRS complex (12-leadsum)	
HNSC	cis	1	rs558764	chr10:131426957	MGMT	chr10:131265454-131565783:+	-0.3	-6.29	6.86E-10	Response to temozolomide	
HNSC	cis	1	rs55879323	chr1:152168740	HRNR	chr1:152184558-152196669:-	0.23	4.85	1.65E-6	Inflammatory skin disease	
HNSC	cis	1	rs55884419	chr9:21673226	CDKN2BAS	chr9:21994790-22121091:+	-0.25	-4.26	2.42E-5	Gut microbiome composition (winter)	
HNSC	cis	1	rs55895244	chr7:65387678	CRCP	chr7:65579805-65619551:+	-0.33	-3.97	8.33E-5	Diabetic kidney disease	
HNSC	cis	1	rs55895244	chr7:65387678	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.98	8.98E-7	Diabetic kidney disease	
HNSC	cis	1	rs55899400	chr1:120267431	ZNF697	chr1:120162000-120190390:-	-0.38	-5.65	2.76E-8	Height	
HNSC	cis	1	rs55899435	chr6:118812099	C6orf204	chr6:118786239-119031238:-	-0.25	-4.39	1.41E-5	Renal cell carcinoma	
HNSC	cis	1	rs55913793	chr3:134285968	ANAPC13	chr3:134196547-134204865:-	0.48	10.44	3.41E-23	Height	
HNSC	cis	1	rs55913793	chr3:134285968	CEP63	chr3:134204575-134293852:+	0.27	5.94	5.32E-9	Height	
HNSC	cis	1	rs55914901	chr19:50528346	SIGLEC16	chr19:50472912-50479075:+	0.41	5.07	5.67E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
HNSC	cis	1	rs55934348	chr2:99246885	UNC50	chr2:99225042-99234975:+	-0.25	-4.27	2.3E-5	Bipolar disorder	
HNSC	cis	1	rs55936726	chr2:258210	SH3YL1	chr2:218138-264810:-	-0.66	-12.85	8.66E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs55938093	chr3:56620172	CCDC66	chr3:56591184-56655846:+	-0.18	-5.04	6.62E-7	Height	
HNSC	cis	1	rs55939327	chr4:17642937	FAM184B	chr4:17633711-17783135:-	-0.16	-3.95	8.87E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs55946380	chr2:268293	SH3YL1	chr2:218138-264810:-	-0.65	-12.71	3.32E-32	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs55962025	chr4:3112109	GRK4	chr4:2965343-3042474:+	-0.22	-4.1	4.87E-5	Parental longevity (mother's age at death)	
HNSC	cis	1	rs55962648	chr7:65625751	NCRNA00174	chr7:65841032-65865395:-	0.75	15.86	4.31E-46	Aortic root size	
HNSC	cis	1	rs55971458	chr17:28427016	EFCAB5	chr17:28256874-28435469:+	0.22	4.02	6.87E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs55979739	chr16:31049155	HSD3B7	chr16:30996519-31000473:+	0.21	3.73	0.000217	Response to metformin (IC50)	
HNSC	cis	1	rs55979739	chr16:31049155	MYST1	chr16:31128985-31142713:+	0.23	5.46	7.6E-8	Response to metformin (IC50)	
HNSC	cis	1	rs56016656	chr7:65383481	CRCP	chr7:65579805-65619551:+	-0.32	-3.73	0.000212	Diabetic kidney disease	
HNSC	cis	1	rs56016656	chr7:65383481	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.6	5.27E-6	Diabetic kidney disease	
HNSC	cis	1	rs56030203	chr6:56783857	BEND6	chr6:56819773-56892138:+	-0.39	-6.91	1.46E-11	Menarche (age at onset)	
HNSC	cis	1	rs56030203	chr6:56783857	RAB23	chr6:57053591-57087101:-	0.22	4.03	6.55E-5	Menarche (age at onset)	
HNSC	cis	1	rs56040780	chr16:28861881	EIF3CL	chr16:28699879-28747052:+;chr16	0.26	5.24	2.42E-7	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
HNSC	cis	1	rs56040780	chr16:28861881	SULT1A2	chr16:28603266-28608391:-	0.21	4.62	4.95E-6	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
HNSC	cis	1	rs56042615	chr5:437667	EXOC3	chr5:443334-467407:+	-0.24	-4.18	3.5E-5	Cystic fibrosis severity	
HNSC	cis	1	rs56043407	chr17:2166078	SRR	chr17:2207248-2228553:+	-0.42	-8.08	4.86E-15	Esophageal cancer (squamous cell)	
HNSC	cis	1	rs56060232	chr14:104386165	TDRD9	chr14:104394817-104519002:+	0.34	5.62	3.14E-8	Bipolar disorder	
HNSC	cis	1	rs56077333	chr15:78899003	CHRNA5	chr15:78857906-78886458:+	-0.25	-5.01	7.59E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs56091821	chr1:171651434	VAMP4	chr1:171669298-171711214:-	0.27	4.72	3.13E-6	Hippocampal atrophy	
HNSC	cis	1	rs56104584	chr5:437542	EXOC3	chr5:443334-467407:+	-0.24	-4.18	3.5E-5	Cystic fibrosis severity	
HNSC	cis	1	rs56113315	chr19:39184166	LGALS7B	chr19:39279850-39282393:+	0.27	6.03	3.2E-9	Heart rate	
HNSC	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.69	10.54	1.48E-23	Diastolic blood pressure	
HNSC	cis	1	rs56127630	chr3:49438036	AMT	chr3:49454212-49460012:-	-0.19	-4.18	3.44E-5	Menarche (age at onset)	
HNSC	cis	1	rs56145559	chr2:73623439	ALMS1P	chr2:73872046-73912692:+	0.26	4.21	3.07E-5	Schizophrenia	
HNSC	cis	1	rs56154726	chr2:73721767	ALMS1P	chr2:73872046-73912692:+	0.26	4.32	1.87E-5	Metabolite levels	
HNSC	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.69	10.54	1.48E-23	Diastolic blood pressure	
HNSC	cis	1	rs56159542	chr19:19682971	HAPLN4	chr19:19366453-19384074:-	-0.28	-4.84	1.74E-6	Attention deficit hyperactivity disorder symptom score	
HNSC	cis	1	rs56167434	chr2:282137	SH3YL1	chr2:218138-264810:-	-0.66	-12.6	9.24E-32	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs56168551	chr6:44104306	TJAP1	chr6:43445261-43474294:+	0.19	3.77	0.000182	Major depressive disorder	
HNSC	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	0.75	10.67	4.66E-24	Diastolic blood pressure	
HNSC	cis	1	rs56240690	chr4:108915052	HADH	chr4:108910940-108956330:+	0.28	4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs56243155	chr2:46173173	MCFD2	chr2:47129017-47168878:-	-0.23	-3.77	0.00018	QT interval	
HNSC	cis	1	rs56280226	chr17:28429575	EFCAB5	chr17:28256874-28435469:+	0.22	4.07	5.49E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs56291018	chr7:65390339	CRCP	chr7:65579805-65619551:+	-0.32	-3.73	0.000212	Diabetic kidney disease	
HNSC	cis	1	rs56291018	chr7:65390339	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.6	5.27E-6	Diabetic kidney disease	
HNSC	cis	1	rs56306402	chr20:33937704	CPNE1	chr20:34213968-34262539:-	0.25	4.52	7.9E-6	Height	
HNSC	cis	1	rs56306402	chr20:33937704	UQCC	chr20:33890383-33999833:-	0.34	6.33	5.67E-10	Height	
HNSC	cis	1	rs56308330	chr4:17643050	FAM184B	chr4:17633711-17783135:-	-0.17	-4.07	5.55E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs56314138	chr3:121356656	IQCB1	chr3:121488610-121553926:-	0.25	6.23	1.0E-9	Cognitive performance	
HNSC	cis	1	rs56321614	chr2:268191	SH3YL1	chr2:218138-264810:-	-0.65	-12.9	5.45E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs56322409	chr10:97395962	ENTPD1	chr10:97471536-97637022:+	0.24	7.37	7.3E-13	Blood metabolite levels	
HNSC	cis	1	rs56345529	chr1:171651372	VAMP4	chr1:171669298-171711214:-	0.28	4.79	2.19E-6	Hippocampal atrophy	
HNSC	cis	1	rs56390833	chr15:78877381	CHRNA5	chr15:78857906-78886458:+	-0.26	-5.2	3.0E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs563920	chr12:121017439	POP5	chr12:121016849-121019201:-	-0.22	-3.92	0.000101	Type 1 diabetes nephropathy	
HNSC	cis	1	rs563920	chr12:121017439	TRIAP1	chr12:120881765-120884215:-	-0.22	-3.69	0.000245	Type 1 diabetes nephropathy	
HNSC	cis	1	rs565974	chr10:131423274	MGMT	chr10:131265454-131565783:+	0.3	6.07	2.55E-9	Response to temozolomide	
HNSC	cis	1	rs56672945	chr2:73622663	ALMS1P	chr2:73872046-73912692:+	0.26	4.45	1.08E-5	Metabolite levels	
HNSC	cis	1	rs567700	chr10:131423126	MGMT	chr10:131265454-131565783:+	0.3	6.07	2.55E-9	Response to temozolomide	
HNSC	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	0.73	12.29	1.85E-30	Diastolic blood pressure	
HNSC	cis	1	rs568129	chr6:84229114	PRSS35	chr6:84222274-84235419:+	0.19	4.06	5.82E-5	Bipolar disorder with mood-incongruent psychosis	
HNSC	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.57	-15.42	4.61E-44	Crohn's disease	
HNSC	cis	1	rs568617	chr11:65653242	SNX32	chr11:65601410-65621170:+	0.43	7.18	2.55E-12	Crohn's disease	
HNSC	cis	1	rs56884994	chr1:247211057	ZNF670	chr1:247200087-247242069:-	-0.29	-6.37	4.24E-10	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs56901035	chr8:96043188	C8orf38	chr8:95908040-96088396:+	-0.34	-5.18	3.27E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs569235	chr10:131411620	MGMT	chr10:131265454-131565783:+	0.29	6.06	2.65E-9	Response to temozolomide	
HNSC	cis	1	rs56974987	chr4:17627856	FAM184B	chr4:17633711-17783135:-	-0.17	-4.17	3.67E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs56985706	chr7:65394562	CRCP	chr7:65579805-65619551:+	-0.33	-3.97	8.29E-5	Diabetic kidney disease	
HNSC	cis	1	rs56985706	chr7:65394562	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.97	9.18E-7	Diabetic kidney disease	
HNSC	cis	1	rs57025426	chr10:102205868	SEC31B	chr10:102246403-102289636:-	-0.18	-5.72	1.86E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs57057549	chr7:65405738	CRCP	chr7:65579805-65619551:+	-0.32	-3.7	0.000242	Diabetic kidney disease	
HNSC	cis	1	rs57057549	chr7:65405738	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.58	5.96E-6	Diabetic kidney disease	
HNSC	cis	1	rs57075379	chr14:35577801	PPP2R3C	chr14:35554679-35591679:-	0.43	7.02	7.45E-12	Atopic dermatitis	
HNSC	cis	1	rs57201867	chr14:66093872	LOC645431	chr14:65877313-65879335:-	-0.28	-3.69	0.000247	Ischemic stroke	
HNSC	cis	1	rs57271189	chr3:99956869	TBC1D23	chr3:99979686-100044078:+	0.23	4.56	6.57E-6	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs57294261	chr10:81729342	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs57307201	chr17:40572793	NAGLU	chr17:40687951-40696464:+	-0.19	-3.78	0.000177	Crohn's disease	
HNSC	cis	1	rs57360215	chr10:81728290	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs57411618	chr17:28273052	EFCAB5	chr17:28256874-28435469:+	0.25	4.44	1.11E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs57434520	chr5:115648765	COMMD10	chr5:115420727-115628978:+	0.32	4.04	6.13E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs5750626	chr22:38977890	LOC646851	chr22:38974125-39052634:-	0.14	3.68	0.000262	Resting heart rate	
HNSC	cis	1	rs5750659	chr22:39068789	LOC646851	chr22:38974125-39052634:-	0.15	3.92	0.000101	Resting heart rate	
HNSC	cis	1	rs5750662	chr22:39072472	LOC646851	chr22:38974125-39052634:-	0.15	3.92	0.000101	Resting heart rate	
HNSC	cis	1	rs5750664	chr22:39072769	LOC646851	chr22:38974125-39052634:-	0.15	3.92	0.000101	Resting heart rate	
HNSC	cis	1	rs5750668	chr22:39079964	LOC646851	chr22:38974125-39052634:-	0.15	3.99	7.52E-5	Resting heart rate	
HNSC	cis	1	rs5750669	chr22:39080638	LOC646851	chr22:38974125-39052634:-	0.15	3.89	0.000112	Resting heart rate	
HNSC	cis	1	rs5751255	chr22:42648408	CYP2D6	chr22:42522502-42526883:-	-0.41	-11.05	1.71E-25	Cognitive function	
HNSC	cis	1	rs5752326	chr22:26843990	HPS4	chr22:26847447-26879820:-	0.4	3.96	8.45E-5	Ischemic stroke	
HNSC	cis	1	rs5752327	chr22:26844070	HPS4	chr22:26847447-26879820:-	0.37	3.69	0.000248	Ischemic stroke	
HNSC	cis	1	rs57542652	chr2:228088	SH3YL1	chr2:218138-264810:-	-0.68	-13.38	4.83E-35	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs5757141	chr22:38957483	LOC646851	chr22:38974125-39052634:-	0.14	3.68	0.000261	Resting heart rate	
HNSC	cis	1	rs5757181	chr22:39013522	LOC646851	chr22:38974125-39052634:-	0.15	3.75	0.000199	Resting heart rate	
HNSC	cis	1	rs5757187	chr22:39021522	LOC646851	chr22:38974125-39052634:-	-0.14	-3.74	0.000206	Resting heart rate	
HNSC	cis	1	rs5757196	chr22:39039855	LOC646851	chr22:38974125-39052634:-	0.14	3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs5757200	chr22:39043491	LOC646851	chr22:38974125-39052634:-	0.14	3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs5757203	chr22:39044152	LOC646851	chr22:38974125-39052634:-	0.14	3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs5757204	chr22:39046700	LOC646851	chr22:38974125-39052634:-	0.14	3.79	0.000167	Resting heart rate	
HNSC	cis	1	rs5757208	chr22:39049230	LOC646851	chr22:38974125-39052634:-	0.14	3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs5757213	chr22:39053888	LOC646851	chr22:38974125-39052634:-	0.14	3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs5757226	chr22:39070550	LOC646851	chr22:38974125-39052634:-	0.15	3.92	0.000101	Resting heart rate	
HNSC	cis	1	rs5757231	chr22:39071658	LOC646851	chr22:38974125-39052634:-	-0.15	-3.97	8.36E-5	Resting heart rate	
HNSC	cis	1	rs5757232	chr22:39071677	LOC646851	chr22:38974125-39052634:-	0.15	3.92	0.000101	Resting heart rate	
HNSC	cis	1	rs57576577	chr16:31036367	HSD3B7	chr16:30996519-31000473:+	0.23	4.23	2.81E-5	Response to metformin (IC50)	
HNSC	cis	1	rs57576577	chr16:31036367	MYST1	chr16:31128985-31142713:+	0.24	5.9	6.74E-9	Response to metformin (IC50)	
HNSC	cis	1	rs5758659	chr22:42622003	CYP2D6	chr22:42522502-42526883:-	-0.42	-11.34	1.23E-26	Cognitive function	
HNSC	cis	1	rs5758660	chr22:42623718	CYP2D6	chr22:42522502-42526883:-	-0.41	-11.27	2.35E-26	Cognitive function	
HNSC	cis	1	rs5758677	chr22:42643039	CYP2D6	chr22:42522502-42526883:-	-0.41	-11.02	2.11E-25	Cognitive function	
HNSC	cis	1	rs5760216	chr22:24539734	SUSD2	chr22:24577444-24585074:+	1.06	11.22	3.61E-26	Amyotrophic lateral sclerosis	
HNSC	cis	1	rs5760220	chr22:24542480	SUSD2	chr22:24577444-24585074:+	1.08	12.16	5.92E-30	Amyotrophic lateral sclerosis	
HNSC	cis	1	rs5760229	chr22:24560254	SUSD2	chr22:24577444-24585074:+	1.04	11.73	3.26E-28	Amyotrophic lateral sclerosis	
HNSC	cis	1	rs5761529	chr22:26843708	HPS4	chr22:26847447-26879820:-	0.4	3.96	8.45E-5	Ischemic stroke	
HNSC	cis	1	rs5761530	chr22:26843916	HPS4	chr22:26847447-26879820:-	0.37	4.07	5.51E-5	Ischemic stroke	
HNSC	cis	1	rs576663	chr11:65498942	RBM14	chr11:66384053-66397390:+	0.24	3.99	7.61E-5	Atopic dermatitis	
HNSC	cis	1	rs5768991	chr22:46983018	GRAMD4	chr22:47022658-47075687:+	-0.23	-4.16	3.73E-5	Urate levels in obese individuals	
HNSC	cis	1	rs57690120	chr20:33731437	PROCR	chr20:33758727-33765164:+	-0.27	-3.85	0.000132	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs577227	chr10:131404528	MGMT	chr10:131265454-131565783:+	0.3	6.04	3.04E-9	Response to temozolomide	
HNSC	cis	1	rs578056	chr11:65514874	SNX32	chr11:65601410-65621170:+	0.25	3.71	0.000228	Systemic lupus erythematosus	
HNSC	cis	1	rs57832572	chr12:8668281	CLEC4D	chr12:8666136-8674958:+	0.25	4.21	3.01E-5	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
HNSC	cis	1	rs57925408	chr8:96062930	C8orf38	chr8:95908040-96088396:+	-0.37	-5.68	2.32E-8	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs57928699	chr18:44645593	HDHD2	chr18:44633782-44676871:-	0.44	5.02	7.41E-7	Sitting height ratio	
HNSC	cis	1	rs57970196	chr14:55600405	KIAA0831	chr14:55833110-55878576:-	-0.2	-3.65	0.000286	Protein biomarker	
HNSC	cis	1	rs580016	chr12:120933977	POP5	chr12:121016849-121019201:-	0.21	3.67	0.000265	Type 1 diabetes nephropathy	
HNSC	cis	1	rs58062456	chr7:65394852	CRCP	chr7:65579805-65619551:+	-0.33	-3.97	8.29E-5	Diabetic kidney disease	
HNSC	cis	1	rs58062456	chr7:65394852	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.97	9.18E-7	Diabetic kidney disease	
HNSC	cis	1	rs580745	chr10:131414401	MGMT	chr10:131265454-131565783:+	0.3	6.05	2.95E-9	Response to temozolomide	
HNSC	cis	1	rs58115860	chr14:66057626	LOC645431	chr14:65877313-65879335:-	-0.29	-3.9	0.000111	Ischemic stroke	
HNSC	cis	1	rs58189451	chr6:149921388	NUP43	chr6:150045453-150067688:-	-0.31	-6.28	7.46E-10	Lung cancer	
HNSC	cis	1	rs58204112	chr14:74359417	LIN52	chr14:74551656-74667117:+	0.25	4.45	1.09E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs583583	chr1:147083114	ACP6	chr1:147119168-147142634:-	0.19	4.15	3.87E-5	Schizophrenia (negative symptoms)	
HNSC	cis	1	rs58380511	chr4:108912716	HADH	chr4:108910940-108956330:+	0.28	4.02	6.74E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs58389158	chr22:38128283	LGALS2	chr22:37966254-37976024:-	-0.15	-4.24	2.65E-5	Age-related hearing impairment	
HNSC	cis	1	rs58455759	chr1:171674987	VAMP4	chr1:171669298-171711214:-	0.25	4.29	2.11E-5	Hippocampal atrophy	
HNSC	cis	1	rs58461606	chr2:267367	SH3YL1	chr2:218138-264810:-	-0.66	-12.87	6.99E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs58603761	chr2:73726605	ALMS1P	chr2:73872046-73912692:+	0.26	4.36	1.59E-5	Metabolite levels	
HNSC	cis	1	rs58660500	chr3:53086573	TMEM110	chr3:52867139-52931547:-	0.5	5.77	1.43E-8	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs58669269	chr7:65951953	NCRNA00174	chr7:65841032-65865395:-	-0.51	-5.48	6.7E-8	Diabetic kidney disease	
HNSC	cis	1	rs58669269	chr7:65951953	STAG3L4	chr7:66767616-66786512:+	-0.4	-4.42	1.23E-5	Diabetic kidney disease	
HNSC	cis	1	rs58704470	chr10:81729390	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs58717741	chr5:150284936	LOC134466	chr5:150310000-150326146:-	0.43	5.7	2.02E-8	Crohn's disease	
HNSC	cis	1	rs58749629	chr20:44571317	WFDC3	chr20:44402847-44420547:-	-0.4	-5.81	1.13E-8	Abdominal aortic aneurysm	
HNSC	cis	1	rs588918	chr11:116856642	PCSK7	chr11:117075789-117102811:-	-0.26	-3.86	0.000128	Protein quantitative trait loci	
HNSC	cis	1	rs58952297	chr20:44560820	CD40	chr20:44746906-44758384:+	0.22	3.66	0.000278	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
HNSC	cis	1	rs58977394	chr3:128337917	RAB43	chr3:128806418-128880029:-	-0.2	-3.94	9.2E-5	Monocyte count	
HNSC	cis	1	rs59032271	chr5:148618749	AFAP1L1	chr5:148651401-148721365:+	0.18	3.84	0.000139	Body mass index	
HNSC	cis	1	rs59117465	chr14:66052472	LOC645431	chr14:65877313-65879335:-	-0.28	-3.76	0.000193	Ischemic stroke	
HNSC	cis	1	rs59150578	chr11:18340862	GTF2H1	chr11:18343816-18388590:+	0.32	5.55	4.8E-8	Pancreatic cancer	
HNSC	cis	1	rs59162293	chr4:142158774	ZNF330	chr4:142142049-142155848:+	-0.28	-4.47	9.85E-6	Conduct disorder	
HNSC	cis	1	rs591992	chr12:121019323	POP5	chr12:121016849-121019201:-	-0.23	-4.04	6.09E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs591992	chr12:121019323	SFRS9	chr12:120899472-120907558:-	-0.24	-3.69	0.000248	Type 1 diabetes nephropathy	
HNSC	cis	1	rs591992	chr12:121019323	TRIAP1	chr12:120881765-120884215:-	-0.22	-3.7	0.000238	Type 1 diabetes nephropathy	
HNSC	cis	1	rs59204447	chr14:66106727	LOC645431	chr14:65877313-65879335:-	-0.28	-3.74	0.000209	Ischemic stroke	
HNSC	cis	1	rs59226697	chr22:25870037	CRYBB2	chr22:25615612-25627836:+	0.54	5.14	3.98E-7	Bipolar disorder with mood-incongruent psychosis	
HNSC	cis	1	rs59233487	chr10:81729450	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs59244547	chr3:156582997	LEKR1	chr3:156544076-156763918:+	-0.45	-7.11	4.16E-12	Bone mineral density	
HNSC	cis	1	rs59274738	chr17:28437635	EFCAB5	chr17:28256874-28435469:+	0.22	4.08	5.24E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs59363432	chr14:74397545	LIN52	chr14:74551656-74667117:+	0.23	4.16	3.76E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs593982	chr11:65513107	RBM14	chr11:66384053-66397390:+	0.25	4.12	4.53E-5	Atopic dermatitis	
HNSC	cis	1	rs594074	chr6:6552994	LY86	chr6:6588934-6655216:+	0.16	4.57	6.19E-6	Diabetic kidney disease	
HNSC	cis	1	rs59468948	chr1:156288058	BGLAP	chr1:156182784-156213112:+	0.2	3.87	0.000122	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs59531858	chr5:150247063	LOC134466	chr5:150310000-150326146:-	0.5	6.3	6.55E-10	Crohn's disease	
HNSC	cis	1	rs59561356	chr14:66020022	LOC645431	chr14:65877313-65879335:-	-0.3	-4.07	5.53E-5	Ischemic stroke	
HNSC	cis	1	rs59583591	chr3:53119581	RFT1	chr3:53122503-53164470:-	0.31	4.26	2.47E-5	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs59644475	chr10:81729160	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs59676254	chr14:65942840	LOC645431	chr14:65877313-65879335:-	-0.29	-3.88	0.000117	Ischemic stroke	
HNSC	cis	1	rs59685862	chr14:66080130	LOC645431	chr14:65877313-65879335:-	-0.28	-3.73	0.000217	Ischemic stroke	
HNSC	cis	1	rs59757169	chr5:148618752	AFAP1L1	chr5:148651401-148721365:+	0.18	3.84	0.000139	Body mass index	
HNSC	cis	1	rs59794892	chr7:65415873	CRCP	chr7:65579805-65619551:+	-0.33	-3.82	0.000151	Diabetic kidney disease	
HNSC	cis	1	rs59794892	chr7:65415873	NCRNA00174	chr7:65841032-65865395:-	-0.45	-4.8	2.12E-6	Diabetic kidney disease	
HNSC	cis	1	rs59822422	chr14:65889566	LOC645431	chr14:65877313-65879335:-	-0.28	-3.82	0.000153	Ischemic stroke	
HNSC	cis	1	rs59921977	chr14:66018659	LOC645431	chr14:65877313-65879335:-	-0.3	-3.99	7.68E-5	Ischemic stroke	
HNSC	cis	1	rs59937473	chr2:271797	SH3YL1	chr2:218138-264810:-	-0.65	-12.95	3.24E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs5995610	chr22:39064681	LOC646851	chr22:38974125-39052634:-	0.15	3.94	9.39E-5	Resting heart rate	
HNSC	cis	1	rs60000965	chr10:81729165	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs6001182	chr22:39047443	LOC646851	chr22:38974125-39052634:-	0.14	3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs6001184	chr22:39052116	LOC646851	chr22:38974125-39052634:-	0.14	3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs6001185	chr22:39052155	LOC646851	chr22:38974125-39052634:-	0.14	3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs6001188	chr22:39062194	LOC646851	chr22:38974125-39052634:-	0.14	3.74	0.000207	Resting heart rate	
HNSC	cis	1	rs6001191	chr22:39074452	LOC646851	chr22:38974125-39052634:-	0.15	3.92	0.000101	Resting heart rate	
HNSC	cis	1	rs6009823	chr22:50086334	PANX2	chr22:50609160-50618723:+	0.21	3.76	0.000189	Natriuretic peptide levels	
HNSC	cis	1	rs6009824	chr22:50086373	PANX2	chr22:50609160-50618723:+	0.21	3.76	0.000189	Natriuretic peptide levels	
HNSC	cis	1	rs601338	chr19:49206674	FUT2	chr19:49199228-49209190:+	-0.51	-13.99	1.07E-37	Blood metabolite levels;Blood metabolite ratios	
HNSC	cis	1	rs601339	chr12:123174743	GPR109B	chr12:123199304-123201439:-	0.35	5.62	3.12E-8	Adiponectin levels	
HNSC	cis	1	rs60149603	chr2:285421	SH3YL1	chr2:218138-264810:-	-0.67	-12.87	6.82E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs60178264	chr4:17685308	FAM184B	chr4:17633711-17783135:-	-0.16	-3.96	8.54E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs60178264	chr4:17685308	LAP3	chr4:17578927-17609590:+	-0.15	-3.98	7.98E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs60184524	chr19:44294215	ZNF155	chr19:44488355-44502477:+	-0.21	-4.34	1.74E-5	Breast cancer	
HNSC	cis	1	rs601923	chr5:176417386	CDHR2	chr5:175976365-176022769:+	0.23	4.21	3.1E-5	Menopause (age at onset);Menarche and menopause (age at onset)	
HNSC	cis	1	rs60228288	chr18:44640412	HDHD2	chr18:44633782-44676871:-	0.44	4.96	9.94E-7	Sitting height ratio	
HNSC	cis	1	rs6028	chr1:169551682	F5	chr1:169481192-169555769:-	-0.27	-7	8.58E-12	Activated partial thromboplastin time	
HNSC	cis	1	rs60326618	chr7:66166358	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.98	8.74E-7	Gout	
HNSC	cis	1	rs60326618	chr7:66166358	STAG3L4	chr7:66767616-66786512:+	-0.39	-4.34	1.74E-5	Gout	
HNSC	cis	1	rs60340200	chr1:27287716	PDIK1L	chr1:26437656-26452024:+	-0.28	-3.65	0.000285	HDL cholesterol;Triglycerides;LDL cholesterol	
HNSC	cis	1	rs6036476	chr20:23610308	CST1	chr20:23728191-23731574:-	0.34	5.25	2.23E-7	Chronic kidney disease	
HNSC	cis	1	rs6036476	chr20:23610308	CST4	chr20:23666277-23669662:-	0.27	4.35	1.64E-5	Chronic kidney disease	
HNSC	cis	1	rs6036478	chr20:23611359	CST1	chr20:23728191-23731574:-	0.34	5.29	1.81E-7	Chronic kidney disease	
HNSC	cis	1	rs6036478	chr20:23611359	CST4	chr20:23666277-23669662:-	0.27	4.36	1.55E-5	Chronic kidney disease	
HNSC	cis	1	rs6037526	chr20:3251248	ITPA	chr20:3190056-3204504:+	-0.19	-3.84	0.000138	IFN-related cytopenia	
HNSC	cis	1	rs6037532	chr20:3267911	ITPA	chr20:3190056-3204504:+	-0.19	-3.87	0.000124	IFN-related cytopenia	
HNSC	cis	1	rs6037533	chr20:3268817	ITPA	chr20:3190056-3204504:+	-0.19	-3.87	0.000124	IFN-related cytopenia	
HNSC	cis	1	rs6037535	chr20:3270621	ITPA	chr20:3190056-3204504:+	-0.19	-3.77	0.000183	IFN-related cytopenia	
HNSC	cis	1	rs6037538	chr20:3282978	ITPA	chr20:3190056-3204504:+	-0.19	-3.87	0.000122	IFN-related cytopenia	
HNSC	cis	1	rs6037547	chr20:3299228	ITPA	chr20:3190056-3204504:+	-0.19	-3.84	0.000138	IFN-related cytopenia	
HNSC	cis	1	rs6037551	chr20:3306690	ITPA	chr20:3190056-3204504:+	-0.19	-3.84	0.000138	IFN-related cytopenia	
HNSC	cis	1	rs6037553	chr20:3313884	ITPA	chr20:3190056-3204504:+	-0.19	-3.84	0.000139	IFN-related cytopenia	
HNSC	cis	1	rs6037554	chr20:3315613	ITPA	chr20:3190056-3204504:+	-0.2	-4.08	5.35E-5	IFN-related cytopenia	
HNSC	cis	1	rs6037556	chr20:3317890	ITPA	chr20:3190056-3204504:+	-0.2	-4.08	5.35E-5	IFN-related cytopenia	
HNSC	cis	1	rs6037560	chr20:3323055	ITPA	chr20:3190056-3204504:+	-0.19	-3.81	0.000158	IFN-related cytopenia	
HNSC	cis	1	rs6037562	chr20:3326141	ITPA	chr20:3190056-3204504:+	-0.19	-3.81	0.000158	IFN-related cytopenia	
HNSC	cis	1	rs6037567	chr20:3332160	ITPA	chr20:3190056-3204504:+	-0.19	-3.88	0.00012	IFN-related cytopenia	
HNSC	cis	1	rs6037579	chr20:3347980	ITPA	chr20:3190056-3204504:+	-0.19	-3.88	0.000118	IFN-related cytopenia	
HNSC	cis	1	rs6037583	chr20:3360632	ITPA	chr20:3190056-3204504:+	-0.2	-4.04	6.19E-5	IFN-related cytopenia	
HNSC	cis	1	rs6037590	chr20:3374085	ITPA	chr20:3190056-3204504:+	-0.19	-3.89	0.000112	IFN-related cytopenia	
HNSC	cis	1	rs60422392	chr18:44621473	HDHD2	chr18:44633782-44676871:-	0.43	4.82	1.93E-6	Sitting height ratio	
HNSC	cis	1	rs60425110	chr15:75333000	SCAMP5	chr15:75287901-75313836:+	0.44	8.81	2.19E-17	Blood trace element (Zn levels)	
HNSC	cis	1	rs6042	chr13:113770068	F7	chr13:113760105-113774994:+	-0.27	-3.86	0.000128	End-stage coagulation	
HNSC	cis	1	rs60482539	chr15:56180297	NEDD4	chr15:56119131-56285835:-	0.22	5.19	3.04E-7	Keloid	
HNSC	cis	1	rs60484953	chr2:221560	SH3YL1	chr2:218138-264810:-	-0.66	-12.69	3.96E-32	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs6048956	chr20:23609301	CST1	chr20:23728191-23731574:-	0.34	5.24	2.44E-7	Chronic kidney disease	
HNSC	cis	1	rs6048956	chr20:23609301	CST4	chr20:23666277-23669662:-	0.27	4.36	1.57E-5	Chronic kidney disease	
HNSC	cis	1	rs6051080	chr20:25975674	LOC100134868	chr20:25990435-26002424:+	-0.38	-7.01	7.68E-12	Colorectal or endometrial cancer	
HNSC	cis	1	rs60512868	chr3:48483445	ATRIP	chr3:48488141-48507708:+	0.16	3.67	0.000265	Longevity	
HNSC	cis	1	rs60512868	chr3:48483445	TREX1	chr3:48501186-48509043:+	-0.26	-6.54	1.57E-10	Longevity	
HNSC	cis	1	rs60513756	chr5:90727692	LOC100129716	chr5:90676164-90716531:+	0.29	4.09	5.0E-5	Smoking behavior	
HNSC	cis	1	rs6051702	chr20:3251924	ITPA	chr20:3190056-3204504:+	-0.19	-3.84	0.000138	IFN-related cytopenia	
HNSC	cis	1	rs6051703	chr20:3252347	ITPA	chr20:3190056-3204504:+	-0.19	-3.88	0.000118	IFN-related cytopenia	
HNSC	cis	1	rs6051705	chr20:3253143	ITPA	chr20:3190056-3204504:+	-0.19	-3.88	0.000118	IFN-related cytopenia	
HNSC	cis	1	rs6051708	chr20:3262493	ITPA	chr20:3190056-3204504:+	-0.21	-4.35	1.63E-5	IFN-related cytopenia	
HNSC	cis	1	rs6051709	chr20:3263685	ITPA	chr20:3190056-3204504:+	-0.19	-3.96	8.67E-5	IFN-related cytopenia	
HNSC	cis	1	rs6051712	chr20:3265029	ITPA	chr20:3190056-3204504:+	-0.19	-3.87	0.000124	IFN-related cytopenia	
HNSC	cis	1	rs6051713	chr20:3265779	ITPA	chr20:3190056-3204504:+	0.19	3.8	0.000166	IFN-related cytopenia	
HNSC	cis	1	rs6051715	chr20:3266548	ITPA	chr20:3190056-3204504:+	-0.19	-3.87	0.000124	IFN-related cytopenia	
HNSC	cis	1	rs6051718	chr20:3270370	ITPA	chr20:3190056-3204504:+	-0.18	-3.67	0.00027	IFN-related cytopenia	
HNSC	cis	1	rs6051722	chr20:3274435	ITPA	chr20:3190056-3204504:+	-0.18	-3.67	0.00027	IFN-related cytopenia	
HNSC	cis	1	rs6051723	chr20:3278512	ITPA	chr20:3190056-3204504:+	-0.18	-3.67	0.00027	IFN-related cytopenia	
HNSC	cis	1	rs6051724	chr20:3279338	ITPA	chr20:3190056-3204504:+	-0.19	-3.87	0.000124	IFN-related cytopenia	
HNSC	cis	1	rs6051732	chr20:3294182	ITPA	chr20:3190056-3204504:+	-0.18	-3.67	0.00027	IFN-related cytopenia	
HNSC	cis	1	rs6051736	chr20:3296898	ITPA	chr20:3190056-3204504:+	-0.18	-3.74	0.000206	IFN-related cytopenia	
HNSC	cis	1	rs6051737	chr20:3296992	ITPA	chr20:3190056-3204504:+	-0.19	-3.91	0.000105	IFN-related cytopenia	
HNSC	cis	1	rs6051745	chr20:3307243	ITPA	chr20:3190056-3204504:+	-0.19	-3.84	0.000138	IFN-related cytopenia	
HNSC	cis	1	rs6051747	chr20:3307945	ITPA	chr20:3190056-3204504:+	-0.2	-4.04	6.16E-5	IFN-related cytopenia	
HNSC	cis	1	rs6051751	chr20:3310049	ITPA	chr20:3190056-3204504:+	-0.19	-3.84	0.000138	IFN-related cytopenia	
HNSC	cis	1	rs6051753	chr20:3315513	ITPA	chr20:3190056-3204504:+	-0.19	-3.88	0.00012	IFN-related cytopenia	
HNSC	cis	1	rs6051763	chr20:3321616	ITPA	chr20:3190056-3204504:+	-0.19	-3.83	0.000147	IFN-related cytopenia	
HNSC	cis	1	rs6051764	chr20:3321807	ITPA	chr20:3190056-3204504:+	0.21	4.32	1.86E-5	IFN-related cytopenia	
HNSC	cis	1	rs6051779	chr20:3333449	ITPA	chr20:3190056-3204504:+	-0.2	-4.08	5.29E-5	IFN-related cytopenia	
HNSC	cis	1	rs6051790	chr20:3342994	ITPA	chr20:3190056-3204504:+	-0.2	-4.05	5.95E-5	IFN-related cytopenia	
HNSC	cis	1	rs6051792	chr20:3343519	ITPA	chr20:3190056-3204504:+	-0.2	-4.08	5.29E-5	IFN-related cytopenia	
HNSC	cis	1	rs6051806	chr20:3350319	ITPA	chr20:3190056-3204504:+	-0.19	-3.89	0.000112	IFN-related cytopenia	
HNSC	cis	1	rs6051807	chr20:3350485	ITPA	chr20:3190056-3204504:+	-0.19	-3.69	0.00025	IFN-related cytopenia	
HNSC	cis	1	rs6051808	chr20:3350697	ITPA	chr20:3190056-3204504:+	-0.2	-4.09	5.0E-5	IFN-related cytopenia	
HNSC	cis	1	rs6051809	chr20:3352551	ITPA	chr20:3190056-3204504:+	-0.2	-4.09	5.0E-5	IFN-related cytopenia	
HNSC	cis	1	rs6051810	chr20:3355384	ITPA	chr20:3190056-3204504:+	-0.2	-4.09	5.0E-5	IFN-related cytopenia	
HNSC	cis	1	rs6051827	chr20:3372007	ITPA	chr20:3190056-3204504:+	-0.2	-4.09	5.0E-5	IFN-related cytopenia	
HNSC	cis	1	rs6051831	chr20:3373712	ITPA	chr20:3190056-3204504:+	0.2	4.16	3.69E-5	IFN-related cytopenia	
HNSC	cis	1	rs6051838	chr20:3389012	ITPA	chr20:3190056-3204504:+	-0.21	-4.21	3.08E-5	IFN-related cytopenia	
HNSC	cis	1	rs6060235	chr20:33691652	PROCR	chr20:33758727-33765164:+	-0.3	-3.94	9.29E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs6060236	chr20:33692618	PROCR	chr20:33758727-33765164:+	-0.3	-3.94	9.29E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs6060244	chr20:33699435	PROCR	chr20:33758727-33765164:+	0.3	4.09	5.07E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs6060245	chr20:33699625	PROCR	chr20:33758727-33765164:+	-0.32	-4.32	1.87E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs6060246	chr20:33701107	PROCR	chr20:33758727-33765164:+	-0.29	-3.91	0.000103	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs6060401	chr20:34005214	CPNE1	chr20:34213968-34262539:-	0.25	4.52	7.7E-6	Height	
HNSC	cis	1	rs6060401	chr20:34005214	UQCC	chr20:33890383-33999833:-	0.33	6.19	1.23E-9	Height	
HNSC	cis	1	rs6060402	chr20:34005240	CPNE1	chr20:34213968-34262539:-	0.26	4.68	3.79E-6	Height	
HNSC	cis	1	rs6060402	chr20:34005240	UQCC	chr20:33890383-33999833:-	0.34	6.32	5.99E-10	Height	
HNSC	cis	1	rs6061231	chr20:60956917	CABLES2	chr20:60963686-60982339:-	-0.17	-3.73	0.000212	Colorectal cancer	
HNSC	cis	1	rs6064401	chr20:55057904	C20orf43	chr20:55043647-55093942:+	0.21	4.2	3.21E-5	Refractive astigmatism	
HNSC	cis	1	rs6064404	chr20:55070798	C20orf43	chr20:55043647-55093942:+	0.2	4.1	4.88E-5	Refractive astigmatism	
HNSC	cis	1	rs6064405	chr20:55070946	C20orf43	chr20:55043647-55093942:+	0.22	4.33	1.84E-5	Refractive astigmatism	
HNSC	cis	1	rs60654041	chr20:55077917	C20orf43	chr20:55043647-55093942:+	0.22	4.31	1.95E-5	Refractive astigmatism	
HNSC	cis	1	rs606775	chr6:150704796	IYD	chr6:150690028-150725764:+	-0.17	-3.73	0.000216	Anger	
HNSC	cis	1	rs60683927	chr7:65394768	CRCP	chr7:65579805-65619551:+	-0.33	-3.97	8.29E-5	Diabetic kidney disease	
HNSC	cis	1	rs60683927	chr7:65394768	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.97	9.18E-7	Diabetic kidney disease	
HNSC	cis	1	rs60693825	chr14:35514456	PPP2R3C	chr14:35554679-35591679:-	0.43	6.91	1.51E-11	Atopic dermatitis	
HNSC	cis	1	rs6069758	chr20:55046735	C20orf43	chr20:55043647-55093942:+	0.21	4.06	5.68E-5	Refractive astigmatism	
HNSC	cis	1	rs6069763	chr20:55071639	C20orf43	chr20:55043647-55093942:+	-0.2	-3.97	8.25E-5	Refractive astigmatism	
HNSC	cis	1	rs6069766	chr20:55079036	C20orf43	chr20:55043647-55093942:+	0.22	4.41	1.28E-5	Refractive astigmatism	
HNSC	cis	1	rs6069767	chr20:55083478	C20orf43	chr20:55043647-55093942:+	0.19	3.71	0.000227	Refractive astigmatism	
HNSC	cis	1	rs6070692	chr20:57586374	TH1L	chr20:57556311-57570186:+	-0.28	-3.85	0.000132	Mean platelet volume	
HNSC	cis	1	rs6070696	chr20:57597645	TH1L	chr20:57556311-57570186:+	-0.27	-4.04	6.3E-5	Mean platelet volume	
HNSC	cis	1	rs6070697	chr20:57599402	TH1L	chr20:57556311-57570186:+	-0.28	-4.04	6.27E-5	Mean platelet volume	
HNSC	cis	1	rs60721872	chr10:81728044	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs6073957	chr20:44549476	CD40	chr20:44746906-44758384:+	0.24	3.91	0.000107	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
HNSC	cis	1	rs6073966	chr20:44570192	CD40	chr20:44746906-44758384:+	0.24	3.77	0.000183	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
HNSC	cis	1	rs6073971	chr20:44589970	CD40	chr20:44746906-44758384:+	0.23	3.79	0.00017	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
HNSC	cis	1	rs6073972	chr20:44590298	CD40	chr20:44746906-44758384:+	-0.22	-3.77	0.00018	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
HNSC	cis	1	rs60823703	chr10:81729345	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs60843830	chr2:286756	SH3YL1	chr2:218138-264810:-	-0.68	-13.15	4.56E-34	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs60844734	chr2:73623205	ALMS1P	chr2:73872046-73912692:+	0.26	4.45	1.08E-5	Metabolite levels	
HNSC	cis	1	rs60854219	chr18:44646664	HDHD2	chr18:44633782-44676871:-	0.44	5.02	7.41E-7	Sitting height ratio	
HNSC	cis	1	rs6087450	chr20:31720906	PLUNC	chr20:31823802-31831114:+	0.22	3.78	0.000178	Ulcerative colitis	
HNSC	cis	1	rs6087698	chr20:33948919	CPNE1	chr20:34213968-34262539:-	0.24	4.33	1.77E-5	Height	
HNSC	cis	1	rs6087698	chr20:33948919	UQCC	chr20:33890383-33999833:-	0.33	6.14	1.7E-9	Height	
HNSC	cis	1	rs6087702	chr20:33995945	CPNE1	chr20:34213968-34262539:-	0.24	4.35	1.66E-5	Height	
HNSC	cis	1	rs6087702	chr20:33995945	UQCC	chr20:33890383-33999833:-	0.32	6.12	1.95E-9	Height	
HNSC	cis	1	rs6087703	chr20:33996433	CPNE1	chr20:34213968-34262539:-	0.25	4.57	6.22E-6	Height	
HNSC	cis	1	rs6087703	chr20:33996433	UQCC	chr20:33890383-33999833:-	0.34	6.36	4.5E-10	Height	
HNSC	cis	1	rs6087704	chr20:34001058	CPNE1	chr20:34213968-34262539:-	0.25	4.57	6.22E-6	Height	
HNSC	cis	1	rs6087704	chr20:34001058	UQCC	chr20:33890383-33999833:-	0.34	6.36	4.5E-10	Height	
HNSC	cis	1	rs6087705	chr20:34001250	CPNE1	chr20:34213968-34262539:-	0.24	4.42	1.22E-5	Height	
HNSC	cis	1	rs6087705	chr20:34001250	UQCC	chr20:33890383-33999833:-	0.34	6.39	3.86E-10	Height	
HNSC	cis	1	rs6088799	chr20:33934301	CPNE1	chr20:34213968-34262539:-	0.24	4.3	2.06E-5	Height	
HNSC	cis	1	rs6088799	chr20:33934301	UQCC	chr20:33890383-33999833:-	0.32	6.05	2.8E-9	Height	
HNSC	cis	1	rs6088812	chr20:33974163	CPNE1	chr20:34213968-34262539:-	0.24	4.33	1.77E-5	Height	
HNSC	cis	1	rs6088812	chr20:33974163	UQCC	chr20:33890383-33999833:-	0.33	6.14	1.7E-9	Height	
HNSC	cis	1	rs6088813	chr20:33975181	CPNE1	chr20:34213968-34262539:-	0.24	4.33	1.77E-5	Height	
HNSC	cis	1	rs6088813	chr20:33975181	UQCC	chr20:33890383-33999833:-	0.33	6.14	1.7E-9	Height	
HNSC	cis	1	rs6088815	chr20:33976474	CPNE1	chr20:34213968-34262539:-	0.23	4.3	2.06E-5	Height	
HNSC	cis	1	rs6088815	chr20:33976474	UQCC	chr20:33890383-33999833:-	0.32	6.08	2.35E-9	Height	
HNSC	cis	1	rs6088816	chr20:33982435	CPNE1	chr20:34213968-34262539:-	0.24	4.4	1.34E-5	Height	
HNSC	cis	1	rs6088816	chr20:33982435	UQCC	chr20:33890383-33999833:-	0.33	6.19	1.29E-9	Height	
HNSC	cis	1	rs6088820	chr20:33987298	CPNE1	chr20:34213968-34262539:-	0.24	4.36	1.59E-5	Height	
HNSC	cis	1	rs6088820	chr20:33987298	UQCC	chr20:33890383-33999833:-	0.32	6.12	1.88E-9	Height	
HNSC	cis	1	rs6088821	chr20:33987576	CPNE1	chr20:34213968-34262539:-	0.25	4.58	6.02E-6	Height	
HNSC	cis	1	rs6088821	chr20:33987576	UQCC	chr20:33890383-33999833:-	0.34	6.37	4.39E-10	Height	
HNSC	cis	1	rs6088823	chr20:33994265	CPNE1	chr20:34213968-34262539:-	0.25	4.58	6.02E-6	Height	
HNSC	cis	1	rs6088823	chr20:33994265	UQCC	chr20:33890383-33999833:-	0.34	6.37	4.39E-10	Height	
HNSC	cis	1	rs6088825	chr20:33995972	CPNE1	chr20:34213968-34262539:-	0.24	4.39	1.4E-5	Height	
HNSC	cis	1	rs6088825	chr20:33995972	UQCC	chr20:33890383-33999833:-	0.33	6.18	1.33E-9	Height	
HNSC	cis	1	rs60927973	chr14:65897331	LOC645431	chr14:65877313-65879335:-	-0.29	-3.83	0.000146	Ischemic stroke	
HNSC	cis	1	rs60942590	chr3:53016421	TMEM110	chr3:52867139-52931547:-	0.46	5.09	5.05E-7	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs60942639	chr14:66107636	LOC645431	chr14:65877313-65879335:-	-0.28	-3.69	0.000247	Ischemic stroke	
HNSC	cis	1	rs60967688	chr17:28437052	GIT1	chr17:27900487-27916610:-	-0.17	-3.82	0.000151	Coffee consumption (cups per day)	
HNSC	cis	1	rs60982898	chr6:49385806	CENPQ	chr6:49431096-49460820:+	-0.4	-9.43	1.6E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs60982898	chr6:49385806	MUT	chr6:49398994-49431031:-	0.42	9.12	1.98E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs6099171	chr20:55071253	C20orf43	chr20:55043647-55093942:+	0.21	4.27	2.33E-5	Refractive astigmatism	
HNSC	cis	1	rs6099184	chr20:55097478	C20orf43	chr20:55043647-55093942:+	0.19	3.85	0.000134	Refractive astigmatism	
HNSC	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.41	-7.22	1.93E-12	Forced vital capacity	
HNSC	cis	1	rs61102033	chr1:46382441	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.71	6.99E-14	Body mass index	
HNSC	cis	1	rs6114206	chr20:23611789	CST1	chr20:23728191-23731574:-	0.33	5.17	3.44E-7	Chronic kidney disease	
HNSC	cis	1	rs6114206	chr20:23611789	CST4	chr20:23666277-23669662:-	0.26	4.24	2.62E-5	Chronic kidney disease	
HNSC	cis	1	rs6114208	chr20:23621734	CST1	chr20:23728191-23731574:-	0.34	5.31	1.66E-7	Chronic kidney disease	
HNSC	cis	1	rs6114208	chr20:23621734	CST4	chr20:23666277-23669662:-	0.27	4.42	1.23E-5	Chronic kidney disease	
HNSC	cis	1	rs6114209	chr20:23622266	CST1	chr20:23728191-23731574:-	0.34	5.16	3.61E-7	Chronic kidney disease	
HNSC	cis	1	rs6114209	chr20:23622266	CST4	chr20:23666277-23669662:-	0.28	4.39	1.39E-5	Chronic kidney disease	
HNSC	cis	1	rs61172708	chr3:52996052	TMEM110	chr3:52867139-52931547:-	0.52	6.02	3.48E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.66	-9.28	5.31E-19	Triglycerides	
HNSC	cis	1	rs613089	chr1:147081187	ACP6	chr1:147119168-147142634:-	-0.2	-4.32	1.88E-5	Schizophrenia (negative symptoms)	
HNSC	cis	1	rs61316646	chr18:44610670	HDHD2	chr18:44633782-44676871:-	0.43	4.81	1.99E-6	Sitting height ratio	
HNSC	cis	1	rs6133036	chr20:3349682	ITPA	chr20:3190056-3204504:+	-0.2	-4.13	4.29E-5	IFN-related cytopenia	
HNSC	cis	1	rs61366424	chr10:60004851	CISD1	chr10:60028895-60049018:+	0.24	4.22	2.89E-5	Inflammatory bowel disease	
HNSC	cis	1	rs61366424	chr10:60004851	IPMK	chr10:59955618-60027694:-	0.28	6.9	1.64E-11	Inflammatory bowel disease	
HNSC	cis	1	rs6139064	chr20:3277050	ITPA	chr20:3190056-3204504:+	-0.19	-3.87	0.000124	IFN-related cytopenia	
HNSC	cis	1	rs6139068	chr20:3284393	ITPA	chr20:3190056-3204504:+	-0.18	-3.67	0.00027	IFN-related cytopenia	
HNSC	cis	1	rs6139088	chr20:3329063	ITPA	chr20:3190056-3204504:+	-0.19	-3.91	0.000105	IFN-related cytopenia	
HNSC	cis	1	rs6139103	chr20:3361140	ITPA	chr20:3190056-3204504:+	-0.19	-3.89	0.000112	IFN-related cytopenia	
HNSC	cis	1	rs6139117	chr20:3387785	ITPA	chr20:3190056-3204504:+	-0.2	-4.09	4.96E-5	IFN-related cytopenia	
HNSC	cis	1	rs6141546	chr20:33949282	CPNE1	chr20:34213968-34262539:-	0.24	4.33	1.77E-5	Height	
HNSC	cis	1	rs6141546	chr20:33949282	UQCC	chr20:33890383-33999833:-	0.33	6.14	1.7E-9	Height	
HNSC	cis	1	rs6141548	chr20:33971085	CPNE1	chr20:34213968-34262539:-	0.24	4.33	1.77E-5	Height	
HNSC	cis	1	rs6141548	chr20:33971085	UQCC	chr20:33890383-33999833:-	0.33	6.14	1.7E-9	Height	
HNSC	cis	1	rs6141549	chr20:33974051	CPNE1	chr20:34213968-34262539:-	0.24	4.33	1.77E-5	Height	
HNSC	cis	1	rs6141549	chr20:33974051	UQCC	chr20:33890383-33999833:-	0.33	6.14	1.7E-9	Height	
HNSC	cis	1	rs614226	chr12:120974510	GATC	chr12:120884284-120897761:+	0.28	4.2	3.11E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs614226	chr12:120974510	POP5	chr12:121016849-121019201:-	0.25	4.44	1.1E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs614226	chr12:120974510	SFRS9	chr12:120899472-120907558:-	0.27	4.18	3.39E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs614226	chr12:120974510	TRIAP1	chr12:120881765-120884215:-	0.26	4.56	6.6E-6	Type 1 diabetes nephropathy	
HNSC	cis	1	rs6142358	chr20:33960308	CPNE1	chr20:34213968-34262539:-	-0.23	-4.16	3.79E-5	Height	
HNSC	cis	1	rs6142358	chr20:33960308	UQCC	chr20:33890383-33999833:-	-0.32	-5.96	4.73E-9	Height	
HNSC	cis	1	rs6142359	chr20:33960450	CPNE1	chr20:34213968-34262539:-	0.24	4.33	1.77E-5	Height	
HNSC	cis	1	rs6142359	chr20:33960450	UQCC	chr20:33890383-33999833:-	0.33	6.14	1.7E-9	Height	
HNSC	cis	1	rs6142360	chr20:33960486	CPNE1	chr20:34213968-34262539:-	0.23	4.09	5.14E-5	Height	
HNSC	cis	1	rs6142360	chr20:33960486	UQCC	chr20:33890383-33999833:-	0.32	5.79	1.29E-8	Height	
HNSC	cis	1	rs6142369	chr20:33973315	CPNE1	chr20:34213968-34262539:-	0.25	4.52	7.9E-6	Height	
HNSC	cis	1	rs6142369	chr20:33973315	UQCC	chr20:33890383-33999833:-	0.34	6.33	5.67E-10	Height	
HNSC	cis	1	rs6142370	chr20:33973378	CPNE1	chr20:34213968-34262539:-	0.24	4.33	1.77E-5	Height	
HNSC	cis	1	rs6142370	chr20:33973378	UQCC	chr20:33890383-33999833:-	0.33	6.14	1.7E-9	Height	
HNSC	cis	1	rs6142373	chr20:33983314	CPNE1	chr20:34213968-34262539:-	0.24	4.36	1.59E-5	Height	
HNSC	cis	1	rs6142373	chr20:33983314	UQCC	chr20:33890383-33999833:-	0.32	6.12	1.88E-9	Height	
HNSC	cis	1	rs6142374	chr20:33985568	CPNE1	chr20:34213968-34262539:-	0.25	4.58	6.02E-6	Height	
HNSC	cis	1	rs6142374	chr20:33985568	UQCC	chr20:33890383-33999833:-	0.34	6.37	4.39E-10	Height	
HNSC	cis	1	rs6142376	chr20:33992761	CPNE1	chr20:34213968-34262539:-	0.24	4.4	1.34E-5	Height	
HNSC	cis	1	rs6142376	chr20:33992761	UQCC	chr20:33890383-33999833:-	0.33	6.19	1.29E-9	Height	
HNSC	cis	1	rs6142379	chr20:33999267	CPNE1	chr20:34213968-34262539:-	0.25	4.57	6.22E-6	Height	
HNSC	cis	1	rs6142379	chr20:33999267	UQCC	chr20:33890383-33999833:-	0.34	6.36	4.5E-10	Height	
HNSC	cis	1	rs61508494	chr14:55587297	KIAA0831	chr14:55833110-55878576:-	-0.21	-3.91	0.000106	Protein biomarker	
HNSC	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-1.06	-11.5	2.79E-27	Blood metabolite levels	
HNSC	cis	1	rs61524473	chr15:45646283	SPATA5L1	chr15:45694519-45713614:+	0.45	8.34	7.51E-16	Metabolite levels (small molecules and protein measures)	
HNSC	cis	1	rs61530785	chr5:150261364	LOC134466	chr5:150310000-150326146:-	0.48	6.19	1.26E-9	Crohn's disease	
HNSC	cis	1	rs61573157	chr10:72520259	C10orf27	chr10:72530995-72545157:-	0.32	3.78	0.000178	Prion diseases	
HNSC	cis	1	rs61596977	chr8:95997165	C8orf38	chr8:95908040-96088396:+	-0.36	-5.22	2.65E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs61601271	chr10:81727941	LOC650623	chr10:81442731-81448648:+	-0.37	-3.94	9.5E-5	Rheumatoid arthritis	
HNSC	cis	1	rs61612071	chr5:90741470	LOC100129716	chr5:90676164-90716531:+	0.31	4.47	9.62E-6	Smoking behavior	
HNSC	cis	1	rs616157	chr12:120925795	GATC	chr12:120884284-120897761:+	0.27	4.09	5.04E-5	Type 1 diabetes nephropathy	
HNSC	cis	1	rs616157	chr12:120925795	POP5	chr12:121016849-121019201:-	0.25	4.51	8.06E-6	Type 1 diabetes nephropathy	
HNSC	cis	1	rs616157	chr12:120925795	SFRS9	chr12:120899472-120907558:-	0.29	4.65	4.26E-6	Type 1 diabetes nephropathy	
HNSC	cis	1	rs616157	chr12:120925795	TRIAP1	chr12:120881765-120884215:-	0.26	4.67	3.83E-6	Type 1 diabetes nephropathy	
HNSC	cis	1	rs61783200	chr1:46297403	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.63	1.2E-13	Body mass index	
HNSC	cis	1	rs61783220	chr1:46335312	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.44	4.66E-13	Body mass index	
HNSC	cis	1	rs61818802	chr1:113181739	ST7L	chr1:113066142-113162405:-	0.4	5.89	7.14E-9	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs61820166	chr1:150556036	GOLPH3L	chr1:150618701-150669672:-	0.3	4.06	5.81E-5	Congenital left-sided heart lesions	
HNSC	cis	1	rs61820166	chr1:150556036	HORMAD1	chr1:150670542-150693352:-	-0.38	-4.68	3.78E-6	Congenital left-sided heart lesions	
HNSC	cis	1	rs61826828	chr1:174015261	SERPINC1	chr1:173872943-173886516:-	0.62	9.48	1.09E-19	Schizophrenia	
HNSC	cis	1	rs61852630	chr1:247210193	ZNF670	chr1:247200087-247242069:-	-0.3	-6.49	2.07E-10	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs61852637	chr1:247219636	ZNF670	chr1:247200087-247242069:-	-0.3	-6.62	9.37E-11	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs61853072	chr10:90961500	IFIT5	chr10:91174325-91180758:+	-0.25	-4.02	6.83E-5	Heart failure	
HNSC	cis	1	rs61858625	chr10:38002042	LOC399744	chr10:38717074-38741080:+	0.28	3.83	0.000145	Obesity (extreme)	
HNSC	cis	1	rs61858629	chr10:38014770	LOC399744	chr10:38717074-38741080:+	0.31	4.31	2.01E-5	Obesity (extreme)	
HNSC	cis	1	rs61859667	chr10:38016379	LOC399744	chr10:38717074-38741080:+	0.28	3.83	0.000147	Obesity (extreme)	
HNSC	cis	1	rs61871790	chr10:97391223	ENTPD1	chr10:97471536-97637022:+	0.24	7.24	1.71E-12	Blood metabolite levels	
HNSC	cis	1	rs61871792	chr10:97397586	ENTPD1	chr10:97471536-97637022:+	0.24	7.37	7.3E-13	Blood metabolite levels	
HNSC	cis	1	rs61871793	chr10:97407738	ENTPD1	chr10:97471536-97637022:+	0.25	7.45	4.11E-13	Blood metabolite levels	
HNSC	cis	1	rs61879300	chr11:22117880	ANO5	chr11:22214722-22304913:+	0.17	3.7	0.00024	Parkinson's disease	
HNSC	cis	1	rs61888887	chr11:57099051	PRG2	chr11:57151267-57191532:-	-0.33	-3.75	0.000196	Low high density lipoprotein cholesterol levels	
HNSC	cis	1	rs62026530	chr15:84775840	LOC388152	chr15:84867600-84898920:-	-0.28	-4.95	1.03E-6	Schizophrenia	
HNSC	cis	1	rs62070270	chr17:28263980	EFCAB5	chr17:28256874-28435469:+	0.21	3.7	0.000238	Coffee consumption (cups per day)	
HNSC	cis	1	rs62070312	chr17:28438877	EFCAB5	chr17:28256874-28435469:+	0.22	4.03	6.55E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs62073605	chr17:18066791	LOC220594	chr17:18414577-18445234:-	-0.29	-4.41	1.26E-5	Obesity-related traits	
HNSC	cis	1	rs62073606	chr17:18069142	LOC220594	chr17:18414577-18445234:-	-0.29	-4.41	1.25E-5	Obesity-related traits	
HNSC	cis	1	rs62096463	chr18:44628928	HDHD2	chr18:44633782-44676871:-	0.43	4.82	1.93E-6	Sitting height ratio	
HNSC	cis	1	rs62096464	chr18:44629207	HDHD2	chr18:44633782-44676871:-	0.43	4.82	1.93E-6	Sitting height ratio	
HNSC	cis	1	rs62096466	chr18:44636171	HDHD2	chr18:44633782-44676871:-	0.43	4.84	1.7E-6	Sitting height ratio	
HNSC	cis	1	rs62096468	chr18:44637566	HDHD2	chr18:44633782-44676871:-	0.44	4.83	1.84E-6	Sitting height ratio	
HNSC	cis	1	rs62096469	chr18:44638298	HDHD2	chr18:44633782-44676871:-	0.44	4.96	9.94E-7	Sitting height ratio	
HNSC	cis	1	rs62096470	chr18:44641466	HDHD2	chr18:44633782-44676871:-	0.44	4.96	9.94E-7	Sitting height ratio	
HNSC	cis	1	rs62096471	chr18:44643814	HDHD2	chr18:44633782-44676871:-	0.44	5.02	7.41E-7	Sitting height ratio	
HNSC	cis	1	rs62096474	chr18:44647504	HDHD2	chr18:44633782-44676871:-	0.44	5.02	7.41E-7	Sitting height ratio	
HNSC	cis	1	rs62096476	chr18:44658621	HDHD2	chr18:44633782-44676871:-	0.44	5.01	7.42E-7	Sitting height ratio	
HNSC	cis	1	rs62096478	chr18:44662409	HDHD2	chr18:44633782-44676871:-	0.44	5.01	7.42E-7	Sitting height ratio	
HNSC	cis	1	rs62114497	chr2:214837	SH3YL1	chr2:218138-264810:-	-0.66	-12.52	1.96E-31	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs62114501	chr2:231741	SH3YL1	chr2:218138-264810:-	-0.67	-13.03	1.47E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs62114505	chr2:242426	SH3YL1	chr2:218138-264810:-	-0.67	-13.19	2.93E-34	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs62114544	chr2:269679	SH3YL1	chr2:218138-264810:-	-0.65	-12.71	3.32E-32	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs62114548	chr2:274672	SH3YL1	chr2:218138-264810:-	-0.65	-12.41	6.03E-31	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs62120832	chr19:23064264	ZNF492	chr19:22817126-22850472:+	-0.32	-4.95	1.03E-6	Bronchopulmonary dysplasia	
HNSC	cis	1	rs62121818	chr19:39167760	LGALS7B	chr19:39279850-39282393:+	0.26	5.84	9.53E-9	Heart rate	
HNSC	cis	1	rs62136864	chr2:46829124	ATP6V1E2	chr2:46738988-46769696:-	-0.24	-4.26	2.46E-5	Height	
HNSC	cis	1	rs62136864	chr2:46829124	PIGF	chr2:46808414-46844251:-	0.25	4.97	9.48E-7	Height	
HNSC	cis	1	rs62151652	chr2:73700131	ALMS1P	chr2:73872046-73912692:+	0.26	4.39	1.4E-5	Metabolite levels	
HNSC	cis	1	rs62210663	chr20:55067481	C20orf43	chr20:55043647-55093942:+	0.21	4.13	4.29E-5	Refractive astigmatism	
HNSC	cis	1	rs62211529	chr20:33959315	CPNE1	chr20:34213968-34262539:-	0.25	4.52	7.9E-6	Height	
HNSC	cis	1	rs62211529	chr20:33959315	UQCC	chr20:33890383-33999833:-	0.34	6.33	5.67E-10	Height	
HNSC	cis	1	rs62236667	chr22:38061520	LGALS2	chr22:37966254-37976024:-	0.13	3.86	0.000128	Fat distribution (HIV)	
HNSC	cis	1	rs62236668	chr22:38063870	LGALS2	chr22:37966254-37976024:-	0.13	3.71	0.000229	Fat distribution (HIV)	
HNSC	cis	1	rs62259933	chr3:49469703	AMT	chr3:49454212-49460012:-	-0.18	-4.02	6.86E-5	Menarche (age at onset)	
HNSC	cis	1	rs62268732	chr3:121370455	IQCB1	chr3:121488610-121553926:-	0.24	6.04	3.01E-9	Cognitive performance	
HNSC	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.48	10.3	1.14E-22	Height	
HNSC	cis	1	rs62269547	chr3:134214042	CEP63	chr3:134204575-134293852:+	0.27	5.9	6.93E-9	Height	
HNSC	cis	1	rs62271513	chr3:134298412	ANAPC13	chr3:134196547-134204865:-	-0.5	-10.71	3.34E-24	Height	
HNSC	cis	1	rs62271513	chr3:134298412	CEP63	chr3:134204575-134293852:+	-0.28	-5.95	5.13E-9	Height	
HNSC	cis	1	rs62271514	chr3:134298554	ANAPC13	chr3:134196547-134204865:-	-0.5	-10.71	3.34E-24	Height	
HNSC	cis	1	rs62271514	chr3:134298554	CEP63	chr3:134204575-134293852:+	-0.28	-5.95	5.13E-9	Height	
HNSC	cis	1	rs62271515	chr3:134300507	ANAPC13	chr3:134196547-134204865:-	0.49	10.56	1.22E-23	Height	
HNSC	cis	1	rs62271515	chr3:134300507	CEP63	chr3:134204575-134293852:+	0.27	5.76	1.51E-8	Height	
HNSC	cis	1	rs62281663	chr3:99936137	TBC1D23	chr3:99979686-100044078:+	0.24	4.63	4.74E-6	Visceral adipose tissue/subcutaneous adipose tissue ratio	
HNSC	cis	1	rs62295634	chr4:17685346	FAM184B	chr4:17633711-17783135:-	-0.17	-3.94	9.35E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs62295634	chr4:17685346	LAP3	chr4:17578927-17609590:+	-0.16	-4.07	5.43E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs62316358	chr4:109432522	RPL34	chr4:109541722-109551637:+	0.15	3.7	0.000242	Height	
HNSC	cis	1	rs62321365	chr4:107013723	TBCK	chr4:106967233-107237861:-	0.27	5.27	2.02E-7	Airflow obstruction	
HNSC	cis	1	rs62327566	chr4:142150894	ZNF330	chr4:142142049-142155848:+	-0.29	-4.57	6.3E-6	Conduct disorder	
HNSC	cis	1	rs62327586	chr4:142159228	ZNF330	chr4:142142049-142155848:+	-0.31	-4.81	1.99E-6	Conduct disorder	
HNSC	cis	1	rs62374373	chr5:82433208	XRCC4	chr5:82373317-82649577:+	-0.2	-3.96	8.59E-5	Hypertension	
HNSC	cis	1	rs62374374	chr5:82440657	XRCC4	chr5:82373317-82649577:+	-0.21	-4.06	5.74E-5	Hypertension	
HNSC	cis	1	rs62384213	chr5:115526795	COMMD10	chr5:115420727-115628978:+	0.41	4.48	9.28E-6	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384215	chr5:115528198	COMMD10	chr5:115420727-115628978:+	0.36	3.77	0.000181	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384231	chr5:115530304	COMMD10	chr5:115420727-115628978:+	0.34	4.01	7.12E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384233	chr5:115533597	COMMD10	chr5:115420727-115628978:+	0.37	4.44	1.1E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384235	chr5:115534234	COMMD10	chr5:115420727-115628978:+	0.38	4.04	6.29E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384236	chr5:115534637	COMMD10	chr5:115420727-115628978:+	0.38	4.04	6.29E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384237	chr5:115540222	COMMD10	chr5:115420727-115628978:+	0.37	4.33	1.82E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384238	chr5:115542531	COMMD10	chr5:115420727-115628978:+	0.41	4.2	3.11E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384253	chr5:115563415	COMMD10	chr5:115420727-115628978:+	0.37	3.74	0.000204	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384468	chr5:115623850	COMMD10	chr5:115420727-115628978:+	0.36	3.88	0.000117	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384469	chr5:115624964	COMMD10	chr5:115420727-115628978:+	0.33	4.12	4.41E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384471	chr5:115631273	COMMD10	chr5:115420727-115628978:+	0.31	3.8	0.000163	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384476	chr5:115649509	COMMD10	chr5:115420727-115628978:+	0.4	4.37	1.5E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384493	chr5:115673448	COMMD10	chr5:115420727-115628978:+	0.36	3.75	0.000196	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384678	chr5:115422688	COMMD10	chr5:115420727-115628978:+	0.36	4.12	4.46E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384697	chr5:115438284	COMMD10	chr5:115420727-115628978:+	0.34	3.95	8.96E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384700	chr5:115443805	COMMD10	chr5:115420727-115628978:+	0.34	3.95	8.96E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62384714	chr5:115452597	COMMD10	chr5:115420727-115628978:+	0.35	3.68	0.000262	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62385980	chr5:115592908	COMMD10	chr5:115420727-115628978:+	0.4	4.03	6.56E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62385993	chr5:115602254	COMMD10	chr5:115420727-115628978:+	0.4	4.05	6.07E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs62402013	chr6:26915000	BTN3A2	chr6:26365398-26378546:+	0.23	5.14	3.92E-7	Schizophrenia	
HNSC	cis	1	rs62402013	chr6:26915000	LOC100270746	chr6:26987146-26988085:-	-0.25	-5.35	1.38E-7	Schizophrenia	
HNSC	cis	1	rs62421536	chr6:118727972	C6orf204	chr6:118786239-119031238:-	-0.24	-4.13	4.22E-5	Renal cell carcinoma	
HNSC	cis	1	rs62421539	chr6:118730559	C6orf204	chr6:118786239-119031238:-	-0.24	-4.36	1.58E-5	Renal cell carcinoma	
HNSC	cis	1	rs62422189	chr6:118907053	C6orf204	chr6:118786239-119031238:-	-0.24	-3.97	8.32E-5	Renal cell carcinoma	
HNSC	cis	1	rs62422220	chr6:118923731	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.54E-5	Renal cell carcinoma	
HNSC	cis	1	rs62422221	chr6:118925581	C6orf204	chr6:118786239-119031238:-	-0.24	-4.14	4.12E-5	Renal cell carcinoma	
HNSC	cis	1	rs62422224	chr6:118941116	C6orf204	chr6:118786239-119031238:-	-0.24	-4.1	4.8E-5	Renal cell carcinoma	
HNSC	cis	1	rs62422227	chr6:118957200	C6orf204	chr6:118786239-119031238:-	-0.24	-4.32	1.86E-5	Renal cell carcinoma	
HNSC	cis	1	rs62422228	chr6:118957276	C6orf204	chr6:118786239-119031238:-	-0.24	-4.32	1.86E-5	Renal cell carcinoma	
HNSC	cis	1	rs62422229	chr6:118959288	C6orf204	chr6:118786239-119031238:-	-0.24	-4.21	3.01E-5	Renal cell carcinoma	
HNSC	cis	1	rs62422235	chr6:118971913	C6orf204	chr6:118786239-119031238:-	-0.24	-4.07	5.54E-5	Renal cell carcinoma	
HNSC	cis	1	rs62422236	chr6:118972633	C6orf204	chr6:118786239-119031238:-	-0.24	-4.07	5.54E-5	Renal cell carcinoma	
HNSC	cis	1	rs62424172	chr6:118777533	C6orf204	chr6:118786239-119031238:-	-0.25	-4.4	1.35E-5	Renal cell carcinoma	
HNSC	cis	1	rs62424175	chr6:118797381	C6orf204	chr6:118786239-119031238:-	-0.24	-4.04	6.19E-5	Renal cell carcinoma	
HNSC	cis	1	rs62424195	chr6:118812108	C6orf204	chr6:118786239-119031238:-	-0.25	-4.39	1.41E-5	Renal cell carcinoma	
HNSC	cis	1	rs62424198	chr6:118827247	C6orf204	chr6:118786239-119031238:-	-0.25	-4.34	1.76E-5	Renal cell carcinoma	
HNSC	cis	1	rs62424199	chr6:118827252	C6orf204	chr6:118786239-119031238:-	-0.25	-4.34	1.76E-5	Renal cell carcinoma	
HNSC	cis	1	rs62466793	chr7:66191517	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.82	1.27E-24	Aortic root size	
HNSC	cis	1	rs62466794	chr7:66191579	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.78	1.84E-24	Aortic root size	
HNSC	cis	1	rs62541929	chr9:35922113	LOC158376	chr9:35909480-35911617:+	-0.33	-3.94	9.21E-5	Urate levels (BMI interaction)	
HNSC	cis	1	rs62663261	chr6:118900553	C6orf204	chr6:118786239-119031238:-	-0.24	-4.14	4.12E-5	Renal cell carcinoma	
HNSC	cis	1	rs627830	chr3:124088009	UMPS	chr3:124449213-124464038:+	0.18	3.9	0.00011	Schizophrenia	
HNSC	cis	1	rs630408	chr12:123172822	GPR109B	chr12:123199304-123201439:-	0.34	5.51	5.75E-8	Adiponectin levels	
HNSC	cis	1	rs635400	chr12:123171089	GPR109B	chr12:123199304-123201439:-	0.33	5.45	8.16E-8	Adiponectin levels	
HNSC	cis	1	rs636736	chr11:118705145	DDX6	chr11:118618473-118661972:-	-0.21	-3.83	0.000145	Vitiligo	
HNSC	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.57	-15.42	4.61E-44	Crohn's disease	
HNSC	cis	1	rs641018	chr11:65655393	SNX32	chr11:65601410-65621170:+	0.43	7.18	2.55E-12	Crohn's disease	
HNSC	cis	1	rs6413523	chr10:81706135	LOC650623	chr10:81442731-81448648:+	0.33	3.71	0.000234	Rheumatoid arthritis	
HNSC	cis	1	rs6422512	chr1:93024844	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs6427049	chr1:166956593	FMO9P	chr1:166573153-166594471:+	0.23	4.41	1.26E-5	Refractive astigmatism	
HNSC	cis	1	rs6429082	chr1:235600129	B3GALNT2	chr1:235610533-235667781:-	0.22	4.47	9.86E-6	Adiposity	
HNSC	cis	1	rs6429082	chr1:235600129	RBM34	chr1:235294499-235324772:-	0.15	3.83	0.000146	Adiposity	
HNSC	cis	1	rs6429082	chr1:235600129	TBCE	chr1:235530728-235612280:+	0.21	4.42	1.2E-5	Adiposity	
HNSC	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.71	-18.56	1.05E-58	Homocysteine levels	
HNSC	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.62	-16.57	2.42E-49	Homocysteine levels	
HNSC	cis	1	rs6429582	chr1:46321843	CCDC163P	chr1:45960581-45965646:-	0.34	7.08	4.88E-12	Body mass index	
HNSC	cis	1	rs6431654	chr2:234161769	ATG16L1	chr2:234160217-234204319:+	0.26	4.56	6.36E-6	Crohn's disease	
HNSC	cis	1	rs6435079	chr2:202200331	PPIL3	chr2:201735680-201753999:-	-0.2	-4.33	1.84E-5	Basal cell carcinoma	
HNSC	cis	1	rs6435081	chr2:202220623	CASP8	chr2:202098166-202152434:+	0.19	4.01	7.16E-5	Basal cell carcinoma	
HNSC	cis	1	rs6435081	chr2:202220623	PPIL3	chr2:201735680-201753999:-	-0.19	-4.03	6.34E-5	Basal cell carcinoma	
HNSC	cis	1	rs6435984	chr2:218314788	DIRC3	chr2:218148748-218621316:-	0.33	4.3	2.09E-5	Metabolite levels (MHPG)	
HNSC	cis	1	rs6437827	chr3:108849373	GUCA1C	chr3:108626642-108672677:-	-0.28	-4.56	6.32E-6	Homeostasis model assessment of beta-cell function (interaction)	
HNSC	cis	1	rs6439135	chr3:128358633	RAB43	chr3:128806418-128880029:-	-0.2	-3.98	7.78E-5	Monocyte count	
HNSC	cis	1	rs6439135	chr3:128358633	RPN1	chr3:128338813-128399918:-	-0.19	-3.93	9.7E-5	Monocyte count	
HNSC	cis	1	rs6439439	chr3:133481498	TF	chr3:133419211-133497635:+	-0.3	-5.53	5.21E-8	Iron status biomarkers	
HNSC	cis	1	rs6439484	chr3:134249899	ANAPC13	chr3:134196547-134204865:-	0.48	10.4	5.1E-23	Height	
HNSC	cis	1	rs6439484	chr3:134249899	CEP63	chr3:134204575-134293852:+	0.27	5.93	5.86E-9	Height	
HNSC	cis	1	rs6439487	chr3:134260860	ANAPC13	chr3:134196547-134204865:-	0.48	10.4	5.1E-23	Height	
HNSC	cis	1	rs6439487	chr3:134260860	CEP63	chr3:134204575-134293852:+	0.27	5.93	5.86E-9	Height	
HNSC	cis	1	rs6439649	chr3:136371691	PCCB	chr3:135969167-136056737:+	-0.21	-4.77	2.42E-6	Schizophrenia	
HNSC	cis	1	rs6441104	chr3:156681441	LEKR1	chr3:156544076-156763918:+	-0.42	-7.08	4.91E-12	Bone mineral density	
HNSC	cis	1	rs6442117	chr3:48419897	ATRIP	chr3:48488141-48507708:+	-0.17	-3.9	0.000108	Longevity	
HNSC	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.26	6.59	1.16E-10	Longevity	
HNSC	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.28	-6.88	1.88E-11	Longevity	
HNSC	cis	1	rs6442119	chr3:48440178	ATRIP	chr3:48488141-48507708:+	0.17	3.89	0.000115	Longevity	
HNSC	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.28	-7.01	7.86E-12	Longevity	
HNSC	cis	1	rs6442120	chr3:48464503	TREX1	chr3:48501186-48509043:+	-0.3	-7.45	4.26E-13	Longevity	
HNSC	cis	1	rs6442123	chr3:48500286	ATRIP	chr3:48488141-48507708:+	0.17	3.94	9.51E-5	Longevity	
HNSC	cis	1	rs6442123	chr3:48500286	TREX1	chr3:48501186-48509043:+	-0.26	-6.53	1.59E-10	Longevity	
HNSC	cis	1	rs6445557	chr3:53083969	TMEM110	chr3:52867139-52931547:-	-0.31	-4.42	1.22E-5	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs6446268	chr3:49445695	AMT	chr3:49454212-49460012:-	-0.19	-4.1	4.87E-5	Menarche (age at onset)	
HNSC	cis	1	rs6446275	chr3:49466871	AMT	chr3:49454212-49460012:-	-0.19	-4.05	6.02E-5	Menarche (age at onset)	
HNSC	cis	1	rs6449319	chr4:17640283	FAM184B	chr4:17633711-17783135:-	-0.16	-4.05	6.0E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs6449319	chr4:17640283	LAP3	chr4:17578927-17609590:+	-0.14	-3.77	0.00018	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs6449323	chr4:17683916	FAM184B	chr4:17633711-17783135:-	-0.18	-4.36	1.59E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs6449323	chr4:17683916	LAP3	chr4:17578927-17609590:+	-0.16	-4.3	2.03E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.81	13.85	4.36E-37	Type 2 diabetes	
HNSC	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.74	13.21	2.44E-34	Type 2 diabetes	
HNSC	cis	1	rs6452519	chr5:82429248	XRCC4	chr5:82373317-82649577:+	-0.19	-3.77	0.000181	Hypertension	
HNSC	cis	1	rs6452520	chr5:82429271	XRCC4	chr5:82373317-82649577:+	-0.19	-3.86	0.000127	Hypertension	
HNSC	cis	1	rs6452521	chr5:82429272	XRCC4	chr5:82373317-82649577:+	-0.19	-3.86	0.000127	Hypertension	
HNSC	cis	1	rs6452526	chr5:82436811	XRCC4	chr5:82373317-82649577:+	-0.2	-3.91	0.000105	Hypertension	
HNSC	cis	1	rs6452527	chr5:82436840	XRCC4	chr5:82373317-82649577:+	-0.2	-3.91	0.000105	Hypertension	
HNSC	cis	1	rs6452528	chr5:82458379	XRCC4	chr5:82373317-82649577:+	-0.19	-3.77	0.00018	Hypertension	
HNSC	cis	1	rs6453429	chr5:78371861	BHMT2	chr5:78365583-78385273:+	0.23	4.02	6.62E-5	Urinary metabolites	
HNSC	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.59	13.5	1.43E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs645491	chr12:123181661	GPR109B	chr12:123199304-123201439:-	0.34	5.43	8.76E-8	Adiponectin levels	
HNSC	cis	1	rs6456733	chr6:26566804	BTN2A3	chr6:26422317-26431927:+	0.16	3.67	0.000272	Educational attainment	
HNSC	cis	1	rs6456733	chr6:26566804	BTN3A2	chr6:26365398-26378546:+	0.17	4.08	5.17E-5	Educational attainment	
HNSC	cis	1	rs6456734	chr6:26566965	BTN2A3	chr6:26422317-26431927:+	0.16	3.67	0.000272	Educational attainment	
HNSC	cis	1	rs6456734	chr6:26566965	BTN3A2	chr6:26365398-26378546:+	0.17	4.08	5.17E-5	Educational attainment	
HNSC	cis	1	rs6456745	chr6:10894268	SYCP2L	chr6:10747995-10974539:+	-0.19	-3.83	0.000145	Age-related hearing impairment (interaction)	
HNSC	cis	1	rs6458685	chr6:49379536	CENPQ	chr6:49431096-49460820:+	-0.57	-14.78	3.66E-41	Homocysteine levels	
HNSC	cis	1	rs6458685	chr6:49379536	MUT	chr6:49398994-49431031:-	0.23	4.56	6.57E-6	Homocysteine levels	
HNSC	cis	1	rs6458688	chr6:49406056	CENPQ	chr6:49431096-49460820:+	-0.57	-14.55	3.67E-40	Homocysteine levels	
HNSC	cis	1	rs6458688	chr6:49406056	MUT	chr6:49398994-49431031:-	0.23	4.62	4.95E-6	Homocysteine levels	
HNSC	cis	1	rs6458690	chr6:49411619	CENPQ	chr6:49431096-49460820:+	-0.4	-9.53	7.05E-20	Folate pathway vitamin levels	
HNSC	cis	1	rs6458690	chr6:49411619	MUT	chr6:49398994-49431031:-	0.43	9.22	8.31E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs6458694	chr6:49445306	CENPQ	chr6:49431096-49460820:+	-0.4	-9.56	5.73E-20	Folate pathway vitamin levels	
HNSC	cis	1	rs6458694	chr6:49445306	MUT	chr6:49398994-49431031:-	0.43	9.27	5.98E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs6460260	chr7:65215455	CRCP	chr7:65579805-65619551:+	0.35	4.03	6.42E-5	Diabetic kidney disease	
HNSC	cis	1	rs6460260	chr7:65215455	NCRNA00174	chr7:65841032-65865395:-	0.46	4.89	1.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs6460261	chr7:65215580	CRCP	chr7:65579805-65619551:+	0.35	4.03	6.42E-5	Diabetic kidney disease	
HNSC	cis	1	rs6460261	chr7:65215580	NCRNA00174	chr7:65841032-65865395:-	0.46	4.89	1.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs6460274	chr7:65628484	NCRNA00174	chr7:65841032-65865395:-	0.44	4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs6460292	chr7:65810075	NCRNA00174	chr7:65841032-65865395:-	0.74	15.41	5.12E-44	Aortic root size	
HNSC	cis	1	rs6460295	chr7:65882728	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.62	5.64E-45	Aortic root size	
HNSC	cis	1	rs6460295	chr7:65882728	TYW1	chr7:66461817-66704496:+	0.2	3.7	0.000237	Aortic root size	
HNSC	cis	1	rs6460296	chr7:65895139	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.89	3.28E-46	Aortic root size	
HNSC	cis	1	rs6461993	chr7:3356463	C7orf27	chr7:2577511-2595146:-	-0.17	-3.95	9.1E-5	Motion sickness	
HNSC	cis	1	rs6461994	chr7:3356483	C7orf27	chr7:2577511-2595146:-	-0.17	-3.9	0.000111	Motion sickness	
HNSC	cis	1	rs6461994	chr7:3356483	GNA12	chr7:2767743-2883959:-	-0.14	-3.7	0.000238	Motion sickness	
HNSC	cis	1	rs6464573	chr7:143748098	ARHGEF35	chr7:143883677-143892736:-	0.35	7.62	1.33E-13	Obesity-related traits	
HNSC	cis	1	rs6464573	chr7:143748098	OR2A7	chr7:143955790-143974852:-	-0.2	-3.73	0.00021	Obesity-related traits	
HNSC	cis	1	rs6464574	chr7:143748257	ARHGEF35	chr7:143883677-143892736:-	-0.37	-7.94	1.42E-14	Obesity-related traits	
HNSC	cis	1	rs6464574	chr7:143748257	OR2A7	chr7:143955790-143974852:-	0.22	4.22	2.97E-5	Obesity-related traits	
HNSC	cis	1	rs6468131	chr8:29981020	MBOAT4	chr8:29989188-30002200:-	-0.33	-4.43	1.16E-5	Migraine	
HNSC	cis	1	rs6468495	chr8:97259953	MTERFD1	chr8:97251645-97273796:-	0.24	5.37	1.24E-7	Lung function (FVC)	
HNSC	cis	1	rs646867	chr1:25709258	RHCE	chr1:25688741-25756683:-	0.33	6.11	2.08E-9	Erythrocyte sedimentation rate	
HNSC	cis	1	rs646867	chr1:25709258	RHD	chr1:25598981-25656935:+	-0.48	-9.7	1.75E-20	Erythrocyte sedimentation rate	
HNSC	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.23	-4.84	1.7E-6	Rheumatoid arthritis	
HNSC	cis	1	rs6479272	chr9:99097527	HABP4	chr9:99212414-99253617:+	-0.15	-3.78	0.000179	Non-small cell lung cancer	
HNSC	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.39	-7.22	1.97E-12	Forced vital capacity	
HNSC	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.42	7.63	1.22E-13	Forced vital capacity	
HNSC	cis	1	rs6488051	chr12:32532733	FGD4	chr12:32638906-32798982:+	-0.37	-7.07	5.43E-12	Response to tocilizumab in rheumatoid arthritis	
HNSC	cis	1	rs6496520	chr15:89238255	ACAN	chr15:89346674-89418585:+	0.19	3.82	0.000152	Obesity-related traits	
HNSC	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.67	-11.81	1.57E-28	Type 2 diabetes	
HNSC	cis	1	rs6499983	chr16:58843909	GOT2	chr16:58741035-58768246:-	-0.24	-4.98	8.8E-7	Blood metabolite ratios	
HNSC	cis	1	rs6503704	chr17:40592253	NAGLU	chr17:40687951-40696464:+	-0.19	-3.68	0.000259	Crohn's disease	
HNSC	cis	1	rs6503877	chr17:56841948	RAD51C	chr17:56769963-56811690:+	0.33	8.5	2.23E-16	Cognitive test performance	
HNSC	cis	1	rs6503882	chr17:56915761	RAD51C	chr17:56769963-56811690:+	0.32	8.24	1.58E-15	Cognitive test performance	
HNSC	cis	1	rs6504169	chr17:61709145	FTSJ3	chr17:61896795-61905031:-	0.2	3.68	0.000256	Body mass index	
HNSC	cis	1	rs6504661	chr17:48580126	MYCBPAP	chr17:48585745-48608861:+	0.24	3.94	9.48E-5	Visceral fat	
HNSC	cis	1	rs6504661	chr17:48580126	SPATA20	chr17:48620419-48633211:+	0.22	3.68	0.000261	Visceral fat	
HNSC	cis	1	rs6505152	chr17:28331466	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.26	2.41E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs6505158	chr17:28403348	EFCAB5	chr17:28256874-28435469:+	-0.21	-3.86	0.000128	Coffee consumption (cups per day)	
HNSC	cis	1	rs650619	chr11:65506483	RBM14	chr11:66384053-66397390:+	0.25	4.07	5.48E-5	Atopic dermatitis	
HNSC	cis	1	rs6508710	chr19:37749886	ZNF793	chr19:37997841-38034237:+	0.25	4.26	2.46E-5	Coronary artery calcification	
HNSC	cis	1	rs6510348	chr19:33601946	GPATCH1	chr19:33571786-33621318:+	0.2	3.81	0.000159	Bone properties (heel)	
HNSC	cis	1	rs6515375	chr20:23610841	CST1	chr20:23728191-23731574:-	0.34	5.25	2.23E-7	Chronic kidney disease	
HNSC	cis	1	rs6515375	chr20:23610841	CST4	chr20:23666277-23669662:-	0.27	4.35	1.64E-5	Chronic kidney disease	
HNSC	cis	1	rs6519120	chr22:38991393	LOC646851	chr22:38974125-39052634:-	-0.14	-3.67	0.00027	Resting heart rate	
HNSC	cis	1	rs6532078	chr4:76920809	NAAA	chr4:76831809-76862166:-	-0.49	-11.25	2.63E-26	Longevity	
HNSC	cis	1	rs6533332	chr4:108919838	HADH	chr4:108910940-108956330:+	-0.28	-4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs6533337	chr4:108933581	HADH	chr4:108910940-108956330:+	-0.28	-4	7.34E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs6533340	chr4:108943532	HADH	chr4:108910940-108956330:+	-0.27	-3.76	0.000189	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs6533341	chr4:108943681	HADH	chr4:108910940-108956330:+	-0.27	-3.76	0.000189	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs6533342	chr4:108943818	HADH	chr4:108910940-108956330:+	-0.27	-3.76	0.000189	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs6540584	chr1:210346137	SYT14	chr1:210111538-210337631:+	-0.2	-3.71	0.000233	Manic episodes in bipolar disorder	
HNSC	cis	1	rs6545883	chr2:61772257	AHSA2	chr2:61404553-61414058:+	-0.16	-5.37	1.22E-7	Tuberculosis	
HNSC	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.43	7.65	1.05E-13	Tuberculosis	
HNSC	cis	1	rs6545946	chr2:62713533	TMEM17	chr2:62727356-62762780:-	-0.26	-3.94	9.38E-5	Crohn's disease	
HNSC	cis	1	rs6546556	chr2:70139001	GMCL1	chr2:70056818-70106727:+	0.12	3.73	0.000216	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs6546558	chr2:70145717	GMCL1	chr2:70056818-70106727:+	0.12	3.75	0.000201	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs6546835	chr2:73664715	ALMS1P	chr2:73872046-73912692:+	0.26	4.39	1.41E-5	Metabolite levels	
HNSC	cis	1	rs6546836	chr2:73677833	ALMS1P	chr2:73872046-73912692:+	0.25	4.15	3.85E-5	Metabolite levels	
HNSC	cis	1	rs6546837	chr2:73677898	ALMS1P	chr2:73872046-73912692:+	0.25	4.32	1.89E-5	Metabolite levels	
HNSC	cis	1	rs6546838	chr2:73679280	ALMS1P	chr2:73872046-73912692:+	0.26	4.41	1.25E-5	Metabolite levels	
HNSC	cis	1	rs6546839	chr2:73680508	ALMS1P	chr2:73872046-73912692:+	0.25	4.32	1.89E-5	Metabolite levels	
HNSC	cis	1	rs6547872	chr2:28978074	TRMT61B	chr2:29072690-29093175:-	-0.34	-7.3	1.19E-12	Body mass index	
HNSC	cis	1	rs6554106	chr4:54292791	USP46	chr4:53457129-53525502:-	0.18	3.75	0.000201	DNA methylation (variation)	
HNSC	cis	1	rs6557265	chr6:153433402	RGS17	chr6:153332041-153452389:-	-0.21	-3.9	0.00011	Prostate cancer	
HNSC	cis	1	rs6557266	chr6:153433534	RGS17	chr6:153332041-153452389:-	-0.21	-3.91	0.000107	Prostate cancer	
HNSC	cis	1	rs655745	chr6:150711226	IYD	chr6:150690028-150725764:+	-0.18	-3.76	0.000193	Anger	
HNSC	cis	1	rs6563389	chr13:36777536	SOHLH2	chr13:36742347-36871992:-	-0.25	-4.55	6.92E-6	Economic and political preferences	
HNSC	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.57	-15.42	4.61E-44	Crohn's disease	
HNSC	cis	1	rs656980	chr11:65656282	SNX32	chr11:65601410-65621170:+	0.43	7.18	2.55E-12	Crohn's disease	
HNSC	cis	1	rs6570043	chr6:136134098	AHI1	chr6:135605112-135818903:-	-0.18	-4.1	4.78E-5	Phosphorus levels	
HNSC	cis	1	rs6573006	chr14:55610432	KIAA0831	chr14:55833110-55878576:-	-0.22	-4.03	6.5E-5	Protein biomarker	
HNSC	cis	1	rs6579234	chr20:33983485	CPNE1	chr20:34213968-34262539:-	0.24	4.36	1.59E-5	Height	
HNSC	cis	1	rs6579234	chr20:33983485	UQCC	chr20:33890383-33999833:-	0.32	6.12	1.88E-9	Height	
HNSC	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.66	-9.43	1.59E-19	Cholesterol, total	
HNSC	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.53	10.61	8.18E-24	Multiple sclerosis	
HNSC	cis	1	rs6581155	chr12:58178162	TSFM	chr12:58176536-58191367:+	-0.34	-7.42	5.15E-13	Multiple sclerosis	
HNSC	cis	1	rs6584379	chr10:102224490	SEC31B	chr10:102246403-102289636:-	-0.18	-5.56	4.33E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs6584383	chr10:102303065	SEC31B	chr10:102246403-102289636:-	-0.19	-5.86	8.32E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs6589589	chr11:116932428	PCSK7	chr11:117075789-117102811:-	-0.31	-4.34	1.76E-5	Protein quantitative trait loci	
HNSC	cis	1	rs6596087	chr5:131968609	SLC22A4	chr5:131630145-131679897:+	0.2	3.76	0.000187	Asthma (childhood onset)	
HNSC	cis	1	rs6598060	chr11:243987	PSMD13	chr11:236808-252984:+	-0.2	-4.12	4.52E-5	Menarche (age at onset)	
HNSC	cis	1	rs6598066	chr11:243185	PSMD13	chr11:236808-252984:+	-0.18	-3.68	0.000257	Menarche (age at onset)	
HNSC	cis	1	rs6598074	chr11:219398	PSMD13	chr11:236808-252984:+	-0.2	-4.08	5.25E-5	Menarche (age at onset)	
HNSC	cis	1	rs6599175	chr3:41786009	ULK4	chr3:41288091-42003660:-	-0.73	-12.58	1.16E-31	Diastolic blood pressure	
HNSC	cis	1	rs6599176	chr3:41788492	ULK4	chr3:41288091-42003660:-	-0.68	-11.73	3.47E-28	Diastolic blood pressure	
HNSC	cis	1	rs6599639	chr10:124743751	C10orf88	chr10:124690419-124713919:-	-0.22	-4.03	6.41E-5	Migraine without aura	
HNSC	cis	1	rs6603033	chr15:83335875	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.16	4.11	4.57E-5	Schizophrenia	
HNSC	cis	1	rs6603975	chr1:92951239	EVI5	chr1:92974255-93257961:-	-0.21	-3.82	0.000152	Cholesterol, total	
HNSC	cis	1	rs6603979	chr1:92979354	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs6603981	chr1:92993807	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs6603982	chr1:92994033	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs6603984	chr1:93011572	EVI5	chr1:92974255-93257961:-	-0.24	-4.27	2.37E-5	Cholesterol, total	
HNSC	cis	1	rs6603985	chr1:93017159	EVI5	chr1:92974255-93257961:-	-0.23	-4.28	2.22E-5	Cholesterol, total	
HNSC	cis	1	rs6603987	chr1:93019313	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs6603990	chr1:93030735	EVI5	chr1:92974255-93257961:-	-0.24	-4.4	1.3E-5	Cholesterol, total	
HNSC	cis	1	rs6604026	chr1:93303603	FAM69A	chr1:93298453-93427079:-	0.21	3.87	0.000123	Multiple sclerosis	
HNSC	cis	1	rs66462353	chr15:56186767	NEDD4	chr15:56119131-56285835:-	0.22	5.2	2.9E-7	Keloid	
HNSC	cis	1	rs6651271	chr8:96047621	C8orf38	chr8:95908040-96088396:+	-0.34	-5.18	3.32E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs6651272	chr8:96047933	C8orf38	chr8:95908040-96088396:+	0.32	4.95	1.02E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs6656432	chr1:93029453	EVI5	chr1:92974255-93257961:-	-0.23	-4.22	2.85E-5	Cholesterol, total	
HNSC	cis	1	rs6656992	chr1:46333068	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.44	4.66E-13	Body mass index	
HNSC	cis	1	rs6656999	chr1:166956807	FMO9P	chr1:166573153-166594471:+	0.21	4	7.33E-5	Refractive astigmatism	
HNSC	cis	1	rs6659874	chr1:171654180	VAMP4	chr1:171669298-171711214:-	0.28	4.76	2.55E-6	Hippocampal atrophy	
HNSC	cis	1	rs6661134	chr1:93010908	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs6661910	chr1:46290632	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.54	2.23E-13	Body mass index	
HNSC	cis	1	rs6662641	chr1:46571509	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.24	1.71E-12	Body mass index	
HNSC	cis	1	rs6662720	chr1:171654616	VAMP4	chr1:171669298-171711214:-	0.28	4.76	2.55E-6	Hippocampal atrophy	
HNSC	cis	1	rs6662833	chr1:171654720	VAMP4	chr1:171669298-171711214:-	0.28	4.76	2.55E-6	Hippocampal atrophy	
HNSC	cis	1	rs66629131	chr6:44101468	TJAP1	chr6:43445261-43474294:+	0.19	3.71	0.000228	Major depressive disorder	
HNSC	cis	1	rs66644309	chr5:112708146	YTHDC2	chr5:112849410-112930979:+	0.19	3.66	0.00028	Cerebral amyloid angiopathy	
HNSC	cis	1	rs66651343	chr15:43558004	TGM5	chr15:43525375-43559055:-	-0.16	-3.67	0.000266	Lung cancer	
HNSC	cis	1	rs6665341	chr1:166947018	FMO9P	chr1:166573153-166594471:+	0.2	3.85	0.000133	Refractive astigmatism	
HNSC	cis	1	rs6666959	chr1:150088955	HORMAD1	chr1:150670542-150693352:-	0.25	3.77	0.000181	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
HNSC	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.72	-18.79	8.0E-60	Homocysteine levels	
HNSC	cis	1	rs6667191	chr1:45982844	MMACHC	chr1:45965856-45976737:+	-0.2	-3.9	0.000109	Homocysteine levels	
HNSC	cis	1	rs6667559	chr1:171653957	VAMP4	chr1:171669298-171711214:-	0.27	4.65	4.23E-6	Hippocampal atrophy	
HNSC	cis	1	rs6668284	chr1:46354510	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.51	2.74E-13	Body mass index	
HNSC	cis	1	rs6669263	chr1:171692311	VAMP4	chr1:171669298-171711214:-	0.27	4.55	6.78E-6	Hippocampal atrophy	
HNSC	cis	1	rs6669371	chr1:11882142	CLCN6	chr1:11866207-11907674:+	0.27	4.43	1.17E-5	QRS complex (12-leadsum)	
HNSC	cis	1	rs6669522	chr1:46397941	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.69	8.25E-14	Body mass index	
HNSC	cis	1	rs6670427	chr1:171654522	VAMP4	chr1:171669298-171711214:-	0.28	4.76	2.55E-6	Hippocampal atrophy	
HNSC	cis	1	rs6672898	chr1:46290588	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.62	1.33E-13	Body mass index	
HNSC	cis	1	rs6675726	chr1:46560643	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.47	3.75E-13	Body mass index	
HNSC	cis	1	rs6675946	chr1:46371774	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.49	3.27E-13	Body mass index	
HNSC	cis	1	rs6677007	chr1:46400590	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.69	8.25E-14	Body mass index	
HNSC	cis	1	rs6678890	chr1:171694566	VAMP4	chr1:171669298-171711214:-	0.26	4.52	7.79E-6	Hippocampal atrophy	
HNSC	cis	1	rs6679002	chr1:63199936	DOCK7	chr1:62920398-63153969:-	0.17	4.05	5.94E-5	Blood metabolite levels	
HNSC	cis	1	rs6679073	chr1:205756484	PM20D1	chr1:205797154-205819245:-	-0.26	-4.79	2.26E-6	Prostate-specific antigen levels	
HNSC	cis	1	rs6679145	chr1:156256000	BGLAP	chr1:156182784-156213112:+	0.19	3.68	0.000262	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs6679354	chr1:171668002	VAMP4	chr1:171669298-171711214:-	0.28	4.73	2.91E-6	Hippocampal atrophy	
HNSC	cis	1	rs6679	chr1:113243048	ST7L	chr1:113066142-113162405:-	0.4	5.92	6.06E-9	Diastolic blood pressure;Blood pressure	
HNSC	cis	1	rs6680380	chr1:46300189	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.63	1.2E-13	Body mass index	
HNSC	cis	1	rs6682062	chr1:166949979	FMO9P	chr1:166573153-166594471:+	-0.21	-4.12	4.38E-5	Refractive astigmatism	
HNSC	cis	1	rs6686643	chr1:165616588	MGST3	chr1:165600450-165624853:+	0.37	7.34	8.95E-13	Total ventricular volume	
HNSC	cis	1	rs66871576	chr14:55629050	KIAA0831	chr14:55833110-55878576:-	-0.21	-3.79	0.000171	Protein biomarker	
HNSC	cis	1	rs6688613	chr1:166951869	FMO9P	chr1:166573153-166594471:+	-0.24	-4.58	6.01E-6	Refractive astigmatism	
HNSC	cis	1	rs6690764	chr1:92976590	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs6692187	chr1:93035020	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.33E-5	Cholesterol, total	
HNSC	cis	1	rs6692729	chr1:227018919	PSEN2	chr1:227058273-227083804:+	-0.19	-4.12	4.49E-5	Electrodermal activity	
HNSC	cis	1	rs6693017	chr1:220977333	RAB3GAP2	chr1:220321610-220445843:-	-0.25	-4.33	1.84E-5	Monocyte early outgrowth colony forming units	
HNSC	cis	1	rs6695162	chr1:166953455	FMO9P	chr1:166573153-166594471:+	0.22	4.4	1.32E-5	Refractive astigmatism	
HNSC	cis	1	rs6695809	chr1:46285461	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.74	5.72E-14	Body mass index	
HNSC	cis	1	rs66965793	chr1:156285814	BGLAP	chr1:156182784-156213112:+	0.2	3.89	0.000115	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs66968227	chr11:64070930	C11orf20	chr11:64067863-64072238:+	-0.26	-3.73	0.000215	Mean platelet volume	
HNSC	cis	1	rs6699159	chr1:166946072	FMO9P	chr1:166573153-166594471:+	0.2	3.85	0.000133	Refractive astigmatism	
HNSC	cis	1	rs6699520	chr1:166955405	FMO9P	chr1:166573153-166594471:+	0.23	4.41	1.26E-5	Refractive astigmatism	
HNSC	cis	1	rs6700597	chr1:46284246	CCDC163P	chr1:45960581-45965646:-	-0.36	-7.75	5.25E-14	Body mass index	
HNSC	cis	1	rs6701553	chr1:171654456	VAMP4	chr1:171669298-171711214:-	0.28	4.76	2.55E-6	Hippocampal atrophy	
HNSC	cis	1	rs6701614	chr1:46309420	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.63	1.2E-13	Body mass index	
HNSC	cis	1	rs6702463	chr1:152598711	LCE3A	chr1:152595311-152595579:-	0.24	5.3	1.79E-7	Psoriasis	
HNSC	cis	1	rs6702463	chr1:152598711	LCE3C	chr1:152573138-152573562:+	-0.61	-15.56	1.1E-44	Psoriasis	
HNSC	cis	1	rs67034206	chr1:156270260	BGLAP	chr1:156182784-156213112:+	0.19	3.7	0.000238	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs6705489	chr2:73648811	ALMS1P	chr2:73872046-73912692:+	0.25	4.15	3.99E-5	Metabolite levels	
HNSC	cis	1	rs67073037	chr2:29119585	TRMT61B	chr2:29072690-29093175:-	0.26	5.08	5.49E-7	Breast cancer (estrogen-receptor negative);Breast cancer	
HNSC	cis	1	rs6707722	chr2:73654363	ALMS1P	chr2:73872046-73912692:+	0.26	4.38	1.44E-5	Metabolite levels	
HNSC	cis	1	rs6707848	chr2:28988083	TRMT61B	chr2:29072690-29093175:-	-0.33	-7.09	4.78E-12	Body mass index	
HNSC	cis	1	rs6708328	chr2:24412413	C2orf84	chr2:24397531-24414566:+	0.33	6.24	9.55E-10	Venous thromboembolism (SNP x SNP interaction)	
HNSC	cis	1	rs6708373	chr2:234172846	ATG16L1	chr2:234160217-234204319:+	0.28	4.94	1.08E-6	Crohn's disease	
HNSC	cis	1	rs6709534	chr2:217334	SH3YL1	chr2:218138-264810:-	-0.67	-13.05	1.17E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs67098772	chr14:55595242	KIAA0831	chr14:55833110-55878576:-	-0.21	-3.69	0.00025	Protein biomarker	
HNSC	cis	1	rs6710438	chr2:73820108	ALMS1P	chr2:73872046-73912692:+	-0.24	-4.02	6.85E-5	Metabolite levels	
HNSC	cis	1	rs6710467	chr2:127889932	BIN1	chr2:127805607-127864864:-	-0.18	-4.2	3.2E-5	Alzheimer's disease (late onset)	
HNSC	cis	1	rs6710959	chr2:28958603	TRMT61B	chr2:29072690-29093175:-	-0.37	-7.84	2.74E-14	Body mass index	
HNSC	cis	1	rs6711033	chr2:73746643	ALMS1P	chr2:73872046-73912692:+	0.23	3.84	0.000139	Metabolite levels	
HNSC	cis	1	rs6711127	chr2:202213515	PPIL3	chr2:201735680-201753999:-	-0.41	-4.75	2.7E-6	Rheumatoid arthritis	
HNSC	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.5	-6.69	5.99E-11	Rheumatoid arthritis	
HNSC	cis	1	rs6712203	chr2:165557318	SLC38A11	chr2:165754812-165812035:-	0.21	4.13	4.28E-5	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
HNSC	cis	1	rs6714736	chr2:202214148	CASP8	chr2:202098166-202152434:+	-0.2	-4.21	3.05E-5	Basal cell carcinoma	
HNSC	cis	1	rs6714736	chr2:202214148	PPIL3	chr2:201735680-201753999:-	0.2	4.2	3.18E-5	Basal cell carcinoma	
HNSC	cis	1	rs6715284	chr2:202154397	PPIL3	chr2:201735680-201753999:-	-0.56	-7.86	2.37E-14	Rheumatoid arthritis	
HNSC	cis	1	rs6715380	chr2:202214505	PPIL3	chr2:201735680-201753999:-	-0.41	-4.8	2.09E-6	Rheumatoid arthritis	
HNSC	cis	1	rs6716937	chr2:70127229	GMCL1	chr2:70056818-70106727:+	0.11	3.69	0.000248	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs6720809	chr2:88528943	THNSL2	chr2:88469835-88486145:+	-0.49	-5.54	4.89E-8	Plasma clusterin levels	
HNSC	cis	1	rs6721891	chr2:70146121	GMCL1	chr2:70056818-70106727:+	0.12	3.76	0.000192	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs6722069	chr2:88533151	THNSL2	chr2:88469835-88486145:+	-0.49	-5.53	5.21E-8	Plasma clusterin levels	
HNSC	cis	1	rs67239267	chr7:143745116	ARHGEF35	chr7:143883677-143892736:-	-0.35	-7.43	4.78E-13	Obesity-related traits	
HNSC	cis	1	rs6724782	chr2:73679990	ALMS1P	chr2:73872046-73912692:+	0.25	4.32	1.89E-5	Metabolite levels	
HNSC	cis	1	rs6725425	chr2:70150674	GMCL1	chr2:70056818-70106727:+	0.12	3.77	0.000186	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs6725887	chr2:203745885	ICA1L	chr2:203637873-203736371:-	-0.24	-3.68	0.000262	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
HNSC	cis	1	rs6729760	chr2:70161032	GMCL1	chr2:70056818-70106727:+	0.12	3.76	0.00019	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs67303814	chr5:112767285	YTHDC2	chr5:112849410-112930979:+	0.2	3.67	0.000266	Cerebral amyloid angiopathy	
HNSC	cis	1	rs6731027	chr2:203202166	NOP58	chr2:203130515-203168382:+	0.24	3.84	0.00014	Urate levels	
HNSC	cis	1	rs6736408	chr2:70137774	GMCL1	chr2:70056818-70106727:+	0.11	3.69	0.000248	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs6736866	chr2:73661986	ALMS1P	chr2:73872046-73912692:+	0.23	3.86	0.000127	Metabolite levels	
HNSC	cis	1	rs6737085	chr2:202221441	CASP8	chr2:202098166-202152434:+	0.19	4	7.35E-5	Basal cell carcinoma	
HNSC	cis	1	rs6737085	chr2:202221441	PPIL3	chr2:201735680-201753999:-	-0.19	-4.05	5.86E-5	Basal cell carcinoma	
HNSC	cis	1	rs6738490	chr2:234161583	ATG16L1	chr2:234160217-234204319:+	0.26	4.65	4.19E-6	Crohn's disease	
HNSC	cis	1	rs67385638	chr11:5290370	HBG1	chr11:5269502-5271087:-	0.23	4.18	3.46E-5	Hemoglobin levels	
HNSC	cis	1	rs6738627	chr2:165544450	SLC38A11	chr2:165754812-165812035:-	0.22	4.31	2.01E-5	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
HNSC	cis	1	rs6739780	chr2:70138111	GMCL1	chr2:70056818-70106727:+	0.11	3.69	0.000248	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs6740223	chr2:73653332	ALMS1P	chr2:73872046-73912692:+	0.26	4.38	1.44E-5	Metabolite levels	
HNSC	cis	1	rs6741449	chr2:70156589	GMCL1	chr2:70056818-70106727:+	0.12	3.75	0.000201	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs6741892	chr2:38916970	GALM	chr2:38893052-38961908:+	0.24	3.75	0.000201	5-HTT brain serotonin transporter levels	
HNSC	cis	1	rs6742276	chr2:61768745	AHSA2	chr2:61404553-61414058:+	-0.15	-4.94	1.1E-6	Tuberculosis	
HNSC	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.46	8.14	3.25E-15	Tuberculosis	
HNSC	cis	1	rs6745368	chr2:73809974	ALMS1P	chr2:73872046-73912692:+	0.26	4.29	2.17E-5	Metabolite levels	
HNSC	cis	1	rs6750488	chr2:70146125	GMCL1	chr2:70056818-70106727:+	0.12	3.76	0.000192	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs67505007	chr15:56196253	NEDD4	chr15:56119131-56285835:-	0.22	5.23	2.54E-7	Keloid	
HNSC	cis	1	rs6752107	chr2:234161448	ATG16L1	chr2:234160217-234204319:+	0.25	4.41	1.27E-5	Crohn's disease	
HNSC	cis	1	rs6752978	chr2:165552942	SLC38A11	chr2:165754812-165812035:-	0.23	4.51	8.07E-6	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
HNSC	cis	1	rs6753142	chr2:165544071	SLC38A11	chr2:165754812-165812035:-	0.21	4.18	3.48E-5	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
HNSC	cis	1	rs6753304	chr2:160040094	WDSUB1	chr2:160092305-160143236:-	-0.21	-4.5	8.6E-6	Resting heart rate	
HNSC	cis	1	rs6753344	chr2:73653138	ALMS1P	chr2:73872046-73912692:+	-0.22	-3.68	0.000261	Metabolite levels	
HNSC	cis	1	rs67536397	chr7:65947917	NCRNA00174	chr7:65841032-65865395:-	-0.51	-5.48	6.7E-8	Diabetic kidney disease	
HNSC	cis	1	rs67536397	chr7:65947917	STAG3L4	chr7:66767616-66786512:+	-0.4	-4.42	1.23E-5	Diabetic kidney disease	
HNSC	cis	1	rs6753739	chr2:220028900	IHH	chr2:219919146-219925189:-	0.26	4.13	4.19E-5	Height	
HNSC	cis	1	rs675413	chr15:45936745	SPATA5L1	chr15:45694519-45713614:+	0.24	3.76	0.000187	Obesity-related traits	
HNSC	cis	1	rs67544533	chr15:75361539	SCAMP5	chr15:75287901-75313836:+	0.42	8.23	1.71E-15	Blood trace element (Zn levels)	
HNSC	cis	1	rs6754896	chr2:70138170	GMCL1	chr2:70056818-70106727:+	0.11	3.69	0.000248	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs6755217	chr2:73641285	ALMS1P	chr2:73872046-73912692:+	0.23	3.82	0.000151	Metabolite levels	
HNSC	cis	1	rs6755241	chr2:73641364	ALMS1P	chr2:73872046-73912692:+	0.24	4.08	5.22E-5	Metabolite levels	
HNSC	cis	1	rs67567111	chr20:23619075	CST1	chr20:23728191-23731574:-	0.35	5.39	1.11E-7	Chronic kidney disease	
HNSC	cis	1	rs67567111	chr20:23619075	CST4	chr20:23666277-23669662:-	0.27	4.41	1.26E-5	Chronic kidney disease	
HNSC	cis	1	rs6756987	chr2:73687077	ALMS1P	chr2:73872046-73912692:+	0.25	4.26	2.5E-5	Metabolite levels	
HNSC	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.62	-10.96	3.62E-25	Triptolide cytotoxicity	
HNSC	cis	1	rs6761514	chr2:202227549	CASP8	chr2:202098166-202152434:+	0.18	3.86	0.00013	Basal cell carcinoma	
HNSC	cis	1	rs6762719	chr3:133480817	TF	chr3:133419211-133497635:+	-0.3	-5.44	8.27E-8	Iron status biomarkers	
HNSC	cis	1	rs6763088	chr3:134254989	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.52	1.7E-23	Height	
HNSC	cis	1	rs6763088	chr3:134254989	CEP63	chr3:134204575-134293852:+	-0.26	-5.68	2.27E-8	Height	
HNSC	cis	1	rs6763093	chr3:134254995	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.52	1.69E-23	Height	
HNSC	cis	1	rs6763093	chr3:134254995	CEP63	chr3:134204575-134293852:+	-0.26	-5.68	2.3E-8	Height	
HNSC	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.47	10.06	9.0E-22	Height	
HNSC	cis	1	rs6765505	chr3:134208132	CEP63	chr3:134204575-134293852:+	0.26	5.76	1.5E-8	Height	
HNSC	cis	1	rs6766510	chr3:12551807	TSEN2	chr3:12525931-12581122:+	0.29	3.9	0.000109	Prostate cancer (gene x gene interaction)	
HNSC	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.5	10.64	5.88E-24	Height	
HNSC	cis	1	rs6766818	chr3:134226159	CEP63	chr3:134204575-134293852:+	0.29	6.19	1.26E-9	Height	
HNSC	cis	1	rs6766897	chr3:134191303	ANAPC13	chr3:134196547-134204865:-	0.52	11.14	7.57E-26	Height	
HNSC	cis	1	rs6766897	chr3:134191303	CEP63	chr3:134204575-134293852:+	0.28	5.98	4.34E-9	Height	
HNSC	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	0.73	12.29	1.85E-30	Diastolic blood pressure	
HNSC	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	0.73	12.02	2.4E-29	Diastolic blood pressure	
HNSC	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	0.73	12.02	2.4E-29	Diastolic blood pressure	
HNSC	cis	1	rs6769885	chr3:134286913	ANAPC13	chr3:134196547-134204865:-	0.48	10.48	2.4E-23	Height	
HNSC	cis	1	rs6769885	chr3:134286913	CEP63	chr3:134204575-134293852:+	0.27	5.97	4.41E-9	Height	
HNSC	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.26	-6.42	3.18E-10	Longevity	
HNSC	cis	1	rs67728539	chr7:65378124	CRCP	chr7:65579805-65619551:+	-0.34	-3.95	8.93E-5	Diabetic kidney disease	
HNSC	cis	1	rs67728539	chr7:65378124	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.67	3.88E-6	Diabetic kidney disease	
HNSC	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.5	10.51	1.84E-23	Height	
HNSC	cis	1	rs6772896	chr3:134203347	CEP63	chr3:134204575-134293852:+	0.26	5.61	3.41E-8	Height	
HNSC	cis	1	rs6774724	chr3:49381911	AMT	chr3:49454212-49460012:-	0.17	3.73	0.000212	Menarche (age at onset)	
HNSC	cis	1	rs6774724	chr3:49381911	TREX1	chr3:48501186-48509043:+	-0.17	-3.7	0.000236	Menarche (age at onset)	
HNSC	cis	1	rs67766926	chr2:61163581	C2orf74	chr2:61372243-61391964:+	0.26	3.68	0.000263	Inflammatory skin disease	
HNSC	cis	1	rs6776700	chr3:48496758	ATRIP	chr3:48488141-48507708:+	0.18	4.01	6.9E-5	Longevity	
HNSC	cis	1	rs6776700	chr3:48496758	TREX1	chr3:48501186-48509043:+	-0.31	-7.7	7.33E-14	Longevity	
HNSC	cis	1	rs677977	chr1:147083744	ACP6	chr1:147119168-147142634:-	-0.2	-4.41	1.3E-5	Schizophrenia (negative symptoms)	
HNSC	cis	1	rs6782563	chr3:134295959	ANAPC13	chr3:134196547-134204865:-	-0.48	-10.21	2.43E-22	Height	
HNSC	cis	1	rs6782563	chr3:134295959	CEP63	chr3:134204575-134293852:+	-0.26	-5.61	3.32E-8	Height	
HNSC	cis	1	rs6784322	chr3:48422235	ATRIP	chr3:48488141-48507708:+	0.16	3.78	0.000177	Longevity	
HNSC	cis	1	rs6784322	chr3:48422235	TREX1	chr3:48501186-48509043:+	-0.28	-6.96	1.07E-11	Longevity	
HNSC	cis	1	rs6784421	chr3:156655494	LEKR1	chr3:156544076-156763918:+	0.23	4.97	9.11E-7	Multiple sclerosis (severity)	
HNSC	cis	1	rs6784421	chr3:156655494	LOC100287227	chr3:156390964-156393502:-	0.2	3.79	0.000166	Multiple sclerosis (severity)	
HNSC	cis	1	rs6785027	chr3:134211649	ANAPC13	chr3:134196547-134204865:-	-0.46	-9.97	1.83E-21	Height	
HNSC	cis	1	rs6785027	chr3:134211649	CEP63	chr3:134204575-134293852:+	-0.26	-5.78	1.35E-8	Height	
HNSC	cis	1	rs6785045	chr3:49435243	AMT	chr3:49454212-49460012:-	-0.19	-4.17	3.58E-5	Menarche (age at onset)	
HNSC	cis	1	rs6787371	chr3:134254991	ANAPC13	chr3:134196547-134204865:-	0.48	10.4	4.96E-23	Height	
HNSC	cis	1	rs6787371	chr3:134254991	CEP63	chr3:134204575-134293852:+	0.27	5.91	6.42E-9	Height	
HNSC	cis	1	rs6787559	chr3:128381086	RAB43	chr3:128806418-128880029:-	-0.2	-4.01	7.0E-5	Monocyte count	
HNSC	cis	1	rs6787952	chr3:156609375	LEKR1	chr3:156544076-156763918:+	-0.45	-7.4	5.92E-13	Bone mineral density	
HNSC	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	0.67	10.26	1.68E-22	Diastolic blood pressure	
HNSC	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.5	10.67	4.64E-24	Height	
HNSC	cis	1	rs6790466	chr3:134197740	CEP63	chr3:134204575-134293852:+	0.27	5.7	2.02E-8	Height	
HNSC	cis	1	rs67927699	chr2:61187415	C2orf74	chr2:61372243-61391964:+	0.39	7.21	2.14E-12	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs6793487	chr3:134299426	ANAPC13	chr3:134196547-134204865:-	-0.48	-10.21	2.43E-22	Height	
HNSC	cis	1	rs6793487	chr3:134299426	CEP63	chr3:134204575-134293852:+	-0.26	-5.61	3.32E-8	Height	
HNSC	cis	1	rs6794875	chr3:48455626	TREX1	chr3:48501186-48509043:+	-0.26	-6.32	5.82E-10	Longevity	
HNSC	cis	1	rs6796491	chr3:48430465	ATRIP	chr3:48488141-48507708:+	0.16	3.71	0.000232	Longevity	
HNSC	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.28	-6.9	1.6E-11	Longevity	
HNSC	cis	1	rs6800862	chr3:134228628	ANAPC13	chr3:134196547-134204865:-	0.48	10.33	9.09E-23	Height	
HNSC	cis	1	rs6800862	chr3:134228628	CEP63	chr3:134204575-134293852:+	0.28	6.03	3.15E-9	Height	
HNSC	cis	1	rs6800	chr1:156262653	BGLAP	chr1:156182784-156213112:+	0.19	3.68	0.000262	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs6801596	chr3:134252114	ANAPC13	chr3:134196547-134204865:-	0.48	10.3	1.12E-22	Height	
HNSC	cis	1	rs6801596	chr3:134252114	CEP63	chr3:134204575-134293852:+	0.27	5.85	8.75E-9	Height	
HNSC	cis	1	rs6802498	chr3:56723660	CCDC66	chr3:56591184-56655846:+	0.19	5.23	2.56E-7	Height	
HNSC	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.49	10.45	3.24E-23	Height	
HNSC	cis	1	rs6802654	chr3:134217072	CEP63	chr3:134204575-134293852:+	0.28	6.08	2.38E-9	Height	
HNSC	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.49	10.42	4.27E-23	Height	
HNSC	cis	1	rs6804770	chr3:134230234	CEP63	chr3:134204575-134293852:+	0.28	6.1	2.1E-9	Height	
HNSC	cis	1	rs6804774	chr3:48430617	ATRIP	chr3:48488141-48507708:+	0.16	3.74	0.000203	Longevity	
HNSC	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.28	-6.83	2.43E-11	Longevity	
HNSC	cis	1	rs6805609	chr3:49471522	TREX1	chr3:48501186-48509043:+	0.19	3.82	0.00015	Menarche (age at onset)	
HNSC	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	0.73	12.02	2.4E-29	Diastolic blood pressure	
HNSC	cis	1	rs6806417	chr3:134211446	ANAPC13	chr3:134196547-134204865:-	-0.47	-10.27	1.54E-22	Height	
HNSC	cis	1	rs6806417	chr3:134211446	CEP63	chr3:134204575-134293852:+	-0.25	-5.59	3.84E-8	Height	
HNSC	cis	1	rs680668	chr6:84229366	PRSS35	chr6:84222274-84235419:+	0.19	4.01	7.13E-5	Bipolar disorder with mood-incongruent psychosis	
HNSC	cis	1	rs6809499	chr3:56687093	CCDC66	chr3:56591184-56655846:+	0.18	4.94	1.09E-6	Height	
HNSC	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.26	-6.43	3.01E-10	Longevity	
HNSC	cis	1	rs6810610	chr4:108930611	HADH	chr4:108910940-108956330:+	-0.28	-4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs6811887	chr4:17640858	FAM184B	chr4:17633711-17783135:-	-0.17	-4.08	5.34E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs68141011	chr6:28217797	ZNF389	chr6:28129551-28137375:+	-0.28	-4.29	2.11E-5	Depression	
HNSC	cis	1	rs68141011	chr6:28217797	ZSCAN23	chr6:28393287-28411279:-	0.25	3.88	0.000117	Depression	
HNSC	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.63	-13.65	3.31E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs6818639	chr4:17633049	FAM184B	chr4:17633711-17783135:-	-0.16	-3.94	9.38E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs68189316	chr7:65409169	CRCP	chr7:65579805-65619551:+	-0.33	-3.89	0.000114	Diabetic kidney disease	
HNSC	cis	1	rs68189316	chr7:65409169	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.91	1.21E-6	Diabetic kidney disease	
HNSC	cis	1	rs6823347	chr4:106962725	TBCK	chr4:106967233-107237861:-	0.26	5	8.07E-7	Airflow obstruction	
HNSC	cis	1	rs6827617	chr4:76916146	NAAA	chr4:76831809-76862166:-	-0.49	-11.27	2.3E-26	Longevity	
HNSC	cis	1	rs6840361	chr4:163738121	NAF1	chr4:164047860-164088073:-	-0.32	-3.7	0.000236	Hair morphology	
HNSC	cis	1	rs6846238	chr4:17629939	FAM184B	chr4:17633711-17783135:-	-0.16	-3.8	0.000162	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs6846579	chr4:107011756	TBCK	chr4:106967233-107237861:-	0.27	5.3	1.75E-7	Airflow obstruction	
HNSC	cis	1	rs6846789	chr4:108915972	HADH	chr4:108910940-108956330:+	0.28	4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs6848360	chr4:17634442	FAM184B	chr4:17633711-17783135:-	-0.16	-4.05	6.0E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs6848360	chr4:17634442	LAP3	chr4:17578927-17609590:+	-0.14	-3.77	0.00018	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs6849704	chr4:17652031	FAM184B	chr4:17633711-17783135:-	-0.17	-3.97	8.36E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs6854733	chr4:17640526	FAM184B	chr4:17633711-17783135:-	-0.16	-3.95	8.87E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs6854845	chr4:75746665	PARM1	chr4:75858298-75975323:+	0.21	3.77	0.000181	Survival in rectal cancer	
HNSC	cis	1	rs6856137	chr4:142160161	ZNF330	chr4:142142049-142155848:+	0.29	4.62	4.91E-6	Conduct disorder	
HNSC	cis	1	rs6860540	chr5:156938327	NIPAL4	chr5:156887027-156901729:+	-0.13	-3.98	7.8E-5	Inflammatory skin disease	
HNSC	cis	1	rs6862125	chr5:90724598	LOC100129716	chr5:90676164-90716531:+	0.28	4.04	6.16E-5	Smoking behavior	
HNSC	cis	1	rs6863300	chr5:82435448	XRCC4	chr5:82373317-82649577:+	-0.2	-3.99	7.7E-5	Hypertension	
HNSC	cis	1	rs6864479	chr5:82462240	XRCC4	chr5:82373317-82649577:+	-0.2	-3.84	0.000142	Hypertension	
HNSC	cis	1	rs6865495	chr5:90746424	LOC100129716	chr5:90676164-90716531:+	0.32	4.57	6.18E-6	Smoking behavior	
HNSC	cis	1	rs6866191	chr5:90746852	LOC100129716	chr5:90676164-90716531:+	0.31	4.32	1.88E-5	Smoking behavior	
HNSC	cis	1	rs6867091	chr5:90734333	LOC100129716	chr5:90676164-90716531:+	0.27	3.88	0.000117	Smoking behavior	
HNSC	cis	1	rs6867219	chr5:90718008	LOC100129716	chr5:90676164-90716531:+	0.29	4.04	6.23E-5	Smoking behavior	
HNSC	cis	1	rs6868817	chr5:82438106	XRCC4	chr5:82373317-82649577:+	-0.2	-3.9	0.000109	Hypertension	
HNSC	cis	1	rs6869717	chr5:90694797	LOC100129716	chr5:90676164-90716531:+	0.28	3.91	0.000104	Smoking behavior	
HNSC	cis	1	rs6872131	chr5:131973382	SLC22A4	chr5:131630145-131679897:+	0.19	3.75	0.000199	Asthma (childhood onset)	
HNSC	cis	1	rs6872131	chr5:131973382	SLC22A5	chr5:131705401-131731302:+	0.22	3.73	0.000217	Asthma (childhood onset)	
HNSC	cis	1	rs6874202	chr5:156391628	TIMD4	chr5:156346293-156390266:-	-0.18	-4.39	1.4E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
HNSC	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.57	15.11	1.2E-42	Crohn's disease	
HNSC	cis	1	rs687672	chr11:65649984	SNX32	chr11:65601410-65621170:+	-0.44	-7.19	2.37E-12	Crohn's disease	
HNSC	cis	1	rs6876972	chr5:115642519	COMMD10	chr5:115420727-115628978:+	0.35	4.17	3.57E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs6879800	chr5:112775010	YTHDC2	chr5:112849410-112930979:+	0.21	4	7.18E-5	Cerebral amyloid angiopathy	
HNSC	cis	1	rs6880213	chr5:115447414	COMMD10	chr5:115420727-115628978:+	0.34	3.95	8.96E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs6882076	chr5:156390297	TIMD4	chr5:156346293-156390266:-	-0.18	-4.39	1.4E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
HNSC	cis	1	rs6882179	chr5:82435401	XRCC4	chr5:82373317-82649577:+	-0.2	-4.01	6.88E-5	Hypertension	
HNSC	cis	1	rs6882220	chr5:82435534	XRCC4	chr5:82373317-82649577:+	-0.2	-3.92	0.000101	Hypertension	
HNSC	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.82	14.14	2.31E-38	Type 2 diabetes	
HNSC	cis	1	rs6887846	chr5:82436361	XRCC4	chr5:82373317-82649577:+	0.21	4.19	3.35E-5	Hypertension	
HNSC	cis	1	rs6889951	chr5:133847772	CDKN2AIPNL	chr5:133737835-133747589:-	0.28	4.54	7.23E-6	Menarche (age at onset)	
HNSC	cis	1	rs6889951	chr5:133847772	UBE2B	chr5:133706870-133727798:+	0.23	3.93	9.62E-5	Menarche (age at onset)	
HNSC	cis	1	rs6901126	chr6:153440062	RGS17	chr6:153332041-153452389:-	0.2	3.67	0.00027	Prostate cancer	
HNSC	cis	1	rs6901317	chr6:106036151	ATG5	chr6:106632354-106773695:-	-0.21	-3.82	0.00015	Beard thickness	
HNSC	cis	1	rs6901317	chr6:106036151	PRDM1	chr6:106534195-106557814:+	-0.15	-3.67	0.00027	Beard thickness	
HNSC	cis	1	rs6901575	chr6:28250984	ZNF389	chr6:28129551-28137375:+	-0.26	-3.9	0.000112	Depression	
HNSC	cis	1	rs6901575	chr6:28250984	ZSCAN23	chr6:28393287-28411279:-	0.27	4.2	3.19E-5	Depression	
HNSC	cis	1	rs6902429	chr6:49393500	CENPQ	chr6:49431096-49460820:+	-0.57	-14.7	8.09E-41	Homocysteine levels	
HNSC	cis	1	rs6902429	chr6:49393500	MUT	chr6:49398994-49431031:-	0.23	4.55	6.62E-6	Homocysteine levels	
HNSC	cis	1	rs6903665	chr6:101148234	ASCC3	chr6:100956609-101329224:-	0.21	5.56	4.39E-8	Menarche (age at onset)	
HNSC	cis	1	rs6903973	chr6:26499942	BTN2A3	chr6:26422317-26431927:+	0.16	3.71	0.000227	Educational attainment	
HNSC	cis	1	rs6903973	chr6:26499942	BTN3A2	chr6:26365398-26378546:+	0.19	4.51	8.23E-6	Educational attainment	
HNSC	cis	1	rs6905391	chr6:28262686	ZSCAN23	chr6:28393287-28411279:-	0.24	3.84	0.000139	Depression	
HNSC	cis	1	rs6906229	chr6:150707849	IYD	chr6:150690028-150725764:+	-0.18	-3.77	0.000186	Anger	
HNSC	cis	1	rs6907823	chr6:153433542	RGS17	chr6:153332041-153452389:-	-0.21	-3.91	0.000107	Prostate cancer	
HNSC	cis	1	rs6909201	chr6:74463894	MTO1	chr6:74171454-74211177:+	0.21	3.95	9.11E-5	Calcium levels	
HNSC	cis	1	rs6910233	chr6:33534726	BAK1	chr6:33540324-33548070:-	0.21	5.35	1.36E-7	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs6910899	chr6:26524339	BTN2A3	chr6:26422317-26431927:+	0.17	3.82	0.000148	Educational attainment	
HNSC	cis	1	rs6910899	chr6:26524339	BTN3A2	chr6:26365398-26378546:+	0.19	4.44	1.13E-5	Educational attainment	
HNSC	cis	1	rs6911965	chr6:24480295	GPLD1	chr6:24428405-24489850:-	-0.23	-3.93	9.86E-5	Hematological and biochemical traits	
HNSC	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.59	-13.43	2.91E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.57	-14.74	5.04E-41	Homocysteine levels	
HNSC	cis	1	rs6915187	chr6:49423547	MUT	chr6:49398994-49431031:-	0.22	4.49	8.76E-6	Homocysteine levels	
HNSC	cis	1	rs6916888	chr6:49383804	CENPQ	chr6:49431096-49460820:+	-0.57	-14.78	3.66E-41	Homocysteine levels	
HNSC	cis	1	rs6916888	chr6:49383804	MUT	chr6:49398994-49431031:-	0.23	4.56	6.57E-6	Homocysteine levels	
HNSC	cis	1	rs6917538	chr6:153440197	RGS17	chr6:153332041-153452389:-	-0.21	-3.94	9.47E-5	Prostate cancer	
HNSC	cis	1	rs6918347	chr6:49406348	CENPQ	chr6:49431096-49460820:+	-0.56	-14.43	1.24E-39	Homocysteine levels	
HNSC	cis	1	rs6918347	chr6:49406348	MUT	chr6:49398994-49431031:-	0.23	4.57	6.28E-6	Homocysteine levels	
HNSC	cis	1	rs6918586	chr6:26097384	BTN3A2	chr6:26365398-26378546:+	-0.16	-3.75	0.000201	Schizophrenia	
HNSC	cis	1	rs6922824	chr6:26553815	BTN3A2	chr6:26365398-26378546:+	-0.18	-4.24	2.64E-5	Educational attainment	
HNSC	cis	1	rs6923124	chr6:49419864	CENPQ	chr6:49431096-49460820:+	-0.4	-9.34	3.23E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs6923124	chr6:49419864	MUT	chr6:49398994-49431031:-	0.42	9.06	3.16E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.6	13.39	4.43E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs6924002	chr6:117114223	FAM26F	chr6:116782556-116784933:+	0.15	3.94	9.51E-5	C-reactive protein levels	
HNSC	cis	1	rs6924373	chr6:87804222	C6orf164	chr6:88032306-88109459:+	0.24	4.67	3.98E-6	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
HNSC	cis	1	rs6924838	chr6:26571756	BTN3A2	chr6:26365398-26378546:+	0.17	3.99	7.64E-5	Educational attainment	
HNSC	cis	1	rs6925703	chr6:26521589	BTN2A3	chr6:26422317-26431927:+	0.17	3.82	0.000149	Educational attainment	
HNSC	cis	1	rs6925703	chr6:26521589	BTN3A2	chr6:26365398-26378546:+	0.19	4.43	1.18E-5	Educational attainment	
HNSC	cis	1	rs6925895	chr6:26572165	BTN3A2	chr6:26365398-26378546:+	0.17	3.99	7.64E-5	Educational attainment	
HNSC	cis	1	rs6926629	chr6:26499903	BTN2A3	chr6:26422317-26431927:+	0.16	3.71	0.000227	Educational attainment	
HNSC	cis	1	rs6926629	chr6:26499903	BTN3A2	chr6:26365398-26378546:+	0.19	4.51	8.23E-6	Educational attainment	
HNSC	cis	1	rs6927188	chr6:42912589	GNMT	chr6:42928500-42931617:+	0.24	4.09	5.07E-5	Diabetic kidney disease	
HNSC	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.51	-7.67	9.22E-14	Diabetic kidney disease	
HNSC	cis	1	rs6927516	chr6:153441831	RGS17	chr6:153332041-153452389:-	-0.22	-4.01	6.91E-5	Prostate cancer	
HNSC	cis	1	rs6930076	chr6:88088654	C6orf162	chr6:88032306-88052043:+	-0.19	-3.88	0.000118	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs6930076	chr6:88088654	C6orf164	chr6:88032306-88109459:+	-0.24	-4.44	1.12E-5	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs6930120	chr6:26555484	BTN2A3	chr6:26422317-26431927:+	0.17	3.8	0.000163	Educational attainment	
HNSC	cis	1	rs6930120	chr6:26555484	BTN3A2	chr6:26365398-26378546:+	0.18	4.25	2.55E-5	Educational attainment	
HNSC	cis	1	rs6931160	chr6:153430451	RGS17	chr6:153332041-153452389:-	-0.21	-3.91	0.000106	Prostate cancer	
HNSC	cis	1	rs6932156	chr6:26571506	BTN3A2	chr6:26365398-26378546:+	0.17	3.99	7.64E-5	Educational attainment	
HNSC	cis	1	rs6932590	chr6:27248931	BTN3A2	chr6:26365398-26378546:+	-0.3	-5.96	4.79E-9	Schizophrenia	
HNSC	cis	1	rs6932590	chr6:27248931	LOC100270746	chr6:26987146-26988085:-	0.23	4.41	1.27E-5	Schizophrenia	
HNSC	cis	1	rs6933176	chr6:26540178	BTN2A3	chr6:26422317-26431927:+	0.16	3.69	0.00025	Educational attainment	
HNSC	cis	1	rs6933176	chr6:26540178	BTN3A2	chr6:26365398-26378546:+	0.18	4.26	2.49E-5	Educational attainment	
HNSC	cis	1	rs6933377	chr6:86705255	SNHG5	chr6:86386726-86388451:-	0.49	11.21	3.89E-26	Response to antipsychotic treatment	
HNSC	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.61	-13.2	2.91E-34	Response to antipsychotic treatment	
HNSC	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.57	-15.42	4.61E-44	Crohn's disease	
HNSC	cis	1	rs693824	chr11:65654783	SNX32	chr11:65601410-65621170:+	0.43	7.18	2.55E-12	Crohn's disease	
HNSC	cis	1	rs6940053	chr6:26562122	BTN2A3	chr6:26422317-26431927:+	0.16	3.72	0.000221	Educational attainment	
HNSC	cis	1	rs6940053	chr6:26562122	BTN3A2	chr6:26365398-26378546:+	0.18	4.24	2.71E-5	Educational attainment	
HNSC	cis	1	rs6940188	chr6:26562029	BTN2A3	chr6:26422317-26431927:+	0.16	3.72	0.000221	Educational attainment	
HNSC	cis	1	rs6940188	chr6:26562029	BTN3A2	chr6:26365398-26378546:+	0.18	4.24	2.71E-5	Educational attainment	
HNSC	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.62	-13.69	2.2E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs6942332	chr6:170131934	C6orf70	chr6:170151721-170181617:+	0.23	4	7.35E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
HNSC	cis	1	rs6945843	chr7:65734783	NCRNA00174	chr7:65841032-65865395:-	0.74	15.4	5.45E-44	Aortic root size	
HNSC	cis	1	rs6946143	chr7:65579722	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.36	8.45E-44	Aortic root size	
HNSC	cis	1	rs6948775	chr7:98945480	CYP3A5	chr7:99245818-99332821:-	0.57	6.93	1.3E-11	Blood metabolite levels	
HNSC	cis	1	rs6949812	chr7:65387101	CRCP	chr7:65579805-65619551:+	-0.34	-3.93	9.9E-5	Diabetic kidney disease	
HNSC	cis	1	rs6949812	chr7:65387101	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.94	1.06E-6	Diabetic kidney disease	
HNSC	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.57	-15.51	1.7E-44	Crohn's disease	
HNSC	cis	1	rs694994	chr11:65653309	SNX32	chr11:65601410-65621170:+	0.43	7.17	2.83E-12	Crohn's disease	
HNSC	cis	1	rs6951245	chr7:1058193	ZFAND2A	chr7:1192544-1199855:-	-0.27	-3.81	0.000154	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs6952407	chr7:66045512	NCRNA00174	chr7:65841032-65865395:-	0.56	11.17	5.36E-26	Cotinine glucuronidation	
HNSC	cis	1	rs6956179	chr7:65806659	NCRNA00174	chr7:65841032-65865395:-	0.71	14.81	2.47E-41	Aortic root size	
HNSC	cis	1	rs6956179	chr7:65806659	TYW1	chr7:66461817-66704496:+	-0.2	-3.73	0.000216	Aortic root size	
HNSC	cis	1	rs6957199	chr7:65978519	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.81	7.38E-46	Aortic root size	
HNSC	cis	1	rs6958271	chr7:65979331	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.43	4.16E-44	Aortic root size	
HNSC	cis	1	rs6958277	chr7:65979349	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.43	4.16E-44	Aortic root size	
HNSC	cis	1	rs6958289	chr7:65657111	NCRNA00174	chr7:65841032-65865395:-	0.44	4.76	2.57E-6	Diabetic kidney disease	
HNSC	cis	1	rs6958420	chr7:65751171	NCRNA00174	chr7:65841032-65865395:-	0.46	4.96	9.65E-7	Diabetic kidney disease	
HNSC	cis	1	rs6958484	chr7:65599446	NCRNA00174	chr7:65841032-65865395:-	0.74	15.53	1.49E-44	Aortic root size	
HNSC	cis	1	rs6958520	chr7:66151453	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs6959002	chr7:65650496	NCRNA00174	chr7:65841032-65865395:-	0.44	4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs6959702	chr7:3356286	C7orf27	chr7:2577511-2595146:-	-0.18	-4.04	6.1E-5	Motion sickness	
HNSC	cis	1	rs6959702	chr7:3356286	GNA12	chr7:2767743-2883959:-	-0.14	-3.68	0.000262	Motion sickness	
HNSC	cis	1	rs6961155	chr7:65933295	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.88	3.77E-46	Aortic root size	
HNSC	cis	1	rs6961155	chr7:65933295	TYW1	chr7:66461817-66704496:+	0.2	3.66	0.000278	Aortic root size	
HNSC	cis	1	rs6961717	chr7:65587537	NCRNA00174	chr7:65841032-65865395:-	0.74	15.46	3.0E-44	Aortic root size	
HNSC	cis	1	rs6961990	chr7:65888570	NCRNA00174	chr7:65841032-65865395:-	-0.73	-14.85	1.63E-41	Aortic root size	
HNSC	cis	1	rs6961990	chr7:65888570	TYW1	chr7:66461817-66704496:+	0.21	3.83	0.000143	Aortic root size	
HNSC	cis	1	rs6963646	chr7:65685767	NCRNA00174	chr7:65841032-65865395:-	0.74	15.68	2.86E-45	Aortic root size	
HNSC	cis	1	rs6964245	chr7:65718717	NCRNA00174	chr7:65841032-65865395:-	0.46	4.93	1.13E-6	Diabetic kidney disease	
HNSC	cis	1	rs6964530	chr7:65718851	NCRNA00174	chr7:65841032-65865395:-	0.46	4.92	1.19E-6	Diabetic kidney disease	
HNSC	cis	1	rs6966322	chr7:65646754	NCRNA00174	chr7:65841032-65865395:-	0.44	4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs6970030	chr7:65968679	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.84	5.47E-46	Aortic root size	
HNSC	cis	1	rs6970030	chr7:65968679	TYW1	chr7:66461817-66704496:+	0.2	3.69	0.000248	Aortic root size	
HNSC	cis	1	rs6970243	chr7:65388490	CRCP	chr7:65579805-65619551:+	-0.34	-3.93	9.9E-5	Diabetic kidney disease	
HNSC	cis	1	rs6970243	chr7:65388490	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.94	1.06E-6	Diabetic kidney disease	
HNSC	cis	1	rs6970597	chr7:21583519	DNAH11	chr7:21582833-21941455:+	-0.51	-11.22	3.48E-26	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
HNSC	cis	1	rs6970985	chr7:21583597	DNAH11	chr7:21582833-21941455:+	-0.52	-11.58	1.34E-27	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
HNSC	cis	1	rs6974723	chr7:65637939	NCRNA00174	chr7:65841032-65865395:-	0.44	4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs6975195	chr7:66124774	NCRNA00174	chr7:65841032-65865395:-	0.55	10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs6976053	chr7:100512119	ZAN	chr7:100331249-100395418:+	-0.19	-4.2	3.23E-5	Plasminogen activator inhibitor type 1 levels (PAI-1)	
HNSC	cis	1	rs6979382	chr7:65886375	NCRNA00174	chr7:65841032-65865395:-	-0.73	-14.85	1.63E-41	Aortic root size	
HNSC	cis	1	rs6979382	chr7:65886375	TYW1	chr7:66461817-66704496:+	0.21	3.83	0.000143	Aortic root size	
HNSC	cis	1	rs697970	chr7:65560052	NCRNA00174	chr7:65841032-65865395:-	0.71	13.93	2.0E-37	Aortic root size	
HNSC	cis	1	rs6980323	chr7:3356207	C7orf27	chr7:2577511-2595146:-	-0.18	-4.19	3.37E-5	Motion sickness	
HNSC	cis	1	rs6980323	chr7:3356207	GNA12	chr7:2767743-2883959:-	-0.14	-3.83	0.000143	Motion sickness	
HNSC	cis	1	rs698500	chr15:83237769	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.16	-4.11	4.54E-5	Schizophrenia	
HNSC	cis	1	rs6985880	chr8:96027599	C8orf38	chr8:95908040-96088396:+	-0.29	-4.45	1.04E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs6989203	chr8:41523745	ZMAT4	chr8:40388116-40755343:-	0.2	4	7.33E-5	Type 2 diabetes	
HNSC	cis	1	rs6989862	chr8:96027568	C8orf38	chr8:95908040-96088396:+	-0.29	-4.45	1.04E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs6999	chr20:55093901	C20orf43	chr20:55043647-55093942:+	0.21	4.17	3.62E-5	Refractive astigmatism	
HNSC	cis	1	rs7002940	chr8:96027392	C8orf38	chr8:95908040-96088396:+	-0.29	-4.45	1.04E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs7003387	chr8:95961979	TP53INP1	chr8:95938201-95961615:-	-0.18	-4.4	1.33E-5	Type 2 diabetes	
HNSC	cis	1	rs7004438	chr8:8574379	FLJ10661	chr8:8086092-8102386:+	0.26	4.41	1.26E-5	Obesity-related traits	
HNSC	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	0.82	18.59	7.21E-59	Bone mineral density	
HNSC	cis	1	rs7008542	chr8:96027863	C8orf38	chr8:95908040-96088396:+	-0.29	-4.45	1.04E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	0.85	19.13	1.93E-61	Bone mineral density	
HNSC	cis	1	rs7022397	chr9:116007677	CDC26	chr9:116029290-116037869:-	-0.44	-8.87	1.31E-17	Hematology traits	
HNSC	cis	1	rs702485	chr7:6449272	KDELR2	chr7:6500713-6523849:-	0.15	3.65	0.000287	HDL cholesterol	
HNSC	cis	1	rs7028950	chr9:21682260	KLHL9	chr9:21324054-21335429:-	-0.27	-4.57	6.15E-6	Pediatric bone mineral content (radius)	
HNSC	cis	1	rs7028950	chr9:21682260	MTAP	chr9:21802635-22029593:+	-0.34	-5.11	4.63E-7	Pediatric bone mineral content (radius)	
HNSC	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.53	-10.67	4.66E-24	Multiple sclerosis	
HNSC	cis	1	rs703842	chr12:58162739	TSFM	chr12:58176536-58191367:+	0.34	7.61	1.44E-13	Multiple sclerosis	
HNSC	cis	1	rs7038769	chr9:116007583	CDC26	chr9:116029290-116037869:-	-0.44	-8.87	1.31E-17	Hematology traits	
HNSC	cis	1	rs7046469	chr9:35923384	LOC158376	chr9:35909480-35911617:+	-0.34	-4	7.18E-5	Urate levels (BMI interaction)	
HNSC	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.52	10.26	1.64E-22	Cognitive function	
HNSC	cis	1	rs706201	chr7:134251041	AKR1B15	chr7:134233849-134264300:+	-0.26	-5.45	8.06E-8	Longevity	
HNSC	cis	1	rs706202	chr7:134250704	AKR1B15	chr7:134233849-134264300:+	-0.26	-5.54	4.98E-8	Longevity	
HNSC	cis	1	rs7068921	chr10:124733526	C10orf88	chr10:124690419-124713919:-	-0.21	-3.92	0.0001	Migraine without aura	
HNSC	cis	1	rs7069235	chr10:118786985	KIAA1598	chr10:118644308-118886097:-	0.29	4.08	5.18E-5	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
HNSC	cis	1	rs7069346	chr10:124729876	C10orf88	chr10:124690419-124713919:-	-0.22	-4.02	6.64E-5	Migraine without aura	
HNSC	cis	1	rs7070776	chr10:102264672	SEC31B	chr10:102246403-102289636:-	-0.21	-6.49	2.05E-10	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7071271	chr10:102264824	SEC31B	chr10:102246403-102289636:-	-0.2	-6.16	1.5E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.64	13.7	1.96E-36	Metabolite levels	
HNSC	cis	1	rs7073497	chr10:100153688	PYROXD2	chr10:100143323-100174978:-	0.59	5.07	5.7E-7	Aspartate aminotransferase	
HNSC	cis	1	rs7073586	chr10:102307671	SEC31B	chr10:102246403-102289636:-	-0.18	-5.76	1.44E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7078012	chr10:81705433	MBL1P	chr10:81664654-81710783:+	0.2	3.88	0.00012	Chronic obstructive pulmonary disease-related biomarkers	
HNSC	cis	1	rs7078160	chr10:118827560	KIAA1598	chr10:118644308-118886097:-	0.31	4.34	1.72E-5	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
HNSC	cis	1	rs7078799	chr10:102301447	SEC31B	chr10:102246403-102289636:-	-0.17	-5.4	1.06E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7079136	chr10:102292709	SEC31B	chr10:102246403-102289636:-	-0.19	-5.81	1.13E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7079756	chr10:102302105	SEC31B	chr10:102246403-102289636:-	-0.18	-5.66	2.61E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7080356	chr10:102266735	SEC31B	chr10:102246403-102289636:-	-0.21	-6.51	1.88E-10	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs708152	chr11:2384348	C11orf21	chr11:2317507-2323143:-	-0.24	-5.74	1.69E-8	Bacteremia	
HNSC	cis	1	rs7084810	chr10:102297546	SEC31B	chr10:102246403-102289636:-	-0.18	-5.63	3.09E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7085439	chr10:102210100	SEC31B	chr10:102246403-102289636:-	-0.18	-5.79	1.24E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7088512	chr10:102303498	SEC31B	chr10:102246403-102289636:-	-0.18	-5.69	2.24E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7088827	chr10:102303865	SEC31B	chr10:102246403-102289636:-	-0.18	-5.48	6.81E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7090431	chr10:102261753	SEC31B	chr10:102246403-102289636:-	-0.2	-6.41	3.44E-10	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7091404	chr10:124745458	C10orf88	chr10:124690419-124713919:-	-0.22	-4.07	5.58E-5	Migraine without aura	
HNSC	cis	1	rs7095889	chr10:124744265	C10orf88	chr10:124690419-124713919:-	-0.21	-4.02	6.83E-5	Migraine without aura	
HNSC	cis	1	rs7095944	chr10:126302936	METTL10	chr10:126447406-126480439:-	-0.23	-4.74	2.78E-6	Asthma	
HNSC	cis	1	rs709595	chr7:65817333	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.65	4.22E-45	Aortic root size	
HNSC	cis	1	rs709597	chr7:65825983	NCRNA00174	chr7:65841032-65865395:-	0.75	15.36	8.58E-44	Aortic root size	
HNSC	cis	1	rs709607	chr7:65449541	CRCP	chr7:65579805-65619551:+	0.29	3.77	0.000185	Diabetic kidney disease	
HNSC	cis	1	rs709607	chr7:65449541	NCRNA00174	chr7:65841032-65865395:-	0.41	5.06	5.91E-7	Diabetic kidney disease	
HNSC	cis	1	rs7096614	chr10:124746801	C10orf88	chr10:124690419-124713919:-	-0.21	-3.76	0.000192	Migraine without aura	
HNSC	cis	1	rs7098825	chr10:104628234	SFXN2	chr10:104474298-104498946:+	-0.33	-4.07	5.52E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
HNSC	cis	1	rs7099913	chr10:102314777	SEC31B	chr10:102246403-102289636:-	-0.17	-5.28	1.95E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7099965	chr10:102301165	SEC31B	chr10:102246403-102289636:-	-0.17	-5.41	9.91E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7099	chr20:43997646	SYS1-DBNDD2	chr20:43991701-44039245:+	-0.34	-5.22	2.59E-7	Psoriasis	
HNSC	cis	1	rs7100386	chr10:102301417	SEC31B	chr10:102246403-102289636:-	-0.17	-5.4	1.06E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7100697	chr10:124745323	C10orf88	chr10:124690419-124713919:-	-0.22	-4.04	6.12E-5	Migraine without aura	
HNSC	cis	1	rs7104764	chr11:229977	PSMD13	chr11:236808-252984:+	-0.19	-3.86	0.000131	Menarche (age at onset)	
HNSC	cis	1	rs7105282	chr11:47805614	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.55	4.67E-8	Subjective well-being	
HNSC	cis	1	rs7105282	chr11:47805614	MYBPC3	chr11:47352958-47374253:-	-0.21	-3.97	8.19E-5	Subjective well-being	
HNSC	cis	1	rs7107356	chr11:47676170	C1QTNF4	chr11:47611216-47615961:-	0.19	3.96	8.74E-5	Neuroticism	
HNSC	cis	1	rs710865	chr1:19568972	KIAA0090	chr1:19544585-19578046:-	-0.21	-5.34	1.41E-7	Brain structure	
HNSC	cis	1	rs710866	chr1:19568722	KIAA0090	chr1:19544585-19578046:-	-0.2	-5.24	2.33E-7	Brain structure	
HNSC	cis	1	rs7111	chr15:90373873	AP3S2	chr15:90373832-90456222:-	-0.66	-11.45	4.31E-27	Type 2 diabetes	
HNSC	cis	1	rs7112513	chr11:117037361	PCSK7	chr11:117075789-117102811:-	-0.3	-4.37	1.52E-5	Protein quantitative trait loci	
HNSC	cis	1	rs7112925	chr11:66826160	ACTN3	chr11:66313866-66330797:+	-0.27	-5.1	4.91E-7	Height	
HNSC	cis	1	rs7114963	chr11:116875983	PCSK7	chr11:117075789-117102811:-	-0.31	-4.39	1.4E-5	Protein quantitative trait loci	
HNSC	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.41	-7.22	1.93E-12	Forced vital capacity	
HNSC	cis	1	rs7120333	chr11:47817441	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.45	7.81E-8	Subjective well-being	
HNSC	cis	1	rs7120333	chr11:47817441	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.9	0.000111	Subjective well-being	
HNSC	cis	1	rs7121347	chr11:116867209	PCSK7	chr11:117075789-117102811:-	-0.31	-4.39	1.4E-5	Protein quantitative trait loci	
HNSC	cis	1	rs7122539	chr11:66662731	ACTN3	chr11:66313866-66330797:+	0.41	7.79	3.93E-14	HIV-1 susceptibility	
HNSC	cis	1	rs7122944	chr11:117034619	PCSK7	chr11:117075789-117102811:-	-0.32	-4.6	5.3E-6	Protein quantitative trait loci	
HNSC	cis	1	rs7123517	chr11:117027755	PCSK7	chr11:117075789-117102811:-	-0.31	-4.57	6.28E-6	Protein quantitative trait loci	
HNSC	cis	1	rs7124676	chr11:64313291	TRMT112	chr11:64084168-64085033:-	-0.15	-3.99	7.57E-5	Obesity-related traits	
HNSC	cis	1	rs7124741	chr11:116752219	PCSK7	chr11:117075789-117102811:-	-0.28	-3.8	0.000161	Protein quantitative trait loci	
HNSC	cis	1	rs7129491	chr11:57095082	PRG2	chr11:57151267-57191532:-	-0.34	-3.98	7.81E-5	Low high density lipoprotein cholesterol levels	
HNSC	cis	1	rs71299622	chr3:52917038	TMEM110	chr3:52867139-52931547:-	0.6	6.4	3.58E-10	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs71301804	chr3:53073314	PHF7	chr3:52444527-52457656:+	0.41	3.93	9.6E-5	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs71301804	chr3:53073314	TMEM110	chr3:52867139-52931547:-	0.45	4.9	1.28E-6	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs71301808	chr3:53085577	TMEM110	chr3:52867139-52931547:-	0.5	5.75	1.58E-8	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs71301809	chr3:53090312	TMEM110	chr3:52867139-52931547:-	0.51	5.87	7.85E-9	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs71301814	chr3:53117663	TMEM110	chr3:52867139-52931547:-	0.45	5.52	5.41E-8	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs71327718	chr3:125592857	ALG1L	chr3:125648118-125655882:-	-0.47	-6.84	2.29E-11	Metabolite levels (HVA/5-HIAA ratio)	
HNSC	cis	1	rs71327718	chr3:125592857	LOC100125556	chr3:125635444-125648865:+	0.33	4.53	7.52E-6	Metabolite levels (HVA/5-HIAA ratio)	
HNSC	cis	1	rs71334202	chr20:23618652	CST1	chr20:23728191-23731574:-	0.34	5.33	1.46E-7	Chronic kidney disease	
HNSC	cis	1	rs71334202	chr20:23618652	CST4	chr20:23666277-23669662:-	0.26	4.24	2.72E-5	Chronic kidney disease	
HNSC	cis	1	rs7134594	chr12:110000193	MMAB	chr12:109991523-110011358:-	-0.18	-4.49	9.03E-6	HDL cholesterol	
HNSC	cis	1	rs71367913	chr17:40589869	NAGLU	chr17:40687951-40696464:+	-0.19	-3.67	0.000266	Crohn's disease	
HNSC	cis	1	rs713835	chr22:38064650	LGALS2	chr22:37966254-37976024:-	0.13	3.86	0.000128	Fat distribution (HIV)	
HNSC	cis	1	rs7140261	chr14:65973956	LOC645431	chr14:65877313-65879335:-	-0.29	-3.87	0.000123	Ischemic stroke	
HNSC	cis	1	rs7140872	chr14:55612744	KIAA0831	chr14:55833110-55878576:-	-0.23	-4.17	3.62E-5	Protein biomarker	
HNSC	cis	1	rs7142235	chr14:75559963	MLH3	chr14:75480467-75518235:-	0.3	6.3	6.6E-10	Height	
HNSC	cis	1	rs7142704	chr14:55630603	KIAA0831	chr14:55833110-55878576:-	-0.23	-4.18	3.51E-5	Protein biomarker	
HNSC	cis	1	rs71430278	chr2:218312448	DIRC3	chr2:218148748-218621316:-	0.31	4.08	5.32E-5	Metabolite levels (MHPG)	
HNSC	cis	1	rs7143682	chr14:104413455	TDRD9	chr14:104394817-104519002:+	0.34	5.47	7.02E-8	Bipolar disorder	
HNSC	cis	1	rs7144423	chr14:35572547	PPP2R3C	chr14:35554679-35591679:-	0.45	7.34	8.65E-13	Atopic dermatitis	
HNSC	cis	1	rs7145159	chr14:75583268	MLH3	chr14:75480467-75518235:-	0.3	6.1	2.16E-9	Height	
HNSC	cis	1	rs7145574	chr14:65884402	LOC645431	chr14:65877313-65879335:-	-0.28	-3.82	0.000153	Ischemic stroke	
HNSC	cis	1	rs7147118	chr14:75610170	MLH3	chr14:75480467-75518235:-	0.3	6.14	1.69E-9	Height	
HNSC	cis	1	rs7148538	chr14:74392342	LIN52	chr14:74551656-74667117:+	0.23	4.17	3.56E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs714909	chr22:31741067	SELM	chr22:31500765-31516055:-	0.16	3.65	0.000285	Paclitaxel-induced neuropathy	
HNSC	cis	1	rs7153160	chr14:74509377	LIN52	chr14:74551656-74667117:+	0.28	7.66	9.93E-14	Common traits (Other)	
HNSC	cis	1	rs7153587	chr14:74509660	LIN52	chr14:74551656-74667117:+	0.29	8.12	3.68E-15	Common traits (Other)	
HNSC	cis	1	rs7153679	chr14:66012954	LOC645431	chr14:65877313-65879335:-	-0.29	-4.05	5.86E-5	Ischemic stroke	
HNSC	cis	1	rs715378	chr4:142161354	ZNF330	chr4:142142049-142155848:+	-0.27	-4.21	3.02E-5	Conduct disorder	
HNSC	cis	1	rs7154306	chr14:35540499	PPP2R3C	chr14:35554679-35591679:-	0.42	6.79	3.17E-11	Atopic dermatitis	
HNSC	cis	1	rs71550519	chr6:56780272	BEND6	chr6:56819773-56892138:+	-0.4	-6.95	1.13E-11	Menarche (age at onset)	
HNSC	cis	1	rs71550519	chr6:56780272	RAB23	chr6:57053591-57087101:-	0.22	3.95	8.97E-5	Menarche (age at onset)	
HNSC	cis	1	rs7155275	chr14:65502271	CHURC1	chr14:65381140-65411309:+	0.4	7	8.24E-12	Red blood cell traits	
HNSC	cis	1	rs7155454	chr14:65502239	CHURC1	chr14:65381140-65411309:+	0.43	7.64	1.16E-13	Red blood cell traits	
HNSC	cis	1	rs7156105	chr14:75541954	MLH3	chr14:75480467-75518235:-	0.28	5.73	1.73E-8	Height	
HNSC	cis	1	rs71562227	chr6:110759274	SLC22A16	chr6:110745907-110797844:-	0.34	3.8	0.000166	Glucose homeostasis traits	
HNSC	cis	1	rs7156322	chr14:35544330	PPP2R3C	chr14:35554679-35591679:-	0.42	6.84	2.35E-11	Atopic dermatitis	
HNSC	cis	1	rs7156328	chr14:75532941	MLH3	chr14:75480467-75518235:-	0.31	6.42	3.18E-10	Height	
HNSC	cis	1	rs71564866	chr6:56771207	BEND6	chr6:56819773-56892138:+	-0.4	-7.04	6.57E-12	Menarche (age at onset)	
HNSC	cis	1	rs71564866	chr6:56771207	RAB23	chr6:57053591-57087101:-	0.22	3.92	0.000101	Menarche (age at onset)	
HNSC	cis	1	rs71564868	chr6:56798441	BEND6	chr6:56819773-56892138:+	-0.42	-7.25	1.58E-12	Menarche (age at onset)	
HNSC	cis	1	rs71564868	chr6:56798441	RAB23	chr6:57053591-57087101:-	0.21	3.73	0.000212	Menarche (age at onset)	
HNSC	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.31	-8.6	1.09E-16	Common traits (Other)	
HNSC	cis	1	rs7157940	chr14:94563193	IFI27L1	chr14:94547639-94569059:+	0.3	7.18	2.53E-12	Anthropometric traits	
HNSC	cis	1	rs7160110	chr14:55594635	KIAA0831	chr14:55833110-55878576:-	-0.22	-4.05	6.04E-5	Protein biomarker	
HNSC	cis	1	rs71617204	chr3:53042951	TMEM110	chr3:52867139-52931547:-	0.49	5.56	4.54E-8	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs7162435	chr15:56121334	NEDD4	chr15:56119131-56285835:-	-0.19	-4.81	1.97E-6	Keloid	
HNSC	cis	1	rs7162900	chr15:75368017	SCAMP5	chr15:75287901-75313836:+	0.37	7.53	2.39E-13	Blood trace element (Zn levels)	
HNSC	cis	1	rs71636795	chr1:27241025	PDIK1L	chr1:26437656-26452024:+	-0.19	-3.82	0.000151	HDL cholesterol;Triglycerides;LDL cholesterol	
HNSC	cis	1	rs7164132	chr15:40675155	C15orf23	chr15:40674922-40686488:+	0.46	7.27	1.42E-12	Heschl's gyrus morphology	
HNSC	cis	1	rs7166991	chr15:40671957	C15orf23	chr15:40674922-40686488:+	0.45	7.17	2.81E-12	Heschl's gyrus morphology	
HNSC	cis	1	rs7167285	chr15:75368769	SCAMP5	chr15:75287901-75313836:+	0.37	7.53	2.39E-13	Blood trace element (Zn levels)	
HNSC	cis	1	rs7168680	chr15:75369212	SCAMP5	chr15:75287901-75313836:+	0.37	7.53	2.39E-13	Blood trace element (Zn levels)	
HNSC	cis	1	rs7169404	chr15:40675443	C15orf23	chr15:40674922-40686488:+	0.46	7.27	1.42E-12	Heschl's gyrus morphology	
HNSC	cis	1	rs7172118	chr15:78862453	CHRNA5	chr15:78857906-78886458:+	-0.27	-5.48	6.91E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs7173833	chr15:75369618	SCAMP5	chr15:75287901-75313836:+	0.36	7.31	1.1E-12	Blood trace element (Zn levels)	
HNSC	cis	1	rs7174	chr12:121017171	POP5	chr12:121016849-121019201:-	-0.22	-3.9	0.00011	Type 1 diabetes nephropathy	
HNSC	cis	1	rs7174	chr12:121017171	TRIAP1	chr12:120881765-120884215:-	-0.22	-3.72	0.000221	Type 1 diabetes nephropathy	
HNSC	cis	1	rs7175720	chr15:75348962	SCAMP5	chr15:75287901-75313836:+	-0.43	-8.7	4.93E-17	Blood trace element (Zn levels)	
HNSC	cis	1	rs717593	chr20:33652964	PROCR	chr20:33758727-33765164:+	-0.3	-3.77	0.000184	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs7176225	chr15:56126857	NEDD4	chr15:56119131-56285835:-	0.21	5.11	4.59E-7	Keloid	
HNSC	cis	1	rs7188445	chr16:79734987	DYNLRB2	chr16:80574854-80584539:+	0.2	3.84	0.000139	Urate levels	
HNSC	cis	1	rs7189550	chr16:29911260	LOC440356	chr16:29875004-29879374:+	0.19	4.01	7.11E-5	Response to taxane treatment (placlitaxel)	
HNSC	cis	1	rs7189750	chr16:29911416	LOC440356	chr16:29875004-29879374:+	-0.19	-3.97	8.16E-5	Response to taxane treatment (placlitaxel)	
HNSC	cis	1	rs7191665	chr16:74688948	RFWD3	chr16:74655298-74700779:-	-0.29	-7.47	3.77E-13	Testicular germ cell tumor	
HNSC	cis	1	rs7195763	chr16:4649300	NMRAL1	chr16:4511696-4526307:-	-0.46	-5.12	4.32E-7	Obesity-related traits	
HNSC	cis	1	rs719909	chr10:91345696	FLJ37201	chr10:91451057-91457685:-	-0.29	-3.89	0.000116	Metabolic traits	
HNSC	cis	1	rs7201320	chr16:74694058	RFWD3	chr16:74655298-74700779:-	-0.29	-7.4	5.82E-13	Testicular germ cell tumor	
HNSC	cis	1	rs7201519	chr16:29859977	LOC440356	chr16:29875004-29879374:+	-0.24	-3.76	0.000193	Multiple sclerosis	
HNSC	cis	1	rs720475	chr7:144074929	OR2A7	chr7:143955790-143974852:-	-0.34	-5.91	6.57E-9	Breast cancer	
HNSC	cis	1	rs7205409	chr16:642610	C16orf13	chr16:684429-686347:-	0.13	3.66	0.000275	Height	
HNSC	cis	1	rs7205409	chr16:642610	PIGQ	chr16:617032-634108:+	-0.22	-5.3	1.71E-7	Height	
HNSC	cis	1	rs7205409	chr16:642610	WFIKKN1	chr16:679239-684116:+	0.26	5.5	6.14E-8	Height	
HNSC	cis	1	rs7206416	chr16:4626724	NMRAL1	chr16:4511696-4526307:-	-0.38	-4.15	3.96E-5	Obesity-related traits	
HNSC	cis	1	rs7207021	chr17:28400516	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.21	3.06E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs7207276	chr17:18065737	LOC220594	chr17:18414577-18445234:-	-0.29	-4.53	7.25E-6	Obesity-related traits	
HNSC	cis	1	rs7209180	chr17:79581519	RAC3	chr17:79989532-79992079:+	0.17	4.14	4.05E-5	Eye color traits	
HNSC	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.22	5.66	2.52E-8	Eye color traits	
HNSC	cis	1	rs7210086	chr17:70641698	CDC42EP4	chr17:71279764-71308143:-	0.23	4.09	5.12E-5	Ulcerative colitis	
HNSC	cis	1	rs7210738	chr17:45757598	C17orf57	chr17:45401142-45518675:+	-0.19	-4.77	2.39E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs7210738	chr17:45757598	TBKBP1	chr17:45772630-45789427:+	0.2	3.96	8.43E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs7212497	chr17:28335949	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.26	2.41E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs7213129	chr17:79581573	RAC3	chr17:79989532-79992079:+	0.17	4.14	4.05E-5	Eye color traits	
HNSC	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.22	5.66	2.52E-8	Eye color traits	
HNSC	cis	1	rs7214921	chr17:40294025	DHX58	chr17:40253422-40264751:-	-0.34	-7.07	5.36E-12	Fibrinogen levels	
HNSC	cis	1	rs7218362	chr17:56888299	RAD51C	chr17:56769963-56811690:+	0.33	8.54	1.62E-16	Cognitive test performance	
HNSC	cis	1	rs7219220	chr17:40294280	DHX58	chr17:40253422-40264751:-	-0.34	-7.07	5.36E-12	Fibrinogen levels	
HNSC	cis	1	rs7221109	chr17:38770286	KRT24	chr17:38854244-38860002:-	0.22	4.58	5.96E-6	Type 1 diabetes	
HNSC	cis	1	rs722133	chr3:150892493	P2RY12	chr3:151055238-151102544:-	0.19	3.67	0.000267	Heschl's gyrus morphology	
HNSC	cis	1	rs7221743	chr17:28407876	EFCAB5	chr17:28256874-28435469:+	-0.21	-3.83	0.000144	Coffee consumption (cups per day)	
HNSC	cis	1	rs7222241	chr17:79574714	RAC3	chr17:79989532-79992079:+	0.16	3.68	0.000258	Eye color traits	
HNSC	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.22	5.55	4.76E-8	Eye color traits	
HNSC	cis	1	rs7222308	chr17:28277041	EFCAB5	chr17:28256874-28435469:+	0.25	4.44	1.11E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs7223613	chr17:79574803	RAC3	chr17:79989532-79992079:+	-0.17	-4.14	4.05E-5	Eye color traits	
HNSC	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.22	-5.66	2.52E-8	Eye color traits	
HNSC	cis	1	rs7223672	chr17:61720565	FTSJ3	chr17:61896795-61905031:-	0.2	3.69	0.000245	Body mass index	
HNSC	cis	1	rs7223784	chr17:40577580	NAGLU	chr17:40687951-40696464:+	-0.2	-4.02	6.62E-5	Crohn's disease	
HNSC	cis	1	rs7223786	chr17:28332107	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.26	2.41E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs7224737	chr17:40289364	DHX58	chr17:40253422-40264751:-	0.34	7.07	5.25E-12	Fibrinogen levels	
HNSC	cis	1	rs7225608	chr17:40298326	DHX58	chr17:40253422-40264751:-	-0.35	-7.22	2.02E-12	Fibrinogen levels	
HNSC	cis	1	rs722997	chr22:26849666	HPS4	chr22:26847447-26879820:-	0.4	3.96	8.45E-5	Ischemic stroke	
HNSC	cis	1	rs723685	chr6:110763875	SLC22A16	chr6:110745907-110797844:-	0.34	3.82	0.000148	Glucose homeostasis traits	
HNSC	cis	1	rs7238284	chr18:48373876	MRO	chr18:48321491-48351754:-	0.26	4.56	6.56E-6	Entorhinal cortical thickness	
HNSC	cis	1	rs7246657	chr19:37747108	ZNF793	chr19:37997841-38034237:+	-0.24	-4.04	6.1E-5	Coronary artery calcification	
HNSC	cis	1	rs7246967	chr19:23056346	ZNF492	chr19:22817126-22850472:+	-0.32	-5.01	7.68E-7	Bronchopulmonary dysplasia	
HNSC	cis	1	rs7247672	chr19:37743928	ZNF793	chr19:37997841-38034237:+	0.28	4.54	6.99E-6	Coronary artery calcification	
HNSC	cis	1	rs724868	chr6:118795152	C6orf204	chr6:118786239-119031238:-	-0.24	-4.04	6.19E-5	Renal cell carcinoma	
HNSC	cis	1	rs7251653	chr19:18608283	SSBP4	chr19:18530221-18545371:+	-0.21	-4.81	2.02E-6	Breast cancer	
HNSC	cis	1	rs7251903	chr19:39184811	LGALS7B	chr19:39279850-39282393:+	0.29	6.35	4.76E-10	Heart rate	
HNSC	cis	1	rs7252589	chr19:39170908	LGALS7B	chr19:39279850-39282393:+	0.26	5.82	1.03E-8	Heart rate	
HNSC	cis	1	rs7252707	chr19:18612257	SSBP4	chr19:18530221-18545371:+	-0.19	-4.43	1.16E-5	Breast cancer	
HNSC	cis	1	rs7252848	chr19:18612351	SSBP4	chr19:18530221-18545371:+	-0.19	-4.44	1.09E-5	Breast cancer	
HNSC	cis	1	rs725309	chr3:48418708	ATRIP	chr3:48488141-48507708:+	-0.17	-3.92	9.95E-5	Longevity	
HNSC	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.27	6.66	7.26E-11	Longevity	
HNSC	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.28	7.16	2.95E-12	Longevity	
HNSC	cis	1	rs7254758	chr19:33608047	GPATCH1	chr19:33571786-33621318:+	0.2	3.81	0.000154	Bone properties (heel)	
HNSC	cis	1	rs7255436	chr19:8433196	RPS28	chr19:8386384-8387278:+	-0.31	-5.67	2.37E-8	HDL cholesterol	
HNSC	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.59	12.47	3.26E-31	Schizophrenia	
HNSC	cis	1	rs7257127	chr19:23056699	ZNF492	chr19:22817126-22850472:+	-0.34	-5.43	8.71E-8	Bronchopulmonary dysplasia	
HNSC	cis	1	rs7258465	chr19:18533642	SSBP4	chr19:18530221-18545371:+	-0.2	-4.53	7.37E-6	Breast cancer	
HNSC	cis	1	rs725908	chr20:33968067	CPNE1	chr20:34213968-34262539:-	0.23	4.05	6.02E-5	Height	
HNSC	cis	1	rs725908	chr20:33968067	UQCC	chr20:33890383-33999833:-	0.32	5.73	1.71E-8	Height	
HNSC	cis	1	rs7260181	chr19:47098427	CALM3	chr19:47104512-47114038:+	-0.19	-3.96	8.54E-5	Late-onset Alzheimer's disease	
HNSC	cis	1	rs72627117	chr14:74355233	LIN52	chr14:74551656-74667117:+	0.24	4.35	1.66E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs72627119	chr14:74356274	LIN52	chr14:74551656-74667117:+	0.24	4.35	1.66E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs72627120	chr14:74363480	LIN52	chr14:74551656-74667117:+	0.23	4.19	3.27E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs72627122	chr14:74368236	LIN52	chr14:74551656-74667117:+	0.23	4.19	3.27E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs72627123	chr14:74368331	LIN52	chr14:74551656-74667117:+	0.23	4.19	3.27E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs72627124	chr14:74369128	LIN52	chr14:74551656-74667117:+	0.24	4.23	2.77E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs72627125	chr14:74369623	LIN52	chr14:74551656-74667117:+	0.24	4.23	2.77E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs72627126	chr14:74370024	LIN52	chr14:74551656-74667117:+	0.23	4.22	2.89E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs72627127	chr14:74370098	LIN52	chr14:74551656-74667117:+	0.24	4.23	2.77E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs72627129	chr14:74374805	LIN52	chr14:74551656-74667117:+	0.23	4.17	3.62E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs72627130	chr14:74374897	LIN52	chr14:74551656-74667117:+	0.23	4.17	3.62E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs72627138	chr14:74401900	LIN52	chr14:74551656-74667117:+	0.24	4.32	1.87E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs7263253	chr20:33649376	PROCR	chr20:33758727-33765164:+	-0.29	-3.69	0.000254	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs72634258	chr1:8150638	PARK7	chr1:8021714-8045341:+	0.18	3.72	0.000222	Inflammatory bowel disease	
HNSC	cis	1	rs72639533	chr10:37997810	LOC399744	chr10:38717074-38741080:+	0.27	3.66	0.000279	Obesity (extreme)	
HNSC	cis	1	rs72644211	chr10:81781695	LOC219347	chr10:81805991-81838949:-	0.59	6.67	6.98E-11	Chronic obstructive pulmonary disease-related biomarkers	
HNSC	cis	1	rs72644213	chr10:81783660	LOC219347	chr10:81805991-81838949:-	0.57	6.72	4.9E-11	Chronic obstructive pulmonary disease-related biomarkers	
HNSC	cis	1	rs72645460	chr11:116771375	PCSK7	chr11:117075789-117102811:-	0.31	4.19	3.26E-5	Protein quantitative trait loci	
HNSC	cis	1	rs7265697	chr20:55070664	C20orf43	chr20:55043647-55093942:+	0.21	4.23	2.84E-5	Refractive astigmatism	
HNSC	cis	1	rs72677306	chr4:106997678	TBCK	chr4:106967233-107237861:-	0.27	5.28	1.94E-7	Airflow obstruction	
HNSC	cis	1	rs72681206	chr4:155478278	RNF175	chr4:154631313-154681387:-	-0.22	-3.72	0.000223	Fibrinogen levels	
HNSC	cis	1	rs72681208	chr4:155478389	RNF175	chr4:154631313-154681387:-	-0.22	-3.72	0.000223	Fibrinogen levels	
HNSC	cis	1	rs72681211	chr4:155479261	RNF175	chr4:154631313-154681387:-	-0.22	-3.72	0.000223	Fibrinogen levels	
HNSC	cis	1	rs72681213	chr4:155479689	RNF175	chr4:154631313-154681387:-	-0.22	-3.72	0.000223	Fibrinogen levels	
HNSC	cis	1	rs7268447	chr20:33649593	PROCR	chr20:33758727-33765164:+	-0.29	-3.69	0.000246	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs7270354	chr20:44607661	DNTTIP1	chr20:44420576-44440064:+	-0.23	-3.66	0.000283	Abdominal aortic aneurysm	
HNSC	cis	1	rs7270354	chr20:44607661	WFDC3	chr20:44402847-44420547:-	-0.4	-5.98	4.19E-9	Abdominal aortic aneurysm	
HNSC	cis	1	rs72717411	chr5:429124	EXOC3	chr5:443334-467407:+	-0.24	-4.22	2.91E-5	Cystic fibrosis severity	
HNSC	cis	1	rs72717412	chr5:429381	EXOC3	chr5:443334-467407:+	-0.24	-4.22	2.96E-5	Cystic fibrosis severity	
HNSC	cis	1	rs72717414	chr5:429818	EXOC3	chr5:443334-467407:+	-0.24	-4.22	2.91E-5	Cystic fibrosis severity	
HNSC	cis	1	rs72718804	chr14:55630610	KIAA0831	chr14:55833110-55878576:-	-0.21	-3.81	0.000156	Protein biomarker	
HNSC	cis	1	rs72734373	chr15:56262183	NEDD4	chr15:56119131-56285835:-	0.25	5.86	8.58E-9	Keloid	
HNSC	cis	1	rs72768397	chr1:247219411	ZNF670	chr1:247200087-247242069:-	-0.3	-6.49	2.05E-10	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs72782294	chr2:28953390	TRMT61B	chr2:29072690-29093175:-	0.37	7.87	2.3E-14	Body mass index	
HNSC	cis	1	rs72792179	chr5:112785815	YTHDC2	chr5:112849410-112930979:+	0.21	3.68	0.000262	Cerebral amyloid angiopathy	
HNSC	cis	1	rs72800847	chr16:31022639	MYST1	chr16:31128985-31142713:+	0.22	4.98	8.78E-7	Response to metformin (IC50)	
HNSC	cis	1	rs72802834	chr2:46177826	MCFD2	chr2:47129017-47168878:-	-0.23	-3.85	0.000134	QT interval	
HNSC	cis	1	rs72823064	chr17:40569974	NAGLU	chr17:40687951-40696464:+	-0.2	-4.04	6.1E-5	Crohn's disease	
HNSC	cis	1	rs72825704	chr2:99239164	UNC50	chr2:99225042-99234975:+	-0.24	-4.22	2.95E-5	Bipolar disorder	
HNSC	cis	1	rs72825710	chr2:99239497	UNC50	chr2:99225042-99234975:+	-0.24	-4.22	2.95E-5	Bipolar disorder	
HNSC	cis	1	rs72825718	chr2:99247152	UNC50	chr2:99225042-99234975:+	-0.26	-4.49	8.76E-6	Bipolar disorder	
HNSC	cis	1	rs72825719	chr2:99247465	UNC50	chr2:99225042-99234975:+	-0.25	-4.29	2.11E-5	Bipolar disorder	
HNSC	cis	1	rs72825720	chr2:99247508	UNC50	chr2:99225042-99234975:+	-0.25	-4.26	2.47E-5	Bipolar disorder	
HNSC	cis	1	rs72825725	chr2:99251259	UNC50	chr2:99225042-99234975:+	-0.25	-4.36	1.59E-5	Bipolar disorder	
HNSC	cis	1	rs72825727	chr2:99252750	UNC50	chr2:99225042-99234975:+	-0.25	-4.42	1.2E-5	Bipolar disorder	
HNSC	cis	1	rs72825732	chr2:99259778	UNC50	chr2:99225042-99234975:+	-0.25	-4.4	1.35E-5	Bipolar disorder	
HNSC	cis	1	rs72840063	chr2:85550396	TGOLN2	chr2:85545147-85555374:-	-0.24	-5.33	1.49E-7	Ear protrusion	
HNSC	cis	1	rs72843784	chr6:26498758	BTN3A2	chr6:26365398-26378546:+	-0.88	-11.83	1.41E-28	Schizophrenia	
HNSC	cis	1	rs72845397	chr11:6950903	ZNF215	chr11:6947654-7005861:+	-0.36	-5.7	2.1E-8	Response to cytadine analogues (cytosine arabinoside)	
HNSC	cis	1	rs72872548	chr11:5289139	HBG1	chr11:5269502-5271087:-	0.22	3.92	9.99E-5	Hemoglobin levels	
HNSC	cis	1	rs72890511	chr4:108888543	HADH	chr4:108910940-108956330:+	0.29	4.16	3.78E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs72890536	chr4:108909446	HADH	chr4:108910940-108956330:+	0.28	4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs7289577	chr22:39042214	LOC646851	chr22:38974125-39052634:-	0.15	3.86	0.000129	Resting heart rate	
HNSC	cis	1	rs7289855	chr22:39042221	LOC646851	chr22:38974125-39052634:-	0.15	3.93	9.68E-5	Resting heart rate	
HNSC	cis	1	rs72922733	chr11:65520746	SNX32	chr11:65601410-65621170:+	0.28	4.12	4.37E-5	Systemic lupus erythematosus	
HNSC	cis	1	rs72929710	chr18:48372427	MRO	chr18:48321491-48351754:-	0.25	4.3	2.02E-5	Entorhinal cortical thickness	
HNSC	cis	1	rs72929734	chr18:48381990	MRO	chr18:48321491-48351754:-	0.25	4.29	2.15E-5	Entorhinal cortical thickness	
HNSC	cis	1	rs72934563	chr2:203995405	NBEAL1	chr2:203879602-204091100:+	-0.21	-3.75	0.000198	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
HNSC	cis	1	rs72934573	chr2:204005072	NBEAL1	chr2:203879602-204091100:+	-0.21	-3.75	0.000198	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
HNSC	cis	1	rs72934944	chr2:202190610	PPIL3	chr2:201735680-201753999:-	-0.51	-6.81	2.82E-11	Rheumatoid arthritis	
HNSC	cis	1	rs72934960	chr2:202204749	PPIL3	chr2:201735680-201753999:-	-0.42	-4.88	1.46E-6	Rheumatoid arthritis	
HNSC	cis	1	rs72934973	chr2:202213934	PPIL3	chr2:201735680-201753999:-	-0.42	-4.94	1.06E-6	Rheumatoid arthritis	
HNSC	cis	1	rs72934999	chr2:202223524	PPIL3	chr2:201735680-201753999:-	-0.42	-4.95	1.0E-6	Rheumatoid arthritis	
HNSC	cis	1	rs72936304	chr2:204036357	NBEAL1	chr2:203879602-204091100:+	-0.21	-3.75	0.000195	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
HNSC	cis	1	rs72936309	chr2:204040296	NBEAL1	chr2:203879602-204091100:+	-0.21	-3.78	0.000176	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
HNSC	cis	1	rs72936323	chr2:204050474	NBEAL1	chr2:203879602-204091100:+	-0.21	-3.76	0.000188	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
HNSC	cis	1	rs72936326	chr2:204054141	NBEAL1	chr2:203879602-204091100:+	-0.21	-3.77	0.000182	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
HNSC	cis	1	rs72936332	chr2:204056678	NBEAL1	chr2:203879602-204091100:+	-0.21	-3.77	0.000182	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
HNSC	cis	1	rs72936348	chr2:204064839	NBEAL1	chr2:203879602-204091100:+	-0.21	-3.77	0.000182	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
HNSC	cis	1	rs72936353	chr2:204070956	NBEAL1	chr2:203879602-204091100:+	-0.21	-3.75	0.000199	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
HNSC	cis	1	rs72937106	chr2:202225520	PPIL3	chr2:201735680-201753999:-	-0.42	-4.95	1.0E-6	Rheumatoid arthritis	
HNSC	cis	1	rs72937118	chr2:202229527	PPIL3	chr2:201735680-201753999:-	-0.42	-4.95	1.0E-6	Rheumatoid arthritis	
HNSC	cis	1	rs72937120	chr2:202232611	PPIL3	chr2:201735680-201753999:-	-0.42	-4.85	1.68E-6	Rheumatoid arthritis	
HNSC	cis	1	rs7294478	chr12:7266805	LOC283314	chr12:7260904-7274446:+	0.19	4.26	2.46E-5	Neuritic plaque	
HNSC	cis	1	rs72952733	chr6:118834452	C6orf204	chr6:118786239-119031238:-	-0.25	-4.11	4.69E-5	Renal cell carcinoma	
HNSC	cis	1	rs72952761	chr6:118866758	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.52E-5	Renal cell carcinoma	
HNSC	cis	1	rs72952793	chr6:118892979	C6orf204	chr6:118786239-119031238:-	-0.24	-4.14	4.12E-5	Renal cell carcinoma	
HNSC	cis	1	rs72954806	chr6:118899965	C6orf204	chr6:118786239-119031238:-	-0.24	-4.14	4.12E-5	Renal cell carcinoma	
HNSC	cis	1	rs72969531	chr6:118729974	C6orf204	chr6:118786239-119031238:-	-0.24	-4.36	1.58E-5	Renal cell carcinoma	
HNSC	cis	1	rs72992466	chr6:130709571	EPB41L2	chr6:131160488-131384462:-	0.23	3.7	0.000238	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);Exploratory eye movement dysfunction in schizophrenia (cognitive search score);Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
HNSC	cis	1	rs7303	chr14:75520065	MLH3	chr14:75480467-75518235:-	0.31	6.43	3.01E-10	Height	
HNSC	cis	1	rs73041998	chr1:171655119	VAMP4	chr1:171669298-171711214:-	0.28	4.76	2.55E-6	Hippocampal atrophy	
HNSC	cis	1	rs73042000	chr1:171655212	VAMP4	chr1:171669298-171711214:-	0.28	4.76	2.55E-6	Hippocampal atrophy	
HNSC	cis	1	rs73042001	chr1:171655251	VAMP4	chr1:171669298-171711214:-	0.28	4.76	2.55E-6	Hippocampal atrophy	
HNSC	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	0.66	10.21	2.59E-22	Diastolic blood pressure	
HNSC	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	0.71	12.55	1.47E-31	Diastolic blood pressure	
HNSC	cis	1	rs73074358	chr3:48427247	ATRIP	chr3:48488141-48507708:+	0.16	3.71	0.000232	Longevity	
HNSC	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.28	-6.9	1.6E-11	Longevity	
HNSC	cis	1	rs73077367	chr3:41851959	ULK4	chr3:41288091-42003660:-	0.74	12.8	1.4E-32	Diastolic blood pressure	
HNSC	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.68	10.28	1.39E-22	Diastolic blood pressure	
HNSC	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	0.73	12.29	1.85E-30	Diastolic blood pressure	
HNSC	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.69	10.26	1.63E-22	Diastolic blood pressure	
HNSC	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.69	10.26	1.63E-22	Diastolic blood pressure	
HNSC	cis	1	rs73081854	chr3:56628226	CCDC66	chr3:56591184-56655846:+	-0.18	-5.04	6.62E-7	Height	
HNSC	cis	1	rs73092537	chr12:51358517	SLC11A2	chr12:51373319-51422058:-	-0.21	-3.82	0.00015	Type 2 diabetes	
HNSC	cis	1	rs7309685	chr12:56935413	RBMS2	chr12:56915609-56989980:+	0.23	4.35	1.68E-5	Adiponectin levels	
HNSC	cis	1	rs7309927	chr12:1000185	RAD52	chr12:1021255-1099219:-	-0.33	-5.07	5.62E-7	Colorectal cancer	
HNSC	cis	1	rs7310284	chr12:56935652	RBMS2	chr12:56915609-56989980:+	-0.23	-4.37	1.51E-5	Adiponectin levels	
HNSC	cis	1	rs7310730	chr12:95976267	TMCC3	chr12:94960900-95044324:-	-0.19	-3.84	0.000138	Post bronchodilator FEV1 in COPD	
HNSC	cis	1	rs731152	chr17:40279680	DHX58	chr17:40253422-40264751:-	-0.35	-7.21	2.15E-12	Fibrinogen levels	
HNSC	cis	1	rs73118833	chr12:56941734	RBMS2	chr12:56915609-56989980:+	0.22	4.07	5.39E-5	Adiponectin levels	
HNSC	cis	1	rs73140069	chr7:75986790	UPK3B	chr7:76139745-76157197:+	-0.23	-4.58	5.91E-6	Multiple sclerosis	
HNSC	cis	1	rs73140069	chr7:75986790	ZP3	chr7:76026841-76071387:+	-0.2	-3.93	9.65E-5	Multiple sclerosis	
HNSC	cis	1	rs73142121	chr7:65311206	CRCP	chr7:65579805-65619551:+	-0.37	-4.29	2.16E-5	Diabetic kidney disease	
HNSC	cis	1	rs73142121	chr7:65311206	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.86	1.57E-6	Diabetic kidney disease	
HNSC	cis	1	rs73142122	chr7:65311298	CRCP	chr7:65579805-65619551:+	-0.36	-4.1	4.8E-5	Diabetic kidney disease	
HNSC	cis	1	rs73142122	chr7:65311298	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.52	7.72E-6	Diabetic kidney disease	
HNSC	cis	1	rs73142162	chr7:65374296	CRCP	chr7:65579805-65619551:+	-0.33	-3.71	0.000228	Diabetic kidney disease	
HNSC	cis	1	rs73142162	chr7:65374296	NCRNA00174	chr7:65841032-65865395:-	-0.41	-4.29	2.12E-5	Diabetic kidney disease	
HNSC	cis	1	rs73142166	chr7:65375832	CRCP	chr7:65579805-65619551:+	-0.33	-3.71	0.000228	Diabetic kidney disease	
HNSC	cis	1	rs73142166	chr7:65375832	NCRNA00174	chr7:65841032-65865395:-	-0.41	-4.29	2.12E-5	Diabetic kidney disease	
HNSC	cis	1	rs73150014	chr7:65450919	CRCP	chr7:65579805-65619551:+	-0.32	-3.68	0.000264	Diabetic kidney disease	
HNSC	cis	1	rs73150014	chr7:65450919	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.54	7.1E-6	Diabetic kidney disease	
HNSC	cis	1	rs73154395	chr13:25081803	PARP4	chr13:24995075-25086948:-	-0.37	-5.78	1.3E-8	Sudden cardiac arrest	
HNSC	cis	1	rs73154401	chr13:25085667	PARP4	chr13:24995075-25086948:-	-0.36	-5.68	2.24E-8	Sudden cardiac arrest	
HNSC	cis	1	rs7320606	chr13:21052521	GJB2	chr13:20761606-20767114:-	-0.14	-4.1	4.82E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
HNSC	cis	1	rs7320606	chr13:21052521	SAP18	chr13:21714653-21723223:+	-0.23	-4.19	3.3E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
HNSC	cis	1	rs732172	chr16:31050033	HSD3B7	chr16:30996519-31000473:+	0.21	3.73	0.000217	Response to metformin (IC50)	
HNSC	cis	1	rs732172	chr16:31050033	MYST1	chr16:31128985-31142713:+	0.23	5.45	7.99E-8	Response to metformin (IC50)	
HNSC	cis	1	rs732173	chr16:31050023	MYST1	chr16:31128985-31142713:+	0.23	5.38	1.16E-7	Response to metformin (IC50)	
HNSC	cis	1	rs7322160	chr13:61061456	TDRD3	chr13:60970591-61148012:+	0.22	3.98	8.09E-5	Menopause (age at onset)	
HNSC	cis	1	rs73242910	chr6:170114670	C6orf70	chr6:170151721-170181617:+	0.22	3.82	0.000152	Thiazide-induced adverse metabolic effects in hypertensive patients	
HNSC	cis	1	rs7324557	chr13:24296862	PCOTH	chr13:24463028-24466241:+	0.28	4.97	9.38E-7	Visceral adipose tissue adjusted for BMI	
HNSC	cis	1	rs732528	chr18:48378234	MRO	chr18:48321491-48351754:-	0.25	4.28	2.25E-5	Entorhinal cortical thickness	
HNSC	cis	1	rs73268512	chr14:66088905	LOC645431	chr14:65877313-65879335:-	-0.27	-3.73	0.000212	Ischemic stroke	
HNSC	cis	1	rs73268521	chr14:66093243	LOC645431	chr14:65877313-65879335:-	-0.28	-3.68	0.000259	Ischemic stroke	
HNSC	cis	1	rs7326932	chr13:25004493	PARP4	chr13:24995075-25086948:-	0.2	4.67	3.88E-6	Obesity-related traits	
HNSC	cis	1	rs7327064	chr13:36771017	SOHLH2	chr13:36742347-36871992:-	0.21	3.74	0.000208	Economic and political preferences	
HNSC	cis	1	rs73276406	chr8:96021760	C8orf38	chr8:95908040-96088396:+	-0.26	-4.07	5.57E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs73276417	chr8:96026312	C8orf38	chr8:95908040-96088396:+	-0.29	-4.45	1.04E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs73276437	chr8:96035511	C8orf38	chr8:95908040-96088396:+	-0.32	-4.82	1.89E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs73276444	chr8:96039247	C8orf38	chr8:95908040-96088396:+	-0.34	-5.19	3.07E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs73282255	chr5:150223647	LOC134466	chr5:150310000-150326146:-	0.36	4.97	9.15E-7	Crohn's disease	
HNSC	cis	1	rs73284121	chr14:65936936	LOC645431	chr14:65877313-65879335:-	-0.29	-3.88	0.000117	Ischemic stroke	
HNSC	cis	1	rs73284133	chr14:65946612	LOC645431	chr14:65877313-65879335:-	-0.29	-3.88	0.00012	Ischemic stroke	
HNSC	cis	1	rs73284141	chr5:150266086	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs732856	chr22:38060691	LGALS2	chr22:37966254-37976024:-	-0.14	-3.92	0.000102	Fat distribution (HIV)	
HNSC	cis	1	rs73286118	chr14:66034821	LOC645431	chr14:65877313-65879335:-	-0.29	-3.85	0.000136	Ischemic stroke	
HNSC	cis	1	rs73286169	chr14:66078448	LOC645431	chr14:65877313-65879335:-	-0.27	-3.67	0.000269	Ischemic stroke	
HNSC	cis	1	rs73286173	chr14:66079540	LOC645431	chr14:65877313-65879335:-	-0.27	-3.73	0.000212	Ischemic stroke	
HNSC	cis	1	rs7329823	chr13:21050127	GJB2	chr13:20761606-20767114:-	-0.14	-4.32	1.88E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
HNSC	cis	1	rs7329823	chr13:21050127	SAP18	chr13:21714653-21723223:+	-0.23	-4.2	3.14E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
HNSC	cis	1	rs7331697	chr13:36763345	SOHLH2	chr13:36742347-36871992:-	-0.23	-3.92	0.000101	Economic and political preferences	
HNSC	cis	1	rs73318135	chr20:23618571	CST1	chr20:23728191-23731574:-	0.36	5.64	2.88E-8	Chronic kidney disease	
HNSC	cis	1	rs73318135	chr20:23618571	CST4	chr20:23666277-23669662:-	0.28	4.5	8.3E-6	Chronic kidney disease	
HNSC	cis	1	rs73348070	chr5:127893533	FBN2	chr5:127593602-127873916:-	0.34	4.21	3.08E-5	Multiple system atrophy	
HNSC	cis	1	rs7340989	chr4:107148720	TBCK	chr4:106967233-107237861:-	0.24	4.83	1.86E-6	Airflow obstruction	
HNSC	cis	1	rs734512	chr10:37973072	LOC399744	chr10:38717074-38741080:+	-0.28	-4.06	5.7E-5	Obesity (extreme)	
HNSC	cis	1	rs73470506	chr11:57008246	PRG2	chr11:57151267-57191532:-	-0.35	-3.7	0.00024	Low high density lipoprotein cholesterol levels	
HNSC	cis	1	rs734801	chr20:23612791	CST1	chr20:23728191-23731574:-	0.34	5.22	2.64E-7	Chronic kidney disease	
HNSC	cis	1	rs734801	chr20:23612791	CST4	chr20:23666277-23669662:-	0.27	4.31	1.97E-5	Chronic kidney disease	
HNSC	cis	1	rs735531	chr20:33947730	CPNE1	chr20:34213968-34262539:-	0.25	4.52	7.9E-6	Height	
HNSC	cis	1	rs735531	chr20:33947730	UQCC	chr20:33890383-33999833:-	0.34	6.33	5.67E-10	Height	
HNSC	cis	1	rs7356093	chr3:134238753	ANAPC13	chr3:134196547-134204865:-	0.49	10.47	2.77E-23	Height	
HNSC	cis	1	rs7356093	chr3:134238753	CEP63	chr3:134204575-134293852:+	0.27	5.82	1.05E-8	Height	
HNSC	cis	1	rs7356947	chr6:118767920	C6orf204	chr6:118786239-119031238:-	-0.24	-4.36	1.58E-5	Renal cell carcinoma	
HNSC	cis	1	rs735765	chr6:28170297	ZNF389	chr6:28129551-28137375:+	-0.26	-3.75	0.000196	Depression	
HNSC	cis	1	rs73591036	chr19:34163722	GPATCH1	chr19:33571786-33621318:+	0.37	3.81	0.000158	Response to antipsychotic treatment in schizophrenia (working memory)	
HNSC	cis	1	rs73591042	chr19:34164320	GPATCH1	chr19:33571786-33621318:+	0.37	3.81	0.000158	Response to antipsychotic treatment in schizophrenia (working memory)	
HNSC	cis	1	rs736344	chr12:110001195	MMAB	chr12:109991523-110011358:-	-0.18	-4.49	9.03E-6	HDL cholesterol	
HNSC	cis	1	rs736825	chr12:54417576	FLJ12825	chr12:54452038-54516018:+	0.21	3.91	0.000105	Bone mineral density	
HNSC	cis	1	rs737008	chr16:11374866	C16orf75	chr16:11343506-11445617:+	0.19	4.52	7.7E-6	Obesity-related traits	
HNSC	cis	1	rs7371896	chr3:134249769	ANAPC13	chr3:134196547-134204865:-	0.48	10.39	5.33E-23	Height	
HNSC	cis	1	rs7371896	chr3:134249769	CEP63	chr3:134204575-134293852:+	0.27	5.92	5.97E-9	Height	
HNSC	cis	1	rs7374158	chr3:134270156	ANAPC13	chr3:134196547-134204865:-	0.48	10.4	5.1E-23	Height	
HNSC	cis	1	rs7374158	chr3:134270156	CEP63	chr3:134204575-134293852:+	0.27	5.93	5.86E-9	Height	
HNSC	cis	1	rs7374325	chr3:134275601	ANAPC13	chr3:134196547-134204865:-	0.49	10.58	1.06E-23	Height	
HNSC	cis	1	rs7374325	chr3:134275601	CEP63	chr3:134204575-134293852:+	0.28	5.98	4.17E-9	Height	
HNSC	cis	1	rs7375325	chr4:108918369	HADH	chr4:108910940-108956330:+	-0.28	-4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs738722	chr22:29130012	TTC28	chr22:28374004-29075853:-	-0.13	-3.69	0.000254	Esophageal cancer and gastric cancer	
HNSC	cis	1	rs73903009	chr20:33678732	PROCR	chr20:33758727-33765164:+	-0.27	-3.74	0.000205	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs73903017	chr20:33724758	PROCR	chr20:33758727-33765164:+	-0.28	-4.03	6.54E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs739139	chr22:38067011	LGALS2	chr22:37966254-37976024:-	0.13	3.86	0.000128	Fat distribution (HIV)	
HNSC	cis	1	rs739637	chr17:40280944	DHX58	chr17:40253422-40264751:-	-0.35	-7.21	2.15E-12	Fibrinogen levels	
HNSC	cis	1	rs7397068	chr12:51401904	SLC11A2	chr12:51373319-51422058:-	-0.21	-3.69	0.000254	Type 2 diabetes	
HNSC	cis	1	rs7406003	chr17:79597597	RAC3	chr17:79989532-79992079:+	0.17	4.07	5.39E-5	Eye color traits	
HNSC	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.23	5.79	1.22E-8	Eye color traits	
HNSC	cis	1	rs7412746	chr1:150860471	CTSS	chr1:150702554-150738305:-	-0.12	-4.51	7.99E-6	Melanoma	
HNSC	cis	1	rs7412746	chr1:150860471	GOLPH3L	chr1:150618701-150669672:-	0.27	5.51	5.94E-8	Melanoma	
HNSC	cis	1	rs7412746	chr1:150860471	HORMAD1	chr1:150670542-150693352:-	-0.63	-13.28	1.32E-34	Melanoma	
HNSC	cis	1	rs7419837	chr2:70146625	GMCL1	chr2:70056818-70106727:+	0.12	3.77	0.000186	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs74209810	chr16:20402466	GPRC5B	chr16:19870295-19896832:-	-0.19	-3.67	0.000273	Urinary uromodulin levels	
HNSC	cis	1	rs74210981	chr10:102287520	SEC31B	chr10:102246403-102289636:-	-0.18	-5.57	4.24E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.48	-5.43	8.71E-8	Plasma clusterin levels	
HNSC	cis	1	rs7426847	chr3:134267519	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.52	1.7E-23	Height	
HNSC	cis	1	rs7426847	chr3:134267519	CEP63	chr3:134204575-134293852:+	-0.26	-5.68	2.27E-8	Height	
HNSC	cis	1	rs7427165	chr3:121364624	IQCB1	chr3:121488610-121553926:-	0.25	6.22	1.04E-9	Cognitive performance	
HNSC	cis	1	rs7427492	chr3:134261654	ANAPC13	chr3:134196547-134204865:-	0.49	10.62	7.09E-24	Height	
HNSC	cis	1	rs7427492	chr3:134261654	CEP63	chr3:134204575-134293852:+	0.28	6.01	3.57E-9	Height	
HNSC	cis	1	rs7428326	chr3:134251184	ANAPC13	chr3:134196547-134204865:-	0.48	10.4	5.1E-23	Height	
HNSC	cis	1	rs7428326	chr3:134251184	CEP63	chr3:134204575-134293852:+	0.27	5.93	5.86E-9	Height	
HNSC	cis	1	rs7428	chr2:85545490	TGOLN2	chr2:85545147-85555374:-	0.24	5.45	8.09E-8	Ear protrusion	
HNSC	cis	1	rs7429866	chr3:134236306	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.36	7.2E-23	Height	
HNSC	cis	1	rs7429866	chr3:134236306	CEP63	chr3:134204575-134293852:+	-0.26	-5.58	3.9E-8	Height	
HNSC	cis	1	rs7432268	chr3:134242051	ANAPC13	chr3:134196547-134204865:-	0.49	10.62	7.09E-24	Height	
HNSC	cis	1	rs7432268	chr3:134242051	CEP63	chr3:134204575-134293852:+	0.28	6.01	3.57E-9	Height	
HNSC	cis	1	rs7433663	chr3:134235790	ANAPC13	chr3:134196547-134204865:-	0.48	10.23	2.02E-22	Height	
HNSC	cis	1	rs7433663	chr3:134235790	CEP63	chr3:134204575-134293852:+	0.27	5.83	1.0E-8	Height	
HNSC	cis	1	rs7433991	chr3:134312292	ANAPC13	chr3:134196547-134204865:-	0.49	10.57	1.09E-23	Height	
HNSC	cis	1	rs7433991	chr3:134312292	CEP63	chr3:134204575-134293852:+	0.27	5.8	1.16E-8	Height	
HNSC	cis	1	rs7436021	chr4:76905472	NAAA	chr4:76831809-76862166:-	-0.5	-11.63	8.58E-28	Longevity	
HNSC	cis	1	rs74363821	chr6:26189524	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.57E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs7436403	chr4:17692685	LAP3	chr4:17578927-17609590:+	0.16	4.26	2.49E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs74372131	chr10:81787214	LOC219347	chr10:81805991-81838949:-	0.57	6.7	5.58E-11	Chronic obstructive pulmonary disease-related biomarkers	
HNSC	cis	1	rs7439150	chr4:155481541	RNF175	chr4:154631313-154681387:-	-0.22	-3.78	0.000178	Fibrinogen levels	
HNSC	cis	1	rs7443669	chr5:115527611	COMMD10	chr5:115420727-115628978:+	0.34	4.01	7.12E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs74471041	chr3:49542543	AMT	chr3:49454212-49460012:-	-0.19	-4.04	6.1E-5	Menarche (age at onset)	
HNSC	cis	1	rs7448080	chr5:123398098	ZNF608	chr5:123972610-124084500:-	0.39	3.72	0.000219	Alcohol dependence (age at onset)	
HNSC	cis	1	rs7448915	chr5:112760880	YTHDC2	chr5:112849410-112930979:+	0.21	3.9	0.000108	Cerebral amyloid angiopathy	
HNSC	cis	1	rs744937	chr10:118865472	KIAA1598	chr10:118644308-118886097:-	0.33	4.74	2.83E-6	Nonsyndromic cleft lip with or without cleft palate;Orofacial clefts	
HNSC	cis	1	rs7452753	chr6:101053726	ASCC3	chr6:100956609-101329224:-	0.22	5.7	2.03E-8	Menarche (age at onset)	
HNSC	cis	1	rs74544416	chr8:82657745	CHMP4C	chr8:82644688-82671746:+	-0.96	-9.77	1.03E-20	Epithelial ovarian cancer;Ovarian cancer	
HNSC	cis	1	rs7456042	chr7:65299778	CRCP	chr7:65579805-65619551:+	-0.37	-4.27	2.35E-5	Diabetic kidney disease	
HNSC	cis	1	rs7456042	chr7:65299778	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.88	1.46E-6	Diabetic kidney disease	
HNSC	cis	1	rs74589786	chr20:61860939	BIRC7	chr20:61867276-61871853:+	0.37	3.86	0.000129	Response to cytadine analogues (cytosine arabinoside)	
HNSC	cis	1	rs74611500	chr14:66009789	LOC645431	chr14:65877313-65879335:-	-0.29	-3.86	0.000127	Ischemic stroke	
HNSC	cis	1	rs74650218	chr10:102293830	SEC31B	chr10:102246403-102289636:-	-0.19	-5.81	1.13E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7474896	chr10:37982097	LOC399744	chr10:38717074-38741080:+	0.27	3.66	0.000278	Obesity (extreme)	
HNSC	cis	1	rs7475154	chr10:131440584	MGMT	chr10:131265454-131565783:+	-0.3	-6.24	9.44E-10	Response to temozolomide	
HNSC	cis	1	rs74758321	chr8:82667320	CHMP4C	chr8:82644688-82671746:+	-0.94	-10.02	1.24E-21	Epithelial ovarian cancer;Ovarian cancer	
HNSC	cis	1	rs7477246	chr10:102261538	SEC31B	chr10:102246403-102289636:-	-0.19	-6.07	2.56E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7483951	chr11:231758	PSMD13	chr11:236808-252984:+	-0.19	-3.82	0.000153	Menarche (age at onset)	
HNSC	cis	1	rs74886004	chr11:116457471	PCSK7	chr11:117075789-117102811:-	0.34	4.01	6.97E-5	Clozapine-induced cytotoxicity	
HNSC	cis	1	rs74886004	chr11:116457471	ZNF259	chr11:116649277-116658739:-	0.31	3.72	0.000218	Clozapine-induced cytotoxicity	
HNSC	cis	1	rs74887741	chr7:1110658	ZFAND2A	chr7:1192544-1199855:-	-0.29	-3.81	0.000158	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs74900588	chr6:170102180	C6orf70	chr6:170151721-170181617:+	0.22	3.75	0.000199	Thiazide-induced adverse metabolic effects in hypertensive patients	
HNSC	cis	1	rs749050	chr10:97376115	ENTPD1	chr10:97471536-97637022:+	0.24	7.29	1.28E-12	Blood metabolite levels	
HNSC	cis	1	rs7493394	chr14:55617755	KIAA0831	chr14:55833110-55878576:-	-0.23	-4.17	3.62E-5	Protein biomarker	
HNSC	cis	1	rs7496954	chr15:83345536	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.17	4.33	1.83E-5	Schizophrenia	
HNSC	cis	1	rs7503679	chr17:79583843	RAC3	chr17:79989532-79992079:+	0.17	4.14	4.05E-5	Eye color traits	
HNSC	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.22	5.66	2.52E-8	Eye color traits	
HNSC	cis	1	rs750474	chr3:53085280	TMEM110	chr3:52867139-52931547:-	0.32	4.44	1.11E-5	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs750625	chr8:41525914	ZMAT4	chr8:40388116-40755343:-	-0.2	-3.85	0.000132	Type 2 diabetes	
HNSC	cis	1	rs75063298	chr10:102213600	SEC31B	chr10:102246403-102289636:-	-0.18	-5.74	1.62E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs75071288	chr5:150224379	LOC134466	chr5:150310000-150326146:-	0.36	4.94	1.09E-6	Crohn's disease	
HNSC	cis	1	rs75080838	chr5:115557467	COMMD10	chr5:115420727-115628978:+	0.42	4.08	5.34E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs75117781	chr16:4654204	NMRAL1	chr16:4511696-4526307:-	-0.56	-5.66	2.54E-8	Obesity-related traits	
HNSC	cis	1	rs7511962	chr1:247212122	ZNF670	chr1:247200087-247242069:-	-0.3	-6.49	2.07E-10	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs7512150	chr1:247212326	ZNF670	chr1:247200087-247242069:-	-0.3	-6.48	2.27E-10	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs7512552	chr1:150265704	ADAMTSL4	chr1:150521898-150533410:+	-0.18	-4.45	1.06E-5	Atopic dermatitis	
HNSC	cis	1	rs7512552	chr1:150265704	ECM1	chr1:150480487-150486264:+	-0.22	-4.81	2.02E-6	Atopic dermatitis	
HNSC	cis	1	rs7515491	chr1:46355079	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.48	3.33E-13	Body mass index	
HNSC	cis	1	rs7515577	chr1:93009438	EVI5	chr1:92974255-93257961:-	-0.26	-4.66	4.16E-6	Cholesterol, total	
HNSC	cis	1	rs75165171	chr20:33651453	PROCR	chr20:33758727-33765164:+	-0.3	-3.77	0.000184	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs7517566	chr1:150850035	GOLPH3L	chr1:150618701-150669672:-	-0.31	-3.8	0.00016	Congenital left-sided heart lesions	
HNSC	cis	1	rs7517566	chr1:150850035	HORMAD1	chr1:150670542-150693352:-	0.35	3.86	0.000127	Congenital left-sided heart lesions	
HNSC	cis	1	rs7517	chr1:150596411	GOLPH3L	chr1:150618701-150669672:-	-0.28	-3.78	0.000177	Congenital left-sided heart lesions	
HNSC	cis	1	rs7517	chr1:150596411	HORMAD1	chr1:150670542-150693352:-	0.41	5.1	4.86E-7	Congenital left-sided heart lesions	
HNSC	cis	1	rs7518155	chr1:166954896	FMO9P	chr1:166573153-166594471:+	-0.22	-4.36	1.61E-5	Refractive astigmatism	
HNSC	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.48	-5.43	8.71E-8	Plasma clusterin levels	
HNSC	cis	1	rs75192006	chr13:96303624	UGGT2	chr13:96453838-96705736:-	-0.25	-3.96	8.67E-5	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
HNSC	cis	1	rs7519795	chr1:247212126	ZNF670	chr1:247200087-247242069:-	-0.3	-6.49	2.07E-10	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs7519918	chr1:150013019	HORMAD1	chr1:150670542-150693352:-	0.25	3.75	0.000196	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
HNSC	cis	1	rs7520516	chr1:150659695	GOLPH3L	chr1:150618701-150669672:-	-0.3	-4.12	4.4E-5	Congenital left-sided heart lesions	
HNSC	cis	1	rs7520516	chr1:150659695	HORMAD1	chr1:150670542-150693352:-	0.35	4.28	2.26E-5	Congenital left-sided heart lesions	
HNSC	cis	1	rs7522601	chr1:46419021	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.6	1.48E-13	Body mass index	
HNSC	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.61	15.77	1.15E-45	Homocysteine levels	
HNSC	cis	1	rs7522948	chr1:156275308	BGLAP	chr1:156182784-156213112:+	0.22	4.25	2.51E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
HNSC	cis	1	rs7524495	chr1:46266932	CCDC163P	chr1:45960581-45965646:-	-0.36	-7.75	5.25E-14	Body mass index	
HNSC	cis	1	rs75278386	chr15:40678312	C15orf23	chr15:40674922-40686488:+	0.46	7.27	1.42E-12	Heschl's gyrus morphology	
HNSC	cis	1	rs7528684	chr1:157670816	FCRL3	chr1:157646278-157670775:-	0.34	11.17	5.77E-26	Type 1 diabetes autoantibodies	
HNSC	cis	1	rs75287019	chr20:33721261	PROCR	chr20:33758727-33765164:+	-0.3	-3.96	8.68E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs7528849	chr1:166954870	FMO9P	chr1:166573153-166594471:+	0.23	4.41	1.3E-5	Refractive astigmatism	
HNSC	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.49	-5.5	5.99E-8	Plasma clusterin levels	
HNSC	cis	1	rs753129	chr4:56668431	EXOC1	chr4:56719816-56771244:+	0.31	5.45	7.84E-8	Psychosis in Alzheimer's disease	
HNSC	cis	1	rs7533623	chr1:110616475	ALX3	chr1:110602998-110613322:-	-0.2	-3.93	9.78E-5	Blood metabolite levels	
HNSC	cis	1	rs7533688	chr1:166944123	FMO9P	chr1:166573153-166594471:+	0.2	3.88	0.000116	Refractive astigmatism	
HNSC	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.7	-18.51	1.74E-58	Homocysteine levels	
HNSC	cis	1	rs7534467	chr1:45988691	MMACHC	chr1:45965856-45976737:+	-0.21	-4.18	3.43E-5	Homocysteine levels	
HNSC	cis	1	rs7536436	chr1:171665914	VAMP4	chr1:171669298-171711214:-	0.28	4.84	1.76E-6	Hippocampal atrophy	
HNSC	cis	1	rs7536543	chr1:171666040	VAMP4	chr1:171669298-171711214:-	0.28	4.84	1.76E-6	Hippocampal atrophy	
HNSC	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.62	-16.38	1.79E-48	Homocysteine levels	
HNSC	cis	1	rs7539932	chr1:46292354	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.63	1.2E-13	Body mass index	
HNSC	cis	1	rs7540325	chr1:46338217	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.44	4.66E-13	Body mass index	
HNSC	cis	1	rs7541569	chr1:210343016	SYT14	chr1:210111538-210337631:+	-0.2	-3.69	0.000253	Manic episodes in bipolar disorder	
HNSC	cis	1	rs7545911	chr1:166947681	FMO9P	chr1:166573153-166594471:+	0.2	3.75	0.000197	Refractive astigmatism	
HNSC	cis	1	rs7546342	chr1:247213292	ZNF670	chr1:247200087-247242069:-	-0.29	-6.37	4.24E-10	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs7549410	chr1:247214167	ZNF670	chr1:247200087-247242069:-	-0.31	-6.69	5.99E-11	Response to taxane treatment (docetaxel)	
HNSC	cis	1	rs7550350	chr1:150003513	HORMAD1	chr1:150670542-150693352:-	0.25	3.66	0.000277	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
HNSC	cis	1	rs7550698	chr1:166951081	FMO9P	chr1:166573153-166594471:+	0.21	4.03	6.59E-5	Refractive astigmatism	
HNSC	cis	1	rs7550746	chr1:46351719	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.62	1.27E-13	Body mass index	
HNSC	cis	1	rs7551732	chr1:89139041	CCBL2	chr1:89401456-89458643:-	0.21	4.07	5.45E-5	Height	
HNSC	cis	1	rs7553622	chr1:150064762	HORMAD1	chr1:150670542-150693352:-	0.25	3.74	0.000205	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
HNSC	cis	1	rs7554962	chr1:166956297	FMO9P	chr1:166573153-166594471:+	0.23	4.41	1.26E-5	Refractive astigmatism	
HNSC	cis	1	rs7556436	chr1:46363880	CCDC163P	chr1:45960581-45965646:-	0.34	7.54	2.2E-13	Body mass index	
HNSC	cis	1	rs7556615	chr1:46461369	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.72	6.63E-14	Body mass index	
HNSC	cis	1	rs7558944	chr2:73810909	ALMS1P	chr2:73872046-73912692:+	0.25	4.21	2.99E-5	Metabolite levels	
HNSC	cis	1	rs7560328	chr2:202164837	ALS2CR12	chr2:202153148-202222101:-	-0.21	-3.71	0.000234	Melanoma;Esophageal squamous cell carcinoma	
HNSC	cis	1	rs7560357	chr2:99247820	UNC50	chr2:99225042-99234975:+	0.28	5.02	7.09E-7	Bipolar disorder	
HNSC	cis	1	rs7561906	chr2:218312731	DIRC3	chr2:218148748-218621316:-	0.3	4.11	4.6E-5	Metabolite levels (MHPG)	
HNSC	cis	1	rs7562072	chr2:218312691	DIRC3	chr2:218148748-218621316:-	0.3	4.11	4.6E-5	Metabolite levels (MHPG)	
HNSC	cis	1	rs7562091	chr2:218312748	DIRC3	chr2:218148748-218621316:-	0.3	4.11	4.6E-5	Metabolite levels (MHPG)	
HNSC	cis	1	rs7562170	chr2:28943516	TRMT61B	chr2:29072690-29093175:-	0.36	7.67	9.21E-14	Body mass index	
HNSC	cis	1	rs75648520	chr20:33724221	PROCR	chr20:33758727-33765164:+	-0.3	-3.89	0.000115	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs7564890	chr2:73641853	ALMS1P	chr2:73872046-73912692:+	0.23	3.91	0.000106	Metabolite levels	
HNSC	cis	1	rs7565792	chr2:48649705	KLRAQ1	chr2:48667908-48742524:+	0.23	4.19	3.33E-5	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	
HNSC	cis	1	rs7566279	chr2:281178	SH3YL1	chr2:218138-264810:-	-0.66	-12.97	2.72E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs7567389	chr2:127982645	GPR17	chr2:128403439-128410212:+	-0.22	-4.01	6.93E-5	Self-rated health	
HNSC	cis	1	rs756920	chr11:2310870	C11orf21	chr11:2317507-2323143:-	0.31	6.42	3.24E-10	Obesity-related traits	
HNSC	cis	1	rs7572722	chr2:73724675	ALMS1P	chr2:73872046-73912692:+	0.26	4.28	2.28E-5	Metabolite levels	
HNSC	cis	1	rs7576245	chr2:73829678	ALMS1P	chr2:73872046-73912692:+	0.27	4.67	3.92E-6	Metabolite levels	
HNSC	cis	1	rs75774363	chr5:150223722	LOC134466	chr5:150310000-150326146:-	0.41	5.39	1.12E-7	Crohn's disease	
HNSC	cis	1	rs7577894	chr2:56008904	EFEMP1	chr2:56093103-56150932:-	0.24	4.65	4.24E-6	Amyotrophic lateral sclerosis	
HNSC	cis	1	rs7579277	chr2:28996295	TRMT61B	chr2:29072690-29093175:-	-0.32	-6.78	3.49E-11	Body mass index	
HNSC	cis	1	rs75800624	chr18:44633605	HDHD2	chr18:44633782-44676871:-	0.43	4.82	1.93E-6	Sitting height ratio	
HNSC	cis	1	rs7580240	chr2:29114372	TRMT61B	chr2:29072690-29093175:-	0.27	5.07	5.5E-7	Breast cancer (estrogen-receptor negative);Breast cancer	
HNSC	cis	1	rs7580825	chr2:73635148	ALMS1P	chr2:73872046-73912692:+	0.25	4.13	4.34E-5	Metabolite levels	
HNSC	cis	1	rs7581224	chr2:84709215	DNAH6	chr2:84743579-85046711:+	0.33	6.92	1.43E-11	Coronary artery calcification	
HNSC	cis	1	rs75824542	chr14:74523047	LIN52	chr14:74551656-74667117:+	0.29	8.1	4.28E-15	Common traits (Other)	
HNSC	cis	1	rs75824619	chr20:61856471	BIRC7	chr20:61867276-61871853:+	0.39	3.93	9.55E-5	Response to cytadine analogues (cytosine arabinoside)	
HNSC	cis	1	rs7582606	chr2:73813945	ALMS1P	chr2:73872046-73912692:+	0.25	4.1	4.74E-5	Metabolite levels	
HNSC	cis	1	rs7583255	chr2:73797996	ALMS1P	chr2:73872046-73912692:+	0.25	4.15	3.84E-5	Metabolite levels	
HNSC	cis	1	rs7584575	chr2:73666402	ALMS1P	chr2:73872046-73912692:+	0.24	4.05	6.05E-5	Metabolite levels	
HNSC	cis	1	rs7585004	chr2:73666645	ALMS1P	chr2:73872046-73912692:+	0.25	4.21	3.02E-5	Metabolite levels	
HNSC	cis	1	rs7586463	chr2:73798476	ALMS1P	chr2:73872046-73912692:+	0.25	4.15	3.84E-5	Metabolite levels	
HNSC	cis	1	rs7588296	chr2:218312698	DIRC3	chr2:218148748-218621316:-	0.3	4.11	4.6E-5	Metabolite levels (MHPG)	
HNSC	cis	1	rs75888794	chr20:33702998	PROCR	chr20:33758727-33765164:+	-0.32	-4.29	2.17E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs75889859	chr14:35539054	PPP2R3C	chr14:35554679-35591679:-	0.42	6.83	2.47E-11	Atopic dermatitis	
HNSC	cis	1	rs758944	chr7:75953297	UPK3B	chr7:76139745-76157197:+	-0.23	-4.55	6.64E-6	Multiple sclerosis	
HNSC	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.47	-5.3	1.76E-7	Plasma clusterin levels	
HNSC	cis	1	rs75913297	chr10:81789845	LOC219347	chr10:81805991-81838949:-	0.59	6.35	4.8E-10	Chronic obstructive pulmonary disease-related biomarkers	
HNSC	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.6	-10.57	1.15E-23	Triptolide cytotoxicity	
HNSC	cis	1	rs75921373	chr6:26191843	HIST1H2AE	chr6:26217148-26217711:+	-0.29	-4.23	2.74E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs75927128	chr14:65895320	LOC645431	chr14:65877313-65879335:-	-0.29	-3.83	0.000146	Ischemic stroke	
HNSC	cis	1	rs7594511	chr2:73681639	ALMS1P	chr2:73872046-73912692:+	0.26	4.28	2.22E-5	Metabolite levels	
HNSC	cis	1	rs7595075	chr2:264019	SH3YL1	chr2:218138-264810:-	-0.67	-13.07	1.02E-33	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs7596362	chr2:61204688	C2orf74	chr2:61372243-61391964:+	0.38	6.93	1.35E-11	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs7597156	chr2:203194062	NOP58	chr2:203130515-203168382:+	0.27	4.55	6.76E-6	Urate levels	
HNSC	cis	1	rs7597469	chr2:203194270	NOP58	chr2:203130515-203168382:+	0.24	3.84	0.00014	Urate levels	
HNSC	cis	1	rs7598396	chr2:73652628	ALMS1P	chr2:73872046-73912692:+	0.25	4.24	2.7E-5	Metabolite levels	
HNSC	cis	1	rs7598419	chr2:73798223	ALMS1P	chr2:73872046-73912692:+	0.24	3.85	0.000135	Metabolite levels	
HNSC	cis	1	rs7598759	chr2:232321956	C2orf52	chr2:232373137-232379050:-	-0.2	-4.18	3.43E-5	Noise-induced hearing loss	
HNSC	cis	1	rs7598876	chr2:28974466	TRMT61B	chr2:29072690-29093175:-	-0.37	-7.85	2.64E-14	Body mass index	
HNSC	cis	1	rs76024966	chr7:75995021	UPK3B	chr7:76139745-76157197:+	-0.24	-4.68	3.79E-6	Multiple sclerosis	
HNSC	cis	1	rs76024966	chr7:75995021	ZP3	chr7:76026841-76071387:+	-0.21	-3.99	7.47E-5	Multiple sclerosis	
HNSC	cis	1	rs7604682	chr2:73788026	ALMS1P	chr2:73872046-73912692:+	0.26	4.39	1.41E-5	Metabolite levels	
HNSC	cis	1	rs7605824	chr2:280819	SH3YL1	chr2:218138-264810:-	0.68	13.53	1.07E-35	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs7607014	chr2:73730174	ALMS1P	chr2:73872046-73912692:+	-0.24	-4.15	3.84E-5	Metabolite levels	
HNSC	cis	1	rs7608697	chr2:61204641	C2orf74	chr2:61372243-61391964:+	0.35	6.48	2.23E-10	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs7608910	chr2:61204856	C2orf74	chr2:61372243-61391964:+	-0.38	-7.14	3.42E-12	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs7609045	chr2:165555207	SLC38A11	chr2:165754812-165812035:-	0.23	4.49	8.73E-6	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
HNSC	cis	1	rs7609851	chr3:156638503	LEKR1	chr3:156544076-156763918:+	-0.47	-7.88	2.1E-14	Bone mineral density	
HNSC	cis	1	rs76112204	chr5:115618889	COMMD10	chr5:115420727-115628978:+	0.36	3.88	0.000117	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs7611611	chr3:134307877	ANAPC13	chr3:134196547-134204865:-	0.49	10.56	1.22E-23	Height	
HNSC	cis	1	rs7611611	chr3:134307877	CEP63	chr3:134204575-134293852:+	0.27	5.76	1.51E-8	Height	
HNSC	cis	1	rs7611828	chr3:134250325	ANAPC13	chr3:134196547-134204865:-	0.48	10.4	5.1E-23	Height	
HNSC	cis	1	rs7611828	chr3:134250325	CEP63	chr3:134204575-134293852:+	0.27	5.93	5.86E-9	Height	
HNSC	cis	1	rs7615952	chr3:125649403	ALG1L	chr3:125648118-125655882:-	0.5	9.74	1.25E-20	Blood pressure (smoking interaction)	
HNSC	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.22	-3.93	9.65E-5	Blood pressure (smoking interaction)	
HNSC	cis	1	rs7616044	chr3:125649354	ALG1L	chr3:125648118-125655882:-	-0.49	-9.23	8.0E-19	Blood pressure (smoking interaction)	
HNSC	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.22	3.86	0.000128	Blood pressure (smoking interaction)	
HNSC	cis	1	rs7617331	chr3:56624159	CCDC66	chr3:56591184-56655846:+	-0.18	-5.04	6.62E-7	Height	
HNSC	cis	1	rs7617397	chr3:41959037	ULK4	chr3:41288091-42003660:-	-0.8	-14.72	6.7E-41	Diastolic blood pressure	
HNSC	cis	1	rs7617912	chr3:156576412	LEKR1	chr3:156544076-156763918:+	-0.46	-7.29	1.24E-12	Bone mineral density	
HNSC	cis	1	rs7619451	chr3:134233238	ANAPC13	chr3:134196547-134204865:-	0.46	9.44	1.45E-19	Height	
HNSC	cis	1	rs7619451	chr3:134233238	CEP63	chr3:134204575-134293852:+	0.24	5.02	7.34E-7	Height	
HNSC	cis	1	rs76194	chr19:18630580	SSBP4	chr19:18530221-18545371:+	-0.21	-4.83	1.81E-6	Breast cancer	
HNSC	cis	1	rs7619789	chr3:49476263	AMT	chr3:49454212-49460012:-	0.17	3.8	0.000162	Menarche (age at onset)	
HNSC	cis	1	rs7620259	chr3:56666025	CCDC66	chr3:56591184-56655846:+	0.18	4.94	1.08E-6	Height	
HNSC	cis	1	rs7620458	chr3:156576850	LEKR1	chr3:156544076-156763918:+	-0.45	-7.32	1.0E-12	Bone mineral density	
HNSC	cis	1	rs76214082	chr7:1102097	ZFAND2A	chr7:1192544-1199855:-	-0.28	-3.72	0.000222	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs7622420	chr3:53111069	RFT1	chr3:53122503-53164470:-	0.3	4.22	2.93E-5	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs7625448	chr3:53120766	RFT1	chr3:53122503-53164470:-	0.3	3.99	7.55E-5	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs7627549	chr3:128353079	RAB43	chr3:128806418-128880029:-	-0.19	-3.88	0.000118	Monocyte count	
HNSC	cis	1	rs7627549	chr3:128353079	RPN1	chr3:128338813-128399918:-	-0.18	-3.74	0.000207	Monocyte count	
HNSC	cis	1	rs76292674	chr5:115625260	COMMD10	chr5:115420727-115628978:+	0.37	4.36	1.56E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs7629490	chr3:87241497	CHMP2B	chr3:87276413-87304697:+	-0.22	-4.38	1.45E-5	Prostate cancer	
HNSC	cis	1	rs763014	chr16:675680	C16orf13	chr16:684429-686347:-	0.15	4.22	2.9E-5	Height	
HNSC	cis	1	rs763014	chr16:675680	PIGQ	chr16:617032-634108:+	-0.22	-5.06	5.97E-7	Height	
HNSC	cis	1	rs763014	chr16:675680	WFIKKN1	chr16:679239-684116:+	0.28	5.86	8.67E-9	Height	
HNSC	cis	1	rs7630741	chr3:48419723	ATRIP	chr3:48488141-48507708:+	0.16	3.73	0.000212	Longevity	
HNSC	cis	1	rs7630741	chr3:48419723	TREX1	chr3:48501186-48509043:+	-0.3	-7.39	6.35E-13	Longevity	
HNSC	cis	1	rs7630874	chr3:134293291	ANAPC13	chr3:134196547-134204865:-	-0.49	-10.55	1.38E-23	Height	
HNSC	cis	1	rs7630874	chr3:134293291	CEP63	chr3:134204575-134293852:+	-0.27	-5.71	1.96E-8	Height	
HNSC	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	0.7	11.47	3.65E-27	Diastolic blood pressure	
HNSC	cis	1	rs76329209	chr6:26196430	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.57E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs7633265	chr3:195048814	C3orf21	chr3:194789015-194991895:-	0.17	3.87	0.000122	Body mass index	
HNSC	cis	1	rs7634377	chr3:48421258	ATRIP	chr3:48488141-48507708:+	0.17	3.83	0.000147	Longevity	
HNSC	cis	1	rs7634377	chr3:48421258	TREX1	chr3:48501186-48509043:+	-0.27	-6.77	3.69E-11	Longevity	
HNSC	cis	1	rs7635522	chr3:48423656	ATRIP	chr3:48488141-48507708:+	0.18	4.07	5.51E-5	Longevity	
HNSC	cis	1	rs7635522	chr3:48423656	TREX1	chr3:48501186-48509043:+	-0.27	-6.71	5.32E-11	Longevity	
HNSC	cis	1	rs7636044	chr3:48484560	ATRIP	chr3:48488141-48507708:+	0.16	3.67	0.000265	Longevity	
HNSC	cis	1	rs7636044	chr3:48484560	TREX1	chr3:48501186-48509043:+	-0.26	-6.54	1.57E-10	Longevity	
HNSC	cis	1	rs76363448	chr20:33655535	PROCR	chr20:33758727-33765164:+	-0.3	-3.77	0.000184	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs7636782	chr3:48421387	ATRIP	chr3:48488141-48507708:+	0.16	3.7	0.000239	Longevity	
HNSC	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.27	-6.65	7.92E-11	Longevity	
HNSC	cis	1	rs7637227	chr3:134244155	ANAPC13	chr3:134196547-134204865:-	0.48	10.31	1.07E-22	Height	
HNSC	cis	1	rs7637227	chr3:134244155	CEP63	chr3:134204575-134293852:+	0.28	6.13	1.84E-9	Height	
HNSC	cis	1	rs7637449	chr3:56628031	CCDC66	chr3:56591184-56655846:+	-0.18	-5.03	6.86E-7	Height	
HNSC	cis	1	rs76388414	chr7:1100694	ZFAND2A	chr7:1192544-1199855:-	-0.28	-3.72	0.000222	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs763919	chr20:44016052	SYS1-DBNDD2	chr20:43991701-44039245:+	-0.36	-5.52	5.46E-8	Psoriasis	
HNSC	cis	1	rs7639514	chr3:156576067	LEKR1	chr3:156544076-156763918:+	-0.48	-7.91	1.72E-14	Bone mineral density	
HNSC	cis	1	rs76414143	chr5:115625396	COMMD10	chr5:115420727-115628978:+	0.37	4.36	1.56E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs76433514	chr5:150306532	LOC134466	chr5:150310000-150326146:-	0.54	6.75	4.2E-11	Crohn's disease	
HNSC	cis	1	rs76435840	chr11:58285981	ZFP91-CNTF	chr11:58346587-58393203:+	0.3	4.23	2.77E-5	Lymphoma	
HNSC	cis	1	rs7644148	chr3:49545241	AMT	chr3:49454212-49460012:-	-0.19	-4.04	6.1E-5	Menarche (age at onset)	
HNSC	cis	1	rs7645295	chr3:134307734	ANAPC13	chr3:134196547-134204865:-	0.51	10.7	3.46E-24	Height	
HNSC	cis	1	rs7645295	chr3:134307734	CEP63	chr3:134204575-134293852:+	0.27	5.78	1.35E-8	Height	
HNSC	cis	1	rs7645611	chr3:53125297	RFT1	chr3:53122503-53164470:-	0.3	4.1	4.75E-5	Immune reponse to smallpox (secreted IL-2)	
HNSC	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	0.69	11.21	3.75E-26	Diastolic blood pressure	
HNSC	cis	1	rs76464924	chr10:81728811	LOC650623	chr10:81442731-81448648:+	-0.36	-3.82	0.000152	Rheumatoid arthritis	
HNSC	cis	1	rs7648578	chr3:41858731	ULK4	chr3:41288091-42003660:-	0.76	13.75	1.23E-36	Diastolic blood pressure	
HNSC	cis	1	rs7648990	chr3:134244390	ANAPC13	chr3:134196547-134204865:-	0.48	10.4	5.1E-23	Height	
HNSC	cis	1	rs7648990	chr3:134244390	CEP63	chr3:134204575-134293852:+	0.27	5.93	5.86E-9	Height	
HNSC	cis	1	rs7648995	chr3:49438803	AMT	chr3:49454212-49460012:-	-0.19	-4.17	3.58E-5	Menarche (age at onset)	
HNSC	cis	1	rs76494403	chr10:81729731	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs7650156	chr3:128361555	RAB43	chr3:128806418-128880029:-	-0.2	-3.99	7.56E-5	Monocyte count	
HNSC	cis	1	rs7650156	chr3:128361555	RPN1	chr3:128338813-128399918:-	-0.2	-3.99	7.62E-5	Monocyte count	
HNSC	cis	1	rs7650227	chr3:41794937	ULK4	chr3:41288091-42003660:-	0.72	12.52	2.06E-31	Diastolic blood pressure	
HNSC	cis	1	rs76506978	chr18:51790340	POLI	chr18:51795849-51824602:+	0.23	4.17	3.59E-5	Psoriasis	
HNSC	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.3	-7.41	5.37E-13	Longevity	
HNSC	cis	1	rs7651757	chr3:195077305	C3orf21	chr3:194789015-194991895:-	0.17	3.72	0.000222	Body mass index	
HNSC	cis	1	rs7653691	chr3:48419689	ATRIP	chr3:48488141-48507708:+	-0.17	-3.91	0.000103	Longevity	
HNSC	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.26	6.58	1.19E-10	Longevity	
HNSC	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.38	-5.21	2.84E-7	Tumor biomarkers	
HNSC	cis	1	rs76542740	chr15:43891512	CATSPER2	chr15:43922774-43959900:-	-0.43	-6.93	1.32E-11	Tumor biomarkers	
HNSC	cis	1	rs76542740	chr15:43891512	CKMT1A	chr15:43985084-43991419:+	-0.47	-6.49	2.16E-10	Tumor biomarkers	
HNSC	cis	1	rs76542740	chr15:43891512	CKMT1B	chr15:43885252-43891603:+	-0.31	-4.3	2.03E-5	Tumor biomarkers	
HNSC	cis	1	rs7654345	chr4:17691796	LAP3	chr4:17578927-17609590:+	-0.14	-3.8	0.000161	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs76546854	chr10:81728658	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs76548544	chr5:150223515	LOC134466	chr5:150310000-150326146:-	0.36	4.97	9.15E-7	Crohn's disease	
HNSC	cis	1	rs765516	chr6:117728118	ROS1	chr6:117609530-117747018:-	-0.18	-4.11	4.61E-5	Lung cancer	
HNSC	cis	1	rs76552490	chr11:212015	PSMD13	chr11:236808-252984:+	0.2	4.06	5.81E-5	Menarche (age at onset)	
HNSC	cis	1	rs765527	chr19:22129555	ZNF257	chr19:22235266-22273901:+	-0.26	-4.89	1.36E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs76553384	chr14:74383679	LIN52	chr14:74551656-74667117:+	0.23	4.27	2.3E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs7656037	chr4:39717965	RPL9	chr4:39455747-39460568:-	-0.31	-5.88	7.72E-9	Plasma amyloid beta peptide concentrations (ABx-40)	
HNSC	cis	1	rs7657962	chr4:106966715	TBCK	chr4:106967233-107237861:-	0.27	5.19	3.12E-7	Airflow obstruction	
HNSC	cis	1	rs76594057	chr18:44637272	HDHD2	chr18:44633782-44676871:-	0.43	4.84	1.7E-6	Sitting height ratio	
HNSC	cis	1	rs7659718	chr4:17638020	FAM184B	chr4:17633711-17783135:-	-0.16	-4.05	6.0E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs7659718	chr4:17638020	LAP3	chr4:17578927-17609590:+	-0.14	-3.77	0.00018	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs7661070	chr4:39724365	RPL9	chr4:39455747-39460568:-	-0.32	-5.95	5.15E-9	Plasma amyloid beta peptide concentrations (ABx-40)	
HNSC	cis	1	rs7661631	chr4:17679751	FAM184B	chr4:17633711-17783135:-	0.19	4.59	5.66E-6	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs7661631	chr4:17679751	LAP3	chr4:17578927-17609590:+	0.16	4.29	2.2E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs7663811	chr4:142154614	ZNF330	chr4:142142049-142155848:+	-0.29	-4.59	5.75E-6	Conduct disorder	
HNSC	cis	1	rs76648234	chr20:33689941	PROCR	chr20:33758727-33765164:+	-0.31	-3.9	0.000109	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs76683169	chr10:102358397	SEC31B	chr10:102246403-102289636:-	-0.19	-5.1	4.74E-7	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7671752	chr4:17661398	FAM184B	chr4:17633711-17783135:-	-0.16	-3.7	0.000237	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs76722536	chr6:26192946	HIST1H2AE	chr6:26217148-26217711:+	-0.31	-4.14	4.12E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs7673500	chr4:17621383	FAM184B	chr4:17633711-17783135:-	-0.17	-4.01	6.88E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs7673916	chr4:108917149	HADH	chr4:108910940-108956330:+	0.28	4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs7674097	chr4:108917244	HADH	chr4:108910940-108956330:+	0.28	4.06	5.75E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs767471	chr6:26557854	BTN2A3	chr6:26422317-26431927:+	0.17	3.8	0.000163	Educational attainment	
HNSC	cis	1	rs767471	chr6:26557854	BTN3A2	chr6:26365398-26378546:+	0.18	4.25	2.55E-5	Educational attainment	
HNSC	cis	1	rs7677248	chr4:106960497	TBCK	chr4:106967233-107237861:-	-0.24	-4.87	1.5E-6	Airflow obstruction	
HNSC	cis	1	rs7678847	chr4:106987426	TBCK	chr4:106967233-107237861:-	0.26	5.15	3.78E-7	Airflow obstruction	
HNSC	cis	1	rs76796947	chr5:115501040	COMMD10	chr5:115420727-115628978:+	0.33	3.85	0.000133	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs7679975	chr4:142154551	ZNF330	chr4:142142049-142155848:+	-0.29	-4.6	5.37E-6	Conduct disorder	
HNSC	cis	1	rs7679	chr20:44576502	CD40	chr20:44746906-44758384:+	-0.22	-3.72	0.000225	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
HNSC	cis	1	rs76804143	chr7:1082021	ZFAND2A	chr7:1192544-1199855:-	-0.27	-3.69	0.00025	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs76812330	chr19:50531860	SIGLEC16	chr19:50472912-50479075:+	0.41	5.04	6.67E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
HNSC	cis	1	rs7682402	chr4:1743343	FAM53A	chr4:1641609-1685854:-	-0.35	-6.09	2.25E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs76841360	chr1:40060025	BMP8A	chr1:39957318-39995537:+	0.21	4.35	1.66E-5	C-reactive protein levels or triglyceride levels (pleiotropy)	
HNSC	cis	1	rs76841360	chr1:40060025	PABPC4	chr1:40026485-40042521:-	-0.33	-5.65	2.79E-8	C-reactive protein levels or triglyceride levels (pleiotropy)	
HNSC	cis	1	rs7684664	chr4:142150860	ZNF330	chr4:142142049-142155848:+	-0.29	-4.56	6.55E-6	Conduct disorder	
HNSC	cis	1	rs76850134	chr20:33671725	PROCR	chr20:33758727-33765164:+	-0.3	-3.77	0.000184	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs7687557	chr4:39769260	RPL9	chr4:39455747-39460568:-	-0.29	-5.59	3.72E-8	Plasma amyloid beta peptide concentrations (ABx-40)	
HNSC	cis	1	rs7688014	chr4:103975060	CENPE	chr4:104026963-104119566:-	-0.19	-4.57	6.27E-6	Schizophrenia	
HNSC	cis	1	rs7688014	chr4:103975060	MANBA	chr4:103552644-103682151:-	0.19	3.88	0.000118	Schizophrenia	
HNSC	cis	1	rs7688682	chr4:17693794	LAP3	chr4:17578927-17609590:+	0.16	4.13	4.24E-5	Parasitemia in Tripanosoma cruzi seropositivity	
HNSC	cis	1	rs7691313	chr4:108941174	HADH	chr4:108910940-108956330:+	-0.27	-3.9	0.00011	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs7691506	chr4:108941283	HADH	chr4:108910940-108956330:+	-0.28	-3.97	8.36E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs7692069	chr4:106959289	TBCK	chr4:106967233-107237861:-	0.24	4.79	2.21E-6	Airflow obstruction	
HNSC	cis	1	rs76964550	chr10:81729733	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	1	33.69	5.35E-130	Birdshot chorioretinopathy	
HNSC	cis	1	rs7705542	chr5:150228318	LOC134466	chr5:150310000-150326146:-	0.37	5.07	5.7E-7	Crohn's disease	
HNSC	cis	1	rs7709464	chr5:150269441	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs7709650	chr5:150246685	LOC134466	chr5:150310000-150326146:-	0.38	5.2	2.97E-7	Crohn's disease	
HNSC	cis	1	rs7710900	chr5:82433020	XRCC4	chr5:82373317-82649577:+	-0.2	-3.89	0.000116	Hypertension	
HNSC	cis	1	rs7714415	chr5:150270292	LOC134466	chr5:150310000-150326146:-	0.35	4.84	1.74E-6	Crohn's disease	
HNSC	cis	1	rs7714584	chr5:150270420	LOC134466	chr5:150310000-150326146:-	0.35	4.87	1.53E-6	Crohn's disease	
HNSC	cis	1	rs7716903	chr5:150258574	LOC134466	chr5:150310000-150326146:-	0.38	5.33	1.52E-7	Crohn's disease	
HNSC	cis	1	rs7716931	chr5:82434675	XRCC4	chr5:82373317-82649577:+	-0.2	-3.89	0.000114	Hypertension	
HNSC	cis	1	rs7716962	chr5:82434732	XRCC4	chr5:82373317-82649577:+	-0.2	-3.96	8.73E-5	Hypertension	
HNSC	cis	1	rs7717000	chr5:112709742	YTHDC2	chr5:112849410-112930979:+	0.19	3.66	0.00028	Cerebral amyloid angiopathy	
HNSC	cis	1	rs77187281	chr19:50507667	SIGLEC16	chr19:50472912-50479075:+	0.52	5.97	4.63E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
HNSC	cis	1	rs7718874	chr5:176358065	CDHR2	chr5:175976365-176022769:+	0.21	3.75	0.000201	Menopause (age at onset);Menarche and menopause (age at onset)	
HNSC	cis	1	rs7720132	chr5:90745105	LOC100129716	chr5:90676164-90716531:+	0.31	4.47	9.68E-6	Smoking behavior	
HNSC	cis	1	rs7721416	chr5:82434993	XRCC4	chr5:82373317-82649577:+	-0.2	-3.89	0.000114	Hypertension	
HNSC	cis	1	rs77214986	chr16:4603722	NMRAL1	chr16:4511696-4526307:-	-0.54	-5.66	2.6E-8	Obesity-related traits	
HNSC	cis	1	rs77257477	chr8:96045399	C8orf38	chr8:95908040-96088396:+	-0.34	-5.18	3.32E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs7726564	chr5:82466093	XRCC4	chr5:82373317-82649577:+	-0.2	-3.85	0.000134	Hypertension	
HNSC	cis	1	rs7727038	chr5:131590257	SLC22A5	chr5:131705401-131731302:+	-0.27	-5.17	3.48E-7	Blood metabolite levels	
HNSC	cis	1	rs7727544	chr5:131590534	SLC22A5	chr5:131705401-131731302:+	-0.27	-5.16	3.53E-7	Blood metabolite levels	
HNSC	cis	1	rs77305932	chr7:1100861	ZFAND2A	chr7:1192544-1199855:-	-0.28	-3.72	0.000222	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs7732092	chr5:82436929	XRCC4	chr5:82373317-82649577:+	-0.2	-4.01	7.05E-5	Hypertension	
HNSC	cis	1	rs7733151	chr5:82430474	XRCC4	chr5:82373317-82649577:+	-0.2	-3.88	0.000119	Hypertension	
HNSC	cis	1	rs7733330	chr5:82430593	XRCC4	chr5:82373317-82649577:+	-0.2	-3.88	0.000119	Hypertension	
HNSC	cis	1	rs7733354	chr5:82430678	XRCC4	chr5:82373317-82649577:+	-0.2	-3.88	0.000119	Hypertension	
HNSC	cis	1	rs77335224	chr10:104636276	SFXN2	chr10:104474298-104498946:+	-0.3	-3.84	0.00014	Hypertension;Systolic blood pressure;Diastolic blood pressure	
HNSC	cis	1	rs77346188	chr7:1114023	ZFAND2A	chr7:1192544-1199855:-	-0.28	-3.65	0.000286	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs7736554	chr5:150258308	LOC134466	chr5:150310000-150326146:-	0.38	5.33	1.52E-7	Crohn's disease	
HNSC	cis	1	rs7736873	chr5:150258482	LOC134466	chr5:150310000-150326146:-	0.38	5.33	1.52E-7	Crohn's disease	
HNSC	cis	1	rs77374467	chr6:24475278	GPLD1	chr6:24428405-24489850:-	0.28	4.06	5.63E-5	Hematological and biochemical traits	
HNSC	cis	1	rs7737470	chr5:131974063	SLC22A5	chr5:131705401-131731302:+	0.24	3.95	8.9E-5	Asthma (childhood onset)	
HNSC	cis	1	rs7740380	chr6:153440711	RGS17	chr6:153332041-153452389:-	-0.21	-3.94	9.47E-5	Prostate cancer	
HNSC	cis	1	rs7740487	chr6:28216486	ZNF389	chr6:28129551-28137375:+	-0.28	-4.29	2.11E-5	Depression	
HNSC	cis	1	rs7740487	chr6:28216486	ZSCAN23	chr6:28393287-28411279:-	0.25	3.88	0.000117	Depression	
HNSC	cis	1	rs7740682	chr6:49488745	CENPQ	chr6:49431096-49460820:+	0.24	5.46	7.64E-8	Brain structure	
HNSC	cis	1	rs7740682	chr6:49488745	MUT	chr6:49398994-49431031:-	-0.19	-3.84	0.000138	Brain structure	
HNSC	cis	1	rs7742626	chr6:136132496	AHI1	chr6:135605112-135818903:-	0.2	4.33	1.84E-5	Phosphorus levels	
HNSC	cis	1	rs77435770	chr6:118819467	C6orf204	chr6:118786239-119031238:-	-0.25	-4.39	1.41E-5	Renal cell carcinoma	
HNSC	cis	1	rs7743683	chr6:153432985	RGS17	chr6:153332041-153452389:-	-0.21	-3.9	0.00011	Prostate cancer	
HNSC	cis	1	rs7747003	chr6:153428982	RGS17	chr6:153332041-153452389:-	-0.21	-3.91	0.000106	Prostate cancer	
HNSC	cis	1	rs77477310	chr14:35615793	PPP2R3C	chr14:35554679-35591679:-	0.45	7.15	3.21E-12	Atopic dermatitis	
HNSC	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.6	-13.54	1.01E-35	Response to antipsychotic treatment	
HNSC	cis	1	rs7750918	chr6:49430082	CENPQ	chr6:49431096-49460820:+	-0.4	-9.43	1.66E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs7750918	chr6:49430082	MUT	chr6:49398994-49431031:-	0.41	8.64	7.76E-17	Folate pathway vitamin levels	
HNSC	cis	1	rs77531164	chr15:40673466	C15orf23	chr15:40674922-40686488:+	0.42	6.66	7.28E-11	Heschl's gyrus morphology	
HNSC	cis	1	rs775322	chr12:57958313	TSFM	chr12:58176536-58191367:+	-0.19	-4.18	3.51E-5	Rheumatoid arthritis	
HNSC	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.62	-13.61	4.71E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs77562891	chr18:51791235	POLI	chr18:51795849-51824602:+	0.24	4.3	2.04E-5	Psoriasis	
HNSC	cis	1	rs77565539	chr10:81732604	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs7756935	chr6:46675025	TDRD6	chr6:46655866-46670149:+	0.2	3.75	0.000199	Lipoprotein-associated phospholipase A2 activity and mass	
HNSC	cis	1	rs7757014	chr6:49491690	CENPQ	chr6:49431096-49460820:+	-0.25	-5.6	3.63E-8	Brain structure	
HNSC	cis	1	rs7759001	chr6:27341409	ZNF391	chr6:27356524-27369227:+	0.31	5.71	1.97E-8	Glomerular filtration rate (creatinine)	
HNSC	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.6	-15.52	1.63E-44	Homocysteine levels	
HNSC	cis	1	rs7759071	chr6:49433198	MUT	chr6:49398994-49431031:-	0.2	3.92	0.000102	Homocysteine levels	
HNSC	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.64	-14.37	2.33E-39	Response to antipsychotic treatment	
HNSC	cis	1	rs77613724	chr10:81730629	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs7762018	chr6:170113244	C6orf70	chr6:170151721-170181617:+	0.23	3.95	8.82E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
HNSC	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.59	-13.56	7.97E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs77698001	chr5:150250367	LOC134466	chr5:150310000-150326146:-	0.37	5.15	3.78E-7	Crohn's disease	
HNSC	cis	1	rs7770848	chr6:44769237	AARS2	chr6:44266463-44281063:-	-0.49	-5.15	3.77E-7	Asthma (childhood onset)	
HNSC	cis	1	rs7770848	chr6:44769237	CDC5L	chr6:44355302-44414779:+	-0.41	-4.1	4.86E-5	Asthma (childhood onset)	
HNSC	cis	1	rs7770848	chr6:44769237	HSP90AB1	chr6:44214849-44221614:+	-0.4	-4.28	2.23E-5	Asthma (childhood onset)	
HNSC	cis	1	rs7770848	chr6:44769237	MRPL14	chr6:44081374-44095191:-	-0.31	-4.4	1.32E-5	Asthma (childhood onset)	
HNSC	cis	1	rs7770923	chr6:117726980	ROS1	chr6:117609530-117747018:-	-0.19	-4.25	2.57E-5	Lung cancer	
HNSC	cis	1	rs7771211	chr6:117727025	ROS1	chr6:117609530-117747018:-	-0.18	-4.04	6.25E-5	Lung cancer	
HNSC	cis	1	rs7771271	chr6:117727236	ROS1	chr6:117609530-117747018:-	-0.18	-4.04	6.25E-5	Lung cancer	
HNSC	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.62	-13.61	4.71E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs7771437	chr6:117727313	ROS1	chr6:117609530-117747018:-	-0.18	-4.04	6.25E-5	Lung cancer	
HNSC	cis	1	rs7771637	chr6:117727491	ROS1	chr6:117609530-117747018:-	-0.18	-3.95	8.9E-5	Lung cancer	
HNSC	cis	1	rs7772046	chr6:117727485	ROS1	chr6:117609530-117747018:-	-0.18	-3.95	8.87E-5	Lung cancer	
HNSC	cis	1	rs7773987	chr6:135707486	AHI1	chr6:135605112-135818903:-	0.3	6.96	1.12E-11	Selective IgA deficiency	
HNSC	cis	1	rs7774688	chr6:49387292	CENPQ	chr6:49431096-49460820:+	-0.57	-14.75	4.56E-41	Homocysteine levels	
HNSC	cis	1	rs7774688	chr6:49387292	MUT	chr6:49398994-49431031:-	0.23	4.57	6.04E-6	Homocysteine levels	
HNSC	cis	1	rs77760339	chr7:1083927	ZFAND2A	chr7:1192544-1199855:-	-0.27	-3.69	0.000248	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs7776244	chr6:117727949	ROS1	chr6:117609530-117747018:-	-0.18	-4.04	6.22E-5	Lung cancer	
HNSC	cis	1	rs77763497	chr20:3250007	ITPA	chr20:3190056-3204504:+	-0.19	-3.88	0.000118	IFN-related cytopenia	
HNSC	cis	1	rs7777389	chr7:143744802	ARHGEF35	chr7:143883677-143892736:-	-0.35	-7.57	1.86E-13	Obesity-related traits	
HNSC	cis	1	rs7778911	chr7:65694506	NCRNA00174	chr7:65841032-65865395:-	0.46	4.97	9.34E-7	Diabetic kidney disease	
HNSC	cis	1	rs77790737	chr8:96037156	C8orf38	chr8:95908040-96088396:+	-0.34	-5.19	3.07E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs7781698	chr7:65896312	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.76	1.28E-45	Aortic root size	
HNSC	cis	1	rs7781698	chr7:65896312	TYW1	chr7:66461817-66704496:+	0.2	3.66	0.000278	Aortic root size	
HNSC	cis	1	rs7781864	chr7:104511576	RINT1	chr7:105172532-105208124:+	0.43	3.75	0.000198	Obesity	
HNSC	cis	1	rs7782320	chr7:66177098	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.76	2.23E-24	Aortic root size	
HNSC	cis	1	rs7783613	chr7:65805261	NCRNA00174	chr7:65841032-65865395:-	0.72	14.74	5.25E-41	Aortic root size	
HNSC	cis	1	rs7783613	chr7:65805261	TYW1	chr7:66461817-66704496:+	-0.2	-3.69	0.000253	Aortic root size	
HNSC	cis	1	rs7783924	chr7:66209057	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs77849630	chr5:115556900	COMMD10	chr5:115420727-115628978:+	0.39	3.86	0.000127	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs7785213	chr7:66138978	NCRNA00174	chr7:65841032-65865395:-	0.55	10.91	5.73E-25	Aortic root size	
HNSC	cis	1	rs778679	chr7:65840911	NCRNA00174	chr7:65841032-65865395:-	-0.47	-5.09	4.98E-7	Diabetic kidney disease	
HNSC	cis	1	rs778679	chr7:65840911	STAG3L4	chr7:66767616-66786512:+	-0.38	-4.21	2.99E-5	Diabetic kidney disease	
HNSC	cis	1	rs778685	chr7:65836176	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.68	2.92E-45	Aortic root size	
HNSC	cis	1	rs7786877	chr7:100214015	EPO	chr7:100318423-100321321:+	0.22	3.76	0.000189	Mean corpuscular volume	
HNSC	cis	1	rs778691	chr7:65873092	NCRNA00174	chr7:65841032-65865395:-	-0.47	-5.09	4.98E-7	Diabetic kidney disease	
HNSC	cis	1	rs778691	chr7:65873092	STAG3L4	chr7:66767616-66786512:+	-0.38	-4.21	2.99E-5	Diabetic kidney disease	
HNSC	cis	1	rs778694	chr7:65871558	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.63	4.86E-45	Aortic root size	
HNSC	cis	1	rs778696	chr7:65870813	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.63	4.86E-45	Aortic root size	
HNSC	cis	1	rs778699	chr7:65868290	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.62	5.64E-45	Aortic root size	
HNSC	cis	1	rs778699	chr7:65868290	TYW1	chr7:66461817-66704496:+	0.2	3.7	0.000237	Aortic root size	
HNSC	cis	1	rs778704	chr7:65863467	NCRNA00174	chr7:65841032-65865395:-	-0.47	-5.09	4.98E-7	Diabetic kidney disease	
HNSC	cis	1	rs778704	chr7:65863467	STAG3L4	chr7:66767616-66786512:+	-0.38	-4.21	2.99E-5	Diabetic kidney disease	
HNSC	cis	1	rs778706	chr7:65860424	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.62	5.64E-45	Aortic root size	
HNSC	cis	1	rs778706	chr7:65860424	TYW1	chr7:66461817-66704496:+	0.2	3.7	0.000237	Aortic root size	
HNSC	cis	1	rs778710	chr7:65854834	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.63	4.86E-45	Aortic root size	
HNSC	cis	1	rs778722	chr7:65844828	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.69	2.66E-45	Aortic root size	
HNSC	cis	1	rs7787230	chr7:65629099	NCRNA00174	chr7:65841032-65865395:-	0.44	4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs778726	chr7:65828731	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.68	2.92E-45	Aortic root size	
HNSC	cis	1	rs778729	chr7:65824419	NCRNA00174	chr7:65841032-65865395:-	-0.47	-5.1	4.74E-7	Diabetic kidney disease	
HNSC	cis	1	rs778729	chr7:65824419	STAG3L4	chr7:66767616-66786512:+	-0.38	-4.2	3.17E-5	Diabetic kidney disease	
HNSC	cis	1	rs778758	chr2:61782161	AHSA2	chr2:61404553-61414058:+	-0.14	-4.93	1.1E-6	Tuberculosis	
HNSC	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.46	8.19	2.22E-15	Tuberculosis	
HNSC	cis	1	rs778762	chr2:61782921	AHSA2	chr2:61404553-61414058:+	-0.14	-4.76	2.5E-6	Tuberculosis	
HNSC	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.46	8.06	5.63E-15	Tuberculosis	
HNSC	cis	1	rs778763	chr2:61785639	AHSA2	chr2:61404553-61414058:+	-0.15	-5.02	7.09E-7	Tuberculosis	
HNSC	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.47	8.29	1.07E-15	Tuberculosis	
HNSC	cis	1	rs7787818	chr7:134251597	AKR1B15	chr7:134233849-134264300:+	0.24	5.12	4.28E-7	Longevity	
HNSC	cis	1	rs7788576	chr7:66148302	NCRNA00174	chr7:65841032-65865395:-	0.55	10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs7789181	chr7:97621263	MGC72080	chr7:97503667-97601638:-	0.42	4.73	2.95E-6	Sudden cardiac arrest	
HNSC	cis	1	rs7789184	chr7:66210195	NCRNA00174	chr7:65841032-65865395:-	-0.55	-10.95	3.96E-25	Aortic root size	
HNSC	cis	1	rs7789554	chr7:65946038	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.88	3.77E-46	Aortic root size	
HNSC	cis	1	rs7789554	chr7:65946038	TYW1	chr7:66461817-66704496:+	0.2	3.66	0.000278	Aortic root size	
HNSC	cis	1	rs7789768	chr7:65938980	NCRNA00174	chr7:65841032-65865395:-	-0.75	-15.88	3.77E-46	Aortic root size	
HNSC	cis	1	rs7789768	chr7:65938980	TYW1	chr7:66461817-66704496:+	0.2	3.66	0.000278	Aortic root size	
HNSC	cis	1	rs7789940	chr7:75951230	UPK3B	chr7:76139745-76157197:+	-0.23	-4.43	1.16E-5	Multiple sclerosis	
HNSC	cis	1	rs77902909	chr6:24478715	GPLD1	chr6:24428405-24489850:-	0.28	3.99	7.66E-5	Hematological and biochemical traits	
HNSC	cis	1	rs7792391	chr7:65773429	NCRNA00174	chr7:65841032-65865395:-	0.46	4.97	9.34E-7	Diabetic kidney disease	
HNSC	cis	1	rs7792391	chr7:65773429	STAG3L4	chr7:66767616-66786512:+	0.4	4.47	9.81E-6	Diabetic kidney disease	
HNSC	cis	1	rs7792762	chr7:66004138	NCRNA00174	chr7:65841032-65865395:-	-0.71	-14.24	9.12E-39	Aortic root size	
HNSC	cis	1	rs7792762	chr7:66004138	STAG3L4	chr7:66767616-66786512:+	-0.21	-3.7	0.000238	Aortic root size	
HNSC	cis	1	rs77930391	chr13:96297821	DZIP1	chr13:96229329-96296957:-	0.27	3.84	0.000137	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
HNSC	cis	1	rs77930391	chr13:96297821	UGGT2	chr13:96453838-96705736:-	-0.24	-3.9	0.000108	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
HNSC	cis	1	rs7794279	chr7:3341806	C7orf27	chr7:2577511-2595146:-	0.17	3.9	0.000108	Motion sickness	
HNSC	cis	1	rs7794661	chr7:65389730	CRCP	chr7:65579805-65619551:+	-0.34	-3.93	9.9E-5	Diabetic kidney disease	
HNSC	cis	1	rs7794661	chr7:65389730	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.94	1.06E-6	Diabetic kidney disease	
HNSC	cis	1	rs7795242	chr7:65390094	CRCP	chr7:65579805-65619551:+	-0.33	-3.97	8.29E-5	Diabetic kidney disease	
HNSC	cis	1	rs7795242	chr7:65390094	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.97	9.18E-7	Diabetic kidney disease	
HNSC	cis	1	rs77957229	chr6:26185226	HIST1H2AE	chr6:26217148-26217711:+	-0.31	-4.25	2.57E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs77961951	chr6:26186075	HIST1H2AE	chr6:26217148-26217711:+	-0.34	-4.47	9.56E-6	Renal underexcretion gout;Gout	
HNSC	cis	1	rs78012445	chr6:26195080	HIST1H2AE	chr6:26217148-26217711:+	-0.3	-4.33	1.8E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs7801282	chr7:65613687	NCRNA00174	chr7:65841032-65865395:-	0.75	15.7	2.34E-45	Aortic root size	
HNSC	cis	1	rs7804223	chr7:65664559	NCRNA00174	chr7:65841032-65865395:-	0.44	4.77	2.45E-6	Diabetic kidney disease	
HNSC	cis	1	rs78075821	chr1:171724645	VAMP4	chr1:171669298-171711214:-	0.25	4.3	2.02E-5	Hippocampal atrophy	
HNSC	cis	1	rs7810543	chr7:110894778	IMMP2L	chr7:110303110-111202538:-	-0.21	-3.74	0.000207	Schizophrenia	
HNSC	cis	1	rs781142	chr7:65438778	CRCP	chr7:65579805-65619551:+	-0.33	-3.88	0.000121	Diabetic kidney disease	
HNSC	cis	1	rs781142	chr7:65438778	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.93	1.12E-6	Diabetic kidney disease	
HNSC	cis	1	rs781149	chr7:65481284	CRCP	chr7:65579805-65619551:+	-0.33	-3.86	0.00013	Diabetic kidney disease	
HNSC	cis	1	rs781149	chr7:65481284	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.6	5.37E-6	Diabetic kidney disease	
HNSC	cis	1	rs781150	chr7:65480973	CRCP	chr7:65579805-65619551:+	-0.32	-3.73	0.000217	Diabetic kidney disease	
HNSC	cis	1	rs781150	chr7:65480973	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.48	9.21E-6	Diabetic kidney disease	
HNSC	cis	1	rs781156	chr7:65479141	CRCP	chr7:65579805-65619551:+	-0.33	-3.81	0.000155	Diabetic kidney disease	
HNSC	cis	1	rs781156	chr7:65479141	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.57	6.25E-6	Diabetic kidney disease	
HNSC	cis	1	rs781157	chr7:65478311	CRCP	chr7:65579805-65619551:+	-0.33	-3.88	0.000118	Diabetic kidney disease	
HNSC	cis	1	rs781157	chr7:65478311	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.6	5.36E-6	Diabetic kidney disease	
HNSC	cis	1	rs78133532	chr18:51794210	POLI	chr18:51795849-51824602:+	0.23	4.1	4.76E-5	Psoriasis	
HNSC	cis	1	rs7814319	chr8:97263418	MTERFD1	chr8:97251645-97273796:-	0.24	5.44	8.39E-8	Lung function (FVC)	
HNSC	cis	1	rs78153629	chr15:40673465	C15orf23	chr15:40674922-40686488:+	0.42	6.66	7.28E-11	Heschl's gyrus morphology	
HNSC	cis	1	rs7818688	chr8:96024082	C8orf38	chr8:95908040-96088396:+	-0.27	-4.1	4.76E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs7820159	chr8:8576215	FLJ10661	chr8:8086092-8102386:+	0.26	4.33	1.81E-5	Obesity-related traits	
HNSC	cis	1	rs78207779	chr14:35506387	PPP2R3C	chr14:35554679-35591679:-	0.42	6.85	2.14E-11	Atopic dermatitis	
HNSC	cis	1	rs78213404	chr1:171685491	VAMP4	chr1:171669298-171711214:-	0.26	4.5	8.5E-6	Hippocampal atrophy	
HNSC	cis	1	rs7824557	chr8:11104111	AMAC1L2	chr8:11188495-11189695:+	0.23	4.25	2.61E-5	Retinal vascular caliber	
HNSC	cis	1	rs782876	chr7:134240770	AKR1B15	chr7:134233849-134264300:+	0.25	5.28	1.93E-7	Longevity	
HNSC	cis	1	rs7832570	chr8:96023795	C8orf38	chr8:95908040-96088396:+	-0.26	-4.04	6.08E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs783531	chr15:83249119	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.16	-4.03	6.52E-5	Schizophrenia	
HNSC	cis	1	rs783540	chr15:83254708	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.14	3.84	0.000138	Schizophrenia	
HNSC	cis	1	rs78376243	chr10:89749148	PAPSS2	chr10:89419476-89507460:+	-0.2	-3.75	0.0002	Type 2 diabetes	
HNSC	cis	1	rs78420872	chr6:24464429	GPLD1	chr6:24428405-24489850:-	0.26	3.78	0.000174	Hematological and biochemical traits	
HNSC	cis	1	rs7843488	chr8:8576217	FLJ10661	chr8:8086092-8102386:+	0.26	4.36	1.56E-5	Obesity-related traits	
HNSC	cis	1	rs78449408	chr10:81730699	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs784830	chr1:84760574	GNG5	chr1:84964007-84972262:-	-0.2	-3.96	8.47E-5	Metabolic syndrome	
HNSC	cis	1	rs78520676	chr11:517173	PHRF1	chr11:576483-612220:+	-0.28	-4.09	4.96E-5	Body mass index	
HNSC	cis	1	rs7853884	chr9:21667373	CDKN2BAS	chr9:21994790-22121091:+	0.25	4.22	2.93E-5	Gut microbiome composition (winter)	
HNSC	cis	1	rs785464	chr1:46523089	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.49	3.21E-13	Body mass index	
HNSC	cis	1	rs785471	chr1:46518677	CCDC163P	chr1:45960581-45965646:-	-0.33	-7.26	1.53E-12	Body mass index	
HNSC	cis	1	rs785479	chr1:46492144	CCDC163P	chr1:45960581-45965646:-	-0.33	-7.14	3.43E-12	Body mass index	
HNSC	cis	1	rs785481	chr1:46554518	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.47	3.75E-13	Body mass index	
HNSC	cis	1	rs785485	chr1:46574424	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.54	2.23E-13	Body mass index	
HNSC	cis	1	rs785488	chr1:46576095	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.55	2.13E-13	Body mass index	
HNSC	cis	1	rs785489	chr1:46576390	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.55	2.13E-13	Body mass index	
HNSC	cis	1	rs785491	chr1:46583418	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.55	2.13E-13	Body mass index	
HNSC	cis	1	rs785492	chr1:46583607	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.33	9.74E-13	Body mass index	
HNSC	cis	1	rs785494	chr1:46586626	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.55	2.13E-13	Body mass index	
HNSC	cis	1	rs785495	chr1:46587887	CCDC163P	chr1:45960581-45965646:-	-0.33	-7.12	3.85E-12	Body mass index	
HNSC	cis	1	rs785503	chr1:46595868	CCDC163P	chr1:45960581-45965646:-	-0.35	-7.55	2.13E-13	Body mass index	
HNSC	cis	1	rs785520	chr1:46568836	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.47	3.75E-13	Body mass index	
HNSC	cis	1	rs7855610	chr9:21664643	CDKN2BAS	chr9:21994790-22121091:+	-0.23	-3.73	0.000211	Gut microbiome composition (winter)	
HNSC	cis	1	rs7855793	chr9:21664623	CDKN2BAS	chr9:21994790-22121091:+	-0.23	-3.73	0.000211	Gut microbiome composition (winter)	
HNSC	cis	1	rs78594996	chr17:40570109	NAGLU	chr17:40687951-40696464:+	-0.2	-4.04	6.1E-5	Crohn's disease	
HNSC	cis	1	rs78604110	chr15:40681854	C15orf23	chr15:40674922-40686488:+	0.46	7.22	1.96E-12	Heschl's gyrus morphology	
HNSC	cis	1	rs7861868	chr9:21671191	CDKN2BAS	chr9:21994790-22121091:+	-0.26	-4.38	1.44E-5	Gut microbiome composition (winter)	
HNSC	cis	1	rs7861968	chr9:35924396	LOC158376	chr9:35909480-35911617:+	-0.31	-3.93	9.55E-5	Urate levels (BMI interaction)	
HNSC	cis	1	rs786425	chr12:124085502	DDX55	chr12:124086672-124105483:+	0.19	4.54	6.92E-6	Pubertal anthropometrics	
HNSC	cis	1	rs7864407	chr9:21666948	CDKN2BAS	chr9:21994790-22121091:+	-0.25	-4.27	2.39E-5	Gut microbiome composition (winter)	
HNSC	cis	1	rs7868151	chr9:21667864	CDKN2BAS	chr9:21994790-22121091:+	-0.26	-4.39	1.38E-5	Gut microbiome composition (winter)	
HNSC	cis	1	rs7868228	chr9:21667762	CDKN2BAS	chr9:21994790-22121091:+	0.26	4.43	1.17E-5	Gut microbiome composition (winter)	
HNSC	cis	1	rs7868333	chr9:21667825	CDKN2BAS	chr9:21994790-22121091:+	-0.27	-4.34	1.7E-5	Gut microbiome composition (winter)	
HNSC	cis	1	rs78707713	chr10:71245276	TSPAN15	chr10:71211226-71267423:+	0.31	3.72	0.000221	Venous thromboembolism	
HNSC	cis	1	rs78724141	chr8:82659661	CHMP4C	chr8:82644688-82671746:+	-0.96	-9.77	1.03E-20	Epithelial ovarian cancer;Ovarian cancer	
HNSC	cis	1	rs78803505	chr7:65382572	CRCP	chr7:65579805-65619551:+	-0.33	-3.97	8.29E-5	Diabetic kidney disease	
HNSC	cis	1	rs78803505	chr7:65382572	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.97	9.18E-7	Diabetic kidney disease	
HNSC	cis	1	rs7893480	chr10:124734829	C10orf88	chr10:124690419-124713919:-	-0.21	-3.92	0.0001	Migraine without aura	
HNSC	cis	1	rs78953187	chr1:93000574	EVI5	chr1:92974255-93257961:-	-0.23	-4.27	2.32E-5	Cholesterol, total	
HNSC	cis	1	rs7896033	chr10:124731507	C10orf88	chr10:124690419-124713919:-	-0.21	-3.81	0.000158	Migraine without aura	
HNSC	cis	1	rs7896691	chr10:3155173	PITRM1	chr10:3179116-3215003:-	0.35	3.92	0.000102	Disc degeneration (lumbar)	
HNSC	cis	1	rs7900134	chr10:124744123	C10orf88	chr10:124690419-124713919:-	-0.22	-4.04	6.12E-5	Migraine without aura	
HNSC	cis	1	rs7902253	chr10:124739748	C10orf88	chr10:124690419-124713919:-	-0.21	-3.92	0.0001	Migraine without aura	
HNSC	cis	1	rs7902273	chr10:124734824	C10orf88	chr10:124690419-124713919:-	-0.21	-3.92	0.0001	Migraine without aura	
HNSC	cis	1	rs79044944	chr15:40676285	C15orf23	chr15:40674922-40686488:+	0.46	7.27	1.42E-12	Heschl's gyrus morphology	
HNSC	cis	1	rs79048371	chr20:33731484	PROCR	chr20:33758727-33765164:+	-0.29	-3.72	0.00022	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs7905961	chr10:102297391	SEC31B	chr10:102246403-102289636:-	-0.19	-5.92	6.05E-9	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs7917792	chr10:97365627	ENTPD1	chr10:97471536-97637022:+	0.25	7.53	2.5E-13	Blood metabolite levels	
HNSC	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.58	13.06	1.14E-33	Response to antipsychotic treatment	
HNSC	cis	1	rs79199019	chr14:35581125	PPP2R3C	chr14:35554679-35591679:-	0.43	7.02	7.45E-12	Atopic dermatitis	
HNSC	cis	1	rs7921096	chr10:124731468	C10orf88	chr10:124690419-124713919:-	-0.21	-3.81	0.000158	Migraine without aura	
HNSC	cis	1	rs7922621	chr10:82251544	C10orf58	chr10:82168242-82196869:+	-0.24	-3.67	0.000267	Post bronchodilator FEV1	
HNSC	cis	1	rs79264785	chr6:26194121	HIST1H2AE	chr6:26217148-26217711:+	-0.32	-4.36	1.57E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs7927771	chr11:47781306	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.55	4.76E-8	Subjective well-being	
HNSC	cis	1	rs7927771	chr11:47781306	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.95	8.85E-5	Subjective well-being	
HNSC	cis	1	rs79292725	chr10:81730770	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs79318564	chr15:84786150	LOC388152	chr15:84867600-84898920:-	-0.28	-4.83	1.8E-6	Schizophrenia	
HNSC	cis	1	rs79327308	chr7:1108141	ZFAND2A	chr7:1192544-1199855:-	-0.28	-3.78	0.000176	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs79341738	chr20:33702104	PROCR	chr20:33758727-33765164:+	-0.33	-4.38	1.46E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs7938380	chr11:64034866	C11orf20	chr11:64067863-64072238:+	-0.32	-4.75	2.69E-6	Mean platelet volume	
HNSC	cis	1	rs7939107	chr11:64034773	C11orf20	chr11:64067863-64072238:+	-0.32	-4.75	2.69E-6	Mean platelet volume	
HNSC	cis	1	rs79396265	chr8:96071272	C8orf38	chr8:95908040-96088396:+	-0.38	-5.52	5.36E-8	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs7940310	chr11:117024481	PCSK7	chr11:117075789-117102811:-	-0.3	-4.39	1.4E-5	Protein quantitative trait loci	
HNSC	cis	1	rs79436302	chr14:35578797	PPP2R3C	chr14:35554679-35591679:-	0.43	6.99	8.86E-12	Atopic dermatitis	
HNSC	cis	1	rs79438986	chr20:33702280	PROCR	chr20:33758727-33765164:+	-0.33	-4.24	2.72E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs79439610	chr20:33654689	PROCR	chr20:33758727-33765164:+	-0.3	-3.77	0.000184	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs7944004	chr11:2311152	C11orf21	chr11:2317507-2323143:-	0.14	4.14	4.12E-5	Chronic lymphocytic leukemia	
HNSC	cis	1	rs7947143	chr11:64090422	C11orf20	chr11:64067863-64072238:+	-0.26	-3.71	0.000231	Mean platelet volume	
HNSC	cis	1	rs7947378	chr11:18381327	GTF2H1	chr11:18343816-18388590:+	0.32	5.46	7.53E-8	Pancreatic cancer	
HNSC	cis	1	rs79475579	chr11:58295900	ZFP91-CNTF	chr11:58346587-58393203:+	0.3	4.32	1.92E-5	Lymphoma	
HNSC	cis	1	rs79477087	chr11:22116168	ANO5	chr11:22214722-22304913:+	0.17	3.76	0.000188	Parkinson's disease	
HNSC	cis	1	rs7947730	chr11:47786184	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.55	4.76E-8	Subjective well-being	
HNSC	cis	1	rs7947730	chr11:47786184	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.95	8.85E-5	Subjective well-being	
HNSC	cis	1	rs7950364	chr11:116898886	PCSK7	chr11:117075789-117102811:-	-0.31	-4.47	9.8E-6	Protein quantitative trait loci	
HNSC	cis	1	rs7953014	chr12:109998097	MMAB	chr12:109991523-110011358:-	-0.18	-4.51	8.17E-6	HDL cholesterol	
HNSC	cis	1	rs7954144	chr12:110015893	MMAB	chr12:109991523-110011358:-	-0.18	-4.39	1.38E-5	HDL cholesterol	
HNSC	cis	1	rs7958691	chr12:124440743	DNAH10	chr12:124247042-124420265:+	0.3	5.6	3.48E-8	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs79602855	chr19:50525725	SIGLEC16	chr19:50472912-50479075:+	0.47	5.7	2.07E-8	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
HNSC	cis	1	rs7961449	chr12:124437215	DNAH10	chr12:124247042-124420265:+	-0.29	-5.2	2.94E-7	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs79617366	chr7:1111958	ZFAND2A	chr7:1192544-1199855:-	-0.28	-3.78	0.000176	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs79633979	chr19:50488612	SIGLEC16	chr19:50472912-50479075:+	0.52	5.95	5.05E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
HNSC	cis	1	rs7964021	chr12:109997645	MMAB	chr12:109991523-110011358:-	-0.17	-4.29	2.2E-5	HDL cholesterol	
HNSC	cis	1	rs7969523	chr12:123168636	GPR109B	chr12:123199304-123201439:-	0.35	5.49	6.43E-8	Adiponectin levels	
HNSC	cis	1	rs79702597	chr14:35558856	PPP2R3C	chr14:35554679-35591679:-	0.43	7.11	4.11E-12	Atopic dermatitis	
HNSC	cis	1	rs79716074	chr2:277003	SH3YL1	chr2:218138-264810:-	-0.65	-12.81	1.23E-32	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs7973683	chr12:124449223	DNAH10	chr12:124247042-124420265:+	0.29	5.29	1.85E-7	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs7973719	chr12:7334813	PEX5	chr12:7341759-7371167:+	0.26	5.16	3.64E-7	IgG glycosylation	
HNSC	cis	1	rs7980687	chr12:123822711	CDK2AP1	chr12:123745542-123756687:-	-0.56	-9.78	9.14E-21	Educational attainment;Height;Head circumference (infant)	
HNSC	cis	1	rs79831012	chr10:102237059	SEC31B	chr10:102246403-102289636:-	-0.18	-5.81	1.11E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs79854439	chr10:81730092	LOC650623	chr10:81442731-81448648:+	-0.37	-3.93	9.53E-5	Rheumatoid arthritis	
HNSC	cis	1	rs79868973	chr6:26189312	HIST1H2AE	chr6:26217148-26217711:+	-0.29	-4.19	3.34E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs798719	chr4:1698183	FAM53A	chr4:1641609-1685854:-	-0.39	-7.01	7.97E-12	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs798724	chr4:1704643	FAM53A	chr4:1641609-1685854:-	-0.37	-6.68	6.49E-11	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs798741	chr4:1712413	FAM53A	chr4:1641609-1685854:-	-0.35	-6.42	3.23E-10	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs798744	chr4:1714684	FAM53A	chr4:1641609-1685854:-	-0.34	-5.97	4.5E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs798754	chr4:1720757	FAM53A	chr4:1641609-1685854:-	-0.3	-5.38	1.18E-7	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs798755	chr4:1720824	FAM53A	chr4:1641609-1685854:-	-0.33	-5.76	1.48E-8	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs798756	chr4:1707447	FAM53A	chr4:1641609-1685854:-	-0.37	-6.73	4.66E-11	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs798762	chr4:1731150	FAM53A	chr4:1641609-1685854:-	-0.34	-5.93	5.67E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs798766	chr4:1734239	FAM53A	chr4:1641609-1685854:-	0.35	6.1	2.09E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs798767	chr4:1734281	FAM53A	chr4:1641609-1685854:-	-0.35	-6.02	3.44E-9	Urinary bladder cancer;Bladder cancer	
HNSC	cis	1	rs7988810	chr13:25019096	PARP4	chr13:24995075-25086948:-	0.22	4.92	1.19E-6	Obesity-related traits	
HNSC	cis	1	rs79888893	chr14:35510676	PPP2R3C	chr14:35554679-35591679:-	0.42	6.84	2.34E-11	Atopic dermatitis	
HNSC	cis	1	rs79889615	chr5:115591292	COMMD10	chr5:115420727-115628978:+	0.4	4.03	6.56E-5	Asthma or chronic obstructive pulmonary disease	
HNSC	cis	1	rs7989332	chr13:21050575	GJB2	chr13:20761606-20767114:-	-0.14	-4.32	1.88E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
HNSC	cis	1	rs7989332	chr13:21050575	SAP18	chr13:21714653-21723223:+	-0.23	-4.2	3.14E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
HNSC	cis	1	rs7995669	chr13:36762986	SOHLH2	chr13:36742347-36871992:-	-0.23	-3.92	0.000101	Economic and political preferences	
HNSC	cis	1	rs7999554	chr13:25009769	PARP4	chr13:24995075-25086948:-	0.2	4.66	4.09E-6	Obesity-related traits	
HNSC	cis	1	rs800142	chr11:2385071	C11orf21	chr11:2317507-2323143:-	-0.23	-5.54	5.04E-8	Bacteremia	
HNSC	cis	1	rs800153	chr11:2373515	C11orf21	chr11:2317507-2323143:-	-0.23	-5.41	9.99E-8	Bacteremia	
HNSC	cis	1	rs800156	chr11:2376436	C11orf21	chr11:2317507-2323143:-	-0.24	-5.56	4.35E-8	Bacteremia	
HNSC	cis	1	rs800157	chr11:2376602	C11orf21	chr11:2317507-2323143:-	-0.24	-5.68	2.32E-8	Bacteremia	
HNSC	cis	1	rs800158	chr11:2378447	C11orf21	chr11:2317507-2323143:-	0.24	5.53	5.13E-8	Bacteremia	
HNSC	cis	1	rs800158	chr11:2378447	MOB2	chr11:1490693-1507976:-	-0.22	-4.38	1.43E-5	Bacteremia	
HNSC	cis	1	rs800160	chr11:2380134	C11orf21	chr11:2317507-2323143:-	0.23	5.44	8.42E-8	Bacteremia	
HNSC	cis	1	rs800160	chr11:2380134	MOB2	chr11:1490693-1507976:-	-0.21	-4.24	2.68E-5	Bacteremia	
HNSC	cis	1	rs8002861	chr13:44474517	CCDC122	chr13:44410491-44453826:-	-0.27	-5.25	2.23E-7	Leprosy	
HNSC	cis	1	rs8003506	chr14:75586288	MLH3	chr14:75480467-75518235:-	-0.32	-6.78	3.47E-11	Height	
HNSC	cis	1	rs8005161	chr14:88472595	GPR65	chr14:88471496-88478414:+	0.12	3.73	0.000214	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs8005309	chr14:66056508	LOC645431	chr14:65877313-65879335:-	-0.29	-3.88	0.000117	Ischemic stroke	
HNSC	cis	1	rs8006352	chr14:88467141	GPR65	chr14:88471496-88478414:+	0.12	3.66	0.000284	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs8006419	chr14:65500735	CHURC1	chr14:65381140-65411309:+	-0.45	-8.02	7.78E-15	Red blood cell traits	
HNSC	cis	1	rs80076579	chr4:106991115	TBCK	chr4:106967233-107237861:-	0.26	5.15	3.85E-7	Airflow obstruction	
HNSC	cis	1	rs80094748	chr7:1103958	ZFAND2A	chr7:1192544-1199855:-	-0.28	-3.75	0.000197	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs80095925	chr6:26184942	HIST1H2AE	chr6:26217148-26217711:+	-0.34	-4.47	9.53E-6	Renal underexcretion gout;Gout	
HNSC	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.31	-6.66	7.13E-11	IgG glycosylation	
HNSC	cis	1	rs8011834	chr14:55625977	KIAA0831	chr14:55833110-55878576:-	-0.22	-4	7.25E-5	Protein biomarker	
HNSC	cis	1	rs8013540	chr14:35513760	PPP2R3C	chr14:35554679-35591679:-	0.43	6.95	1.17E-11	Atopic dermatitis	
HNSC	cis	1	rs8014798	chr14:88456559	GPR65	chr14:88471496-88478414:+	0.13	3.91	0.000107	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
HNSC	cis	1	rs8017642	chr14:75590822	MLH3	chr14:75480467-75518235:-	0.31	6.34	5.12E-10	Height	
HNSC	cis	1	rs8018909	chr14:65960405	LOC645431	chr14:65877313-65879335:-	-0.3	-4.02	6.75E-5	Ischemic stroke	
HNSC	cis	1	rs8018967	chr14:73976934	ACOT1	chr14:74003928-74042357:+	-0.21	-4.44	1.11E-5	Blood metabolite ratios	
HNSC	cis	1	rs8018967	chr14:73976934	HEATR4	chr14:73945193-74025651:-	-0.4	-7.88	2.13E-14	Blood metabolite ratios	
HNSC	cis	1	rs80202648	chr19:50494386	SIGLEC16	chr19:50472912-50479075:+	0.51	6.04	3.12E-9	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
HNSC	cis	1	rs80212261	chr7:1114012	ZFAND2A	chr7:1192544-1199855:-	-0.28	-3.65	0.000286	C-reactive protein levels or total cholesterol levels (pleiotropy)	
HNSC	cis	1	rs8021692	chr14:104428576	TDRD9	chr14:104394817-104519002:+	0.32	5.12	4.3E-7	Bipolar disorder	
HNSC	cis	1	rs8024944	chr15:56125135	NEDD4	chr15:56119131-56285835:-	0.21	5.12	4.36E-7	Keloid	
HNSC	cis	1	rs80259160	chr6:26190199	HIST1H2AE	chr6:26217148-26217711:+	-0.3	-4.33	1.8E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs8026172	chr15:56125182	NEDD4	chr15:56119131-56285835:-	0.21	5.12	4.36E-7	Keloid	
HNSC	cis	1	rs80285556	chr19:50540170	SIGLEC16	chr19:50472912-50479075:+	0.44	5.2	2.89E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
HNSC	cis	1	rs8029247	chr15:56273446	NEDD4	chr15:56119131-56285835:-	-0.23	-5.37	1.24E-7	Keloid	
HNSC	cis	1	rs80313145	chr6:26194965	HIST1H2AE	chr6:26217148-26217711:+	-0.29	-3.97	8.32E-5	Renal underexcretion gout;Gout	
HNSC	cis	1	rs80314222	chr19:50525514	SIGLEC16	chr19:50472912-50479075:+	0.55	6.32	5.94E-10	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
HNSC	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.66	-11.56	1.68E-27	Type 2 diabetes	
HNSC	cis	1	rs8031948	chr15:78816057	CHRNA5	chr15:78857906-78886458:+	-0.25	-5.19	3.12E-7	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs8032158	chr15:56194877	NEDD4	chr15:56119131-56285835:-	0.22	5.23	2.54E-7	Keloid	
HNSC	cis	1	rs8033837	chr15:75353975	SCAMP5	chr15:75287901-75313836:+	0.43	8.72	4.22E-17	Blood trace element (Zn levels)	
HNSC	cis	1	rs8033938	chr15:40703114	C15orf23	chr15:40674922-40686488:+	0.48	7.45	4.14E-13	Heschl's gyrus morphology	
HNSC	cis	1	rs8034191	chr15:78806023	CHRNA5	chr15:78857906-78886458:+	-0.25	-5.15	3.84E-7	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs8036197	chr15:75370232	SCAMP5	chr15:75287901-75313836:+	0.37	7.53	2.39E-13	Blood trace element (Zn levels)	
HNSC	cis	1	rs803688	chr15:83216793	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.18	-4.6	5.27E-6	Schizophrenia	
HNSC	cis	1	rs8038646	chr15:56263346	NEDD4	chr15:56119131-56285835:-	0.25	5.84	9.29E-9	Keloid	
HNSC	cis	1	rs8042849	chr15:78817929	CHRNA5	chr15:78857906-78886458:+	0.24	5.13	4.17E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs8046697	chr16:75442144	CFDP1	chr16:75327609-75467387:-	-0.21	-4.68	3.76E-6	Migraine	
HNSC	cis	1	rs8046998	chr16:58825013	GOT2	chr16:58741035-58768246:-	-0.25	-5.32	1.59E-7	Blood metabolite ratios	
HNSC	cis	1	rs8049173	chr16:11436882	C16orf75	chr16:11343506-11445617:+	0.22	5.08	5.42E-7	Vein graft stenosis in coronary artery bypass grafting	
HNSC	cis	1	rs8049439	chr16:28837515	EIF3CL	chr16:28699879-28747052:+;chr16	0.22	4.54	7.03E-6	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
HNSC	cis	1	rs8049439	chr16:28837515	SULT1A2	chr16:28603266-28608391:-	0.2	4.51	8.25E-6	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
HNSC	cis	1	rs8050324	chr16:4613292	NMRAL1	chr16:4511696-4526307:-	-0.52	-5.19	3.05E-7	Obesity-related traits	
HNSC	cis	1	rs8050907	chr16:4646878	NMRAL1	chr16:4511696-4526307:-	-0.53	-5.28	1.91E-7	Obesity-related traits	
HNSC	cis	1	rs8052287	chr16:67865073	C16orf86	chr16:67700717-67702659:+	-0.28	-3.7	0.000243	Crohn's disease	
HNSC	cis	1	rs8052287	chr16:67865073	GFOD2	chr16:67708437-67753273:-	-0.28	-4.43	1.16E-5	Crohn's disease	
HNSC	cis	1	rs8054034	chr16:67773652	GFOD2	chr16:67708437-67753273:-	-0.24	-4.05	5.86E-5	Crohn's disease	
HNSC	cis	1	rs8055427	chr16:11436883	C16orf75	chr16:11343506-11445617:+	0.22	5.08	5.42E-7	Vein graft stenosis in coronary artery bypass grafting	
HNSC	cis	1	rs8057892	chr16:58832759	GOT2	chr16:58741035-58768246:-	-0.26	-5.48	6.94E-8	Blood metabolite ratios	
HNSC	cis	1	rs8058835	chr16:67814865	C16orf86	chr16:67700717-67702659:+	-0.26	-3.8	0.000165	Crohn's disease	
HNSC	cis	1	rs8058835	chr16:67814865	GFOD2	chr16:67708437-67753273:-	-0.29	-5.03	6.74E-7	Crohn's disease	
HNSC	cis	1	rs805989	chr6:150711974	IYD	chr6:150690028-150725764:+	-0.18	-3.76	0.000193	Anger	
HNSC	cis	1	rs805992	chr6:150709152	IYD	chr6:150690028-150725764:+	-0.17	-3.71	0.000227	Anger	
HNSC	cis	1	rs8061699	chr16:4632723	NMRAL1	chr16:4511696-4526307:-	-0.39	-4.3	2.06E-5	Obesity-related traits	
HNSC	cis	1	rs8062783	chr16:74691264	RFWD3	chr16:74655298-74700779:-	0.29	7.34	8.82E-13	Testicular germ cell tumor	
HNSC	cis	1	rs8065059	chr17:28417376	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.09	5.06E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs8065261	chr17:28418041	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.11	4.62E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs8065437	chr17:45721653	C17orf57	chr17:45401142-45518675:+	0.19	4.54	7.13E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs8065437	chr17:45721653	TBKBP1	chr17:45772630-45789427:+	-0.22	-4.4	1.34E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs8065669	chr17:45724996	C17orf57	chr17:45401142-45518675:+	0.2	4.86	1.56E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs8065669	chr17:45724996	TBKBP1	chr17:45772630-45789427:+	-0.23	-4.61	5.13E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs8069687	chr17:61883023	FTSJ3	chr17:61896795-61905031:-	-0.21	-3.78	0.000173	Body mass index	
HNSC	cis	1	rs8070446	chr17:40285879	DHX58	chr17:40253422-40264751:-	-0.35	-7.21	2.15E-12	Fibrinogen levels	
HNSC	cis	1	rs8070650	chr17:61744040	FTSJ3	chr17:61896795-61905031:-	0.21	3.82	0.000153	Body mass index	
HNSC	cis	1	rs8072100	chr17:45674687	C17orf57	chr17:45401142-45518675:+	-0.19	-4.7	3.41E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs8072100	chr17:45674687	TBKBP1	chr17:45772630-45789427:+	0.21	4.26	2.5E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
HNSC	cis	1	rs8074708	chr17:40286354	DHX58	chr17:40253422-40264751:-	0.35	7.16	2.93E-12	Fibrinogen levels	
HNSC	cis	1	rs8074771	chr17:61735865	FTSJ3	chr17:61896795-61905031:-	0.21	3.82	0.000153	Body mass index	
HNSC	cis	1	rs807669	chr22:19154522	SLC25A1	chr22:19163095-19166301:-	-0.34	-7.01	7.91E-12	Metabolite levels	
HNSC	cis	1	rs807670	chr22:19154608	SLC25A1	chr22:19163095-19166301:-	-0.27	-5.7	2.07E-8	Metabolite levels	
HNSC	cis	1	rs8077577	chr17:18064730	LOC220594	chr17:18414577-18445234:-	-0.28	-4.4	1.3E-5	Obesity-related traits	
HNSC	cis	1	rs8093534	chr18:48368020	MRO	chr18:48321491-48351754:-	0.23	3.97	8.41E-5	Entorhinal cortical thickness	
HNSC	cis	1	rs809775	chr1:46538040	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.47	3.75E-13	Body mass index	
HNSC	cis	1	rs8100392	chr19:33605933	GPATCH1	chr19:33571786-33621318:+	0.19	3.78	0.000175	Bone properties (heel)	
HNSC	cis	1	rs8101881	chr19:33364628	SLC7A9	chr19:33321421-33360683:-	-0.18	-4.05	5.89E-5	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
HNSC	cis	1	rs8103622	chr19:18572834	SSBP4	chr19:18530221-18545371:+	-0.2	-4.5	8.35E-6	Breast cancer	
HNSC	cis	1	rs8105994	chr19:18593553	SSBP4	chr19:18530221-18545371:+	-0.18	-4.04	6.15E-5	Breast cancer	
HNSC	cis	1	rs8107367	chr19:18564705	SSBP4	chr19:18530221-18545371:+	-0.19	-4.36	1.57E-5	Breast cancer	
HNSC	cis	1	rs8107416	chr19:39237950	LGALS7B	chr19:39279850-39282393:+	0.31	6.75	4.18E-11	Heart rate	
HNSC	cis	1	rs8109573	chr19:18617151	SSBP4	chr19:18530221-18545371:+	-0.22	-5.05	6.27E-7	Breast cancer	
HNSC	cis	1	rs8110011	chr19:37745813	ZNF793	chr19:37997841-38034237:+	0.28	4.54	6.99E-6	Coronary artery calcification	
HNSC	cis	1	rs8110181	chr19:33605939	GPATCH1	chr19:33571786-33621318:+	0.19	3.78	0.000175	Bone properties (heel)	
HNSC	cis	1	rs8111708	chr19:18558876	SSBP4	chr19:18530221-18545371:+	-0.2	-4.42	1.21E-5	Breast cancer	
HNSC	cis	1	rs8111746	chr19:39212859	LGALS7B	chr19:39279850-39282393:+	0.3	6.55	1.46E-10	Heart rate	
HNSC	cis	1	rs8113312	chr19:23061182	ZNF492	chr19:22817126-22850472:+	-0.34	-5.31	1.69E-7	Bronchopulmonary dysplasia	
HNSC	cis	1	rs8117100	chr20:33692261	PROCR	chr20:33758727-33765164:+	-0.3	-3.94	9.29E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs811880	chr7:65818646	NCRNA00174	chr7:65841032-65865395:-	-0.74	-15.65	4.22E-45	Aortic root size	
HNSC	cis	1	rs8119827	chr20:33726873	PROCR	chr20:33758727-33765164:+	-0.3	-3.91	0.000104	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs8121957	chr20:33676109	PROCR	chr20:33758727-33765164:+	-0.26	-3.66	0.000282	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs8123062	chr20:55069310	C20orf43	chr20:55043647-55093942:+	0.22	4.32	1.9E-5	Refractive astigmatism	
HNSC	cis	1	rs8125425	chr20:55067135	C20orf43	chr20:55043647-55093942:+	-0.21	-4.33	1.79E-5	Refractive astigmatism	
HNSC	cis	1	rs8134075	chr21:43779853	C21orf128	chr21:43522244-43528644:-	0.21	3.77	0.00018	Pancreatic cancer	
HNSC	cis	1	rs8138799	chr22:24556902	SUSD2	chr22:24577444-24585074:+	0.93	10.91	5.91E-25	Amyotrophic lateral sclerosis	
HNSC	cis	1	rs8138996	chr22:39047435	LOC646851	chr22:38974125-39052634:-	0.14	3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs8140617	chr22:38970439	LOC646851	chr22:38974125-39052634:-	-0.15	-3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs8141797	chr22:24582041	SUSD2	chr22:24577444-24585074:+	-0.81	-9.71	1.7E-20	Amyotrophic lateral sclerosis	
HNSC	cis	1	rs8142098	chr22:39058757	LOC646851	chr22:38974125-39052634:-	0.14	3.72	0.000224	Resting heart rate	
HNSC	cis	1	rs8177240	chr3:133477701	TF	chr3:133419211-133497635:+	-0.32	-5.73	1.79E-8	Iron status biomarkers	
HNSC	cis	1	rs8177247	chr3:133479499	TF	chr3:133419211-133497635:+	-0.31	-5.53	5.25E-8	Iron status biomarkers	
HNSC	cis	1	rs8177248	chr3:133479626	TF	chr3:133419211-133497635:+	-0.32	-5.75	1.57E-8	Iron status biomarkers	
HNSC	cis	1	rs8177252	chr3:133480174	TF	chr3:133419211-133497635:+	-0.31	-5.58	3.99E-8	Iron status biomarkers	
HNSC	cis	1	rs8177253	chr3:133480192	TF	chr3:133419211-133497635:+	0.3	5.54	5.0E-8	Iron status biomarkers	
HNSC	cis	1	rs8177261	chr3:133480588	TF	chr3:133419211-133497635:+	-0.31	-5.62	3.15E-8	Iron status biomarkers	
HNSC	cis	1	rs8177262	chr3:133480652	TF	chr3:133419211-133497635:+	0.3	5.51	5.93E-8	Iron status biomarkers	
HNSC	cis	1	rs8177271	chr3:133482230	TF	chr3:133419211-133497635:+	-0.31	-5.47	7.07E-8	Iron status biomarkers	
HNSC	cis	1	rs8177272	chr3:133482870	TF	chr3:133419211-133497635:+	-0.31	-5.51	5.76E-8	Iron status biomarkers	
HNSC	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.53	10.36	7.1E-23	Multiple sclerosis	
HNSC	cis	1	rs8181644	chr12:58173466	TSFM	chr12:58176536-58191367:+	-0.37	-7.88	2.14E-14	Multiple sclerosis	
HNSC	cis	1	rs8192482	chr15:78886198	CHRNA5	chr15:78857906-78886458:+	-0.26	-5.3	1.76E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs8192781	chr10:135354251	CYP2E1	chr10:135340867-135374724:+	0.27	4.65	4.21E-6	Obesity-related traits	
HNSC	cis	1	rs823301	chr3:195123495	C3orf21	chr3:194789015-194991895:-	-0.16	-3.68	0.000264	Body mass index	
HNSC	cis	1	rs823302	chr3:195104741	C3orf21	chr3:194789015-194991895:-	-0.17	-3.88	0.000117	Body mass index	
HNSC	cis	1	rs823306	chr3:195108320	C3orf21	chr3:194789015-194991895:-	-0.16	-3.67	0.000272	Body mass index	
HNSC	cis	1	rs823310	chr3:195127093	C3orf21	chr3:194789015-194991895:-	-0.16	-3.67	0.000272	Body mass index	
HNSC	cis	1	rs823311	chr3:195141029	C3orf21	chr3:194789015-194991895:-	-0.16	-3.68	0.000264	Body mass index	
HNSC	cis	1	rs823314	chr3:195132402	C3orf21	chr3:194789015-194991895:-	-0.16	-3.67	0.000272	Body mass index	
HNSC	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	0.82	13.99	1.1E-37	Type 2 diabetes	
HNSC	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.83	14.77	3.71E-41	Type 2 diabetes	
HNSC	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.81	14.62	1.87E-40	Type 2 diabetes	
HNSC	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	0.83	14.42	1.42E-39	Type 2 diabetes	
HNSC	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	0.83	14.42	1.42E-39	Type 2 diabetes	
HNSC	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	0.83	14.34	3.13E-39	Type 2 diabetes	
HNSC	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.85	15.11	1.13E-42	Type 2 diabetes	
HNSC	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	0.81	13.9	2.57E-37	Type 2 diabetes	
HNSC	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	0.81	13.9	2.57E-37	Type 2 diabetes	
HNSC	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.82	-14.57	2.99E-40	Type 2 diabetes	
HNSC	cis	1	rs847648	chr7:102553850	FAM185A	chr7:102389399-102467706:+	-0.23	-3.95	9.0E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs847649	chr7:102556011	FAM185A	chr7:102389399-102467706:+	-0.23	-3.98	7.9E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs849898	chr1:228153917	OBSCN	chr1:228395861-228566575:+	0.17	4.06	5.8E-5	Parkinson's disease	
HNSC	cis	1	rs853676	chr6:28299687	ZSCAN23	chr6:28393287-28411279:-	0.25	3.92	0.000103	Depression	
HNSC	cis	1	rs853678	chr6:28297313	ZNF389	chr6:28129551-28137375:+	-0.23	-3.69	0.000254	Depression	
HNSC	cis	1	rs853678	chr6:28297313	ZSCAN23	chr6:28393287-28411279:-	0.25	4.07	5.45E-5	Depression	
HNSC	cis	1	rs853679	chr6:28296863	ZNF389	chr6:28129551-28137375:+	-0.23	-3.69	0.000254	Depression	
HNSC	cis	1	rs853679	chr6:28296863	ZSCAN23	chr6:28393287-28411279:-	0.25	4.07	5.45E-5	Depression	
HNSC	cis	1	rs853685	chr6:28288785	ZSCAN23	chr6:28393287-28411279:-	0.26	4.13	4.22E-5	Depression	
HNSC	cis	1	rs853694	chr6:28279100	ZNF389	chr6:28129551-28137375:+	-0.24	-3.75	0.000195	Depression	
HNSC	cis	1	rs853694	chr6:28279100	ZSCAN23	chr6:28393287-28411279:-	0.26	4.13	4.24E-5	Depression	
HNSC	cis	1	rs856053	chr1:159001504	AIM2	chr1:159032275-159046647:-	0.2	4.01	6.96E-5	Obesity-related traits	
HNSC	cis	1	rs856055	chr1:159001593	AIM2	chr1:159032275-159046647:-	0.2	4.01	6.87E-5	Obesity-related traits	
HNSC	cis	1	rs856056	chr1:159001709	AIM2	chr1:159032275-159046647:-	0.2	4.01	6.87E-5	Obesity-related traits	
HNSC	cis	1	rs856057	chr1:159001735	AIM2	chr1:159032275-159046647:-	0.2	4.01	6.87E-5	Obesity-related traits	
HNSC	cis	1	rs858239	chr7:23286315	GPNMB	chr7:23286316-23314728:+	-0.19	-3.74	0.000206	Parkinson's disease	
HNSC	cis	1	rs858240	chr7:23284237	GPNMB	chr7:23286316-23314728:+	-0.19	-3.82	0.000151	Parkinson's disease	
HNSC	cis	1	rs8589	chr6:49403282	CENPQ	chr6:49431096-49460820:+	-0.56	-14.43	1.24E-39	Homocysteine levels	
HNSC	cis	1	rs8589	chr6:49403282	MUT	chr6:49398994-49431031:-	0.23	4.57	6.28E-6	Homocysteine levels	
HNSC	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.85	-15.6	7.09E-45	Type 2 diabetes	
HNSC	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	0.82	13.99	1.1E-37	Type 2 diabetes	
HNSC	cis	1	rs861318	chr1:159002222	AIM2	chr1:159032275-159046647:-	0.2	4.01	6.87E-5	Obesity-related traits	
HNSC	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.75	12.95	3.09E-33	Type 2 diabetes	
HNSC	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	0.82	13.99	1.1E-37	Type 2 diabetes	
HNSC	cis	1	rs867186	chr20:33764554	PROCR	chr20:33758727-33765164:+	0.28	3.77	0.00018	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
HNSC	cis	1	rs873063	chr8:8572447	FLJ10661	chr8:8086092-8102386:+	0.27	4.46	9.97E-6	Obesity-related traits	
HNSC	cis	1	rs873064	chr8:8572380	FLJ10661	chr8:8086092-8102386:+	0.27	4.46	9.97E-6	Obesity-related traits	
HNSC	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.44	10.58	1.07E-23	Kawasaki disease	
HNSC	cis	1	rs8758	chr10:97366107	ENTPD1	chr10:97471536-97637022:+	0.25	7.52	2.62E-13	Blood metabolite levels	
HNSC	cis	1	rs875971	chr7:65617595	NCRNA00174	chr7:65841032-65865395:-	0.75	15.86	4.36E-46	Aortic root size	
HNSC	cis	1	rs876402	chr14:75601862	MLH3	chr14:75480467-75518235:-	-0.31	-6.33	5.49E-10	Height	
HNSC	cis	1	rs876403	chr14:75602834	MLH3	chr14:75480467-75518235:-	0.31	6.36	4.58E-10	Height	
HNSC	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.57	-12.2	4.32E-30	Cognitive function	
HNSC	cis	1	rs877710	chr12:109993976	KCTD10	chr12:109886460-109915155:-	-0.17	-3.92	0.000103	HDL cholesterol	
HNSC	cis	1	rs877710	chr12:109993976	MMAB	chr12:109991523-110011358:-	-0.19	-4.72	3.04E-6	HDL cholesterol	
HNSC	cis	1	rs879568	chr18:34311659	C18orf10	chr18:34366472-34409158:-	-0.27	-5.26	2.2E-7	QRS duration	
HNSC	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.23	-4.75	2.71E-6	Rheumatoid arthritis	
HNSC	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.64	-16.71	5.65E-50	Homocysteine levels	
HNSC	cis	1	rs883394	chr19:39205613	LGALS7B	chr19:39279850-39282393:+	0.3	6.48	2.23E-10	Heart rate	
HNSC	cis	1	rs883433	chr19:39206288	LGALS7B	chr19:39279850-39282393:+	-0.29	-6.55	1.46E-10	Heart rate	
HNSC	cis	1	rs883565	chr3:39055317	TTC21A	chr3:39149152-39180394:+	0.18	4.22	2.87E-5	Handedness	
HNSC	cis	1	rs883648	chr8:8569521	FLJ10661	chr8:8086092-8102386:+	0.28	4.6	5.3E-6	Obesity-related traits	
HNSC	cis	1	rs884247	chr14:65895706	LOC645431	chr14:65877313-65879335:-	-0.28	-3.82	0.000153	Ischemic stroke	
HNSC	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.63	-13.85	4.52E-37	Response to antipsychotic treatment	
HNSC	cis	1	rs885000	chr8:8568875	FLJ10661	chr8:8086092-8102386:+	0.28	4.6	5.3E-6	Obesity-related traits	
HNSC	cis	1	rs886448	chr7:24240165	C7orf30	chr7:23338940-23349182:+	-0.35	-3.69	0.000248	Asthma (childhood onset)	
HNSC	cis	1	rs888192	chr12:109995097	KCTD10	chr12:109886460-109915155:-	0.17	3.82	0.000153	HDL cholesterol	
HNSC	cis	1	rs888192	chr12:109995097	MMAB	chr12:109991523-110011358:-	0.19	4.67	3.89E-6	HDL cholesterol	
HNSC	cis	1	rs889213	chr5:90682151	LOC100129716	chr5:90676164-90716531:+	0.29	4.04	6.3E-5	Smoking behavior	
HNSC	cis	1	rs889312	chr5:56031884	C5orf35	chr5:56205103-56213010:+	0.32	5.76	1.44E-8	Breast cancer (early onset);Breast cancer	
HNSC	cis	1	rs8897	chr3:49460407	AMT	chr3:49454212-49460012:-	0.18	4.03	6.37E-5	Menarche (age at onset)	
HNSC	cis	1	rs889877	chr7:134232615	AKR1B15	chr7:134233849-134264300:+	0.24	5.14	3.93E-7	Longevity	
HNSC	cis	1	rs891368	chr3:53123273	RFT1	chr3:53122503-53164470:-	-0.27	-5.41	9.81E-8	Height	
HNSC	cis	1	rs892864	chr5:127835859	FBN2	chr5:127593602-127873916:-	0.35	4.14	4.13E-5	Multiple system atrophy	
HNSC	cis	1	rs894737	chr12:54418143	FLJ12825	chr12:54452038-54516018:+	0.24	4.3	2.09E-5	Bone mineral density	
HNSC	cis	1	rs894737	chr12:54418143	HOXC5	chr12:54410642-54429142:+	0.2	3.7	0.000237	Bone mineral density	
HNSC	cis	1	rs894738	chr12:54417525	FLJ12825	chr12:54452038-54516018:+	0.23	4.27	2.34E-5	Bone mineral density	
HNSC	cis	1	rs894738	chr12:54417525	HOXC5	chr12:54410642-54429142:+	0.21	4	7.19E-5	Bone mineral density	
HNSC	cis	1	rs896854	chr8:95960511	TP53INP1	chr8:95938201-95961615:-	-0.18	-4.45	1.07E-5	Type 2 diabetes	
HNSC	cis	1	rs897120	chr2:70160982	GMCL1	chr2:70056818-70106727:+	-0.11	-3.68	0.000263	Carotid plaque burden (smoking interaction)	
HNSC	cis	1	rs898225	chr3:48413179	ATRIP	chr3:48488141-48507708:+	-0.18	-4.13	4.29E-5	Longevity	
HNSC	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.27	6.64	8.4E-11	Longevity	
HNSC	cis	1	rs900012	chr11:116966435	PCSK7	chr11:117075789-117102811:-	-0.29	-4.23	2.79E-5	Protein quantitative trait loci	
HNSC	cis	1	rs906134	chr7:65444288	CRCP	chr7:65579805-65619551:+	-0.32	-3.7	0.000242	Diabetic kidney disease	
HNSC	cis	1	rs906134	chr7:65444288	NCRNA00174	chr7:65841032-65865395:-	-0.43	-4.58	5.96E-6	Diabetic kidney disease	
HNSC	cis	1	rs910316	chr14:75626042	MLH3	chr14:75480467-75518235:-	0.29	6.06	2.77E-9	Height	
HNSC	cis	1	rs911119	chr20:23612737	CST1	chr20:23728191-23731574:-	-0.33	-5.15	3.68E-7	Chronic kidney disease	
HNSC	cis	1	rs911119	chr20:23612737	CST4	chr20:23666277-23669662:-	-0.27	-4.34	1.7E-5	Chronic kidney disease	
HNSC	cis	1	rs916134	chr12:54069803	ATP5G2	chr12:54058945-54070512:-	0.22	5.96	4.91E-9	Height	
HNSC	cis	1	rs917911	chr12:9905851	CLECL1	chr12:9868457-9885860:-	0.25	7.16	2.89E-12	Type 1 diabetes	
HNSC	cis	1	rs9213	chr2:218386	SH3YL1	chr2:218138-264810:-	-0.64	-12.49	2.77E-31	Spherical equivalent (joint main effects and education interaction)	
HNSC	cis	1	rs922075	chr3:48489398	ATRIP	chr3:48488141-48507708:+	-0.18	-4.06	5.61E-5	Longevity	
HNSC	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.26	6.54	1.51E-10	Longevity	
HNSC	cis	1	rs922483	chr8:11351912	BLK	chr8:11351521-11422107:+	-0.2	-5.2	2.91E-7	Systemic lupus erythematosus	
HNSC	cis	1	rs924607	chr5:610093	SLC9A3	chr5:473334-524549:-	-0.21	-4.05	6.02E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.82	14.08	4.3E-38	Type 2 diabetes	
HNSC	cis	1	rs9288316	chr2:202163483	ALS2CR12	chr2:202153148-202222101:-	0.24	4.08	5.34E-5	Melanoma;Esophageal squamous cell carcinoma	
HNSC	cis	1	rs9288887	chr3:108856292	GUCA1C	chr3:108626642-108672677:-	-0.27	-4.39	1.37E-5	Homeostasis model assessment of beta-cell function (interaction)	
HNSC	cis	1	rs9289275	chr3:125648659	ALG1L	chr3:125648118-125655882:-	-0.52	-9.55	6.03E-20	Blood pressure (smoking interaction)	
HNSC	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.5	10.46	2.95E-23	Height	
HNSC	cis	1	rs9289471	chr3:134230811	CEP63	chr3:134204575-134293852:+	0.29	6.13	1.76E-9	Height	
HNSC	cis	1	rs9289475	chr3:134236459	ANAPC13	chr3:134196547-134204865:-	0.48	10.23	2.02E-22	Height	
HNSC	cis	1	rs9289475	chr3:134236459	CEP63	chr3:134204575-134293852:+	0.27	5.83	1.0E-8	Height	
HNSC	cis	1	rs9289476	chr3:134237103	ANAPC13	chr3:134196547-134204865:-	0.48	10.15	4.31E-22	Height	
HNSC	cis	1	rs9289476	chr3:134237103	CEP63	chr3:134204575-134293852:+	0.27	5.76	1.48E-8	Height	
HNSC	cis	1	rs9289478	chr3:134268619	ANAPC13	chr3:134196547-134204865:-	0.48	10.29	1.21E-22	Height	
HNSC	cis	1	rs9289478	chr3:134268619	CEP63	chr3:134204575-134293852:+	0.27	5.89	7.12E-9	Height	
HNSC	cis	1	rs929039	chr22:38071511	LGALS2	chr22:37966254-37976024:-	0.13	3.79	0.000172	Fat distribution (HIV)	
HNSC	cis	1	rs9293332	chr5:82437365	XRCC4	chr5:82373317-82649577:+	-0.19	-3.78	0.000179	Hypertension	
HNSC	cis	1	rs9293334	chr5:82452803	XRCC4	chr5:82373317-82649577:+	-0.21	-4.01	6.92E-5	Hypertension	
HNSC	cis	1	rs9293568	chr5:90737845	LOC100129716	chr5:90676164-90716531:+	0.31	4.4	1.34E-5	Smoking behavior	
HNSC	cis	1	rs9294377	chr6:88084839	C6orf162	chr6:88032306-88052043:+	-0.19	-3.82	0.000153	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs9294377	chr6:88084839	C6orf164	chr6:88032306-88109459:+	-0.24	-4.52	7.81E-6	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs9295695	chr6:26528250	BTN3A2	chr6:26365398-26378546:+	-0.18	-4.15	3.84E-5	Educational attainment	
HNSC	cis	1	rs9296404	chr6:42925803	GNMT	chr6:42928500-42931617:+	-0.37	-7.91	1.74E-14	Plasma homocysteine levels (post-methionine load test)	
HNSC	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.83	18.81	7.13E-60	Plasma homocysteine levels (post-methionine load test)	
HNSC	cis	1	rs9296504	chr6:46629505	SLC25A27	chr6:46620679-46645925:+	0.14	3.87	0.000124	QRS complex (Sokolow-Lyon)	
HNSC	cis	1	rs9296505	chr6:46629841	TDRD6	chr6:46655866-46670149:+	-0.17	-3.78	0.000175	QRS complex (Sokolow-Lyon)	
HNSC	cis	1	rs9296616	chr6:49414235	CENPQ	chr6:49431096-49460820:+	-0.4	-9.4	2.05E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs9296616	chr6:49414235	MUT	chr6:49398994-49431031:-	0.41	8.66	6.55E-17	Folate pathway vitamin levels	
HNSC	cis	1	rs9296617	chr6:49428360	CENPQ	chr6:49431096-49460820:+	-0.4	-9.6	4.03E-20	Folate pathway vitamin levels	
HNSC	cis	1	rs9296617	chr6:49428360	MUT	chr6:49398994-49431031:-	0.42	9.12	1.88E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs9297950	chr8:96025659	C8orf38	chr8:95908040-96088396:+	-0.28	-4.27	2.34E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs9297951	chr8:96041437	C8orf38	chr8:95908040-96088396:+	-0.33	-5.14	3.95E-7	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
HNSC	cis	1	rs929843	chr16:70045748	CLEC18A	chr16:69984626-69997887:+	-0.38	-6.54	1.54E-10	Menarche (age at onset)	
HNSC	cis	1	rs929843	chr16:70045748	EXOSC6	chr16:70284134-70285833:-	-0.23	-3.99	7.63E-5	Menarche (age at onset)	
HNSC	cis	1	rs929843	chr16:70045748	PDXDC2	chr16:70010210-70099851:-	-0.21	-5.15	3.77E-7	Menarche (age at onset)	
HNSC	cis	1	rs9303401	chr17:56847945	RAD51C	chr17:56769963-56811690:+	0.33	8.41	4.45E-16	Cognitive test performance	
HNSC	cis	1	rs9304578	chr19:39250337	LGALS7B	chr19:39279850-39282393:+	-0.3	-6.6	1.08E-10	Heart rate	
HNSC	cis	1	rs9304742	chr19:53451291	ZNF320	chr19:53367119-53400946:-	0.2	3.78	0.000174	Psoriasis	
HNSC	cis	1	rs9304742	chr19:53451291	ZNF321	chr19:53430388-53466114:-	0.29	5.96	4.81E-9	Psoriasis	
HNSC	cis	1	rs9304742	chr19:53451291	ZNF702P	chr19:53471505-53496784:-	0.23	4.51	8.13E-6	Psoriasis	
HNSC	cis	1	rs9306329	chr22:39072454	LOC646851	chr22:38974125-39052634:-	0.15	3.92	0.000101	Resting heart rate	
HNSC	cis	1	rs9307050	chr4:76905649	NAAA	chr4:76831809-76862166:-	-0.5	-11.63	8.58E-28	Longevity	
HNSC	cis	1	rs9309473	chr2:73743982	ALMS1P	chr2:73872046-73912692:+	0.25	4.07	5.57E-5	Metabolite levels	
HNSC	cis	1	rs931058	chr5:150333698	LOC134466	chr5:150310000-150326146:-	0.52	6.09	2.26E-9	Crohn's disease	
HNSC	cis	1	rs9311423	chr3:48420308	ATRIP	chr3:48488141-48507708:+	0.17	3.83	0.000147	Longevity	
HNSC	cis	1	rs9311423	chr3:48420308	TREX1	chr3:48501186-48509043:+	-0.27	-6.77	3.69E-11	Longevity	
HNSC	cis	1	rs9311676	chr3:58470351	PDHB	chr3:58413355-58419565:-	-0.17	-3.89	0.000113	Systemic lupus erythematosus	
HNSC	cis	1	rs931794	chr15:78826180	CHRNA5	chr15:78857906-78886458:+	0.27	5.51	5.69E-8	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs9320287	chr6:109744690	AKD1	chr6:109814059-110012415:-	-0.21	-4.29	2.12E-5	Height	
HNSC	cis	1	rs9320287	chr6:109744690	SMPD2	chr6:109761931-109765121:+	0.28	5.85	9.06E-9	Height	
HNSC	cis	1	rs9320656	chr6:118894468	C6orf204	chr6:118786239-119031238:-	0.24	4.34	1.72E-5	Renal cell carcinoma	
HNSC	cis	1	rs9320660	chr6:118956827	C6orf204	chr6:118786239-119031238:-	-0.24	-4.32	1.86E-5	Renal cell carcinoma	
HNSC	cis	1	rs9322193	chr6:149919143	NUP43	chr6:150045453-150067688:-	-0.26	-5.25	2.31E-7	Lung cancer	
HNSC	cis	1	rs932644	chr6:167404187	RNASET2	chr6:167343008-167412795:-	-0.22	-5.55	4.62E-8	Crohn's disease	
HNSC	cis	1	rs9329165	chr8:8576642	FLJ10661	chr8:8086092-8102386:+	-0.23	-4.01	7.03E-5	Obesity-related traits	
HNSC	cis	1	rs9329166	chr8:8576655	FLJ10661	chr8:8086092-8102386:+	0.25	4.15	3.91E-5	Obesity-related traits	
HNSC	cis	1	rs9333289	chr2:187498107	FAM171B	chr2:187558789-187630684:+	0.25	5.67	2.49E-8	Urinary albumin-to-creatinine ratio;Urinary albumin-to-creatinine ratio in non-diabetics	
HNSC	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.51	10.85	9.29E-25	Height	
HNSC	cis	1	rs934093	chr3:134195885	CEP63	chr3:134204575-134293852:+	0.28	6.05	2.86E-9	Height	
HNSC	cis	1	rs9341808	chr6:80953257	BCKDHB	chr6:80816344-81055987:+	0.17	3.96	8.68E-5	Sitting height ratio	
HNSC	cis	1	rs9357010	chr6:26527945	BTN3A2	chr6:26365398-26378546:+	0.19	4.52	7.74E-6	Educational attainment	
HNSC	cis	1	rs9357037	chr6:27327349	LOC222699	chr6:28183116-28186707:-	0.22	3.72	0.000219	Glomerular filtration rate (creatinine)	
HNSC	cis	1	rs9357037	chr6:27327349	ZNF391	chr6:27356524-27369227:+	0.31	5.99	4.01E-9	Glomerular filtration rate (creatinine)	
HNSC	cis	1	rs9357512	chr6:46642875	TDRD6	chr6:46655866-46670149:+	-0.21	-3.83	0.000143	Lipoprotein-associated phospholipase A2 activity and mass	
HNSC	cis	1	rs9357619	chr6:49490094	CENPQ	chr6:49431096-49460820:+	0.25	5.67	2.42E-8	Brain structure	
HNSC	cis	1	rs9357619	chr6:49490094	MUT	chr6:49398994-49431031:-	-0.19	-3.92	0.0001	Brain structure	
HNSC	cis	1	rs9362426	chr6:88089874	C6orf164	chr6:88032306-88109459:+	-0.21	-3.86	0.000128	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs936525	chr19:23056189	ZNF492	chr19:22817126-22850472:+	-0.33	-5.41	9.89E-8	Bronchopulmonary dysplasia	
HNSC	cis	1	rs936526	chr19:23055987	ZNF492	chr19:22817126-22850472:+	-0.32	-5.01	7.68E-7	Bronchopulmonary dysplasia	
HNSC	cis	1	rs9369898	chr6:49382193	CENPQ	chr6:49431096-49460820:+	-0.57	-14.78	3.66E-41	Homocysteine levels	
HNSC	cis	1	rs9369898	chr6:49382193	MUT	chr6:49398994-49431031:-	0.23	4.56	6.57E-6	Homocysteine levels	
HNSC	cis	1	rs937108	chr7:65428452	CRCP	chr7:65579805-65619551:+	-0.33	-3.88	0.00012	Diabetic kidney disease	
HNSC	cis	1	rs937108	chr7:65428452	NCRNA00174	chr7:65841032-65865395:-	-0.46	-4.96	9.91E-7	Diabetic kidney disease	
HNSC	cis	1	rs9371226	chr6:151986594	AKAP12	chr6:151561134-151679692:+	0.2	3.66	0.00028	Breast cancer	
HNSC	cis	1	rs9371884	chr6:155645607	TFB1M	chr6:155578791-155635626:-	-0.28	-4.25	2.54E-5	Life satisfaction	
HNSC	cis	1	rs9372480	chr6:117760579	ROS1	chr6:117609530-117747018:-	-0.19	-4.26	2.43E-5	Lung cancer	
HNSC	cis	1	rs9373571	chr6:101133834	ASCC3	chr6:100956609-101329224:-	0.22	5.88	7.62E-9	Menarche (age at onset)	
HNSC	cis	1	rs9374663	chr6:117782634	ROS1	chr6:117609530-117747018:-	-0.18	-3.87	0.000125	Lung cancer	
HNSC	cis	1	rs937495	chr7:65779798	NCRNA00174	chr7:65841032-65865395:-	0.72	14.57	2.96E-40	Aortic root size	
HNSC	cis	1	rs937495	chr7:65779798	TYW1	chr7:66461817-66704496:+	-0.2	-3.66	0.000282	Aortic root size	
HNSC	cis	1	rs9377228	chr6:149921998	LRP11	chr6:150139894-150185480:-	0.19	3.8	0.000161	Lung cancer	
HNSC	cis	1	rs9377228	chr6:149921998	NUP43	chr6:150045453-150067688:-	-0.26	-5.37	1.24E-7	Lung cancer	
HNSC	cis	1	rs9377229	chr6:149928791	NUP43	chr6:150045453-150067688:-	-0.26	-5.31	1.65E-7	Lung cancer	
HNSC	cis	1	rs9381469	chr6:46630068	SLC25A27	chr6:46620679-46645925:+	-0.14	-3.87	0.000122	QRS complex (Sokolow-Lyon)	
HNSC	cis	1	rs9381784	chr6:49398115	CENPQ	chr6:49431096-49460820:+	0.52	12.09	1.17E-29	Homocysteine levels	
HNSC	cis	1	rs9383649	chr6:153428102	RGS17	chr6:153332041-153452389:-	-0.21	-3.91	0.000106	Prostate cancer	
HNSC	cis	1	rs9384082	chr6:153440515	RGS17	chr6:153332041-153452389:-	-0.21	-3.94	9.47E-5	Prostate cancer	
HNSC	cis	1	rs9385012	chr6:117733191	ROS1	chr6:117609530-117747018:-	-0.18	-3.89	0.000115	Lung cancer	
HNSC	cis	1	rs9387478	chr6:117786180	ROS1	chr6:117609530-117747018:-	-0.18	-3.95	8.95E-5	Lung cancer	
HNSC	cis	1	rs9390502	chr6:101057478	ASCC3	chr6:100956609-101329224:-	0.23	5.91	6.3E-9	Menarche (age at onset)	
HNSC	cis	1	rs9390626	chr6:101163109	ASCC3	chr6:100956609-101329224:-	0.23	6.07	2.57E-9	Menarche (age at onset)	
HNSC	cis	1	rs9393728	chr6:26509330	BTN3A2	chr6:26365398-26378546:+	0.19	4.41	1.25E-5	Educational attainment	
HNSC	cis	1	rs9393729	chr6:26514166	BTN2A3	chr6:26422317-26431927:+	0.16	3.72	0.000219	Educational attainment	
HNSC	cis	1	rs9393729	chr6:26514166	BTN3A2	chr6:26365398-26378546:+	0.19	4.43	1.16E-5	Educational attainment	
HNSC	cis	1	rs9393731	chr6:26529374	BTN2A3	chr6:26422317-26431927:+	0.16	3.66	0.000275	Educational attainment	
HNSC	cis	1	rs9393731	chr6:26529374	BTN3A2	chr6:26365398-26378546:+	0.18	4.36	1.57E-5	Educational attainment	
HNSC	cis	1	rs9393732	chr6:26530898	BTN2A3	chr6:26422317-26431927:+	0.16	3.66	0.000275	Educational attainment	
HNSC	cis	1	rs9393732	chr6:26530898	BTN3A2	chr6:26365398-26378546:+	0.18	4.36	1.57E-5	Educational attainment	
HNSC	cis	1	rs9394931	chr6:42873245	GNMT	chr6:42928500-42931617:+	0.24	4.74	2.81E-6	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
HNSC	cis	1	rs9394931	chr6:42873245	PEX6	chr6:42931613-42946981:-	-0.55	-10.36	6.82E-23	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
HNSC	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.57	-14.78	3.59E-41	Homocysteine levels	
HNSC	cis	1	rs9395493	chr6:49427409	MUT	chr6:49398994-49431031:-	0.23	4.52	7.92E-6	Homocysteine levels	
HNSC	cis	1	rs939558	chr3:41976040	ULK4	chr3:41288091-42003660:-	-0.8	-14.72	6.7E-41	Diastolic blood pressure	
HNSC	cis	1	rs939876	chr12:65252118	GNS	chr12:65107224-65153226:-	-0.22	-3.79	0.000169	Cognitive performance	
HNSC	cis	1	rs9399652	chr6:101120006	ASCC3	chr6:100956609-101329224:-	-0.21	-5.6	3.64E-8	Menarche (age at onset)	
HNSC	cis	1	rs9399656	chr6:101127124	ASCC3	chr6:100956609-101329224:-	0.23	6	3.9E-9	Menarche (age at onset)	
HNSC	cis	1	rs9399693	chr6:149933854	LRP11	chr6:150139894-150185480:-	0.19	3.93	9.7E-5	Lung cancer	
HNSC	cis	1	rs9399693	chr6:149933854	NUP43	chr6:150045453-150067688:-	-0.27	-5.57	4.22E-8	Lung cancer	
HNSC	cis	1	rs940045	chr3:49449638	AMT	chr3:49454212-49460012:-	0.17	3.94	9.15E-5	Menarche (age at onset)	
HNSC	cis	1	rs9401006	chr6:117732924	ROS1	chr6:117609530-117747018:-	-0.19	-4.2	3.1E-5	Lung cancer	
HNSC	cis	1	rs940174	chr3:136309710	PCCB	chr3:135969167-136056737:+	0.21	4.71	3.16E-6	Schizophrenia	
HNSC	cis	1	rs9403962	chr6:101129997	ASCC3	chr6:100956609-101329224:-	0.23	6	3.9E-9	Menarche (age at onset)	
HNSC	cis	1	rs941653	chr14:35592538	PPP2R3C	chr14:35554679-35591679:-	0.45	7.46	4.07E-13	Atopic dermatitis	
HNSC	cis	1	rs9416684	chr10:59994722	CISD1	chr10:60028895-60049018:+	0.23	4.01	7.11E-5	Inflammatory bowel disease	
HNSC	cis	1	rs9416684	chr10:59994722	IPMK	chr10:59955618-60027694:-	0.27	6.49	2.08E-10	Inflammatory bowel disease	
HNSC	cis	1	rs9417261	chr10:38111769	LOC399744	chr10:38717074-38741080:+	0.26	3.66	0.000277	Obesity (extreme)	
HNSC	cis	1	rs9417263	chr10:38114690	LOC399744	chr10:38717074-38741080:+	0.28	3.85	0.000134	Obesity (extreme)	
HNSC	cis	1	rs9417264	chr10:38117570	LOC399744	chr10:38717074-38741080:+	0.28	3.85	0.000134	Obesity (extreme)	
HNSC	cis	1	rs9417268	chr10:38133194	LOC399744	chr10:38717074-38741080:+	0.26	3.66	0.000277	Obesity (extreme)	
HNSC	cis	1	rs9418288	chr10:38107136	LOC399744	chr10:38717074-38741080:+	0.26	3.66	0.000277	Obesity (extreme)	
HNSC	cis	1	rs9418289	chr10:38109805	LOC399744	chr10:38717074-38741080:+	0.26	3.66	0.000277	Obesity (extreme)	
HNSC	cis	1	rs9418294	chr10:38115586	LOC399744	chr10:38717074-38741080:+	0.26	3.66	0.000277	Obesity (extreme)	
HNSC	cis	1	rs9418298	chr10:38137236	LOC399744	chr10:38717074-38741080:+	0.28	3.85	0.000134	Obesity (extreme)	
HNSC	cis	1	rs9418299	chr10:38140227	LOC399744	chr10:38717074-38741080:+	0.28	3.84	0.000141	Obesity (extreme)	
HNSC	cis	1	rs9419897	chr10:102246125	SEC31B	chr10:102246403-102289636:-	-0.18	-5.79	1.24E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs9420782	chr10:102235015	SEC31B	chr10:102246403-102289636:-	-0.18	-5.8	1.19E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs9420785	chr10:102240451	SEC31B	chr10:102246403-102289636:-	-0.18	-5.77	1.37E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs9420797	chr10:102331147	SEC31B	chr10:102246403-102289636:-	-0.18	-5.76	1.51E-8	Palmitoleic acid (16:1n-7) plasma levels	
HNSC	cis	1	rs9423239	chr10:124740727	C10orf88	chr10:124690419-124713919:-	0.21	3.97	8.22E-5	Migraine without aura	
HNSC	cis	1	rs9423295	chr10:124733664	C10orf88	chr10:124690419-124713919:-	-0.2	-3.8	0.000163	Migraine without aura	
HNSC	cis	1	rs9425766	chr1:173853127	SERPINC1	chr1:173872943-173886516:-	0.34	6.38	3.97E-10	Life satisfaction	
HNSC	cis	1	rs9426691	chr1:23484904	RPL11	chr1:24018294-24022913:+	0.15	3.77	0.000182	Coenzyme Q10 levels	
HNSC	cis	1	rs942812	chr10:100153664	PYROXD2	chr10:100143323-100174978:-	0.59	5.07	5.67E-7	Aspartate aminotransferase	
HNSC	cis	1	rs9429183	chr1:46524582	CCDC163P	chr1:45960581-45965646:-	-0.34	-7.49	3.21E-13	Body mass index	
HNSC	cis	1	rs9436116	chr1:150454724	ADAMTSL4	chr1:150521898-150533410:+	0.24	6.02	3.39E-9	Morning vs. evening chronotype	
HNSC	cis	1	rs9436116	chr1:150454724	ECM1	chr1:150480487-150486264:+	0.2	4.43	1.14E-5	Morning vs. evening chronotype	
HNSC	cis	1	rs944260	chr20:60243411	CDH4	chr20:59827559-60512299:+	0.21	3.92	9.99E-5	Sudden cardiac arrest	
HNSC	cis	1	rs9450662	chr6:88088593	C6orf162	chr6:88032306-88052043:+	-0.19	-3.87	0.000124	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs9450662	chr6:88088593	C6orf164	chr6:88032306-88109459:+	-0.24	-4.47	9.93E-6	Depressive episodes in bipolar disorder	
HNSC	cis	1	rs945635	chr1:157670290	FCRL3	chr1:157646278-157670775:-	0.35	11.4	7.14E-27	Type 1 diabetes autoantibodies	
HNSC	cis	1	rs9457247	chr6:167392174	RNASET2	chr6:167343008-167412795:-	-0.22	-5.56	4.46E-8	Crohn's disease	
HNSC	cis	1	rs9461259	chr6:26504835	BTN3A2	chr6:26365398-26378546:+	0.19	4.41	1.27E-5	Educational attainment	
HNSC	cis	1	rs9461271	chr6:26554968	BTN2A3	chr6:26422317-26431927:+	0.16	3.74	0.000208	Educational attainment	
HNSC	cis	1	rs9461271	chr6:26554968	BTN3A2	chr6:26365398-26378546:+	0.18	4.32	1.85E-5	Educational attainment	
HNSC	cis	1	rs9463078	chr6:45181340	SUPT3H	chr6:44777054-45345670:-	-0.21	-3.94	9.2E-5	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	
HNSC	cis	1	rs9463473	chr6:49380121	CENPQ	chr6:49431096-49460820:+	-0.4	-9.43	1.6E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs9463473	chr6:49380121	MUT	chr6:49398994-49431031:-	0.42	9.12	1.98E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs9463474	chr6:49380199	CENPQ	chr6:49431096-49460820:+	-0.4	-9.43	1.6E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs9463474	chr6:49380199	MUT	chr6:49398994-49431031:-	0.42	9.12	1.98E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs9463475	chr6:49380899	CENPQ	chr6:49431096-49460820:+	0.4	9.43	1.56E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs9463475	chr6:49380899	MUT	chr6:49398994-49431031:-	-0.42	-9.03	3.8E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs9463477	chr6:49386446	CENPQ	chr6:49431096-49460820:+	-0.4	-9.43	1.6E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs9463477	chr6:49386446	MUT	chr6:49398994-49431031:-	0.42	9.12	1.98E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs9463478	chr6:49386564	CENPQ	chr6:49431096-49460820:+	-0.57	-14.78	3.66E-41	Homocysteine levels	
HNSC	cis	1	rs9463478	chr6:49386564	MUT	chr6:49398994-49431031:-	0.23	4.56	6.57E-6	Homocysteine levels	
HNSC	cis	1	rs9463479	chr6:49393275	CENPQ	chr6:49431096-49460820:+	-0.4	-9.45	1.33E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs9463479	chr6:49393275	MUT	chr6:49398994-49431031:-	0.42	9.09	2.41E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs9463480	chr6:49400795	CENPQ	chr6:49431096-49460820:+	-0.4	-9.48	1.08E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs9463480	chr6:49400795	MUT	chr6:49398994-49431031:-	0.41	8.9	1.07E-17	Folate pathway vitamin levels	
HNSC	cis	1	rs946529	chr1:46485548	CCDC163P	chr1:45960581-45965646:-	-0.33	-7.17	2.77E-12	Body mass index	
HNSC	cis	1	rs9467773	chr6:26498426	BTN2A3	chr6:26422317-26431927:+	0.16	3.71	0.000227	Educational attainment	
HNSC	cis	1	rs9467773	chr6:26498426	BTN3A2	chr6:26365398-26378546:+	0.19	4.51	8.23E-6	Educational attainment	
HNSC	cis	1	rs9467774	chr6:26505036	BTN3A2	chr6:26365398-26378546:+	0.19	4.41	1.25E-5	Educational attainment	
HNSC	cis	1	rs9467778	chr6:26534743	BTN2A3	chr6:26422317-26431927:+	0.16	3.66	0.000275	Educational attainment	
HNSC	cis	1	rs9467778	chr6:26534743	BTN3A2	chr6:26365398-26378546:+	0.18	4.36	1.57E-5	Educational attainment	
HNSC	cis	1	rs9467779	chr6:26536687	BTN2A3	chr6:26422317-26431927:+	-0.17	-3.85	0.000131	Educational attainment	
HNSC	cis	1	rs9467779	chr6:26536687	BTN3A2	chr6:26365398-26378546:+	-0.18	-4.31	1.96E-5	Educational attainment	
HNSC	cis	1	rs9467782	chr6:26542773	BTN2A3	chr6:26422317-26431927:+	0.16	3.68	0.000262	Educational attainment	
HNSC	cis	1	rs9467782	chr6:26542773	BTN3A2	chr6:26365398-26378546:+	0.18	4.28	2.27E-5	Educational attainment	
HNSC	cis	1	rs9467783	chr6:26542894	BTN2A3	chr6:26422317-26431927:+	0.17	3.93	9.84E-5	Educational attainment	
HNSC	cis	1	rs9467783	chr6:26542894	BTN3A2	chr6:26365398-26378546:+	0.18	4.32	1.86E-5	Educational attainment	
HNSC	cis	1	rs9467787	chr6:26556769	BTN2A3	chr6:26422317-26431927:+	0.16	3.79	0.000167	Educational attainment	
HNSC	cis	1	rs9467787	chr6:26556769	BTN3A2	chr6:26365398-26378546:+	0.18	4.25	2.54E-5	Educational attainment	
HNSC	cis	1	rs9467791	chr6:26562486	BTN3A2	chr6:26365398-26378546:+	-0.18	-4.22	2.87E-5	Educational attainment	
HNSC	cis	1	rs9467796	chr6:26568411	BTN2A3	chr6:26422317-26431927:+	0.16	3.67	0.000273	Educational attainment	
HNSC	cis	1	rs9467796	chr6:26568411	BTN3A2	chr6:26365398-26378546:+	0.17	4.08	5.24E-5	Educational attainment	
HNSC	cis	1	rs9467797	chr6:26568473	BTN2A3	chr6:26422317-26431927:+	0.16	3.67	0.000273	Educational attainment	
HNSC	cis	1	rs9467797	chr6:26568473	BTN3A2	chr6:26365398-26378546:+	0.17	4.08	5.24E-5	Educational attainment	
HNSC	cis	1	rs947211	chr1:205752665	PM20D1	chr1:205797154-205819245:-	-0.3	-5.74	1.7E-8	Parkinson's disease	
HNSC	cis	1	rs947211	chr1:205752665	RAB7L1	chr1:205737115-205744610:-	0.3	5.37	1.21E-7	Parkinson's disease	
HNSC	cis	1	rs9473549	chr6:49380020	CENPQ	chr6:49431096-49460820:+	-0.4	-9.34	3.37E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs9473549	chr6:49380020	MUT	chr6:49398994-49431031:-	0.41	8.53	1.82E-16	Folate pathway vitamin levels	
HNSC	cis	1	rs9473550	chr6:49385182	CENPQ	chr6:49431096-49460820:+	-0.57	-14.6	2.16E-40	Homocysteine levels	
HNSC	cis	1	rs9473550	chr6:49385182	MUT	chr6:49398994-49431031:-	0.19	3.86	0.000129	Homocysteine levels	
HNSC	cis	1	rs9473552	chr6:49387154	CENPQ	chr6:49431096-49460820:+	-0.4	-9.45	1.33E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs9473552	chr6:49387154	MUT	chr6:49398994-49431031:-	0.42	9.09	2.41E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs9473553	chr6:49395977	CENPQ	chr6:49431096-49460820:+	-0.4	-9.47	1.14E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs9473553	chr6:49395977	MUT	chr6:49398994-49431031:-	0.42	9.08	2.67E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs9473555	chr6:49409487	CENPQ	chr6:49431096-49460820:+	-0.4	-9.48	1.11E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs9473555	chr6:49409487	MUT	chr6:49398994-49431031:-	0.42	9.02	4.25E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs9473560	chr6:49427918	CENPQ	chr6:49431096-49460820:+	-0.4	-9.6	4.03E-20	Folate pathway vitamin levels	
HNSC	cis	1	rs9473560	chr6:49427918	MUT	chr6:49398994-49431031:-	0.42	9.12	1.88E-18	Folate pathway vitamin levels	
HNSC	cis	1	rs9473561	chr6:49428755	CENPQ	chr6:49431096-49460820:+	-0.4	-9.64	2.94E-20	Folate pathway vitamin levels	
HNSC	cis	1	rs9473561	chr6:49428755	MUT	chr6:49398994-49431031:-	0.41	8.85	1.56E-17	Folate pathway vitamin levels	
HNSC	cis	1	rs9473563	chr6:49453651	CENPQ	chr6:49431096-49460820:+	-0.4	-9.43	1.65E-19	Folate pathway vitamin levels	
HNSC	cis	1	rs9473563	chr6:49453651	MUT	chr6:49398994-49431031:-	0.41	8.59	1.16E-16	Folate pathway vitamin levels	
HNSC	cis	1	rs9473582	chr6:49488908	CENPQ	chr6:49431096-49460820:+	0.24	5.49	6.61E-8	Brain structure	
HNSC	cis	1	rs9473582	chr6:49488908	MUT	chr6:49398994-49431031:-	-0.19	-3.95	9.05E-5	Brain structure	
HNSC	cis	1	rs9475752	chr6:56780741	BEND6	chr6:56819773-56892138:+	-0.37	-6.8	3.09E-11	Menarche (age at onset)	
HNSC	cis	1	rs9475752	chr6:56780741	RAB23	chr6:57053591-57087101:-	0.21	4.04	6.32E-5	Menarche (age at onset)	
HNSC	cis	1	rs947583	chr6:136133659	AHI1	chr6:135605112-135818903:-	-0.18	-3.76	0.000187	Phosphorus levels	
HNSC	cis	1	rs9479517	chr6:153442789	RGS17	chr6:153332041-153452389:-	-0.21	-3.87	0.000122	Prostate cancer	
HNSC	cis	1	rs9480339	chr6:150706496	IYD	chr6:150690028-150725764:+	-0.18	-3.8	0.000161	Anger	
HNSC	cis	1	rs9480340	chr6:150706846	IYD	chr6:150690028-150725764:+	-0.18	-3.8	0.000161	Anger	
HNSC	cis	1	rs9480933	chr6:109671391	AKD1	chr6:109814059-110012415:-	-0.21	-4.34	1.7E-5	Height	
HNSC	cis	1	rs9480933	chr6:109671391	SMPD2	chr6:109761931-109765121:+	0.28	5.68	2.27E-8	Height	
HNSC	cis	1	rs9480953	chr6:109739144	AKD1	chr6:109814059-110012415:-	-0.21	-4.29	2.11E-5	Height	
HNSC	cis	1	rs9480953	chr6:109739144	SMPD2	chr6:109761931-109765121:+	0.28	5.85	8.92E-9	Height	
HNSC	cis	1	rs9480955	chr6:109744533	AKD1	chr6:109814059-110012415:-	-0.21	-4.29	2.12E-5	Height	
HNSC	cis	1	rs9480955	chr6:109744533	SMPD2	chr6:109761931-109765121:+	0.28	5.85	9.06E-9	Height	
HNSC	cis	1	rs9481076	chr6:110781933	SLC22A16	chr6:110745907-110797844:-	-0.32	-3.82	0.000151	Glucose homeostasis traits	
HNSC	cis	1	rs9481808	chr6:118784571	C6orf204	chr6:118786239-119031238:-	-0.25	-4.41	1.3E-5	Renal cell carcinoma	
HNSC	cis	1	rs9481821	chr6:118846022	C6orf204	chr6:118786239-119031238:-	-0.22	-3.83	0.000147	Renal cell carcinoma	
HNSC	cis	1	rs9481825	chr6:118876092	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.52E-5	Renal cell carcinoma	
HNSC	cis	1	rs9481833	chr6:118919631	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.54E-5	Renal cell carcinoma	
HNSC	cis	1	rs9487094	chr6:109742015	AKD1	chr6:109814059-110012415:-	-0.21	-4.29	2.12E-5	Height	
HNSC	cis	1	rs9487094	chr6:109742015	SMPD2	chr6:109761931-109765121:+	0.28	5.85	9.06E-9	Height	
HNSC	cis	1	rs9489394	chr6:118758234	C6orf204	chr6:118786239-119031238:-	-0.24	-4.36	1.58E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489395	chr6:118758884	C6orf204	chr6:118786239-119031238:-	-0.24	-4.36	1.58E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489399	chr6:118767147	C6orf204	chr6:118786239-119031238:-	-0.24	-4.36	1.58E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489407	chr6:118792337	C6orf204	chr6:118786239-119031238:-	0.24	4.3	2.06E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489409	chr6:118802721	C6orf204	chr6:118786239-119031238:-	-0.24	-4.28	2.29E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489428	chr6:118852935	C6orf204	chr6:118786239-119031238:-	-0.25	-4.34	1.76E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489433	chr6:118867006	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.52E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489436	chr6:118873817	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.52E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489442	chr6:118885950	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.52E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489447	chr6:118900846	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.54E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489450	chr6:118904385	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.54E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489452	chr6:118910868	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.54E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489457	chr6:118920285	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.54E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489458	chr6:118920503	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.54E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489460	chr6:118925754	C6orf204	chr6:118786239-119031238:-	-0.24	-4.37	1.54E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489467	chr6:118935206	C6orf204	chr6:118786239-119031238:-	-0.24	-4.32	1.86E-5	Renal cell carcinoma	
HNSC	cis	1	rs9489477	chr6:118946192	C6orf204	chr6:118786239-119031238:-	-0.24	-4.32	1.86E-5	Renal cell carcinoma	
HNSC	cis	1	rs9491140	chr6:124691237	NKAIN2	chr6:124125069-125146784:+	0.4	7.95	1.3E-14	Neuroticism	
HNSC	cis	1	rs9491142	chr6:124693017	NKAIN2	chr6:124125069-125146784:+	0.39	7.61	1.43E-13	Neuroticism	
HNSC	cis	1	rs950027	chr15:45801035	SPATA5L1	chr15:45694519-45713614:+	-0.21	-4.04	6.18E-5	Response to fenofibrate (adiponectin levels)	
HNSC	cis	1	rs950146	chr3:36680099	GOLGA4	chr3:37284738-37408241:+	0.15	4.28	2.26E-5	Erectile dysfunction in type 1 diabetes	
HNSC	cis	1	rs950169	chr15:84706461	LOC388152	chr15:84867600-84898920:-	-0.28	-4.84	1.72E-6	Schizophrenia	
HNSC	cis	1	rs9507341	chr13:25006578	PARP4	chr13:24995075-25086948:-	-0.2	-4.7	3.36E-6	Obesity-related traits	
HNSC	cis	1	rs9511265	chr13:25012359	PARP4	chr13:24995075-25086948:-	0.21	4.68	3.64E-6	Obesity-related traits	
HNSC	cis	1	rs951366	chr1:205685352	PM20D1	chr1:205797154-205819245:-	-0.27	-5.37	1.22E-7	Menarche (age at onset)	
HNSC	cis	1	rs951366	chr1:205685352	RAB7L1	chr1:205737115-205744610:-	0.32	6.05	2.91E-9	Menarche (age at onset)	
HNSC	cis	1	rs9527	chr10:104623578	AS3MT	chr10:104613967-104661653:+	-0.23	-4.42	1.2E-5	Arsenic metabolism	
HNSC	cis	1	rs9527	chr10:104623578	C10orf32	chr10:104613967-104624718:+	-0.38	-6.7	5.63E-11	Arsenic metabolism	
HNSC	cis	1	rs9528136	chr13:61013615	TDRD3	chr13:60970591-61148012:+	0.22	4.08	5.28E-5	Menopause (age at onset)	
HNSC	cis	1	rs9538719	chr13:61052747	TDRD3	chr13:60970591-61148012:+	0.22	4	7.39E-5	Menopause (age at onset)	
HNSC	cis	1	rs9546652	chr13:36773131	SOHLH2	chr13:36742347-36871992:-	0.22	4.22	2.91E-5	Economic and political preferences	
HNSC	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.64	14.04	6.72E-38	Response to antipsychotic treatment	
HNSC	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.63	-13.83	5.46E-37	Response to antipsychotic treatment	
HNSC	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.65	-13.61	4.92E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs957644	chr1:165616157	MGST3	chr1:165600450-165624853:+	0.37	7.37	7.07E-13	Total ventricular volume	
HNSC	cis	1	rs9581094	chr13:25082630	PARP4	chr13:24995075-25086948:-	-0.28	-4.67	3.93E-6	Sudden cardiac arrest	
HNSC	cis	1	rs958550	chr7:65635679	CRCP	chr7:65579805-65619551:+	0.39	4.48	9.3E-6	Diabetic kidney disease	
HNSC	cis	1	rs958550	chr7:65635679	NCRNA00174	chr7:65841032-65865395:-	0.44	4.65	4.28E-6	Diabetic kidney disease	
HNSC	cis	1	rs958755	chr3:56716922	CCDC66	chr3:56591184-56655846:+	0.18	5.13	4.27E-7	Height	
HNSC	cis	1	rs9593	chr12:109994870	MMAB	chr12:109991523-110011358:-	-0.18	-4.45	1.06E-5	HDL cholesterol	
HNSC	cis	1	rs959617	chr1:165616881	MGST3	chr1:165600450-165624853:+	0.37	7.61	1.45E-13	Total ventricular volume	
HNSC	cis	1	rs9607566	chr22:39075434	LOC646851	chr22:38974125-39052634:-	0.15	3.89	0.000113	Resting heart rate	
HNSC	cis	1	rs9610986	chr22:39025277	LOC646851	chr22:38974125-39052634:-	0.14	3.79	0.000167	Resting heart rate	
HNSC	cis	1	rs9610993	chr22:39042818	LOC646851	chr22:38974125-39052634:-	0.14	3.77	0.000186	Resting heart rate	
HNSC	cis	1	rs9616064	chr22:46982293	GRAMD4	chr22:47022658-47075687:+	-0.22	-4.08	5.26E-5	Urate levels in obese individuals	
HNSC	cis	1	rs962221	chr1:92970770	EVI5	chr1:92974255-93257961:-	-0.23	-4.3	2.02E-5	Cholesterol, total	
HNSC	cis	1	rs962222	chr1:92970953	EVI5	chr1:92974255-93257961:-	-0.23	-4.3	2.02E-5	Cholesterol, total	
HNSC	cis	1	rs9624447	chr22:24681555	POM121L9P	chr22:24647589-24661490:+	-0.33	-7.12	3.85E-12	Gut microbiome composition (summer)	
HNSC	cis	1	rs9635251	chr14:65928468	LOC645431	chr14:65877313-65879335:-	-0.29	-3.88	0.000117	Ischemic stroke	
HNSC	cis	1	rs9637655	chr4:142159065	ZNF330	chr4:142142049-142155848:+	-0.28	-4.35	1.64E-5	Conduct disorder	
HNSC	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.59	-13.56	7.97E-36	Response to antipsychotic treatment	
HNSC	cis	1	rs9653282	chr2:165554658	SLC38A11	chr2:165754812-165812035:-	0.23	4.5	8.64E-6	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
HNSC	cis	1	rs9653557	chr2:73795962	ALMS1P	chr2:73872046-73912692:+	0.25	4.09	4.96E-5	Metabolite levels	
HNSC	cis	1	rs965469	chr20:3381549	ITPA	chr20:3190056-3204504:+	-0.19	-3.89	0.000112	IFN-related cytopenia	
HNSC	cis	1	rs9661504	chr1:205915667	PM20D1	chr1:205797154-205819245:-	0.2	3.78	0.000177	Cystic fibrosis-related diabetes	
HNSC	cis	1	rs9661596	chr1:171652664	VAMP4	chr1:171669298-171711214:-	0.28	4.79	2.19E-6	Hippocampal atrophy	
HNSC	cis	1	rs9662174	chr1:171652144	VAMP4	chr1:171669298-171711214:-	0.28	4.79	2.19E-6	Hippocampal atrophy	
HNSC	cis	1	rs9662221	chr1:205915745	PM20D1	chr1:205797154-205819245:-	0.2	3.79	0.000171	Cystic fibrosis-related diabetes	
HNSC	cis	1	rs9662506	chr1:171655984	VAMP4	chr1:171669298-171711214:-	0.28	4.76	2.55E-6	Hippocampal atrophy	
HNSC	cis	1	rs966321	chr1:4315204	LOC388588	chr1:3689352-3692545:+	-0.16	-3.67	0.000265	Factor VII	
HNSC	cis	1	rs9665626	chr10:104300638	SFXN2	chr10:104474298-104498946:+	0.31	4.06	5.65E-5	Schizophrenia	
HNSC	cis	1	rs9674872	chr17:79581931	RAC3	chr17:79989532-79992079:+	0.17	4.14	4.05E-5	Eye color traits	
HNSC	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.22	5.66	2.52E-8	Eye color traits	
HNSC	cis	1	rs968567	chr11:61595564	FADS2	chr11:61583728-61634825:+	0.32	5.39	1.09E-7	Blood metabolite levels;Rheumatoid arthritis;Glycerophospholipid levels	
HNSC	cis	1	rs9689	chr1:25688276	RHCE	chr1:25688741-25756683:-	0.32	6.07	2.59E-9	Erythrocyte sedimentation rate	
HNSC	cis	1	rs9689	chr1:25688276	RHD	chr1:25598981-25656935:+	-0.46	-9.13	1.71E-18	Erythrocyte sedimentation rate	
HNSC	cis	1	rs9715911	chr5:156394441	TIMD4	chr5:156346293-156390266:-	-0.18	-4.3	2.05E-5	Triglycerides;Cholesterol, total;LDL cholesterol	
HNSC	cis	1	rs9718453	chr7:102594976	FAM185A	chr7:102389399-102467706:+	0.22	3.88	0.000117	Morning vs. evening chronotype	
HNSC	cis	1	rs974495	chr3:49400482	AMT	chr3:49454212-49460012:-	0.17	3.92	0.000102	Menarche (age at onset)	
HNSC	cis	1	rs9747349	chr17:79584297	RAC3	chr17:79989532-79992079:+	0.17	4.14	4.05E-5	Eye color traits	
HNSC	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.22	5.66	2.52E-8	Eye color traits	
HNSC	cis	1	rs9748176	chr17:79584043	RAC3	chr17:79989532-79992079:+	0.18	4.22	2.85E-5	Eye color traits	
HNSC	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.23	5.88	7.76E-9	Eye color traits	
HNSC	cis	1	rs9767077	chr6:150109615	NUP43	chr6:150045453-150067688:-	-0.27	-5.5	6.13E-8	Lung cancer	
HNSC	cis	1	rs9769882	chr7:65642925	NCRNA00174	chr7:65841032-65865395:-	0.44	4.7	3.38E-6	Diabetic kidney disease	
HNSC	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.38	6.83	2.49E-11	Forced vital capacity	
HNSC	cis	1	rs9783347	chr11:18384938	GTF2H1	chr11:18343816-18388590:+	0.29	5.07	5.64E-7	Pancreatic cancer	
HNSC	cis	1	rs9788721	chr15:78802869	CHRNA5	chr15:78857906-78886458:+	0.26	5.43	8.93E-8	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
HNSC	cis	1	rs9795476	chr11:235894	PSMD13	chr11:236808-252984:+	-0.18	-3.71	0.000231	Menarche (age at onset)	
HNSC	cis	1	rs9797861	chr19:10743126	ICAM5	chr19:10400655-10407452:+	0.22	4.08	5.16E-5	Thrombosis	
HNSC	cis	1	rs979971	chr19:39144244	LGALS7B	chr19:39279850-39282393:+	0.26	5.63	2.97E-8	Heart rate	
HNSC	cis	1	rs979972	chr19:39144167	LGALS7B	chr19:39279850-39282393:+	0.27	6	3.77E-9	Heart rate	
HNSC	cis	1	rs9804317	chr10:130248926	NPS	chr10:129347613-129350935:+	0.18	4.12	4.44E-5	Cognitive performance	
HNSC	cis	1	rs9804992	chr12:988894	RAD52	chr12:1021255-1099219:-	0.31	5.13	4.14E-7	Colorectal cancer	
HNSC	cis	1	rs9805979	chr14:75566209	MLH3	chr14:75480467-75518235:-	0.3	6.16	1.48E-9	Height	
HNSC	cis	1	rs9809619	chr3:134280948	ANAPC13	chr3:134196547-134204865:-	0.48	10.42	4.03E-23	Height	
HNSC	cis	1	rs9809619	chr3:134280948	CEP63	chr3:134204575-134293852:+	0.27	5.96	4.91E-9	Height	
HNSC	cis	1	rs9809843	chr3:48434398	ATRIP	chr3:48488141-48507708:+	0.16	3.71	0.000232	Longevity	
HNSC	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.28	-6.9	1.6E-11	Longevity	
HNSC	cis	1	rs9810089	chr3:135807609	PCCB	chr3:135969167-136056737:+	-0.2	-4.58	5.84E-6	Gestational age at birth (child effect)	
HNSC	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.25	6.05	2.82E-9	Longevity	
HNSC	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.49	10.42	4.27E-23	Height	
HNSC	cis	1	rs9813774	chr3:134227100	CEP63	chr3:134204575-134293852:+	0.28	6.1	2.1E-9	Height	
HNSC	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.48	-10.37	6.43E-23	Height	
HNSC	cis	1	rs9814567	chr3:134218557	CEP63	chr3:134204575-134293852:+	-0.26	-5.74	1.65E-8	Height	
HNSC	cis	1	rs9815103	chr3:48414215	ATRIP	chr3:48488141-48507708:+	0.17	3.9	0.000109	Longevity	
HNSC	cis	1	rs9815103	chr3:48414215	TREX1	chr3:48501186-48509043:+	-0.3	-7.48	3.34E-13	Longevity	
HNSC	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.69	10.2	2.62E-22	Diastolic blood pressure	
HNSC	cis	1	rs9817615	chr3:48470756	TREX1	chr3:48501186-48509043:+	-0.26	-6.42	3.28E-10	Longevity	
HNSC	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	0.75	12.51	2.22E-31	Diastolic blood pressure	
HNSC	cis	1	rs9818941	chr3:157686457	SHOX2	chr3:157813801-157823952:-	0.22	3.83	0.000142	Height	
HNSC	cis	1	rs9819532	chr3:134288644	ANAPC13	chr3:134196547-134204865:-	0.48	10.44	3.41E-23	Height	
HNSC	cis	1	rs9819532	chr3:134288644	CEP63	chr3:134204575-134293852:+	0.27	5.94	5.32E-9	Height	
HNSC	cis	1	rs982256	chr7:110904226	IMMP2L	chr7:110303110-111202538:-	0.21	3.83	0.000144	Schizophrenia	
HNSC	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.68	10.03	1.15E-21	Diastolic blood pressure	
HNSC	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.68	10.03	1.15E-21	Diastolic blood pressure	
HNSC	cis	1	rs9826195	chr3:48433635	ATRIP	chr3:48488141-48507708:+	0.16	3.71	0.000232	Longevity	
HNSC	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.28	-6.9	1.6E-11	Longevity	
HNSC	cis	1	rs9826496	chr3:134224437	ANAPC13	chr3:134196547-134204865:-	0.49	10.35	7.31E-23	Height	
HNSC	cis	1	rs9826496	chr3:134224437	CEP63	chr3:134204575-134293852:+	0.28	6.03	3.21E-9	Height	
HNSC	cis	1	rs9827987	chr3:134272621	ANAPC13	chr3:134196547-134204865:-	0.49	10.58	1.06E-23	Height	
HNSC	cis	1	rs9827987	chr3:134272621	CEP63	chr3:134204575-134293852:+	0.28	5.98	4.17E-9	Height	
HNSC	cis	1	rs9828815	chr3:134265749	ANAPC13	chr3:134196547-134204865:-	0.48	10.4	5.1E-23	Height	
HNSC	cis	1	rs9828815	chr3:134265749	CEP63	chr3:134204575-134293852:+	0.27	5.93	5.86E-9	Height	
HNSC	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.5	10.54	1.5E-23	Height	
HNSC	cis	1	rs9829092	chr3:134229866	CEP63	chr3:134204575-134293852:+	0.27	5.85	8.86E-9	Height	
HNSC	cis	1	rs9832785	chr3:134213070	ANAPC13	chr3:134196547-134204865:-	0.49	10.52	1.66E-23	Height	
HNSC	cis	1	rs9832785	chr3:134213070	CEP63	chr3:134204575-134293852:+	0.28	5.98	4.27E-9	Height	
HNSC	cis	1	rs9833926	chr3:56650178	CCDC66	chr3:56591184-56655846:+	0.18	5	8.13E-7	Height	
HNSC	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.5	10.68	4.3E-24	Height	
HNSC	cis	1	rs9834755	chr3:134206845	CEP63	chr3:134204575-134293852:+	0.28	6.06	2.75E-9	Height	
HNSC	cis	1	rs9835204	chr3:134261342	ANAPC13	chr3:134196547-134204865:-	0.48	10.4	5.1E-23	Height	
HNSC	cis	1	rs9835204	chr3:134261342	CEP63	chr3:134204575-134293852:+	0.27	5.93	5.86E-9	Height	
HNSC	cis	1	rs9835332	chr3:56667682	CCDC66	chr3:56591184-56655846:+	0.18	4.94	1.09E-6	Height	
HNSC	cis	1	rs9836053	chr3:150885877	P2RY12	chr3:151055238-151102544:-	0.17	3.66	0.00028	Heschl's gyrus morphology	
HNSC	cis	1	rs9837038	chr3:156568469	LEKR1	chr3:156544076-156763918:+	-0.24	-5.38	1.15E-7	Multiple sclerosis (severity)	
HNSC	cis	1	rs9837038	chr3:156568469	LOC100287227	chr3:156390964-156393502:-	-0.21	-4.2	3.14E-5	Multiple sclerosis (severity)	
HNSC	cis	1	rs9838618	chr3:48487353	ATRIP	chr3:48488141-48507708:+	0.16	3.66	0.000279	Longevity	
HNSC	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.31	-7.73	5.93E-14	Longevity	
HNSC	cis	1	rs9839065	chr3:56716089	CCDC66	chr3:56591184-56655846:+	0.18	5.13	4.27E-7	Height	
HNSC	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.55	12.22	3.43E-30	Height	
HNSC	cis	1	rs9841212	chr3:134191938	CEP63	chr3:134204575-134293852:+	0.32	6.98	9.38E-12	Height	
HNSC	cis	1	rs9842132	chr3:49427933	AMT	chr3:49454212-49460012:-	-0.19	-4.17	3.58E-5	Menarche (age at onset)	
HNSC	cis	1	rs984222	chr1:119503843	WARS2	chr1:119573841-119683295:-	-0.35	-6.41	3.38E-10	Waist-to-hip ratio adjusted for body mass index;Waist-hip ratio	
HNSC	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-0.66	-11.54	1.99E-27	Diastolic blood pressure	
HNSC	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.68	10.06	8.62E-22	Diastolic blood pressure	
HNSC	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	0.66	9.95	2.29E-21	Diastolic blood pressure	
HNSC	cis	1	rs9848754	chr3:41753647	ULK4	chr3:41288091-42003660:-	0.68	10.21	2.47E-22	Diastolic blood pressure	
HNSC	cis	1	rs9849509	chr3:48483432	ATRIP	chr3:48488141-48507708:+	0.16	3.67	0.000265	Longevity	
HNSC	cis	1	rs9849509	chr3:48483432	TREX1	chr3:48501186-48509043:+	-0.26	-6.54	1.57E-10	Longevity	
HNSC	cis	1	rs9850015	chr3:134269541	ANAPC13	chr3:134196547-134204865:-	0.49	10.57	1.17E-23	Height	
HNSC	cis	1	rs9850015	chr3:134269541	CEP63	chr3:134204575-134293852:+	0.28	5.99	4.08E-9	Height	
HNSC	cis	1	rs9851441	chr3:134315091	ANAPC13	chr3:134196547-134204865:-	0.49	10.58	1.03E-23	Height	
HNSC	cis	1	rs9851441	chr3:134315091	CEP63	chr3:134204575-134293852:+	0.27	5.9	6.95E-9	Height	
HNSC	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.48	10.25	1.75E-22	Height	
HNSC	cis	1	rs9854299	chr3:134206728	CEP63	chr3:134204575-134293852:+	0.27	5.88	7.42E-9	Height	
HNSC	cis	1	rs985434	chr5:90744509	LOC100129716	chr5:90676164-90716531:+	0.31	4.47	9.68E-6	Smoking behavior	
HNSC	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	0.75	12.51	2.22E-31	Diastolic blood pressure	
HNSC	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	0.75	12.51	2.22E-31	Diastolic blood pressure	
HNSC	cis	1	rs9856633	chr3:42013850	ULK4	chr3:41288091-42003660:-	0.78	14.18	1.61E-38	Diastolic blood pressure	
HNSC	cis	1	rs9856693	chr3:134306913	ANAPC13	chr3:134196547-134204865:-	0.49	10.56	1.22E-23	Height	
HNSC	cis	1	rs9856693	chr3:134306913	CEP63	chr3:134204575-134293852:+	0.27	5.76	1.51E-8	Height	
HNSC	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	0.72	12.5	2.38E-31	Diastolic blood pressure	
HNSC	cis	1	rs9860055	chr3:49506900	AMT	chr3:49454212-49460012:-	-0.19	-4.04	6.1E-5	Menarche (age at onset)	
HNSC	cis	1	rs9862452	chr3:20354712	RAB5A	chr3:19988572-20026658:+	-0.18	-4.76	2.5E-6	Behavioural disinhibition (generation interaction)	
HNSC	cis	1	rs9862534	chr3:49598064	AMT	chr3:49454212-49460012:-	0.17	3.83	0.000145	Menarche (age at onset)	
HNSC	cis	1	rs9863786	chr3:134247203	ANAPC13	chr3:134196547-134204865:-	0.48	10.4	5.1E-23	Height	
HNSC	cis	1	rs9863786	chr3:134247203	CEP63	chr3:134204575-134293852:+	0.27	5.93	5.86E-9	Height	
HNSC	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	0.65	10.1	6.52E-22	Diastolic blood pressure	
HNSC	cis	1	rs9864346	chr3:134312352	ANAPC13	chr3:134196547-134204865:-	0.49	10.65	5.42E-24	Height	
HNSC	cis	1	rs9864346	chr3:134312352	CEP63	chr3:134204575-134293852:+	0.28	6.1	2.17E-9	Height	
HNSC	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.3	-7.5	2.94E-13	Longevity	
HNSC	cis	1	rs9864439	chr3:134298671	ANAPC13	chr3:134196547-134204865:-	0.48	10.32	9.98E-23	Height	
HNSC	cis	1	rs9864439	chr3:134298671	CEP63	chr3:134204575-134293852:+	0.26	5.7	2.04E-8	Height	
HNSC	cis	1	rs9865905	chr3:156649594	LEKR1	chr3:156544076-156763918:+	0.23	4.97	9.11E-7	Multiple sclerosis (severity)	
HNSC	cis	1	rs9865905	chr3:156649594	LOC100287227	chr3:156390964-156393502:-	0.2	3.79	0.000166	Multiple sclerosis (severity)	
HNSC	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.67	-10.37	6.5E-23	Diastolic blood pressure	
HNSC	cis	1	rs9869981	chr3:134248801	ANAPC13	chr3:134196547-134204865:-	0.48	10.4	5.1E-23	Height	
HNSC	cis	1	rs9869981	chr3:134248801	CEP63	chr3:134204575-134293852:+	0.27	5.93	5.86E-9	Height	
HNSC	cis	1	rs9871024	chr3:49554241	AMT	chr3:49454212-49460012:-	-0.18	-3.85	0.000135	Menarche (age at onset)	
HNSC	cis	1	rs9871305	chr3:134213538	ANAPC13	chr3:134196547-134204865:-	0.49	10.42	4.12E-23	Height	
HNSC	cis	1	rs9871305	chr3:134213538	CEP63	chr3:134204575-134293852:+	0.26	5.65	2.78E-8	Height	
HNSC	cis	1	rs9871864	chr3:20352766	RAB5A	chr3:19988572-20026658:+	-0.18	-4.65	4.36E-6	Behavioural disinhibition (generation interaction)	
HNSC	cis	1	rs9872999	chr3:133457514	TF	chr3:133419211-133497635:+	-0.34	-6.49	2.15E-10	Iron status biomarkers	
HNSC	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.69	10.54	1.48E-23	Diastolic blood pressure	
HNSC	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.69	10.26	1.63E-22	Diastolic blood pressure	
HNSC	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	0.66	10.08	7.64E-22	Diastolic blood pressure	
HNSC	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	0.71	12.18	5.24E-30	Diastolic blood pressure	
HNSC	cis	1	rs9876658	chr3:134179453	ANAPC13	chr3:134196547-134204865:-	-0.47	-10.3	1.12E-22	Height	
HNSC	cis	1	rs9876658	chr3:134179453	CEP63	chr3:134204575-134293852:+	-0.24	-5.24	2.39E-7	Height	
HNSC	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.27	-6.76	4.02E-11	Longevity	
HNSC	cis	1	rs9878373	chr3:56666957	CCDC66	chr3:56591184-56655846:+	0.18	4.94	1.09E-6	Height	
HNSC	cis	1	rs9879311	chr3:10415343	GHRLOS	chr3:10322637-10335132:+	0.22	4.9	1.32E-6	Schizophrenia	
HNSC	cis	1	rs9881491	chr3:48487911	ATRIP	chr3:48488141-48507708:+	0.17	3.84	0.00014	Longevity	
HNSC	cis	1	rs9881491	chr3:48487911	TREX1	chr3:48501186-48509043:+	-0.31	-7.68	8.87E-14	Longevity	
HNSC	cis	1	rs9883753	chr3:134247231	ANAPC13	chr3:134196547-134204865:-	0.48	10.3	1.12E-22	Height	
HNSC	cis	1	rs9883753	chr3:134247231	CEP63	chr3:134204575-134293852:+	0.27	5.85	8.75E-9	Height	
HNSC	cis	1	rs9883759	chr3:48463618	TREX1	chr3:48501186-48509043:+	-0.3	-7.45	4.26E-13	Longevity	
HNSC	cis	1	rs9883927	chr3:48463711	TREX1	chr3:48501186-48509043:+	-0.26	-6.42	3.28E-10	Longevity	
HNSC	cis	1	rs9884031	chr3:134256500	ANAPC13	chr3:134196547-134204865:-	0.48	10.41	4.5E-23	Height	
HNSC	cis	1	rs9884031	chr3:134256500	CEP63	chr3:134204575-134293852:+	0.27	5.92	6.03E-9	Height	
HNSC	cis	1	rs9889296	chr17:32570547	RFFL	chr17:33336131-33448541:-	-0.18	-3.82	0.000151	Inflammatory bowel disease	
HNSC	cis	1	rs9889618	chr17:40293467	DHX58	chr17:40253422-40264751:-	-0.34	-7.07	5.36E-12	Fibrinogen levels	
HNSC	cis	1	rs9889640	chr17:40293497	DHX58	chr17:40253422-40264751:-	-0.34	-7.07	5.36E-12	Fibrinogen levels	
HNSC	cis	1	rs9890205	chr17:28382704	EFCAB5	chr17:28256874-28435469:+	-0.26	-4.66	4.03E-6	Coffee consumption (cups per day)	
HNSC	cis	1	rs9890886	chr17:28391076	EFCAB5	chr17:28256874-28435469:+	-0.26	-4.66	4.04E-6	Coffee consumption (cups per day)	
HNSC	cis	1	rs9891871	chr17:28370191	EFCAB5	chr17:28256874-28435469:+	-0.26	-4.66	4.03E-6	Coffee consumption (cups per day)	
HNSC	cis	1	rs9894429	chr17:79596811	RAC3	chr17:79989532-79992079:+	0.17	4.07	5.39E-5	Eye color traits	
HNSC	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.23	5.79	1.22E-8	Eye color traits	
HNSC	cis	1	rs9896062	chr17:28357047	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.26	2.41E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs9897206	chr17:28406108	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.21	3.06E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs9901225	chr17:40755811	PSMC3IP	chr17:40724329-40729747:-	-0.16	-4.67	3.83E-6	Colorectal or endometrial cancer	
HNSC	cis	1	rs9902453	chr17:28349095	EFCAB5	chr17:28256874-28435469:+	-0.23	-4.28	2.2E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs9903204	chr17:40288062	DHX58	chr17:40253422-40264751:-	-0.35	-7.15	3.2E-12	Fibrinogen levels	
HNSC	cis	1	rs9904677	chr17:56873025	RAD51C	chr17:56769963-56811690:+	0.33	8.42	4.13E-16	Cognitive test performance	
HNSC	cis	1	rs9906340	chr17:28398977	EFCAB5	chr17:28256874-28435469:+	-0.22	-4.04	6.31E-5	Coffee consumption (cups per day)	
HNSC	cis	1	rs9909940	chr17:80689036	FN3KRP	chr17:80674582-80685889:+	-0.32	-5.58	3.96E-8	Glycated hemoglobin levels	
HNSC	cis	1	rs9909992	chr17:61731931	FTSJ3	chr17:61896795-61905031:-	0.2	3.74	0.000208	Body mass index	
HNSC	cis	1	rs9909	chr11:47799775	C1QTNF4	chr11:47611216-47615961:-	-0.27	-5.55	4.76E-8	Subjective well-being	
HNSC	cis	1	rs9909	chr11:47799775	MYBPC3	chr11:47352958-47374253:-	-0.2	-3.95	8.85E-5	Subjective well-being	
HNSC	cis	1	rs9912088	chr17:40288278	DHX58	chr17:40253422-40264751:-	-0.35	-7.15	3.2E-12	Fibrinogen levels	
HNSC	cis	1	rs9912741	chr17:28359511	EFCAB5	chr17:28256874-28435469:+	-0.26	-4.66	4.03E-6	Coffee consumption (cups per day)	
HNSC	cis	1	rs9912904	chr17:61763534	FTSJ3	chr17:61896795-61905031:-	0.21	3.82	0.000153	Body mass index	
HNSC	cis	1	rs9914266	chr17:2133250	SRR	chr17:2207248-2228553:+	0.24	4.8	2.12E-6	Myocardial infarction	
HNSC	cis	1	rs9915255	chr17:40284191	DHX58	chr17:40253422-40264751:-	-0.34	-6.98	9.54E-12	Fibrinogen levels	
HNSC	cis	1	rs9921338	chr16:11416839	C16orf75	chr16:11343506-11445617:+	-0.2	-4.52	7.85E-6	Vein graft stenosis in coronary artery bypass grafting	
HNSC	cis	1	rs9923145	chr16:74686166	RFWD3	chr16:74655298-74700779:-	-0.29	-7.45	4.18E-13	Testicular germ cell tumor	
HNSC	cis	1	rs992416	chr17:61745905	FTSJ3	chr17:61896795-61905031:-	0.21	3.82	0.000153	Body mass index	
HNSC	cis	1	rs9925964	chr16:31129895	MYST1	chr16:31128985-31142713:+	-0.27	-6.4	3.6E-10	Body mass index	
HNSC	cis	1	rs9929496	chr16:74668473	RFWD3	chr16:74655298-74700779:-	-0.28	-7.25	1.58E-12	Testicular germ cell tumor	
HNSC	cis	1	rs9931225	chr16:74699293	RFWD3	chr16:74655298-74700779:-	-0.29	-7.4	5.8E-13	Testicular germ cell tumor	
HNSC	cis	1	rs9938630	chr16:29837108	LOC440356	chr16:29875004-29879374:+	-0.25	-4.17	3.63E-5	Multiple sclerosis	
HNSC	cis	1	rs9938630	chr16:29837108	LOC595101	chr16:30278914-30346695:-	-0.28	-3.76	0.000192	Multiple sclerosis	
HNSC	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.5	-10.58	1.01E-23	Height	
HNSC	cis	1	rs9968172	chr3:134231251	CEP63	chr3:134204575-134293852:+	-0.28	-5.97	4.65E-9	Height	
HNSC	cis	1	rs9971695	chr12:124413491	DNAH10	chr12:124247042-124420265:+	0.29	5.23	2.53E-7	Waist-to-hip ratio adjusted for body mass index	
HNSC	cis	1	rs9978611	chr21:37807318	DYRK1A	chr21:38739859-38887678:+	-0.18	-3.66	0.000282	Myopia (pathological)	
HNSC	cis	1	rs9981595	chr21:40560678	PSMG1	chr21:40547390-40555440:-	0.26	3.84	0.000141	Venous thromboembolism (SNP x SNP interaction)	
HNSC	cis	1	rs9981595	chr21:40560678	WRB	chr21:40752213-40769814:+	0.27	3.99	7.52E-5	Venous thromboembolism (SNP x SNP interaction)	
HNSC	cis	1	rs9984974	chr21:37809377	DYRK1A	chr21:38739859-38887678:+	0.21	4.24	2.7E-5	Myopia (pathological)	
HNSC	cis	1	rs9985356	chr3:134232920	ANAPC13	chr3:134196547-134204865:-	-0.43	-9.05	3.2E-18	Height	
HNSC	cis	1	rs9985356	chr3:134232920	CEP63	chr3:134204575-134293852:+	-0.23	-4.9	1.32E-6	Height	
HNSC	cis	1	rs9986131	chr5:82444856	XRCC4	chr5:82373317-82649577:+	-0.21	-4.06	5.74E-5	Hypertension	
HNSC	cis	1	rs9986382	chr6:26550619	BTN2A3	chr6:26422317-26431927:+	0.17	3.83	0.000146	Educational attainment	
HNSC	cis	1	rs9986382	chr6:26550619	BTN3A2	chr6:26365398-26378546:+	0.18	4.25	2.5E-5	Educational attainment	
HNSC	cis	1	rs9986596	chr6:28219661	ZNF389	chr6:28129551-28137375:+	-0.28	-4.33	1.85E-5	Depression	
HNSC	cis	1	rs9986596	chr6:28219661	ZSCAN23	chr6:28393287-28411279:-	0.25	3.88	0.00012	Depression	
HNSC	cis	1	rs9986696	chr7:65704576	NCRNA00174	chr7:65841032-65865395:-	0.73	15.15	7.75E-43	Aortic root size	
HNSC	cis	1	rs9988450	chr1:62924448	DOCK7	chr1:62920398-63153969:-	-0.25	-5.96	4.82E-9	Triglycerides	
HNSC	cis	1	rs9988866	chr11:18392983	GTF2H1	chr11:18343816-18388590:+	0.28	4.85	1.63E-6	Pancreatic cancer	
HNSC	cis	1	rs9989967	chr3:134238964	ANAPC13	chr3:134196547-134204865:-	0.48	10.3	1.12E-22	Height	
HNSC	cis	1	rs9989967	chr3:134238964	CEP63	chr3:134204575-134293852:+	0.27	5.85	8.75E-9	Height	
HNSC	cis	1	rs9990351	chr3:134239191	ANAPC13	chr3:134196547-134204865:-	-0.45	-9.82	6.63E-21	Height	
HNSC	cis	1	rs9990351	chr3:134239191	CEP63	chr3:134204575-134293852:+	-0.26	-5.71	1.98E-8	Height	
HNSC	cis	1	rs9992101	chr4:77360431	STBD1	chr4:77172853-77232282:+	-0.27	-5.53	5.12E-8	Creatinine levels	
HNSC	cis	1	rs9994128	chr4:108888163	HADH	chr4:108910940-108956330:+	0.29	4.16	3.78E-5	Amyotrophic lateral sclerosis (sporadic)	
HNSC	cis	1	rs9995007	chr4:76897791	NAAA	chr4:76831809-76862166:-	-0.5	-11.65	7.37E-28	Longevity	
HNSC	trans	1	rs10037055	chr5:176691279	LOC388955	chr2:63849182-63850159:-	-0.3	-6.98	9.75E-12	Migraine without aura	
HNSC	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.4	8.27	1.28E-15	Educational attainment	
HNSC	trans	1	rs10456362	chr6:28221816	BTN3A2	chr6:26365398-26378546:+	0.53	9.93	2.62E-21	Depression	
HNSC	trans	1	rs10456362	chr6:28221816	HLA-L	chr6:30227339-30234728:+	0.42	6.19	1.25E-9	Depression	
HNSC	trans	1	rs10456362	chr6:28221816	ZFP57	chr6:29640171-29648887:-	-0.41	-5.98	4.38E-9	Depression	
HNSC	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.4	8.08	5.13E-15	Educational attainment	
HNSC	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.39	7.99	9.75E-15	Educational attainment	
HNSC	trans	1	rs10742862	chr11:48649316	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.78	4.19E-14	HDL cholesterol	
HNSC	trans	1	rs10769371	chr11:48531184	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.98	1.05E-14	HDL cholesterol	
HNSC	trans	1	rs10769390	chr11:48618222	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.87	2.21E-14	HDL cholesterol	
HNSC	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.4	8.23	1.66E-15	Educational attainment	
HNSC	trans	1	rs10794671	chr1:121168242	NBPF14	chr1:148003643-148346791:-	0.44	10.18	3.32E-22	Hip geometry	
HNSC	trans	1	rs10838801	chr11:48098280	FOLH1B	chr11:89392465-89431885:+	-0.43	-7.62	1.35E-13	Height	
HNSC	trans	1	rs10838912	chr11:48496477	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.16	2.9E-15	HDL cholesterol	
HNSC	trans	1	rs10838917	chr11:48503127	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.16	2.9E-15	HDL cholesterol	
HNSC	trans	1	rs10838931	chr11:48540973	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.15	3.0E-15	HDL cholesterol	
HNSC	trans	1	rs10838943	chr11:48557442	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.76	4.92E-14	HDL cholesterol	
HNSC	trans	1	rs10838944	chr11:48559571	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.74	5.58E-14	HDL cholesterol	
HNSC	trans	1	rs10838954	chr11:48579323	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.99	9.89E-15	HDL cholesterol	
HNSC	trans	1	rs10838966	chr11:48589723	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.9	1.8E-14	HDL cholesterol	
HNSC	trans	1	rs10838971	chr11:48606624	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.93	1.45E-14	HDL cholesterol	
HNSC	trans	1	rs10838975	chr11:48617615	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.93	1.45E-14	HDL cholesterol	
HNSC	trans	1	rs10839171	chr11:48923034	FOLH1B	chr11:89392465-89431885:+	0.41	7.95	1.24E-14	HDL cholesterol	
HNSC	trans	1	rs10903159	chr1:121181997	NBPF14	chr1:148003643-148346791:-	0.45	10.42	4.18E-23	Hip geometry	
HNSC	trans	1	rs10903161	chr1:121178741	NBPF14	chr1:148003643-148346791:-	0.44	10.1	6.48E-22	Hip geometry	
HNSC	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.39	8.01	8.55E-15	Educational attainment	
HNSC	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.39	8.01	8.55E-15	Educational attainment	
HNSC	trans	1	rs11039745	chr11:48463811	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.92	1.61E-14	HDL cholesterol	
HNSC	trans	1	rs11039777	chr11:48517049	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.13	3.57E-15	HDL cholesterol	
HNSC	trans	1	rs11039779	chr11:48517895	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.13	3.57E-15	HDL cholesterol	
HNSC	trans	1	rs11039800	chr11:48542579	FOLH1B	chr11:89392465-89431885:+	0.38	7.56	2.0E-13	HDL cholesterol	
HNSC	trans	1	rs11039817	chr11:48561480	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.76	5.04E-14	HDL cholesterol	
HNSC	trans	1	rs11039819	chr11:48562181	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.96	1.15E-14	HDL cholesterol	
HNSC	trans	1	rs11039820	chr11:48562252	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.85	2.54E-14	HDL cholesterol	
HNSC	trans	1	rs11039821	chr11:48562875	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.77	4.49E-14	HDL cholesterol	
HNSC	trans	1	rs11039851	chr11:48600839	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.86	2.5E-14	HDL cholesterol	
HNSC	trans	1	rs11039854	chr11:48607688	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.87	2.21E-14	HDL cholesterol	
HNSC	trans	1	rs11039857	chr11:48610853	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.92	1.6E-14	HDL cholesterol	
HNSC	trans	1	rs11039859	chr11:48611988	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.93	1.45E-14	HDL cholesterol	
HNSC	trans	1	rs11039862	chr11:48618306	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.78	4.23E-14	HDL cholesterol	
HNSC	trans	1	rs11039868	chr11:48622146	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.87	2.21E-14	HDL cholesterol	
HNSC	trans	1	rs11039871	chr11:48626620	FOLH1B	chr11:89392465-89431885:+	0.38	7.35	8.47E-13	HDL cholesterol	
HNSC	trans	1	rs11039890	chr11:48653468	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.9	1.79E-14	HDL cholesterol	
HNSC	trans	1	rs11110901	chr12:102030113	LOC220594	chr17:18414577-18445234:-	-0.49	-6.1	2.12E-9	Lung function (FEV1)	
HNSC	trans	1	rs11249350	chr1:121178446	NBPF14	chr1:148003643-148346791:-	0.45	10.43	3.89E-23	Hip geometry	
HNSC	trans	1	rs11249351	chr1:121171942	NBPF14	chr1:148003643-148346791:-	0.45	10.24	1.99E-22	Hip geometry	
HNSC	trans	1	rs115224187	chr11:48757499	FOLH1B	chr11:89392465-89431885:+	0.41	7.78	4.4E-14	HDL cholesterol	
HNSC	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.39	8.01	8.55E-15	Educational attainment	
HNSC	trans	1	rs11965538	chr6:28239915	BTN3A2	chr6:26365398-26378546:+	-0.52	-9.3	4.42E-19	Depression	
HNSC	trans	1	rs11965538	chr6:28239915	HLA-L	chr6:30227339-30234728:+	-0.44	-6.25	8.85E-10	Depression	
HNSC	trans	1	rs12047116	chr1:121185770	NBPF14	chr1:148003643-148346791:-	0.43	9.93	2.71E-21	Hip geometry	
HNSC	trans	1	rs12145080	chr1:121185531	NBPF14	chr1:148003643-148346791:-	-0.42	-9.62	3.5E-20	Hip geometry	
HNSC	trans	1	rs12293522	chr11:49558425	FOLH1B	chr11:89392465-89431885:+	-0.36	-6.84	2.41E-11	Height	
HNSC	trans	1	rs12361812	chr11:48563104	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.76	5.04E-14	HDL cholesterol	
HNSC	trans	1	rs12365220	chr11:48555957	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.76	4.92E-14	HDL cholesterol	
HNSC	trans	1	rs12366208	chr11:48563128	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.8	3.73E-14	HDL cholesterol	
HNSC	trans	1	rs12419576	chr11:48581644	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.91	1.71E-14	HDL cholesterol	
HNSC	trans	1	rs12420372	chr11:48497603	FOLH1B	chr11:89392465-89431885:+	0.42	8.27	1.21E-15	HDL cholesterol	
HNSC	trans	1	rs12421159	chr11:48624841	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.87	2.21E-14	HDL cholesterol	
HNSC	trans	1	rs12421879	chr11:48689978	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.59	1.59E-13	HDL cholesterol	
HNSC	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.39	7.87	2.25E-14	Educational attainment	
HNSC	trans	1	rs12806328	chr11:48647971	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.97	1.08E-14	HDL cholesterol	
HNSC	trans	1	rs13195401	chr6:26463574	ZFP57	chr6:29640171-29648887:-	0.69	7.23	1.81E-12	Schizophrenia	
HNSC	trans	1	rs13195402	chr6:26463575	ZFP57	chr6:29640171-29648887:-	0.69	7.23	1.81E-12	Schizophrenia	
HNSC	trans	1	rs13200462	chr6:28218199	BTN3A2	chr6:26365398-26378546:+	-0.52	-9.38	2.35E-19	Depression	
HNSC	trans	1	rs13200462	chr6:28218199	HLA-L	chr6:30227339-30234728:+	-0.41	-5.96	4.85E-9	Depression	
HNSC	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.38	-7.76	4.99E-14	Educational attainment	
HNSC	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.39	7.9	1.81E-14	Educational attainment	
HNSC	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.39	7.99	9.31E-15	Educational attainment	
HNSC	trans	1	rs13220495	chr6:26441640	ZFP57	chr6:29640171-29648887:-	0.69	7.11	4.0E-12	Schizophrenia	
HNSC	trans	1	rs1419183	chr6:28242794	BTN3A2	chr6:26365398-26378546:+	-0.53	-9.4	1.97E-19	Depression	
HNSC	trans	1	rs1419183	chr6:28242794	HLA-L	chr6:30227339-30234728:+	-0.43	-6.19	1.26E-9	Depression	
HNSC	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.4	8.23	1.66E-15	Educational attainment	
HNSC	trans	1	rs1591882	chr1:121183313	NBPF14	chr1:148003643-148346791:-	0.45	10.35	7.74E-23	Hip geometry	
HNSC	trans	1	rs1605364	chr11:48684843	FOLH1B	chr11:89392465-89431885:+	-0.38	-7.42	5.06E-13	HDL cholesterol	
HNSC	trans	1	rs1679709	chr6:28228342	BTN3A2	chr6:26365398-26378546:+	0.5	8.85	1.57E-17	Depression	
HNSC	trans	1	rs1679709	chr6:28228342	HLA-L	chr6:30227339-30234728:+	0.44	6.45	2.61E-10	Depression	
HNSC	trans	1	rs1679732	chr6:28221264	BTN3A2	chr6:26365398-26378546:+	0.5	9.2	1.03E-18	Depression	
HNSC	trans	1	rs1679732	chr6:28221264	HLA-L	chr6:30227339-30234728:+	0.42	6.23	9.99E-10	Depression	
HNSC	trans	1	rs1778508	chr6:28229881	BTN3A2	chr6:26365398-26378546:+	0.51	9.41	1.83E-19	Depression	
HNSC	trans	1	rs1778511	chr6:28229411	BTN3A2	chr6:26365398-26378546:+	0.5	8.91	9.71E-18	Depression	
HNSC	trans	1	rs1778511	chr6:28229411	HLA-L	chr6:30227339-30234728:+	0.44	6.44	2.86E-10	Depression	
HNSC	trans	1	rs1809986	chr11:48987539	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.03	7.2E-15	HDL cholesterol	
HNSC	trans	1	rs1814175	chr11:49559172	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.51	2.8E-13	Height	
HNSC	trans	1	rs1832558	chr1:121177380	NBPF14	chr1:148003643-148346791:-	0.44	9.87	4.37E-21	Hip geometry	
HNSC	trans	1	rs1856572	chr1:121169579	NBPF14	chr1:148003643-148346791:-	0.44	10.18	3.32E-22	Hip geometry	
HNSC	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.39	8.07	5.27E-15	Educational attainment	
HNSC	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.4	8.23	1.66E-15	Educational attainment	
HNSC	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.4	8.23	1.66E-15	Educational attainment	
HNSC	trans	1	rs1936365	chr6:28268452	BTN3A2	chr6:26365398-26378546:+	0.51	9.43	1.65E-19	Depression	
HNSC	trans	1	rs1936365	chr6:28268452	HLA-L	chr6:30227339-30234728:+	0.44	6.59	1.15E-10	Depression	
HNSC	trans	1	rs1986111	chr1:121204788	NBPF14	chr1:148003643-148346791:-	0.44	9.96	1.99E-21	Hip geometry	
HNSC	trans	1	rs2084385	chr3:196553867	LOC646214	chr15:21932514-21940739:-	-0.37	-7.19	2.48E-12	Total ventricular volume (Alzheimer's disease interaction)	
HNSC	trans	1	rs2185281	chr1:121179991	NBPF14	chr1:148003643-148346791:-	0.44	10.19	2.97E-22	Hip geometry	
HNSC	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.39	7.99	9.75E-15	Educational attainment	
HNSC	trans	1	rs2221559	chr11:48707973	FOLH1B	chr11:89392465-89431885:+	0.4	7.83	2.98E-14	HDL cholesterol	
HNSC	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.39	7.91	1.67E-14	Educational attainment	
HNSC	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.4	8.18	2.37E-15	Educational attainment	
HNSC	trans	1	rs2319969	chr1:121207335	NBPF14	chr1:148003643-148346791:-	0.37	8.06	5.68E-15	Hip geometry	
HNSC	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.39	8.01	8.55E-15	Educational attainment	
HNSC	trans	1	rs2799077	chr6:28234597	BTN3A2	chr6:26365398-26378546:+	-0.51	-9.07	2.84E-18	Depression	
HNSC	trans	1	rs2799077	chr6:28234597	HLA-L	chr6:30227339-30234728:+	-0.44	-6.47	2.3E-10	Depression	
HNSC	trans	1	rs2799079	chr6:28235176	BTN3A2	chr6:26365398-26378546:+	-0.51	-9.57	4.96E-20	Depression	
HNSC	trans	1	rs2799079	chr6:28235176	HLA-L	chr6:30227339-30234728:+	-0.41	-6.19	1.26E-9	Depression	
HNSC	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.39	8.01	8.44E-15	Educational attainment	
HNSC	trans	1	rs34636547	chr11:48590103	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.9	1.8E-14	HDL cholesterol	
HNSC	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.39	7.99	9.63E-15	Educational attainment	
HNSC	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.39	7.99	9.63E-15	Educational attainment	
HNSC	trans	1	rs41266839	chr6:26409890	ZFP57	chr6:29640171-29648887:-	0.69	7.08	4.85E-12	Schizophrenia	
HNSC	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.39	7.95	1.32E-14	Educational attainment	
HNSC	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.39	7.99	9.31E-15	Educational attainment	
HNSC	trans	1	rs4844380	chr1:121193620	LOC728875	chr1:144300514-144341755:-;chr1	-0.31	-5.95	5.07E-9	Hip geometry	
HNSC	trans	1	rs4844380	chr1:121193620	NBPF14	chr1:148003643-148346791:-	0.43	9.68	2.04E-20	Hip geometry	
HNSC	trans	1	rs4844381	chr1:121184898	NBPF14	chr1:148003643-148346791:-	0.43	10.11	5.63E-22	Hip geometry	
HNSC	trans	1	rs4844607	chr1:121184059	NBPF14	chr1:148003643-148346791:-	-0.44	-10.19	3.05E-22	Hip geometry	
HNSC	trans	1	rs4844616	chr1:121171208	NBPF14	chr1:148003643-148346791:-	0.46	10.63	6.86E-24	Hip geometry	
HNSC	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.39	8.06	5.81E-15	Educational attainment	
HNSC	trans	1	rs4881994	chr11:48498139	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.16	2.9E-15	HDL cholesterol	
HNSC	trans	1	rs4882010	chr11:48559173	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.76	4.92E-14	HDL cholesterol	
HNSC	trans	1	rs4882015	chr11:48565573	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.82	3.25E-14	HDL cholesterol	
HNSC	trans	1	rs4882016	chr11:48570125	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.76	5.04E-14	HDL cholesterol	
HNSC	trans	1	rs4882017	chr11:48570182	FOLH1B	chr11:89392465-89431885:+	0.41	8.03	7.02E-15	HDL cholesterol	
HNSC	trans	1	rs4882019	chr11:48598748	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.94	1.41E-14	HDL cholesterol	
HNSC	trans	1	rs4882021	chr11:48615966	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.93	1.45E-14	HDL cholesterol	
HNSC	trans	1	rs4882096	chr11:48534102	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.98	1.05E-14	HDL cholesterol	
HNSC	trans	1	rs4882111	chr11:48558447	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.76	4.92E-14	HDL cholesterol	
HNSC	trans	1	rs4882117	chr11:48565468	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.82	3.25E-14	HDL cholesterol	
HNSC	trans	1	rs4882120	chr11:48573529	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.77	4.46E-14	HDL cholesterol	
HNSC	trans	1	rs4882123	chr11:48575739	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.8	3.78E-14	HDL cholesterol	
HNSC	trans	1	rs4882129	chr11:48588774	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.9	1.8E-14	HDL cholesterol	
HNSC	trans	1	rs4882130	chr11:48588954	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.9	1.8E-14	HDL cholesterol	
HNSC	trans	1	rs4882132	chr11:48593125	FOLH1B	chr11:89392465-89431885:+	-0.44	-8.37	5.96E-16	HDL cholesterol	
HNSC	trans	1	rs4882134	chr11:48598795	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.94	1.41E-14	HDL cholesterol	
HNSC	trans	1	rs4882136	chr11:48615311	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.87	2.21E-14	HDL cholesterol	
HNSC	trans	1	rs4925166	chr17:18210810	LOC162632	chr17:16614993-16707819:+	0.35	6.62	9.47E-11	Multiple sclerosis	
HNSC	trans	1	rs4929903	chr11:48913332	FOLH1B	chr11:89392465-89431885:+	-0.36	-6.98	9.81E-12	HDL cholesterol	
HNSC	trans	1	rs55834832	chr11:48562583	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.76	5.04E-14	HDL cholesterol	
HNSC	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.4	8.23	1.67E-15	Educational attainment	
HNSC	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.4	8.23	1.67E-15	Educational attainment	
HNSC	trans	1	rs6485872	chr11:48579710	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.97	1.12E-14	HDL cholesterol	
HNSC	trans	1	rs6485875	chr11:48581034	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.9	1.8E-14	HDL cholesterol	
HNSC	trans	1	rs6485882	chr11:48592435	FOLH1B	chr11:89392465-89431885:+	0.37	7.21	2.1E-12	HDL cholesterol	
HNSC	trans	1	rs6485888	chr11:48605339	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.93	1.45E-14	HDL cholesterol	
HNSC	trans	1	rs6485903	chr11:48639004	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.99	9.34E-15	HDL cholesterol	
HNSC	trans	1	rs6485907	chr11:48651695	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.88	2.06E-14	HDL cholesterol	
HNSC	trans	1	rs6485911	chr11:48654784	FOLH1B	chr11:89392465-89431885:+	-0.39	-7.72	6.67E-14	HDL cholesterol	
HNSC	trans	1	rs6600669	chr1:121213639	NBPF14	chr1:148003643-148346791:-	0.44	9.95	2.19E-21	Hip geometry	
HNSC	trans	1	rs6600671	chr1:121200490	NBPF14	chr1:148003643-148346791:-	-0.39	-8.4	4.86E-16	Hip geometry	
HNSC	trans	1	rs68141011	chr6:28217797	BTN3A2	chr6:26365398-26378546:+	-0.52	-9.38	2.35E-19	Depression	
HNSC	trans	1	rs68141011	chr6:28217797	HLA-L	chr6:30227339-30234728:+	-0.41	-5.96	4.85E-9	Depression	
HNSC	trans	1	rs6886255	chr5:176718361	LOC388955	chr2:63849182-63850159:-	0.32	7.5	3.07E-13	Migraine without aura	
HNSC	trans	1	rs6901575	chr6:28250984	BTN3A2	chr6:26365398-26378546:+	-0.51	-9.02	4.07E-18	Depression	
HNSC	trans	1	rs6901575	chr6:28250984	HLA-L	chr6:30227339-30234728:+	-0.42	-6.01	3.7E-9	Depression	
HNSC	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.39	8.01	8.31E-15	Educational attainment	
HNSC	trans	1	rs6905391	chr6:28262686	BTN3A2	chr6:26365398-26378546:+	-0.52	-9.32	3.77E-19	Depression	
HNSC	trans	1	rs6905391	chr6:28262686	HLA-L	chr6:30227339-30234728:+	-0.43	-6.23	9.84E-10	Depression	
HNSC	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.39	7.96	1.23E-14	Educational attainment	
HNSC	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.39	-7.92	1.55E-14	Educational attainment	
HNSC	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.41	8.23	1.71E-15	Educational attainment	
HNSC	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.39	7.95	1.3E-14	Educational attainment	
HNSC	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.41	8.23	1.71E-15	Educational attainment	
HNSC	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.39	8.01	8.31E-15	Educational attainment	
HNSC	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.4	8.08	4.98E-15	Educational attainment	
HNSC	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.41	8.23	1.71E-15	Educational attainment	
HNSC	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.39	7.99	9.31E-15	Educational attainment	
HNSC	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.4	8.13	3.48E-15	Educational attainment	
HNSC	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.4	8.13	3.48E-15	Educational attainment	
HNSC	trans	1	rs7107184	chr11:48577069	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.84	2.9E-14	HDL cholesterol	
HNSC	trans	1	rs7121460	chr11:48545232	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.9	1.86E-14	HDL cholesterol	
HNSC	trans	1	rs7121992	chr11:48592582	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.87	2.21E-14	HDL cholesterol	
HNSC	trans	1	rs7129386	chr11:48616694	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.93	1.45E-14	HDL cholesterol	
HNSC	trans	1	rs7129556	chr11:77300048	INTS4L1	chr7:64601603-64694599:+	-0.48	-8.43	3.83E-16	Weight loss (gastric bypass surgery)	
HNSC	trans	1	rs72843784	chr6:26498758	ZFP57	chr6:29640171-29648887:-	0.7	7.24	1.7E-12	Schizophrenia	
HNSC	trans	1	rs735765	chr6:28170297	BTN3A2	chr6:26365398-26378546:+	-0.49	-8.09	4.65E-15	Depression	
HNSC	trans	1	rs7395662	chr11:48518893	FOLH1B	chr11:89392465-89431885:+	0.41	8.02	7.62E-15	HDL cholesterol	
HNSC	trans	1	rs7478900	chr11:48544003	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.84	2.88E-14	HDL cholesterol	
HNSC	trans	1	rs7479134	chr11:48625409	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.87	2.21E-14	HDL cholesterol	
HNSC	trans	1	rs7479498	chr11:48660499	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.68	8.68E-14	HDL cholesterol	
HNSC	trans	1	rs7481308	chr11:48600067	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.87	2.21E-14	HDL cholesterol	
HNSC	trans	1	rs7481880	chr11:48609347	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.87	2.21E-14	HDL cholesterol	
HNSC	trans	1	rs7482176	chr11:48604620	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.77	4.72E-14	HDL cholesterol	
HNSC	trans	1	rs7482528	chr11:48640052	FOLH1B	chr11:89392465-89431885:+	-0.41	-8.15	2.96E-15	HDL cholesterol	
HNSC	trans	1	rs7483920	chr11:48599969	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.94	1.41E-14	HDL cholesterol	
HNSC	trans	1	rs7532615	chr1:121172840	NBPF14	chr1:148003643-148346791:-	-0.45	-10.46	2.8E-23	Hip geometry	
HNSC	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.4	8.08	4.98E-15	Educational attainment	
HNSC	trans	1	rs7740487	chr6:28216486	BTN3A2	chr6:26365398-26378546:+	-0.52	-9.38	2.35E-19	Depression	
HNSC	trans	1	rs7740487	chr6:28216486	HLA-L	chr6:30227339-30234728:+	-0.41	-5.96	4.85E-9	Depression	
HNSC	trans	1	rs7770848	chr6:44769237	XPO5	chr6:43490069-43543812:-	-0.5	-5.92	5.95E-9	Asthma (childhood onset)	
HNSC	trans	1	rs7925955	chr11:48647533	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.97	1.08E-14	HDL cholesterol	
HNSC	trans	1	rs7928083	chr11:48613148	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.93	1.45E-14	HDL cholesterol	
HNSC	trans	1	rs7931984	chr11:48580835	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.89	1.91E-14	HDL cholesterol	
HNSC	trans	1	rs7938880	chr11:48642154	FOLH1B	chr11:89392465-89431885:+	-0.41	-7.99	9.34E-15	HDL cholesterol	
HNSC	trans	1	rs7944356	chr11:48610154	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.92	1.6E-14	HDL cholesterol	
HNSC	trans	1	rs7945192	chr11:48580737	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.89	1.91E-14	HDL cholesterol	
HNSC	trans	1	rs7948486	chr11:48912140	FOLH1B	chr11:89392465-89431885:+	0.39	7.6	1.53E-13	HDL cholesterol	
HNSC	trans	1	rs7949348	chr11:48493801	FOLH1B	chr11:89392465-89431885:+	-0.42	-8.16	2.9E-15	HDL cholesterol	
HNSC	trans	1	rs7949554	chr11:48581992	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.9	1.8E-14	HDL cholesterol	
HNSC	trans	1	rs853676	chr6:28299687	BTN3A2	chr6:26365398-26378546:+	-0.53	-9.6	4.01E-20	Depression	
HNSC	trans	1	rs853676	chr6:28299687	HLA-L	chr6:30227339-30234728:+	-0.42	-6.16	1.55E-9	Depression	
HNSC	trans	1	rs853678	chr6:28297313	BTN3A2	chr6:26365398-26378546:+	-0.51	-9.42	1.72E-19	Depression	
HNSC	trans	1	rs853678	chr6:28297313	HLA-L	chr6:30227339-30234728:+	-0.42	-6.18	1.32E-9	Depression	
HNSC	trans	1	rs853679	chr6:28296863	BTN3A2	chr6:26365398-26378546:+	-0.51	-9.42	1.72E-19	Depression	
HNSC	trans	1	rs853679	chr6:28296863	HLA-L	chr6:30227339-30234728:+	-0.42	-6.18	1.32E-9	Depression	
HNSC	trans	1	rs853685	chr6:28288785	BTN3A2	chr6:26365398-26378546:+	-0.52	-9.58	4.89E-20	Depression	
HNSC	trans	1	rs853685	chr6:28288785	HLA-L	chr6:30227339-30234728:+	-0.43	-6.3	6.76E-10	Depression	
HNSC	trans	1	rs853694	chr6:28279100	BTN3A2	chr6:26365398-26378546:+	-0.52	-9.54	6.81E-20	Depression	
HNSC	trans	1	rs853694	chr6:28279100	HLA-L	chr6:30227339-30234728:+	-0.43	-6.34	5.34E-10	Depression	
HNSC	trans	1	rs877636	chr12:56480583	RPS26P11	chrX:71264259-71264809:+	-0.34	-5.94	5.26E-9	Cognitive function	
HNSC	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.38	-7.72	6.35E-14	Educational attainment	
HNSC	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.38	7.82	3.13E-14	Educational attainment	
HNSC	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.39	7.99	9.75E-15	Educational attainment	
HNSC	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.39	8.05	6.4E-15	Educational attainment	
HNSC	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.39	8.01	8.55E-15	Educational attainment	
HNSC	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.39	8.01	8.55E-15	Educational attainment	
HNSC	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.39	7.99	9.63E-15	Educational attainment	
HNSC	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.39	7.91	1.67E-14	Educational attainment	
HNSC	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.39	8.01	8.31E-15	Educational attainment	
HNSC	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.39	7.99	9.75E-15	Educational attainment	
HNSC	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.39	8.01	8.55E-15	Educational attainment	
HNSC	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.39	-8.09	4.69E-15	Educational attainment	
HNSC	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.39	7.99	9.89E-15	Educational attainment	
HNSC	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.38	7.78	4.23E-14	Educational attainment	
HNSC	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.4	8.08	5.15E-15	Educational attainment	
HNSC	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.39	-7.79	3.95E-14	Educational attainment	
HNSC	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.4	8.23	1.66E-15	Educational attainment	
HNSC	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.4	8.23	1.66E-15	Educational attainment	
HNSC	trans	1	rs9645642	chr11:48705455	FOLH1B	chr11:89392465-89431885:+	-0.4	-7.81	3.55E-14	HDL cholesterol	
HNSC	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.39	8.03	7.12E-15	Educational attainment	
HNSC	trans	1	rs9986596	chr6:28219661	BTN3A2	chr6:26365398-26378546:+	-0.52	-9.32	4.0E-19	Depression	
